
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-15901-16200*
  '(".1215+1G" ".3082+811A" ".380+1G" "1 + " "474-+30" "A-1195G" "A-1210477"
    "A-1290G" "A-E" "A-G-20" "A-Gravin" "A-Plk1" "A-binding" "A-induced"
    "A-mediated" "A-related" "A-treated" "A-type" "A1" "A172-2C" "A188T" "A1L"
    "A276D" "A2a" "A2b" "A300-263A" "A305A" "A369T" "A375M" "A375P" "A3B" "A3G"
    "A497-L498LVIAins" "A89S" "AAATG" "AAV" "ABCSG-90" "ABI7900"
    "ABL-inhibitor" "ABPrism" "ABT-737-mediated" "AC-T" "AC-TH" "AC220–002"
    "ACA-motif" "ACE-011" "ACLY-induced" "ACLY-α-ketoglutarate-ETV4"
    "ACNU-induced" "ACTCCG" "ACTVR1B" "ACUP" "ADME" "ADMIXMAP"
    "ADP-ribosylation" "AE" "AEG" "AG+GG" "AGC" "AG + GG" "AHRR" "AIC" "AICs"
    "AIF-C" "AIF-FL" "AIF-M" "AIF-N" "AIFsh" "AIFsh2" "AIFsh3" "AIFshort" "AIQ"
    "AJCC" "AKG" "AKGDH" "AKT-DN" "AKT-targeted" "ALK-DelGR" "ALK-ECD-Fc"
    "ALK-FAM150" "ALK-R" "ALK-rearrangement" "ALK-rearrangements" "AMBIT"
    "AML-ETO-expressing" "AML-ETO-induced" "AML1-ETO" "AML1-ETO-depleted"
    "AML1-ETO-expressing" "AML1-ETO-induced" "AML1-ETO-knockdown"
    "AMP-stimulated" "AMPKK" "AMPKα2" "AMPKβ1" "AMPylate" "AMP–ATP" "ANITA"
    "ANLN" "ANRIL" "ANX–4" "AP-MS" "AP24163" "AP24534" "APC+Axin" "APC2+Axin"
    "APC2660" "APC2AA" "APC2DD" "APC2R2" "APC2ΔArm" "APC2ΔB" "APC2ΔR2" "APC2∆B"
    "APC2∆R2" "APC∆B" "APMS" "APOBEC" "APOBEC3" "APOBEC3A" "APOBECs" "APPsw"
    "APSM" "AR-FL" "AR-KDM4" "AR-NTD" "AR-immunoreactive" "ARBS" "ARBSs"
    "AREIII" "ARF-GDP" "ARF-GTP" "ARF1-GTP" "ARF6-GTP" "ARHGAR26"
    "ARNO–binding" "ARNO–induced" "ARNO–knockdown" "ASC-J9" "ASCO" "ASD-like"
    "ASXL" "AT10" "AT20" "ATAD2-MKK3" "ATC-28" "ATCC" "ATM-defective"
    "ATM-dependent" "ATM-specificity" "ATMi" "ATRi2" "ATS" "ATTS" "AUG" "AUP1"
    "AXIN13-5x" "AZD-6738" "AZD-7762" "AZD1208" "AZD1840" "Abcam" "Abdulaziz"
    "Abelson" "Ac" "Ac-Arg-His-Lys" "AcGFP" "Acetyl-α-tubulin" "Achilles"
    "Acyl-Biotin" "Ad" "Ad-GFP" "Ad-GSK-3β" "Ad-cycE" "Ad-cycE-infected"
    "Ad-cycE-treated" "Ad-induced" "Ad-mediated" "Ad11" "Ad12" "Ad5-Null"
    "Ad5-PKCδ-transfected" "Ad5-null" "Ad5-null-transfected" "Ad9"
    "AdGFP-HBx-infected" "AdGFP-HCCR" "AdGFP-HCCR-infected" "AdSqLCs" "Adamo"
    "Adwt" "Affymetrix" "Africa" "African" "African-American"
    "African-Americans" "Africans" "African–American" "Ag" "Ahn" "Ai" "Ai+Di"
    "Aigner" "Akerman" "Akp" "Akt-CA" "Akt-dependent" "Akt-mediated"
    "Akt-phosphorylation-mediated" "Akt1" "Akt2" "Akti-2" "Alamo" "Alexa"
    "AlexaFluor-488" "Alford" "Alk" "Alström" "Althought" "Alves" "Alzheimer"
    "Alzheimer's" "Alzheimer’s" "America" "American" "Americans" "Amino-acid"
    "Ampliseq" "Anderson" "Andina" "AngII" "Anstee" "Antagomir-9-3p"
    "Anthriscus" "ApaLI" "Apgar" "ApoE4-induced" "Arber" "Arg0" "Arg10"
    "Arg399Gln" "Arg72ProGG" "Arizona" "Armt1" "Article" "Aryee"
    "AsPC-1-pBABE-TAZ" "Asbury" "Ashkenazi" "Asian" "Asians" "Asn258Glufs"
    "Asn258Glufs*11" "Asp479Glufs" "Aspc‐1" "Atg5-Atg12" "AuNP" "AuNPs"
    "Auranen" "Aurora" "Aurora-a" "Australia" "Austria" "Auto-Regulated"
    "AutoDock" "Avruch" "Axin" "Axin-alone" "Aβ" "A–4C" "A–S2C" "A–S4E"
    "B-L-100" "B-NHL" "B-SMAD2" "B-containing" "B-induced" "B-like"
    "B-lymphoid" "B-precursor" "B-type" "B1" "B197D6" "B1B1" "B2" "B2-allele"
    "B3" "B4" "B8" "BACA" "BAF3-JAK2-V617F" "BAG6" "BAK-dependent" "BAL-L"
    "BALB" "BALF" "BAPTA-AM" "BARD1-BL" "BARD1β" "BARD1ε" "BAX" "BBSome"
    "BBSsome" "BC554" "BCAR4" "BCR-ABL1" "BCSCs" "BC‐related" "BEL7402" "BH1-3"
    "BH3-M6" "BH3-ligand" "BH3-like" "BH3-mimetic" "BH3-only" "BHRF-1"
    "BI-847325" "BIBW" "BIBW-2992" "BICseq" "BIN-67" "BIN-67-induced"
    "BIN-67-mediated" "BJ" "BKP" "BLT1-NAD(P)H" "BLT1-NOX-ROS-EGFR-PI3K-ERK1"
    "BLT1-NOX-linked" "BMI" "BMN" "BMRB" "BN82685" "BODIPY-493" "BOX-I" "BPC"
    "BPIFA1" "BR19" "BRAC2" "BRCA1-A" "BRCA1-C" "BRCA1-N" "BRCA2-C" "BRCA2-N"
    "BRCA2-null" "BRCAness" "BRD9" "BS153" "BSE" "BT747" "BTCs" "BZLF1"
    "BaF3-JAK2-V617F" "BaF3-JAK2-V617F-R" "Bag-4" "Balb" "Balbin"
    "Bannayan–Riley–Ruvalcaba" "Baracitinib" "Barrett" "Barrett’s"
    "Barrios-Garcia" "Basal-type" "Basquiera" "Bax" "Bay117085" "Baylin"
    "Bayrer" "Bcl-2" "Bcl-2L11" "Bcl-Abl" "BeadChip" "Beesley" "Begg" "Begg's"
    "Begg’s" "Behav" "Beige" "Bejar" "Bela" "Benin" "Beninese" "Benjamini"
    "Benjamini-Hochberg" "Berek" "Bergamaschi" "Bergisch" "Berkeley-SS" "Bern"
    "Bernasconi" "BestKeeper" "Bethyl" "Between-group-comparisons" "Beyotime"
    "Biacore" "Bichat" "Bienz" "BigDye" "Billups" "Billups-Rothenberg"
    "Bim-double-deficient" "BimABC" "BimABCD" "BimAC" "BimACD" "BimAD"
    "BimC29201T" "Bimα1" "Bimα2" "Bimα3" "Bimγ" "Bimγ1" "Bimγ2" "Bio-6-OAP"
    "Bio-6-OAP-Skp1" "BioGRID" "Biochem" "Biolabs" "Biolegend" "Biomax"
    "Biosystems" "Biotec" "Biotech" "Biotin" "Bioworld" "Birt-Hogg-Dubé"
    "Birt–Hogg–Dubé" "Bissell" "Blc-2" "Blood-borne" "Bni-1" "Bologna"
    "Bonaduz" "Bonardi" "Bond-Max" "Bonferroni" "Bonni" "Bose" "Bousquet"
    "Boyden" "Boyer" "BphA4" "Braak" "Brady" "Brazil" "BrdUrd" "Breakpoint"
    "Brien" "Brij96" "Britain" "British" "Brittain" "Broad-Novartis"
    "Broad-spectrum" "Browser" "Bruton" "Bruton's" "Bub-KD"
    "Bub1-589A-expressing" "Bub1-KD-expressing" "Bub1-T589A-expressing"
    "Bub1-WT-expressing" "Bueren" "Burkitt" "Burkitt's" "BxN" "Bxpc" "Bxpc‐3"
    "Bxpc‐3‐DKK3" "Bxpc‐3‐NC" "BΔSAMPs" "C+202T" "C-899G" "C-Cullin2-CIS"
    "C-E-F" "C-allele" "C-glucose" "C-labelled" "C-labelling" "C-rich"
    "C-serine" "C-terminally" "C-to-T" "C-to-U" "C-type" "C-β2" "C124R" "C124S"
    "C147R" "C18" "C20" "C2α" "C3" "C3H" "C57BK" "CA16" "CA19" "CA199"
    "CABOSUN" "CACGTG" "CAFTD" "CAFTD01" "CAFTD03" "CAIRO-2" "CALGB" "CAMKKβ"
    "CAP" "CAP18" "CASMC" "CASMCs" "CASP3DN" "CB-839" "CB17-Prkdc" "CBF-AML"
    "CBF-AMLs" "CBF-fusion" "CBFB-MYH11-expressing" "CBFB-MYH11-induced"
    "CBL-depleted" "CBL-mutant" "CBLB" "CBLC-7" "CC+CG" "CC10-rtTA"
    "CCAAT-enhancer-binding" "CCT031374" "CC " "CD" "CD-C451A" "CD-C464A"
    "CD102" "CD135" "CD151-LB" "CD151-α3" "CD151-α3β1" "CD25 + "
    "CD74‐positive" "CD90" "CDC25s" "CDC48" "CDE" "CDK2-mediated" "CDLDN19"
    "CEER" "CENPA-S7" "CEP10" "CEP10⩾3" "CEP17" "CEP7" "CEP8" "CEU" "CFPAC"
    "CFPAC‐1" "CGC" "CGG" "CGK" "CGK733-inducecd" "CGP3" "CGP53353" "CGTC"
    "CGTG" "CH25OH" "CHDs" "CHG5" "CHOP-like" "CHR-regulated" "CHRs" "CID"
    "CIMP" "CIN612" "CIP2A–PP2A–c-Myc–dependent" "CK1epsilon" "CK1ɛ"
    "CK1ɛ-DVL2-mediated" "CK1ɛ-dependent" "CK1δ" "CKB" "CKB-C283S" "CL" "CLASH"
    "CLB-GAR" "CLIA" "CLTPM1L" "CM-118" "CM030499" "CMGC" "CMI" "CMTMRos"
    "CN03" "CN03treatment" "CN04" "CNK3" "CNVer" "CNVseq" "CONSORT" "COP"
    "COPII" "COX-2–765" "COX-2–homozygous" "COX-2–null" "CPBEs" "CPEB3" "CPEB4"
    "CPEBs" "CRFS" "CRICKET" "CRISPR-Cas9" "CSA" "CSAP" "CSAP-Cherry"
    "CSC-like" "CT+CC" "CT+TT" "CT04" "CTD" "CTTGAA" "CV" "CVs"
    "CXCL12-mediated" "CXR" "CYP1B" "CYT-387" "CYT387" "CaMKKβ" "Café-au-lait"
    "Cal" "Cal-120" "Cal520" "CalcuSyn" "Calphostin" "Camurati–Engelmann"
    "Cancer" "CancerSCAN" "Cardiac-specific" "Carey" "Carlsbad" "Carole"
    "Castellsague" "Caucasians" "Cav1" "Cavone" "Cbl_hi" "Cbl_lo" "CdLS-like"
    "Cdc42‐GTP" "Cdh1-dependent" "Cdk1" "Cecener" "Celastraceae" "CellROX"
    "CellSearch" "Cells" "Cellworks" "Centipeda" "Centrin-red" "Cerami"
    "Cerulean-EHD1" "ChIP" "ChIP-PCR" "ChIP-PET" "ChIP-exo" "ChIP-on-chip"
    "ChIP-qPCR" "Chan" "Chang" "Chatterjee" "CheR-like" "Chem" "Cheng"
    "Cheverud" "Chi-square" "Chiabrera" "Chigita" "Chiron99021" "Chittenden"
    "Chlamydomonas" "Choi" "Choromatin" "Chr5p15.33" "Christgen" "Christopher"
    "Chung" "Cip" "Cip1" "Circos" "Cistrome" "Citrobacter" "ClG" "Clarke"
    "Clinicaltrials" "Clontech" "CoA-Cy3" "CoA-Cy5" "CoA-biotin"
    "CoA-fluorophore" "Cocchi" "Cockayne" "Cohen" "Cohen’s" "Collard" "College"
    "Comassie" "Comp" "CompPASS" "Con" "Cornelia" "Costantino" "Cowan"
    "Cowchock" "Cowden" "Cox-IV" "Cox2" "Cr" "Cramer" "Craxton"
    "Cre-transducedPhb2" "CreateSignature" "Crohn" "Crohn's" "Crooke"
    "Crooke’s" "Cross-sectional" "Cruz" "CryAB" "Cr " "Cse4" "Ct" "Cterminus"
    "Ctr-3" "Cu" "Cullin2" "Curie" "Custódio" "Cx43-mRFP" "CytoDEATH"
    "CytoSelect" "Cytohesin-2" "Cytoscape" "Cytox" "Cα" "Cδ" "C‐kinase" "C‐to"
    "C–Cdc20–substrate" "D-CDK" "D-CDK4" "D-HPLC" "D-X-D" "D-aspartate"
    "D-aspartyl" "D-box" "D1-CDK4-containing" "D1-CDK4-p27" "D1-Rb-Cdc25A"
    "D10" "D2" "D233–K202–S276" "D25N" "D3" "D92A" "DAB2IPloss"
    "DAB2IP‐deficient" "DAB2IP‐knockdown" "DAB2IP‐reduced" "DAB2IP‐reduction"
    "DAB2IP‐retained" "DACS" "DACVR1B" "DAVID" "DBF4B" "DBH-AS1"
    "DBH-AS1-induced" "DBH-AS1-overexpressing" "DBeQ" "DCBCL" "DCC-2036"
    "DCP-Bio1" "DFG-in" "DHFU" "DHPLC" "DHS" "DHSs" "DIANA" "DIANA-mirPath"
    "DIs" "DKK3‐expressing" "DKK3‐transfected" "DLEU1" "DLEU2-miR-15b" "DMC"
    "DNA-DNA" "DNA-DSBs" "DNA-DSBs-related" "DNA-End" "DNA-damage-induced"
    "DNA-methyltransferase" "DNA-protein" "DNAJA2" "DNA–DNA" "DNA–PK-dependent"
    "DNA–protein" "DNM3os" "DNase-seq" "DNaseI" "DOC‐2" "DOI" "DOX-DNA" "DPT"
    "DPT's" "DRFI" "DSBs" "DSPs" "DUB-cofactor" "DUF89" "DUSP14" "DYRK2-EDVP"
    "DYRK2-MT" "Dabbs" "Dancey" "Daniela" "Danon" "Daphnia" "Darby"
    "Darwinian-like" "Davicioni" "Davidson" "DeCicco" "Decidua"
    "Decidual-stromal-cell-derived" "Defectsin" "Dehan" "Deleted" "Dellacono"
    "Denmark" "Deoxypodophyllotoxin" "Derdak" "DiF62" "DiFi62" "DiFiG"
    "Diaphanous‐related" "Dickkopf" "Dickkopf‐related" "Diego" "Dominican"
    "Donaldson" "Dong" "Dose-response" "Dox" "Dreh" "Drip" "Duclos" "Dulbecco"
    "Dulbecco's" "Dulbecco’s" "Dvinge" "DxD" "DyeCycle" "Dyson" "D–S1F"
    "E-CSC-like" "E-CSCs" "E-box" "E-boxes" "E-cadherin-1" "E1-2" "E1-like"
    "E156K-ARNO–expressing" "E156K-expressing" "E1^E4" "E1b" "E1b55K"
    "E2-signaling" "E204Fs" "E260Term" "E260term" "E2A" "E2B" "E2C"
    "E2F-consensus" "E2F-regulated" "E2F1-3" "E2F1-4" "E2F1-E2F3a"
    "E2F1-binding" "E2F1-dependent" "E2F1-induced" "E2F1-mediated"
    "E2F1-related" "E2F3a" "E2β" "E2–ER" "E3-Ligase" "E3-ligase" "E3-like" "E4"
    "E4BP4" "E5" "E596QS" "E6E7" "E7" "E7-induced" "E746-A750" "E748-A752"
    "E9.5" "EAATs" "EB47" "EBNA" "EBPb" "EBPα-complex" "EC109-RASSF8"
    "EC109-RASSF8-RNAi" "ECAR" "ECFP2" "ECFP4" "ECH‐associated" "ED" "EFGR"
    "EFM" "EFM-19" "EGF-TM7" "EGF-like" "EGFP-Fbxw7a" "EGFP-NleB1" "EGFP-SseK1"
    "EGFP-SseK2" "EGFP-SseK3AAA" "EGFR-AS1" "EGFR-PI3-kinase-ERK1"
    "EGFR-PI3K-ERK1" "EGFR-competent" "EGFR-evoked" "EGRF" "EHD" "EHEC" "EKR"
    "ELF-EMF" "ELF-EMF-dependent" "ELF-EMF-exposed" "ELF-EMF-exposure"
    "ELF-EMF-induced" "ELISPOT" "ELOV7" "ELR" "EMBOSS" "EMCCs" "EML-4ALK"
    "EML4-ALK-positive" "EMT-CTCs" "EMT-like" "EMT-suppressive" "EMTsignalling"
    "ENSEMBL" "ENSG00000183763" "ENSMUSP00000005504" "ENSMUSP00000130379" "ENZ"
    "ENaC" "EPEC" "EPSM" "ER-Golgi" "ER-positive" "ER-positivity"
    "ER-stress-induced" "ER-α36" "ER-α66" "ERD7" "ERK-dependent" "ERK-mediated"
    "ERS" "ERp29\\MGMT" "ERα-and" "ERα-replete" "ERα-splice" "ER‐positive"
    "ESCRT" "ESFT" "EVTs" "EVs" "EW-2" "EYFP-IFT-B" "EZH" "Early-stage"
    "East-Asian" "Ebenbichler" "Eca109pCMV" "Edmondson" "Effects" "Egger"
    "Egger's" "Egger’s" "Egr" "Eighty-nine" "Elbel" "Ellis" "Ellison" "Elmo"
    "Elsammak" "Elston" "Emodin-3-methyl" "Endosomal-like" "Engelmann"
    "English" "Entrogen" "Epithelial-to-mesenchymal" "Epithelial–mesenchymal"
    "Eps" "Eps-15" "ErbB2-positive" "ErbB2–ErbB3" "ErbB2–ErbB3-mediated"
    "ErbB3" "Erdélyi" "Ertuk" "Estrogen-and" "Eto" "Euclidean" "EudraCT"
    "Europe" "European" "Europeans" "Evans" "Exherin" "Exosomes" "Eμ" "Eμ-Myc"
    "Eμ-vAbl" "E‐cadherin" "F+I" "F-purification" "F-purified" "F-tagged" "F4"
    "F6P" "FA-Lys" "FA-like" "FACD2" "FAD2" "FAF2" "FAK-Y" "FAM150A-HA"
    "FAM150A " "FAM150B-HA" "FAM150ba" "FAM150bb" "FANC-D1" "FANC-proficient"
    "FANCC-proficient" "FANCD2-I" "FANCD2-L" "FANCD2-S" "FANCD2-siRNA-depleted"
    "FANCcore" "FCFP2" "FCFP4" "FCFP6" "FERM" "FERM-domain" "FFBF" "FFS"
    "FG-Sh-TAZ-1" "FGF-2and" "FIGO" "FIMO" "FISH" "FISH-negative"
    "FISH-positive" "FITC–LC3" "FKB12-rapamycin-binding" "FLAG-HAUBXD"
    "FLAG-epitope-tagged" "FLAG-tag" "FLCN-1" "FLCN-dificient" "FLIPR"
    "FLT3-ITD" "FLT3-ITD-mediated" "FLT3L" "FMS-like" "FNAs" "FOLFIRI"
    "FOLFOXIRI" "FOPflash" "FOXA1-dependency" "FOXO1A3" "FOXO3-GFP-transfected"
    "FOXa" "FPCMs" "FPE" "FRB" "FSL-1" "FXS-2" "FXS-3" "FXS-4" "FXYD" "Fackler"
    "Fancd" "Fancd2" "Fancd2-single" "Farez" "FasR" "Fayyad-Kazan" "Fbxo1717"
    "Fbxw7α-SOX10" "Fbxw7αin" "Fbxw7β" "Fbxw7γ" "Fc" "Fc=1.08±0.02"
    "Fc=1.08±0.04" "Fcγ" "FcγR" "FcγRI" "FcγRII" "FcγRIIA131H" "FcγRIII"
    "FcγRIIIA" "FcγRIIIA158F" "FcγRIIIA158V" "FcγRIIIA " "FcγRs" "FcεRI"
    "FdUMP" "Fe" "Fe(II)-dependent" "Feng" "Ferlay" "Fernandez" "Ferraldeschi"
    "Fersht" "Fhearraigh" "Fichorova" "Fifty-seven" "Fifty-three" "Fifty-two"
    "Finnigan" "Fiona" "Fischer" "Fission-deficient" "Flag-PTEN-N-transfected"
    "Flcn-null" "Flow-FISH" "Flow-cytometry" "Flow-cytometry-based" "Fluc"
    "Fluo" "Fluo-8" "Fogh" "FokI" "Fontaine" "Fopflash" "Fora" "Forest-plot"
    "Formin‐like" "Forty-eight" "Forty-five" "Forty-nine" "Forty-one"
    "Forty-seven" "Forty-six" "Forty-three" "Fpm" "Fraumeni" "Freed-Pastor"
    "French" "Friedrich" "Friedriech" "Fu" "Fuhrman" "Fukuyoshi" "Fulda" "Fus"
    "F‐actin" "G-765C" "G-899C" "G-LISA" "G-X-D-X-D" "G-actin" "G-allele"
    "G-protein-coupled-receptor" "G-rich" "G0" "G0-G1" "G1" "G1-G0" "G1-S"
    "G12V" "G2" "G2-M" "G302–G303–G304–G305" "G6P" "G776insYVMA" "GA" "GA+AA"
    "GA+GG" "GA201" "GADD45-α" "GADD45α" "GALNTs" "GAPLINC" "GAR" "GAS2L3"
    "GATHER" "GBC" "GBR2" "GC-boxes" "GCB" "GCCCTA" "GCK733" "GCa" "GDP→GTP"
    "GEC" "GECs" "GEDI" "GEF-activity" "GEF-inactive" "GFP-Atg8p"
    "GFP-FLAG-USP4-FL" "GFP-HFF" "GFP-SseK1" "GFP-SseK2" "GFP-SseK3AAA"
    "GFP-SseL3AAA" "GFP-fusion" "GFP-immunoprecipitates"
    "GFP-immunoprecipitation" "GFP-immunoprecipitations"
    "GFP-luciferase-labeled" "GFP-nanotrap" "GFP-only" "GFP‐PH" "GG" "GG+GA"
    "GGAACGtccAGTGCC" "GGGCGG" "GGTACAnnnTGTTCT" "GGTTTGAT" "GH-treatment"
    "GHET1" "GI50s" "GIFE" "GIG’s" "GK733-induced" "GKAs" "GLIS" "GMB" "GMR"
    "GMR-Gal4" "GNF" "GNF2" "GNF4877" "GNF5" "GNF6324" "GNF7156" "GOV"
    "GPyPyPy" "GRCh37" "GRO-seq" "GSE15459" "GSE22219" "GSE26511" "GSE50710"
    "GSE51105" "GSE6532" "GSE6532-plus2" "GSE6919" "GSE71471" "GSK-3β-Ser-9"
    "GSK3-3β" "GSK3β-Ser-9" "GSK‐3" "GSK‐3–β" "GST-AIF-C" "GST-AIF-M"
    "GST-fusion" "GST-only" "GST-pulldowns" "GST-ΔN" "GTEx" "GWAS030"
    "GX15-070" "Gain-of-function" "Gallagher" "Galunisertib" "Gambino" "Garcia"
    "Garouniatis" "Gasther-1" "GeMDBJ" "Gefintib" "Geile" "Gel-Pro"
    "Gemtuzumab-Ozogamicin" "GenBank" "Gene-dose" "GeneChip" "GenePharma"
    "Geneva" "GenoMEL" "Genome-wide" "Genotype-Tissue" "Germ-line" "German"
    "Germany" "Gervais" "Giannini" "Giemsa" "Gilley" "Gimesa" "Giordano"
    "Gladbach" "GlcNAc" "Gleason" "Gleeson" "Gln66-Lys77" "Globocan" "GlutaMAX"
    "Goellner" "Goetz" "GogB" "Gogada" "Goh" "Golub" "Gonzalez" "Google" "Gori"
    "Gosh" "Gothenburg" "Goulart" "GraphPad" "Grasso" "Gravin" "Gravin-Aurora"
    "Gravin-associated-PKA" "Grebe-type" "Grompe" "Grüber" "Gu" "Guan"
    "Guanine–cytosine-rich" "Guedan" "Guerra" "Guerrero" "Gutekunst" "Gy"
    "Gy-irradiated" "Gyceraldehyde" "Gynostemma" "Gypenosides" "Gómez"
    "Gómez-Lechón" "Gö6986" "G–6M" "G–S1R" "H&E" "H-bond" "H-bonds" "H-score"
    "H-scores" "H1" "H1-H1" "H1.4K26" "H2-S3" "H2A-pT120-Sgo1" "H2AK15" "H3"
    "H3-H4" "H3B" "H3K18" "H3K18ac" "H3K27" "H3K36" "H3K56" "H3K56Ac" "H3K9"
    "H3K9Ac" "H3K9Myr" "H4" "H4K16" "H4K16ac" "H4K20" "H6" "HA-1077"
    "HA-FLAG-UBXN1" "HA-Huh7.5.1" "HA-UBXN10" "HA-mock" "HAUBXD" "HBPol" "HBe"
    "HBe-Ag" "HBx-HCCR-E-cadherin" "HCB" "HCE8693" "HCIPs" "HCT"
    "HDAC6-positve" "HDAC8–substrate" "HDCA6" "HDF" "HEC-1" "HEC-50" "HEC1-B"
    "HEL-R" "HELF" "HER-family" "HER2+-E-CSC" "HER2-equivocal" "HER2-negative"
    "HER2-normal" "HER2-positivity" "HER2e" "HESCs" "HEp-3" "HEp-hi" "HEp-lo"
    "HFKs" "HGMD" "HGSC" "HIF-α" "HIF1a-AS1" "HIF1α-AS1" "HIV-1-adsorption"
    "HLA-B8-DR3" "HLEC" "HLECs" "HN" "HOSE" "HOTTIP" "HOXA-AS2-induced"
    "HOXA-AS2-mediated" "HOXB13-dependency" "HOXC" "HPLC-ESI-MS" "HPMVECs"
    "HPV-1" "HPV-5" "HPV-8" "HPV16-E6" "HPrE" "HR-defective" "HR-repair"
    "HR=1.39" "HRCT" "HRE-1" "HRE-2" "HREm" "HRMGs" "HS888" "HSP1AL" "HSP2cTg"
    "HSP90-Src-mediated" "HSPB2NTg" "HSPB2cKO" "HSPB2cTg" "HSPB2wt" "HSQC"
    "HSV-1" "HT-hi" "HT-lo" "HT1080" "HUG" "HULC" "HXRXXS" "Haem-Oxygenase-1"
    "HaloPlex" "Hamburg" "Hamedani" "Hamilton" "Hans" "HapMap" "HapMap2"
    "Haploview" "Hardy-Weinberg" "Hardy–Weinberg" "Harrys" "Has" "Hassa"
    "Haugsten" "Hauser" "HeCOG" "HeH-C57BL" "HealthSystem" "Healthy-N"
    "Heemskerk" "Hegi" "Heilongjiang" "Hela" "Helsinki" "Hematology"
    "Hematology-University" "Hematoxylin-eosin" "Henle" "HepJ5"
    "Hepatocellualr" "Her2" "Her2-negative" "Her2-positive" "Hergovich"
    "Herrant" "Hess" "HiSeq" "High-level" "High-mobility" "HincII" "HindIII"
    "Hino" "Hinsenkamp" "Hippo" "Hippo-ERBB" "Hippo-independent" "His-FADD"
    "His-TRIM32" "His-USP4-WT" "His-USP7" "Hispanic" "HistoQuest" "Histone2AX"
    "Hmox" "Hochberg" "Hodgkin" "Hodgkin's" "Hoechst" "Hong" "Honoraria"
    "Hoorn" "Horiuchi" "HotStarTaq" "Hottiger" "HphI" "Hrt1" "Hsa-miR29a"
    "Hsa-miRNA-139-5p" "HspB10" "Hsu" "HuH-7R" "Huang" "Huh" "Human-1"
    "Human1.2M-Duo" "HumanHT" "HumanHT-12" "Hunter-Thompson-type" "Huntington"
    "Huntington's" "Hurteau" "Hurwitz" "Hutcheson" "Hwang" "Hz" "Hε" "H–J"
    "I-II" "I-III" "I-IV" "I1018F" "IALT" "IASLC" "IC50" "IC50s" "IC50s=10-15"
    "ICAN" "ICI" "ICR10" "ICR61" "IDCs" "IDs" "IEF" "IEQ" "IFT-A" "IFT-B"
    "IFTB" "IFU" "IFWY" "IGF1R-beta" "IGHV" "IHC-negative" "IHC3+" "IHCof"
    "IHC 3+" "II-III" "II-IV" "II-like" "IIA" "IIF5" "IIH" "III-IV" "IIIA"
    "IIIB" "IIIB-IV" "IIIC" "III~IV" "III–IV" "IIa" "II–IV" "IKK-γ" "IL-22RA1"
    "IL-6-STAT3-miR-24" "IL2RG-SGM3" "ILC-like" "ILD" "ILM" "IM-MS" "IMCD"
    "INA" "INCan" "INF-β" "INL" "INTRA-TUMOR" "IPG" "IPI 3-5" "IPR002719"
    "IPS-1degradation" "IPS-1diverges" "IPS-1function" "IPS-1is"
    "IPS-1mediated" "IPS-1pathway" "IPS-1signalling" "IPSS-R" "IPed" "IQ" "IQR"
    "IQR " "IRC" "IRC-083864" "ISG" "ISGs" "ISH-negative" "ISH-positive" "ISRE"
    "ISVs" "ITC" "IVA" "IVIg" "IVS" "IVS14" "IVS14 " "IWR-1significantly"
    "Ibrutinb" "Idarubicine" "Ig" "Illumina" "ImageJ" "ImageXpress"
    "Immunohistology" "In-vitro" "Inc" "Inhba" "Institut" "IntPath"
    "Inter-group" "Inter-individual" "Inter-observer" "Inter-run" "Inter-study"
    "Interferon-α" "Intra-Golgi" "Invitrogen" "Ion-Mobility" "Iran"
    "Ishiwatari" "Italians" "Ito" "Iwamoto" "I~II" "Iε" "Iκ-Bα" "I–II" "I–III"
    "J-shaped" "JAK2-V617F" "JAK2-V617F-Y931C" "JAK2-V617F-addicted"
    "JAK2-V617F-dependent" "JAK2-V617F-driven" "JAK2-V617F-induced"
    "JAK2-V617F-mediated" "JAK2-V617F-positive" "JAK2-V617F-transformed"
    "JAK2V617F" "JAK2V617F-Y931C" "JARID1" "JBC" "JEKO" "JEKO-1-R" "JEKO-1R"
    "JEKO1-R" "JGCA" "JH1" "JJC" "JKY" "JKY-2-169" "JMJD2A-D" "JPN" "JPT" "JQ1"
    "JRFL" "JRS" "JUNB" "JZs" "James" "Japanese" "Jeb" "Jeb-like" "Jeb " "Jeff"
    "Jemal" "Jewish" "Jews" "Jf" "Ji" "Jiang" "Joerger" "Jordan" "Jose" "Jr"
    "Juan" "Juglans" "Junbo" "Jurkat-shTCERG1" "K-ATPase" "K-Rasmutation"
    "K-fibre" "K-fibre-stabilising" "K-fibres" "K14CreER" "K202–S276" "K3326X"
    "K34c" "K373" "K382" "K3R" "K9" "KAT" "KAT5-dependence" "KAT5i" "KATO"
    "KBI" "KDM4A-D" "KDM5" "KEGG" "KG" "KICH" "KINOMEscan" "KIRC" "KIRP"
    "KLGR1" "KMN" "KMTs" "KN-62" "KN-92" "KRAS-non-cancer" "Kadam-Pai" "Kadono"
    "Kaiser" "Kallman" "Kameoka" "Kandioler" "Kang" "Kaplan" "Kaplan-Meier"
    "Kaplan–Meier" "Kaposi" "Kappel" "Katsogiannou" "Kaufman" "Kaul" "Kazan"
    "Kazi" "Kd" "Keap1-Cul3-dependent" "Keap1-Nrf2-ARE" "Kee"
    "Kelch-interactors" "Kelch-like" "Kelch‐like" "Kesarwani" "Keuls" "Ki-67"
    "Ki-67-positive" "Ki-67–positive" "Ki8751" "Kim" "Kip" "Kirschner"
    "Kirsten" "Kiyono" "Knock-down" "Knowles" "Knudson" "Korea" "Korean"
    "Koshland" "Koutsky" "Kraft" "Kraft-Terry" "Kraus" "Kruskal-Wallis"
    "Kruskal–Wallis" "Krüppel" "Krüppel-like" "Ku" "Ku80-defective" "Kuhn"
    "Kumar" "Kumarswamy" "Kurtulus" "Kyoto" "K‐Ras" "K‐Ras‐mediated" "L-Myc"
    "L-OHP" "L-OPA1" "L-isoapartyl" "L-isoaspartate" "L-type" "L1" "L2" "L37S"
    "L4" "L5" "L7" "L858" "L858R" "L983F" "LACE" "LACE-Bio" "LADCs" "LC3-I"
    "LC3B-I" "LC3B-II" "LCMT1" "LDHb" "LDL-particle" "LDL-size" "LEDIGD" "LEK"
    "LEOPARD" "LEPRb" "LETM1" "LEV" "LEV " "LFA" "LHSAR" "LHSAR+FOXA1+HOXB13"
    "LINE‐1" "LISA" "LKB1-depicient" "LN299" "LNB" "LNCaP-7B7"
    "LNCaP-AR-V7-pHage" "LNCaP95" "LOC100506688" "LOD" "LODs" "LOD " "LPAR"
    "LR" "LRRFS" "LRRIGD" "LRRIGDEFN" "LS-174" "LTR-luciferase" "LTX-315"
    "LUMIER" "LV-cofilin-shRNA" "LV-control-siRNA" "LV-shRNA" "LVIAins" "LXRα"
    "LXXLL" "LY-217299" "LY293111" "LaBarge" "Lac" "LacI-Bub1-KD-expressing"
    "LacO" "Lakeway" "Lal" "Lambert" "Lange" "Langley" "Large-scale" "Larrubia"
    "Lasota" "Latin" "Latin-America" "Latino" "Lauren" "Lauren’s" "Lavecchia"
    "Leary" "Leay" "Lechón" "Leeds" "Leica" "Lenzsér" "Lescot" "Lesniak"
    "Letendre" "Leu688Hisfs" "Leung" "Lewontin" "Lhermitte" "Lhermitte–Duclos"
    "Li" "Li-Fraumeni" "Li-Fraumeni-like" "LifeAct" "Lifepool" "Lipinski"
    "Lipofectamine" "Lipton" "Litvinov" "Liu" "Liu-Chittenden" "Loco-regional"
    "Log-rank" "Lombardo" "Long-Evans" "Lopez-Rios" "Lorén" "Loss-of-function"
    "Loss‐of‐function" "Low-complexity" "Low-dose" "Low-frequency" "Low-level"
    "Lowenstein" "Lrh" "LtSz" "LtSz-scid" "Ltd" "Lu" "Luc" "Luc-MET-3"
    "Luminal-A" "Luminal-B" "Luminex" "Lutz" "Lv-DBH-AS1" "Lv-cofilin1-shRNA"
    "Lv-control-shRNA" "Ly6G" "Lymph-node" "Lys0" "Lys3326Ter" "Lys8" "M+7"
    "M-CSC" "M-CSC-like" "M-CSCs" "M-states" "M-tropic" "M0-2" "M15A" "M1L"
    "M2L" "M6" "MADE1" "MALDI-TOF" "MALDI-TOF-MS" "MAP1b-LC" "MAPK-mediated"
    "MARCKSknockdown" "MARCKS‐GFP" "MARCKS‐overexpressing" "MARK" "MARQUEE"
    "MAT-Tag-Flag" "MBCs" "MCAO" "MCC-32" "MCF-10" "MCF-Re" "MCF7-Pa" "MCF7-Re"
    "MCF‐7" "MCP-TERT-labeling" "MCPIP1-centric" "MCPIP1induction"
    "MDA-MB231-pLKO1" "MDA-MB231-shBLT1" "MDA-MB231_4175" "MDA-PC-2B"
    "MDA‐MB‐231" "MDA‐MB‐231cells" "MDLC" "MDM2-C" "ME180-CTRL" "ME180-MXIV"
    "ME180-YAP" "ME180-shYAP#1" "MECA32" "MEFS" "MEM" "MEME" "MESACUP"
    "MET-like" "MET-related" "MET4" "METTEN" "METex14" "METex14del" "MEVPR"
    "MFS" "MGTM" "MHH" "MHH-ES1" "MHz" "MI192" "MI192 " "MINDACT" "MIP-1â"
    "MJ-56" "ML323" "MLH6" "MLL-AF9-expressing" "MM-15" "MM-74" "MMTV-Polyoma"
    "MMTV-PyMT" "MODS" "MOI" "MOIs" "MPN-like" "MREs" "MS" "MS-HRM" "MS-MLPA"
    "MS-PCR" "MSC4" "MSC7" "MSCV" "MSI-H" "MTBRa" "MTF16" "MTases" "MUT1"
    "MUT2" "MUT3" "MV4-11cells" "MW∼15,000" "MW∼19,000" "MW∼23,000" "Mackay"
    "Mad-homology-2" "Maddon" "Madin" "Madin-Darby" "Madin–Darby" "Magainin1"
    "Magkoufopoulou" "Mahammad" "Mahdavi" "MammaPrint" "Manish" "Manley"
    "Mannheim" "Marani" "Mark53" "Marzo" "Mascaux" "MassARRAY" "Massie"
    "Material" "Maternal" "Matouk" "Maurer" "Mayo" "McCormack" "McCormick"
    "McGraw" "Meckel" "Meckel–Grüber" "Mediator" "Medici" "Mediterranean"
    "Medzhitov" "Mehrjardi" "Meier" "Meleda" "Melguizo" "Melk" "Melnikow"
    "Menten" "Mercier" "Merkel" "Mestizo" "MetLUNG" "Meta-regression" "MetaLR"
    "MetaSVM" "MetaXpress" "Metcalfe" "Methods" "Methyl-Profiler" "Mexican"
    "Mexican-Mestizo" "Mexicans" "Mexico" "MiR-101" "MiR-22" "MiR-22-deficient"
    "MiR-484" "MiSeq" "MiaPaCa" "MiaPaCa‐2" "MiaPaca‐2" "Michael" "Michaelis"
    "Michaelis-Menten" "Microarray‐based" "Microlife" "Microscale"
    "Mild-inflammatory" "Millipore" "Miltenyi" "Minneapolis" "Mir-548" "Mir22"
    "Mir22hg" "Mira-900" "Mirochnik" "Mis12-Bub1-T589A" "Mis12-Bub1WT"
    "Mis12-tag" "MitoTracker" "Miyata" "MluI" "MoDCs" "MoHBW" "MoLBW"
    "Mochinaga" "Moderate" "Montagut" "Moog" "Moog-Lutz" "Mooney" "Moore"
    "Morelli" "Moringa" "Morrison" "Motic" "Mps" "Mtv-9" "Muchmore" "Mueller"
    "Munger" "Munich" "Muramatsu" "Mut865" "MutIL6R-2" "MutSTAT3"
    "MutationTaster" "Mutliple" "MuvB" "Mv" "Mv1Lu-pcDNA3cells" "Myc-Max-DNA"
    "Myc-RhoA-Q63L" "Myc-Skp2" "Myc-USP4-WT" "Myf" "MyoII" "MyoII-mediated"
    "MyoR" "Myr-Akt" "N-ARBS" "N-HSQC" "N-T" "N-acetyl"
    "N-acetyl-D-glucosamine" "N-acetylglucoasmine" "N-glycosidase" "N-labeled"
    "N-linked" "N-methyl-nitrosourea-treated" "N-methylate" "N-methylation"
    "N-tagged" "N0" "N1-guanine-N3-cytosine" "N143A" "N1a" "N1b" "N981I" "N=30"
    "NAAIRS" "NADPH" "NAMDR2B" "NCCIT-R" "NCCTG" "NCEP" "NCEP-ATP" "NCI"
    "NCI-60" "NCT01485861" "NCT02223923" "NCU" "NCX4040" "NCsi" "NECP"
    "NECP-ATP" "NEXT-1" "NF-E2L2" "NF-κB-MMP2" "NF-κB-mediated" "NF-κB1"
    "NF-κBα" "NGCA" "NGF-deprivation-induced" "NGS-wild-type" "NH" "NHDFs"
    "NHGRI" "NH " "NI" "NK-kB" "NKIRAS1" "NLST" "NLSs" "NMS-862" "NMS-873"
    "NMSCs" "NNsplice" "NO-synthase" "NOD-SCID" "NOD-like" "NOD–SCID" "NON"
    "NOX-ROS-EGFR-PI3K-ERK1" "NOX-derived" "NOX1-5" "NOXs" "NP396-404" "NPV"
    "NPV-BGT226" "NRCM" "NRG1-null" "NRG1–ErbB2–ErbB3" "NS-ML" "NS-like"
    "NSLCL" "NTERA" "NTERA-2R" "NU1025" "NVP" "NVP-BGT226" "NWD" "NWD-Score"
    "Na" "Naguib" "Nagy" "Naif" "Nakagawa" "Nakano" "Nalepa" "Namanja"
    "Nano-LC" "Nechama" "Neo" "Nernst" "NetPhos" "Netherlands" "Neu" "Newman"
    "Next-generation" "NextGENe" "Nfe2I2" "Niebuhr" "Niemann" "Niemann–Pick"
    "Nijmegan" "Ninety-three" "Ninety‐eight" "Nizri" "NleB" "NleB1AAA"
    "NleBAAA" "NleC" "NleE" "No-deletion" "Nogueira" "Noonan" "NormFinder"
    "Normal-AR" "North-Central" "NorthShore" "Notch-activating" "Nov"
    "Novartis" "NovoNordisk" "Nox" "Nrf" "Nrf2" "Nrf2-oxidative"
    "Nrf2‐mediated" "Nrf2‐regulated" "Nrf‐2" "NuLI-1" "NuLi-1" "NuRD" "NusG"
    "Nutlinpre" "Nutlinpre-treatment" "N " "N‐cadherin" "O-glycosylation"
    "O-linked" "O-methyl" "O-methylate" "O-methylating" "O-methylation"
    "O-purification" "O-purified" "O6-MeG" "O6-alkylguanine"
    "O6-methlyguanine-DNA-methyltransferase" "O6-methylguanine" "O6BG"
    "OA-like" "OAG" "OAG‐induced" "OAP" "OAP's" "OB-fold" "OCUM‐2M" "OGDD"
    "OGDDs" "OHF" "OHT" "ONO12380" "ONYX" "ONYX-015" "OPA1-ΔS1" "OPB-31121"
    "OPB-51602" "OPUS" "OR=0.48" "OR=0.73" "OR=0.79" "OR=0.84" "OR=0.87"
    "OR=0.88" "OR=0.93" "OR=0.94" "OR=0.96" "OR=0.97" "OR=0.99" "OR=1.00"
    "OR=1.01" "OR=1.03" "OR=1.030" "OR=1.05" "OR=1.06" "OR=1.064" "OR=1.07"
    "OR=1.08" "OR=1.10" "OR=1.13" "OR=1.15" "OR=1.18" "OR=1.25" "OR=1.31"
    "OR=1.32" "OR=1.45" "OR=1.50" "OR=1.73" "OR=2.02" "OR=3.71" "ORs"
    "OR = 0.99" "OR = 1.00" "OSEC2" "OSI" "OSI-027" "OSU" "OVX" "Ob" "Ocana"
    "Oct3" "Ogasawara" "Ogn" "Ohba" "Olfr1508" "Olfr68" "Onco" "Oncology"
    "Oncomine" "One-hundred" "One-third" "Ontario" "Origene" "Ortiz"
    "Ortiz-Zapater" "Orwell" "OspC3" "Osx" "Otitis" "Otsuka" "Ottone"
    "Overholtzer" "Ozcan" "Ozogamicin" "P+1" "P0–P2" "P1" "P1-TKIP" "P112Q"
    "P1B5" "P2" "P24L" "P2X" "P2Y" "P58A" "P6.1" "P72R" "P9" "P91L"
    "P91L–Y306F" "P9–P10" "P=0.0004" "P=0.002" "P=0.003" "P=0.007" "P=0.0086"
    "P=0.009" "P=0.01" "P=0.02" "P=0.026" "P=0.03" "P=0.036" "P=0.04" "P=0.043"
    "P=0.36" "P=0.95" "P=1.2×10" "P=1.58×10" "P=1.6×10" "P=1.73×10" "P=1×10"
    "P=3.7×10" "P=4.6×10" "PAGE" "PAM50" "PAM50-based" "PANC" "PANCHO" "PANC‐1"
    "PANERB" "PARGi" "PARPi" "PAT21" "PBX-family" "PBXIP1" "PC-hi" "PC-lo"
    "PC3-Lenti-AR" "PCA" "PCI-R" "PCM-like" "PCR-RFLP" "PCT" "PD-1L"
    "PD-20corr" "PD20" "PD20KR" "PD331" "PD980589" "PDAs" "PDGF‐induced"
    "PDI-like" "PDK" "PDK-1-activity" "PDK-1binding" "PDK-1dephosphorylation"
    "PDQuest" "PDR" "PEC" "PEST" "PF-004777736" "PFGE" "PFKm" "PFT-α" "PFT-μ"
    "PG-21" "PHA" "PHA-II" "PHTPP" "PI3KC3" "PI3KCA" "PIK3CA1-mutant"
    "PIK3CAhel" "PIK3CAkin" "PIK3CAmut" "PIK3CAwt" "PIKKs" "PIM1L" "PIM1S"
    "PIP3K" "PIWI-piRNA" "PK45-p" "PK59" "PKCα" "PKCβII" "PKCη" "PKC‐dependent"
    "PKC‐mediated" "PKR-like" "PKRB22" "PKRB51" "PLC‐δ" "PLoS" "PMA‐induced"
    "PMA‐insensitive" "PMA‐sensitive" "PMK-1" "PMN-like" "PNAS" "PNS" "POOREST"
    "POZ" "PP-1α" "PP-1β" "PP-1γ" "PP2A-mediated" "PP2A–c-Myc–dependent"
    "PP2A–mediated" "PPAR-β" "PPAR-δ" "PPAR-δ-dependent" "PPAR-δ-specific"
    "PPI" "PPx" "PR-619" "PRKKA1" "PROGNOSTIC-PREDICTIVE" "PROMO" "PR + "
    "PTEN-C" "PTEN-Long" "PTEN-N" "PTEN=0" "PTEN=1" "PTEN⩾2" "PTKD" "PTs" "PU"
    "PXBIP1" "Paget" "Paget's" "Pair-wise" "Pakistan" "Pakistani"
    "Pam2CGDPKHPKSF" "Panasiuk" "Pandey" "Papanicolaou" "Parkinson"
    "Parkinson's" "Pasare" "Paschos" "Pearse" "Pearson" "Pearson’s"
    "Penetratin-1" "Perez" "Perez-Pinera" "Periodic-Acid-Schiff" "Periyasamy"
    "Petitjean" "Petrocca" "Peutz" "Peutz–Jegher's" "Pglycoprotein" "Pharmacol"
    "Phenotyping-2" "Philadelphia" "Phosphotransferases" "Phospho‐MARCKS"
    "Physcion-6PGD" "Physcion-treated" "Pi-Pi" "Pillai" "Pin1-CPEB1" "Pinera"
    "Pintide" "Pit-Oct-Unc" "Plamitoyl" "Plk1" "Plumbaginaceae" "Pogue"
    "Pogue-Geile" "Pol1" "Polakis" "Polansky" "PolyPhen-2"
    "Polycomb-repressive" "Pombo-Suarez" "Porębska" "Post-Transcriptional"
    "Post-Translational" "Post-UVB" "Post-infection" "Post-operative"
    "Post-transcriptional" "Post-translational" "Postmenopausal-levels" "Ppant"
    "Pri-miR-15a" "Prkdc" "Pro+Arg" "Pro-inflammatory" "Pro1180fs" "Profiler"
    "Promega" "Promega's" "Pronobis" "Protein" "Proteus-like" "Pthα" "PuPuPuC"
    "Puerto" "PvuII" "PyST" "P = 0.009" "Pénzváltó" "Pérez" "Pérez-Vallés"
    "Q-MSP" "QIAGEN" "QOL" "QT" "QTc" "QW" "Qiao" "Qiu" "Qmax" "Quanto" "Q‐PCR"
    "R-5-P" "R-CHOP" "R-CHOP-treated" "R-Ras-GTP" "R0" "R1" "R156A"
    "R156A-mutant" "R2" "R3" "R4" "R5" "R7T1" "RASSF1C-dependent" "RASSF7–10"
    "RASSF8" "RASSF8-RNAi" "RASSF8-RNAi–transduced" "RAS‐GAP" "RB22FC" "RB22a"
    "RB22b" "RB40MC" "RB44MC" "RB44a" "RB44b" "RB44c" "RBF-1" "RESISTANCE"
    "RFLP" "RFP‐PH" "RFP‐tagged" "RGD" "RHEB-GDP" "RHEB-GTP" "RIG-I-like"
    "RIGER" "RII" "RIP-DTA" "RKLs" "RL-952" "RMH" "RNA-SIRT1" "RNA-like" "RNA2"
    "RNATES" "RNAeasy" "RNApol" "RNA‐induced" "RNA–RNA" "RNV" "ROCK-actin"
    "ROCK-to-MLCK" "ROCK1-co-transfected" "ROCK1-to-MLCK" "ROCK2-to-MLCK"
    "ROS-generation-inducing" "RQ-PCR" "RRL-F" "RRL-O" "RS4-11" "RTK"
    "RTK-ligand" "RTLs" "RT‐PCR" "RUNX" "RUNX1-RUNX1T1" "RUV" "RabGGTA"
    "Rac-GTP" "Rac1" "Rac1‐GTP" "Rad3" "Rad3-related" "Radioresistance"
    "Raf-MEK-ERK-mediated" "Rahman" "Rahmani" "Raimondi" "Ramirez" "Rapamycin"
    "Rapamycin-FKBP12" "Ras2p" "Raskin" "Rat‐specific" "Rb" "Rbx1"
    "Re-addition" "Re-analysis" "Re-expression" "Real-Time-PCR" "RealTime"
    "Rebelo" "Recepteur" "RegulomeDB" "Reidy" "Reinhardt" "Relatedness" "Renga"
    "Renilla" "Reshmi" "RhoA-GTP" "RhoGDI-1or" "RhoGDI-2" "RhoGDI-α" "RhoGDI-β"
    "RhoGDIs" "Rhod2" "Riahi" "Ribeiro" "Riboside" "Ricans" "Richter"
    "Rictor-KO" "Riker" "Rios" "Robertson" "Roche" "Rockville" "Rodda" "Role"
    "Rossmann" "Rossmann-fold" "Roswell" "Rothenberg" "Rouleau" "Rpl" "RpoE"
    "Ru-5-P" "Ru-5-P-dependent" "Runx1" "S-X-X-X-S" "S-adenosyl" "S-checkpoint"
    "S-methionine" "S1" "S1-treated" "S10S" "S16" "S16-STMN1" "S1981-ATM" "S1C"
    "S1D" "S1–S6" "S2215F" "S245" "S25" "S291fs" "S2A" "S2B" "S2C" "S2D" "S2G"
    "S3" "S3-6PGD" "S3-resistance" "S38" "S38-phospho-STMN1" "S3C" "S3D" "S3E"
    "S3F" "S3G" "S3H" "S3I" "S447X" "S4A" "S4A–S4D" "S4B" "S4C" "S4C-D" "S4D"
    "S4E" "S4G" "S4S8p" "S5A" "S5C" "S5D" "S5F" "S5H" "S6" "S63" "S6A" "S6C"
    "S6J" "S6RP" "S7" "S7A" "S7C" "S8" "S807" "S9" "S9-S10" "S9A" "S9–S10"
    "SABCS" "SABER" "SALL4A" "SALL4B" "SAMP" "SAMPs" "SARAH" "SB20358046" "SBI"
    "SBI-0061739" "SBI-0069272" "SBI-061739" "SBI-0640599" "SBI-0640601"
    "SC-815x" "SCCOHT-1" "SCOPUS" "SD4" "SET2-R" "SFP" "SFSR1" "SH-3"
    "SH-groups" "SH10" "SH2-pseudokinase" "SHR-C" "SHR-H" "SHR-L" "SIN3a"
    "SIRT" "SIRTs" "SISH" "SK-ES1" "SK-N-BE2" "SK-N-DZ" "SK6" "SKA2-luc" "SKH"
    "SKH-I" "SL1344" "SLC04A1" "SLURP1" "SNP" "SNP-array" "SNP-arrays"
    "SNP-associations" "SNP6.0" "SNPinfo" "SNPs" "SNPstats" "SNV" "SNVs" "SOX"
    "SOX10–2A" "SOX2-over" "SPI-II" "SPRYs" "SPS1-related" "SPSS" "SPi-1"
    "SRC-NFKB" "SRCC" "SRCCs" "SRCE378G" "SRD" "SRD-13A" "SRM-MS"
    "SRM-MS-negative" "SRM-MS-positive" "SSPC" "STAG–RAD21" "STAT3-C"
    "STAT3-specifically" "STAT5-dependent" "STATA" "STAU" "STE20-like"
    "STM2137" "STM4157" "STMN-like" "STMN1-S38-phosphorylation" "SUN-387"
    "SW-480" "SW-620" "SW156" "SW1900" "SWISS" "SWISS-MODEL" "SXL4" "SYBR" "SZ"
    "SZ-4" "SaOS‐2" "Sachs" "Saigusa" "Salehi" "Sampei" "Sanger" "Santini"
    "Saudi" "Scheffner" "Scheiber" "Schelhorn" "Schiff" "Schiffman" "Schlemm"
    "Schlemm’s" "Schreuder" "Schrevel" "Scorpion" "Sec31" "Seca" "Seckel"
    "Semi-quantitative" "Sen" "Sendai" "Sephardi" "Sequenom" "Ser-4" "Ser-473"
    "Ser-8" "Ser-9" "Ser-Glu-containing" "Ser1139ArgfsX16" "Ser19-CHK2"
    "Ser1981" "Ser235" "Ser240" "Ser33" "Ser33,37" "Ser4" "Ser63" "Ser67-Arg69"
    "Ser69" "Ser73" "Ser8-phosphorylated" "Ser807" "Ser93" "Sertoli"
    "Seràgnoli" "Seventy-seven" "Seventy-three" "Seventy-two" "Seventy‐nine"
    "Sh-DBH-AS1" "ShMOLLI" "Shai" "Shen" "Shirasaka" "Shmelkov" "Short-term"
    "Sica" "Siegel" "SifA" "Sigismund" "Siglec" "Siglec-G" "Siglecs" "Silvany"
    "Silybum" "SinceUHRF1over‐expression" "Singh" "Single-base"
    "Single-molecule" "Single-nucleotide" "Sirtuin-7" "Site-II" "Sixty-eight"
    "Sixty-nine" "Sixty-three" "Sizemore" "Skp1" "Skp1-Cul1-F-box"
    "Skp1-Cullin1-F-box" "Skp1–6-OAP" "Skp2‐mediated" "Sloan" "Smad-E2F"
    "Smad1" "Smad2" "Smad3" "Smad3-phosphoisoforms" "Smad4-mediated" "Smads"
    "Small-Cell" "Small-cell" "Small-interfering" "Snapin" "Snijders" "Society"
    "Sodium-chloride" "Solarbio" "Solid-Phase" "Sonja" "Soonthornthum" "Sp1"
    "Sp1-1" "Spain" "Spearman" "Spearman's" "Spearman’s" "Spi-1" "Spinreact"
    "Springer" "Srivastava" "SseK" "SseK1" "SseK2" "SseK3-TRIM32" "SseK3AAA"
    "SseKs" "Stanbio" "Starley" "Stat1" "StataCorp" "Stathmin-1" "Steinhardt"
    "Steven" "Stoler" "Stolp" "Strano" "Strep" "Strep-Tactin" "Stress-release"
    "Structure-based" "Strzelczyk" "Sts" "Sts-1" "Student-Newman" "Suarez"
    "Sub-regions" "Suit‐2" "Sup-T" "Super-resolution" "Swindall" "SwissDock"
    "Switzerland" "S‐phase" "T+8473C" "T-ARBS" "T-C-C-C" "T-C-T-C"
    "T-Rex-HEK293T" "T-T-T-C" "T-allele" "T-complex" "T-large" "T-lymphotropic"
    "T-regulatory" "T1" "T1+T2" "T1-relaxation" "T145A" "T1D" "T1c" "T2"
    "T2-relaxation" "T202" "T2D" "T3" "T3+T4" "T304" "T3SS" "T4" "T47D-Pa"
    "T47D-Re" "T7-Hsc70" "T7-tagged" "T790M" "T790M-EGFR" "TAB1–TAB2"
    "TAB1–TAB2-dependent" "TAB1–TAB2–NEDD4-2–mediated" "TAB1–TAB2–dependent"
    "TAB1–TAB2–p38" "TAB2–TAB1–p38" "TAB2–TAB1–p38-α" "TAB–p38" "TAE" "TAE-684"
    "TAGGAA" "TANK-MCPIP1-USP10" "TAR" "TAT-BH3" "TATA" "TATA-less" "TBK1S527A"
    "TBM" "TC+CC" "TCF-binding" "TCF-responsive" "TCF‐4" "TCR-deficient" "TEA"
    "TEADs" "TEN-domain-truncated" "TERT-hTR" "TERT-∆PAL" "TESK" "TF556PS"
    "TFIIH-repair" "TFLLRN" "TFSEARCH" "TGFβRII" "TIANGEN" "TKD"
    "TKI-resistance" "TL4" "TLR2-ERK-dependent" "TM251" "TM4SF" "TNBCs"
    "TNF-α-treatment" "TNSK2" "TOP" "TOPflash" "TORCH" "TP-0903" "TRIBE"
    "TRPC6‐mediated" "TRPC6‐overexpressing" "TS1-B" "TSC1-TSC2-regulated"
    "TSG-motif" "TSKN2" "TSNs" "TSz" "TT+TC" "TTAGGG-3" "TTAGGGs" "TTC"
    "TTCAAA" "TTCGAA" "TTCGAG" "TTCtacGAA" "TTCttgGAA" "TTT" "TTTAAA" "TTTGAA"
    "TTTGAG" "TTTGAT" "TTTGTA" "TTTTAACA" "TURP" "TYPER" "Tactin" "Taiwan"
    "Taiwanese" "Takahashi" "Takeuchi" "Taniguchi" "Tanimoto" "Tanita" "Taq"
    "Taq1B" "TaqIB" "TaqMan" "TaqMeth" "TargetScan" "Tattoli" "Tay" "Tay–Sachs"
    "Tc22" "Tcf-regulated" "Telomerase-mediated" "Tennakoon" "Terry" "Tet-Off"
    "Tetra-primer-ARMS" "Tetrahymena" "Tetsuhiko" "Tg" "Tg2576" "Th17" "Th22"
    "ThPOk" "Thermo" "Thirty-eight" "Thirty-five" "Thirty-four" "Thirty-seven"
    "Thirty-six" "Thirty-three" "Thompson" "Thr-37" "Thr-46" "Thr202"
    "Thr21-RPA32" "Thr373Glnfs" "Thr41" "Three-dimensional" "Thunb" "Thy1.1"
    "Thy1.1-DP" "Thy1.1-double" "Time-lapse" "Tissue-specificity" "Tjian"
    "Tokio" "Tokushima" "Toll-like" "Tomonaga" "Toon" "Topflash" "ToppGene"
    "Tox" "Traip" "Tramtrack" "Transwell" "Transwells" "Treeview" "Treg-like"
    "Tribolium" "Tripartate" "Tserga" "Tsr151" "Tuma" "Tumor-adjacent"
    "Twenty-five" "Twenty-four" "Twenty-four-hour" "Twenty-one"
    "Twenty-one-week" "Twenty-seven" "Twenty‐eight" "Twist-AP1" "Two-hundred"
    "Ty" "Tyr204" "TβR" "U-138MG" "U-13C" "U-shaped" "U-test" "U1" "U118"
    "U251-GFP" "U251-GSK-3β" "U2O2" "U343" "U75302" "UBAC2" "UBX" "UBX-domain"
    "UBXDs" "UBXN1-HA-FLAG" "UBXN10-IFT-B" "UBXN11" "UBXN6" "UBXN7" "UBXN8"
    "UCSC" "UDP-glucoronosyl" "UHFR1" "UHRF1depletion" "UHRF1expression"
    "UHRF1over‐expression" "UHRF1suppression" "UHRF1‐mediated" "UHRF1‐positive"
    "UICC" "UICC-TNM" "UNC-51-like" "UNC13A" "UPN" "UPN4" "UPS4"
    "UPS7-dependent" "URHC" "USA" "USP-Family" "USP-family" "USP13si" "USP3si"
    "USP7-depenedent" "UTR-G" "UTRs" "UV-irradiation" "UV-light" "UV5" "UVC"
    "Ubiquitin-specific-processing" "Ubiquitin‐like" "Uchida" "Uke1-R"
    "Umapathy" "Uni" "Uni-and" "Uniprot" "Uppsala" "V-C8" "V-E5" "V-Ki-ras2"
    "V-value" "V3" "V3-YAC" "V5–ALK" "V600" "V600E–mutant" "VAF" "VBA"
    "VCP-UBXN10" "VCP-UBXN2B" "VCPIP" "VCPUBXN10" "VDAs" "VE-821-sensitivity"
    "VE1" "VE821" "VECs" "VLDL" "VLDLs" "VOOH" "VOOH-pic" "VT65A" "VTA" "VTAs"
    "VTLISFG" "Vakiani" "Valencia" "Vallés" "Vanni" "Vaziri" "Vec" "Venlo"
    "Venn" "Ventana" "Venus" "Verdier" "Vernier" "Veste3" "Veteläinen" "ViP"
    "Vielfort" "Vikhanskaya" "Virotherapy" "Vito" "Vivaria" "Vogelstein" "Vpu"
    "Vβ5" "WBC" "WBCs" "WC" "WECARE" "WHAMM" "WKY-C" "WM1552" "WNT" "WT-ARNO"
    "WT-ARNO–expressing" "WT-ARNO–transfected" "WT-C464A" "WT-UTR" "WT129"
    "WT21" "WT865" "WT‐1" "WW3" "Wakulich" "Walboomers" "Wallis" "Walts" "Wap"
    "Warburg" "Weant" "Webster" "Wee1i" "Weel" "Weinberg" "Weise" "Weiss"
    "Welch" "Wenham" "Western-blot" "Wg" "Whitelaw" "Whitlock" "Whitlock-Witte"
    "Whitney" "Widhalm" "Wijnhoven" "Wilcoxon" "Wiley" "Wilson" "Witek" "Witte"
    "Wolff-Parkinson-White" "Wright-Giemsa" "Wu" "Wu’s" "X-ChIP" "X-induced"
    "X-irradiation" "X-ray" "X-shaped" "X-tile" "XRCC3-5" "XRCCs" "XX" "XbaI"
    "Xbal" "Xdd1" "Xiang" "Xiao" "Xinjiang" "Xp11.22" "Xq" "Xq11.2-q12"
    "Xq21.2" "Xu" "Y1007" "Y1008" "Y204" "Y2H" "Y877" "Y878" "Y931C"
    "Y931C-expressing" "YAC" "YP" "YS" "YSPTSPS" "YVMA" "Yamakuchi" "Yang"
    "Yarden" "Yee" "Yes-associated" "Yi" "Yip" "Yokoi" "Yoshino" "Yu"
    "Z-DEVD-FMK" "Z-score" "Z-scores" "ZL" "ZODIAC" "ZZ" "ZZ-domain" "Zapater"
    "Zebraﬁsh" "Zeidan" "Zender" "Zeng" "Zenzmaier" "Zerfaoui" "Zernicka"
    "Zernicka-Goetz" "Zhang" "Zhao" "Zhou" "Zn" "ZnCl" "Zoughlami" "Zurawski"
    "a-FOXO1A" "a-pFOXO1A" "aCGH" "aOR=1.08" "aOR=1.16" "aOR=1.18" "aOR=1.37"
    "aOR=1.38" "aOR=1.50" "aOR=1.73" "aPKCζ" "aPKCλ" "ab5694" "abdominal-B"
    "aberrancies" "above-referenced" "absorbance"
    "acetyl-11-keto-beta-boswellic" "acetyl-α-tubulin" "acetylcholine"
    "acetylglucoasmine" "acetylhistone" "acetyllysine" "acid-Schiff"
    "acid-extracted" "acinar-predominant" "acinus-like" "actin-cytoskeleton"
    "activatingKRAS" "activatingPIK3CA" "activatioin-loop-localizing"
    "activation-loop" "activator-like" "activators" "active-site" "activityin"
    "acute-phase" "acyl" "acyl-carnitine" "acyl-carnitines" "acylthiourea"
    "adduct" "adducts" "adenine–thymine-rich" "adeno" "adeno-squamous"
    "adenocacinomas" "adenoma–carcinoma" "adenosyl" "adenovirues"
    "adenylate-uridylate-rich" "adenylyl" "adherens" "adhesiveness"
    "ado-trastuzumab" "adult-born" "adult-onset" "advanced-stage"
    "afﬁnity-regulating" "agar" "age-associated" "age-dependency"
    "age-dependent" "agomir" "agonism" "agonist‐induced" "agyria" "air-tight"
    "alanine-rich" "alanine‐rich" "alanyl" "algorithm" "algorithms" "alkyl"
    "alkylguanine" "all-hydrocarbon" "all-time" "allele-dosage" "alleles"
    "allograft" "allografts" "alpha-B" "alteredTRPC6" "alveoli" "amino-acid"
    "amino-terminal" "amino-terminal-associated" "amino-terminal-occluded"
    "amino-terminus" "aminoacid" "aminomethylcoumarin" "aminopyrazine"
    "aminopyrazines" "amplicon" "amplicons" "analyte" "analytes" "ancer" "and9"
    "andDAB2IP" "andFMNL2" "andKEAP1gene" "andKRAS" "andMDA" "andOma1"
    "andPCSS" "andPKCη" "andPhb2" "andTables" "andTrp53" "andUHRF1restored"
    "and\\or" "andbim" "androgen-deprivation" "androgen‐dependent"
    "androgen‐independent" "andromedin" "andromedins" "aneurysm"
    "aneurysm-osteoarthritis" "angeloylplenolin" "angiogenesis-dependent"
    "angiogenesis-inducing" "angiostatic-angiogenic" "angiotensinII" "anions"
    "anophthalmia-esophageal-genital" "anoxia" "anoïkis" "antagomir"
    "antagomir-9-3p" "antegrade" "anterior–posterior" "anterograde"
    "anthracycline-regimens" "antibody-drug" "antigen" "antigen-6"
    "antigen-reactive" "antigens" "antiparallel" "antiplatelet" "antiport"
    "antitumour" "anti‐apoptotic" "apocrine" "apocyanin" "apoptosis‐related"
    "apoptpsis-associated" "app" "appropriateness" "approximately10–20%"
    "arabinocytosine" "arachidonate" "arginine-rich" "arginyl" "arisen"
    "arm-repeat" "asVE" "asVE-821" "asparatate" "asparginyl" "aspartyl"
    "assymetry" "asthma-like" "at-risk" "at4" "atg-18" "ation" "atria"
    "augmentedTRPC6" "aureus" "aurilide" "auto-ADP-ribosylation"
    "auto-activation" "autophagia" "autophagy-like" "autoradiography"
    "autostainers" "axis-mediated" "axis-specific" "axon" "aza-deocycitidine"
    "azoxymethane" "a–c" "a–d" "a–e" "b-AP15" "bar=10" "bars=10" "basal-apical"
    "basal-like" "basal-type" "basic-helix-loop-helix-leucine" "begun" "bek"
    "benzamidazole" "benzo" "benzylguanine" "beta-oxidation" "beta-sheet"
    "beta-strand" "beta=0.79" "better-known" "better-quality" "between-group"
    "betweenESR1" "betweenUHRF1and" "bevacizumab-chemotherapy" "bi"
    "bi-directional" "bi-phasic" "bicyclo" "bilayer" "biliverdin" "bio"
    "bio-informatics" "bio-marker" "bio-markers" "bio-synthesis" "biofluid"
    "biofluids" "bioisosteres" "biologically-distinct" "biomarker-test"
    "biomolecules" "biopsy-proven" "biospecimens" "biotag"
    "biotin–streptavidin" "bis-hydroxamic" "bisphosphate"
    "bithiophenyl-5-carboxylic" "bivariate" "blast-like" "blast-phase"
    "blood-based" "blood-brain" "blood–derived" "blown" "blue-purple"
    "blue–conjugated" "body-plethsmography" "bone-marrow" "bothTRPC6"
    "botryoid" "box-8" "box-containing" "box-lacking" "bp" "brainstem"
    "breackdown" "break-apart" "breakpoints" "breast-ovarian" "breedingFlcn"
    "brevis" "brighter" "broad-acting" "broad-spectrum" "broader"
    "bromopalmitate" "bronchoscopy" "build-up" "bulla" "bullae" "bursa"
    "by-product" "byMARCKSsequesteringPIP" "byUHRF1" "b–d" "c-Jun-induced"
    "c-NHEJ" "cAMP-AM" "cFBS" "cHER2" "cHER2-negative" "cMYC-MCF10A" "cPARP"
    "cPKC" "cPKCs" "cPKCα" "cTNM" "caesarean" "calipers" "callosum" "calpaina"
    "cancer-like" "cancer-relevant" "cancerous-noncancerous" "cancer‐related"
    "cancer‐specific" "candidate-gene" "cap-dependent" "capillary-like"
    "capsase-3" "capsule-like" "carbon-5" "carbonyl" "carbonyls"
    "carboxyfluorescein" "carboxyl" "carboxyl-terminal" "carboxyl-termini"
    "carboxyl-terminus" "carboxylcytosine" "carboxyl‐terminal"
    "carcinoma-metastatic" "cardia" "cardiac-restricted" "cardiac-specific"
    "cardiomyopathies" "cardiomyotrophy" "cardioprotectant" "carnitine"
    "carnitines" "carotid" "carriers" "carriership" "carryout"
    "cartilage-specific" "case-ascertainment" "case-control" "case-only"
    "casepase-3" "case–control" "caspaes" "caspase‐3" "cassette-G2"
    "castration-induced" "catheter" "caveolar-mediated" "ccRCC" "cecal" "cecum"
    "celastrol-that" "cell-context-dependent" "cell-context-specific"
    "cell-cycle-related" "cell-intrinsic" "cell-like" "cell-of-origin"
    "cell-permeable" "cell-substratum" "cell-to-cell" "cell-to-matrix"
    "cell-wide" "cells" "cellulo" "centriole" "centroid" "centroids"
    "centromere" "ceramides" "cerebellum" "cerevisiae" "certainPKCisoforms"
    "cfDNA" "ch-TOG" "ch-TOG-TACC3" "channel-forming" "charcoal-stripped"
    "checkerboard" "chemically-induced" "chemico" "chemistries" "chemo"
    "chemo-response" "chemo-sensitizer" "chemo-sensitizers" "chemo-therapy"
    "chemoattractant" "chemoendocrine" "chemoradioresistance"
    "chemoradiotherapy" "chemoreceptors" "chemoresistance" "chemoresistant"
    "chemotherapy-naïve" "chemotherapy-trastuzumab" "chemotherapy‐induced"
    "chi-square" "chloroethyl" "chloroethylguanine" "chloromethyl"
    "chloromethyltetramethylrosamine" "chlorophenyl" "chlorophylls" "chondro"
    "chondro-osteophyte" "chondrodysplasia" "choroid" "choroideremia" "chosen"
    "chr19" "chr19_37756707_37760335" "chr3_129101148_129103476"
    "chr5_1607662_1663720" "chromatid" "chromatids" "chromatograms"
    "chromophobe" "chromosome-negative" "chromsone" "ciliate" "cinerea"
    "circuitries" "cis-regulatory" "cis-to-trans" "cisplatin-naive" "cisternae"
    "cistrome-wide" "cistromes" "clear-cell" "clear-cut" "clearer" "clickbox"
    "clientele-specificity" "clinic-pathological" "clinic-pathologically"
    "clinical-pathological" "clinically-critical" "clinicians" "clinico"
    "clinico-pathologic" "clinico-pathological" "clinic–pathological"
    "clonorchis" "close-to" "close-to-immediate" "close-to-normal"
    "closed-loop" "coactivator-1α" "coagulant" "coassociate" "cobas"
    "cobblestone-like" "codominant" "codon-12" "cohesinopathy" "coiled-coil"
    "cold-induced" "coli" "collagens" "collectives" "colocalizatin"
    "colonoscopies" "colonoscopy" "colony-formation" "colony-forming" "comedo"
    "comlex" "commercially-available" "commom" "commonest" "compacta"
    "compartment-specific" "complex-association" "complex-proficient"
    "components-beads" "computer-based" "concentration-and"
    "concentration-dependently" "concentration-response" "conformers"
    "confounders" "confusing-one" "contact-induced" "continuum" "control_1"
    "coomassie" "copper-dependent" "coprecipitate" "copy-number" "core-binding"
    "core-complex" "coregulators" "corticoids" "corticosteroid"
    "corticosteroids" "cost-effective" "cost-effectiveness"
    "counter-protective" "counter-regulation" "covariance" "covariates"
    "coworkers" "cox-hazard" "co‐expressed" "co‐expression" "coﬁlin"
    "cribriform" "cross-cancer" "cross-control" "cross-interaction"
    "cross-matching" "cross-overs" "cross-reacting" "cross-resistance"
    "cross-sectional" "cross-sections" "cross-species" "cross-trait"
    "cryoelectron" "cryotherapy" "ctDNA" "cuboid" "cullin-RING" "curve-based"
    "custom-written" "cut-off" "cut-off-dependent" "cut-offs" "cut-points"
    "cyclase-associated" "cycler" "cyclin-T" "cyclotherapy" "cycloxygenase-2"
    "cyctosine" "cyst-like" "cysteine-histidine-rich" "cytohesin" "cytohesins"
    "cytology" "cytopenias" "cytosine-phosphatidyl-guanosine"
    "cytosol-to-nucleus" "c‐Myc" "c–h" "dFdC" "dG" "dL" "dU"
    "damage-containing" "damage-dependent" "damage-independent"
    "damage-induced" "damage-inducing" "damage-response" "damage-responsive"
    "damage–induced" "databank" "dataset" "datasets" "day-to-day" "days"
    "dbSNP" "ddATP" "de-acetylase" "de-differentiated" "de-fatty"
    "de-regulated" "de-regulation" "de-repression" "de-stabilize"
    "de-stabilizes" "de-ubiquitinases" "deacetylase-activating"
    "death-receptor" "decondensatinon" "dedifferentiate" "deeper" "degrader"
    "del-ex19" "del19" "deletants" "deletion-type" "denticle" "denticles"
    "deocycitidine" "deoxynucleotide" "deoxynucleotidyl" "deoxyuridine"
    "depleter" "deprivation-dependent" "deprivation‐induced" "der"
    "desaturase-1" "desmoplasia" "destabilizer" "detergent-like" "determents"
    "detoxifier" "dexamethasone-sensitive" "di-phosphorylated" "diM-α-KG"
    "diabetes-associated" "diaminobenzidine" "diaryl" "dibenzylideneacetone"
    "dichlororibofuranosylbenzimidazole" "diet-fed" "diethyl"
    "differentERphenotypes" "differentiatedVSMCs" "diffraction-limited"
    "difluoride" "difluorodeoxycytidine" "difluorophenacetyl"
    "dihexyloxacarbocyanine" "dihydroartemisinin" "dihydrocelastrol"
    "dihydrocelastrol-a" "dihydrofluorouracil" "dimethyl-succinate"
    "dimethyl-α-KG" "dimethylsulfoxide" "dimorphisms" "dinucleotides"
    "dioxygenases" "diphenyltertrazolium" "diphosphate" "diplegia" "diploid"
    "dis-equilibrium" "disaggregat" "discrepant" "disease-and" "disfunctions"
    "distant-stage" "ditag" "dithiocarbamate" "diversity-mediated" "dl1520"
    "doi" "domain-1" "dominant-negative" "dominantly-inherited"
    "donor-specific" "dosages" "dose-dependently" "dose-escalation"
    "dose-limiting" "dose-response" "dose‐dependent" "dose–effect"
    "double-blind" "double-blockades" "double-cysteine"
    "double-immunocytochemistry" "double-knockout" "double-layer"
    "double-membrane" "double-minute" "double-mutant" "double-strand"
    "double-transfectant" "down-modulation" "down-regurated" "down-slanting"
    "down-stream" "downregulators" "down‐regulated" "down‐regulating"
    "down‐regulation" "drawn" "drivesUHRF1expression" "droplet"
    "droplet-digital" "droplets" "drug-like" "drug-naïve" "drug-selection"
    "dsDNA" "dual-color" "dual-stabilization" "dual-staining" "dual-tropic"
    "duct-Henle's" "duct-specific" "duplexes" "dynamin-like" "dysgeneses"
    "dyslipidemia" "dyslipidemias" "dysplasia" "dysplasias" "d–f" "eFluor670"
    "eGFP-fusion" "eGFP–HDAC3-expressing" "eGFP–HDAC3-overexpressing" "eLife"
    "eQTL" "eRNA" "eRNAs" "earlier-stage" "early-on" "early-onset"
    "early-stage" "early-treatment" "echocardiography" "eclampsia-associated"
    "ectoderm" "ectonucleotidases" "edema" "effector-host" "effectuate"
    "eight-week" "eighty-five" "electron-lucent" "electrophile-glutathione"
    "eleven-day" "eluate" "eluates" "embolus" "embryology" "emtpy"
    "encephalomyelitis" "encephalomyopathy" "end-diastolic" "end-organ"
    "end-resection" "end-stage" "end-to-end" "endocrine-therapy-resistant"
    "endoderm" "endometrioid" "endometrium" "endoperoxide" "endothelia"
    "endotype" "endotypes" "endpoint" "endpoints" "enhancer" "enhaner"
    "enterica" "enteropathogen" "environment-dependent" "enzyme–activator"
    "enzyme–substrate" "enzymology" "eosin" "eosinophilia" "ependyma"
    "epestfind" "epididymis" "episome" "episomes" "epithelia" "epithelial-like"
    "epithelial-mesenchymal" "epithelial-specific" "epithelial-to-mesenchymal"
    "epithelial‐to" "epithelial–mesenchymal" "epithelium" "erbB" "erbB2"
    "erloitinb" "erythema" "erythrocytes" "estrogen-ER-dependent"
    "estrogen-and" "estrogen-deprived" "estrone-3-sulfate" "et" "eta"
    "ethenoguanine" "et " "euglycemia" "eukaryocytes" "ever-expanding"
    "ever-growing" "ex" "ex-smoker" "ex-smokers" "ex-vivo" "exKDM4A"
    "excavatum" "exo" "exocrine" "exome" "exomechip" "exomes" "exon-intron"
    "exon14" "exon19" "exons" "exosome" "expressedmRNAs" "expressers"
    "extra-islet" "extra-ribosomal" "extra-terminal" "extra-uterine"
    "extract-derived" "extrauterine" "ex " "e–g" "faciliate" "factor-kB"
    "fair-skinned" "falciparum" "fallen" "false-discovery" "false-positives"
    "far-fetched" "farnesyl" "fast-growing" "fast-migrating" "fatigue-induced"
    "feed-back" "feedback-mediated" "female-derived" "female-specific"
    "femtosecond" "feto" "feto-maternal" "feto–maternal" "fiber-like" "fibro"
    "fibro-proliferation" "fibro-proliferative" "fibroblastoid" "fibrofatty"
    "field-induced" "filopodia-like" "fine-tune" "fine-tuned" "fine-tuning"
    "first-degree" "first-in-class" "first-line" "five-bladed"
    "five-fluorouracil" "five-year" "flat-mounts" "flavagline" "flavaglines"
    "flavonoids" "flavonolignan" "flcn-1" "flexneri" "flowchart"
    "flow‐mediated" "fluoresce" "fluorizoline" "fluorodeoxyglucose"
    "fluorophore" "fluorophores" "flurouracil" "focus-forming" "foeto"
    "foeto–maternal" "follicle" "follicles" "follow-up" "follow-ups"
    "followed-up" "followup" "footpad" "footpads" "forMARCKS"
    "forMARCKSknockdown" "forPIP" "force-generation" "formatiom"
    "formylcytosine" "forty-eight" "four-serine" "fourth-largest" "fragmenter"
    "frame-shift" "frameshift" "frameshifts" "fresh-frozen" "front-back"
    "front-line" "front-to-back" "frozen" "fructose-6-phosphate" "fs" "fsX16"
    "full-term" "fumarate" "gDNAs" "gadolinium" "gain-of-function"
    "gain-of-functions" "gain‐of‐function" "gallbladder" "gamma-chain"
    "gamma-herpes" "gammaglobulinemia" "ganglion-10" "gaster" "gastrectomy"
    "gastrostomy" "gate-keeper" "gatekeeper" "geNorm" "gene-1" "gene-disease"
    "gene-distal" "gene-expression-based" "gene-gene" "gene-panel"
    "gene-regulatory" "gene-therapeutic" "generatetet" "generatetet-op"
    "geneset" "genesets" "genetic-association" "genetic-epidemiological"
    "genetically-defined" "genetically-distinct" "gene–environment" "gene–gene"
    "genome" "genome-wide" "genomes" "genotype" "genotype-phenotype"
    "genotypes" "genotype–phenotype" "germ-line" "germline" "gk378" "glia"
    "globulins" "glomeruli" "glomerulonephritis" "glucocorticoid-response"
    "glucose-1-phosphate" "glucose-6-P-dehydrogenase" "glutamate-glutamine"
    "glutamine-to-leucine" "glutamyl" "glycine-rich" "glycosyl" "gm" "goes"
    "gossypol" "gp87" "gpdh" "gpdh-2" "gradient-sensing" "graft-versus-host"
    "gram-negative" "gram-positive" "gram-scale" "granulocytopenia" "greater"
    "greatest" "green-fluorescent" "grommet" "growth-regulatory"
    "growth-restrictive" "growth-stimulatory" "gsy-1" "gt33"
    "guanine–cytosine-rich" "gymnestrogenin" "gynecopathology" "hAPC1"
    "hAPC1's" "hAPC1-1338aa" "hAPC1Arm" "hAPC1R2" "hAPC2" "hAxin1-RFP" "hHER2"
    "hPXR" "hRMVECs" "hRluc" "hTER" "hTERT-cells" "hTPO" "hTRmin"
    "haemolysis-associated" "hair-like" "half-fold" "half-life" "half-lives"
    "half-maximal" "half-sites" "half-sized" "halo-like" "haplotype"
    "haplotypes" "haptoglobin–haemoglobin" "harboringKRAS" "hard-to-disrupt"
    "has-miR29" "head-to-tail" "healthy-N" "heart-specific" "heat-inactivated"
    "heat-induced" "heat-inducible" "heat-shock" "heatmap" "helices" "helix"
    "helixes" "hemagglutinin-epitope-tagged" "hematoxylin-eosin"
    "hemihepatectomy" "heparin-agarose" "heparins" "hepatectomy" "hepatocyes"
    "hepatocyte-derived" "hepatoid" "hept-5-ene-2-carboxylic" "heptad"
    "heptapeptide" "heregulin-stimulated-HER2-overexpressing" "hetero"
    "hetero-complexes" "hetero-duplex" "hetero-oligomer"
    "hetero-oligomerization" "hetero-polymerization" "hetero-tetramer"
    "heterocomplexes" "heteroduplex" "heterozygote" "hexamer" "hg13" "hg19"
    "hidden" "high-RKIP-expressing" "high-affinity" "high-calcium"
    "high-confidence" "high-content" "high-coverage" "high-degree" "high-dose"
    "high-energy" "high-grade" "high-heterogeneity" "high-input"
    "high-input-power" "high-irradiance" "high-level" "high-levels"
    "high-penetrance" "high-quality" "high-resistance" "high-resolution"
    "high-risk" "high-sensitivity" "high-tension" "higher-dose" "higher-order"
    "highest-scoring" "highly-activated" "highly-annotated" "highly-sensitive"
    "high‐risk" "hilar" "hinge–hinge" "hirsutism" "histochemistry"
    "histologies" "histology" "histopathology" "histotype" "histotypes" "hoc"
    "homeobox-1" "homo-oligomerization" "homo-tetramer" "homoduplex"
    "homoduplexes" "homogenates" "homolgy" "homolog" "homolog-5" "homologs"
    "homopurine" "homopyrimidine" "homozygote" "homozygotes"
    "hormonal-positive" "host-pathogen" "host-specific" "host–bacteria"
    "host–microbe" "hot-spot" "hotspot" "hotspots" "hr" "hsa-miR-125b"
    "hsa-miR-21-5p" "hsa-miR-29a" "hsa-miR-29b" "hsa-miR-4443"
    "hsa-miR-513a-5p" "hsa-miR-628-3p" "hsa-miR-9-1" "hsa-miR-9-2"
    "hsa-miR-9-3" "hsa-miR-99a-3p" "hydrogen-bond" "hydroxybutyrate"
    "hydroxycholesterol" "hydroxyisovalerate" "hydroxymethlycytosine"
    "hydroxyprostaglandin" "hypar" "hyper" "hyper-gammaglobulinemia"
    "hyper-proliferation" "hyperinsulinemia" "hypernatremia" "hyperoxia-CCN1"
    "hyperresponsiveness" "hypo-acetylation" "hypo-expression" "hypodermis"
    "hypotonia" "hypoxia-LY294002" "hypoxia-niche" "hypoxia-protective"
    "hypoxia-survival" "i+4" "iBMK" "iCOGs" "iE" "iEA" "iEA " "iEs" "iPLEX"
    "iTRAQ" "iVSD" "iVSDs" "ii" "iii" "iii–v" "image-based" "imgatuzumab"
    "imidazole" "imidazole-4-carboxamide" "imidazotetrazine" "immediate-early"
    "immune-histochemical" "immune-histochemistry" "immune-mediated"
    "immune-related" "immuno-FISH" "immuno-histochemistry" "immuno-modulatory"
    "immunoarray" "immunoassay" "immunoassays" "immunobot" "immunochemistry"
    "immunocytochemistry" "immunodominant" "immunoelectron" "immunoglobulin"
    "immunoglobulin-like" "immunohistochemistry" "immunophenotype"
    "immunophenotypes" "immunostainings" "immunotherapy" "importin-α" "in-cell"
    "in-depth" "in-frame" "in-gel" "in-house" "in-situ" "in-vitro" "in-vivo"
    "inBim" "inK-ras" "inMCF‐7" "inNoxa" "inPDACtumours" "inPhb2" "inTab1"
    "inTables" "inTsc2" "includingFFBF" "inconsistant" "indel" "indels"
    "indole-2-carboxylic" "inducecd" "inducecyclinA" "induced-apoptosis"
    "infection-dependent" "inflammation-associated" "inflammation-impervious"
    "inflammation-stable" "inflammation-suppressor" "inflammatory-like"
    "influenceTRPC6" "influx-induced" "inhibitd" "inhibition-not" "inhitors"
    "inker" "input-power" "input-power-dependent" "inside-out" "insipidus"
    "insulin-induced" "insulin-mediated" "insulin-positive" "insulin-producing"
    "insulin-sensitive" "insulin-stimulated" "insulitis" "intact-looking"
    "intact-male" "inter-chromosomal" "inter-day" "inter-domain"
    "inter-experimental" "inter-group" "inter-individual" "inter-membrane"
    "inter-observer" "inter-patient" "inter-relationship" "inter-strand"
    "interacome" "interactome" "interactomes" "interarray" "intercrosses"
    "intermediacy" "intermediate-conformation" "intermediate-sized"
    "intermembrane" "intermitochondria" "internet" "interquartile"
    "interstrand" "intestinal-type" "intima" "intra-Golgi" "intra-S"
    "intra-S-phase" "intra-articular" "intra-islet" "intra-lobular"
    "intra-mitochondrial" "intra-ovarian" "intra-patient" "intra-peritoneal"
    "intra-residual" "intra-run" "intra-stack" "intra-tumor" "intra-tumoral"
    "intra-tumour" "intrachromosome" "intramitochondrial-calcium-dependent"
    "intrastrand" "intron-2" "invariant" "invasion-metastasis" "inversus"
    "in‐house" "ion-pair" "ionic" "ionization-time" "irradiance" "irradiances"
    "irradiatedTrp53" "irradiation-induced" "irradiation-treated" "ischaemia"
    "iso" "iso-elasticity" "isoapartyl" "isoenzyme" "isoenzymes" "isosteres"
    "isotopomer" "isotopomers" "isotype" "isotypes" "isozymes" "iv" "jejuni"
    "jejunostomy" "juxtacrine" "kappa-light-chain-enhancer" "karyotype" "kb24"
    "kb33" "kbp" "kcal" "keto" "ketoacid" "kg" "killer-cell" "kinase-2"
    "kinase-activity-dependent" "kinase1" "kinase‐3" "kinase‐associated"
    "kinome" "kit-8" "km25" "knock-down" "knock-in" "knockin" "knocking-down"
    "l-glutathione" "lactoferricin" "laevis" "lamellipodium-like" "lamina"
    "laminin-5" "laparoscopy" "laparotomy" "large-scale" "larger-scale"
    "laser-capture" "laser-damage" "laser-induced" "laser-irradiated"
    "late-onset" "late-passage" "late-stage" "latency-associated" "latters"
    "lattice-like" "lavage" "lavages" "lead-like" "learnt" "leave-one-out"
    "left-right" "left-sided" "lenti" "lenti-viral" "lesions" "let-7a"
    "let-7a-2" "let-7b" "let-7d" "let-7f" "let-7f-5p" "leukemia-1" "leukemia-2"
    "leukocoria" "levothyroxine" "lifespan" "ligand-less" "ligand-receptor"
    "light-chain" "lincRNA-p21" "lineage-specific" "lines-three"
    "lipopolysaccharide" "lipoproteins" "liriodenine" "littermate"
    "littermates" "live-cell" "lncRNA+mRNA" "lncRNA-anti-differentiation"
    "lncRNAand" "lncRNA‐DLEU1" "lncRNA‐related" "lncRNA–mRNA" "lo" "lobectomy"
    "lobules" "loc285194" "lock-and-key" "locked-nucleic" "loco-regional"
    "locus-specific" "log-additive" "log-fold" "logORs" "long-chain"
    "long-lasting" "long-lived" "long-range" "long-standing" "longer-lasting"
    "longer-lived" "longer-term" "long‐term" "loss-of-function"
    "loss-of-heterozygosity" "loss‐of‐function" "low-ER-staining"
    "low-HER-2-expressing" "low-RKIP-expressing" "low-calcium" "low-complexity"
    "low-coverage" "low-density" "low-differentiation" "low-dose" "low-energy"
    "low-frequency" "low-grade" "low-input-power" "low-intermediate"
    "low-irradiance" "low-level" "low-levels" "low-passage" "low-penetrance"
    "low-penetrant" "low-penetrate" "low-power" "low-proliferative" "low-risk"
    "low-serum" "low-set" "low-sodium" "lower-bound" "lower-differentiated"
    "lower-differentiation" "lower-temperature" "lpr" "lsdb" "lumen-containing"
    "lumens" "luminal-like" "luminal-to-basal" "luminal-type"
    "luminescence-based" "lumpectomy" "lupus-like" "lymph-node"
    "lymph-node-positive" "lymphadenopathy" "lymphoblastoid" "lymphoma-2"
    "lymphopenia" "lysine-9" "lysis" "m-201" "m-217" "m-chlorophenyl" "mADC"
    "mADCs" "mAb135" "mAb48" "mCRCs" "mGluRs" "mHER2" "mJ" "mKRAS" "mL·h"
    "mPrE" "mRNAnetwork" "mRNA‐ESR1" "mRNA–ncRNA" "mT" "mTOR-p70S6K" "mTORCs"
    "mTOR‐specific" "mTor-dependency" "macropulse" "macropulses" "made"
    "magainin1" "magnesium-ATP-binding" "magnesium-activated" "mainline"
    "major-specific" "male-to-female" "maleate" "malignance" "malignances"
    "malignancy‐specific" "mammary-specific" "mammograms" "mammography"
    "mammoplasty" "mammosphere" "marianum" "mastectomies" "mastectomy"
    "mastermix" "match-pair" "materials" "materno" "materno–fetal"
    "mating-type" "matrix-detachment" "mattings" "maximum-tolerated"
    "maytansinoid" "mdm2-C" "mean±SD" "mean ± SD" "median=9" "mediastinum"
    "medulla" "melanogaster" "melatonin" "mellitus" "membrane-cytoskeletal"
    "membrane-permeable" "membranePIP" "membrane‐associated" "membrane‐bound"
    "memory-associated" "meprin" "mercaptan" "mesenchymal-CSCs"
    "mesenchymal-epithelial" "mesenchymal-like" "mesenchymal-related"
    "mesenchymal-to-epithelial" "mesenchymal–epithelial" "meshwork"
    "mesothelium" "mesylate" "metagroups" "metal-dependent"
    "metalloproteinase-1" "metamizole" "metaphase–anaphase" "metestrus"
    "methanesulfonate" "methide" "methides" "methyl-methanesulfonate"
    "methylcytosine" "methylguanine-DNA-methyl" "methyllycaconitine"
    "methylome" "mevalonate" "miR-100" "miR-100-5p" "miR-101" "miR-106b"
    "miR-106b∼25" "miR-106b∼93∼25" "miR-106∼25" "miR-107" "miR-107-induced"
    "miR-107-mediated" "miR-107-overexpressing" "miR-122" "miR-124" "miR-125"
    "miR-125-5p" "miR-1254" "miR-125b-5p" "miR-128" "miR-1280" "miR-1287"
    "miR-129-5p" "miR-1307-3p" "miR-130a" "miR-132" "miR-133b" "miR-135"
    "miR-139-5p" "miR-139-5p-expressing" "miR-139-5p-expression" "miR-140-3p"
    "miR-141" "miR-142" "miR-142-5p" "miR-143" "miR-143-3p" "miR-144"
    "miR-144-SW1463" "miR-144-SW837" "miR-144-overexpressing"
    "miR-144-trans-fected" "miR-145" "miR-146a" "miR-148" "miR-148a" "miR-149"
    "miR-150" "miR-150-RET" "miR-150-RET-infected" "miR-150-expressing"
    "miR-153" "miR-155" "miR-155-5p" "miR-155–5p" "miR-15a" "miR-16-1" "miR-17"
    "miR-17∼92" "miR-181" "miR-181b" "miR-181c" "miR-182" "miR-1826" "miR-183"
    "miR-185-3p" "miR-185-5p" "miR-18b" "miR-19" "miR-195"
    "miR-195-5p-agomir-treated" "miR-197-3p" "miR-199a2" "miR-1NC"
    "miR-1inhbitor" "miR-1inhibitor" "miR-1mimic" "miR-20" "miR-200" "miR-200b"
    "miR-203" "miR-205" "miR-205-5p" "miR-206" "miR-20a" "miR-20a-5p"
    "miR-21-5p" "miR-210" "miR-212" "miR-212-3p" "miR-212-induced" "miR-214"
    "miR-216a" "miR-216b" "miR-217" "miR-218" "miR-22" "miR-22-deficient"
    "miR-22-dependent" "miR-22-treated" "miR-223" "miR-22–deficient"
    "miR-22–sufficient" "miR-24" "miR-25" "miR-26a" "miR-26b" "miR-27a"
    "miR-29b-3p" "miR-30" "miR-302" "miR-30c" "miR-3162-3p" "miR-32" "miR-320"
    "miR-320b" "miR-320c" "miR-331-3p" "miR-335" "miR-34" "miR-340"
    "miR-342-3p" "miR-34b" "miR-34c" "miR-361" "miR-361-3p" "miR-361-5p"
    "miR-363" "miR-3676-5p" "miR-373" "miR-375" "miR-378" "miR-378a" "miR-425"
    "miR-4306" "miR-4433" "miR-4443" "miR-4455" "miR-449a" "miR-451" "miR-454"
    "miR-4633-5p" "miR-4688" "miR-4778-5p" "miR-484" "miR-486-5p" "miR-494"
    "miR-495" "miR-497" "miR-5010-5p" "miR-503" "miR-503-5p" "miR-513a-5p"
    "miR-548c" "miR-548c-5p" "miR-551b" "miR-574-5p" "miR-575" "miR-584"
    "miR-628-3p" "miR-629-HNF4-miR-124" "miR-663b" "miR-9" "miR-9-3p"
    "miR-9-5p" "miR-9-5q" "miR-92" "miR-93" "miR-93-5p" "miR-937-5p" "miR-95"
    "miR-96" "miR-98" "miR-99a" "miR-chips" "miR-control-SW1463"
    "miR-control-SW837" "miR-control-transfected" "miR133a" "miR139-5p"
    "miR15a" "miR488" "miRNA-205" "miRNA-21" "miRNA-212" "miRNA-23a" "miRNAwas"
    "miRNA‐mediated" "miRNA–lncRNA" "miRNA–mRNAnetwork" "miRNA–mRNA–lncRNA"
    "miRNA–mRNA–lncRNAinteraction" "miRNA–mRNA–lncRNAinteractions" "miRNome"
    "miRXplore" "miRanda" "miR‐106a" "miR‐106a~363" "miR‐130a‐3p" "miR‐141"
    "miR‐148b‐3p" "miR‐17" "miR‐17‐3p" "miR‐17‐5p" "miR‐17‐92" "miR‐18a‐5p"
    "miR‐19" "miR‐19a" "miR‐19a‐3p" "miR‐19b‐3p" "miR‐200c" "miR‐20a" "miR‐20b"
    "miR‐25‐3p" "miR‐363" "miR‐92a‐1" "miR‐92‐2" "miR‐92‐3p" "miR‐93‐5p" "mice"
    "micro-CT" "micro-computed" "micro-dissected" "micro-environment"
    "micro-injuries" "micro-irradiation" "micro-metastases" "micro-organs"
    "micro-tumor" "micro-tumors" "microRNA-144" "microRNA-182" "microRNA-22"
    "microarchitecture" "microbiota" "microcirculations" "microdomain"
    "microdomains" "microenvironmental-derived" "micrographs" "microparticles"
    "micropipette" "microplate" "microsatellite" "microstructure"
    "microvasculature" "microvessels" "microﬁlaments" "mid-anteroseptal"
    "mid-brain" "mid-inferior" "mid-infero-lateral" "mid-inferolateral"
    "mid-life" "mid-myocardial" "mid-myocardium" "midbrain" "middle-T"
    "middle-ear" "midline" "midstratum" "midwall" "mild-inflammatory"
    "milliseconds" "minigene" "minimal-subunit" "minute-2" "mir" "mir-548"
    "mir30-based" "mirDB" "mirPath" "mircotubules" "mis-coordination"
    "mis-incorporate" "mis-leading" "mis-sense" "mispairs" "missense"
    "mitEGFR-GFP" "mitoAcGFP" "mitochondria-targeting-EGFR"
    "mitochondrial-binding" "mitochondrial-dependent" "mitochondrial-mediated"
    "mitochondrial-targeting" "mitochondrialO" "mitomycin" "mitotic-specific"
    "mixed-lineage" "mixed-type" "ml " "mobility-shift" "mock-infected"
    "mock-infection" "mock-irradiated" "mock-irradiation" "modals"
    "moderate-inflammatory" "moderate-risk" "moderately-differentiated"
    "mono-ciliated" "mono-protonated" "mono-site" "mono-therapy" "monoadducts"
    "monocyte-derived" "monolayer" "monomethyl" "mononucleocytes"
    "monotherapies" "monotherapy" "moonlights" "morbidities" "morphants"
    "morpholino" "morpholinos" "morphometry" "mortality-to-incidence" "mortem"
    "motif-containing" "motifs" "motile" "motile-to-motile" "motor-cargo"
    "mtEGFR" "mucoepidermoid" "mucosa" "multi-case" "multi-component"
    "multi-copy" "multi-domain" "multi-drug" "multi-hit" "multi-institutional"
    "multi-organ" "multi-pathways" "multi-protein" "multi-punch" "multi-step"
    "multi-system" "multi-targets" "multi-tissue" "multicenter" "multicentre"
    "multicilia" "multidomain" "multifold" "multigene" "multimer" "multimers"
    "multiorgan" "multiphoton" "multiple-punch" "multiple-species"
    "multiprotein" "multisite" "multistage" "multitarget" "multivariate"
    "murtivariate" "muscle-specific" "mutant–substrate" "mutations"
    "mutlivariate" "myelo" "myelo-monocytic" "mylohypoid" "myocardium"
    "myocytes" "myofiber" "myofibers" "myofibroblasts" "myomiRs" "myosin-like"
    "myotube-like" "myristate" "myristoyl" "myristoylation‐deficient" "n+1"
    "n=12" "n=3" "n=30" "n=4" "n=5" "n=9" "nCB" "nCounter" "nPKCs" "naevus"
    "nano" "nano-particle-mediated" "nanomaterial-mediated" "nanoparticulate"
    "nanosecond" "nanosurgery" "nantais" "napsin" "naturally-occurring" "naïve"
    "ncRNAprofile" "ncRNA‐mediated" "ncRNA–mRNA" "ncomms9364" "ncomms9372"
    "ncomms9388" "near-infrared" "near-significance" "near-tetraploid"
    "nearest" "needle-catheter" "neo-adjuvant" "neoT" "neoadjuvant"
    "neoantigens" "neointima" "neoplasias" "neovasculature" "neovessels"
    "nephrectomy" "nephron" "nephropathy" "nervous-system" "network-localized"
    "neurite" "neuro" "neuro-cognitive" "neuro-degenerative" "neuro-protective"
    "neuroendocrine" "neurokinin" "neuron-like" "neuronally-differentiated"
    "neuropathology" "never-smokers" "newer" "next-generation" "ngTMA"
    "nick-end" "nigra" "nil-by-mouth" "nitrosoureas" "nmv" "no-cardia"
    "no-probe" "nocturia" "node-positive" "nondominant" "nonfat" "nonhistone"
    "nonleaky" "nonmalignant" "nonrandom" "nonsense-mediated" "nonsignificant"
    "nonsmall" "nonsmokers" "nontarget" "non‐cancerous" "non‐coding"
    "non‐synonymous" "normal-1" "normal-resistance" "novelPKCisoforms" "nt"
    "nt+1351" "ntigen" "nts" "nuclear-to-cytoplasmic" "nucleate"
    "nucleation-promoting" "nucleoplasma" "nucleotide-dependent-‘specific’"
    "null-mice" "nultin3a" "numbes" "occupany" "occurance" "oestrogen"
    "oestrogens" "ofCC10-rtTA" "ofCDKN2Apromoter" "ofDAB2IP" "ofDKK3" "ofERis"
    "ofESR1" "ofFlcn" "ofKEAP1promoter" "ofKeap1" "ofMARCKSfrom" "ofMARCKSin"
    "ofMARCKS‐mediated" "ofPKCα" "ofRASSF1" "ofRNAs" "ofTRPC6"
    "ofUHRF1fromPDACcells" "ofUHRF1is" "ofUHRF1reduced" "ofbim" "off-target"
    "offs" "ofmRNA" "ofmTORin" "ofmTORthat" "ok524" "ok975" "oku" "oleic"
    "oleifera" "olfactomedin-like" "oligo" "oligodeoxynucleotide" "oligomycin"
    "oligos" "oligosaccharide-binding" "omega-3" "omics" "on-target"
    "on-the-fly" "onKRAS" "onTRPC6" "oncodriver" "oncodrivers" "oncomirs"
    "oncomouse" "oncoprotein-18" "oncotarget" "one-carbon" "one-cell"
    "one-ended" "one-letter" "one-third" "one-way" "one-year" "one‐fourth"
    "oocytes" "oophorectomy" "open-label" "operant" "optimedin" "orKRAS"
    "orTrp53" "orange-yellow" "organelle" "organelles" "origine" "ortholog"
    "orthologue" "orthologues" "osm-11" "osm-7" "osmo" "osmo-protective"
    "osteoblasts" "osteophyte" "osteophytes" "otherMET" "ought"
    "ovarian-specific" "ovariectomy" "ovarioleukodystrophy" "ovarium"
    "over-accumulate" "over-activated" "over-activation" "over-diploid"
    "over-dominant" "over-emphasized" "over-estimate" "over-excited"
    "over-proliferation" "over-replication" "over-representation"
    "over-winding" "overabundance" "overdominant" "overexpressors"
    "overly-expressed" "overnight-cultivated" "overs" "overuse" "overview"
    "over‐expressed" "over‐expression" "oxidase-IV" "oxidases"
    "oxidative-reductive" "oxidative-stress-responsive" "oxido-reductase"
    "oxoglutarate" "oxoguanine" "oxygenase-1" "oxythiamine" "p21-Luc" "p21-luc"
    "p21RAC" "p21waf" "p288-Aurora" "p38-α" "p38-β" "p38K" "p53-LOH" "p53-RE"
    "p53-adenoviral" "p53-antagonist" "p53-depedent" "p53-gene-specific"
    "p53-heterozygotic" "p53-independence" "p53-independent"
    "p53-independently" "p53-null" "p53-p21-DREAM-CDE" "p53-pathway"
    "p53-proficient" "p53-transcriptional" "p53-wildtype" "p53FL" "p53RE"
    "p53REs" "p53wt" "p53–null" "p766-Gravin-Plk1" "p85α" "p=0.018" "p=0.02"
    "p=0.03" "p=0.05" "p=0.09" "p=0.15" "p=0.22" "p=0.37" "p=0.56" "p=0.60"
    "p=0.90" "p=0.93" "p=1.06×10" "p=1×10" "p=4.3e-22" "pAKT473" "pALK"
    "pALK-Y1604" "pAMPK" "pAMPKα" "pCM184" "pCMV-N-His" "pCMV-N-His-SOX2"
    "pCMV-SOX2" "pCMV6E2F1" "pCR" "pCdc2" "pChk1" "pChk1s" "pChk2" "pDCIS"
    "pDHPLC" "pDNA-PK" "pDNA-PKcs" "pDNA3.1" "pEGFP-AR" "pEGFP-V" "pEGFR"
    "pEYFP" "pEYFP-Tat101" "pFOXO1" "pFOXO1A" "pGADT7" "pGBKT7"
    "pGL3-B-miR-101-L" "pGL3-B-miR-101-M" "pGL3-B-miR-101-MBS"
    "pGL3-B-miR-101-S" "pGL3-B-miR-101-W" "pGL3-B-miR-101-WBS" "pGL3-Basic"
    "pGL3-Basic-transfected" "pGL3-E-cadherinP" "pGL3-HCCR" "pGL3-HCCRP"
    "pGL3-basic" "pGSK-3" "pH" "pH3T3" "pHBV1.2" "pHER-2" "pHER-3" "pJAK2"
    "pLXSN" "pLuc" "pLuc-979" "pM" "pMET" "pMdm2" "pN" "pN808S" "pNBS1"
    "pRL-null" "pRNA" "pRNA-U6.1" "pS143" "pS143-DVL2" "pS184" "pS204-pS208"
    "pS210-CPEB1" "pS38-STMN1" "pS423" "pS679" "pS935" "pSLIK" "pSMAD2"
    "pSTAT3" "pSUPER" "pSUPERp53" "pSV2Neo" "pSer-Pro" "pSerPro" "pSilencer"
    "pSilencer2.1-HCCR" "pSmad3L" "pStage" "pT" "pT1-4" "pT4" "pT589" "pTEFb"
    "pTNM" "pThreonine" "pYFP" "pYFP-C1" "pachygyria" "pack-years" "pair-wise"
    "paired-end" "paired-normal" "pairings" "pairwise" "pale-looking"
    "palmitoyl" "palmitoyl-CoA" "pan-inhibitor" "pan-nuclear" "panHER"
    "pancreatitis" "pancytopenia" "paracrine" "paraendocrine"
    "parallel-symmetric" "paralog" "paralogues" "parenchyma" "parthanatos"
    "partial-rescue" "partially-positive" "pathobiology" "pathogen-associated"
    "pathologies" "pathology-based" "pathophysiology" "pathwa"
    "pathway-proficient" "pattern-based" "pattern-recognition" "pcDNA-survivin"
    "pcDNA3" "pcDNA6B" "pectoris" "pectus" "penetrance" "penetrant"
    "pentaphyllum" "peptidases" "peptide-like" "peptide-substrate-binding"
    "per-allele" "perhaps" "peri-operative" "perinucleus" "peritoneum"
    "permeant" "person-time" "phAR" "phAR1.6Luc" "phAR1.6Luc-UTR"
    "phAR1.6Luc-UTRm1" "phAR1.6Luc-UTRm2" "phAR1.6Luc-UTRm3" "phAR1.6Luc-UTRm4"
    "phAR1.6Luc-UTRm5" "phAR1.6Luc-UTRm6" "phAR1.6Luc-UTRΔm1" "phAR1.6Luc-Δm1"
    "phalloidin-FITC-reactive" "phase-II" "phase-contrast" "phenocopies"
    "phenocopy" "phenylcarbamothioyl" "phlebotomy" "pho" "phosphagen"
    "phospho-EGFR" "phospho-STMN1" "phospho-TXR" "phosphodegron"
    "phosphodiester" "phosphogluconate" "phosphoinositides-1" "phosphoisoforms"
    "phospholipid-binding" "phosphomutants" "phosphopantetheinyl"
    "phosphopeptide" "phosphopeptides" "phosphorylases"
    "phosphorylation-dephosphorylation" "phosphorylation‐deficient"
    "phosphosites" "phosphotylations" "phospho‐MARCKS" "phospho‐PAK1"
    "photo-ablation" "photo-thermal" "photodamage" "photoproducts" "phyllodes"
    "physician-records" "physio" "physio-pathological" "physiology-relevant"
    "physiopathology" "picosecond" "pifithrin-α" "pilaris" "piscine" "pixel"
    "placebo-controlled" "placebo-treated" "planus" "plasmacytoid" "plasmon"
    "plate-like" "platform-is" "platinum-doublet" "pleiotropy" "plethsmography"
    "pleura" "plexiform" "ploidy" "plug-in" "plus-end" "pmiR" "pmiR-RB-REPORT"
    "podocyte‐expressed" "polII" "polarizer" "polyA" "polyQ" "polycistron"
    "polyenes" "polyether" "polyglutamine-repeat" "polymicrogyria-like"
    "polymorphism" "polymorphisms" "polyphenols" "polysomy" "polyvinylidene"
    "poor-prognosis" "poor-risk" "poorer" "poorly-differentiated"
    "population-representative" "positron" "positve" "post-PCR" "post-PV"
    "post-UVB" "post-analytic" "post-chemotherapy" "post-docetaxel"
    "post-elution" "post-exposure" "post-incubation" "post-induction"
    "post-infection" "post-initiation" "post-injection" "post-inoculation"
    "post-irradiation" "post-ischemic" "post-lysis" "post-menopausal"
    "post-mitotic" "post-mortem" "post-natal" "post-operative" "post-ovulatory"
    "post-release" "post-replication" "post-surgery" "post-therapy"
    "post-transcription" "post-transcriptional" "post-transcriptionally"
    "post-transduction" "post-transfection" "post-translation"
    "post-translational" "post-translationally" "post-treatment" "postbaseline"
    "postmortem" "postradiotherapy" "postsurgery" "precancer" "preform"
    "preimmune" "premutations" "pretreatmentDAB2IPreduction" "pri"
    "pri-miR-101" "pri-miR-15a" "pri-miR-34b" "pri-miR-9" "pri-miR-9-1"
    "pri-miR-9-2" "pri-miR-9-3" "primary-cultured" "prior-responders" "priori"
    "pro-MMP9" "pro-MT1-MMP" "pro-NHEJ" "pro-adhesive" "pro-angiogenic"
    "pro-apoptosis" "pro-autophagic" "pro-caspase-3" "pro-drug" "pro-drugs"
    "pro-fibrogenic" "pro-fibrotic" "pro-growth" "pro-inflammatory"
    "pro-lymphangiogenic" "pro-malignant" "pro-metastasis" "pro-metastatic"
    "pro-oncogene" "pro-oncogenes" "pro-proliferative" "pro-survival"
    "pro-tumor" "pro-tumoral" "pro-tumorigenic" "probesets" "progeny"
    "progression‐free" "prohibitins" "proliferator-activated"
    "promoter-proximal" "promoter-reporter" "proof-of-concept" "propeller-like"
    "propionamide" "propyl" "prostaglandins" "prostatectomy"
    "prostate‐specific" "protein-12" "protein-DNA" "protein-RNA"
    "protein-lipid" "protein‐2" "protein‐coding" "proteome" "proteomes"
    "proteomics-based" "proto" "protonophore" "protusions" "proven"
    "pseudo-phosphorylated" "pseudoknot" "psoriacin" "psoriasis-like"
    "publically-available" "pull-down" "pull-downs" "pulldown" "pulled-down"
    "pulse-chase" "punctae" "punctate-to-tubular" "puntae" "pur-α" "pur-α-rich"
    "purified-complexes" "pygl-1" "pyrazole" "pyro" "p = 0.02" "p = 0.09"
    "qPCR" "qRT" "qRT-PCR" "qRT‐PCR" "quality-of-life" "quantitative-PCR"
    "quasi" "quencher" "quinonoid" "r=0.67" "r=0.684" "radiation-induced"
    "radiation‐based" "radio-resistance" "radio-sensitivity" "radio-therapy"
    "radioiodine" "radioresistant" "radiosensitiser" "random-effects"
    "rapalogs" "rapamycin‐insensitive" "rapamycin‐sensitive" "rapid-onset"
    "rarer" "ras-like" "ras2" "rb1-lsdb" "re-analysis" "re-analyzed"
    "re-analyzing" "re-assessment" "re-challenge" "re-circularized"
    "re-classified" "re-classifies" "re-confirm" "re-confirmed" "re-distribute"
    "re-distribution" "re-embedded" "re-emerging" "re-enable" "re-encountering"
    "re-enter" "re-entered" "re-entry" "re-epithelialization" "re-establish"
    "re-established" "re-evaluate" "re-evaluated" "re-examined" "re-exposure"
    "re-expressed" "re-expressing" "re-expression" "re-focused" "re-grouped"
    "re-introduction" "re-operation" "re-overexpression" "re-penetration"
    "re-plated" "re-probed" "re-probing" "re-programming" "re-seeded"
    "re-sensitize" "re-sensitized" "re-sensitizes" "re-sequence" "re-start"
    "re-suspension" "re-synthesis" "re-testing" "re-treatment" "re-uptake"
    "reChIP" "reaction–restriction" "reactive-immunoassay" "read-out" "readout"
    "readouts" "real-world" "reangerangements" "receiver-operating"
    "receptor-α" "rechallenge" "recombination-deficient"
    "recombination-mediated" "recut" "red-colored" "red-fluorescent"
    "reducedDAB2IPdemonstrated" "reducedDAB2IPhas" "reductionin"
    "reduction–oxidation" "reevaluate" "refold" "refractoriness" "reg" "regia"
    "region-Abelson" "regrowth" "regulatesTRPC6" "regulator-1"
    "regulatorUHRF1suppresses" "regulators" "regurgitant" "remodelers"
    "repair-defective" "replication-associated" "replication-blocking"
    "replication-competent" "replication-induced" "repopulate" "repressors"
    "reprogramming-like" "residuals" "resp" "responder" "responders"
    "resultingtet" "resultingtet-op" "retainingDAB2IP" "retro"
    "retro-orbitally" "retro-viral" "retrovirus" "reuse" "revealedDAB2IP"
    "rever" "reverse-phase" "reverse-transcription" "rginine" "rhSLURP1"
    "rhabdoid" "rho-module" "rhodamin" "rhodamin-phalloidin" "ribbon-like"
    "ribose" "ribose-5-phosphate" "ribulose-5-phosphate" "rich-cell"
    "right-handed" "right-sided" "ring-like" "risk-reducing" "risk-reductive"
    "rodentium" "rootlet" "rootlets" "rotein" "round-to-elongated"
    "rpS6-mediated" "rs10069690" "rs1042522" "rs1043618" "rs1049007"
    "rs1061581" "rs1078806" "rs1078806-rs2420946-rs2981579-rs2981582"
    "rs1078806C-rs2420946T-rs2981579T-rs2981582T"
    "rs1078806T-rs2420946C-rs2981579C-rs2981582C" "rs11571833" "rs1219648"
    "rs12371165" "rs13172201" "rs13301537" "rs13361707" "rs140267842"
    "rs143383" "rs144848" "rs16941" "rs16942" "rs1799794" "rs1799966"
    "rs1801132" "rs1801132-G" "rs1801274" "rs1884051" "rs1884051-G" "rs1966265"
    "rs2075800" "rs2077647" "rs2077647-C" "rs2154754" "rs2227956" "rs2234693"
    "rs2234693-C" "rs2234909" "rs2278422" "rs2293347" "rs2293347G"
    "rs2293347GA" "rs2293347GG" "rs2293347 " "rs2293607" "rs237902" "rs2420946"
    "rs2420946T" "rs25487" "rs2736098" "rs2736108" "rs2844337" "rs2853669"
    "rs2853677" "rs2867461" "rs2867461G" "rs2867461 " "rs2972388" "rs2981579"
    "rs2981579T" "rs2981582" "rs2981582T" "rs2982684" "rs3015993" "rs3135848"
    "rs320" "rs328" "rs328-G" "rs351855" "rs3798577" "rs3798577-C" "rs396991"
    "rs412658" "rs4151580" "rs451360" "rs4938723" "rs4938723C" "rs4938723CT"
    "rs4938723TT" "rs4938723 " "rs4938723 CT" "rs708272" "rs708272-A"
    "rs7109645" "rs712" "rs724710" "rs75770066" "rs7705526" "rs7726159"
    "rs78378222" "rs799917" "rs8179181" "rs861539" "rs9340799" "rs9340799-G"
    "rubella" "rubidium" "ruffle-like" "run-to-run" "s10689-015-9841-9"
    "s12860-015-0070-8" "s12885-015-1661-7" "s12885-015-1701-3"
    "s12885-015-1721-z" "s12885-015-1731-x" "s12885-015-1740-9"
    "s12885-015-1772-1" "s12885-015-1778-8" "s12890-015-0127-7"
    "s12929-015-0196-1" "s12931-015-0278-3" "s12931-015-0286-3"
    "s12936-015-0888-8" "s12967-015-0680-0" "s12967-015-0685-8"
    "s13041-015-0145-7" "s13046-015-0239-1" "s13054-015-1052-0"
    "s13058-015-0610-3" "s13058-015-0643-7" "sCD40L" "sHSP" "sHSPs"
    "sT-antigen" "sT-antigens" "sTantigen" "salpingo" "salpingo-oophorectomy"
    "salt-and-pepper" "sarcoid" "sarcomatoid" "sc-493" "sc-6243" "sc-7372"
    "sc-7373" "scaffolding-like" "scatterplot" "scenarii" "scratch-wound" "sd"
    "second-degree" "second-generation" "second-largest" "second-leading"
    "second-line" "segmentectomy" "self-GlcNAcylation" "self-aggregate"
    "self-antigen" "self-antigen-driven" "self-antigens" "self-assembly"
    "self-association" "self-degradative" "self-eliminate" "self-interact"
    "self-interaction" "self-oligimerize" "self-oligomerization"
    "self-polymerization" "self-polymerizes" "self-protective" "self-reactive"
    "self-renew" "self-renewal" "self-specificities" "self-sufficient"
    "self-tolerance" "self-ubiquitination" "semi" "semi-quantitative"
    "sensitizer" "sensitizers" "sequence-1" "sequence-2" "sequence-carrying"
    "sequence-specific" "serine-2" "serine-9" "serine-to-alanine" "serotypes"
    "serous-like" "sessile" "set-up" "seventy-five" "severe-inflammatory"
    "sh-DBH-AS1" "sh-con" "shACC1" "shAIF" "shAIF#1" "shAIF#2" "shBcl"
    "shBcl-2" "shBcl-xL" "shCBL" "shCBL-Vector" "shCtrl" "shDNA" "shDNA-PK"
    "shDYRK2" "shERβ" "shETV4" "shGFP" "shHO-1" "shKDM4A" "shKDM4B" "shLRRK2"
    "shMET" "shNC" "shNSC" "shR" "shR-CBL" "shRNA-vector" "shRNA1" "shRNA2"
    "shSIRT1" "shSIRT1-1" "shSIRT1-5" "shSNC" "shSUPT5H" "shSUPT5H-1"
    "shSUPT5H-2" "shSUPT5H-3" "shScramble" "shUBASH-1" "shUBASH-2" "shYAP#1"
    "sham-irradiated" "sheddases" "sheet-like" "sheets" "shinone" "shockwave"
    "shockwaves" "short-interfering" "short-term" "shorter-term" "showedd"
    "shrunken" "shβ-catenin#1" "shβ-catenin#2" "si-Survivin" "si16"
    "siA3B-transfected" "siAR" "siCDH2" "siControl" "siCtrl" "siEGFR" "siGCN5"
    "siKDM4A" "siLRH-1" "siLUC" "siMET" "siPRMT6" "siRNA" "siRNA-1"
    "siRNA-1886" "siRNA-Con" "siRNA1" "siRNA2" "siRNA‐mediated" "siRhoGDI"
    "siRhoGDI-I" "siRhoGDI-II" "siSART3" "siUSP4-2" "siYAP"
    "sickle-Antilles-haemoglobin" "side-by-side" "side-chain" "side-chains"
    "side-effects" "sigmoid" "signalling-competent" "silic" "silico"
    "siltiximab" "simpler" "simplest" "simplex" "single-base" "single-cell"
    "single-center" "single-driver" "single-exponentials" "single-gene"
    "single-hit" "single-institution" "single-molecule" "single-nucleotide"
    "single-particle" "single-repeat" "single-round" "single-step"
    "single-strand" "sircol" "sirtuin" "site-II" "situ" "situs" "six-gene"
    "six-residue" "sixty-eight" "slow-growing" "slower-migrating" "small-cell"
    "small-interference" "small-molecule" "small-sized" "small-study"
    "smallGTPases" "smaller-sized" "smokers" "socio" "socio-economic"
    "sodium-bicarbonate" "sodium-chloride" "sodium-containing"
    "sodium-dependent" "sodium-dicarboxylate" "sodium-induced"
    "sodium-mediated" "sodium-proton" "soft-agar" "soft-tissue" "solid-state"
    "somites" "sown" "spacer" "spasmogen" "spatial-temporal" "spatio"
    "spatio-temporal" "spectrometer" "sphere-derived" "sphingosine" "spin-down"
    "spindle-assembly" "spindle-checkpoint" "spindle-like" "spiral-shaped"
    "spirometry" "spot-count" "srep14362" "srep14534" "srep14538" "srep14615"
    "srep14723" "srep14800" "srep14806" "srep14990" "srep15090" "srep15165"
    "srep15365" "srep15403" "ss" "ssDNA" "sseK1" "stadiometer" "stainings"
    "standard-of-care" "star-like" "stathmin-like" "status-dependent"
    "steady-state" "stem-cell" "stem-junction" "stem-like" "stem-line"
    "stem-loop" "stemness" "stem‐like" "step-wise" "stepwise" "stereoview"
    "steroid-induced" "stess" "stimulator-1" "stiposome" "strain-specific"
    "strand-invasion" "stratifier" "stress-activated" "stress-adaptation"
    "stress-adaption" "stress-associated" "stress-dependent" "stress-induced"
    "stress-inducible" "stress-release" "stress-release-induced"
    "stress-released" "stress-responding" "stressful" "stressors"
    "structure-activity" "structure-based" "structure–activity"
    "structure–function" "studie" "studies" "study-wise" "sub-G1"
    "sub-G1-phase" "sub-acute" "sub-analysis" "sub-capsular" "sub-categories"
    "sub-category" "sub-cellular" "sub-class" "sub-classification"
    "sub-classifications" "sub-clones" "sub-cohort" "sub-complex"
    "sub-complexes" "sub-diploid" "sub-divided" "sub-domains" "sub-families"
    "sub-family" "sub-group" "sub-meta-analysis" "sub-nuclear" "sub-optimal"
    "sub-pathway" "sub-population" "sub-populations" "sub-region" "sub-regions"
    "sub-sets" "sub-stoichiometric" "sub-type" "sub-unit" "sub-units" "subG1"
    "subclass" "subclasses" "subdomain" "suberoyl" "subfamilies" "sublines"
    "submicron" "submucosa" "subpopulations" "subproteome" "subserosa" "subset"
    "subsets" "subsite" "substoichiometric-associated" "substrate-binding"
    "substrate-binding-site" "substrate-recognition" "substrate-site" "subtype"
    "subunitgene" "succinate" "succinimidyl" "succinyl" "succinyl-CoA"
    "sulfhydryl" "super-antigen" "super-expressor" "super-expressors"
    "super-high" "super-imposed" "super-resolution" "superactivate"
    "supernatant" "supernatants" "supportive-system" "suppresser"
    "suppressorDAB2IPis" "supra-physiological" "supress" "survivors"
    "switch-like" "switching-loop" "sylvestris" "synapses" "syndrome-like"
    "synergism" "synophrys" "synthases" "syringe-like" "system-wide" "t-tpS6"
    "tag-SNPs" "tagSNP" "tagSNPs" "tamoxifan" "tan-shinone" "tandem-binding"
    "targetoid" "taxoids" "tcf" "tdTomato" "teh" "telomerase-mediated"
    "telomerase-positive" "telomeric-repeat" "template-complementary" "temporo"
    "tet-off" "tet-on" "tet-op" "teto" "teto-DTA" "tetranor-PGEM" "tetraplegia"
    "tetraploid" "tetrazolium" "thatDKK3" "thatDYRK2" "thatTRPC6"
    "thatUHRF1‐mediated" "thatmTORacquires" "theCDKN2Atumour" "theDAB2IP"
    "theERmay" "theFAT" "theFlcn" "theH" "theKEAP1gene" "theKEAP1promoter"
    "theLINE‐1promoter" "theMCF‐7" "thePKCs" "thePKCsystem" "theTRPC6"
    "theTrp53" "thee" "themRNAand" "themTORgene" "therapy-induced"
    "therapy-refractory" "therapy-specific" "thermo-elastic" "thiazoline"
    "thick-walled" "thiol-containing" "thiol-disulfide" "third-largest"
    "third-line" "thirty-five" "this-so" "three-colour" "three-day-old"
    "three-dimensional" "three-finger" "three-letter" "three-or-more"
    "three-order" "three-step" "three-stranded" "three-tiered"
    "thrombocythemia" "thrombopenia" "thrombus" "thymidine-adenine"
    "thymocytes" "time-course" "time-dependence" "time-dependency"
    "time-dependently" "time-frame" "time-lapse" "time-line" "time-point"
    "time-points" "times-points" "time‐dependent" "tisse" "tissue-resident"
    "tissue-susceptibility" "tissues" "titers" "titrant" "titre" "tm1044"
    "tm1944" "tm1Wjl" "to-mesenchymal" "toPhb2" "topoisomerases" "topology"
    "toto" "tracheas" "tracheotomy" "trachomatis" "trade-off" "trans-membrane"
    "trans-well" "transacti" "transactivators" "transcription-factor-promoted"
    "transcription-quantitative" "transcriptional-related"
    "transcriptionally-dependent" "transcriptome" "transcriptome‐wide"
    "transducedPhb2" "transducer" "transducing-β-like" "transfectant"
    "transfected " "transformation-like" "transient-transfection"
    "translocalizes" "translocon" "transporter-1" "transtuzumab"
    "transversions" "trastuzumab-DM1" "trastuzumab-chemotherapy"
    "trastuzumab-chemotherapy-resistant" "treatment-naïve" "treatment-period"
    "trichlormethiazide" "tricuspid" "tridactylus" "trifluorothiazoline"
    "trimester" "trimethoxy" "triphosphate" "triphosphates" "triple-negative"
    "triple-positive" "triple‐negative" "trisomy" "trisphosphate" "troponin-1"
    "trunk-branch" "tryglicerides" "tubastatin" "tubercle" "tubular-like"
    "tubule" "tubules" "tubulin-RhoA" "tubulinopathies" "tumor-adjacent"
    "tumor-agnostic" "tumor-distant" "tumor-node-metastasis" "tumor-permissive"
    "tumor-supportive" "tumor-suppressive" "tumorDAB2IPstatus" "tumors"
    "tumour-associated" "tumour-promoting" "tumour-suppressive"
    "tumour-suppressor" "twenty-five" "twenty-four" "twenty-seven" "two-base"
    "two-chamber" "two-color" "two-factor" "two-hairpin" "two-hit" "two-hybrid"
    "two-photon" "two-residue" "two-sided" "two-stage" "two-step" "two-subunit"
    "two-tailed" "two-thirds" "two-way" "tympanostomy" "type-1" "type-I"
    "typhimurium" "typo" "tyrosine-15-phosphorylated"
    "tyrosine-phosphorylation-regulated" "ubiquitin-proteosome"
    "ubiquitin-thioester" "ubiquitously-expressed" "uc001ver" "uc031tfk"
    "uftelin" "ug" "ultra-deep" "ultra-deep-sequencing" "ultra-short"
    "ultrasonography" "ultrastructure" "un" "uncoupler" "und"
    "under-appreciated" "under-representation" "under-stated" "underflow"
    "undergoes" "undergone" "underpinnings" "undertaken" "unitinib"
    "univariate" "unmet" "unphosphorylatedMARCKS" "unresponsiveness" "unsplit"
    "up-stream" "up-take" "up-to-date" "upshift" "up‐regulated" "up‐regulation"
    "uraciles" "uracils" "urea" "urethra" "urothelium" "usedPhb2" "users"
    "utero" "uvB" "uveal" "v-raf" "vIII" "vacuole" "vacuoles" "values" "vasal"
    "vascular-disrupting" "vasculitits" "vaso" "vaso-occlusive" "vector-only"
    "vector‐transfected" "vehicle-treated" "ventilator-associated" "vera"
    "vermis" "vessel-like" "vi" "viceversa" "vii" "villi" "vinca"
    "viral-induced" "viral-specific" "virotherapies" "vis-a-vis" "vitr" "vitro"
    "vivo" "vs.TT" "v‐Ras" "v–vii" "waist-to-hip" "web-based" "website"
    "well-annotated" "well-balanced" "well-being" "well-controlled"
    "well-defined" "well-designed" "well-differentiated" "well-documented"
    "well-moderately" "well-perfused" "well-preserved" "well-quantified"
    "well-recognized" "well-structured" "well-studied" "well-tolerated"
    "well‐regulated" "whetherMARCKSknockdown" "whileOma1" "white-European"
    "white-skinned" "whole-body" "whole-cell" "whole-exome" "whole-genome"
    "whole-transcriptome" "wildtyp" "wild‐type" "with-no-lysine" "withNCCN"
    "withdrawl" "work-up" "workers" "workflow" "wound‐healing" "written"
    "wt-p53" "wt-p53-Huh7.5.1" "wtEGFR" "x10" "xL" "xenograph" "xonegraft"
    "yellow-brown" "yellow-colored" "yet-to-be-identified" "ylori" "yyy"
    "z-projections" "z-score" "z-scores" "zero-transformation" "zeylanica"
    "zinc-dependent" "zipper-EF-hand-containing" "zymography" "×10" "× 10"
    "× 10" "ɛ-amino" "Αn" "Δ133p53" "Δ16" "Δ160p53" "Δ385–543" "Δ458–476"
    "Δ740–766" "ΔArm" "ΔB" "ΔE8" "ΔF" "ΔL747-S752" "ΔN-HDAC6-His"
    "ΔN-HDAC6-His-induced" "ΔN-HDAC6-His-transfected" "ΔNADH" "ΔNp73α" "ΔPKA"
    "ΔR2" "ΔSAMPs" "ΔST64B" "ΔTPR" "ΔZF" "Δloop" "Δm1" "Δm2" "ΔΨ" "ΔΨm" "Δψ"
    "Δψm" "Ιndeed" "ΦxΦΦΦ" "α-FLAG" "α-KG" "α-MyHC" "α-defensin2" "α-enolase"
    "α-helical" "α-helices" "α-helix" "α-myosin" "α-smooth-muscle-actin"
    "α-subunit" "α-toxin" "α-β" "α1a-tubulin" "α4" "α5-integrin" "α6" "α6β1"
    "α6β4" "α7-nAChR" "α7-nAChR-deficient" "α7-nAChR-mediated" "α7-nAChRs"
    "α7-nicotinic" "α9" "αIIb" "αv" "β-adrenoceptor" "β-cat"
    "β-catenin-mediated" "β-defensin2" "β-gal-activity" "β-helixes"
    "β-oxidation" "β-sheet" "β-sheets" "β-site" "β-strand" "β-subunit"
    "β-sympathomimetics" "β-transducin" "β-tubulins" "β1-4" "β1-strand" "β3"
    "β3-integrin" "β3-strand" "β6" "βA" "βAβA" "βAβB" "βB" "βBβB" "βcat"
    "βeta-catenin" "β‐actin" "β‐catenin" "γ-ATP" "γ-irradiation-induced"
    "γ-subunit" "γ-subunits" "γ2" "γ3" "γH2A" "γH2aX" "ε-amino" "κB" "μL" "μg"
    "μg " "μl" "μm-pore" "μmol" "χ2" "χ²" "кB" "‘BRCAness’" "‘superactivate’"
    " 000" "↓and" "∆Arm" "∆Armrpts" "∆B" "∆N151" "∆PAL" "∆R2" "∆SAMPs" "│1.5"
    "│and"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-15901-16200*
  '("transtuzumab" "active mtEGFR" "mtEGFR" "wtEGFR" "mt" "alanyl"
    "difluorophenacetyl" "co-exist" "20 μg/ml" "1/10" "5 ×10"
    "4,5-dimethylthiazol-2-yl" "TSKN2" "TNSK2" "miR-1 mimic"
    "MCF-7/miR-1 inhibitor" "MCF-7/miR-1inhibitor" "miR-1mimic"
    "miR-1inhibitor" "miR-1NC" "SKBR3/miR-1inhibitor" "MCF-7/miR-1mimic"
    "SKBR3/miR-1NC" "CD44+CD24−" "SKBR3/miR-1mimic" "MCF-7/miR-1NC" "PCT"
    "SKBR3/miR-1 mimic" "MCF-7/miR-1" "miR-1 inhibitor" "MCF-7/CSC" "h"
    "MCF-7/CSCs" "CD24+" "agomir" "pmiR" "hRluc" "casepase-3"
    "miR-139-5p-expression" "miR-139-5p-expressing" "HELF" "Hsa-miRNA-139-5p"
    "= 6" "5-bromo-2" "sub-acute toxicity studies" "flavaglines" "flavagline"
    "aurilide" "inNoxa" "ring-like" "non-cleavable" "leukemia/lymphoma"
    "Prohibitins" "CellROX" "ΔS1" "micrographs" "inPhb2" "andPhb2"
    "fluorizoline-" "fl/fl" "prohibitins" "large heteromeric ring-like"
    "thiazoline" "Fluorizoline" "fluorizoline" "trifluorothiazoline" "diaryl"
    "3X" "phosphorylases" "E2F1-4" "Globocan" "Hepatocellualr" "mean± SD"
    "co-incubated" "MKK3/6" "shHO-1" "shBcl-2" "xL" "shBcl" "TL4" "A276D"
    "−229" "−740" "−1036" "Nrf2/ARE" "p = 0.018" "de-regulated"
    "a transcriptional co-suppressor" "Hu" "Lal" "Garcia" "Weel"
    "TTP/adenovirus" "кB" "Dox-" "Zn" "ER +" "dithiocarbamate" "Leay"
    "phosphoisoforms" "BLT1-NOX-ROS-EGFR-PI3K-ERK1/2-linked" "postmortem"
    "the LTB 4 -mediated pSmad3L" "Calphostin" "apocyanin" "EPSM"
    "Mv1Lu-pcDNA3cells" "Mv" "-Luc" "U75302"
    "extracellular signal-regulated kinase 1/2" "p21 WAF1" "pSmad3L"
    "kinase1/2" "p85α" "Smad3/4" "Zapater" "Ortiz" "CPEB3/EGFR" "miR-216b"
    "miR-107 functionally targets CPEB3" "CPEB3" "* p" "miR-331-3p"
    "antiparallel" "heptad" "cardiomyotrophy" "neurites" "endosome/lysosome"
    "other subcellular organelles" "1.5~2-fold" "ImageXpress" "AcGFP"
    "colocalizatin" "mitoAcGFP" "mitEGFR" "iTRAQ" "auto-activation" "auto-"
    "further association studies" "EGRF" "5p" "PXBIP1" "34.55-month"
    "34.32-month" "LOC 100506688" "LOC100506688" "BRD9" "_37756707" "chr19"
    "_1607662" "_129101148" "_129103476" "_1368500" "_1023251" "_508485"
    "_257662" "_37760335" "_1663720" "_681306" "_297746" "Circos" "CNVer"
    "BICseq" "CNVseq" "PBXIP1" "WGS" "CNVs" "non-smoking" "3-year" "JRS" "BKP"
    "LNB" "WG" "JPN" "UHRF1 suppression" "occasional high UHRF1 expressers"
    "‐TrCP" "GSK‐3" "kinase‐3" "active K‐Ras"
    "the weak and moderate UHRF1 expressers" "expressers" "UHRF1expression"
    "CFPac‐1" "S‐phase" "maleate (DEM)" "maleate" "diethyl" "depleter" "K‐Ras"
    "1C1" "‐depletion" "Panc‐1" "ofKEAP1" "Suit‐2" "MiaPaca‐2" "ofRASSF1"
    "UHRF1 depletion" "theLINE‐1promoter" "CFpac‐1" "MiaPaca" "ofUHRF1is"
    "over‐expression" "a pancreatic cancer tissue micro‐array"
    "UHRF1 expression" "UHRF1over‐expression" "over‐expressed" "Britain"
    "Wiley" "drivesUHRF1expression" "byUHRF1" "ofUHRF1reduced" "UHRF1depletion"
    "ofUHRF1fromPDACcells" "inPDACtumours" "ofKeap1" "=  0" "=  0.002" "‐phase"
    "S4B" "p = 0.02" "p = 0.09" "χ 2  " "‐cell" "‐G" "midwall" "Danon"
    "ShMOLLI" "cardiomyopathies" "Schiff" "non-enhanced" "non-symmetric" "EDV"
    "otherwise full CMR" "fibrofatty" "a distinctive cardiac histopathology"
    "antegrade" "approximately 0.23–1 " "mid-infero-lateral" "g/m2" "LGE"
    "gadolinium" "LVH" "CMR" "and 9 " "non-linear" "transacti" "Rodda"
    "stabilization/accumulation" "osteoblastogenic differentiation studies"
    "Stanbio" "Mut865/836" "WT865/836" "promoter/luciferase" "−657" "−661"
    "−669" "−852" "−858" "PROMO" "FOPflash" "∆N151/active" "∆N151"
    "cytoplasmic/soluble" "CCT031374" "teh" "which supports previous studies"
    "0/3" "comedo" "the unique immunophenotypes" "oncodriver"
    "immunophenotypes" "mammograms" "Oncodrivers" "pDCIS" "oncodrivers"
    "H-Score" "3/3" "non-surgical" "Italians" "Taiwanese" "Italian Caucasians"
    "the homozygous TT genotype" "a statistical power greater"
    "these previous studies" "associated functional polymorphisms"
    "the autoimmune-associated HLA-B8-DR3 haplotypes"
    "Previously published functional studies" "HSP1AL" "Haploview"
    "the heterozygous AG genotype" "+2437" "+190 " "+190" "Mexicans"
    "rs1043618" "rs2075800" "rs2227956" "rs1061581" "= 0.01" "AG + GG" "= 0.12"
    "95 % CI " "10.1038/ncomms9372" "syndrome-like" "DSCR" "trisomy" "GKAs"
    "Chiron99021" "GNF6324" "databank" "-phosphorylation-regulated kinase 1A"
    "KINOMEscan" "Akp"
    "consequent diabetes Tg(Ins2-rtTA)2Efr Tg(teto-DTA)1Gfi/J" "DTA" "teto"
    "T1D" "/SzJ" "Prkdc" "/J" "euglycemia" "GNF7156-" "GNF" "IEQ" "puntae"
    "methanesulfonate" "dimethylsulfoxide" "eFluor670" "GNF7156" "GNF4877"
    "Aminopyrazines"
    "dual specificity tyrosine-phosphorylation-regulated kinase 1A"
    "tyrosine-phosphorylation-regulated kinase 1A" "aminopyrazines"
    "genome-wide association studies" "Aminopyrazine" "aminopyrazine"
    "Co-localization" "Auto-" "ketamine/xylazine" "=8" "=6" "8±2" "∼1.5"
    "other ovarian cancer subtypes" "epididymis" "FokI" "Austria" "1.06–2.01"
    "1.01–1.89" "1.04–1.87" "NH" "NH " "Wenham" "Auranen" "Beesley"
    "the serous subtype" "1.01–1.48" "the only common polymorphism" "P- values"
    "P -value " "P  = 0.01" "P  = 0.03" "= 0.06" "= 0.04" "P  = 0.04"
    "P  = 0.026" "collectives"
    "future prognostic and possible predictive biomarker studies" "Toon"
    "weak/inconclusive" "Lasota" "Leica" "autostainers" "Vakiani"
    "Nearly all published studies" "the preoperative biopsy"
    "available preoperative biopsies" "preoperative biopsy" "Switzerland"
    "Bern" "Munich" "2/18" "normal colonic mucosa" "ngTMA"
    "an additional seven cases underwent VE1 immunohistochemistry" "CAIRO-2"
    "OPUS" "Preoperative biopsy" "preoperative biopsies" "VE1" "= 123"
    "Xinjiang" "61/80" "25/30" "embolus" "chronic hepatitis/cirrhosis"
    "thrombus" "7/30" "13/30" "0/30" "1/30" "8/30" "fibrosis/cirrhosis" "n=30"
    "P=0.002" "χ²" "10.1038/srep15165" "Yokoi" "A369T" "vermis" "Kumar"
    "TUBA1A -related cortical dysgeneses" "agyria" "tubulinopathies"
    "frameshifts" "cortical dysgeneses" "KBI" "cryoelectron"
    "Subsequent Sanger" "levothyroxine" "insipidus" "trichlormethiazide"
    "gastrostomy" "tracheotomy" "TORCH" "simplex" "rubella"
    "spastic tetraplegia" "Truncal hypotonia" "hypotonia" "Apgar"
    "ultrasonography" "caesarean" "tetraplegia" "diplegia"
    "thin or absent corpus callosum" "brainstem" "callosum" "pachygyria"
    "an extremely thin cerebral parenchyma" "severe cortical dysgeneses"
    "dysgeneses" "1000 Genomes" "GRCh37/hg19" "+0.3" "4-2" "PHA" "Takahashi"
    "Uchida" "Ellison" "Hoorn" "hyperinsulinemia" "OLETF" "Tokushima" "Otsuka"
    "Proximal tubules" "PTs" "McGraw" "Gonzalez" "-triphosphate"
    "-bisphosphate" "mineral corticoids" "corticoids" "nephron" "ROMK"
    "distal convoluted tubules" "ENaC" "proximal tubules" "chromosome 17q"
    "late/high" "ELR" "monotherapies" "μ L" "24 h" "DNAJA2" "Nfe2I2" "nigra"
    "cinerea" "regia" "Juglans" "zeylanica" "5-hydroxy-2-methyl-1"
    "Plumbaginaceae" "TSCC" "N -acetyl"
    "uNK cell-associated killer immunoglobulin-like receptor haplotypes"
    "placental pathologies" "constitutively active viral (v)-ErbB" "-ErbB"
    "Placental explants" "sheddases" "BACE" "non-dividing" "CytoDEATH"
    "placental explants" "placental floating explants" "invasive EVTs"
    "placental tissue explants" "EVTs" "trimester" "decidua" "Decidua" "ITGA"
    "Placental villi" "–protein-kinase-B" "EVT" "foeto" "=15" "48 h" "20 μg/ml"
    "n =9" "24 h" "4±1.4" "mTOR/p70S6K" "Akt2/" "p-p70S6K" "Ser240/244"
    "Akti-2" "anti-metastasis" "= 0.015" "Anti-p53" "murtivariate" "IHCof"
    "0.41–1.17" "0.37–1.77" "ORR" "25/36" "42/54" "multistage" "Luminex" "U/mL"
    "whose KRAS genotype" "P  = 0.15" "14/18" "= 60" "5 mg/kg" "mg/m 2" "Diana"
    "MiRPath" "Dvinge" "miR-503-5p" "MADE1" "Cecener" "Ertuk" "Vallés" "Pérez"
    "and 3e" "miR-548c" "cytokeratin 5/6" "miR-197-3p" "miR-143-3p"
    "miR-205-5p" "miR-21-5p" "miR-142-5p" "uni-" "uni" "‘BRCAness’"
    "the triple negative breast cancer (TNBC) subtype" "miR-548c-5p" "17q21"
    "CK 5/6" "bursa" "CL" "vaginal lavages" "lavages" "Papanicolaou" "Vivaria"
    "mouse olfactory tubercle" "tubercle" "Olfr68" "a Graafian follicle"
    "ovarian follicles" "follicles" "menstrual/estrous" "metestrus"
    "the deadliest histological subtype" "serous subtype" "30-minute" "1 ng/mL"
    "burkitt" "miR-185-3p" "pairings" "CLASH" "showedd" "miR-320b" "n =3"
    "/Mouse" "gastric mucosal epithelia" "ylori" "Nagy"
    "the gastric epithelium" "Minimal PDK-1 dephosphorylation"
    "PDK-1 dephosphorylation" "SD4" "AGC" "3-OH-kinase" "bisphosphate"
    "immunodominant" "24 h" "radiosensitiser" "Fus" "shDNA" "sensitises" "asVE"
    "OSEC2" "McCormick" "YAC" "EudraCT" "AZD-6738" "re-start" "PIKKs"
    "Defectsin" "2 Gy" "Non-Target" "SNP 6.0" "VE821" "8q24" "pChk1s" "Rad3"
    "p21 WAF1/CIP1" "inducecd" "CGK" "`s" "p21 Waf1/Cip1" "1/Cip1" "PK59"
    "CGK733-induced LC3 II formatiom" "formatiom" "RNA-like" "/IP" "p21 WAF"
    "P21 Waf" "/autophagy" "p21 Waf" "NGCA" "Korea" "PRKKA1" "vs.TT/CT"
    "at 5p13.1" "rs13361707" "GCa" "CT+TT" "CT+CC" "ABI7900" "non-cardia"
    "ovariectomy" "OVX" "MCAO" "/extracellular" "ER-α66" "Sampei" "E2β"
    "ER-α36" "non-ER" "n = 9" "mutation/s" "OPCS" "Ontario" "_3042delAAG" "VUS"
    "Veste3" "MetaLR" "MetaSVM" "_2589delAAAA" "K3326X" "Jewish" "FPC"
    "hereditary pancreatitis" "pancreatitis" "HBOC" "+1G" "p =0.05" "1100delC"
    "intron/exon" "non-adenocarcinoma" "12-month" "non-polarized"
    "CN03 treatment" "CN03treatment" "∼14%" "24h" "CN03" "centroid"
    "a dense F-actin meshwork" "24 h" "centroids" "BJ" "Sen" "non-uniform"
    "anti-tumorigenicity" "morphological/migratory" "2-3" "∼5%" "non-motile"
    "co-ordinately" "C-labelled" "M+7" "Novartis" "operant"
    "chromatography/mass spectrometry" "NADPH/NADP+" "GC/MS" "FOXa" "SPSS"
    "Minneapolis" "GenePharma" "Bioworld" "nonfat" "difluoride"
    "polyvinylidene" "cycler" "an SYBR" "Valencia"
    "Semiconfluent HT29 monolayers" "Dulbecco's" "ATCC" "Mayo" "colonoscopy"
    "colonoscopies" "UC" "10.1038/srep15365" "Hino" "immunostainings"
    "co-overexpression" "mRFP" "GJIC" "5-Bromo-2" "35-mm" "non-oxidative"
    "mononucleocytes" "mylohypoid" "mg/kg/day" "HDF" "212LN" "M15A" "keto"
    "NADPH/NADP +" "Ru-5-P-dependent" "PFK" "oligomycin" "oxythiamine (OT)"
    "oxythiamine" "phosphogluconate" "globulins" "IVIg" "Mackay" "lupus-like"
    "~10–15 " "PEC" "cell-like" "Pearse" "sCD40L" "Cowan (SAC)" "Cowan"
    "anti-Ig" "Bernasconi" "Naïve" "ELISPOT" "AT10" "Rahman" "ITIM-" "ITIM"
    "~40 %" "~30 %" "CD19 +" "GBC" "Hans" "Ogasawara" "sown" "2/24" "44/66"
    "66/80" "24/80" "INCan" "DCBCL" "the Germinal Center B-cell subtype (GCB)"
    "subtype (GCB)" "GCB" "unresponsiveness" "p  = 0.05" "6-year" "≥ 30 "
    "re-evaluated" "Non-Hodgkin" "napsin" "The mass-forming subtype"
    "segmentectomy" "hemihepatectomy" "lobectomy" "clonorchis" "hilar" "BTCs"
    "gallbladder" "papillary or mucinous histology" "non-expressing" "≥5 "
    "Five-year" "study oncolytic virotherapy" "Guedan" "Cheng" "capsule-like"
    "IFU" "non-replicative" "oncolytic dl1520" "Adwt" "Swiss"
    "oncolytic virotherapy" "virotherapy" "MOIs" "titers"
    "E1b55K -deleted dl1520" "dl1520" "E1b" "E1B55K" "virotherapies"
    "preclinical animal studies" "E1b55K -deleted ONYX-015" "ONYX-015" "ONYX"
    "E1b55K" "Virotherapy" "Ad12" "5 × 10" "G2M cell"
    "basic in vivo and in vitro studies" "G2M phase" "PDAs" "3 /" "+ 3"
    "μg/ml " "GWAS030" "GeMDBJ" "website" "IntPath" "rs2867461G" "rs2293347G"
    "Mochinaga" "BEL7402/5-FU" "Pénzváltó" "BeadChip" "IDs" "iEA "
    "only rs2867461 + rs2293347" "AIC" "Chem" "AICs" "Cr " "rs2293347 "
    "rs2867461" "IVS14 " "Northern Europeans" "+ 1G" "DHFU"
    "dihydrofluorouracil" "Shirasaka" "Tetsuhiko" "z" "iEA" "rs2867461 "
    "rs2293347" "Human-1" "many genome-wide association studies" "= 6" "= 0 "
    "PR + " "= 5" "+ 1" "rechallenge" "CRICKET" "non-exon" "Morelli" "Fora"
    "≥ 6 " "0.43-1.15" "RMH" "≥6 " "re-challenge" "PANERB" "Santini"
    "p  = 0.02" "mg/m2" "= 0.67" "= 0.99" "≥ median" "PI3KCA" "= 18" "n  = 12"
    "anoïkis" "Mercier" "lentiviral RNAi miR133a" "miR133a" "motile/invasive"
    "cuboid" "K34c" "MFS" "miRNome" "methylome" "omics" "LNM" "±0" "α v" "β 3"
    "multipotent stem-like" "CD24 +" "non-stem" "non-CSC" "repopulate"
    "B/cHER2" "maytansinoid" "METTEN" "claudin-low/cHER2+" "/cHER2+" "Giordano"
    "cHER2−" "their CSC-driven refractoriness" "cHER2-" "poorest" "cHER2"
    "the biologically-distinct intrinsic BC subtypes" "newer"
    "adjuvant/neoadjuvant" "checkerboard" "Basal/cHER2+" "Lesniak"
    "basal/HER2+" "A/cHER2+" "HER2e/cHER2+" "B/cHER2+" "HER2e" "SUBTYPES"
    "Orwell" "Harrys" "overexpression/amplification" "POOREST" "SUBTYPE"
    "CHER2+" "co-presence" "a unique BC subtype" "basal/cHER2+" "ALDH+"
    "overlap all the intrinsic subtypes" "continuum" "cHER2+" "non-genetic"
    "EPITHELIAL/MESENCHYMAL" "BASAL-LIKE" "mesenchymal-like" "Th22" "Nizri"
    "methyllycaconitine" "IL-22RA1" "Magainin1" "magainin1" "rhSLURP1" "PATE"
    "PD980589" "psoriasis-like" "erythema" "Niebuhr" "acetylcholine" "IMQ"
    "SLURP1" "Meleda (MDM)" "Meleda" "1 ng/ml" "SBI-0640599"
    "terminally differentiating and accumulating neutral lipid droplets"
    "SBI-0069272" "myelo" "an active quinone methide" "dihydroartemisinin"
    "JKY-2-169" "the α-helical mimetic JKY-2-169" "SBI" "methides"
    "dihydrocelastrol" "CA19" "CA16" "Celastraceae" "proteomes" "JKY"
    "promiscuously forms Michael adducts" "Michael" "methide" "de-stabilizes"
    "N-labeled" "E-box" "Rb/E2F" "an invasive ovarian tumors geneset"
    "co-clustered" "an invasive ovarian epithelial cancer geneset"
    "the papillary subtype" "WT21" "Wap-" "Wap" "OAP's" "vinca" "eukaryocytes"
    "pCdc2" "GI50s" "liriodenine" "kcal/mol" "Lipinski" "H-bonds" "H-bond"
    "cell growth/proliferation" "anti-lung" "Centipeda" "#25" "OAP"
    "-angeloylplenolin" "angeloylplenolin" "36/64" "n=12" "both Golub's"
    "Golub" "I-III" "Cbl_hi" "LR" "_hi" "Cbl_lo" "_lo" "HBe" "RKLs"
    "curative hepatectomy" "modals" "hepatectomy" "10-years" "5- year"
    "anti-melanoma" "bicyclo" "-xanthen-9-yl" "DTP" "isosteres" "FCFP6" "FCFP4"
    "FCFP2" "Muchmore" "ECFP4" "ECFP2" "Tanimoto" "lead-like" "drug-like"
    "BN82685" "IRC-083864" "IRC" "bioisosteres" "a comprehensive overview"
    "Lavecchia" "non-consideration" "multigene" "CDC25s" "DSPs"
    "a possible oncotarget" "oncotarget" "NCI" "quinonoid" "/K" "1 +" "2c"
    "non-Hodgkin" "EZH" "xonegraft" "pGL3-B-miR-101-W" "pGL3-B-miR-101-M"
    "pGL3-B-miR-101-S" "pGL3-B-miR-101-L" "pEGFP" "degrader" "~5-fold"
    "~3-fold" "Tattoli" "Ser-473" "Zurawski" "IQ" "translocon"
    "the colonic mucosa" "the human intestinal epithelium" "-473"
    "telomerase/telomere" "shortening/dysfunction" "Weise"
    "cell death/apoptosis" "retro" "lenti" "hTER" "TL"
    "20 kb tandemly repetitive TTAGGGs" "TTAGGGs" "ubiquitin/proteasome"
    "homeostasis/function" "± 0" "AZD1208/ruxolitinib" "JAK2-V617F-driven"
    "possible AZD1208" "exogenous PIM1L" "PIM1L" "PIM1S" "Uke1-R"
    "BaF3-JAK2-V617F-R" "JAK2-V617F-dependent" "JAK2-V617F-positive"
    "phlebotomy" "AZD1208" "ug/mL" "IC 50 s" "jejuni" "DAB2IP‐deficient"
    "malignancy‐specific" "‐GAP" "‐T2b" "‐DAB2IP" "5‐years" "postradiotherapy"
    "DAB2IP‐retained" "4‐years" "a significantly worse FFBF" "DAB2IP‐reduced"
    "‐retained" "‐reduced" "22/79" "‐nine"
    "a hepatocellular carcinoma subclass" "subclass" "cancer‐specific"
    "protein‐2" "accelerated DNA double‐strand" "‐strand" "/G" "‐free" "5‐year"
    "‐term" "≥20" "≥cT3a" "high‐risk" "ofDAB2IP" "‐fourth" "‐risk"
    "tumorDAB2IPstatus" "retainingDAB2IP" "andPCSS" "includingFFBF"
    "‐reduction" "‐eight" "CRFS" "FFBF" "pretreatmentDAB2IPreduction" "PCSS"
    "suppressorDAB2IPis" "= 0.0007" "‐years" "≥2.0 " "‐embedded" "‐fixed"
    "‐knockdown" "‐independent" "cancer‐related" "‐year" "pt" "0.48–1.34"
    "0.58–2.16" "MTs" "_004985" "p = 0.01" "the relevant SNP" "pathobiology"
    "Jf-" "Jf/+" "helixes" "developing epithelia" "Jf/Jf" "p53 /+" "Jf /+"
    "heterozygotes" "less disrupted lung histology" "intercrosses" "bulla"
    "bullae" "clickbox" "heterozygote" "p53/+" "grommet" "TGFβRII" "pSMAD2"
    "Junbo" "/+" "Jf" "homozygotes" "Jeff" "otitis" "commonest" "tympanostomy"
    "Otitis" "P =0.0004" "SERMs/SERDs" "agonism" "anti-hormone" "occurance"
    "Mutliple" "proliferative/prosurvival" "PDK" "downregulators"
    "-trisphosphate" "Non-Targeting" "non-hepatocyte" "pSilencer2.1"
    "pSilencer" "pDNA3.1" "tcf" "-166" "+30" "− 166" "−167" "-474" "HCCRP"
    "P-474-+30" "AdGFP-HBx-infected" "AdGFP" "HBPol" "HBLS" "pHBV1.2" "HCCR"
    "n = 12" "non-transgenic" "AMPKK" "synergistic anti-angiogenesis"
    "anti-angiogenesis" "Tg" "ISV" "destabilizer" "GTP-bound RhoA"
    "Microﬁlaments" "microﬁlaments" "H&E" "ISVs" "Zebraﬁsh" "Vec" "CaMKKβ"
    "RhoA/ROCK" "coﬁlin" "RhoA/" "DPT's" "VTA" "Deoxypodophyllotoxin" "VDAs"
    "VTAs" "sylvestris" "Anthriscus" "DPT" "24-hour" "KO/p53" "Multidomain"
    "MDR+" "Pglycoprotein" "chloroethyl" "p21waf" "RabGGTA" "Eto" "and 2-kb"
    "GPyPyPy" "PuPuPuC" "U343" "diphosphate" "mevalonate" "≤0.001" "* P"
    "a-pFOXO1A" "IFI" "50  μ g/ml" "μ g/ml" "10.1038/srep15403" "Renga"
    "breackdown" "gymnestrogenin" "AT20" "hepatocyes" "TTC"
    "hydroxycholesterol" "*p "
    "(PPARγ, KAT5, BRD8, PSMC5, HDAC7, ARNT) in HepG2 cells" "LXRα"
    "disfunctions" "dyslipidemias" "3/16" "co-regulators"
    "IHC scoring algorithms" "Of interest Balbin" "Balbin" "analyte" "workflow"
    "Mueller" "pure cancer epithelia" "the Pearson's" "1/2 S217/221" "analytes"
    "expression/activation" "Farnesyl" "biospecimens" "≥ 5" "non-stratified"
    "non-randomized" "T202/Y204" "1/2 S" "p =0.03"
    "hypoxia inducible factor 1α" "tisse" "33/41" "The Pearson’s" "bivariate"
    "nocturia" "OAB" "urothelium" "± 4" "± 3" "pilaris/hyperkeratosis"
    "excavatum" "ROI" "bi-directional Sanger" "NextGENe" "HaloPlex"
    "Café-au-lait" "NovoNordisk" "kg" "Gothenburg" "Uppsala" "Helsinki"
    "LEOPARD" "pectus" "Noonan" "11/" "non-related" "Heemskerk" "HRs" "WECARE"
    "the two multi-center retrospective cohort studies" "Metcalfe"
    "either contralateral risk-reducing mastectomy"
    "a contralateral risk-reducing mastectomy" "salpingo" "carriership"
    "15-year" "unilateral mastectomy" "bilateral mastectomy"
    "contralateral risk-reducing mastectomy" "CBC" "Nalepa" "WT129" "pixel"
    "co-labeled" "PD220" "anti-phospho-STMN1" "PD331/C" "PD331" "effectuate"
    "STMN-like" "CENP" "NEK" "crosslink (ICL)" "pancytopenia" "thrombopenia"
    "mitotic aberrancies" "aberrancies" "Stathmin-1" "mmol/L"
    "Polo-Like Kinase-1" "desmoplasia" "9/10" "only biopsy proven"
    "had associated epithelial severe dysplasia" "10/72" "Haugsten"
    "endothelia" "19/52" "29/72" "81/108" "Dellacono" "8/52" "24/72" "62/108"
    "Wakulich" "precancer" "Raimondi" "squamous epithelium" "14/" "23/72"
    "53/108" "FGF-2 and" "and 9/10" "15/62" "mild dysplasia" "midstratum" "bek"
    "Taiwan" "planus" "dysplasias" "23/62" "16/62" "6/10"
    "the cardiac HspB2 interactome" "synapses" "refold" "heterocomplexes"
    "the HspB2 cardiac interacome" "cardioprotectant"
    "a cardiac HspB2 interactome" "Gyceraldehyde"
    "the combined HspB2 cardiac interactome" "fermentation/respiration"
    "interactomes" "Katsogiannou" "mattings" "Clontech" "Y2H" "Kadono" "Keuls"
    "Newman" "neutral pH" "phosphagen" "PCr" "echocardiography" "HSPB2wt"
    "HSPB2cKO" "littermate" "HSPB2NTg" "non-statistically" "HSPB2cTg"
    "interacome" "a cardiac protein interactome" "ischemia/reperfusion"
    "a large-scale cardiac HspB2 protein interactome" "Morrison" "DKO" "Brady"
    "CryAB" "sHSP" "sHSPs" "non-mammalian" "genotype/phenotype" "n = 5"
    "reductionin" "cTNM" "LRRFS" "P  = 0.002" "Srivastava" "TM251"
    "-acylthiourea" "acylthiourea" "Singh" "2V5W" "the tetrapeptide
assay substrate Ac-Arg-His-Lys(Ac)-Lys(Ac)-aminomethylcoumarin"
    "Ac-Arg-His-Lys" "-aminomethylcoumarin" "aminomethylcoumarin" "Ac"
    "plate-like" "Cα" "OH---Zn 2+" "G302–G303–G304–G305" "imidazole"
    "acetyllysine" "reuse" "cohesinopathy" "synophrys" "phenylcarbamothioyl"
    "P91L" "Lange" "Cornelia" "= 5" "10.1038/srep15090" "Lu" "2 /M" "re-entry"
    "2 /M phase" "re-entered" "ARMS/ERMS" "Biomax" "204798_at" "_at" "Myf"
    "Davicioni" "botryoid" "myofibers" "= 8" "shTCERG1" "ΔΨm"
    "pGeneClip-shTCERG1-" "-STAU" "STAU" "minigene" "ss" "ΔΨ" "LXXLL" "ML323"
    "sensitise" "AREIII" "LNCaP-7B7" "ZODIAC" "Kee" "WDR" "LPAR" "Bonardi"
    "iso" "the cell permeable Rho inhibitor CT04" "wildtyp" "M4/5" "M0-2"
    "M6/7" "TM7" "granulocytopenia" "p = 0.02" "= 15" "Fbxw7α in" "SOX10–2A"
    "leukemia-1" "JUNB" "ΦxΦΦΦ" "phosphodegron (CPD)" "T/S" "PPx" "Fbxw7α"
    "Hypoxia-inducible factor-1α" "choroideremia" "miR-361-5p" "≈6"
    "non-metastatic" "miR-574-5p" "Endoscopic biopsies" "at least 4 biopsy"
    "endoscopic biopsy" "equivocal 2+" "only endoscopic biopsy"
    "diagnostic biopsy" "130 (18.5%) endoscopic biopsies" "WB" "nucleoplasma"
    "stiposome" "rotein" "uftelin" "Anti-Flag" "Deeper" "TBCB" "Mahammad" "INA"
    "the online gene ontology tool DAVID" "MALDI-TOF/TOF" "Nano"
    "the soluble eluate" "eluate" "kelch" "biotag" "PRPH" "BTB/Kelch" "/Kelch"
    "Tramtrack" "PNS" "axons" "Asbury" "GIG’s" "HSP90AA1/AB1" "Kelch" "GIG"
    "= 47" "~25%" "Mooney" "cardia" "37/41" "70/81" "Northern Brazil"
    "neoplasias" "8q13" "Phosphotransferases" "CKB" "ectoderm" "endoderm"
    "Histology" "ClinicalTrials" "a unique CRC subtype" "CIMP" "positron"
    "fluorodeoxyglucose" "postbaseline" "μg/mL·h" "·h" "milliseconds" "QTc"
    "QT" "AEs" "AE" "Twenty-one" "multisite" "domain-1" "siRNA2" "siRNA1"
    "acetylhistone" "Osteoblasts" "D10" "1α-anti-sense" "os"
    "their respective MREs" "co-synthesized" "+444" "+422" "re-analysis"
    "miR-199a2" "co-regulated" "+1657/+1660" "+1367/+1370" "+1641/+1663"
    "+1351/+1373" "MREs" "-UTR-luc" "∼90%" "MRE" "nts" "qRT" "silic" "HPMVECs"
    "miR-30c" "co-located" "co-transcriptionally" "HPMVEC" "Brittain" "TRV"
    "regurgitant" "lipopolysaccharide (LPS)" "injury/fibrosis" "vaso"
    "Berkeley" "-UTRs" "co-regulation" "co-incubation" "∼2-fold" "+60"
    "∼3-fold" "∼2 kb" "co-regulates" "subproteome" "S/M phase" "pathwa"
    "MAPK3/1" "IVA" "DBF4B" "Riahi" "VECs" "disaggregat" "PPI" "~4.9±0.98%"
    "thee" "n=5" "NKIRAS1" "mol/led" "=5" "MALDI-TOF-MS" "PDQuest" "mmol/l"
    "CGP53353" "Datasets" "retinal apoptosis/angiogenesis" "Forkhead box O3A"
    "previously published studies" "ILM" "INL" "plexiform"
    "anti-neovascularization" "hyperoxia" "oxygen-induced ischemic RNV"
    "cryotherapy" "RVO" "PDR" "RNV" "+429" "=60" "C57BL/6J" "2 /"
    "transformation/proliferation" "further increase c-Myc– pri-miR-9-2"
    "mTORCs" "its nonstar counterpart miR-9-5p" "Further in vivo studies"
    "antagomir-9-3p" "Antagomir-9-3p" "–E2F1" "upshift" "/E2F1" "hsa-miR-9-3"
    "miR-9-3p / 5p" "hsa-miR-9-2" "miR-9-3p/5p" "mature miR-9-3p" "antagomir"
    "mTORC1/2" "rapalogs" "miR-9-3p" "pri-miR-9-2" "Ser 235/236" "Saigusa"
    "Takeuchi" "Zeng" "Further molecular in vitro and in vivo studies"
    "subsite" "Abdulaziz" "Non-parametric" "flurouracil" "non-SP"
    "non-transfected" "miR-144-" "LHSAR+FOXA1+HOXB13" "LHSAR" "cistromes"
    "ARBS" "prostatectomy" "CWAS" "cistrome" "_1" "+ 3" "& E" "48-hour"
    "non-specificity" "Manley" "James" "monomer/dimer" "the DNA-bound subset"
    "co-enriched" "O-purified" "co-purified" "TERT-∆PAL" "F-tagged" "∆PAL"
    "non-disruptive" "NAAIRS" "roline/" "inker" "ciliate" "∼fourfold"
    "TTAGGG-3" "at least ∼100-fold greater" "F-purified" "O-purification"
    "F-purification" "ddATP" "TERTs" "SFP" "Ppant" "phosphopantetheinyl"
    "Tetrahymena" "P6.1" "pseudoknot" "hTRmin" "RRL" "H/ACA" "Tribolium"
    "#21470" "#24152" "#21886" "#22383" "NCX4040" "SW156" "desaturase-1" "SRD"
    "UAS" "Vogelstein" "supress" "emtpy" "H3K56Ac" "LDHb" "PFKm" "Menten"
    "Michaelis" "H3K9Myr" "H3K56" "dox" "larger fatty acyl" "myristoyl" "A89S"
    "Rossmann" "non-GFP" "E260Term" "D25N" "long-chain fatty acyl" "X10" "≥ 75"
    "H3K9Ac" "10.1038/srep14990" "Schelhorn" "Namanja" "WW3" "P-motifs"
    "conformers" "stereoview" "pS184" "Pintide" "1 H- 15" "nmv" "BMRB"
    "phosphopeptides" "IM-MS" "SPPS" "titrant" "ITC" "CPEB 1" "HSQC" "Nechama"
    "2n1o" "CPBEs" "CPEB4" "a ZZ-domain" "ZZ-domain" "ZZ" "CPEBs" "pSerPro"
    "CPEB1" "at 4 " "= 7" "oxidative stressors" "two oxidative stressors"
    "Braak" "IQR " "EAATs" "Aβ" "NFT" "CFAS" "neuropathology" "= 0.99"
    "OR = 1.00" "OR = 0.99" "= 0.06" "=  0" "= 89" "10.1038/srep14800"
    "reevaluate" "6503delTT" "genome-wide association studies (GWAS)" "iCOGS"
    "exomes" "236/18,187" "Google Scholar, and identified 23 studies" "Google"
    "Lifepool" "non-carrier" "14/33" "breast/ovarian" "ViP" "1.00–2.34"
    "the relatively common rs11571833" "rarer" "dis" "IVS" "iCOGs" "66/2634"
    "33/1996" "a neutral polymorphism" "rs11571833" "= 0.89" "re-evaluate"
    "CD-C464A" "disrupted/weakened" "S4S8p" "siUSP4-2" "IRIF"
    "which yields replication-associated one-ended DSBs" "Wijnhoven" "S5D"
    "non-covalent" "∼25%" "SMAD2/3" "miR-628-3p" "Hsa-miR-628-3p"
    "immunophenotype" "hsa-miR-628-3p" "hsa-miR-513a-5p" "factor-kB" "PCA"
    "other aggressive B-cell non Hodgkin’s"
    "other aggressive B-cell non Hodgkin" "8/10" "4/6" "CEP 8" "USP13si" "NCsi"
    "migratory/invasive" "Myofibroblasts" "fibrillar collagens" "collagens"
    "the pulmonary parenchyma" "= 3" "Migration/invasion" "non-kinase"
    "LFS/LFLS" "Custódio" "Ribeiro" "5–9" "rs78378222" "polymorphism (SNP)"
    "adrenal medulla" "Southern Brazil" "phyllodes" "LFLS" "Brazil" "Geile"
    "Pogue" "PIK3CAwt" "PIK3CAmut" "lobular histology" "Cohen’s" "Cohen"
    "PIK3CAkin" "PIK3CAhel" "Lobular histology" "Sanger/qPCR" "HeCOG"
    "GRCh37 / hg19" "JARID1" "an essential co-activator" "~30%" "Carey" "pyro"
    "Succinate" "OGDD" "OGDDs" "dioxygenases" "oxoglutarate" "carnitines"
    "shETV4" "CreateSignature" "Cistrome" "GATHER" "probesets" "shScramble"
    "shACC1" "RIGER" "MSCV" "KG" "succinate" "AKGDH" "TME" "= 7" "~50%"
    "arachidonate" "hydroxyprostaglandin" "tumors/mouse"
    "both hyperplastic bronchial epithelium" "Ex"
    "hyperplastic bronchial epithelium" "the most common histological subtype"
    "13,14-dihydro-15-keto-PGE 2" "50-ml" "± 3.2" "miR-181b" "miR-155–5p"
    "= 30" "co-administered" "rs1042522" "Arg/Pro+Arg/Arg" "Pro/Pro+Arg/Pro"
    "95%CI=0.83–1.35" "95%CI=0.62–1.13" "95%CI=0.55–1.13" "95%CI=0.71–1.22"
    "95%CI=0.81–1.10" "OR=0.84" "OR=0.79" "OR=0.94" "→proline" "P =0.60"
    "OR=1.06" "OR=0.93" "Exherin" "non-seminomas" "Chung"
    "parental and cisplatin-resistant GCT sublines" "Gutekunst" "co-knockdown"
    "NTERA-2R-" "NTERA" "NCCIT-R-" "NCCIT-R" "intestinal epithelium" "-R"
    "NTERA-2R" "YS" "2–2" "MI192 " "3.4±0.4%" "4.9±0.6%"
    "bound non-specifically" "MI192" "Anti-acetylated" "K-fibre" "K-fibres"
    "learnt" "O-methylate" "residual protein O-methylation" "L-isoaspartate"
    "asparginyl" "isoapartyl" "Clarke" "chemoreceptors" "Jr" "Koshland"
    "Springer" "O-methylation" "glutamyl" "aspartyl" "arginyl" "-adenosyl"
    "adenosyl" "sTantigen" "Moore" "Merkel" "&E" "HREm" "AAATG" "ACGTG" "PHTPP"
    "PCPT" "BERKO" "C57BL/6" "IWR-1 significantly" "Histopathology" "ApaLI"
    "MluI" "HincII" "HindIII" "pLuc" "–11" "−990" "si" "IWR-1significantly"
    "zymography" "IWR" "Zeidan" "TESK" "Iκ-Bα" "diabetic nephropathy"
    "43-week-old" "vasal" "tubular edema" "AngiotensinII" "Immunohistology"
    "SHR" "histopathology" "hypertensive nephropathy" "AngII" "angiotensinII"
    "eosin (HE)" "GSPE" "SHRs" "hypertensive nephropathy (HN)" "HN"
    "nephropathy" "non-specifically" "polymorphisms/ADCC"
    "larger cohort studies" "Hurwitz" "H/H" "FcγRIIIA " "CVs" "CV"
    "favourable genotypes" "unfavourable genotypes" "BT747"
    "a favourable genotype" "FcγRIIIA158F" "158 V/V" "FcγRIIIA 158F" "158V/V"
    "R/R" "FcγRIIIA 158 V/V" "E:T" "g/ml" "the heterozygous genotype"
    "both homozygous genotypes" "FcγRIIIA 158V"
    "the homozygous FcγRIIIA 158V/V genotype" "FcγRIIIA 158V/V" "FcγRIIIA158V"
    "131H/H" "FcγRIIIA" "rs1801274" "rs396991" "aminoacid" "FcγR" "isotype"
    "activatory FcγRs" "FcγRs" "FcγRI" "FcγRII" "FcγRIII" "Fcγ"
    "ADCC favorable genotypes" "neoadjuvant (NEO)" "FcγRIIIA/IIA" "P  = 0.002"
    "P = 0.009" "at 4 " "‐described" "gain‐of‐function" "only 25 nmol/L"
    "nmol/L" "‐deficient" "phosphoinositide 3‐kinase" "MARCKS+/−"
    "the internal elastic lamina" "lamina" "Phospho‐MARCKS" "phospho‐MARCKS"
    "Carotid" "42.4%±5.2%" "MARCKS‐GFP" "‐healing" "PLC‐δ" "‐tagged" "‐motile"
    "‐GFP" "membrane‐bound" "‐bound" "GFP‐PH" "Fpm/Fc" "‐PH" "‐δ"
    "membrane‐associated" "‐MARCKS" "S4G" "100%±2.3%" "bovine wild‐type (WT)"
    "‐fused" "±0.07" "phospho‐PAK1" "Rac1‐GTP" "Cdc42‐GTP" "‐GTP" "‐culture"
    "CASMC" "postsurgery" "ex " "4,5‐bisphosphate" "ED" "‐actin" "alanine‐rich"
    "neointima" "intima" "‐migration–dependent" "dedifferentiate"
    "antiplatelet" "the rational forMARCKSknockdown" "‐mediatedVSMCmigration"
    "forMARCKSknockdown" "byMARCKSsequesteringPIP" "carotid" "membranePIP"
    "differentiatedVSMCs" "ofMARCKSin" "forPIP" "unphosphorylatedMARCKS"
    "‐bisphosphate" "ofMARCKSfrom" "smallGTPases" "CASMCs" "MARCKSknockdown"
    "whetherMARCKSknockdown" "S4D" "Wild‐Type" "=10 " "±3" "‐Associated" "‐ to"
    "‐associated" "‐rich" "hTPO" "ASXL" "FLT3L" "depletion/mutation"
    "CBFB-MYH11-" "shUBASH-2" "shUBASH-1" "q" "miR-9-5p" "DHSs"
    "AML1-ETO-knockdown" "UBASH3B/Sts-1" "Sts" "AML1-ETO-expressing"
    "mutations/depletion" "shR" "co-transduced" "ΔE8/9" "shCBL" "AML1-ETO-"
    "Giemsa" "LtSz" "CD34+" "knockin" "8–9" "RUNX"
    "the most common cytogenetic subtype" "CD14+" "and 9" "NOD/SCID" "Huang"
    "BigDye" "Guerra" "radioiodine" "nondominant" "Ahn" "Kuhn" "Giannini"
    "overuse" "mediastinum" "followup" "Walts" "Entrogen" "/3" "P = 0.04"
    "P = 0.02" "P = 0.09" "ICAN" "~0.02%" "LDCT" "NLST" "19Del"
    "gefitinib/erlotinib" "more comprehensive comparison studies" "/Scorpion"
    "xenograph" "SABER" "the salivary genome" "microbiota"
    "The salivary genome" "biomolecules" "urinary cfDNA"
    "further implied urinary cfDNA" "urinary cfDNA genotype" "droplet"
    "nearly all prior studies" "other noninvasive biofluid" "biofluid"
    "ancient genomes" "the pure genomic studies" "pDHPLC" "homoduplex"
    "Heteroduplex" "heteroduplex" "fluoresce" "around 95°C" "around 50°C"
    "the relevant DNA-DNA duplexes" "duplexes" "peptide-like" "phosphodiester"
    "fluorophores" "quencher" "fluorophore" "nontarget" "ASPCR" "biofluids"
    "EFIRM" "DHPLC" "EVs" "cfDNA" "bronchoscopy" "cytology" "ctDNA"
    "quantitative immunohistochemistry (AQUA)" "pMET" "Miyata" "Choi"
    "immunohistochemistry (AQUA)" "CABOSUN" "Fuhrman" "interarray" "clinicians"
    "Further phase III studies" "nephrectomy" "clinical/pathological" "ntigen"
    "ancer" "monomethyl" "HGSC" "7BS" "KMTs" "MTases" "un-" "= 45" "FOXO1A3"
    "pFOXO1" "=0.004" "8- μ m" "μ l" "AKBA" "appropriateness" "HphI"
    "phAR1.6Luc-UTRΔm1" "only 100 bp" "C-rich" "non-denaturing" "dsDNA"
    "G-rich" "Sp1-1" "preimmune" "DNA:protein" "phAR" "Δm2" "+345" "+322" "Δm1"
    "cyctosine" "phAR1.6Luc" "piscine" "an alternative AR-driven transcriptome"
    "Achilles" "ARS" "an approximately 90 bp" "TATA-less" "TATA"
    "approximately 180 kbp" "Xq" "kbp" "Gleeson" "coregulators" "anti-tumour"
    "Krüppel-like" "+87" "SH10" "intestinal histology" "JGCA/7" "pN" "JGCA"
    "UICC" "non-aberration" "Lauren’s" "Lauren" "GECs" "GEC" "TaqMeth" "SSPC"
    "pStage" "HRMGs" "KATO" "= 0.06" "p53 WT" "p = 0.05" "p = 0.03" "5-years"
    "x 10" "x10" "-Aza-dC" "non-radioactive" "displaying anti-proliferative"
    "ZnCl" "succinimidyl" "carboxyfluorescein" "neoT"
    "type 2 methionine amino peptidases" "peptidases" "CAMKK" "mTOR-p70S6K"
    "mTOR" "Fe" "Ser807/811" "± 4" "post-translational mechanism/s" "RNAPII"
    "SKH" "mJ/cm 2" "marianum" "Silybum" "agent/s" "Fraumeni"
    "subsequent gap-filling DNA re-synthesis" "IIH" "Cockayne" "photoproducts"
    "NMSCs" "photodamage" "GADD45α" "formation/repair" "NHDFs" "flavonolignan"
    "GMB" "Kim" "Melguizo" "chemoradioresistance" "parthanatos" "calpaina"
    "Yip" "Bueren" "determining TMZ IC 50" "Yoshino" "μmol/L" "Hegi"
    "Althought" "RealTime" "CD133+" "MGTM" "Goellner" "adduct" "alkylguanine"
    "mispairs" "imidazotetrazine" "-benzylguanine" "benzylguanine" "± 3"
    "50 μg/mL" "5-aza-2" "Adamo" "depletion/inactivation" "Fancd" "Grompe"
    "S3G" "pDNA" "PD20" "non-monoubiquitinable" "ICL-associated DSBs"
    "radiation-induced DSBs" "FANCP/SXL4" "FANCcore" "intrachromosome" "H4K16"
    "S3F" "S3C" "S1C" "S1D" "H4K16Ac" "H4 K20" "H4K20" "non-breast" "rs861539"
    "rs25487" "Africans" "genotypic polymorphisms" "XRCCs" "=2.02" "0.60-3.51"
    "OR=0.73" "A/G" "inTables" "Genotypes" "Arg399Gln" "Jordan" "rs1799794"
    "399Gln" "XRCC" "p =0.02" "polyphenols" "chlorophylls" "polyenes"
    "non-thiol-containing" "Nrf2-" "Nrf" "at 4" "approximately 50~70%"
    "chemico" "Bay117085" "shinone" "AuNP" "AuNPs" "ILD" "Porębska"
    "a unique subset" "PBMNC" "Smads" "sarcoid" "HRCT" "spirometry" "Smad 2/3"
    "CD25 + " "P  = 0.02" "P  = 0.01" "P  = 0.03" "1 /" "p  = 0.01" "p  = 0.03"
    "CD8 +" "TAE" "titre" "SNV" "SNVs" "aCGH" "GTEx" "RNApol" "Ser235/236"
    "Non-synonymous" "≥100" "non-melanoma" "jejunostomy"
    "had prophylactic laparoscopic total gastrectomy"
    "the prophylactic laparoscopic total gastrectomy" "6/11" "60-day"
    "laparoscopy" "re-operation" "prophylactic laparoscopic total gastrectomy"
    "laparoscopic total gastrectomy"
    "Prophylactic laparoscopic total gastrectomy" "11/11" "9/11"
    "underwent prophylactic laparoscopic total gastrectomy"
    "Laparoscopic total gastrectomy" "prophylactic gastrectomy" "E-cadherin-1"
    "10.1038/srep14806" "Pandey" "moonlights" "oncomouse" "re-introduction"
    "blown" "histochemistry" "WAF1/Cip1" "de-regulation" "H3K18ac" "H3K18"
    "P-value" "4, 5-dimethylthiazol-2-yl" "non-transcriptional" "Kumarswamy"
    "immunotherapy" "BAT" "EV" "SFM" "mechanism/s" "miR-212-3p" "non-protein"
    "∼22nt" "SIRT" "ug/ml" "anti-oncogenic" "oncomirs" "Hoechst/PI"
    "anti-miR-23a" "Caspase 3/7" "caspase 3/7" "miR-26a" "MetLUNG"
    "non-squamous" "MARQUEE" "unmet" "FNAs" "stratifier" "immunoarray" "CU"
    "non-activating" "19/34" "immunoassay" "circuitries"
    "Several subsequent randomized phase III studies" "offs" "non-responders"
    "= 8" "PF-004777736" "NFKB" "JEKO" "deocycitidine" "BrdUrd" "JEKO-1 R"
    "JEKO-1R" "AZD-7762" "re-overexpression" "IC50s" "± 6" "HLEC" "footpad"
    "footpads" "EC109" "TSNs" "HLECs" "LYVE" "SARAH" "1/" "capillary-like"
    "non-tumorous"
    "the AMP mimetic drug 5-Aminoimidazole-4-Carboxamide Riboside (AICAR)"
    "Riboside (AICAR)" "Riboside" "KICH" "KIRC" "KIRP"
    "the proximal and distal renal tubules" "Henle"
    "Periodic-Acid-Schiff (PAS)" "km25" "osmo" "gpdh" "flcn - 1" "gk378"
    "tm1944" "gt33" "ok524" "anoxia" "pygl-1" "gsy-1" "glucose-1-phosphate"
    "hypodermis" "ok975" "hypernatremia" "FLCN-1" "gpdh-2" "flcn-1" "~2-fold"
    "Birt-Hogg-Dubé" "possible confounders" "*A/G" "T+8473C" "non-Chinese"
    "GA+GG" "English" "synthases" "endoperoxide" "SCOPUS" "=0.99" "p=0.09"
    "GA+AA" "modulation/preservation" "Fontaine" "latters" "Gambino" "Scheiber"
    "Lombardo" "wt-p53-Huh7.5.1" "Wt" "Cu" "Lowenstein" "Yamakuchi" "Vaziri"
    "Lechón" "Gómez" "Baylin" "tryglicerides" "oleic" "Wilson" "Medici"
    "Aigner" "Leary" "Cytox" "Gori" "Fersht" "Joerger" "Petitjean" "Derdak"
    "Panasiuk" "Starley" "Schreuder" "Anstee" "Veteläinen" "Vanni" "NAFLD"
    "corticosteroid" "Corticosteroids"
    "created mouse conditional Hdac4 APC deletants" "deletants" "Ogn" "NF-κB1"
    "co-stimulatory" "TFSearch" "2.3-kb" "Mir22hg" "FSL-1" "MoDCs"
    "non-emphysema" "BALF" "overnight ex vivo" "homogenates" "Mir22" "Mir"
    "approximately 23 nt" "the pulmonary microvasculature" "microvasculature"
    "alveoli" "nCB" "nanoparticulate" "mice/group" "Eight-week" "eight-week"
    "I:C" "non-users" "mesenchymal stroma/stem cells" "further in vivo studies"
    "/mouse" "22d" "SCCOHT-1-" "p44/42" "preform"
    "the ovarian adenocarcinoma NIH:OVCAR-3" "/ mouse" "71d" "10d" "8d"
    "the ovarian adenocarcinoma cells NIH:OVCAR-3" "Thr202/Tyr204" "/Tyr204"
    "gynecopathology" "Mannheim" "glycosyl" "CD90"
    "the established human ovarian adenocarcinoma NIH:OVCAR-3" "rhabdoid"
    "Pro1180fs" "epithelial-like" "paraendocrine" "SCCOHT-1" "SCCOHT"
    "NIH:OVCAR-3" "non-small-cell" "6/15" "Zhou" "chromatograms" "LC-MS/MS"
    "HCT116 p53 +/+" "nuclear/cytoplasmic" "APC/C" "artefact/mutations" "Ito"
    "DeCicco" "2/33" "Missense" "and 2+" "only two studies"
    "the major histological subtype" "13/33" "11/33" "13/40" "10/35" "nonsmall"
    "2/" "μ g/mL" "and 3+" "only PvuII polymorphism" "only 2 studies"
    "further functional studies" "only TT genotype" "p=0.02" "Egger’s" "Begg’s"
    "OR=1.08" "OR=1.05" "p=0.03" "p=0.01" "TC+CC" "TT+TC" "Alzheimer’s" "Gu"
    "TT + TC" "XbaI" "=0.97" "≤50" "Marzo" "the glandular epithelium"
    "glandular epithelium" "Qmax" "QOL" "RUV" "the glandular lumens"
    "myofibroblasts" "SI" "NI" "TURP" "mean ±SD" "non-inflammatory" "naevus"
    "Denmark" "relatedness" "Relatedness" "Leeds" "uveal" "GenoMEL" "~50 %"
    "3/" "FRB" "‐terminal" "‐D" "v‐Ras" "‐Ras" "pM" "wild‐type" "Thr 37/46"
    "S6RP" "‐existent" "OCUM‐2M" "in‐house" "‐house" "‐type" "#G4T" "‐exome"
    "‐Val" "‐to" "non‐synonymous" "3‐kinase" "‐kinase" "thatmTORacquires"
    "theFAT" "ofmTORin" "‐synonymous" "ofmTORthat" "themTORgene" "‐time"
    "‐apoptotic" "‐of" "‐insensitive" "the eutopic endometrium" "peritoneum"
    "pre-transplantation eutopic endometrium" "laparotomy" "21-day"
    "intense nuclear co-localization" "Dual immunofluorescence studies"
    "pulldown" "TOPflash" "ICI" "mol/l" "non-obese" "eutopic endometrium"
    "dual immunofluorescence studies" "HESCs" "non-phosphorylated" "48 h"
    "Co-transfection" "∼10%" "Chiabrera" "Gervais" "Has" "Hinsenkamp" "Collard"
    "non-exposed" "mind previous studies" "re-programming" "physio" "mT" "Hz"
    "EMF" "±3.1" "mean±SD" "myofiber" "polyQ" "4p16.3"
    "an important polymorphism" "Europeans" "5q35–qter" "co-dominant"
    "rs3135848" "rs2234909" "Genome-wide association studies" "rs351855"
    "rs1966265" "Heilongjiang" "HepJ5" "the well-differentiated HCC sublines"
    "ICDH" "antioxidant/metabolic" "andTables" "pH 3–10 nonlinear IPG"
    "Approximately 450 μg" "IPG" "IEF" "Chang" "De-differentiated" "multifold"
    "Cδ" "microparticles" "caspaes" "Ki8751" "supernatant" "CASP3DN" "Fluc"
    "hidden" "± SEM" "6 Gy" "μmol" "X-irradiation" "Nutlinpre"
    "labeling nucleoside analogue 5-ethynyl-2" "5-ethynyl-2" "-deoxyuridine"
    "Histone2AX" "Wee1i" "cyclotherapy"
    "available deoxyribonucleotide triphosphates" "triphosphates" "dFdC"
    "-difluorodeoxycytidine" "difluorodeoxycytidine" "20μg/ml" "co-cultures"
    "co-culture" "= 0.05" "9 ± 3" "P = 0.009" "stem/progenitor" "intermediacy"
    "mitochondrialO" "Hodgkin's" "+0.9180" "+0.9339" "PCC" "HeLa/Neo"
    "Hela/Bcl-2" "CEM/Bcl-2" "HeLa/Bcl-2" "vis" "14q32" "18q21" "breakpoint"
    "•−" "Nox" "Cellworks" "20 μg/ml" "Christgen" "Dabbs" "day-to-day"
    "the previously reported concordance studies" "DRFI" "scatterplot"
    "ASCO/CAP" "ECOG" "Oncology/College" "Kaiser" "FPE" "polysomy"
    "chemoendocrine" "NCCTG" "Clinicaltrials" "nonsignificant" "Onco" "= 9"
    "HER2 /CEP17" "IHC 3+" "IHC 3+" "–III" "SISH" "CEP8" "cobas" "24/79"
    "Reidy" "Dancey" "sigmoid" ":CEP8" "a heterogenic genotype"
    "targeted therapy-specific mutation studies" "Christopher" "II-III"
    "copies/nucleus" ":centromere" "≥ 3" "P- value" "-III" "co-existence"
    "At least 3 scenarii" "unusual genotype/phenotype co-occurrence"
    "co-occurrence" "large-scale inter-chromosomal breakpoints" "breakpoints"
    "BRCAness" "tetraploid" "a prophylactic oophorectomy" "oophorectomy"
    "Elston" "non-sentinel" "heterogeneously dense breast parenchyma"
    "Digital mammography" "mammography" "Curie" "Institut" "year-old"
    "scenarii" "≥ 1" "CK5/6" "tricuspid" "urethra" "embryology"
    "non-cardiomyocyte" "0.11 ±" "non- cardiomyocyte" "±4" "±6"
    "non- cardiomyocytes" "iVSDs" "atria" "markedly hypoplastic myocardium"
    "non-cardiomyocytes" "iVSD"
    "embryonic development causes VSD-associated CHDs" "CHDs" "P-values" "Bela"
    "Kappel" "Sonja" "Mark53" "Ltd" "Kandioler" "Daniela" "PANCHO"
    "p53-gene-specific" "-gene-specific" "IIIA/B" "non-significant"
    "1.344–3.378" "LEV " "LEV" "IIIC" "The prognostic covariates" "NNsplice"
    "ABCSG-90" "ABCSG" "= 1" "95 % CI" "rs412658" "rs2293607" "rs7705526"
    "rs2736108" "only two SNPs" "|=0.95" "|D" "histologic subtype"
    "95% CI=1.07-2.07" "95% CI=1.18-2.54" "rs2853669" "Korean" "P =0.03"
    "P =0.02" "ionic" "/cm 3" "shockwaves" "DNA/chromatin" "quasi"
    "Multiphoton" "the consecutive macropulses" "macropulse"
    "smaller peak irradiances" "macropulses" "MHz" "shockwave" "picosecond"
    "nanosecond"
    "precise site-specific nano-processing and cellular nanosurgery"
    "nanosurgery" "nano" "multiphoton" "thermo" "tissue/cells" "NuRD"
    "methylated H4K20" "focal spot peak irradiance" "PARGi" "pChk2" "pChk1"
    "H2AK15" "Ai+Di" "Ai" "NU1025" "UVC" "W/cm 2" "polarizer" "irradiances"
    "fs" "tridactylus" "irradiance" "TTAGGG" "Ku" "UVA" "UDR" "submicron"
    "cause chromosomal rearrangements/loss" "femtosecond" "conditions/dosages"
    "co-inhibition" "S2C" "PAM50" "SABCS" "NSABP" "re-classifies" "1–9 "
    "Iwamoto" "ERD7" "MINDACT" "HR+" "an excellent 10 years DMFS"
    "surrogate pathology-based clinical subtypes" "re-assessment"
    "the surrogate pathology-based IHC/FISH subtype"
    "a discordant molecular subtype" "Central re-assessment" "Uni" "1.38–9.50"
    "a 10-year" "re-classified" "B-type" "A-type" "pCR" "10-year" "DMFS" "1-2B"
    "HealthSystem" "NorthShore" "mastectomy" "lumpectomy" "MammaPrint" "–9 "
    "= 10" "= 44" "= 60" "IHC/FISH" "95 %CI" "10.1038/srep14615" "BCSCs"
    "Kazan" "ThPOk" "FOXP3+" "CD25−" "CD" "Th17" "SZ" "Medzhitov" "Pasare"
    "-β1" "co-assay" "isozymes" "Material/Methods"
    "the most meaningful endpoint" "ASCO" "NA" "na" "non-super-expressors"
    "the optimal HER2 SRM-MS" "HER2 IHC 2+" "GCN" "HER2/CEP17"
    "non-overexpressors" "retest" "overexpressors" "IHC3+" "HER2 IHC 0+" "sd"
    "0+" "1+" "diagnostic core biopsies" "SRM-MS" "amol/μg" "= 9" "~20%"
    "the different histologic subtype" "only few studies" "mADC" "and 3/10"
    "7/10" "5/12" "12/122" "cribriform" "lepidic or mixed subtype" "histotype"
    "Sica" "ERS" "ATS" "IASLC" "adenocacinomas" "AdSqLCs" "mADCs" "exon 19"
    "larger datasets" "ORs" "classic case control studies" "CEU" "Caucasians"
    "rs2981582T" "rs2981579T" "rs2420946T" "Jews" "Sephardi" "Ashkenazi"
    "Raskin" "intron-2" "rs1078806" "Rs2981582"
    "the homozygous minor allele genotype" "homozygote" "C/T" "resp"
    "rs1219648" "JPT" "HCB" "confounders" "postmenupausal HT non-user"
    "non-user" "SCBCGS" "large genome-wide association studies (GWAS)" "&PR−"
    "&HER2+" "rs2981582" "rs2981579" "rs2420946" "P = 3.7 × 10" "T/C" "95% CIs"
    "χ  2" "≥10" "PR+" "luminal-like" "S-checkpoint"
    "hydrolytically labile Lys monoadducts" "accessible H3K9" "monoadducts"
    "ATMi" "carbonyls" "multimers" "non-reducing/non-heated" "ssDNA" "PFGE"
    "ATRi2" "Seckel" "other genotoxic stressors" "Ser1981"
    "readily forms adducts" "global chromatin decondensatinon"
    "decondensatinon" "MRN" "form amino group-based adducts" "dG" "± 4.2"
    "10.1038/srep14723" "siRNA/radiation" "non-target" "pcDNA" "non-targeted"
    "-aza-dC" "Profiler" "MB-231/ERp29" "radioresistant" "ERp29\\MGMT" "alkyl"
    "DOX" "adducts" "\\MGMT" "5-Aza-2" "H3K27" "6 Gy" "10.1038/srep14538"
    "Kesarwani" "ONO12380" "further structural and biochemical studies"
    "subdomains" "subdomain" "JH1" "erloitinb" "mono-therapy" "JAK2-V617F-"
    "Y1045W/" "IFWY" "I1018F/W" "bulkier" "Microscale" "app" "Tactin" "Strep"
    "3TJD" "2B7A" "Autodock" "AutoDock" "SWissDock" "PDB:2B7A" "AZD1840"
    "P-loop" "der" "SwissDock" "TF556PS" "Witte" "Whitlock" "SWISS" "FERM"
    "CYT-387" "anti-kinase" "d  " "Balb/c" "JAK2V617F" "and 2J"
    "the isogenetic EGFRvIII− and EGFRvIII+ sublines"
    "our established isogenetic sublines" "the two DKMG sublines" "Gy"
    "the DKMG sublines" "activation/phosphorylation" "EGFRvIII+" "EGFRvIII−/+"
    "radioresistance" "already several pre-clinical studies" "DMC" "BS153"
    "DKMG" "re-seeded" "p53wt" "HU" "HNSCC" "FasR" "Ohba" "supershift" "ofbim"
    "andbim" "inducecyclinA" "re-synthesis" "pSUPER" "p38K"
    "chloroethylating nitrosoureas" "eta" "nitrosoureas" "Hodgkin"
    "-ethenoguanine" "ethenoguanine" "crosslinks" "ClG" "-chloroethylguanine"
    "chloroethylguanine" "CCNU" "exosomes" "Exosomes" "exosome" "P = 0.03"
    "P = 0.01" "P = 0.002" "P = 0.003" "P = 0.043" "Cse4" "Immunoglobulin"
    "E-boxes (CACGTG)" "CACGTG" "RpoE" "NusG" "shSUPT5H" "shSUPT5H-1" "shNSC"
    "shSNC" "Spearman's" "internet" "Finnigan" "Thermo" "MDLC" "Comassie" "Ty"
    "E-boxes" "Manish" "Strzelczyk" "Du" "Bissell" "LaBarge" "Shmelkov"
    "anti-metastatic" "Ser33,37/Thr41" "CSC-like"
    "adenomatous polyposis coli (APC)" "mammosphere" "Ocana" "0.001r"
    "subserosa" "submucosa" "Con/sh" "TOP/FOP" "re-distribution" "Ser33/37"
    "significantly ( p < 0.001) greater" "significantly ( p < 0.01) greater"
    "cells/mouse" "calipers" "Vernier" "HT29 cells/mouse" "MFI"
    "significantly ( p < 0.01–0.05) greater" "stem cell-like" "mCRCs"
    "harboringKRAS" "HOSE" "iBMK" "orKRAS" "activatingKRAS" "andKRAS" "onKRAS"
    "vacuole" "pCM184" "the autophagic marker Atg8p" "Atg8p" "ras2"
    "non-cancer" "stressful" "orthologues"
    "normal human colon mucosal epithelium" "_5" "/V" "anti-tumorigenic"
    "ccRCC" "urea" "ofFlcn" "SRCCs" "sarcomatoid" "SRCC" "theFlcn"
    "breedingFlcn" "UOK 257-1" "RCC/oncocytoma" "chromophobe" "dermal Kaposi's"
    "dermal Kaposi" "Kaposi" "5× 10" "Birt–Hogg–Dubé" "very few studies"
    "Behav" "Biochem" "Pharmacol" "PNAS" "Ozcan" "PLoS" "Witek" "JBC" "Lutz"
    "Moog" "agonist/antagonist" "Lorén" "DelGR" "‘superactivate’" "Jeb"
    "heparins" "GAR" "CLB" "superactivate" "mAb48" "plasmon" "Biacore" "GMR"
    "pALK" "FAM150A " "FAM150B" "FAM150A/B" "FAM150A" "FAM150" "readout"
    "proteome" "meprin" "Jeb " "Umapathy" "B-containing" "∼70%" "Goh"
    "Sigismund" "Munger" "Akerman" "Sizemore" "Hwang" "PyST" "Fulda" "Yarden"
    "HPV-1" "Kiyono" "Elbel" "Ishiwatari" "Pillai" "Reshmi" "Boyer" "Scheffner"
    "Dyson" "Schiffman" "cervical adeno-" "Castellsague" "Walboomers" "adeno-"
    "adeno" "and 3D" "Taniguchi" "Goetz" "Zernicka" "Leung" "∼81%"
    "Soonthornthum" "Schrevel" "vi"
    "the multidimensional cancer genomic datasets" "Xu" "Melnikow" "Xiao"
    "Stoler" "the cervical epithelia" "HFK" "Shai" "Lambert" "CK1δ/ε" "Yee"
    "Fogh" "Chittenden" "the soft agar" "Friedrich" "Hippo/YAP" "EGF-like"
    "Hong" "shCtrl" "Fluorescent immunohistochemistry" "Biolabs" "soft agar"
    "siYAP" "The cervical epithelial cell line Ect1/E6E7" "Ect1/E6E7"
    "Anderson" "Fichorova" "MXIV" "ME180"
    "Further analysis using 135 cervical cancer genome" "Cerami"
    "the ectocervical epithelium" "Strano" "Guan" "Steinhardt" "Muramatsu"
    "Fernandez" "Zender" "Overholtzer" "Snijders" "Hergovich" "Avruch" "Kang"
    "Zhao" "Dong" "large tumor suppressor kinase 1/2" "Mps"
    "cervical epithelium" "Berek" "Chan" "Mahdavi" "Siegel" "Koutsky" "Ferlay"
    "Jemal" "et " "5 × 10" "× 10" "CK1δ" "or/and" "autocrine/paracrine" "=   0"
    "LATS1/2" "one histologic subtype" "Tomonaga" "EGFR -Mutated LADCs"
    "Ventana" "recut" "acinar-predominant LADCs" "LADCs" "LADC"
    "ectonucleotidases" "FPR-" "FPR" "potentially no detectable Δψm" "Δψm"
    "Rhod2" "-chlorophenyl" "micropipette" "MyoII" "Carole" "A2a" "= 0 µ" "5 B"
    "S2 C" "P2Y" "ZL" "JJC" "QW" "Silico" "‐199a" "‐214" "‐DANCR" "‐10A"
    "‐UCA1" "MDA‐MB‐231 cells" "lncRNA‐ DLEU1" "qRT‐PCR" "chromsone" "‐REPORT"
    "miR‐19" "‐19" "DLEU1" "triple‐negative" "miR‐19b‐3p" "miR‐19a‐3p"
    "uc001ver" "‐ESR1" "Cytoscape" "‐square" "‐ and" "mirDB" "protein‐coding"
    "‐5" "miR‐20a" "miR‐17‐5p" "RT‐PCR" "‐18b" "miR‐106a~363" "‐106b~25" "‐18a"
    "miR‐20b" "miR‐106a" "miR‐25‐3p" "‐93" "‐20a" "miR‐17‐3p" "miR‐17"
    "miR‐17‐92" "‐5p" "‐106b‐363" "‐106b‐25" "paralogues" "‐19b‐3p" "miR‐19a"
    "‐17" "miRNA‐mediated" "quantitative RT‐PCR" "Hurteau" "miR‐200c" "miR‐141"
    "‐141" "‐200c" "‐wide" "MDA‐MB‐231" "MCF‐7" "‐231" "‐MB" "‐negative"
    "this very aggressive subtype" "ER‐positive" "‐positive" "well‐regulated"
    "‐inactivation" "‐coding" "RNA‐induced" "the intricate transcriptome"
    "ncRNAprofile" "themRNAand" "ofERis" "ofESR1" "‐regulate" "‐19a" "13q"
    "lncRNA‐DLEU1" "co‐expression" "‐DLEU1" "‐expression" "‐25" "‐106a" "‐363"
    "‐20b" "‐92" "theMCF‐7" "‐148b‐3p" "‐130a‐3p" "‐19a‐3p"
    "‐codingRNAexpression" "differentERphenotypes" "mRNAnetwork"
    "expressedmRNAs" "inMCF‐7" "miRNAwas" "lncRNAand" "ofmRNA" "theERmay"
    "ofRNAs" "Up‐regulated" "‐based" "μ g" "IALT" "CALGB" "ANITA" "LACE"
    "Mascaux" "the last 20 years many studies" "1.00-1.94" "HR = 1.39"
    "1.03-1.94" "CONSORT" "co-morbidities" "95%Confidence" "Non-Small-Cell"
    "phosphotylations" "HCT116/P" "HCT116/R" "–9" "cobblestone-like"
    "5-dimethylthiazol-2-yl" "8-chloro-adenosine" "significantly change H3K36"
    "heptapeptide (YSPTSPS)" "YSPTSPS" "mir" "a Burkitt's" "8AA" "T/T" "G/G"
    "14–3-3 σ" "p53REs" "Non-genotoxic" "co-localizes" "transducers" "4SA"
    "YAP/TAZ" "HXRXXS" "MST1/2" "nonmalignant" "TEADs" "PDA" "regulator-1"
    "Further mechanistic studies" "TEA" "PcDNA3" "cytopenias" "Bejar"
    "mutlivariate" "the ancestral T-allele" "5q34" "G-allele" "C-allele"
    "karyotype" "non-del" "minute-2" "= 0.04" "EMT-like" "Semi" "MET-like"
    "CAFTD01" "CAFTD03" "CAFTD" "homolog (MDM)" "20 μg/mL"
    "epithelial/mesenchymal" "p53 wt" "prostaglandins" "RhoGDI-2" "siLuc-"
    "siRhoGDI" "pRNA" "siLuc" "RhoGDIs" "1 × 10" "co-precipitates"
    "10.1038/srep14362" "Qiu" "ROP" "inhibitd" "hRMVECs" "oxidases"
    "SB20358046" "P-1+" "P-1 + " "DUOX1/2" "sequence-2" "sequence-1" "siRNA-1"
    "AAV" "CNV" "OIR" "pho" "Cytochrome b558" "NOXs" "± SEM" "× 10" "1 × 10"
    "its pro-proliferative action BARD1β"
    "its pro-proliferative isoform BARD1β" "BARD1ε" "semi" "sircol" "NuLI-1"
    "GraphPad" "RNAeasy" "Qiagen" "Biolegend" "an endotracheal catheter"
    "Bonaduz" "Hamilton" "catheter" "diaminobenzidine" "Abcam" "Bethyl"
    "the Hôpital Bichat" "Geneva (HUG)" "Bichat" "HUG" "Geneva" "BARD1β"
    "particular BARD1β" "fibro" "IPF" "coworkers" "Naguib" "Cowchock"
    "encephalomyopathy" "cecum" "shNC-" "Boyden" "shβ-catenin#2" "spindle-like"
    "Grasso" "Fopflash" "Topflash" "shAIF#2-" "shAIF#1-" "shAIF" "shAIF#2"
    "shAIF#1" "shNC" "Bio" "ΔNADH" "non-reducing" "immunoelectron"
    "intermitochondria" "FAD2" "AIFsh2" "AIFsh3" "AIFsh" "AIFshort" "NAPDH"
    "FAD" "P -value" "P -values" "5 × 10" "× 10" "+3" "+2"
    "the female reproductive lifespan" "follicle" "neurokinin" "Kallman"
    "overs" "oocytes" "SLC04A1" "non-DDR" "18 previously identified ANM SNPs"
    "OR=1.030" "=2.78×10" "one-year" "=2.25×10" "BCAC" "logORs" "HapMap 2"
    "P=0.01" "P Binomial =0" "P=0.003" "p=1×10" "pleiotropy" "NHGRI"
    "traits/diseases" "premutations" "ovarioleukodystrophy" "#5" "in/near"
    "eQTL" "#37" "non-synonymous" "nearest" "exomechip"
    "at least two non-redundant"
    "SLCO4A1 (solute carrier organic anion transporter family, member 4A1) transports organic anions"
    "anions" "= 3" "Exome" "the previously identified 18 index SNPs" "5×10"
    "1×10" "=3" "×10" "HapMap" "studies (GWAS)" "reproductive lifespan" "ANM"
    "=9" "=10" "=0.67" "2 +" "=0.04" "non-redundant" "=4" "=0.003"
    "Baracitinib" "the Richter's" "Richter" "Philadelphia" "d-" "d" "b-"
    "LFA-1-" "LFA" "underflow" "Penetratin-1" "+ 2" "10.1038/srep14534" "Alves"
    "nodular protusions" "protusions" "toto"
    "robust cytoskeletal reangerangements" "reangerangements" "stess"
    "rhodamin" "MEFS" "Kinome" "autophagia" "TSC1/2" "kinome" "2  +" "Steven"
    "Treeview" "AR ChIP-seq reads around all ARBSs" "HOTAIR -induced ARBSs"
    "a significant decrease at most ARBSs" "very few ARBSs" "ARBSs" "WCL"
    "oligo" "Cruz" "Millipore" "re-analyzed two publicly available datasets"
    "re-analyzed" "HOXC" "Transcriptome" "mainline"
    "biological processes begun" "co-targeting" "200 nt" "global A3B"
    "carboxylcytosine" "formylcytosine" "hydroxymethlycytosine"
    "methylcytosine" "Tjian" "transcription-factor-promoted DSBs"
    "the exceptionally high genome-wide co-localization" "oxoguanine"
    "topoisomerases" "eRNAs" "modification/remodeling" "A/C"
    "biotin-16-deoxyuridine triphosphate" "biotin" "deoxynucleotide"
    "two ubiquitous co-activators" "estrogen/ER" "FUL" "OHT" "UGI" "dU"
    "ER/A3B" "58/155" "13/163" "siControl" "12/109" "43/114" "deoxyuridine"
    "reChIP" "ERE" "browser" "CDA" "the METABRIC dataset" "AID/APOBECs"
    "APOBEC3A" "DSBs" "APOBEC3" "eRNA" "PolII" "Periyasamy" "A3B" "hg19"
    "enhancer/promoter" "co-incident" "S4E" "= 1 " "non-immune" "co-regulator"
    "ER+" "non-homologous" "activation/upregulation" "hypar" "gaster" "ovarium"
    "-Con-transfected" "malignance" "re-examined" "=12" "∼75%" "coprecipitate"
    "nonhistone" "subfamilies" "-κB" "HDAC1/2" "mercaptan" "anti-oxidation"
    "anti-oxidative" "Non-specific" "Yu" "Chigita" "Huh" "Maurer" "mucosa"
    "an essential cytoplasmic signal transducer" "11p11.2" "TM4SF"
    "95 % confidence" "6-month" "co-opted" "nonleaky" "neovessels" "EFGR"
    "siEGFR-" "μl" "5-day" "lumens" "siCtrl-" "siCtrl" "siEGFR" "HEp-3"
    "microarchitecture" "lo/diss" "hi/diss" "± SEM" "non–small-cell" "EDVP"
    "spatio" "TBK1 S527A" "RNATES" "NetPhos" "shDYRK2" "HSV-1" "#3"
    "herpes simplex virus-1" "Sendai" "hPXR" "CMGC"
    "-phosphorylation-regulated kinase 2" "chemoresistant" "SALL4A-" "SALL4B"
    "SALL4A" "RL-952" "stem-like" "≥ 4" "the most significant SNP"
    "the top most significant SNPs" "Browser" "rs237902"
    "The most significant OXTR SNP" "rs2982684" "The most significant SNP" "un"
    "its premalignant condition Barrett’s" "VEGAS" "ribose" "Polymorphisms"
    "Europe" "Australia" "Barrett’s" "BO" "Barrett" "anti-epileptic"
    "metamizole" "Non-conserved" "unitinib" "Cytohesin" "metagroups" "choroid"
    "V-value" "n+1" "pairwise" "VBA" "NormFinder" "geNorm" "BestKeeper"
    "physiopathology" "genesets" "Rpl" "ought" "Crohn's" "mellitus" "Crohn"
    "myocardium" "geneset" "algorithms" "BBB" "Neoadjuvant" "HER2+"
    "Basal-like" "immunobot" "orthologs"
    "murine Gravin −/− seminiferous tubules" "yyy" "seminiferous tubule"
    "Oct3/4" "Seminiferous tubules" "at least two extended Aurora A-binding"
    "A-binding" "p288-Aurora" "heptapeptide" "GSDIM" "p766-Gravin/Aurora"
    "p766-Gravin" "RII" "wild-type seminiferous tubule"
    "the mitotic marker p-H3B" "Seminiferous tubule" "p-H3B"
    "the mitotic marker phospho-Ser 10-Histone 3B" "phospho-Ser 10-Histone 3B"
    "the seminiferous tubules" "nucleate" "the seminiferous tubule" "centriole"
    "overabundance" "enzymology" "seminiferous tubules" "= 37"
    "episomal genomes" "extrachromosomal HPV genomes" "relocalizes" "URR"
    "the late viral protein E1^E4" "^E4" "late transcripts encoding E1^E4/E5"
    "*/E7/E1/E2/E5" "^E4/E5" "HPV episomal genomes" "episome" "2–3" "Sirtuin"
    "shSIRT1" "LHCYE" "pLXSN" "CIN612" "SIRTs" "sirtuins"
    "1 (CIN I) cervical biopsy" "re-circularized viral genomes" "HFKs"
    "viral episomes" "Nijmegan" "DSB" "sirtuin" "S/G2" "viral genomes"
    "episomes" "H4K16ac" "siltiximab" "PD-1L/PD-1" "pre-made" "IGHV" "non-V600"
    "Bruton's" "Bruton" "nantais" "origine" "Recepteur" "CM-118" "NPV" "NVP"
    "The dual mTORC1/TORC2 inhibitor OSI-027" "OSI-027" "OSI" "TORC1/2"
    "taxoids" "crosslink" "Kazi" "B197D6" "gossypol" "Alford"
    "vorinostat/ABT-737" "Eμ-Myc" "serous ovarian cancer ex vivo" "Rahmani"
    "SBHA" "suberoyl" "bis" "Chemoresistance" "Friedriech" "gene-1" "AJCC"
    "IGR" "1/Exportin 1" "E4BP4" "Petrocca" "certain Burkitt's" "PyMT"
    "Radioresistance" "a spherical monolayer" "Kelch-like" "Bcl-xL-" "Bcl"
    "homeobox-1" "compacta" "/Lin" "larger Bim −/− NK memory subsets" "MCMV"
    "Andina" "oligodeoxynucleotide" "Siglec" "Siglecs" "immunoglobulin"
    "Craxton" "the Burkitt's" "anti-μ" "various Burkitt's" "aureus" "Larrubia"
    "lo" "Kurtulus" "triphosphate" "encephalomyelitis"
    "pre-TCR-deficient thymocytes" "the thymic medulla" "medulla" "insulitis"
    "vasculitits" "Weant" "Hutcheson" "T-regulatory" "numbes"
    "cerebral microvessels" "APPsw" "post-mortem Alzheimer's" "cerebellum"
    "mortem" "co-ordinator" "Glucagon-like peptide-1"
    "consequent de-repression" "lifespan" "D-box" "Gilley" "Fhearraigh"
    "phosphodegron" "sphingosine" "to 14-3-3" "non-neuronal cells" "Bonni"
    "RSK1/2" "The pineal gland hormone melatonin" "melatonin" "β-TrCP1/2"
    "Dehan" "NSLCL" "E2B" "miR-129-5p" "miR-27a" "miR-29a" "miR-216a"
    "homology-2" "midbrain" "1,25-dihydroxyvitamin D3" "arabinocytosine"
    "miR-148a" "106b" "the intronic microRNAs 106b∼93∼25" "106b∼93∼25"
    "polycistron" "miR-106b∼25" "miR-9" "co-chaperones" "Juan" "Jiang"
    "Nogueira" "GLIS" "Intron" "Paschos" "EBNA" "lymphoblastoid"
    "hypoxia-inducible factor-1α" "BPC" "JQ1" "pTEFb" "mucoepidermoid"
    "dibenzylideneacetone" "GGGCGG" "Krüppel" "POZ" "Spi-1/PU" "Yang"
    "Horiuchi" "miR-17∼92" "Burkitt's" "Burkitt" "TTCttgGAA" "TTCtacGAA" "Gosh"
    "Gogada" "miR-106∼25" "β1/2" "Abe" "FHBE" "Smad2/3" "Iε" "Chatterjee"
    "Gleason" "FHRE" "Abelson" "Breakpoint" "Egr" "VTLISFG" "homolgy" "Herrant"
    "This study contrasts previous studies" "helices" "α9" "BHRF-1" "Sertoli"
    "peripheral neoantigens" "neoantigens" "inBim" "autoreactive thymocytes"
    "reg" "gammaglobulinemia" "lymphadenopathy" "E9.5" "BimC29201T"
    "The intronic deletion polymorphism"
    "a common intronic 2903bp-deletion polymorphism" "LRRIGD" "LEDIGD" "DKSTQT"
    "E2A" "Bimγ" "MW∼15,000" "Marani" "LEK" "GIFE" "BimABCD" "BimACD" "BimAD"
    "BimABC" "BimAC" "E2C" "an amphipathic α helix" "LRRIGDEFN" "2q13"
    "the severe lymphopenia" "lymphopenia" "KO" "MVILRLLRYIVRLVW" "ortholog"
    "Hsu" "Alzheimer's" "Parkinson's" "Huntington's" "Huntington" "Parkinson"
    "Alzheimer" "Anti-Cancer" "non-small cell lung carcinomas" "miR-221/222"
    "miR-106b" "protein phosphatase 2A" "TSz" "JZs" "further pre‐clinical"
    "‐clinical" "‐expressed" "‐entry" "Bousquet" "Gö6986" "‐response" "cPKC"
    "nPKCs" "cPKCs" "TRPC6‐mediated" "time‐dependent" "PMA‐induced"
    "‐insensitive " "‐sensitive" "PKCη" "‐signal" "‐mediated" "‐incubated"
    "‐elevation" "Q‐PCR" "the atypical aPKCζ" "cPKCα" "isoenzymes" "‐imaging"
    "‐PCR" "‐dependent" "13‐acetate (PMA)" "‐acetate" "‐myristate"
    "glomerulonephritis" "up‐regulation" "‐β" "isoenzyme" "‐function"
    "glomeruli" "‐level" "‐glycerol" "‐sn" "‐acetyl" "‐oleoyl‐2"
    "certainPKCisoforms" "‐expressedPKCs" "andPKCη" "ofPKCα" "onTRPC6"
    "‐acetate (PMA)" "thePKCsystem" "novelPKCisoforms" "thePKCs" "‐influx"
    "‐glycerol (OAG)" "OAG" "ofTRPC6" "‐6" "β 1" "‐overexpressing" "‐specific"
    "50 μg/ml" "all available published studies" "Nakano" "Begg's" "Egger's"
    "Egger" "Begg" "Arg/Arg" "flowchart" "Bergamaschi" "responders" "= 0.67"
    "95%CIs" "= 0.99" "95% confidence" "rs4938723CT/CC " "German"
    "rs4938723 CT/CC" "miR-34c" "rs4938723TT" "codominant" "Quanto"
    "rs4938723 " "CG/CC" "miR-34b/c" "RFLP" "rs4938723" "miR-34b" "= 0.02"
    "= 0.003" "= 0" "95%CI " "= 1" "McCormack" "Salehi" "Crooke’s" "Crooke"
    "Whitelaw" "Widhalm" "covariates" "spearman" "Immunohistochemistry"
    "immunochemistry" "determents" "1.027–1.236" "≤50 " "= 10" "95 % CIs" "χ 2"
    "95 % CI" "= 1" "co-repressor" "Bayrer" "co-operativity" "Lrh"
    "microsatellite" "p53RE" "luc" "Luc" "siLRH-1" "KEGG" "Kyoto" "Genomes"
    "the online tool DAVID" "HumanHT" "siLUC" "azoxymethane"
    "peroxisome proliferator-activated receptor γ coactivator-1α"
    "coactivator-1α" "non-genotoxic" "Co-IP" "co-activators"
    "the previous studies" "1-day" "immunocytochemistry" "MCPIP1 induction"
    "kinase-2" "chloromethyl" "20 min stress-released FPCMs" "FPCMs" "HFFs"
    "the stress-released FPCM" "re-epithelialization" "FPCM" "re-embedded"
    "Toll-like" "10.1038/ncomms9388" "C2α" "3Flag-DVL2" "VOOH-pic ( xref )"
    "VOOH-pic" "VOOH" "o" "vitr" "pS143" "DACS" "pS143-DVL2"
    "Polo-like kinase-1" "3Flag-PTEN" "2–3 " "re-enter"
    "a dominant-negative version Xdd1" "Xdd1" "co-injected" "casein kinase 1e"
    "LUMIER" "EMCCs" "ependyma" "glia" "tracheas" "ciliary rootlets" "rootlets"
    "the ciliary or basal rootlet" "rootlet" "co-injection" "CE" "morphants"
    "morpholino" "laevis" "Duclos" "Lhermitte" "Cowden" "inversus" "situs"
    "Alström" "Grüber" "Meckel" "Motile" "multicilia" "Anti-FLAG" "≥3" "5B"
    "co-stained" "co-localize" "10.1038/ncomms9364" "doi" "pThreonine" "P+1"
    "orthologue" "cerevisiae" "Mis12-Bub1-T589A" "Mis12-Bub1-" "Bub1-" "Bub"
    "Mis12-Bub1WT" "Bub1-WT-expressing" "∼52%" "Bub1-KD-" "Bub1-WT-"
    "chromatids" "H2A-pT120" "NEBD" "lacI-Bub1-WT-" "LacO" "lac" "Lac"
    "Δ740–766" "Δ229–256" "ΔTPR" "Anti-pS679" "pT589" "Anti-pT589" "non-polar"
    "phosphopeptide:peptide" "phosphosites" "phosphopeptide" "SILAC"
    "complex/cyclosome" "KMN" "begun" "benzamidazole" "centromeres"
    "centromere" "≥1" "48 h" "μg " "VAF" "GFRD" "PTKD" "cancerSCAN" "Nov"
    "HiSeq" "CancerSCAN" "panHER" "Bose" "MBCs" "refractoriness" "MBC" "proto"
    "UCEC" "AN3CA/NC" "AN3CA/shKDM4A" "shKDM4A" "siAR" "co-precipitate" "H3K9"
    "MFE-296/NC" "MFE-296/shKDM4B" "shKDM4B" "immunoassays" "H3K36" "KDM4"
    "hirsutism" "activityin" "≥4" "GSE6532"
    "all the publicly available datasets" "GSE22219"
    "a publicly available mRNA microarray dataset" "re-sensitizes" "Choromatin"
    "TFSEARCH" "+132" "+320" "Pri" "pri" "MiR-15a" "re-sensitize" "tamoxifan"
    "pcDNA6B" "oligos" "re-sensitized" "GeneChip" "cFBS"
    "several publicly available datasets" "Δ16" "13q14" "MiR-15a/16"
    "Cyclin E1" "miR-15a/16" "lymphoma-2" "miR-15a" "target/s" "remodelers"
    "cellulo" "AUG" "p53FL" "p53/47" "UTRs" "RB40MC" "RB44MC" "PKRB22"
    "Asn258Glufs*11" "OMIM" "Germline" "suppresser" "940–64C"
    "One novel intronic variant c" "1815–104A" "lsdb" "rb" "HGMD" "PolyPhen-2"
    "Asians" "non-familial" "a 3-year-old" ".1215+1G" ".380+1G" "dbSNP"
    "Uniprot" "non-hereditary" "Asn258Glufs" "*10" "*11" "*13" "*6"
    "unilateral non-heritable" "Pakistan" "_2061insTCATT" "_776del"
    "_1437delAC" "_1119delCACT" "Phenotyping-2" "MutationTaster" "Polymorphism"
    "unilateral/heritable" "bilateral/heritable" "unilateral/non-heritable"
    "bilateral/non-heritable" "penetrant" "non-heritable" "Knudson" "13q14.2"
    "GenBank" "1:20,000" "Pakistani" "leukocoria" "A/B" "ErbB2/ErbB3"
    "cell/surface" "IL-1/NF-kappaB" "Polansky" "~25-fold" "olfactomedin-like"
    "re-emerging" "optimedin" "glaucomatous trabecular meshwork" "Schlemm’s"
    "adhesion molecule-1" "Schlemm" "IOP" "IL-1/NF-κB" "IL-1/" "MYOCs" "pSLIK"
    "A427T" "Q368X" "POAG" "the trabecular meshwork (TBM)" "TBM" "meshwork"
    "Co-treatment" "co-transfected " "‐resistant" "only down‐regulating"
    "‐regulating" "‐induced" "caspase‐3" "apoptosis‐related" "stem cell‐like"
    "c‐Myc" "Xiang" "down‐regulation" "Zenzmaier" "PANC‐1" "up‐regulated" "‐NC"
    "‐DKK3" "‐7" "DKK3‐expressing" "down‐regulated" "DKK3‐transfected"
    "vector‐transfected" "‐regulated" "‐expressing" "‐transfected" "E‐cadherin"
    "‐4" "‐Myc" "Wnt/β‐catenin" "pancreatic ductal carcinoma cell lines Bxpc‐3"
    "non‐cancerous" "‐cancerous" "CFPAC‐1" "Aspc‐1" "CFPAC" "PANC" "MiaPaCa"
    "SW1900" "‐2" "‐1" "Wnt/β" "Dickkopf‐related" "‐like" "‐cadherin"
    "‐regulation" "β‐catenin/EMTsignalling" "thatDKK3" "β‐catenin" "Bxpc‐3"
    "Bxpc" "‐3" "‐catenin" "‐related" "ofDKK3" "OA-like" "Davidson" "explants"
    "osteophytes" "Verdier" "Wu’s" "Pombo-Suarez" "Suarez" "chondro"
    "the last intron" "aneurysm" "a synonymous polymorphism" "rs1049007"
    "Hunter-Thompson-type acromesomelic dysplasia" "congenital hip dysplasia"
    "chondrodysplasia" "dysplasia" "rs143383" "Engelmann" "British" "Japanese"
    "osteophyte" "socio" "Spearman’s" "OA" "= 0.04" "= 0.05" "= 0.02"
    "non-parametric" "SifA" "strong co-localisation" "Pearson’s"
    "co-localisation" "obvious co-localisation" "NleBAAA" "NleB1AAA"
    "asparatate" "adenylyl" "AMPylate" "recognises" "GFP-SseK3AAA"
    "EGFP-SseK3AAA" "non-ubiquitinated" "co-precipitated" "Tripartate"
    "Colloidal Coomassie" "nanotrap" "UVB" "NleB1" "NleC" "NleE" "GogB" "SseKs"
    "sseK1/2/3" "sseK1" "SL1344" "SseK1" "SseK2"
    "enteropathogenic and enterohemorrhagic Escherichia coli" "rodentium"
    "Citrobacter" "SseK" "T3SS" "enterica" "DxD" "N-acetylglucoasmine" "SseK3"
    "acetylglucoasmine" "EPEC" "NleB" "Typhimurium" "Matouk" "loc285194" "EKR"
    "G1/s" "re-expressing" "Edmondson" "9q34" "uc031tfk" "_102735" "UCSC"
    "Magkoufopoulou" "Dreh" "URHC" "HOTTIP" "HULC" "±SEM" "48h" "200nt" "ESFT"
    "Knowles" "microdomain" "farnesyl" "Silvany" "Gladbach" "Bergisch" "Biotec"
    "Miltenyi" "miRXplore" "22q" "11q" "1189±219mm3" "MHH" "5b" "CGTG" "CGTC"
    "hrs" "hr" "Rothenberg" "Billups" "immuno" "Multivariate" "let-7a-2"
    "let-7a" "Vito" "Aryee" "let-7 as" "non-treated" "= 0.01" "-COP" "COP"
    "Sec31" "COPII" "GALNTs" "ultrastructure" "WHAMM" "fragmenter" "MetaXpress"
    "ribbon-like" "CBLB" "cisternae" "mGluRs" "Cal520" "brighter" "FXS-3"
    "Ctr-3" "i-IP 3" "permeant" "FXS-2" "UV" "isotypes" "co-morbidity"
    "the Ca 2+ -sensitive fluorescent indicator Fluo-8" "Fluo-8" "Fluo" "FLIPR"
    "Niemann" "Sachs" "Tay" "temporo" "axon" "trisphosphate" "F / F"
    "Cterminus" "APC2 R2/B" "Daphnia" "Coomassie" "hAPC1R2/B" "R2/B/GSK3"
    "typo" "Reinhardt" "20 Rs" "photoactivatible ßcat" "confusing-one"
    "APC2∆R2" "∆R2" "APC2+Axin" "if/how" "CK1epsilon" "∼30%" "Polakis"
    "non-phosphorylatable" "APC2 + Axin" "Bienz" "Kirschner" "APC+Axin" "ßcat"
    "phospho-mimetic transgenes" "transgenes" "coomassie" "1338 AA"
    "abundance/increase" "size/volume" "accurate/clearer" "clearer"
    "proteosome" "an online journal eLife" "Fiona" "re-focused" "co-IPs"
    "hAPC1 S" "co-IP" "photoactivatible βcat" "Maternal/zygotic"
    "only cortical βcat" "nearly all denticles" "denticle" "denticles" "Wg"
    "∼50%" "phosphomutants" "APC2DD" "APC2AA" "APC2ΔR2" "APC2Arm"
    "APC2ΔSAMPs:Axin" "BIO" "ΔR2" "ΔB" "rpts:Axin" "∆B" "∆Armrpts" "APC2∆SAMPs"
    "simpler" "APC2ΔSAMPs" "APC2ΔArm" "ΔSAMPs" "ΔArm" "hAPC2" "ImageJ"
    "length/complexity" "cables/sheets" "SIM" "hAPC1's" "1338aa" "20R1"
    "co-IPed" "∆SAMPs" "hAxin1" "5-20x" "multimer" "hAPC1" "R2/B" "20Rs" "20R2"
    "CID" "simplest" "effectively target βcat" "hetero" "βcat"
    "Adenomatous polyposis coli (APC)" "coli (APC)" "∼80%" "coli" "DOI"
    "Pronobis" "eLife" "/μM" "∼20%" "the metastatic A375M" "Riker" "Oncomine"
    "SPRYs" "shGFP" "type-1" "= 0.02" "Euclidean" "IDCs" "0.764-1.000" "CMI"
    "x" "apocrine" "targetoid" "IDC" "= 0.004" "= 0.002" "= 0" "= 0.003"
    "Z-scores" "≥10 " "de-differentiated" "histotypes" "-trimethoxy"
    "trimethoxy" "flavonoids" "expression/stability" "benzo" "clinico"
    "five previously published microarray datasets" "AHRR" "penetrance"
    "its most frequent histologic subtype" "expression/activity" "3B" "DUSP14"
    "coassociate" "ESCRT" "TFLLRN" "Evans" "monolayers" "K3R"
    "endocytic punctae" "punctae" "tdTomato" "anti-pan"
    "multivesicular bodies/lysosomes" "q/11" "12/13" "coagulant" "S5 C" "1–3"
    "3 B" "S2 D" "19q13.41" "malignances" "fibroblastoid" "Re-expression"
    "miRanda" "TargetScan" "Ag" "anti-oncogene" "FIGO" "U -test" "= 0.001"
    "= 1" "non-cancerous" "further mechanistic studies" "UBXDs" "Ubxn7"
    "midline" "situ" "morpholinos" "assymetry" "BBSsome" "NMS-873"
    "Chlamydomonas" "CSAP" "DBeQ" "MEVPR" "co-trafficked" "TIRF" "IMCD" "IFTB"
    "CompPASS" "UBXN2B" "hexamer" "UBXN6" "UBXN11" "FAF2" "APMS" "BioGRID"
    "BAG6" "the known VCP-associated deubiquitinating enzyme VCPIP" "VCPIP"
    "UBXN7" "nonrandom" "datasets" "topology" "Overview" "Z-score" "NWD" "APSM"
    "Comp" "HCIPs" "AP-MS" "C-terminally" "HAUBXD" "BBSome" "Paget's" "Paget"
    "UBXN10" "anterograde" "IFT" "UBX-domain containing adaptors that provide"
    "UBXD" "UBX-domain" "UBX" "48 h" "anti-FLAG" "Co-depletion" "adenovirues"
    "Ser-9" "immunohistochemical stainings" "stainings" "microvessels" "++"
    "+++" "ΔN-HDAC6-His-transfected" "ΔN-HDAC6-His" "Univariate" "positve"
    "HistoQuest" "subunitgene" "theH" "anti-acetylated" "anti-Acetyl-α-tubulin"
    "= 0.015" "biliverdin" "Hmox" "non-classical" "Non-classical"
    "haemoglobin:haptoglobin" "materno" "utero" "Beninese"
    "Monocyte/macrophage" "U-test" "MoHBW" "MoLBW" "covariance" "Wilcoxon"
    "a peripheral parasitaemia ≥1 " "≥1 " "Africa" "Benin" "oxygenase-1"
    "detoxifier" "2-like" "CSA" "significantly less iEs" "iEs"
    "monocyte/macrophages" "ADCI" "monocyte/macrophage" "placental villi"
    "feto" "villi" "-iE" "iE" "falciparum" "= 0" "= 0.02" "Perhaps" "comlex"
    "co-depleted" "co-depletion" "mitomycin" "paralog" "interstrand"
    "intrastrand" "A549/DDP" "= 0.001" "= 4" "48 h" "1–3 " "HCT" "T304/377A "
    "shLRRK2" "NLSs" "autoradiography" "T304/377A" "TQR" "Snapin" "neurite"
    "T304/377D" "translocalizes" "TXR" "6-diamidino-2-phenylindole" "S4A" "ΔN"
    "doi:10.1186" "CDE/CHR" "Two previous studies" "ANLN"
    "four genome-wide cell cycle expression studies" "DAVID" "HFF"
    "non-canonical" "GAS2L3" "potential CHRs" "CHRs" "TTCGAT" "TTCGAG" "TTTGAG"
    "TTTGAT" "Melk" "TTTGTA" "TTCGAA" "TAGGAA" "TTTAAA" "CTTGAA" "TTCAAA"
    "TTTGAA" "MuvB" "CDE" "uv" "uvB" "p53-p21-DREAM-CDE/CHR"
    "p53-p21-DREAM-CDE" "CHR" "faciliate" "occupany" "GSE15459" "gastrectomy"
    "commom" "Our previous studies" "ANRIL" "GHET1" "GAPLINC" "enhaner" "RNA2"
    "pcDNA 3" "Shen" "Hamedani" "inconsistant" "Ji"
    "An immunohistochemical analysis re-confirmed" "re-confirmed" "CQ" "siMET"
    "responder" "large autophagic vacuoles" "vacuoles" "multitarget" "HCQ"
    "greatest" "endpoint" "microcirculations" "FOLFOXIRI" "FOLFIRI" "TRIBE"
    "FFS" "codons" "PFS" "95%CI" "= 0.004" "3-SMAD4-dependent" "Fc" "IIA" "1/2"
    "LY-217299" "Galunisertib" "HEC-50" "Inhba" "Pre" "B-induced" "αv"
    "adhesiveness" "serous histology" "Meier" "Kaplan" "ISH"
    "minimal co-localization" "~70%" "βA" "βB subunits" "endometrium" "βB"
    "extrauterine" "~40%" "~10%" "non-endometrioid" "endometrioid" "America"
    "β3" "βB subunit" "the serous histological subtype" "Non-targeting" "= 53"
    "exome" "GS" "Illumina" "MiSeq" "even small FLT3 ITD+" "Ottone" "0,2–2"
    "Bologna" "Hematology" "Seràgnoli" "Ozogamicin" "Idarubicine" "BST" "UPN"
    "multiple minimal ITD" "AMBIT" "barcode" "Roche" "non-homogeneous"
    "viceversa" "TKD" "MRD" "ITD+" "UDS" "ITD-" "ITD" "+ cases" "MyoR"
    "osteoblasts" "non-small cell lung carcinoma" "somites" "miR-378a" "shMET"
    "our previous studies" "Ly6G/6C" "cPARP" "myomiRs" "fiber-like"
    "alveolar (ARMS) subtype" "alveolar RMS subtype (ARMS)" "subtype (ARMS)"
    "ERMS" "= 10" "co-localized" "Robertson" "Fukuyoshi" "Tuma"
    "treating such aggressive breast cancer subtypes" "non-TNBC" "neoadjuvant"
    "lobular subtype" "Mehrjardi" "the lobular subtype" "Pinera" "Perez"
    "mucinous histology" "EFM" "Cal" "70/980" "non-interpretable"
    "ductal carcinoma subtype" "an intense 3+" "IQR" "2p23" "Saudi"
    "ductal histologic subtype" "non-amplified" "5-year" "H-score" "= 0"
    "tubastatin" "subsets" "antiport" "A-induced" "Studies" "co-localizing"
    "A-treated" "end/total" "mircotubules" "anti-phospho-EGFR" "rubidium"
    "polyether" "bilayer" "helix" "brevis" "FXYD"
    "undergoes reversible acetylation/deacetylation" "non-histone" "IIa" "Na"
    "anti-Flag" "co-localization" "S2B" "S2A" "YP" "SR" "anti-retroviral"
    "Cavone" "Swindall" "Zerfaoui" "Erdélyi" "Lis" "Wu" "the viral genome"
    "studies" "neuro" "Letendre" "Lipton" "Kaul" "co-activator" "Nakagawa"
    "Liu" "Hauser" "Hottiger" "Hassa" "Kaufman" "pYFP" "pEYFP" "Ramirez" "CN04"
    "Arber" "Cocchi" "Maddon" "LISA" "Costantino" "Fackler" "Stolp" "CT04"
    "RhoA" "Zoughlami" "EB47" "BMN" "AIQ" "AZD" "PARPi" "M-tropic" "Yi" "Naif"
    "JRFL" "Ebenbichler" "Ha" "TEFb" "TAR" "Kameoka" "Zhang" "edema" "Lescot"
    "Farez" "Lenzsér" "Kraus" "ation" "Rouleau" "arisen" "Thompson" "Terry"
    "Kraft" "Ellis" "CNS" "LTR" "myristate" "transactivators" "anti-HIV"
    "studie" "infectious progeny" "progeny" "Vielfort" "typhimurium" "flexneri"
    "enteropathogen"
    "the intracellular bacterial pathogen Chlamydia trachomatis" "trachomatis"
    "gastric epithelial cells co-cultured" "gastric cells co-cultured"
    "co-cultured" "the viral genomes" "genomes" "viral protein BZLF1" "BZLF1"
    "serotypes" "Ferraldeschi" "Non-Deleted" "CLIA" "1.17–3.62" "Spearman"
    "CellSearch" "PTEN ⩾2" "PTEN=1" "intra-" "non-rearranged" "⩽10"
    "insufficient evaluable CTCs" "⩾2" "=1" "PTEN=0" "vs" "0–1" "interquartile"
    "⩾3" "=0" "vii" "v" "diploid" "the centromeric marker CEP10" "CEP10" "WBCs"
    "Pearson" "naïve" "heterogeneous PTEN and CEP10 genotypes" "ploidy" "GOV"
    "pharmacodynamic endpoints" "endpoints" "CTCs" "CTC" "non-invasive"
    "Gimesa" "transwell" "siGCN5" "microplate" "absorbance" "MTS" "CHG5" "U251"
    "non-tumor" "the first identified transcriptional-related KAT" "KAT"
    "chemoradiotherapy" "non-specific" "CNK3/IPCEF1" "β3-integrin"
    "phenocopies" "cytohesins" "active β1" "α5-integrin" "phenocopy"
    "typical ruffle-like" "LifeAct" "EHD1-" "EHD" "coverslips" "43N-R-Ras"
    "transfectants" "transfectant" "morphometry" "phosphoinositides-1" "∼2.5"
    "Venus" "tubule" "tubules" "perinucleus" "Donaldson" "GEF-activity" "Eps"
    "Darby" "Madin" "DOCK180/Elmo" "multiprotein" "invariant" "cytohesin"
    "GEF-inactive" "pCDNA3" "β1" "S5A" "bio" "non-carriers" "intra" "lobules"
    "miR-140-3p" "miR-20a-5p" "let-7f" "miR-20a" "miR-486-5p" "miR-320c"
    "BRCA1 /2" "c" "miR-200b" "proven" "overview" "│ and" "mirPath" "DIANA"
    "heatmap" "7q32.2" "Fischer" "miR-99a" "Let-7b" "miR-551b" "let-7b"
    "prophylactic mastectomies" "mastectomies" "BRCA1/2" "non-mutation"
    "sessile" "erythrocytes" "organelles" "iv" "a major co-localization"
    "MitoTracker" "-dihexyloxacarbocyanine" "dihexyloxacarbocyanine"
    "uncoupler" "CMTMRos" "chloromethyltetramethylrosamine" "Δψ"
    "detergent-like" "lysis" "chlorophenyl" "carbonyl" "non-toxic" "undertaken"
    "lactoferricin" "Nernst" "organelle" "protonophore" "multidomain"
    "intermembrane" "LTX-315" "ΔNp73α" "Vikhanskaya" "E204Fs" "non-functional"
    "IARC" "ceramides" "caspase-3/7" "#1" "#2" "hotspots" "perhaps"
    "Insulin-like growth factor binding protein-3" "basal-like" "TNBCs" "TNBC"
    "the growth-regulatory protein insulin-like growth factor binding protein-3"
    "insulin-like growth factor binding protein-3" "broader" "iii" "CHX"
    "pMdm2" "LNCaP95" "Protein phosphatase-1" "residuals"
    "amplification/rearrangement" "ENZ" "protein phosphatase-1"
    "chemoresistance" "carboxyl" "sulfhydryl" "HA" "Plamitoyl" "bromopalmitate"
    "ABE" "Biotin" "Acyl" "vIII" "palmitoyl" "mean ± SD" "PCDNA3" "Anti-flag"
    "the subsequent synthesis/usage" "droplets" "ELOV7" "1-13C" "5-13C"
    "Tennakoon" "spectrometer" "succinyl" "fumarate" "F6P" "G6P" "isotopomers"
    "isotopomer" "AKG" "and 3PG/2PG" "Massie" "OXPHOS" "Warburg" "3b" "1-3"
    "LBD" "ECAR" "CRPC" "/small" "stemness" "α6" "microdomains" "vivo" "ex"
    "Genome" "poorer" "α3" "RGD" "fallen" "motile" "α3β1" "8-μm" "five-year"
    "RegulomeDB" "seq" "SNPinfo" "pack-years" "histology" "rs2844337"
    "rs7109645" "0.81–1.00" "95% CI" "GWAS" "rs3015993" "rs2154754" "= 0.003"
    "= 0.67" "=  0.004" "= 0.004" "previously defined endotype" "ketoacid"
    "hydroxyisovalerate" "hydroxybutyrate" "Langley" "carnitine" "acyl"
    "non-survivors" "GEDI" "septic shock endotype"
    "previously validated gene expression-based subclasses" "ToppGene" "Venn"
    "a Welch’s" "Hochberg" "Benjamini" "Welch" "Weiss" "cecal"
    "lipopolysaccharide" "septic shock endotypes" "sepsis-associated MODS"
    "PICU" "MODS" "multiorgan" "endotype" "endotypes" "subclasses"
    "multicenter" "discrepant" "using exomic and whole genome" "Basquiera"
    "oku" "transducer" "JAK2 V617F" "JAK 2V617F" "Qiao" "Li" "indel" "Wallis"
    "type2+" "type1+" "V617F+" "WBC" "_1220delinsTCTTGTCT" "_1233delinsAGG"
    "_1229insTCCTTGTC" "indels" "_1238insAAGGA" "_1236insTGTCG" "_1226del"
    "_1218del" "_1221del" "_1219del" "A497-L498LVIAins" "LVIAins" "frameshift"
    "_1235insTTGTC" "_1230del" "vera (PV)" "vera"
    "essential thrombocythemia (ET)" "thrombocythemia" "= 0.002" "= 0.003" "+1"
    "allografts" "neovasculature" "re-expression" "stepwise" "MECA32"
    "juxtacrine" "the least aggressive Luminal subtype" "subtypes"
    "aggressive Basal subtype" "subtype" "_4175" "allograft" "underpinnings"
    "=30" "20X" "Non-malignant" "non-malignant" "non-transformed" "NF-κB"
    "non-immune cells" "plasmacytoid" "RLR/IPS-1 pathways" "IPS-1 pathways"
    "IPS-1 is" "IPS-1 mediated" "b" "κB" "IPS-1 pathway" "IPS-1 degradation"
    "IPS-1 signalling" "retroviruses" "IRF-3/7" "ISRE" "goes" "IPS-1signalling"
    "IPS-1pathway" "ELISA" "ISG" "ISGs" "pathophysiology" "retrovirus" "deeper"
    "co-transfection" "BIBW" "inhitors" "776 insertional mutation HER2 YVMA"
    "HKI-272/Rapamycin" "readouts" "deoxynucleotidyl" "TUNEL" "withdrawl" "Dox"
    "rtTA" "resultingtet" "hHER2" "polyA" "generatetet" "YVMA" "wildtype"
    "agar" "G776insYVMA" "Y1007/Y1008" "Kd" "oncology" "algorithm"
    "So far all METex14del +" "TCGA" ".3082+811A" "our GI METex14del +cancer"
    "gDNAs" "Sanger" "a unique molecular subset" "METex14 +" "otherMET"
    "+cases" "METex14" "MET/CEP" "GGTTTGAT" "TTTTAACA" "Ct" "2+" "3+" "ACUP"
    "METex14del +" "endoscopic biopsies" "Oncology" "biopsies" "FFPE" "frozen"
    "_1028del47" "METex14del+" "intronic sequence deletions around MET exon 14"
    "exon 14" "immunohistochemistry (IHC)" "immunohistochemistry" "nCounter"
    "METex14del" "μg/ ml" "Gefintib" "FACS" "Ibrutinb" "Del19" "Promega's"
    "Promega" "anti-colony" "propionamide" "GI" "L858R/T790M" "H1975" "del19"
    "I/II" "del 19" "Del 19" "wt" "gatekeeper" "μL" "50 mg/Kg" "mg/Kg"
    "anti-proliferation" "dimorphisms" "pAMPK" "CAMKKβ"
    "Co-immunoprecipitation" "skeletal myocytes" "myocytes" "interactome"
    "non-genomic" "ERα/β" "oestrogens" "non-responsive" "diabetes/obesity"
    "pulldowns" "SDS/PAGE" "anti-flag" "indeed AMPKα2 using LC–MS/MS"
    "LC–MS/MS" "Arizona" "AMPKα2" "NRCM" "eluates" "OSU" "pAMPKα" "Oestrogen"
    "cardiac ischaemia" "ischaemia" "Peutz" "α/β" "17β-oestradiol" "stressors"
    "oestrogen" "shRNA2" "shRNA1" "IHC" "homologs" "antigen" "antigens"
    "pcDNA3" "subpopulations" "a synonymous SNP" "intergenic SNPs" "tagSNP"
    "shorter RTL" "CLTPM1L" "5p15.33" "RTLs" "1.14–1.47" "=7.03" "rs451360"
    "rs10069690" "rs13172201" "rs2853677" "rs7726159" "WHR" "BMI" "Brien"
    "germline" "the shortest RTL" "the longest RTL" "Bonferroni" "rs2736098"
    "RTL" "tagSNPs" "anti-apoptotic" "= 4" "drawn" "enhancers" "enhancer" "p"
    "non-B cell" "DHS" "DNaseI" "polII" "unsplit" "nt" "FIMO" "MEME"
    "non-irradiated" "orTrp53" "non-B cells" "dataset" "thymocytes" "spacer"
    "exo" "ditag" "50 μg/ml" "co-repressors" "non-coding" "multicentre"
    "univariate" "pTNM" "chemoattractant" "Alamo" "=0.06" "the Memorial Sloan"
    "Sloan" "=0.076" "histologies" "IIIA" "=0.02" "=0.05" "=0.001" "pT"
    "=0.002" "non-G12V" "=0.89" "transversions" "VT65A" "pT4"
    "significantly more pN+" "pN+" "Cramer" "French" "Asian" "=0.01" "DFS"
    "Kirsten rat sarcoma viral oncogene homolog ( KRAS )" "homolog ( KRAS )"
    "mKRAS" "homolog" "Kirsten" "non-receptor tyrosine kinase" "antitumour"
    "Montagut" "7p11.2" "mesylate" "Alk" "pHER-2" "pEGFR" "sublines" "missense"
    "hotspot" "Ampliseq" "ErbB" "ICR10" "subsequent re-probing" "ICR61"
    "imgatuzumab" "et" "Garouniatis" "erbB" "DiFi62" "DiFiG" "IC 50" "μ g "
    "introns" "the elementary half-sites GGTACAnnnTGTTCT" "GGTACAnnnTGTTCT"
    "GGAACGtccAGTGCC" "non-tumorigenic" "non-hydrolysable"
    "subsequent tumor regrowth" "parenchyma" "Mirochnik" "S807/811" "Litvinov"
    "E1-2" "amplicons" "undergone" "dichlororibofuranosylbenzimidazole"
    "cyclin D1/2" "serine 807/811" "DCV" "DyeCycle" "OHF" "Alexa" "mPrE" "HPrE"
    "G 1 /S-" "carryout" "andromedin" "andromedins" "littermates"
    "neuroendocrine" "epithelium" "epithelia" "exocrine" "subsequent regrowth"
    "regrowth" "PC3-Lenti-AR" "G 0 /G 1" "G 0 /G 1 phase" "G 0 /G 1 -phase"
    "μg" "μg/mL" "G 1 /S" "Lipofectamine" "cells/well" "transcriptome"
    "Carlsbad" "Invitrogen" "Rockville" "Origene" "chosen" "MEM" "DMEM" "Jose"
    "Transwells" "Motic" "cells/mL" "Transwell" "Biotech" "ABPrism" "Solarbio"
    "mastermix" "SYBR" "TIANGEN" "Eca109/pCMV" "Beyotime" "Dulbecco’s"
    "Wisent Inc" "Dulbecco" "Roswell" "migration/invasion" "head/neck"
    "Eca-109/pCMV" "AEG" "3q26.3-q27" "SOX" "northern Iran" "Iran"
    "cell migration/invasion" "pCMV" "Mean ± SD" "mestizo" "Cheverud" "Lakeway"
    "StataCorp" "STATA" "SNPstats" "Haplotype" "Whitney" "TYPER" "MassARRAY"
    "Taq" "Netherlands" "Venlo" "QIAGEN" "HotStarTaq" "Diego" "Sequenom"
    "iPLEX" "biallelic SNPs" "Affymetrix" "°C" "Biosystems" "TaqMan" "rs320"
    "rs3798577" "Spinreact" "≥130/85" "BC554" "Inc" "USA" "Microlife" "Germany"
    "Hamburg" "Seca" "stadiometer" "Tokio" "Tanita" "WC" "written" "pectoris"
    "Guerrero" "Elsammak" "B1B1" "Spain" "Rios" "TaqIB" "genotypes" "447X"
    "Webster" "XX" "VLDLs" "Gallagher" "Rebelo" "Goulart" "rs1801132" "intron"
    "rs2077647" "transcription/translocation" "LEPRb" "pyrazole" "propyl" "Ob"
    "Ricans" "Puerto" "Hess" "Americans" "Dominican" "Latin" "Lewontin"
    "rs9340799" "PvuII" "Xbal" "GCCCTA" "overdominant" "130/85" "Co-dominant"
    "T2D" "≥110" "SNP" "rs328" "rs3798577-C" "rs2077647-C" "rs1801132-G"
    "rs9340799-G" "rs2234693" "rs1884051" "HWE" "Weinberg" "Genotype"
    "rs708272" "NCBI" "African" "European" "American" "ADMIXMAP" "Mestizo"
    "Mexican" "haplotypes" "Southwestern Mexico" "Mexico" "lipoproteins (VLDL)"
    "VLDL" "lipoproteins" "SNPs" "dyslipidemia" "mg/dL" "NECP" "NCEP"
    "haplotype" "ACTCCG" "GA" "CC" "GG" "genotype" "polymorphisms" "und"
    "Tserga" "LOD " "heteroduplexes" "mismatches"
    "homogenously methylated templates form homoduplexes" "homoduplexes"
    "uracils" "uraciles" "10/17" "10/16" "6/16" "7/17" "6/17" "9/17" "14/17"
    "mammoplasty" "amplicon" "inter-day" "S/N " "LOQs" "LODs" "LOQ" "LOD"
    "biopsy" "normal-1" "Feng" "exons" "dinucleotides" "subset" "/FVC"
    "spasmogen" "FVC" "oleifera" "Moringa" "Mediterranean" "BSE" "lavage" "bi"
    "priori" "chemistries" "non-smokers" "multivariate" "hoc" "ii" "DIs"
    "hyper" "eosinophilia" "kappa-light-chain-enhancer" "pathologies"
    "anti-inflammatory" "corticosteroids" "hyperresponsiveness" "pre-" "pre"
    "plethsmography" "BD" "mean ± SD" "melanogaster" "chromatid" "EMBOSS"
    "epestfind" "PEST" "greater" "-UTR" "UTR" "genome"
    "tamoxifen-treated Rb F/F" "F/F" "Rb" "Traip" "−621" "−628" "TTGGAGG" "CGC"
    "G/C" "TTT" "TTTGGCTC" "168bp" "MOI" "non-biotinylated" "TPA" "+25"
    "168 bp" "bp" "Renilla" "co-transfected" "ENSEMBL" "codon" "+117" "+16"
    "1.4kbp" "silico" "pCMV6E2F1" "G1/S" "NOPO" "/7.5" "vitro" "undergoes"
    "RING" "1400bp" "G0/G1 phase" "G0/G1" "synergism" "rever" "anti-cancer"
    "Cr" "BUN" "microstructure" "eosin" "50mg/kg" "5mg/kg" "50 mg/kg" "mg/kg"
    "5 mg/kg" "Anti-tumor" "co-treated" "co-treatment" "γH2A" "G0/G1-phase"
    "shrunken" "Hoechst" "CalcuSyn" "˂" "anti-proliferative" "IC50"
    "the human colorectal cancer SW-480" "anti-tumor" "SW-620" "Gypenosides"
    "multi" "monotherapy" "mis" "FdUMP" "monophosphate" "chemo-" "sensitizer"
    "SW-480" "the 5-Fu-caused SW-480" "tetrazolium" "diphenyltertrazolium"
    "Thunb" "pentaphyllum" "Gynostemma" "sensitizers" "chemo" "Fu" "μg/ml"
    "paracrine" "polymorphism" "-9" "non-targeting" "TLR2/4" "pg/ml"
    "supernatants" "≥ 10" "anti-TB" "6-months" "pH" "CXR"
    "a metabolically active monolayer" "monolayer" "pleura"
    "pleural mesothelium" "mesothelium" "MTBRa"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-15901-16200*
  '(("Kras" . SPARSER::PROTEIN) ("only one type" . TYPE)
    ("NICD and EGFR" . SPARSER::COLLECTION)
    ("ester (DAPT)" . SPARSER::MOLECULE) ("- 1-" . SPARSER::PROTEIN)
    ("phenylglycine" . SPARSER::MOLECULE)
    ("EGFR and Wnt" . SPARSER::COLLECTION)
    ("a transmembrane heterodimeric receptor" . SPARSER::RECEPTOR)
    ("anti-angiogenic and anti-EGFR" . SPARSER::COLLECTION)
    ("bevacizumab and EGFR" . SPARSER::COLLECTION)
    ("A typical example" . SPARSER::EXAMPLE)
    ("NICD and EGF" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("NICD" . SPARSER::PROTEIN) ("ADAM12" . SPARSER::PROTEIN)
    ("Notch 3" . SPARSER::PROTEIN) ("EGF 1 " . SPARSER::PROTEIN)
    ("t- butyl" . SPARSER::MOLECULE) ("Notch 2" . SPARSER::PROTEIN)
    ("Notch 1" . SPARSER::PROTEIN) ("Anti-angiogenic" . SPARSER::DRUG)
    ("Pterostilbene" . SPARSER::DRUG) ("Nestin" . SPARSER::PROTEIN)
    ("co-receptor and regulator" . SPARSER::COLLECTION)
    ("MET, Slug and PI3KCA" . SPARSER::COLLECTION)
    ("ATM, REDD1 and TET" . SPARSER::COLLECTION)
    ("H-RAS, HMGA2, Bmi-1, Ubc9, ZEB1/2, PRC1/2, Notch4, and Wip1"
     . SPARSER::COLLECTION)
    ("CD44−" . SPARSER::PROTEIN) ("TNKS2 and c-Myc" . SPARSER::COLLECTION)
    ("Frizzled 4 and Frizzled 5" . SPARSER::COLLECTION)
    ("TNKS" . SPARSER::PROTEIN) ("Oct4 and Nanog" . SPARSER::COLLECTION)
    ("Nanog and sex determining region Y-box" . SPARSER::COLLECTION)
    ("N-cadherin, vimentin and Zinc finger protein SNAI1"
     . SPARSER::COLLECTION)
    ("/CD44" . SPARSER::COLLECTION) ("ESA" . SPARSER::PROTEIN)
    ("miR- 1" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("CD18" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("miR-200a" . SPARSER::MOLECULE) ("REDD1" . SPARSER::PROTEIN)
    ("Wip1" . SPARSER::PROTEIN) ("Notch4" . SPARSER::PROTEIN)
    ("Frizzled 5" . SPARSER::PROTEIN) ("Frizzled 4" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN)
    ("Zinc finger protein SNAI1" . SPARSER::PROTEIN)
    ("Sox2" . SPARSER::PROTEIN) ("sex determining region Y" . SPARSER::PROTEIN)
    ("TNKS2" . SPARSER::PROTEIN) ("Tankyrase-2" . SPARSER::PROTEIN)
    ("hepatocyte growth factor and a tyrosine kinase (receptor-type tyrosine kinase)"
     . SPARSER::COLLECTION)
    ("RAP1B [ xref ] and IGF-IR [ xref ]" . SPARSER::COLLECTION)
    ("the possible gene effectors" . SPARSER::EFFECTOR)
    ("extracellular proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("morpho-genesis" . SPARSER::COLLECTION)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-7 and MMP-9" . SPARSER::COLLECTION)
    ("vital anti-apoptosis protein Bcl2" . SPARSER::PROTEIN)
    ("c-Met and c-Met" . SPARSER::COLLECTION)
    ("mRNA and miR-139-5" . SPARSER::COLLECTION)
    ("™-mut-MET-3" . SPARSER::COLLECTION) ("-MET-3" . SPARSER::COLLECTION)
    ("a vital anti-apoptosis protein" . SPARSER::PROTEIN)
    ("bank" . SPARSER::PROTEIN) ("annexin/PI" . SPARSER::COLLECTION)
    ("MMP-9 and MMP-7" . SPARSER::COLLECTION)
    ("inhibitor or miR-139-5" . SPARSER::COLLECTION)
    ("NC, and miR-139-5" . SPARSER::COLLECTION)
    ("the mature miR-139-5" . SPARSER::PROTEIN)
    ("caspase-3, caspase-7, and caspase-8" . SPARSER::COLLECTION)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ac-DEVD-pNA" . SPARSER::DRUG) ("IGF-IR" . SPARSER::PROTEIN)
    ("RAP1B" . SPARSER::PROTEIN) ("Rho-kinase 2" . SPARSER::PROTEIN)
    ("c-met" . SPARSER::PROTEIN) ("Kip2" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("Rocaglamide" . SPARSER::DRUG)
    ("depsipeptide" . SPARSER::DRUG) ("capsaicin" . SPARSER::DRUG)
    ("p53, E2F1, and estrogen receptor" . SPARSER::COLLECTION)
    ("MAPK and the tyrosine kinase Syk [ xref - xref ]" . SPARSER::COLLECTION)
    ("Ras-Raf-MAPK" . SPARSER::COLLECTION)
    ("MEFs and NOXA" . SPARSER::COLLECTION)
    ("the activator Bim and the sensitizer Noxa" . SPARSER::COLLECTION)
    ("mitochondrial PHBs" . SPARSER::PROTEIN)
    ("PHB1 or PHB2" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-X" . SPARSER::COLLECTION)
    ("functional PHBs" . SPARSER::PROTEIN)
    ("B cell chronic lymphoproliferative syndrome and adult T-cell leukemia/lymphoma"
     . SPARSER::COLLECTION)
    ("B cell chronic lymphoproliferative syndrome" . SPARSER::PROTEIN)
    ("BIM and NOXA protein" . SPARSER::COLLECTION)
    ("NOXA and BIM" . SPARSER::COLLECTION)
    ("PUMA and MCL-1" . SPARSER::COLLECTION)
    ("BIM , PUMA, NOXA , and BAK" . SPARSER::COLLECTION)
    ("the pro-apoptotic genes Bim , Noxa , Bmf , and Moap1"
     . SPARSER::COLLECTION)
    ("Bim , Noxa , Bmf , and Moap1" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION) ("Moap1" . SPARSER::PROTEIN)
    ("CrmA" . SPARSER::PROTEIN)
    ("these two pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bak  −/− and Bax  −/−" . SPARSER::COLLECTION)
    ("Bax  −/− , Bak  −/− and Bax  −/−" . SPARSER::COLLECTION)
    ("two multidomain pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("the SOD mimetic manganese (III)-tetrakis (4-benzoic acid) porphyrin"
     . SPARSER::DRUG)
    ("MnTBAP" . SPARSER::DRUG)
    ("superoxide anion and hydroxyl radical" . SPARSER::COLLECTION)
    ("a mitochondrial protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OPA1-ΔS1" . SPARSER::PROTEIN-PAIR) ("OPA1-" . SPARSER::PROTEIN)
    ("caspase 3, PARP, and L-OPA1" . SPARSER::COLLECTION)
    ("ActD-" . SPARSER::MOLECULE) ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("fluorizoline-treated Phb2  −/− MEFs" . SPARSER::PROTEIN)
    ("caspase 3 and poly ADP-ribose polymerase (PARP)" . SPARSER::COLLECTION)
    ("PHB1 and L-OPA1" . SPARSER::COLLECTION) ("Phb2" . SPARSER::PROTEIN)
    ("Phb" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("PHB1 and PHB2" . SPARSER::COLLECTION) ("IMM" . SPARSER::PROTEIN)
    ("MEFs and NOXA-" . SPARSER::COLLECTION) ("NOXA-" . SPARSER::PROTEIN)
    ("PHB" . SPARSER::PROTEIN) ("PHBs" . SPARSER::PROTEIN)
    ("Superoxide anion" . SPARSER::MOLECULE) ("Oma1" . SPARSER::PROTEIN)
    ("NOXA protein" . SPARSER::PROTEIN) ("Z-IETD-FMK" . SPARSER::DRUG)
    ("Q-VD-OPh" . SPARSER::DRUG) ("BCL-X" . SPARSER::PROTEIN)
    ("manganese (III)-tetrakis (4-benzoic acid) porphyrin" . SPARSER::DRUG)
    ("hydroxyl radical" . SPARSER::MOLECULE)
    ("superoxide anion" . SPARSER::MOLECULE) ("OMA1" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("PHB2" . SPARSER::PROTEIN)
    ("PHB1" . SPARSER::PROTEIN) ("prohibitin 1" . SPARSER::PROTEIN)
    ("a clinically and biologically relevant therapeutic target"
     . SPARSER::TARGET-PROTEIN)
    ("ATAD2-MKK3/6" . SPARSER::PROTEIN-PAIR)
    ("p38 and MKK6" . SPARSER::COLLECTION)
    ("Parc and mortalin" . SPARSER::COLLECTION) ("mortalin" . SPARSER::PROTEIN)
    ("Parc" . SPARSER::PROTEIN) ("SMO and Gli" . SPARSER::COLLECTION)
    ("SMO" . SPARSER::PROTEIN) ("subcutaneous HCC" . SPARSER::PROTEIN)
    ("ATAD2-shRNA" . SPARSER::COLLECTION) ("tet-" . SPARSER::PROTEIN)
    ("siRNA and MKK3/6" . SPARSER::COLLECTION)
    ("p38 and MKK3/6" . SPARSER::COLLECTION)
    ("p53-Bcl-2" . SPARSER::COLLECTION)
    ("ATAD2 siRNA and specific inhibitors" . SPARSER::COLLECTION)
    ("p53 (PFT-α and PFT-μ) or p38 (p168316)" . SPARSER::COLLECTION)
    ("phosphorylated p53 and the pro-apoptotic proteins Puma, Bax, Bad, Bak, and Bim"
     . SPARSER::COLLECTION)
    ("ATAD2 siRNA, phosphorylated p53 and the pro-apoptotic proteins Puma, Bax, Bad, Bak, and Bim"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins Puma, Bax, Bad, Bak, and Bim"
     . SPARSER::COLLECTION)
    ("Puma, Bax, Bad, Bak, and Bim" . SPARSER::COLLECTION)
    ("p53-Bcl- 2" . SPARSER::COLLECTION)
    ("p53 and/or p38" . SPARSER::COLLECTION)
    ("the estrogen receptor [ xref ] and the androgen receptor [ xref ]"
     . SPARSER::COLLECTION)
    ("clinically and biologically relevant molecular targets"
     . SPARSER::TARGET-PROTEIN)
    ("p-p53" . SPARSER::COLLECTION) ("p53 and p38" . SPARSER::COLLECTION)
    ("MKK-6" . SPARSER::PROTEIN) ("MKK-3" . SPARSER::PROTEIN)
    ("Bcl- 2" . SPARSER::PROTEIN)
    ("ATPase family AAA domain-containing protein 2" . SPARSER::PROTEIN)
    ("ATAD2" . SPARSER::PROTEIN)
    ("ATPase family, AAA domain containing 2" . SPARSER::PROTEIN)
    ("Brusatol" . SPARSER::DRUG)
    ("K-ras G12D and BrafV619V" . SPARSER::COLLECTION)
    ("BrafV" . SPARSER::PROTEIN) ("Nrf2/Keap1" . SPARSER::COLLECTION)
    ("high-Bcl-2 or high-Bcl-xL" . SPARSER::COLLECTION)
    ("high-Nrf2 and low-Nrf2" . SPARSER::COLLECTION)
    ("keap1 and Nrf2" . SPARSER::COLLECTION) ("shBcl-2" . SPARSER::COLLECTION)
    ("shHO-1" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and HO-1" . SPARSER::COLLECTION)
    ("Annexin-V/PI" . SPARSER::COLLECTION)
    ("Nrf2, Bcl-2, Bcl-xL, and HO-1" . SPARSER::COLLECTION)
    ("H1975, CL3, and TL4" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and HO-1" . SPARSER::COLLECTION)
    ("p53 or Sp1" . SPARSER::COLLECTION)
    ("H1975 and CL3" . SPARSER::COLLECTION)
    ("VC and H1299" . SPARSER::COLLECTION)
    ("p53 or mutant" . SPARSER::COLLECTION) ("VC" . SPARSER::MOLECULE)
    ("p53 and Sp1" . SPARSER::COLLECTION)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("Sp1 and p53" . SPARSER::COLLECTION)
    ("NQO1 and heme oxygenase 1" . SPARSER::COLLECTION)
    ("Nrf2 and p53" . SPARSER::COLLECTION) ("TPA" . SPARSER::DRUG)
    ("Keap1/Nrf2" . SPARSER::COLLECTION)
    ("Kelch-like ECH-associated protein 1 (Keap1) or Nrf2"
     . SPARSER::COLLECTION)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("CL1-5" . SPARSER::PROTEIN) ("ERT2" . SPARSER::PROTEIN)
    ("vp16" . SPARSER::DRUG) ("keap1" . SPARSER::PROTEIN)
    ("Nrf-2" . SPARSER::PROTEIN) ("CL3" . SPARSER::PROTEIN)
    ("k-ras" . SPARSER::PROTEIN) ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN)
    ("HuR and TTP" . SPARSER::COLLECTION) ("HuR" . SPARSER::PROTEIN)
    ("c-Jun and Wee1" . SPARSER::COLLECTION)
    ("Cdk1/Cdc2" . SPARSER::COLLECTION)
    ("cdc2 and cyclinB" . SPARSER::COLLECTION) ("cyclinB" . SPARSER::PROTEIN)
    ("E2F1 [ xref ] and LATS2 [ xref ]" . SPARSER::COLLECTION)
    ("TTP/c-Jun/Wee1" . SPARSER::COLLECTION)
    ("c-Jun/Wee1" . SPARSER::COLLECTION)
    ("p65, c-Rel, and p50" . SPARSER::COLLECTION)
    ("TTP and NF-кB" . SPARSER::COLLECTION)
    ("p65, p50, and c-Rel" . SPARSER::COLLECTION)
    ("p50 and c-Rel" . SPARSER::COLLECTION)
    ("p65 and c-Rel" . SPARSER::COLLECTION)
    ("Annexin and PI" . SPARSER::COLLECTION) ("Annexin" . SPARSER::PROTEIN)
    ("Tet" . SPARSER::PROTEIN) ("c-Jun, JunB and JunD" . SPARSER::COLLECTION)
    ("Jun and Fos" . SPARSER::COLLECTION)
    ("c-Fos, FosL1, FosL2, and FosB" . SPARSER::COLLECTION)
    ("FosL1" . SPARSER::PROTEIN) ("FosB" . SPARSER::PROTEIN)
    ("JunD" . SPARSER::PROTEIN) ("JunB" . SPARSER::PROTEIN)
    ("uPA/uPAR" . SPARSER::COLLECTION) ("uPAR" . SPARSER::PROTEIN)
    ("TNF-α, IL-23 and GM-CSF" . SPARSER::COLLECTION)
    ("cancer-associated genes" . SPARSER::GENE)
    ("uridylate" . SPARSER::MOLECULE)
    ("tristetraprolin (TTP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TTP" . SPARSER::PROTEIN) ("tristetraprolin" . SPARSER::PROTEIN)
    ("N-myristoyltransferase" . SPARSER::PROTEIN) ("WEE1" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) ("zinc-finger protein" . SPARSER::PROTEIN)
    ("FosL2" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("proinflammatory LTB 4" . SPARSER::PROTEIN)
    ("hydrochloride" . SPARSER::MOLECULE) ("pyrrolidine" . SPARSER::DRUG)
    ("kappaB" . SPARSER::PROTEIN) ("NOX4/Akt" . SPARSER::COLLECTION)
    ("TLR/NOX1" . SPARSER::COLLECTION)
    ("HETEs and HPETEs" . SPARSER::COLLECTION) ("HPETEs" . SPARSER::MOLECULE)
    ("HETEs" . SPARSER::MOLECULE)
    ("a proinflammatory eicosanoid" . SPARSER::MOLECULE)
    ("Pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("p-Smad3" . SPARSER::COLLECTION)
    ("BLT1 and MDA-MB231-pLKO1" . SPARSER::COLLECTION)
    ("AG1478, or U0126" . SPARSER::COLLECTION)
    ("BLT1 (Figure xref ) or NOX4 (Figure xref )" . SPARSER::COLLECTION)
    ("phosphor-ERK1/2, and phosphor-EGFR" . SPARSER::COLLECTION)
    ("BLT1 and NOX4" . SPARSER::COLLECTION)
    ("ERK1/2, and EGFR" . SPARSER::COLLECTION)
    ("BLT1-Rac1/NOX4-EGFR-ERK1/2" . SPARSER::COLLECTION)
    ("U0126, LY294002, or AG1478" . SPARSER::COLLECTION)
    ("MEK1 or p85α" . SPARSER::COLLECTION)
    ("EGFR, PI3-kinase, and ERK1/2" . SPARSER::COLLECTION)
    ("AG1478, LY294002, or U0126" . SPARSER::COLLECTION)
    ("protein-ERK" . SPARSER::COLLECTION)
    ("NOX4 or H 2 O 2" . SPARSER::COLLECTION)
    ("NOX1 and NOX4" . SPARSER::COLLECTION) ("/BLT1/NOX" . SPARSER::COLLECTION)
    ("flavoproteins" . SPARSER::MOLECULE) ("-BLT1" . SPARSER::COLLECTION)
    ("GAL4-Smad3" . SPARSER::COLLECTION)
    ("LTB 4 and its cognate receptors" . SPARSER::COLLECTION)
    ("Mad-homology-2" . SPARSER::PROTEIN-PAIR)
    ("Mad-homology-1" . SPARSER::COLLECTION)
    ("p107 and E2F4/5" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("TβRI and TβRII" . SPARSER::COLLECTION)
    ("c-Myc and Id1" . SPARSER::COLLECTION)
    ("p15 INK4B and p21 WAF1" . SPARSER::COLLECTION)
    ("Transforming growth factor-β1" . SPARSER::COLLECTION)
    ("/BLT" . SPARSER::COLLECTION) ("BLT" . SPARSER::PROTEIN)
    ("subtypes, BLT1 and BLT2" . SPARSER::COLLECTION)
    ("BLT1-NOX-ROS-EGFR-PI3K-ERK1/2" . SPARSER::COLLECTION)
    ("/BLT1" . SPARSER::COLLECTION)
    ("-phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("-epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("p15 INK4B and p27 KIP1" . SPARSER::COLLECTION)
    ("a potent pro-inflammatory eicosanoid" . SPARSER::MOLECULE)
    ("eicosanoid" . SPARSER::MOLECULE) ("Leukotriene" . SPARSER::MOLECULE)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("H 2 DCFDA" . SPARSER::DRUG)
    ("PD169316" . SPARSER::DRUG)
    ("extracellular signal-regulated kinase 5" . SPARSER::PROTEIN)
    ("BIX02189" . SPARSER::DRUG) ("BI-D1870" . SPARSER::MOLECULE)
    ("GAL4" . SPARSER::PROTEIN) ("MH1" . SPARSER::PROTEIN)
    ("TβRII" . SPARSER::PROTEIN) ("Id1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("BLT2" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("5-LO" . SPARSER::PROTEIN) ("5-lipoxygenase" . SPARSER::PROTEIN)
    ("p27 KIP1" . SPARSER::PROTEIN) ("p15 INK4B" . SPARSER::PROTEIN)
    ("BLT1" . SPARSER::PROTEIN) ("LTB 4" . SPARSER::PROTEIN)
    ("AKT/pAKT" . SPARSER::COLLECTION)
    ("CPEB1 and CPEB4" . SPARSER::COLLECTION)
    ("a translational repressor or activator" . SPARSER::COLLECTION)
    ("repressor or activator" . SPARSER::COLLECTION)
    ("AKT/Ras" . SPARSER::COLLECTION) ("FGFR1/ERK" . SPARSER::COLLECTION)
    ("EGFR and pAKT" . SPARSER::COLLECTION)
    ("the correlative genes" . SPARSER::GENE)
    ("siRNA or CPEB3" . SPARSER::COLLECTION) ("p-21" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("element binding protein" . SPARSER::PROTEIN)
    ("EGFR and Mfn1" . SPARSER::COLLECTION)
    ("membranous EGFR" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("Drp1, Fis1, Mfn1, Mfn2, and OPA1" . SPARSER::COLLECTION)
    ("the contrary molecular mechanism EGFR" . SPARSER::PROTEIN)
    ("mitochondrial elongation" . SPARSER::PROTEIN) ("Dnm1" . SPARSER::PROTEIN)
    ("Fission-deficient mitochondria" . SPARSER::PROTEIN)
    ("endocytotic EGFR" . SPARSER::PROTEIN)
    ("a multifunctional regulator" . SPARSER::REGULATOR)
    ("a classic membranous receptor" . SPARSER::RECEPTOR)
    ("EGFR and Tom20" . SPARSER::COLLECTION)
    ("cell membranous EGFR" . SPARSER::PROTEIN)
    ("CL1–5/Ctrl" . SPARSER::COLLECTION)
    ("CL1–5/mitEGFR" . SPARSER::COLLECTION)
    ("the mitochondrial EGFR" . SPARSER::PROTEIN)
    ("optical atrophy protein 1 (OPA1) and dynamin-related protein 1 (Drp1)"
     . SPARSER::COLLECTION)
    ("Mfn1 [ xref ], optical atrophy protein 1 (OPA1) and dynamin-related protein 1 (Drp1)"
     . SPARSER::COLLECTION)
    ("optical atrophy protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MitEGFR" . SPARSER::PROTEIN)
    ("tubular and fragmented mitochondria" . SPARSER::PROTEIN)
    ("DsRed and AcGFP" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("PEG" . SPARSER::PROTEIN) ("mitEGFR" . SPARSER::PROTEIN)
    ("Tom20 and endogenous mitochondrial EGFR ( xref )" . SPARSER::COLLECTION)
    ("endogenous mitochondrial EGFR" . SPARSER::PROTEIN)
    ("mitEGFR-GFP" . SPARSER::PROTEIN-PAIR)
    ("mitEGFR-EGFP" . SPARSER::COLLECTION)
    ("Mitochondrial EGFR" . SPARSER::PROTEIN)
    ("mitochondria and EGF" . SPARSER::COLLECTION)
    ("EGF and chloroquine" . SPARSER::COLLECTION) ("Tim23" . SPARSER::PROTEIN)
    ("Tim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a membrane-cytoskeletal protein" . SPARSER::PROTEIN)
    ("Vinculin" . SPARSER::PROTEIN)
    ("the highly invasive CL1–5" . SPARSER::PROTEIN)
    ("CL1–0 and CL1–5" . SPARSER::COLLECTION)
    ("the well-studied nuclear EGFR" . SPARSER::PROTEIN)
    ("mitochondrial EGFR and the EGFR variant" . SPARSER::COLLECTION)
    ("mitochondrial EGFR" . SPARSER::PROTEIN) ("EGFRviii" . SPARSER::PROTEIN)
    ("Huntingtin" . SPARSER::PROTEIN) ("HR2" . SPARSER::PROTEIN)
    ("Mfn2" . SPARSER::PROTEIN) ("Fis1" . SPARSER::PROTEIN)
    ("syntaxin-6" . SPARSER::PROTEIN) ("Drp1" . SPARSER::PROTEIN)
    ("dynamin-related protein 1" . SPARSER::PROTEIN)
    ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MTCO1" . SPARSER::PROTEIN)
    ("CL1–5" . SPARSER::PROTEIN) ("CL1–0" . SPARSER::PROTEIN)
    ("Mfn1" . SPARSER::PROTEIN) ("the genomic CNVs" . SPARSER::PROTEIN)
    ("TP53 , EGRF , KRAS and BRAF" . SPARSER::COLLECTION)
    ("PBX" . SPARSER::PROTEIN-FAMILY)
    ("telomerase reverse transcriptase ( TERT ) and an RNA component"
     . SPARSER::COLLECTION)
    ("the 9 mutant driver genes and the prognosis" . SPARSER::COLLECTION)
    ("CEP72, BRD9, TRIP13, SLC9A3, SDHA, SLC6A19 and PDCD6"
     . SPARSER::COLLECTION)
    ("CNV" . SPARSER::PROTEIN) ("TPPP and SLC6A18" . SPARSER::COLLECTION)
    ("TPPP" . SPARSER::PROTEIN) ("CNVs and mutant" . SPARSER::COLLECTION)
    ("the top 10 most frequently mutant CNVs" . SPARSER::PROTEIN)
    ("CNVs" . SPARSER::PROTEIN) ("FGFR1 and PIK3CA" . SPARSER::COLLECTION)
    ("TERT and PBXIP1" . SPARSER::COLLECTION) ("Pre-B" . SPARSER::PROTEIN)
    ("a 11" . SPARSER::PROTEIN) ("SLC6A18" . SPARSER::PROTEIN)
    ("SLC6A19" . SPARSER::PROTEIN) ("TRIP13" . SPARSER::PROTEIN)
    ("CEP72" . SPARSER::PROTEIN) ("SLC9A3" . SPARSER::PROTEIN)
    ("PDCD6" . SPARSER::PROTEIN) ("chr3" . SPARSER::PROTEIN)
    ("chr1" . SPARSER::PROTEIN) ("WA and JRS" . SPARSER::COLLECTION)
    ("WA, TG and TN" . SPARSER::COLLECTION) ("WA and TG" . SPARSER::COLLECTION)
    ("luciferase, glutathione and ROS" . SPARSER::COLLECTION)
    ("WA, TG and AO" . SPARSER::COLLECTION) ("FC and TA" . SPARSER::COLLECTION)
    ("WA" . SPARSER::MOLECULE) ("–ATK" . SPARSER::COLLECTION)
    ("ATK" . SPARSER::PROTEIN) ("TrCP" . SPARSER::PROTEIN)
    ("oxidants and electrophiles" . SPARSER::COLLECTION)
    ("UHRF1 and Nrf2" . SPARSER::COLLECTION)
    ("Keap1 and UHRF1" . SPARSER::COLLECTION)
    ("caspase 3 and Cyclin E" . SPARSER::COLLECTION)
    ("UHRF1 and Keap1" . SPARSER::COLLECTION)
    ("UHRF1 or Nrf2" . SPARSER::COLLECTION)
    ("–luciferase" . SPARSER::COLLECTION)
    ("protein and Nrf2" . SPARSER::COLLECTION) ("KPC" . SPARSER::PROTEIN)
    ("aldo" . SPARSER::PROTEIN) ("GcLc" . SPARSER::PROTEIN)
    ("Panc" . SPARSER::PROTEIN) ("Nrf2–Keap1" . SPARSER::COLLECTION)
    ("‐express nuclear UHRF1 and its over‐expression" . SPARSER::COLLECTION)
    ("Np95" . SPARSER::PROTEIN) ("Nrf2 and Keap1" . SPARSER::COLLECTION)
    ("enzymes and xenobiotic" . SPARSER::COLLECTION)
    ("PDACs" . SPARSER::MOLECULE) ("Keap1–Nrf2" . SPARSER::COLLECTION)
    ("a pivotal regulator" . SPARSER::REGULATOR)
    ("glutamate–cysteine ligase catalytic subunit" . SPARSER::PROTEIN)
    ("H2DCFDA" . SPARSER::DRUG) ("ICBP90" . SPARSER::PROTEIN)
    ("PHD and RING finger domains 1" . SPARSER::PROTEIN)
    ("Dnmt1" . SPARSER::PROTEIN) ("erythroid 2" . SPARSER::PROTEIN)
    ("UHRF1" . SPARSER::PROTEIN) ("AHA" . SPARSER::MOLECULE)
    ("RV and LV" . SPARSER::COLLECTION) ("macromolecule" . SPARSER::MOLECULE)
    ("left and right atrial fat" . SPARSER::PROTEIN)
    ("LV and RV" . SPARSER::COLLECTION) ("EF" . SPARSER::PROTEIN)
    ("macromolecular intracellular glycogen" . SPARSER::PROTEIN)
    ("–1 " . SPARSER::PROTEIN) ("year-olds" . SPARSER::PROTEIN)
    ("year-old" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("family 2" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("PRKAG2" . SPARSER::PROTEIN)
    ("Osx and soluble β-cat" . SPARSER::COLLECTION)
    ("Jun-Jun" . SPARSER::COLLECTION) ("Jun-Fos" . SPARSER::COLLECTION)
    ("Osx" . SPARSER::PROTEIN)
    ("OSX and cytoplasmic/soluble" . SPARSER::COLLECTION)
    ("lentiviral cJun shRNA" . SPARSER::PROTEIN)
    ("anti-cJun and anti-cFos" . SPARSER::COLLECTION)
    ("cFos" . SPARSER::PROTEIN) ("cJun" . SPARSER::PROTEIN)
    ("Oligonucleotide" . SPARSER::MOLECULE)
    ("AP-1/c-Jun/c-Fos" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("OSX and β-cat" . SPARSER::COLLECTION)
    ("mild detergents" . SPARSER::MOLECULE)
    ("β-catenin (β-cat) and osterix (OSX, also known as SP7)"
     . SPARSER::COLLECTION)
    ("ALP" . SPARSER::PROTEIN) ("c-Myc and c-Jun" . SPARSER::COLLECTION)
    ("Both β-catenin (β-cat) and osterix (OSX)" . SPARSER::COLLECTION)
    ("OSX" . SPARSER::PROTEIN) ("osterix" . SPARSER::PROTEIN)
    ("runt-related transcription factor 2" . SPARSER::PROTEIN)
    ("P-40" . SPARSER::PROTEIN) ("G-4" . SPARSER::PROTEIN)
    ("SP7" . SPARSER::PROTEIN) ("HER1, HER3, and C-MET" . SPARSER::COLLECTION)
    ("ER (20.8 %) or PR (20.8 %)" . SPARSER::COLLECTION)
    ("HER3, C-MET and HER1" . SPARSER::COLLECTION)
    ("ER, PR, HER2, and HER3" . SPARSER::COLLECTION)
    ("progesterone receptor (PR) and human epidermal growth factor receptor (HER2/neu)"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2/neu)"
     . SPARSER::COLLECTION)
    ("HER3 and C-MET" . SPARSER::COLLECTION) ("BRCA1−" . SPARSER::PROTEIN)
    ("ER, PR or HER2" . SPARSER::COLLECTION)
    ("ER, PR, and HER3" . SPARSER::COLLECTION)
    ("ER, PR, HER1, HER2, and HER3, and C-MET" . SPARSER::COLLECTION)
    ("HER3, and C-MET" . SPARSER::COLLECTION) ("BRCA-2" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("HSPA1L and HSPA1B" . SPARSER::COLLECTION)
    ("heterozygous CG" . SPARSER::PROTEIN)
    ("The genotypic frequencies HSPA1L" . SPARSER::PROTEIN)
    ("pro-fibrotic proteins" . SPARSER::PROTEIN) ("HOM" . SPARSER::PROTEIN)
    ("an hydrophilic amino acid" . SPARSER::AMINO-ACID)
    ("The HSPA1L polymorphic G allele" . SPARSER::ALLELE)
    ("a polar neutral Thr" . SPARSER::AMINO-ACID) ("GC " . SPARSER::PROTEIN)
    ("HSPA1L (rs2227956) and co-dominant" . SPARSER::COLLECTION)
    ("The allele and frequencies" . SPARSER::COLLECTION)
    ("HSPA1A and HSPA1B" . SPARSER::COLLECTION)
    ("a similar heat-inducible Hsp70 protein" . SPARSER::PROTEIN)
    ("HSP70-1 and HSP70-2" . SPARSER::COLLECTION)
    ("HSP70 -2 ( HSPA1B ; OMIM: 603012) and HSP70 -HOM ( HSP70 A1L; OMIM: 140559)"
     . SPARSER::COLLECTION)
    ("HSP70 -1 ( HSPA1A , OMIM: 140550), HSP70 -2 ( HSPA1B ; OMIM: 603012) and HSP70 -HOM ( HSP70 A1L; OMIM: 140559)"
     . SPARSER::COLLECTION)
    ("MICA" . SPARSER::PROTEIN)
    ("Toll-interacting protein ( TOLLIP )" . SPARSER::PROTEIN)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("TOLLIP" . SPARSER::PROTEIN)
    ("HSPA1L (rs2227956) and HSPA1 (rs1043618) polymorphisms"
     . SPARSER::COLLECTION)
    ("HSPA1B (rs1061581), HSPA1L (rs2227956) and HSPA1 (rs1043618) polymorphisms"
     . SPARSER::COLLECTION)
    ("HSP-70" . SPARSER::PROTEIN) ("DR3" . SPARSER::PROTEIN)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hsp70s" . SPARSER::PROTEIN)
    ("HSP1" . SPARSER::PROTEIN) ("HSP70-HOM" . SPARSER::PROTEIN)
    ("HSP70-2" . SPARSER::PROTEIN) ("HSP70-1" . SPARSER::PROTEIN)
    ("HSP70 -HOM" . SPARSER::PROTEIN) ("HSP70 -2" . SPARSER::PROTEIN)
    ("HSP70 -1" . SPARSER::PROTEIN)
    ("Toll-interacting protein" . SPARSER::PROTEIN)
    ("HSPA1B" . SPARSER::PROTEIN) ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSPA1L" . SPARSER::PROTEIN)
    ("Dyrk1a and another gene" . SPARSER::COLLECTION)
    ("FK506 or cyclosporine" . SPARSER::COLLECTION)
    ("FK506 or cyclosporin A" . SPARSER::COLLECTION)
    ("DYRK1A/GSK3B" . SPARSER::COLLECTION)
    ("GSK3B and DYRK1A" . SPARSER::COLLECTION)
    ("Ki67, EdU and BrdU" . SPARSER::COLLECTION)
    ("glibenclamide" . SPARSER::DRUG)
    ("high glucose or pharmacological activators of glucokinase ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("NFATc" . SPARSER::PROTEIN) ("glucokinase" . SPARSER::PROTEIN)
    ("Dyrk1a-NFAT" . SPARSER::COLLECTION) ("CsA" . SPARSER::PROTEIN)
    ("NFATc1-GFP" . SPARSER::COLLECTION)
    ("Dyrk1a and Gsk3b" . SPARSER::COLLECTION)
    ("harmine and TG003" . SPARSER::COLLECTION) ("pdb" . SPARSER::MOLECULE)
    ("a Wnt-driven luciferase reporter gene" . SPARSER::GENE)
    ("Gsk3b and Dyrk1a" . SPARSER::COLLECTION) ("Gsk3b" . SPARSER::PROTEIN)
    ("DTA" . SPARSER::PROTEIN) ("RIP-DTA" . SPARSER::COLLECTION)
    ("Gfi" . SPARSER::PROTEIN) ("Il2rg" . SPARSER::PROTEIN)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("STZ-treated NOD" . SPARSER::PROTEIN)
    ("DNA and ATP" . SPARSER::COLLECTION)
    ("CDK6 and Cyclin D1" . SPARSER::COLLECTION)
    ("p53 binding protein (53bp1) and phospho-γH2aX" . SPARSER::COLLECTION)
    ("53bp1" . SPARSER::PROTEIN) ("streptozotocin" . SPARSER::DRUG)
    ("bromodeoxy-uridine" . SPARSER::COLLECTION) ("harmine" . SPARSER::DRUG)
    ("DYRK1A and GSK3B" . SPARSER::COLLECTION) ("Ins1" . SPARSER::PROTEIN)
    ("NFAT3" . SPARSER::PROTEIN) ("WT 1" . SPARSER::PROTEIN)
    ("INS1" . SPARSER::PROTEIN) ("g −1" . SPARSER::PROTEIN)
    ("DSCR1" . SPARSER::PROTEIN) ("sulfonylurea receptor 1" . SPARSER::PROTEIN)
    ("Ca2 +" . SPARSER::CALCIUM-ION) ("NFATc1" . SPARSER::PROTEIN)
    ("TG003" . SPARSER::DRUG) ("regulated kinase 1A" . SPARSER::PROTEIN)
    ("β catenin" . SPARSER::PROTEIN) ("Gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Cell" . SPARSER::PROTEIN) ("diphtheria toxin" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3 beta" . SPARSER::PROTEIN)
    ("tyrosine-phosphorylation-regulated kinase 1" . SPARSER::PROTEIN)
    ("Dyrk1a" . SPARSER::PROTEIN) ("GSK3B" . SPARSER::PROTEIN)
    ("DYRK1A" . SPARSER::PROTEIN) ("A-B" . SPARSER::PROTEIN)
    ("Gene, and Google" . SPARSER::COLLECTION) ("RAD52" . SPARSER::PROTEIN)
    ("Vitamin D" . SPARSER::MOLECULE) ("G–I" . SPARSER::PROTEIN)
    ("D–F" . SPARSER::PROTEIN) ("P/CAF" . SPARSER::PROTEIN)
    ("CA-125" . SPARSER::DRUG)
    ("MLH1, MSH2, MSH6 and PMS2" . SPARSER::COLLECTION)
    ("MLH1/PMS2" . SPARSER::COLLECTION) ("possible BRAF" . SPARSER::PROTEIN)
    ("Prognostic cohorts" . SPARSER::MOLECULE)
    ("a commercial monoclonal antibody" . SPARSER::DRUG)
    ("MSI-H colorectal cancer cohorts" . SPARSER::MOLECULE)
    ("MSS" . SPARSER::PROTEIN) ("Two prognostic cohorts" . SPARSER::MOLECULE)
    ("P250" . SPARSER::PROTEIN) ("PLX4032" . SPARSER::DRUG)
    ("GPC3 and glutamine synthetase" . SPARSER::COLLECTION)
    ("well-differentiated HCC" . SPARSER::PROTEIN)
    ("both overt and early HCC" . SPARSER::PROTEIN)
    ("a stress-induced gene" . SPARSER::GENE)
    ("HSP70 and P53" . SPARSER::COLLECTION)
    ("glypican-3 (GPC3) and IGF-1R" . SPARSER::COLLECTION)
    ("cyclase-associated protein" . SPARSER::PROTEIN)
    ("family and P53" . SPARSER::COLLECTION)
    ("More specific and sensitive immunochemical biomarkers"
     . SPARSER::MOLECULE)
    ("P53 or HSP70" . SPARSER::COLLECTION)
    ("P53 and HSP70" . SPARSER::COLLECTION)
    ("heat-shock protein" . SPARSER::PROTEIN) ("GPC3" . SPARSER::PROTEIN)
    ("glypican-3" . SPARSER::PROTEIN) ("CAP2" . SPARSER::PROTEIN)
    ("heat shock protein 70" . SPARSER::PROTEIN)
    ("protein, or MAP" . SPARSER::COLLECTION)
    ("the most severe form" . SPARSER::FORM) ("asters" . SPARSER::BIO-COMPLEX)
    ("the transgene and an anti–α-tubulin antibody" . SPARSER::COLLECTION)
    ("E3, F53, and S54" . SPARSER::COLLECTION)
    ("-S2 and H2-S3 loops xref" . SPARSER::COLLECTION)
    ("-S2" . SPARSER::MOLECULE)
    ("no potentially pathogenic variants" . SPARSER::VARIANT)
    ("his name" . SPARSER::AMINO-ACID) ("a 2-year-old" . SPARSER::PROTEIN-PAIR)
    ("No potentially pathogenic variants" . SPARSER::VARIANT)
    ("A de novo heterozygous c" . SPARSER::PROTEIN)
    ("hydrocortisone and levothyroxine" . SPARSER::COLLECTION)
    ("hydrocortisone" . SPARSER::DRUG) ("phenobarbital" . SPARSER::DRUG)
    ("focal rhythmic delta" . SPARSER::PROTEIN)
    ("focal clonic seizures" . SPARSER::PROTEIN)
    ("Foetal MRI" . SPARSER::PROTEIN)
    ("congenital microcephaly" . SPARSER::PROTEIN)
    ("dynamic polymers" . SPARSER::MOLECULE)
    ("microcephaly" . SPARSER::PROTEIN)
    ("LIS1 (also known as PAFAH1B1 ) and DCX" . SPARSER::COLLECTION)
    ("DCX" . SPARSER::PROTEIN) ("LIS1" . SPARSER::PROTEIN)
    ("TUBG1" . SPARSER::PROTEIN) ("TUBB2A" . SPARSER::PROTEIN)
    ("TUBB4A" . SPARSER::PROTEIN) ("TUBB3" . SPARSER::PROTEIN)
    ("TUBB2B" . SPARSER::PROTEIN) ("PAFAH1B1" . SPARSER::PROTEIN)
    ("TUBA1A" . SPARSER::PROTEIN) ("DCTs" . SPARSER::PROTEIN)
    ("Sgk1" . SPARSER::PROTEIN)
    ("Akt and other components" . SPARSER::COLLECTION)
    ("Akt, SGK1, and WNK1" . SPARSER::COLLECTION)
    ("Akt1 and SGK1" . SPARSER::COLLECTION)
    ("dicarboxylate" . SPARSER::MOLECULE) ("ROMK" . SPARSER::PROTEIN)
    ("PDK1 and PDK2" . SPARSER::COLLECTION)
    ("SGK1, SGK2, and SGK3" . SPARSER::COLLECTION)
    ("SGK2 and SGK3" . SPARSER::COLLECTION)
    ("PI3K or Akt" . SPARSER::COLLECTION)
    ("renal Akt as well as NCC" . SPARSER::COLLECTION)
    ("renal Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thiazide" . SPARSER::MOLECULE)
    ("WNK-OSR1/SPAK-NCC" . SPARSER::COLLECTION)
    ("OSR1/SPAK" . SPARSER::COLLECTION)
    ("STE20/SPS1-related proline/alanine-rich kinase (SPAK) and oxidative-stress-responsive kinase"
     . SPARSER::COLLECTION)
    ("oxidative-stress-responsive kinase" . SPARSER::KINASE)
    ("kinase (SPAK)" . SPARSER::KINASE) ("SPAK" . SPARSER::PROTEIN)
    ("DCT" . SPARSER::PROTEIN) ("isoforms and variants" . SPARSER::COLLECTION)
    ("KS-WNK1" . SPARSER::COLLECTION) ("KS" . SPARSER::PROTEIN)
    ("WNK" . SPARSER::PROTEIN-FAMILY) ("WNKs" . SPARSER::PROTEIN-FAMILY)
    ("angiotensin II, glucocorticoids, and aldosterone" . SPARSER::COLLECTION)
    ("NBCe1 and Akt" . SPARSER::COLLECTION)
    ("IRS1 or IRS2" . SPARSER::COLLECTION) ("IRS2/PI3K" . SPARSER::COLLECTION)
    ("the facilitative glucose transporter family" . SPARSER::PROTEIN-FAMILY)
    ("phosphoinositide-dependent protein kinase 1 (PDK1) and Akt2"
     . SPARSER::COLLECTION)
    ("PDK1 and Akt2" . SPARSER::COLLECTION)
    ("substrate (IRS)" . SPARSER::SUBSTRATE)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("Akts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("skeletal muscle and adipocytes" . SPARSER::COLLECTION)
    ("Akt2 and Akt3" . SPARSER::COLLECTION)
    ("Akt1, Akt2, and Akt3" . SPARSER::COLLECTION)
    ("renal tubular transporters" . SPARSER::PROTEIN)
    ("CCDs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glucocorticoids and mineral corticoids" . SPARSER::COLLECTION)
    ("protein kinase B (PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("such renal tubular transporters" . SPARSER::PROTEIN)
    ("Akt and SGK1" . SPARSER::COLLECTION)
    ("renal outer medullary potassium channel (ROMK)" . SPARSER::PROTEIN)
    ("SGK1 and Akt" . SPARSER::COLLECTION)
    ("renal transporters" . SPARSER::PROTEIN)
    ("aldosterone" . SPARSER::PROTEIN)
    ("cotransporter (NCC)" . SPARSER::PROTEIN)
    ("cotransporter" . SPARSER::PROTEIN) ("GSK650394" . SPARSER::DRUG)
    ("Kir1.1" . SPARSER::PROTEIN) ("PPAR γ" . SPARSER::PROTEIN)
    ("Nedd4-2" . SPARSER::PROTEIN) ("PDK2" . SPARSER::PROTEIN)
    ("SGK2" . SPARSER::PROTEIN) ("OSR1" . SPARSER::PROTEIN)
    ("SPS1" . SPARSER::PROTEIN) ("WNK4" . SPARSER::PROTEIN)
    ("WNK3" . SPARSER::PROTEIN) ("WNK2" . SPARSER::PROTEIN)
    ("WNK1" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AS160" . SPARSER::PROTEIN)
    ("phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("Insulin receptor" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("NHE3" . SPARSER::PROTEIN) ("potassium channel" . SPARSER::PROTEIN)
    ("epithelial sodium channel" . SPARSER::PROTEIN)
    ("NBCe1" . SPARSER::PROTEIN)
    ("insulin receptor substrate 2" . SPARSER::PROTEIN)
    ("AR and CX43" . SPARSER::COLLECTION)
    ("suppressor and proliferator" . SPARSER::COLLECTION)
    ("connexins" . SPARSER::PROTEIN) ("homologous proteins" . SPARSER::PROTEIN)
    ("LNCaP and 22RV1" . SPARSER::COLLECTION) ("RV" . SPARSER::MOLECULE)
    ("CX43 and AR" . SPARSER::COLLECTION) ("AR/CX43" . SPARSER::COLLECTION)
    ("CX43 and GJIC" . SPARSER::COLLECTION)
    ("nonfunctional state" . SPARSER::BIO-STATE)
    ("a nonfunctional state" . SPARSER::BIO-STATE)
    ("connexin 43" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CX43" . SPARSER::PROTEIN)
    ("mRNA and COX-2" . SPARSER::COLLECTION)
    ("NF- κ B and AP-1" . SPARSER::COLLECTION) ("p-EGFR" . SPARSER::COLLECTION)
    ("glutamic acid-leucine-arginine" . SPARSER::COLLECTION)
    ("proteins or growth factors" . SPARSER::COLLECTION)
    ("cetuximab and celecoxib" . SPARSER::COLLECTION)
    ("mAbs, cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("EGFR and MAPK" . SPARSER::COLLECTION)
    ("U0126 and SB203580" . SPARSER::COLLECTION)
    ("p50 and p65" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("IL-8 mRNA and the COX-2 protein" . SPARSER::COLLECTION)
    ("p-p38 and p-ERK" . SPARSER::COLLECTION)
    ("cis -Diamminedichloroplatinum(II)" . SPARSER::DRUG)
    ("an anti-EGFR immunoglobulin G1 chimeric mAb" . SPARSER::DRUG)
    ("other clinically relevant mAbs" . SPARSER::DRUG)
    ("clinically approved monoclonal antibodies" . SPARSER::ANTIBODY)
    ("COX-2, IL-8, and AP-1 and NF- κ B" . SPARSER::COLLECTION)
    ("cetuximab and cisplatin" . SPARSER::COLLECTION)
    ("AP-1 and NF- κ B" . SPARSER::COLLECTION)
    ("cyclooxygenase-2 (COX-2) and interleukin-8 (IL-8) mRNA"
     . SPARSER::COLLECTION)
    ("cetuximab or cisplatin" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and MAP kinase (p-ERK and p-p38)"
     . SPARSER::COLLECTION)
    ("p-ERK and p-p38" . SPARSER::COLLECTION) ("or 2 " . SPARSER::MOLECULE)
    ("histone-H1" . SPARSER::PROTEIN) ("I κ B" . SPARSER::PROTEIN)
    ("tween 20" . SPARSER::MOLECULE)
    ("cis -Diamminedichloroplatinum" . SPARSER::DRUG)
    ("activator protein-1" . SPARSER::PROTEIN)
    ("Keap1 and Cullin3" . SPARSER::COLLECTION)
    ("β-catenin, and vimentin" . SPARSER::COLLECTION)
    ("claudin-1 and ZO-1" . SPARSER::COLLECTION)
    ("E-cadherin, claudin, and occludin" . SPARSER::COLLECTION)
    ("N-cadherin, vimentin, snail, slug, and ZO-1" . SPARSER::COLLECTION)
    ("Wnt, TGF-β, and STAT3" . SPARSER::COLLECTION)
    ("Twist1 and Prrx1" . SPARSER::COLLECTION)
    ("FADD, TRADD, and DR5" . SPARSER::COLLECTION)
    ("the nuclear kinase Wee1 and the dual-specificity phosphatase cdc25"
     . SPARSER::COLLECTION)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("cdc2 and Cyclin B1" . SPARSER::COLLECTION)
    ("cdc2, cyclin B1, and cdc25" . SPARSER::COLLECTION)
    ("these molecules and related signaling pathways" . SPARSER::COLLECTION)
    ("VCL, ZYX, CBR, DNAJA2, GSTP1, NQO1, HSP90AA1, PPIB, SOD1, STIP1, and VCP"
     . SPARSER::COLLECTION)
    ("Akt/mTOR/HIF-1a" . SPARSER::COLLECTION)
    ("N-cadherin, Oct-4, Bmi-1, and Nanog" . SPARSER::COLLECTION)
    ("NAC and PLB or GSH and PLB" . SPARSER::COLLECTION)
    ("PLB or GSH and PLB" . SPARSER::COLLECTION)
    ("GSH and PLB" . SPARSER::COLLECTION) ("c-Nrf2" . SPARSER::COLLECTION)
    ("n-Nrf2" . SPARSER::COLLECTION)
    ("NQO1, GST, and HSP90" . SPARSER::COLLECTION)
    ("-Nrf2" . SPARSER::COLLECTION) ("antioxidative genes" . SPARSER::GENE)
    ("Kelch-like ECH-associated protein 1 (Keap1) and Cullin3"
     . SPARSER::COLLECTION)
    ("Bmi-1, Nanog, and Sox-2" . SPARSER::COLLECTION)
    ("Oct-4, Sox-2, Nanog, and Bni-1" . SPARSER::COLLECTION)
    ("Oct-4 and Sox-2" . SPARSER::COLLECTION)
    ("Oct-4, Sox-2, Nanog, and Bmi-1" . SPARSER::COLLECTION)
    ("Unc" . SPARSER::PROTEIN) ("Oct" . SPARSER::PROTEIN)
    ("Oct-4, Bmi-1, Nanog, and Sox-2" . SPARSER::COLLECTION)
    ("ZO-1 and claudin-1" . SPARSER::COLLECTION)
    ("TCF-8/ZEB1" . SPARSER::COLLECTION)
    ("snail and slug" . SPARSER::COLLECTION)
    ("Snail and slug" . SPARSER::COLLECTION)
    ("TCF8/ZEB1" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("Claudin and occludin" . SPARSER::COLLECTION)
    ("β-catenin, γ-catenin, and p120 catenin" . SPARSER::COLLECTION)
    ("snail" . SPARSER::PROTEIN) ("occludin" . SPARSER::PROTEIN)
    ("EMT and stemness" . SPARSER::COLLECTION)
    ("TRADD and DR5" . SPARSER::COLLECTION) ("a typical type" . TYPE)
    ("cyclin B1, CDK1/cdc2, and cdc25 in SCC25 cells" . SPARSER::COLLECTION)
    ("cyclin B1, and cdc25" . SPARSER::COLLECTION)
    ("EMT, and redox" . SPARSER::COLLECTION)
    ("NAC and GSH" . SPARSER::COLLECTION)
    ("ACTA1, ACTG1, CBR, DNAJA2, GSTP1, NQO1, HSP90AA1, PPIB, SOD1, STIP1, and VCP"
     . SPARSER::COLLECTION)
    ("PPIB" . SPARSER::PROTEIN) ("CBR" . SPARSER::PROTEIN)
    ("molecules and signaling pathways" . SPARSER::COLLECTION)
    ("VCL, and ZYX" . SPARSER::COLLECTION) ("ZYX" . SPARSER::PROTEIN)
    ("VAL" . SPARSER::AMINO-ACID) ("TUBB" . SPARSER::PROTEIN)
    ("JUP" . SPARSER::PROTEIN) ("ACTR" . SPARSER::PROTEIN)
    ("ACIN1, CAPNS1, MAPK1, RRAS, LMNA, CAPN2, SPTAN1, CYCS, CDK1, PARP1, AIFM1, FADD, and ACTB"
     . SPARSER::COLLECTION)
    ("CYCS" . SPARSER::PROTEIN) ("LMNA" . SPARSER::PROTEIN)
    ("YWHAQ, PRKDC, YWHAG, YWHAE, YWHAH, YWHAB, YWHAZ, SFN, SKP1, and CDK1"
     . SPARSER::COLLECTION)
    ("SFN" . SPARSER::PROTEIN) ("YWHAB" . SPARSER::PROTEIN)
    ("YWHAH" . SPARSER::PROTEIN) ("YWHAE" . SPARSER::PROTEIN)
    ("YWHAG" . SPARSER::PROTEIN) ("YWHAQ" . SPARSER::PROTEIN)
    ("FADD, Nrf2, MAPK, mTOR, p70S6K, E-cadherin, and vimentin"
     . SPARSER::COLLECTION)
    ("CDK1/cdc2" . SPARSER::COLLECTION)
    ("a natural naphthoquinone" . SPARSER::MOLECULE) ("PLB" . SPARSER::PROTEIN)
    ("naphthoquinone" . SPARSER::MOLECULE) ("Plumbagin" . SPARSER::DRUG)
    ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TNFR1" . SPARSER::PROTEIN)
    ("procaspase-8" . SPARSER::PROTEIN) ("galectin-1" . SPARSER::PROTEIN)
    ("Cullin3" . SPARSER::PROTEIN) ("Oct-3" . SPARSER::PROTEIN)
    ("TCF-8" . SPARSER::PROTEIN) ("p120 catenin" . SPARSER::PROTEIN)
    ("γ-catenin" . SPARSER::PROTEIN) ("E-cadherins" . SPARSER::PROTEIN)
    ("STIP1" . SPARSER::PROTEIN) ("TUBB4B" . SPARSER::PROTEIN)
    ("TUBA4A" . SPARSER::PROTEIN) ("TUBA1C" . SPARSER::PROTEIN)
    ("RHO1" . SPARSER::PROTEIN) ("DNM1L" . SPARSER::PROTEIN)
    ("CTNND1" . SPARSER::PROTEIN) ("CTNNA1" . SPARSER::PROTEIN)
    ("ACTN4" . SPARSER::PROTEIN) ("ACTN1" . SPARSER::PROTEIN)
    ("ACTG1" . SPARSER::PROTEIN) ("ACTA1" . SPARSER::PROTEIN)
    ("AIFM1" . SPARSER::PROTEIN) ("SPTAN1" . SPARSER::PROTEIN)
    ("CAPN2" . SPARSER::PROTEIN) ("CAPNS1" . SPARSER::PROTEIN)
    ("ACIN1" . SPARSER::PROTEIN) ("EIF2" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("claudin-1" . SPARSER::PROTEIN)
    ("zona occludens protein 1" . SPARSER::PROTEIN) ("TCF8" . SPARSER::PROTEIN)
    ("zinc finger E-box-binding homeobox 1" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("TRAIL-R2" . SPARSER::PROTEIN)
    ("TNFRSF6" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("l -arginine" . SPARSER::MOLECULE) ("d -glucose" . SPARSER::MOLECULE)
    ("Sox-2" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("chemokines and growth factors" . SPARSER::COLLECTION)
    ("uteroplacental macrophages" . SPARSER::PROTEIN)
    ("uNK" . SPARSER::PROTEIN) ("tissue-resident DSCs" . SPARSER::PROTEIN)
    ("EGFR-" . SPARSER::PROTEIN)
    ("Akt1, mTOR, S6K and ERK1/2" . SPARSER::COLLECTION)
    ("ErbB2 or NRG1" . SPARSER::COLLECTION)
    ("growth factors and binding proteins" . SPARSER::COLLECTION)
    ("multiple exogenous cytokines, growth factors and binding proteins"
     . SPARSER::COLLECTION)
    ("multiple exogenous cytokines" . SPARSER::PROTEIN)
    ("amyloid precursor protein-cleaving enzyme (BACE)" . SPARSER::PROTEIN)
    ("disintegrin and metalloproteinase (ADAM)" . SPARSER::COLLECTION)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("ADAM10, ADAM17 and ADAM19 or β-site" . SPARSER::COLLECTION)
    ("ADAM19 or β-site" . SPARSER::COLLECTION) ("ADAM" . SPARSER::PROTEIN)
    ("disintegrin" . SPARSER::PROTEIN) ("a huge variety" . SPARSER::VARIETY)
    ("ERK1/2, Akt1, mTOR, S6K and RPS6" . SPARSER::COLLECTION)
    ("ErbB3-" . SPARSER::PROTEIN)
    ("ErbB2, ErbB3 and NRG1" . SPARSER::COLLECTION)
    ("PI3K–Akt–S6K" . SPARSER::COLLECTION)
    ("CPT and/or recombinant human NRG1 ( xref A)" . SPARSER::COLLECTION)
    ("its downstream target caspase-cleaved cytokeratin 18 (KRT18; recognized by the M30 antibody) and p53"
     . SPARSER::COLLECTION)
    ("cleaved caspase 3, its downstream target caspase-cleaved cytokeratin 18 (KRT18; recognized by the M30 antibody) and p53"
     . SPARSER::COLLECTION)
    ("/ErbB3" . SPARSER::COLLECTION)
    ("signalling-competent ErbB2–ErbB3 heterodimers" . SPARSER::HETERODIMER)
    ("ErbB3 and Akt1" . SPARSER::COLLECTION)
    ("Akt1 and ERK1/2" . SPARSER::COLLECTION)
    ("the respective receptors" . SPARSER::PROTEIN)
    ("ErbB2 or ErbB3" . SPARSER::COLLECTION)
    ("HLA-G and ErbB2" . SPARSER::COLLECTION)
    ("HLA-G and ErbB3" . SPARSER::COLLECTION) ("/HLA-G" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin (mTOR) and S6 kinase (S6K)"
     . SPARSER::COLLECTION)
    ("ErbB3, Akt1, ERK1/2 and RPS6" . SPARSER::COLLECTION)
    ("MAPK3 and MAPK1" . SPARSER::COLLECTION) ("DSC" . SPARSER::PROTEIN)
    ("DSCs" . SPARSER::PROTEIN) ("FGFR1 and FGFR3" . SPARSER::COLLECTION)
    ("FLT1 and FLT4" . SPARSER::COLLECTION)
    ("ErbB3 and related downstream kinases" . SPARSER::COLLECTION)
    ("HLA" . SPARSER::PROTEIN) ("the distal part" . SPARSER::COMPONENT)
    ("villous CTBs" . SPARSER::PROTEIN) ("CTBs" . SPARSER::PROTEIN)
    ("EGFR and ErbB4" . SPARSER::COLLECTION)
    ("ErbB2, ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("/ErbB1" . SPARSER::COLLECTION)
    ("ErbB3 and related downstream effectors" . SPARSER::COLLECTION)
    ("ErbB2, ErbB3 and related downstream effectors" . SPARSER::COLLECTION)
    ("exogenous NRG1" . SPARSER::PROTEIN)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION) ("ITGA1" . SPARSER::PROTEIN)
    ("HLA-C" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-33" . SPARSER::PROTEIN) ("BACE1" . SPARSER::PROTEIN)
    ("amyloid precursor protein-cleaving enzyme" . SPARSER::PROTEIN)
    ("ADAM19" . SPARSER::PROTEIN) ("ADAM17" . SPARSER::PROTEIN)
    ("ADAM10" . SPARSER::PROTEIN) ("KRT18" . SPARSER::PROTEIN)
    ("cytokeratin 18" . SPARSER::PROTEIN) ("collagen-I" . SPARSER::PROTEIN)
    ("HLA-G" . SPARSER::PROTEIN) ("FLT4" . SPARSER::PROTEIN)
    ("FLT1" . SPARSER::PROTEIN) ("ITGA5" . SPARSER::PROTEIN)
    ("phosphatidylinositide 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB1" . SPARSER::PROTEIN) ("Neuregulin 1" . SPARSER::PROTEIN)
    ("neuregulin-1" . SPARSER::PROTEIN) ("NRG1" . SPARSER::PROTEIN)
    ("neuregulin 1" . SPARSER::PROTEIN) ("rpS6 and Akt" . SPARSER::COLLECTION)
    ("Akt3/p-Akt3" . SPARSER::COLLECTION) ("Akt1/p-Akt1" . SPARSER::COLLECTION)
    ("CDKs, cyclins and p-Rb" . SPARSER::COLLECTION)
    ("p-Akt3" . SPARSER::COLLECTION) ("p-Akt1" . SPARSER::COLLECTION)
    ("a cell-permeable Akt1/2 inhibitor" . SPARSER::INHIBITOR)
    ("Paxillin and MMP-9" . SPARSER::COLLECTION)
    ("p-Paxillin" . SPARSER::COLLECTION) ("Paxillin" . SPARSER::PROTEIN)
    ("HBE and transwell" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION) ("HBE and NC" . SPARSER::COLLECTION)
    ("similarly active" . SPARSER::ACTIVE) ("II " . SPARSER::PROTEIN)
    ("different gender, age or tumor histological types" . TYPE)
    ("tumor histological types" . TYPE)
    ("Akt shRNA or phosphorylation inhibitor" . SPARSER::COLLECTION)
    ("the principal regulator and signaling pathway" . SPARSER::COLLECTION)
    ("Akt and rpS6" . SPARSER::COLLECTION)
    ("regulator and signaling pathway" . SPARSER::COLLECTION)
    ("Akti-2" . SPARSER::COLLECTION) ("Akti" . SPARSER::PROTEIN)
    ("XII" . SPARSER::PROTEIN) ("Akt1, Akt2 and Akt3" . SPARSER::COLLECTION)
    ("total rpS6 (t-rpS6) and p-rpS6 in NSCLC clinical tissues"
     . SPARSER::COLLECTION)
    ("antiproliferative drugs" . SPARSER::DRUG)
    ("Ribosomes" . SPARSER::BIO-COMPLEX) ("Akt2 or Akt2" . SPARSER::COLLECTION)
    ("Akt1 or Akt3" . SPARSER::COLLECTION)
    ("mTOR, p70S6K and rpS6" . SPARSER::COLLECTION)
    ("p-rpS6/t-rpS6" . SPARSER::COLLECTION)
    ("Akt inhibitor and subsequent cellular bioactivity" . SPARSER::COLLECTION)
    ("HBE" . SPARSER::PROTEIN) ("p-rpS6" . SPARSER::COLLECTION)
    ("t-rpS6" . SPARSER::COLLECTION) ("rpS6" . SPARSER::PROTEIN)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("rpS" . SPARSER::PROTEIN) ("Akt3" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("Ribosomal protein S6" . SPARSER::PROTEIN)
    ("TP53 or KRAS" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("auto-antibody" . SPARSER::PROTEIN) ("the anti-p53" . SPARSER::ANTIBODY)
    ("monocloncal antibodies" . SPARSER::ANTIBODY)
    ("antibody and KRAS" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION) ("TP 53" . SPARSER::PROTEIN)
    ("CCND2 and CCND3" . SPARSER::COLLECTION)
    ("The commercially available antibodies" . SPARSER::ANTIBODY)
    ("mRNA, protein and BARD1" . SPARSER::COLLECTION)
    ("fix" . SPARSER::PROTEIN) ("-val " . SPARSER::COLLECTION)
    ("val " . SPARSER::AMINO-ACID) ("-val" . SPARSER::COLLECTION)
    ("val" . SPARSER::AMINO-ACID) ("Exp" . SPARSER::PROTEIN)
    ("miRNAs and BRCA1" . SPARSER::COLLECTION)
    ("a methylated BRCA1 promoter" . SPARSER::PROMOTER)
    ("tumoral DNA" . SPARSER::DNA) ("PLAs" . SPARSER::PROTEIN)
    ("27 tumoral miRNAs" . SPARSER::PROTEIN)
    ("prognostic biomarkers " . SPARSER::MOLECULE)
    ("biomarkers " . SPARSER::MOLECULE) ("CCND3" . SPARSER::PROTEIN)
    ("Micro-RNA" . SPARSER::MICRO-RNA) ("c-5" . SPARSER::PROTEIN)
    ("cytokeratin 5" . SPARSER::PROTEIN)
    ("olfactory ligands" . SPARSER::LIGAND)
    ("sexual pheromones" . SPARSER::MOLECULE)
    ("volatile chemicals" . SPARSER::MOLECULE)
    ("immunoreactive olfactory receptor proteins" . SPARSER::PROTEIN)
    ("Neuronal olfactory receptors" . SPARSER::PROTEIN)
    ("ovarian olfactory receptors" . SPARSER::PROTEIN)
    ("intra-ovarian olfactory receptors" . SPARSER::PROTEIN)
    ("renin" . SPARSER::PROTEIN)
    ("possibly sexual pheromones" . SPARSER::MOLECULE)
    ("Olfactory receptors" . SPARSER::PROTEIN)
    ("the larger fraction" . SPARSER::COMPONENT)
    ("neuronal olfactory receptors" . SPARSER::PROTEIN)
    ("glass" . SPARSER::MOLECULE)
    ("mutant and wild type animals" . SPARSER::COLLECTION)
    ("pheromones" . SPARSER::MOLECULE)
    ("such receptors and their specific ligands" . SPARSER::COLLECTION)
    ("human OR52A5 and 73% homology" . SPARSER::COLLECTION)
    ("a dimeric form" . SPARSER::FORM)
    ("approximately 36 kDa" . SPARSER::PROTEIN)
    ("gonadotropins" . SPARSER::PROTEIN) ("Fshr-Cre" . SPARSER::COLLECTION)
    ("Fshr" . SPARSER::PROTEIN) ("olfactory receptors" . SPARSER::PROTEIN)
    ("the sporadic form" . SPARSER::FORM)
    ("a functional Brca1" . SPARSER::PROTEIN) ("OR52A1" . SPARSER::PROTEIN)
    ("OR52A5" . SPARSER::PROTEIN)
    ("follicle stimulating hormone" . SPARSER::PROTEIN)
    ("olfactory receptor" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("miR-34a in renal cell carcinoma [ xref ] and miR-185-3p"
     . SPARSER::COLLECTION)
    ("miRNA-mRNA" . SPARSER::COLLECTION)
    ("c-Myc and Cyclin D1" . SPARSER::COLLECTION)
    ("oligonucleotides, and c-MYC" . SPARSER::COLLECTION)
    ("either a tumor suppressor or an oncogene" . SPARSER::COLLECTION)
    ("CD71)" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("a previously known H. pylori target" . SPARSER::TARGET-PROTEIN)
    ("-PDK-1" . SPARSER::COLLECTION)
    ("blot and re-probed" . SPARSER::COLLECTION)
    ("Src and Grb2" . SPARSER::COLLECTION) ("apex" . SPARSER::PROTEIN)
    ("VIII" . SPARSER::PROTEIN) ("PDK-1 and Akt" . SPARSER::COLLECTION)
    ("PI 3-kinase/PDK-1/Akt" . SPARSER::COLLECTION)
    ("SHP2 phosphatase and the Src family" . SPARSER::COLLECTION)
    ("a cytotoxin-associated gene" . SPARSER::GENE) ("cagA" . SPARSER::PROTEIN)
    ("3-phosphoinositide-dependent kinase-1" . SPARSER::PROTEIN)
    ("PI-3" . SPARSER::PROTEIN) ("D-3" . SPARSER::PROTEIN)
    ("PI 3-K" . SPARSER::PROTEIN)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("PDK-1" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("DNA-PKcs and ATR" . SPARSER::COLLECTION) ("DS" . SPARSER::PROTEIN)
    ("53BP1 or DNA-PKcs" . SPARSER::COLLECTION)
    ("cMYC and γH2AX and RAD51" . SPARSER::COLLECTION)
    ("ERCC2 (XPD)" . SPARSER::PROTEIN)
    ("an interesting novel target and two ATR inhibitors"
     . SPARSER::COLLECTION)
    ("IR and gemcitabine" . SPARSER::COLLECTION)
    ("γH2AX and RAD51" . SPARSER::COLLECTION) ("Fus1" . SPARSER::PROTEIN)
    ("ATR and CHK1" . SPARSER::COLLECTION) ("cMYC" . SPARSER::PROTEIN)
    ("ATR and PRKDC" . SPARSER::COLLECTION)
    ("ATR ( ATR ) and DNA-PKcs ( PRKDC )" . SPARSER::COLLECTION)
    ("PRKDC" . SPARSER::PROTEIN) ("shDNA-PKcs" . SPARSER::COLLECTION)
    ("Ku70 and Ku80" . SPARSER::COLLECTION) ("EM9" . SPARSER::PROTEIN)
    ("AA8" . SPARSER::PROTEIN) ("PiR" . SPARSER::PROTEIN)
    ("ATM [ xref ] and VE-821" . SPARSER::COLLECTION)
    ("ATM or the BER scaffold protein" . SPARSER::COLLECTION)
    ("XRCC3 or BRCA2" . SPARSER::COLLECTION)
    ("platinum or gemcitabine" . SPARSER::COLLECTION)
    ("ATR/CHK1" . SPARSER::COLLECTION) ("TP53/RB" . SPARSER::COLLECTION)
    ("ATR (ATM and Rad3 related) and DNA-PKcs (DNA-dependent protein kinase catalytic subunit)"
     . SPARSER::COLLECTION)
    ("ATM and Rad3" . SPARSER::COLLECTION)
    ("the trimeric non-homologous end-joining (NHEJ) protein DNA-PK"
     . SPARSER::PROTEIN)
    ("ATM, BRCA2 and XRCC3" . SPARSER::COLLECTION)
    ("ATRis" . SPARSER::MOLECULE) ("DNA-PKCS" . SPARSER::PROTEIN)
    ("Fus-1" . SPARSER::PROTEIN) ("ERCC2" . SPARSER::PROTEIN)
    ("C8 B" . SPARSER::PROTEIN) ("XRCC5" . SPARSER::PROTEIN)
    ("NU6027" . SPARSER::DRUG) ("VX-970" . SPARSER::DRUG)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Ku80" . SPARSER::PROTEIN) ("VE-821" . SPARSER::DRUG)
    ("Thapsigargin" . SPARSER::MOLECULE) ("GK" . SPARSER::PROTEIN)
    ("Irinotecan or doxorubicin" . SPARSER::COLLECTION)
    ("Irinotecan" . SPARSER::DRUG) ("AMPK and PERK/CHOP" . SPARSER::COLLECTION)
    ("AMPK and CHOP" . SPARSER::COLLECTION)
    ("p62 and GFP-LC3" . SPARSER::COLLECTION) ("p62-LC3" . SPARSER::COLLECTION)
    ("CQ" . SPARSER::PROTEIN) ("GCK" . SPARSER::PROTEIN)
    ("p62/SQSTM1" . SPARSER::COLLECTION) ("Lysosomal" . SPARSER::PROTEIN)
    ("LC3A, LC3B, and LC3C" . SPARSER::COLLECTION)
    ("siRNA or chemical inhibitor" . SPARSER::COLLECTION)
    ("PERK/CHOP" . SPARSER::COLLECTION) ("LC3-puncta" . SPARSER::COLLECTION)
    ("Microtubule-associated protein 1A/1B-light chain 3"
     . SPARSER::COLLECTION)
    ("P62" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("NBR1" . SPARSER::PROTEIN) ("GSK2606414" . SPARSER::DRUG)
    ("mammalian target of Rapamycin" . SPARSER::PROTEIN)
    ("SQSTM1" . SPARSER::PROTEIN) ("LC3C" . SPARSER::PROTEIN)
    ("LC3A" . SPARSER::PROTEIN) ("LC3 A" . SPARSER::PROTEIN)
    ("LC3 B" . SPARSER::PROTEIN) ("CGK733" . SPARSER::DRUG)
    ("Microtubule-associated protein 1A" . SPARSER::PROTEIN)
    ("GCA and NGCA" . SPARSER::COLLECTION) ("GCA" . SPARSER::PROTEIN)
    ("-AMP–activated" . SPARSER::COLLECTION)
    ("PSCA, MUC1, and PLCE1" . SPARSER::COLLECTION) ("PSCA" . SPARSER::PROTEIN)
    ("genetic variants and GCa risk [ xref – xref ]" . SPARSER::COLLECTION)
    ("HP" . SPARSER::PROTEIN) ("AMP–activated" . SPARSER::PROTEIN)
    ("PLCE1" . SPARSER::PROTEIN) ("MUC1" . SPARSER::PROTEIN)
    ("PRKAA1" . SPARSER::PROTEIN) ("‘pure’ anti-estrogen" . SPARSER::DRUG)
    ("Sham" . SPARSER::DRUG)
    ("a novel plasma membrane-associated estrogen receptor" . SPARSER::PROTEIN)
    ("estrogen and TAM" . SPARSER::COLLECTION)
    ("tamoxifen (TAM)" . SPARSER::DRUG)
    ("a previously unidentified promoter" . SPARSER::PROMOTER)
    ("oxygen and glucose" . SPARSER::COLLECTION) ("OGD" . SPARSER::PROTEIN)
    ("estrogen (E2) and tamoxifen" . SPARSER::COLLECTION)
    ("ER-β" . SPARSER::PROTEIN) ("thymidine kinase" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG)
    ("selective estrogen receptor modulator" . SPARSER::DRUG)
    ("protein expressed in" . SPARSER::PROTEIN)
    ("ATM, and PALB2" . SPARSER::COLLECTION)
    ("BARD1 and NBN" . SPARSER::COLLECTION)
    ("ATM, PALB2, BRCA1, BRCA2, and MSH6" . SPARSER::COLLECTION)
    ("known pathogenic missense variants" . SPARSER::VARIANT)
    ("NBN and CHEK2" . SPARSER::COLLECTION) ("insA" . SPARSER::PROTEIN)
    ("BRCA1, BARD1 , and FANCM" . SPARSER::COLLECTION)
    ("ATM, BRCA1, BRCA2, MLH1, MSH2, MSH6 , and TP53" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, PALB2 , and CDKN2A" . SPARSER::COLLECTION)
    ("BRCA2 , CHEK2 , and MSH6" . SPARSER::COLLECTION)
    ("BARD1 , BRCA1 , FANCM , and NBN" . SPARSER::COLLECTION)
    ("MRE11A" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("actin and microtubules" . SPARSER::COLLECTION)
    ("Rho and downstream targets" . SPARSER::COLLECTION)
    ("ROCK and myosin" . SPARSER::COLLECTION)
    ("ROCK/myosin" . SPARSER::COLLECTION) ("FM and Sen" . SPARSER::COLLECTION)
    ("Nocodazole" . SPARSER::DRUG) ("fibrillar 1D" . SPARSER::PROTEIN)
    ("Cdc42 and PAR proteins [ xref , xref ]" . SPARSER::COLLECTION)
    ("ROCK or myosin" . SPARSER::COLLECTION) ("dense actin" . SPARSER::PROTEIN)
    ("actin and Rho/ROCK/myosin inhibitors" . SPARSER::COLLECTION)
    ("Rho, ROCK and myosin II ATPase activity" . SPARSER::PROTEIN)
    ("Rho, ROCK and myosin" . SPARSER::COLLECTION)
    ("blebbistatin" . SPARSER::DRUG)
    ("microtubules and RhoA" . SPARSER::COLLECTION)
    ("regulators of actin and microtubule cytoskeletal networks"
     . SPARSER::COLLECTION)
    ("EB1-EGFP" . SPARSER::COLLECTION) ("TIP" . SPARSER::PROTEIN)
    ("vinculin" . SPARSER::PROTEIN) ("corona" . SPARSER::MOLECULE)
    ("filamentous proteins" . SPARSER::PROTEIN)
    ("filaments, actin, and microtubules" . SPARSER::COLLECTION)
    ("FM" . SPARSER::PROTEIN) ("interleukins" . SPARSER::PROTEIN)
    ("senescent associated heterochromatic foci" . SPARSER::PROTEIN)
    ("Rho/ROCK/myosin" . SPARSER::COLLECTION)
    ("F-actin and microtubule" . SPARSER::COLLECTION)
    ("cytokines, chemokines, growth factors and proteases"
     . SPARSER::COLLECTION)
    ("RhoA" . SPARSER::PROTEIN) ("SASP" . SPARSER::PROTEIN)
    ("latrunculin B" . SPARSER::DRUG)
    ("End-Binding protein 1" . SPARSER::PROTEIN)
    ("Latrunculin B" . SPARSER::DRUG) ("myosin light chain" . SPARSER::PROTEIN)
    ("a 3D" . SPARSER::PROTEIN) ("ATF4 and PHGDH" . SPARSER::COLLECTION)
    ("NRF2–KEAP1" . SPARSER::COLLECTION) ("antiporters" . SPARSER::PROTEIN)
    ("PHGDH , PSAT1 and SHMT2" . SPARSER::COLLECTION)
    ("ATF4, PHGDH, PSAT1, and SHMT2" . SPARSER::COLLECTION)
    ("methionine (SAM)" . SPARSER::MOLECULE)
    ("histone or DNA" . SPARSER::COLLECTION) ("SAH" . SPARSER::MOLECULE)
    ("purines and thymidine" . SPARSER::COLLECTION)
    ("glutathione, cystathionine and homocysteine" . SPARSER::COLLECTION)
    ("homocysteine" . SPARSER::MOLECULE)
    ("glutathione and purines" . SPARSER::COLLECTION)
    ("ADP, and inosine" . SPARSER::COLLECTION)
    ("PHGDH or ATF4" . SPARSER::COLLECTION) ("inosine" . SPARSER::MOLECULE)
    ("IMP" . SPARSER::PROTEIN) ("purines" . SPARSER::DRUG)
    ("purine and thymidine" . SPARSER::COLLECTION)
    ("folate" . SPARSER::MOLECULE)
    ("PHGDH, NRF2 or ATF4" . SPARSER::COLLECTION)
    ("cystathionine" . SPARSER::MOLECULE)
    ("NQO1, ATF4 and serine" . SPARSER::COLLECTION)
    ("serine biosynthetic genes" . SPARSER::GENE)
    ("serine biosynthetic enzymes" . SPARSER::ENZYME)
    ("NRF2 or PHGDH" . SPARSER::COLLECTION)
    ("PHGDH and PSAT1" . SPARSER::COLLECTION)
    ("PHGDH , PSAT1 , PSPH , SHMT1 , and SHMT2" . SPARSER::COLLECTION)
    ("PSPH" . SPARSER::PROTEIN)
    ("Neither serine nor glycine" . SPARSER::COLLECTION)
    ("serine and glycine" . SPARSER::COLLECTION)
    ("glutathione and nucleotide production" . SPARSER::COLLECTION)
    ("PHGDH, PSAT1 and SHMT2" . SPARSER::COLLECTION)
    ("PHGDH" . SPARSER::PROTEIN) ("serine/glycine" . SPARSER::COLLECTION)
    ("PTGR1" . SPARSER::PROTEIN) ("ABCC2" . SPARSER::PROTEIN)
    ("NR0B1" . SPARSER::PROTEIN) ("SRXN1" . SPARSER::PROTEIN)
    ("KIAA0319" . SPARSER::PROTEIN) ("AKR1B10" . SPARSER::PROTEIN)
    ("CYP4F11" . SPARSER::PROTEIN) ("AKR1C3" . SPARSER::PROTEIN)
    ("ALDH3A1" . SPARSER::PROTEIN) ("SPP1" . SPARSER::PROTEIN)
    ("AKR1C2" . SPARSER::PROTEIN) ("AKR1C1" . SPARSER::PROTEIN)
    ("SLC7A11" . SPARSER::PROTEIN) ("M+2" . SPARSER::MOLECULE)
    ("KEAP1" . SPARSER::PROTEIN) ("SHMT1" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN)
    ("nuclear factor erythroid-2–related factor 2" . SPARSER::PROTEIN)
    ("serine hydroxymethyltransferase" . SPARSER::PROTEIN)
    ("SHMT2" . SPARSER::PROTEIN) ("PSAT1" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("DSS" . SPARSER::PROTEIN)
    ("inflammatory mediators and cytokines" . SPARSER::COLLECTION)
    ("mediators and cytokines" . SPARSER::COLLECTION)
    ("either anti-FOXO3a or anti-β-actin primary antibodies (all used at 1:1000 dilution; Bioworld, Shanghai, China) at 4°C"
     . SPARSER::COLLECTION)
    ("anti-β-actin" . SPARSER::COLLECTION) ("EDTA" . SPARSER::MOLECULE)
    ("ethylenediamine" . SPARSER::DRUG) ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("FOXO3a and the glyceraldehyde 3-phosphate dehydrogenase (GAPDH)"
     . SPARSER::COLLECTION)
    ("glyceraldehyde 3-phosphate dehydrogenase (GAPDH)" . SPARSER::PROTEIN)
    ("Colonic mucosa pinch" . SPARSER::PROTEIN) ("pinch" . SPARSER::PROTEIN)
    ("IL-6, and IL-8" . SPARSER::COLLECTION)
    ("messenger RNA and protein" . SPARSER::COLLECTION)
    ("CDK6-p27" . SPARSER::COLLECTION)
    ("Hsc70-associated cyclin D1-CDK4-p27 complex" . SPARSER::BIO-COMPLEX)
    ("S-phase kinase-associated protein" . SPARSER::PROTEIN)
    ("D1 and p27 in the complex" . SPARSER::PROTEIN)
    ("CDK4 and Hsc70" . SPARSER::COLLECTION)
    ("cMyc-cyclin" . SPARSER::COLLECTION) ("FLAG-CDK4" . SPARSER::COLLECTION)
    ("CKI" . SPARSER::PROTEIN) ("Cx43 or p27" . SPARSER::COLLECTION)
    ("Hsc70 and p27" . SPARSER::COLLECTION)
    ("Cx43, p27 and Hsc70" . SPARSER::COLLECTION)
    ("p27 ( xref ) or Cx43 ( xref )" . SPARSER::COLLECTION)
    ("Hsc70 and p27, or Cx43" . SPARSER::COLLECTION)
    ("p27, or Cx43" . SPARSER::COLLECTION)
    ("Hsc70, p27 and Cx43" . SPARSER::COLLECTION)
    ("HA-p27" . SPARSER::COLLECTION) ("p27 or Cx43" . SPARSER::COLLECTION)
    ("either empty vector mRFP or Cx43-mRFP" . SPARSER::COLLECTION)
    ("mRFP" . SPARSER::PROTEIN) ("Cx43-mRFP" . SPARSER::COLLECTION)
    ("Cx43 and p27" . SPARSER::COLLECTION)
    ("CKIs and Cx43" . SPARSER::COLLECTION) ("CKIs" . SPARSER::PROTEIN)
    ("connexin" . SPARSER::PROTEIN-FAMILY)
    ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Connexins" . SPARSER::PROTEIN)
    ("Cx43-Hsc70" . SPARSER::COLLECTION)
    ("the complex and the G1/S transition" . SPARSER::COLLECTION)
    ("Connexin43" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cx43" . SPARSER::PROTEIN)
    ("Connexin 43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H6PD and 6PGD" . SPARSER::COLLECTION)
    ("active LKB1-MO25-STRAD complex" . SPARSER::BIO-COMPLEX)
    ("LKB1-MO25-STRAD" . SPARSER::COLLECTION)
    ("nucleotide or RNA" . SPARSER::COLLECTION)
    ("AMPK ( xref ) and ACC1 ( xref )" . SPARSER::COLLECTION)
    ("PFK" . SPARSER::PROTEIN)
    ("M15, K76, K261 and H452" . SPARSER::COLLECTION)
    ("glutamate dehydrogenase 1 (GLUD1) and isocitrate dehydrogenase 1 (IDH1)"
     . SPARSER::COLLECTION)
    ("LDHA and PGAM1" . SPARSER::COLLECTION) ("LDHA" . SPARSER::PROTEIN)
    ("10 commercially available Physcion derivatives" . SPARSER::DERIVATIVE)
    ("ether" . SPARSER::MOLECULE) ("Emodin" . SPARSER::DRUG)
    ("Compound C or NAC" . SPARSER::COLLECTION)
    ("NAC and Compound C or AMPK" . SPARSER::COLLECTION)
    ("Compound C or AMPK" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("purified active LKB1 complex" . SPARSER::BIO-COMPLEX)
    ("LKB1-STRAD-MO25" . SPARSER::COLLECTION)
    ("LKB1, STRAD and MO25" . SPARSER::COLLECTION)
    ("LKB1, MO25 and STRAD" . SPARSER::COLLECTION)
    ("purified AMPK ( xref , upper right and xref ) or myelin basic protein (MBP) ( xref , lower right )"
     . SPARSER::COLLECTION)
    ("myelin basic protein (MBP)" . SPARSER::PROTEIN)
    ("exogenous substrates" . SPARSER::SUBSTRATE) ("MBP" . SPARSER::PROTEIN)
    ("an exogenous substrate" . SPARSER::SUBSTRATE)
    ("AMPK and ACC1" . SPARSER::COLLECTION)
    ("active LKB1 complex" . SPARSER::BIO-COMPLEX)
    ("Compound C or shRNA" . SPARSER::COLLECTION)
    ("ATP citrate lyase (ACLY) and fatty acid synthase (FASN)"
     . SPARSER::COLLECTION)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("transketolase (TKT)" . SPARSER::PROTEIN) ("OT" . SPARSER::PROTEIN)
    ("TKT" . SPARSER::PROTEIN) ("transketolase" . SPARSER::PROTEIN)
    ("monophosphate-activated protein kinase (AMPK)" . SPARSER::PROTEIN-PAIR)
    ("monophosphate-activated protein kinase" . SPARSER::PROTEIN-PAIR)
    ("a crucial antioxidant" . SPARSER::PROTEIN)
    ("the active LKB1 complex" . SPARSER::BIO-COMPLEX)
    ("ribulose" . SPARSER::MOLECULE) ("H6PD" . SPARSER::PROTEIN)
    ("6-phosphogluconolactonase" . SPARSER::PROTEIN) ("M15" . SPARSER::DRUG)
    ("H 10" . SPARSER::PROTEIN) ("O 5" . SPARSER::PROTEIN)
    ("H 12" . SPARSER::PROTEIN) ("myelin basic protein" . SPARSER::PROTEIN)
    ("Compound C" . SPARSER::MOLECULE) ("ATP synthase" . SPARSER::PROTEIN)
    ("NADP +" . SPARSER::MOLECULE) ("fatty-acid" . SPARSER::MOLECULE)
    ("PGAM1" . SPARSER::PROTEIN) ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("6PGD" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("autoreactive PCs" . SPARSER::PROTEIN)
    ("autoantibodies" . SPARSER::PROTEIN) ("the c-Abl’s" . SPARSER::PROTEIN)
    ("QR" . SPARSER::PROTEIN) ("a long-lived PC" . SPARSER::PROTEIN)
    ("PCs and naïve" . SPARSER::COLLECTION) ("new PCs" . SPARSER::PROTEIN)
    ("long-lived PCs" . SPARSER::PROTEIN)
    ("IL-10 or F (ab’) 2 anti-Ig" . SPARSER::COLLECTION)
    ("CpG, cytokines and BCR" . SPARSER::COLLECTION)
    ("a JNK inhibitor or SB203580" . SPARSER::COLLECTION)
    ("Btk and JNK" . SPARSER::COLLECTION)
    ("LFM-A13 and ibrutinib" . SPARSER::COLLECTION)
    ("IL-21 and sCD40L" . SPARSER::COLLECTION)
    ("both IgM- and IgG-producing PCs" . SPARSER::COLLECTION)
    ("CpG and S. aureus Cowan (SAC)" . SPARSER::COLLECTION)
    ("CpG and F (ab’) 2 anti-Ig" . SPARSER::COLLECTION)
    ("IL-2 and IL-10" . SPARSER::COLLECTION)
    ("CpG and other mitogens" . SPARSER::COLLECTION)
    ("cytokines and BCR" . SPARSER::COLLECTION)
    ("IgM- and IgG-secreting PCs at 5 μg/ml" . SPARSER::COLLECTION)
    ("IgM- and IgG-secreting PCs (Fig.  xref , top)" . SPARSER::COLLECTION)
    ("both IgG- and IgM-secreting PCs" . SPARSER::COLLECTION)
    ("nonspecific control mAb" . SPARSER::DRUG)
    ("both IgM- and IgG-secreting PCs" . SPARSER::COLLECTION)
    ("either IgM- or IgG-specific antibodies" . SPARSER::COLLECTION)
    ("flow cytometry (Fig.  xref ) and no ASCs" . SPARSER::COLLECTION)
    ("IgD" . SPARSER::PROTEIN)
    ("IL-2 and IL-10 or SAC and PWM" . SPARSER::COLLECTION)
    ("IL-10 or SAC and PWM" . SPARSER::COLLECTION)
    ("SAC and PWM" . SPARSER::COLLECTION) ("PWM" . SPARSER::DRUG)
    ("Newly differentiated IgM- and IgG-secreting PCs" . SPARSER::COLLECTION)
    ("approximately 50 PCs" . SPARSER::PROTEIN)
    ("IgG-antibody" . SPARSER::COLLECTION)
    ("most (~80–90 %) mature circulating antibody-secreting PCs"
     . SPARSER::PROTEIN)
    ("ODN" . SPARSER::PROTEIN)
    ("no exogenous growth factors or cytokines" . SPARSER::COLLECTION)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("IgG-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both IgM- and IgG-ASCs (Fig.  xref )" . SPARSER::COLLECTION)
    ("IgM-" . SPARSER::PROTEIN) ("IgM-ASCs" . SPARSER::COLLECTION)
    ("IgG-ASCs" . SPARSER::COLLECTION) ("ASCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PCs " . SPARSER::PROTEIN)
    ("long-lived bone marrow PCs" . SPARSER::PROTEIN)
    ("Lyn-" . SPARSER::PROTEIN) ("SHIP" . SPARSER::PROTEIN)
    ("Btk and p38" . SPARSER::COLLECTION) ("Btk" . SPARSER::PROTEIN)
    ("PCs" . SPARSER::PROTEIN) ("sensitive to apoptosis" . SPARSER::PROTEIN)
    ("2–4 " . SPARSER::PROTEIN) ("LFM-A13" . SPARSER::DRUG)
    ("Pokeweed mitogen" . SPARSER::DRUG) ("HI30" . SPARSER::PROTEIN)
    ("FcγRIIB" . SPARSER::PROTEIN) ("Fc receptor" . SPARSER::PROTEIN)
    ("unfavorable EFS" . SPARSER::PROTEIN)
    ("p-p38 MAPK and the DLBCL subtype" . SPARSER::COLLECTION)
    ("p38, p-p38 MAPK and the DLBCL subtype" . SPARSER::COLLECTION)
    ("PS and p-p38" . SPARSER::COLLECTION)
    ("Bcl-2 and p38" . SPARSER::COLLECTION)
    ("Stat-3 and Bcl-2" . SPARSER::COLLECTION)
    ("MAPK/Bcl-2" . SPARSER::COLLECTION)
    ("R-CHOP-treated cohorts" . SPARSER::MOLECULE)
    ("CHOP or CHOP-like" . SPARSER::COLLECTION)
    ("cytokines or growth factors" . SPARSER::COLLECTION)
    ("MAPK and ERK" . SPARSER::COLLECTION)
    ("kinase, and JNK" . SPARSER::COLLECTION)
    ("arsenic trioxide and bortezomib" . SPARSER::COLLECTION)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("longer EFS" . SPARSER::PROTEIN) ("IPI and Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2 and p-p38" . SPARSER::COLLECTION) ("/GC" . SPARSER::COLLECTION)
    ("p-p38 and the GC/ABC subtypes" . SPARSER::COLLECTION)
    ("p38, p-p38 and the GC/ABC subtypes" . SPARSER::COLLECTION)
    ("/Bcl2" . SPARSER::COLLECTION) ("/Bcl-2" . SPARSER::COLLECTION)
    ("p38/p-p38" . SPARSER::COLLECTION)
    ("p38 or p-p38 and Bcl-2" . SPARSER::COLLECTION)
    ("p-p38 and Blc-2" . SPARSER::COLLECTION)
    ("p38 or p-p38" . SPARSER::COLLECTION)
    ("both the PS and the ABC subtype" . SPARSER::COLLECTION)
    ("p-p38 or p-38" . SPARSER::COLLECTION) ("poor PS" . SPARSER::PROTEIN)
    ("LDH/p38" . SPARSER::COLLECTION) ("LDH/p-p38" . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION) ("SSA" . SPARSER::PROTEIN)
    ("MAPK and p-p38" . SPARSER::COLLECTION) ("just CHOP" . SPARSER::PROTEIN)
    ("-p38" . SPARSER::COLLECTION) ("P38 α and p38" . SPARSER::COLLECTION)
    ("p53, Myc, Bcl-2 and NF-κB" . SPARSER::COLLECTION)
    ("IPI" . SPARSER::PROTEIN)
    ("Bcl2 and the ABC subtype" . SPARSER::COLLECTION)
    ("p38, p-p38, Bcl2 and the ABC subtype" . SPARSER::COLLECTION)
    ("poor EFS" . SPARSER::PROTEIN) ("p-p38 and Bcl-2" . SPARSER::COLLECTION)
    ("EFS" . SPARSER::PROTEIN) ("p38 and p-p38" . SPARSER::COLLECTION)
    ("p38 MAPK (82 %) and p-p38 MAPK (30 %)" . SPARSER::COLLECTION)
    ("Bcl-2 and NF-κB" . SPARSER::COLLECTION)
    ("p38 and phospho p38 (p-p38) MAPK" . SPARSER::COLLECTION)
    ("MSK 1" . SPARSER::PROTEIN) ("Stat-3" . SPARSER::PROTEIN)
    ("p-p 38" . SPARSER::PROTEIN) ("arsenic trioxide" . SPARSER::MOLECULE)
    ("MKK4" . SPARSER::PROTEIN) ("p-38" . SPARSER::PROTEIN)
    ("IPI 3" . SPARSER::PROTEIN) ("IPI 3" . SPARSER::PROTEIN)
    ("MUM-1" . SPARSER::PROTEIN) ("P38 α" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both ROS1 and its frequent fusion partner FIG" . SPARSER::COLLECTION)
    ("FIG-ROS1" . SPARSER::COLLECTION)
    ("TTF1 and napsin" . SPARSER::COLLECTION)
    ("intraductal growth type" . TYPE)
    ("the last few remaining orphan receptor tyrosine kinases"
     . SPARSER::PROTEIN)
    ("crizotinib or foretinib" . SPARSER::COLLECTION)
    ("IL-6/STAT" . SPARSER::COLLECTION) ("KRAS/MAPK" . SPARSER::COLLECTION)
    ("HGF/MET" . SPARSER::COLLECTION)
    ("the histologic subtypes" . SPARSER::PROTEIN) ("intraductal type" . TYPE)
    ("Histological subtypes" . SPARSER::PROTEIN) ("FIG" . SPARSER::PROTEIN)
    ("MET/anaplastic lymphoma kinase" . SPARSER::COLLECTION)
    ("protein kinase B (AKT)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHP-1 and SHP-2" . SPARSER::COLLECTION)
    ("STAT3 and VAV3" . SPARSER::COLLECTION) ("BTC" . SPARSER::PROTEIN)
    ("TTF1" . SPARSER::PROTEIN) ("VAV3" . SPARSER::PROTEIN)
    ("SHP-1" . SPARSER::PROTEIN) ("hyaluronidase" . SPARSER::PROTEIN)
    ("Hyaluronan" . SPARSER::PROTEIN)
    ("47 kDa and 37 kDa [ xref , xref ]" . SPARSER::COLLECTION)
    ("Ad2 and Ad5" . SPARSER::COLLECTION) ("BALB/c" . SPARSER::COLLECTION)
    ("Ad2" . SPARSER::PROTEIN)
    ("the homologous Ad receptor CAR" . SPARSER::PROTEIN)
    ("integrins and heparan sulfate" . SPARSER::COLLECTION)
    ("glycosaminoglycans" . SPARSER::MOLECULE)
    ("coreceptors" . SPARSER::PROTEIN) ("CAR" . SPARSER::PROTEIN)
    ("The strong hexon" . SPARSER::PROTEIN) ("hexon" . SPARSER::PROTEIN)
    ("the viral hexon protein" . SPARSER::PROTEIN)
    ("AdGFP or Ad-cycE" . SPARSER::COLLECTION)
    ("promoter (SP-C) promoter" . SPARSER::PROMOTER)
    ("surfactant" . SPARSER::PROTEIN)
    ("viral capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Human oncolytic Ads" . SPARSER::PROTEIN)
    ("Ad-induced cyclin E" . SPARSER::PROTEIN) ("CTLs" . SPARSER::PROTEIN)
    ("dl" . SPARSER::MOLECULE) ("cycE" . SPARSER::PROTEIN)
    ("oncolytic Ads" . SPARSER::PROTEIN) ("Ads" . SPARSER::PROTEIN)
    ("heparan sulfate" . SPARSER::MOLECULE)
    ("hexon protein" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("18 h" . SPARSER::PROTEIN) ("type 5" . SPARSER::PROTEIN)
    ("SP-C" . SPARSER::PROTEIN) ("E1B55K" . SPARSER::PROTEIN)
    ("b55" . SPARSER::PROTEIN) ("ED-1" . SPARSER::PROTEIN)
    ("trastuzumab and emtansine" . SPARSER::COLLECTION)
    ("a micro RNA" . SPARSER::RNA) ("Micro RNAs" . SPARSER::RNA)
    ("OHP" . SPARSER::PROTEIN)
    ("lapatinib and docetaxel" . SPARSER::COLLECTION)
    ("trastuzumab and taxanes" . SPARSER::COLLECTION)
    ("trastuzumab and DM1" . SPARSER::COLLECTION)
    ("maytansine" . SPARSER::DRUG)
    ("gemcitabine (GEM) or capecitabine" . SPARSER::COLLECTION)
    ("a 185-kDa transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("synergic cytotoxic" . SPARSER::PROTEIN)
    ("GEM and T-DM1" . SPARSER::COLLECTION) ("GEM" . SPARSER::PROTEIN)
    ("e2" . SPARSER::MOLECULE) ("Medicine" . SPARSER::DRUG)
    ("ANXA3 and rs2293347" . SPARSER::COLLECTION)
    ("ANXA3 and EGFR" . SPARSER::COLLECTION)
    ("only four downregulated genes" . SPARSER::GENE)
    ("sunitinib, erlotinib, lapatinib, sorafenib, and gefitinib"
     . SPARSER::COLLECTION)
    ("ERBB/RAS" . SPARSER::COLLECTION)
    ("a well-known multigene family of Ca 2+ -regulated phospholipid- and membrane-binding proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("phospholipid-" . SPARSER::PHOSPHOLIPID)
    ("ANXA3 and drug" . SPARSER::COLLECTION)
    ("the most preliminary types" . TYPE) ("NC " . SPARSER::PROTEIN)
    ("CR " . SPARSER::PROTEIN)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least 68 variant DPYD alleles" . SPARSER::ALLELE)
    ("antiproliferative nucleotides" . SPARSER::NUCLEOTIDE)
    ("Dihydropyrimidine dehydrogenase (DPD)" . SPARSER::PROTEIN)
    ("capecitabine and S-1" . SPARSER::COLLECTION) ("prodrugs" . SPARSER::DRUG)
    ("fluoropyrimidines" . SPARSER::DRUG) ("DPYD" . SPARSER::PROTEIN)
    ("DPD" . SPARSER::PROTEIN) ("EGFR and ANXA3" . SPARSER::COLLECTION)
    ("fluoropyrimidine" . SPARSER::DRUG)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dominant and recessive" . SPARSER::PROTEIN) ("TS-1" . SPARSER::PROTEIN)
    ("Dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("ANXA3" . SPARSER::PROTEIN) ("NRAS and non-exon" . SPARSER::COLLECTION)
    ("DNA and tissue" . SPARSER::COLLECTION) ("KRAS-wt" . SPARSER::COLLECTION)
    ("cetuximab and erlotinib" . SPARSER::COLLECTION)
    ("CR, PR, or SD" . SPARSER::COLLECTION) ("good PS" . SPARSER::PROTEIN)
    ("cetuximab-" . SPARSER::DRUG)
    ("KRAS exon 2-wt metastatic CRC" . SPARSER::PROTEIN)
    ("-wt" . SPARSER::COLLECTION) ("-wildtype" . SPARSER::COLLECTION)
    ("cetuximab (n = 76) or cetuximab" . SPARSER::COLLECTION)
    ("This retrospective study aims" . SPARSER::PROTEIN)
    ("integrin and MMPs" . SPARSER::COLLECTION)
    ("laminin or collagen" . SPARSER::COLLECTION)
    ("β 1 and α v β 3" . SPARSER::COLLECTION)
    ("Zeb2 [ xref ], Twist-AP1 [ xref ] and SNAIL [ xref ]"
     . SPARSER::COLLECTION)
    ("AP1" . SPARSER::PROTEIN) ("major inducers" . SPARSER::MOLECULE)
    ("Snail, Slug, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("integrin/FAK/Src" . SPARSER::COLLECTION)
    ("Predictive biomarkers" . SPARSER::MOLECULE)
    ("Zeb1 or vimentin" . SPARSER::COLLECTION)
    ("Slug, Snail and E-cadherin" . SPARSER::COLLECTION)
    ("ctrl and shRNA" . SPARSER::COLLECTION) ("SNAIL" . SPARSER::PROTEIN)
    ("vimentin/E-cadherin" . SPARSER::COLLECTION)
    ("Zeb1 and Zeb2" . SPARSER::COLLECTION) ("Zeb2" . SPARSER::PROTEIN)
    ("Zeb1" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("the mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("α 5 integrin subunits or inhibiting α 5 β 1 integrin"
     . SPARSER::COLLECTION)
    ("another non peptidic α 5 β 1 integrin antagonist" . SPARSER::MOLECULE)
    ("both SCC9-shRNA ctrl (by 31.5%) and SCC9-shRNA cav1 (by 52.9%, Figure xref , right)"
     . SPARSER::COLLECTION)
    ("collagen and FN" . SPARSER::COLLECTION)
    ("β 1 and α 5 β 1" . SPARSER::COLLECTION)
    ("β 1 and β 3" . SPARSER::COLLECTION) ("FN" . SPARSER::PROTEIN)
    ("ctrl" . SPARSER::PROTEIN)
    ("the principal structural protein" . SPARSER::PROTEIN)
    ("integrins/Cav1" . SPARSER::COLLECTION)
    ("molecular prognostic biomarkers" . SPARSER::MOLECULE)
    ("Tobacco" . SPARSER::DRUG) ("Cav-1" . SPARSER::PROTEIN)
    ("α v β 3" . SPARSER::PROTEIN) ("cav-1" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("β 5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α 3" . SPARSER::PROTEIN)
    ("β 1" . SPARSER::PROTEIN) ("cav1" . SPARSER::PROTEIN)
    ("α 5 β 1" . SPARSER::PROTEIN) ("Cav1" . SPARSER::PROTEIN)
    ("INTRA" . SPARSER::PROTEIN)
    ("epigenetically poised (bivalent) chromatin" . SPARSER::BIO-COMPLEX)
    ("luminal-to-basal subtypes" . SPARSER::PROTEIN)
    ("less-plastic DNA" . SPARSER::DNA)
    ("a mesenchymal state" . SPARSER::BIO-STATE)
    ("E-cadherin and other epithelial-specific genes" . SPARSER::COLLECTION)
    ("other epithelial-specific genes" . SPARSER::GENE)
    ("developmental genes" . SPARSER::GENE)
    ("bivalent chromatin" . SPARSER::PROTEIN)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("solely two major types" . TYPE)
    ("translational medicine" . SPARSER::DRUG)
    ("the mesenchymal state" . SPARSER::BIO-STATE) ("Kadcyla" . SPARSER::DRUG)
    ("emtansine" . SPARSER::DRUG) ("ado" . SPARSER::PROTEIN)
    ("trastuzumab-unresponsive CSC mesenchymal states" . SPARSER::BIO-STATE)
    ("Beta1-integrin" . SPARSER::COLLECTION)
    ("beta1-integrin" . SPARSER::COLLECTION)
    ("EMT-CTCs" . SPARSER::PROTEIN-PAIR)
    ("no clear biomarkers" . SPARSER::MOLECULE) ("SLUG" . SPARSER::PROTEIN)
    ("the trastuzumab-refractory CD44 + /CD24 −/low mesenchymal CSC state"
     . SPARSER::BIO-STATE)
    ("a partially-positive type" . TYPE) ("/CD24" . SPARSER::COLLECTION)
    ("a new mesenchymal state" . SPARSER::BIO-STATE)
    ("estrogen receptor and E-cadherin" . SPARSER::COLLECTION)
    ("a CD44 + CD24 −/low mesenchymal state" . SPARSER::BIO-STATE)
    ("the epithelial-like (ALDH+) state and the mesenchymal-like (CD44 + CD24 −/low ) state"
     . SPARSER::COLLECTION)
    ("INTERCHANGEABLE EPITHELIAL/MESENCHYMAL CSC CELLULAR STATES"
     . SPARSER::BIO-STATE)
    ("ALDH and HER2" . SPARSER::COLLECTION)
    ("mesenchymal (M)-like states" . SPARSER::BIO-STATE)
    ("STATES" . SPARSER::BIO-STATE) ("CSCS" . SPARSER::PROTEIN)
    ("SUBTYPES" . SPARSER::PROTEIN)
    ("trastuzumab and vinorelbine" . SPARSER::COLLECTION)
    ("TRASTUZUMAB" . SPARSER::DRUG)
    ("DNA, RNA, and protein" . SPARSER::COLLECTION) ("Prat" . SPARSER::PROTEIN)
    ("Herceptin" . SPARSER::DRUG)
    ("the otherwise irrelevant HER2" . SPARSER::PROTEIN)
    ("claudin" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase (ALDH)" . SPARSER::PROTEIN)
    ("ALDH" . SPARSER::PROTEIN) ("anti-diabetic" . SPARSER::DRUG)
    ("Beta1" . SPARSER::PROTEIN) ("beta1" . SPARSER::PROTEIN)
    ("mIR-200c" . SPARSER::MOLECULE) ("CK17" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("TNF-α, IL-17 and IL22" . SPARSER::COLLECTION)
    ("nicotine" . SPARSER::DRUG)
    ("as yet unknown targets" . SPARSER::TARGET-PROTEIN)
    ("severe PPK" . SPARSER::PROTEIN)
    ("IL-22 receptor and STAT3" . SPARSER::COLLECTION)
    ("IL-17A and IL-17F" . SPARSER::COLLECTION)
    ("neither IL-17A nor TNF-α" . SPARSER::COLLECTION)
    ("IL-22, neither IL-17A nor TNF-α" . SPARSER::COLLECTION)
    ("the respective proteins" . SPARSER::PROTEIN)
    ("STAT3 or STAT5" . SPARSER::COLLECTION)
    ("the STAT5 inhibitor 573108 or the MAP kinase kinase inhibitor PD980589 ( xref )"
     . SPARSER::COLLECTION)
    ("IL-22-STAT3" . SPARSER::COLLECTION)
    ("TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("IL-17A or TNF-α" . SPARSER::COLLECTION)
    ("IL-17A and TNF-α" . SPARSER::COLLECTION) ("Defensin" . SPARSER::PROTEIN)
    ("IL-1β, IL-17A, IFN-γ or TNF-α" . SPARSER::COLLECTION)
    ("Several inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-1β, IL-17A, IL-22 and TNF-α" . SPARSER::COLLECTION)
    ("hyperproliferative keratinocytes" . SPARSER::PROTEIN)
    ("defensin" . SPARSER::PROTEIN) ("AMPs" . SPARSER::AMP)
    ("SEB" . SPARSER::PROTEIN) ("staphylococcal" . SPARSER::PROTEIN)
    ("PASI" . SPARSER::PROTEIN) ("ACh" . SPARSER::PROTEIN)
    ("PPK" . SPARSER::PROTEIN) ("IL-17 and IL-22" . SPARSER::COLLECTION)
    ("antimicrobial proteins" . SPARSER::PROTEIN)
    ("IL-17, IL-22 and TNF-α" . SPARSER::COLLECTION) ("IMQ" . SPARSER::DRUG)
    ("imiquimod (IMQ)" . SPARSER::DRUG) ("imiquimod" . SPARSER::DRUG)
    ("Mal" . SPARSER::PROTEIN) ("IL22" . SPARSER::PROTEIN)
    ("IL-22 receptor" . SPARSER::PROTEIN) ("IL-17F" . SPARSER::PROTEIN)
    ("SLURP-1" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("S100" . SPARSER::PROTEIN) ("E . coli )" . SPARSER::PROTEIN)
    ("STAT-5" . SPARSER::PROTEIN)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S3I-201" . SPARSER::MOLECULE) ("LL37" . SPARSER::MOLECULE)
    ("S100A7" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("restoring at least partial" . SPARSER::PROTEIN)
    ("Celastrol and some" . SPARSER::COLLECTION) ("thiols" . SPARSER::MOLECULE)
    ("the quinone methide group's" . SPARSER::MOLECULE)
    ("celastrol and several" . SPARSER::COLLECTION)
    ("HL60 and Burkitt" . SPARSER::COLLECTION)
    ("Celastrol and some related triterpenoids" . SPARSER::COLLECTION)
    ("12-O-tetradecanoylphorbol-13-acetate (TPA)" . SPARSER::DRUG)
    ("the classical myeloid differentiating agent DMSO" . SPARSER::MOLECULE)
    ("Myc or N-Myc" . SPARSER::COLLECTION) ("BODIPY" . SPARSER::DRUG)
    ("ATP and the phosphorylation-dependent activation of AMPK (Figure xref and xref )"
     . SPARSER::COLLECTION)
    ("HL60" . SPARSER::PROTEIN) ("neutral lipid" . SPARSER::LIPID)
    ("class or structure" . SPARSER::COLLECTION)
    ("enzyme Brd4 and the synthetic lethal compound dihydroartemisinin"
     . SPARSER::COLLECTION)
    ("the Myc-associated chromatin" . SPARSER::PROTEIN)
    ("that celastrol and SBI analogs" . SPARSER::COLLECTION)
    ("the latter protein" . SPARSER::PROTEIN)
    ("Myc or Max" . SPARSER::COLLECTION) ("enone" . SPARSER::MOLECULE)
    ("ester and amide" . SPARSER::COLLECTION) ("Myc-Max" . SPARSER::COLLECTION)
    ("Myc and Max" . SPARSER::COLLECTION)
    ("Chinese herbal medicine" . SPARSER::DRUG)
    ("celastrol and related quinone methide-containing triterpenoids"
     . SPARSER::COLLECTION)
    ("triterpenoids" . SPARSER::MOLECULE)
    ("Hsp90, Cdc37, IKKB, and annexin" . SPARSER::COLLECTION)
    ("Cdc37" . SPARSER::PROTEIN) ("avid" . SPARSER::DRUG)
    ("IKKB" . SPARSER::PROTEIN)
    ("celastrol and several related molecules" . SPARSER::COLLECTION)
    ("at least one direct Myc inhibitor" . SPARSER::INHIBITOR)
    ("α-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("Max and bind DNA [ xref – xref ]" . SPARSER::COLLECTION)
    ("contiguous amino acids" . SPARSER::AMINO-ACID)
    ("Myc and N-Myc" . SPARSER::COLLECTION)
    ("a potent indirect Myc inhibitor" . SPARSER::INHIBITOR)
    ("numerous target proteins and other free sulfhydryl-containing molecules"
     . SPARSER::COLLECTION)
    ("bHLH-ZIP" . SPARSER::COLLECTION) ("ZIP" . SPARSER::PROTEIN)
    ("bHLH" . SPARSER::PROTEIN) ("Max" . SPARSER::PROTEIN)
    ("β−actin" . SPARSER::PROTEIN) ("P20" . SPARSER::PROTEIN)
    ("oleanolic acid" . SPARSER::MOLECULE) ("p37" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("CD15" . SPARSER::DRUG) ("ursolic acids" . SPARSER::MOLECULE)
    ("ursolic acid" . SPARSER::MOLECULE) ("Myc protein" . SPARSER::PROTEIN)
    ("STAT3 and Myc" . SPARSER::COLLECTION) ("PTPs" . SPARSER::PROTEIN)
    ("Phosphatases" . SPARSER::PHOSPHATASE) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("MMTV-Neu" . SPARSER::COLLECTION) ("PTPRD and E2F2" . SPARSER::COLLECTION)
    ("E2F2 and PTPRD" . SPARSER::COLLECTION)
    ("an indirect E2F2 target" . SPARSER::TARGET-PROTEIN)
    ("a loose prediction and 3 genes" . SPARSER::GENE)
    ("SMAD2, SMAD3 , and SMAD4" . SPARSER::COLLECTION)
    ("their histological type" . TYPE) ("MMTV-Myc" . SPARSER::COLLECTION)
    ("Myc and MMTV-" . SPARSER::COLLECTION)
    ("E2F2 or E2F3" . SPARSER::COLLECTION)
    ("Neu and Myc" . SPARSER::COLLECTION)
    ("E2F1 and E2F2" . SPARSER::COLLECTION) ("PyMT" . SPARSER::PROTEIN)
    ("MMTV-PyMT" . SPARSER::COLLECTION) ("PTPRD" . SPARSER::PROTEIN)
    ("MMTV-" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("c- Myc" . SPARSER::PROTEIN) ("PTPN22" . SPARSER::PROTEIN)
    ("p16Ink4A" . SPARSER::PROTEIN) ("BCAR1" . SPARSER::PROTEIN)
    ("Evodiamine" . SPARSER::DRUG) ("alkaloids" . SPARSER::MOLECULE)
    ("cyclin B1, p27 and E-cadherin" . SPARSER::COLLECTION)
    ("its substrates p27 [ xref ] and E-cadherin [ xref ]"
     . SPARSER::COLLECTION)
    ("directly target APC or SAC component" . SPARSER::COMPONENT)
    ("Mad2 and Cdc20" . SPARSER::COLLECTION)
    ("APC or SAC" . SPARSER::COLLECTION)
    ("the APC/C–Cdc20–substrate ternary complex" . SPARSER::BIO-COMPLEX)
    ("anaphase-promoting complex (APC)" . SPARSER::PROTEIN)
    ("Bub3, Mad1 and Mad2" . SPARSER::COLLECTION) ("Mad2" . SPARSER::PROTEIN)
    ("BubR1/Mad3" . SPARSER::COLLECTION)
    ("Cyclin E, MCL-1 and C-JUN" . SPARSER::COLLECTION)
    ("NIPA [ xref ] and other F-box proteins [ xref ]" . SPARSER::COLLECTION)
    ("Cyclin B1, P27, E-Cadherin, and IκBα" . SPARSER::COLLECTION)
    ("oncogenic E3 ligases and their downstream molecules"
     . SPARSER::COLLECTION)
    ("NFκB [ xref ] and β-Catenin [ xref ]" . SPARSER::COLLECTION)
    ("NIPA, Skp2 and β-TRCP" . SPARSER::COLLECTION)
    ("aminotransferase (AST) and creatinine (CR) (Figure xref )"
     . SPARSER::COLLECTION)
    ("creatinine (CR)" . SPARSER::PROTEIN)
    ("aminotransferase" . SPARSER::PROTEIN)
    ("Cyclin B1 and E-cadherin" . SPARSER::COLLECTION)
    ("NIPA and Skp2" . SPARSER::COLLECTION) ("tubulins" . SPARSER::PROTEIN)
    ("the tyrosine-15-phosphorylated Cdc2" . SPARSER::PROTEIN)
    ("pH3 and cyclin B1" . SPARSER::COLLECTION)
    ("cyclin B1/Cdc2" . SPARSER::COLLECTION)
    ("double-thymidine" . SPARSER::PROTEIN)
    ("=Skp1/β-Actin" . SPARSER::COLLECTION) ("HLF" . SPARSER::PROTEIN)
    ("Fbxw7 and its substrates Cyclin E, MCL-1 and C-Jun (Figure xref )"
     . SPARSER::COLLECTION)
    ("Cyclin E, MCL-1 and C-Jun" . SPARSER::COLLECTION)
    ("β-TRCP (Figure xref ) and Fbxw7 (Figure xref )" . SPARSER::COLLECTION)
    ("Skp1-Cul1" . SPARSER::COLLECTION)
    ("P27 [ xref ] and E-cadherin [ xref ]" . SPARSER::COLLECTION)
    ("Skp2, β-TRCP and Fbxw7" . SPARSER::COLLECTION)
    ("Flag-NIPA" . SPARSER::COLLECTION) ("Skp1-NIPA" . SPARSER::COLLECTION)
    ("Skp2 and Skp1" . SPARSER::COLLECTION)
    ("Skp2 and NIPA" . SPARSER::COLLECTION) ("evodiamine" . SPARSER::DRUG)
    ("Skp1-Skp2-Cks1" . SPARSER::COLLECTION)
    ("L858R/T790M-EGFR" . SPARSER::PROTEIN-PAIR)
    ("Skp2, NIPA, and β-TRCP" . SPARSER::COLLECTION)
    ("ALK (NIPA)" . SPARSER::PROTEIN) ("Skp2-Skp1" . SPARSER::COLLECTION)
    ("the essential adaptor protein" . SPARSER::PROTEIN)
    ("protein and Cul1" . SPARSER::COLLECTION)
    ("oncoproteins (e.g., Skp2, NIPA and β-TRCP) or tumor suppressors (e.g., Fbxw7)"
     . SPARSER::COLLECTION)
    ("Skp2, NIPA and β-TRCP" . SPARSER::COLLECTION)
    ("The S phase kinase-associated protein 1 (Skp1)–Cullin 1 (Cul1)–F-box protein (SCF)"
     . SPARSER::PROTEIN)
    ("protein (SCF)" . SPARSER::PROTEIN) ("–Cullin 1" . SPARSER::COLLECTION)
    ("NIPA, Skp2, and β-TRCP" . SPARSER::COLLECTION)
    ("Cyclin B1, P27 and E-Cadherin" . SPARSER::COLLECTION)
    ("Skp1-Skp2" . SPARSER::COLLECTION) ("NIPA" . SPARSER::PROTEIN)
    ("an essential adaptor protein" . SPARSER::PROTEIN)
    ("Anti-mitotic" . SPARSER::MOLECULE) ("Mad3" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("C-JUN" . SPARSER::PROTEIN) ("C-Jun" . SPARSER::PROTEIN)
    ("N143" . SPARSER::PROTEIN) ("Cks1" . SPARSER::PROTEIN)
    ("Fbxo27" . SPARSER::PROTEIN) ("Fbxo6" . SPARSER::PROTEIN)
    ("Fbxo44" . SPARSER::PROTEIN) ("Cullin 1" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("β-TRCP" . SPARSER::PROTEIN)
    ("hepatocyte-derived monocyte chemotaxis protein-1" . SPARSER::PROTEIN)
    ("Src-Jak2-STAT3" . SPARSER::COLLECTION)
    ("growth factors and their receptors [ xref ]" . SPARSER::COLLECTION)
    ("Hepatocytes" . SPARSER::PROTEIN)
    ("residually histologic HCC" . SPARSER::PROTEIN)
    ("intratumoral Cbl and EGFR" . SPARSER::COLLECTION)
    ("peritumoral EGFR" . SPARSER::PROTEIN) ("poor TTR" . SPARSER::PROTEIN)
    ("low peritumoral Cbl" . SPARSER::PROTEIN)
    ("the adjusted Cox proportional HR" . SPARSER::PROTEIN)
    ("The univariate Cox proportional HR" . SPARSER::PROTEIN)
    ("peritumoral Cbl" . SPARSER::PROTEIN) ("IOD" . SPARSER::MOLECULE)
    ("peritumoral Cbl and EGFR" . SPARSER::COLLECTION)
    ("Cbl and EGFR" . SPARSER::COLLECTION)
    ("The peritumoral Cbl" . SPARSER::PROTEIN) ("HBeAg" . SPARSER::PROTEIN)
    ("intratumoral Cbl" . SPARSER::PROTEIN) ("cbl" . SPARSER::PROTEIN)
    ("intratumoral and peritumoral Casitas B-lineage Lymphoma (cb1) and epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("intratumoral and peritumoral Casitas B-lineage Lymphoma"
     . SPARSER::PROTEIN)
    ("IRE2" . SPARSER::PROTEIN)
    ("Casitas B-lineage Lymphoma" . SPARSER::PROTEIN)
    ("a typical inhibitor" . SPARSER::INHIBITOR) ("-3-" . SPARSER::PROTEIN)
    ("the only common inhibitor" . SPARSER::INHIBITOR)
    ("the pro-apoptotic Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("cpd" . SPARSER::PROTEIN) ("CDC25B and CDC25C" . SPARSER::COLLECTION)
    ("OMFP" . SPARSER::MOLECULE)
    ("close analogs and possible variations" . SPARSER::COLLECTION)
    ("substructural fragments" . SPARSER::FRAGMENT)
    ("xanthone" . SPARSER::DRUG) ("VS" . SPARSER::PROTEIN)
    ("CDK2 and CDK6" . SPARSER::COLLECTION) ("CX" . SPARSER::PROTEIN-FAMILY)
    ("quinone" . SPARSER::MOLECULE) ("CDK2-Cyclin E" . SPARSER::COLLECTION)
    ("CDK2-Cyclin A" . SPARSER::COLLECTION)
    ("CDK1-Cyclin" . SPARSER::COLLECTION) ("CDK6-Cyclin" . SPARSER::COLLECTION)
    ("CDK4-Cyclin" . SPARSER::COLLECTION)
    ("tyrosine and threonine" . SPARSER::COLLECTION)
    ("N-acetyl-cysteine (NAC)" . SPARSER::DRUG) ("SAN" . SPARSER::PROTEIN)
    ("analogs" . SPARSER::ANALOG) ("N-acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("penicillin G" . SPARSER::MOLECULE) ("cc1" . SPARSER::PROTEIN)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("CDC25" . SPARSER::PROTEIN)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Enzalutamide or Bicalutamide" . SPARSER::COLLECTION)
    ("Bicalutamide" . SPARSER::DRUG)
    ("Abiraterone and Enzalutamide" . SPARSER::COLLECTION)
    ("Abiraterone" . SPARSER::DRUG)
    ("Exogenous AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF-1/BNIP3" . SPARSER::COLLECTION)
    ("PC-3 as well as other type" . SPARSER::COLLECTION)
    ("functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("autophagic flux Bafilomycin A1" . SPARSER::DRUG)
    ("Enzalutamide" . SPARSER::DRUG)
    ("either AR antibody or control mouse IgG" . SPARSER::COLLECTION)
    ("MiRNA" . SPARSER::PROTEIN)
    ("exogenous AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pEGFP" . SPARSER::PROTEIN) ("pEGFP-AR" . SPARSER::COLLECTION)
    ("AR and its target PSA ( xref )" . SPARSER::COLLECTION)
    ("ATG5 and ATG7" . SPARSER::COLLECTION)
    ("ATG4D , RAB5A and STMN1" . SPARSER::COLLECTION)
    ("Grp78 and AMPK" . SPARSER::COLLECTION) ("Grp78" . SPARSER::PROTEIN)
    ("the traditional Chinese medicine" . SPARSER::DRUG)
    ("triterpenoid" . SPARSER::MOLECULE) ("Celastrol" . SPARSER::MOLECULE)
    ("hypoxia, or hormone" . SPARSER::COLLECTION)
    ("celastrol" . SPARSER::MOLECULE) ("BNIP3" . SPARSER::PROTEIN)
    ("p89" . SPARSER::PROTEIN) ("bafilomycin A1" . SPARSER::DRUG)
    ("GFP-LC3" . SPARSER::PROTEIN) ("CAT-3" . SPARSER::PROTEIN)
    ("ATG7" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("RAB5A" . SPARSER::PROTEIN) ("ATG4D" . SPARSER::PROTEIN)
    ("OspF" . SPARSER::PROTEIN) ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("OspB and mTOR" . SPARSER::COLLECTION) ("RICTOR" . SPARSER::PROTEIN)
    ("RAPTOR" . SPARSER::PROTEIN)
    ("DEPTOR, mLST8, TTI1, and TEL2" . SPARSER::COLLECTION)
    ("Bacterial type 3" . SPARSER::PROTEIN)
    ("master regulators and coordinators" . SPARSER::COLLECTION)
    ("an upstream regulator of mTORC1 activity and a binding partner"
     . SPARSER::COLLECTION)
    ("cap-dependent translation elongation" . SPARSER::PROTEIN)
    ("growth factors and nutrient" . SPARSER::COLLECTION)
    ("infectious foci" . SPARSER::PROTEIN)
    ("the classical cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherin-cadherin" . SPARSER::COLLECTION) ("ospB" . SPARSER::PROTEIN)
    ("IQGAP1 and OspB" . SPARSER::COLLECTION)
    ("the protein (residues 864–1657) or the fragment" . SPARSER::COLLECTION)
    ("myosin essential light chain, and S100B" . SPARSER::COLLECTION)
    ("light chain, and S100B" . SPARSER::COLLECTION)
    ("RasGAP" . SPARSER::PROTEIN) ("GRD" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("polyproline" . SPARSER::PROTEIN)
    ("GST-OspB" . SPARSER::COLLECTION)
    ("the effector IpgD and the secreted translocon protein IpaC"
     . SPARSER::COLLECTION)
    ("IpaC" . SPARSER::PROTEIN) ("OspB-FLAG" . SPARSER::COLLECTION)
    ("GST-IQGAP1" . SPARSER::COLLECTION) ("Myc-IQGAP1" . SPARSER::COLLECTION)
    ("bacterial effector proteins" . SPARSER::PROTEIN)
    ("OspB and IQGAP1" . SPARSER::COLLECTION) ("spp" . SPARSER::PROTEIN)
    ("OspB-mTORC1" . SPARSER::COLLECTION)
    ("a regulator of mTORC1 and mTORC1-dependent cell proliferation"
     . SPARSER::COLLECTION)
    ("OspB or IQGAP1" . SPARSER::COLLECTION) ("OspB" . SPARSER::PROTEIN)
    ("Effector" . SPARSER::EFFECTOR)
    ("FK506-binding protein" . SPARSER::PROTEIN) ("TEL2" . SPARSER::PROTEIN)
    ("TTI1" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("Dia1" . SPARSER::PROTEIN) ("CLIP-170" . SPARSER::PROTEIN)
    ("S100B" . SPARSER::PROTEIN) ("MEK2" . SPARSER::PROTEIN)
    ("phospholipase A 2" . SPARSER::PROTEIN) ("caspase-4" . SPARSER::PROTEIN)
    ("IQGAP1" . SPARSER::PROTEIN) ("bcl2 and hTERT" . SPARSER::COLLECTION)
    ("hTERT and NF-κB" . SPARSER::COLLECTION)
    ("RAP1 and TIN2" . SPARSER::COLLECTION)
    ("significantly fewer 53BP1 foci" . SPARSER::PROTEIN)
    ("a significantly higher fraction" . SPARSER::COMPONENT)
    ("RAP1 and TPP1" . SPARSER::COLLECTION)
    ("the only shelterin protein" . SPARSER::PROTEIN)
    ("TRF1 and TRF2" . SPARSER::COLLECTION)
    ("TRF1, TRF2, TPP1 and RAP1" . SPARSER::COLLECTION)
    ("significantly fewer TIF" . SPARSER::PROTEIN)
    ("HEL-hTERT and BGC-823-hTERT" . SPARSER::COLLECTION)
    ("foci (TIF)" . SPARSER::PROTEIN) ("immuno-FISH" . SPARSER::PROTEIN-PAIR)
    ("TIF" . SPARSER::PROTEIN) ("hTERT and shelterin" . SPARSER::COLLECTION)
    ("TRF1, TRF2 and POT1" . SPARSER::COLLECTION)
    ("TRF1, TRF2, TPP1 and POT1" . SPARSER::COLLECTION)
    ("TIN2 and RAP1" . SPARSER::COLLECTION)
    ("hTERT and hTER" . SPARSER::COLLECTION)
    ("hTERT, hTER and telomerase" . SPARSER::COLLECTION)
    ("TRF1, TRF2, POT1, TPP1, RAP1 and TIN2" . SPARSER::COLLECTION)
    ("DNA and form" . SPARSER::COLLECTION)
    ("the pro-apoptotic factor NOXA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOXA" . SPARSER::PROTEIN)
    ("mammalian cells and plays essential parts" . SPARSER::COMPONENT)
    ("Tel 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tel 1" . SPARSER::PROTEIN)
    ("TFR2" . SPARSER::PROTEIN) ("TIN2" . SPARSER::PROTEIN)
    ("RAP1" . SPARSER::PROTEIN) ("bcl2" . SPARSER::PROTEIN)
    ("bcl-2" . SPARSER::PROTEIN)
    ("PIM inhibitors and JAK2 inhibitors" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION) ("Ras or GNB1" . SPARSER::COLLECTION)
    ("JAK1 and Tyk2" . SPARSER::COLLECTION)
    ("JAK2 and mTOR" . SPARSER::COLLECTION)
    ("4EBP1 as well as p70S6K and ribosomal protein S6" . SPARSER::COLLECTION)
    ("p70S6K and ribosomal protein S6" . SPARSER::COLLECTION)
    ("c-Kit and TrkA" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN) ("PIM and Akt" . SPARSER::COLLECTION)
    ("shock protein inhibitors and histone deacetylase inhibitors"
     . SPARSER::COLLECTION)
    ("exogenous PIM1" . SPARSER::PROTEIN)
    ("a retroviral promoter" . SPARSER::PROMOTER)
    ("synergizes" . SPARSER::PROTEIN) ("PIM1 and PIM2" . SPARSER::COLLECTION)
    ("PIM1 and PIM 2" . SPARSER::COLLECTION)
    ("JAK2/STAT5" . SPARSER::COLLECTION)
    ("ribosomal S6 protein, and 4EBP1" . SPARSER::COLLECTION)
    ("protein, and 4EBP1" . SPARSER::COLLECTION)
    ("methylcellulose" . SPARSER::DRUG) ("erythropoietin" . SPARSER::PROTEIN)
    ("JAK2 and PIM" . SPARSER::COLLECTION)
    ("ruxolitinib and AZD1208 affected the growth rate by affecting the cell cycle"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic protein BAD" . SPARSER::PROTEIN)
    ("ruxolitinib and PIM" . SPARSER::COLLECTION)
    ("BCR-ABL (not shown) and ruxolitinib" . SPARSER::COLLECTION)
    ("ruxolitinib and SGI-1776" . SPARSER::COLLECTION)
    ("either SGI-1776 (Fig. xref & xref ) or AZD1208 (Fig. xref & xref ) PIM inhibitors"
     . SPARSER::COLLECTION)
    ("PIM1, PIM2, and PIM3" . SPARSER::COLLECTION)
    ("TrkA and Flt3" . SPARSER::COLLECTION) ("TrkA" . SPARSER::PROTEIN)
    ("JAK2/STAT" . SPARSER::COLLECTION) ("cMyc" . SPARSER::PROTEIN)
    ("JAK2-STAT5" . SPARSER::COLLECTION) ("JAK2 or Mpl" . SPARSER::COLLECTION)
    ("CalR" . SPARSER::PROTEIN) ("JAK2 as well as JAK2" . SPARSER::COLLECTION)
    ("Mpl and Lnk" . SPARSER::COLLECTION) ("Lnk" . SPARSER::PROTEIN)
    ("Mpl" . SPARSER::PROTEIN) ("Classical MPNs" . SPARSER::PROTEIN)
    ("STAT5, ERK, and Akt" . SPARSER::COLLECTION)
    ("classical Philadelphia chromosome-negative MPNs" . SPARSER::PROTEIN)
    ("PIM and JAK2" . SPARSER::COLLECTION)
    ("PIMs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p70S6K and S6 protein" . SPARSER::COLLECTION) ("PIM" . SPARSER::PROTEIN)
    ("1 - 4" . SPARSER::PROTEIN) ("P-S6" . SPARSER::PROTEIN)
    ("EBP1" . SPARSER::PROTEIN) ("P-4" . SPARSER::PROTEIN)
    ("GNB1" . SPARSER::PROTEIN) ("Tyk2" . SPARSER::PROTEIN)
    ("PIM 2" . SPARSER::PROTEIN) ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("PIM3" . SPARSER::PROTEIN) ("PIM2" . SPARSER::PROTEIN)
    ("SET2" . SPARSER::PROTEIN) ("PIM1" . SPARSER::PROTEIN)
    ("SGI-1776" . SPARSER::DRUG) ("the protein's" . SPARSER::PROTEIN)
    ("Cytolethal distending toxin (CTD)" . SPARSER::MOLECULE)
    ("toxin (CTD)" . SPARSER::MOLECULE) ("toxin" . SPARSER::MOLECULE)
    ("DNA methyltransferase inhibitors as well as histone deacetylase inhibitors"
     . SPARSER::COLLECTION)
    ("the already high‐risk group" . SPARSER::MOLECULE)
    ("Group (ECOG)" . SPARSER::MOLECULE)
    ("suppressor and member" . SPARSER::COLLECTION)
    ("testosterone" . SPARSER::MOLECULE)
    ("the DAB2IP‐reduced group and DAB2IP‐retained group"
     . SPARSER::COLLECTION)
    ("DOC‐2/DAB2 interactive protein" . SPARSER::PROTEIN)
    ("DOC" . SPARSER::DRUG) ("DAP2" . SPARSER::PROTEIN)
    ("Enhancer of Zeste homolog 2" . SPARSER::PROTEIN)
    ("DAB2IP" . SPARSER::PROTEIN)
    ("bevacizumab and KRAS" . SPARSER::COLLECTION)
    ("carboplatin and pemetrexed" . SPARSER::COLLECTION)
    ("Platinum" . SPARSER::MOLECULE)
    ("pemetrexed or bevacizumab" . SPARSER::COLLECTION)
    ("paclitaxel or docetaxel" . SPARSER::COLLECTION)
    ("96% received carboplatin and the remainder cisplatin"
     . SPARSER::COLLECTION)
    ("MTs" . SPARSER::PROTEIN)
    ("cisplatin and vinorelbine" . SPARSER::COLLECTION)
    ("EGFR and EML-4ALK" . SPARSER::COLLECTION) ("EML-4" . SPARSER::PROTEIN)
    ("p21 as well as SET8" . SPARSER::COLLECTION)
    ("FBXO11 and CDT2" . SPARSER::COLLECTION)
    ("cullin-1 and CDT2" . SPARSER::COLLECTION)
    ("FBXO11 or p53" . SPARSER::COLLECTION)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("p21 and pSMAD2" . SPARSER::COLLECTION)
    ("both Jf and p53 homozygous mutants" . SPARSER::MUTANT)
    ("homozygous mutants" . SPARSER::MUTANT)
    ("p53 and FBXO11" . SPARSER::COLLECTION)
    ("CDCA7 and SP3" . SPARSER::COLLECTION)
    ("SMAD2 and SMAD4" . SPARSER::COLLECTION)
    ("TLR4 and MUC5B" . SPARSER::COLLECTION)
    ("CDT2 or SET8" . SPARSER::COLLECTION)
    ("SET8 and p21" . SPARSER::COLLECTION)
    ("CDT2 and SET8" . SPARSER::COLLECTION)
    ("BCL6, CDT2 and SET8" . SPARSER::COLLECTION)
    ("p21, PAI-1 and MMP-2" . SPARSER::COLLECTION)
    ("p21, PAI-1 and MMP2" . SPARSER::COLLECTION)
    ("p21 and PAI-1" . SPARSER::COLLECTION) ("p53 /+" . SPARSER::PROTEIN)
    ("p53/+" . SPARSER::PROTEIN) ("mutant and Jf/+" . SPARSER::COLLECTION)
    ("the homozygous mutant" . SPARSER::MUTANT)
    ("MDM2 and FBXO11" . SPARSER::COLLECTION)
    ("at least three proteins" . SPARSER::PROTEIN)
    ("p53 or phosphorylated/acetylated" . SPARSER::COLLECTION)
    ("approximately 53, 60 and 71 kDa" . SPARSER::PROTEIN)
    ("-p53" . SPARSER::COLLECTION)
    ("a 930-amino-acid F-box protein" . SPARSER::PROTEIN)
    ("proteins and sugar" . SPARSER::COLLECTION) ("CASH" . SPARSER::PROTEIN)
    ("FBXO11-p53" . SPARSER::COLLECTION)
    ("cullin 4-RING" . SPARSER::COLLECTION)
    ("the larger FBXO11 isoform" . SPARSER::ISOFORM)
    ("CUL1 and CUL4" . SPARSER::COLLECTION)
    ("Cullins" . SPARSER::PROTEIN-FAMILY)
    ("the larger isoform" . SPARSER::ISOFORM)
    ("p53 and Fbxo11" . SPARSER::COLLECTION) ("p53/p53" . SPARSER::COLLECTION)
    ("FBXO11 and TGF-β" . SPARSER::COLLECTION) ("perinatal" . SPARSER::PROTEIN)
    ("sv" . SPARSER::MOLECULE)
    ("MMP2 (matrix metalloproteinase) and SM22 (smooth muscle specific 22 kDa protein)"
     . SPARSER::COLLECTION)
    ("p21, PAI-1 (plasminogen activator inhibitor), MMP2 (matrix metalloproteinase) and SM22 (smooth muscle specific 22 kDa protein)"
     . SPARSER::COLLECTION)
    ("p53 and SMADs" . SPARSER::COLLECTION)
    ("p53, and p53" . SPARSER::COLLECTION) ("FBX" . SPARSER::PROTEIN)
    ("chronic OM" . SPARSER::PROTEIN)
    ("FBXO11-CDT2-SET8" . SPARSER::COLLECTION)
    ("p21 and SET8" . SPARSER::COLLECTION)
    ("CUL1-FBXO11" . SPARSER::COLLECTION)
    ("Rbx1/Roc1/Hrt1 RING domain protein and an F-box protein"
     . SPARSER::COLLECTION)
    ("the SCF ubiquitin-ligase complexes containing Skp1, Cullin, Rbx1/Roc1/Hrt1 RING domain protein and an F-box protein"
     . SPARSER::COLLECTION)
    ("RING" . SPARSER::PROTEIN) ("SMAD3 and TGFβRII" . SPARSER::COLLECTION)
    ("cellular hypoxia" . SPARSER::PROTEIN)
    ("TGF-β and hypoxia-inducible factor-1α" . SPARSER::COLLECTION)
    ("TGF-β and hypoxia" . SPARSER::COLLECTION)
    ("Fbxo11 and Evi1" . SPARSER::COLLECTION)
    ("Fbxo11 , Evi1 and Tgif1" . SPARSER::COLLECTION)
    ("Evi1" . SPARSER::PROTEIN) ("genes  " . SPARSER::GENE)
    ("Evi" . SPARSER::PROTEIN) ("Tgif1" . SPARSER::PROTEIN)
    ("Fbxo11 and p53" . SPARSER::COLLECTION)
    ("TGF-β and p53" . SPARSER::COLLECTION)
    ("Both p53 and double mutants" . SPARSER::COLLECTION)
    ("p53 (also known as Tp53 ) homozygous mutants and double heterozygous mutants ( Jf /+ p53 /+)"
     . SPARSER::COLLECTION)
    ("double heterozygous mutants" . SPARSER::MUTANT)
    ("p53 (also known as Tp53 ) homozygous mutants" . SPARSER::MUTANT)
    ("FBXO11 and p53" . SPARSER::COLLECTION)
    ("a chronic proliferative OM" . SPARSER::PROTEIN)
    ("Fbxo11" . SPARSER::PROTEIN) ("media (OM)" . SPARSER::PROTEIN)
    ("OM" . SPARSER::PROTEIN) ("P120" . SPARSER::PROTEIN)
    ("N-3" . SPARSER::PROTEIN) ("BCL-6" . SPARSER::PROTEIN)
    ("cullin-4" . SPARSER::PROTEIN) ("cullin-1" . SPARSER::PROTEIN)
    ("SP3" . SPARSER::PROTEIN) ("CDCA7" . SPARSER::PROTEIN)
    ("GALNT14" . SPARSER::PROTEIN) ("CAPN14" . SPARSER::PROTEIN)
    ("MUC5B" . SPARSER::PROTEIN) ("SUMO-1" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN) ("cullin 4" . SPARSER::PROTEIN)
    ("CUL4" . SPARSER::PROTEIN) ("NEDD8" . SPARSER::PROTEIN)
    ("SM22" . SPARSER::PROTEIN)
    ("ubiquitin-like protein NEDD8" . SPARSER::PROTEIN)
    ("SET8" . SPARSER::PROTEIN) ("CRL1" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN) ("Cdt2" . SPARSER::PROTEIN)
    ("Hrt1" . SPARSER::PROTEIN) ("TGIF1" . SPARSER::PROTEIN)
    ("EVI1" . SPARSER::PROTEIN) ("Tp53" . SPARSER::PROTEIN)
    ("FBXO11" . SPARSER::PROTEIN)
    ("tamoxifen, ICI182,780 and raloxifene" . SPARSER::COLLECTION)
    ("GPER and the EGFR" . SPARSER::COLLECTION)
    ("p110α/PI3Kinase" . SPARSER::COLLECTION)
    ("the two ubiquitous PI3Kinase p110 catalytic subunits"
     . SPARSER::FRAGMENT)
    ("ERα and FOXO3a" . SPARSER::COLLECTION) ("caveolin" . SPARSER::PROTEIN)
    ("ERα or GPER" . SPARSER::COLLECTION)
    ("both PI3Kinase and the EGFR [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("estrogen, tamoxifen and G-1" . SPARSER::COLLECTION)
    ("PI3Kinase/Akt" . SPARSER::COLLECTION)
    ("its classical nuclear receptors" . SPARSER::RECEPTOR)
    ("a pro-apoptotic state" . SPARSER::BIO-STATE)
    ("that estrogen- as well as G-1-mediated phosphorylation"
     . SPARSER::COLLECTION)
    ("a proapoptotic transcription factor" . SPARSER::PROTEIN)
    ("a more prosurvival state" . SPARSER::BIO-STATE)
    ("estrogen- " . SPARSER::MOLECULE)
    ("Estrogen and G-1" . SPARSER::COLLECTION)
    ("TGX-221 and PIK-75" . SPARSER::COLLECTION)
    ("EGF, estrogen and G-1" . SPARSER::COLLECTION)
    ("LY294002 (LY)" . SPARSER::MOLECULE)
    ("estrogen, G-1 and EGF" . SPARSER::COLLECTION)
    ("tamoxifen and ICI182,780" . SPARSER::COLLECTION)
    ("ICI182,780 or tamoxifen" . SPARSER::COLLECTION)
    ("ICI182,780, raloxifene and tamoxifen" . SPARSER::COLLECTION)
    ("tamoxifen and an additional SERM" . SPARSER::COLLECTION)
    ("SERM" . SPARSER::DRUG) ("GPER or ERα" . SPARSER::COLLECTION)
    ("GPER, ERα and ERβ" . SPARSER::COLLECTION)
    ("G-1 and estrogen" . SPARSER::COLLECTION)
    ("estrogen and G-1" . SPARSER::COLLECTION)
    ("growth factors and cell stimulants" . SPARSER::COLLECTION)
    ("stimulants" . SPARSER::DRUG)
    ("non-selective agonist 17β-estradiol (estrogen) or the GPER-selective agonist G-1 [ xref ]"
     . SPARSER::COLLECTION)
    ("no detactable FOXO3-GFP" . SPARSER::COLLECTION)
    ("clearly observable FOXO3-GFP" . SPARSER::COLLECTION)
    ("FOXO3-GFP" . SPARSER::COLLECTION)
    ("the proapoptotic transcription factor" . SPARSER::PROTEIN)
    ("ERα and GPER" . SPARSER::COLLECTION)
    ("Bim, p21 and p27" . SPARSER::COLLECTION)
    ("Akt and PDK" . SPARSER::COLLECTION)
    ("p110α and p110β" . SPARSER::COLLECTION)
    ("phosphatidylinositol-" . SPARSER::PROTEIN)
    ("estrogen or GPER" . SPARSER::COLLECTION)
    ("estrogen or tamoxifen" . SPARSER::COLLECTION)
    ("Akt-PH-RFP" . SPARSER::COLLECTION) ("COS" . SPARSER::MOLECULE)
    ("estrogen and tamoxifen" . SPARSER::COLLECTION)
    ("the classical nuclear receptors ERα and ERβ" . SPARSER::COLLECTION)
    ("tamoxifen and raloxifene" . SPARSER::COLLECTION) ("SERD" . SPARSER::DRUG)
    ("raloxifene" . SPARSER::PROTEIN) ("GPER and ERα" . SPARSER::COLLECTION)
    ("modulators and downregulators" . SPARSER::COLLECTION)
    ("SERMs and SERDs" . SPARSER::COLLECTION) ("SERDs" . SPARSER::DRUG)
    ("SERMs" . SPARSER::DRUG)
    ("siRNA and the selective GPER agonist G-1" . SPARSER::COLLECTION)
    ("PI3Kinases and EGFR" . SPARSER::COLLECTION)
    ("the 7-transmembrane spanning G protein-coupled estrogen receptor (GPER)"
     . SPARSER::PROTEIN)
    ("estrogen receptor (GPER)" . SPARSER::PROTEIN)
    ("caspases 3" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("Tyrphostin AG1478" . SPARSER::DRUG) ("TGX-221" . SPARSER::DRUG)
    ("PIK-75" . SPARSER::DRUG) ("p85β" . SPARSER::PROTEIN)
    ("p85" . SPARSER::PROTEIN) ("p110β" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("HB-EGF" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("G-1" . SPARSER::PROTEIN) ("PI3Kinases" . SPARSER::PROTEIN)
    ("PI3Kinase" . SPARSER::PROTEIN) ("HBx-HCCR" . SPARSER::COLLECTION)
    ("HCCR/LETMD1" . SPARSER::COLLECTION) ("matrine" . SPARSER::DRUG)
    ("an excellent therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("tumor suppressor p53 and DP-1" . SPARSER::COLLECTION)
    ("p21-HBx" . SPARSER::COLLECTION) ("HBx and HCCR" . SPARSER::COLLECTION)
    ("p53 and DP-1" . SPARSER::COLLECTION)
    ("oncogene (HCCR)" . SPARSER::ONCOGENE)
    ("pSilencer2.1/pSilencer2.1-HCCR" . SPARSER::COLLECTION)
    ("pSilencer2.1" . SPARSER::PROTEIN)
    ("E-cadherin mRNA (Figure xref ) and protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("pSilencer2.1-HCCR" . SPARSER::PROTEIN-PAIR)
    ("HCCR mRNA (Figure xref ) and protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("HCCR and E-cadherin mRNA (Figure xref ) and protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("HCCR and E-cadherin" . SPARSER::COLLECTION)
    ("a key adhesion molecule" . SPARSER::PROTEIN) ("AdGFP" . SPARSER::PROTEIN)
    ("AdGFP-HCCR and AdGFP" . SPARSER::COLLECTION)
    ("AdGFP-HCCR" . SPARSER::COLLECTION) ("-HCCR" . SPARSER::COLLECTION)
    ("sulindac" . SPARSER::DRUG)
    ("the full promoter (HCCRP -474/+30 ) and HCCRP -166/+30"
     . SPARSER::COLLECTION)
    ("HCCRP" . SPARSER::PROTEIN) ("pGL3-HCCRP" . SPARSER::COLLECTION)
    ("pGL3-" . SPARSER::PROTEIN) ("-HBx" . SPARSER::COLLECTION)
    ("HBLS" . SPARSER::PROTEIN) ("pGL3-HCCR" . SPARSER::PROTEIN-PAIR)
    ("pRL" . SPARSER::PROTEIN) ("AdGFP-HBx" . SPARSER::COLLECTION)
    ("viral polymerase" . SPARSER::PROTEIN)
    ("surface protein (HBLS)" . SPARSER::PROTEIN)
    ("TCF/β-catenin" . SPARSER::COLLECTION) ("PI-3K/Akt" . SPARSER::COLLECTION)
    ("the tumor suppressor p53 [ xref ] and the HCCR-1 binding protein"
     . SPARSER::COLLECTION)
    ("small and large HCC" . SPARSER::PROTEIN)
    ("alpha-fetoprotein (AFP)" . SPARSER::PROTEIN)
    ("human cervical cancer proto-oncogene (HCCR)" . SPARSER::PROTEIN)
    ("HCC and/or a potential therapeutic target" . SPARSER::COLLECTION)
    ("/β-catenin" . SPARSER::COLLECTION) ("HCCR" . SPARSER::PROTEIN)
    ("Human cervical cancer proto-oncogene (HCCR)" . SPARSER::PROTEIN)
    ("proto-oncogene (HCCR)" . SPARSER::PROTEIN)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide"
     . SPARSER::MOLECULE)
    ("PI3 kinase" . SPARSER::PROTEIN) ("LY-294002" . SPARSER::PROTEIN)
    ("LETMD1" . SPARSER::PROTEIN) ("K+" . SPARSER::MOLECULE)
    ("DP-1" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("tcf-1" . SPARSER::PROTEIN) ("Tcf-1" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HCCR-1" . SPARSER::PROTEIN)
    ("transmembrane protein 1" . SPARSER::PROTEIN)
    ("EF-hand" . SPARSER::PROTEIN-FAMILY)
    ("DPT selectively targets tumor vasculature" . SPARSER::PROTEIN)
    ("tubulin-RhoA" . SPARSER::PROTEIN-PAIR)
    ("tubulin and RhoA/ROCK" . SPARSER::COLLECTION)
    ("the tumor suppressor LKB1 and the tumor suppressors"
     . SPARSER::COLLECTION)
    ("TSC2 and p53" . SPARSER::COLLECTION)
    ("LKB1 and AMPK" . SPARSER::COLLECTION)
    ("kinases (AMPKK)" . SPARSER::PROTEIN)
    ("LKB1 and CaMKKβ" . SPARSER::COLLECTION)
    ("compound C (CC)" . SPARSER::MOLECULE)
    ("GTPases and actin" . SPARSER::COLLECTION) ("MAPs" . SPARSER::PROTEIN)
    ("tubulin and RhoA" . SPARSER::COLLECTION)
    ("microtubule-associated proteins" . SPARSER::PROTEIN)
    ("F-actin and its subsequent assembly" . SPARSER::COLLECTION)
    ("combretastatin" . SPARSER::DRUG) ("MVD" . SPARSER::PROTEIN)
    ("green ﬂuorescent protein (GFP)" . SPARSER::PROTEIN)
    ("compound C and AMPK" . SPARSER::COLLECTION)
    ("Rho/Rho kinase" . SPARSER::COLLECTION)
    ("actin and tubulin" . SPARSER::COLLECTION)
    ("stabilizer" . SPARSER::MOLECULE) ("AIs" . SPARSER::PROTEIN)
    ("VEGFR2:GFP" . SPARSER::BIO-COMPLEX)
    ("both anti-angiogenic and vascular-disrupting activities"
     . SPARSER::COLLECTION)
    ("β-CD" . SPARSER::MOLECULE) ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("M-5" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("LKB1-AMPK" . SPARSER::PROTEIN) ("I/II" . SPARSER::PROTEIN)
    ("A-4" . SPARSER::PROTEIN) ("STO-609" . SPARSER::DRUG)
    ("Liver kinase B1" . SPARSER::PROTEIN) ("compound C" . SPARSER::MOLECULE)
    ("Bax-" . SPARSER::PROTEIN)
    ("those involving pro-apoptotic Bcl-2 family proteins" . SPARSER::PROTEIN)
    ("a naturally occurring isoflavone and prominent isoflavonoid"
     . SPARSER::COLLECTION)
    ("prominent isoflavonoid" . SPARSER::MOLECULE)
    ("a naturally occurring isoflavone" . SPARSER::MOLECULE)
    ("Bax or Bak" . SPARSER::COLLECTION)
    ("Bcl-xL or Bcl-2" . SPARSER::COLLECTION)
    ("isoflavonoid" . SPARSER::MOLECULE)
    ("Smac and caspase-9" . SPARSER::COLLECTION)
    ("t-Akt" . SPARSER::COLLECTION) ("c, AIF, and endoG" . SPARSER::COLLECTION)
    ("Bak, AIF, and endoG" . SPARSER::COLLECTION)
    ("mitochondrial AIF and endoG" . SPARSER::COLLECTION)
    ("KD/p53" . SPARSER::COLLECTION) ("p53 or Bax" . SPARSER::COLLECTION)
    ("Cyt" . SPARSER::MOLECULE) ("Annexin V/PI" . SPARSER::COLLECTION)
    ("Genistein" . SPARSER::PROTEIN) ("tBid" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL, and Mcl-1" . SPARSER::COLLECTION)
    ("cytochrome c, Smac, AIF, and endoG" . SPARSER::COLLECTION)
    ("dysfunctional Bax and p53" . SPARSER::COLLECTION)
    ("Bax and p53" . SPARSER::COLLECTION) ("AIF-" . SPARSER::PROTEIN)
    ("Akt-Bid" . SPARSER::COLLECTION) ("AIF or endoG" . SPARSER::COLLECTION)
    ("AIF, endoG, and Bak" . SPARSER::COLLECTION)
    ("AIF and endoG" . SPARSER::COLLECTION) ("endoG" . SPARSER::PROTEIN)
    ("Bax or p53" . SPARSER::COLLECTION) ("DU 145" . SPARSER::PROTEIN)
    ("Cox IV" . SPARSER::PROTEIN) ("Cas-3" . SPARSER::PROTEIN)
    ("Pgp" . SPARSER::PROTEIN) ("p53 and CHO" . SPARSER::COLLECTION)
    ("LDLR and RabGGTA" . SPARSER::COLLECTION)
    ("CHO and isoprenoid" . SPARSER::COLLECTION)
    ("HMGCR, MVK, FDPS, FDFT1, RabGGTA and LDLR" . SPARSER::COLLECTION)
    ("a competitive inhibitor" . SPARSER::INHIBITOR) ("Lov" . SPARSER::PROTEIN)
    ("Lovastatin" . SPARSER::DRUG) ("SREBP1 and SREBP2" . SPARSER::COLLECTION)
    ("SREBPs" . SPARSER::PROTEIN-FAMILY)
    ("MVK, FDPS, FDFT1, RabGGTA and LDLR" . SPARSER::COLLECTION)
    ("anti-FLAG antibodies or a control antibody (IgG)" . SPARSER::COLLECTION)
    ("FLAG-p53" . SPARSER::COLLECTION)
    ("HMGCR, MVK, FDPS and FDFT1" . SPARSER::COLLECTION)
    ("p53 or a control antibody (IgG)" . SPARSER::COLLECTION)
    ("intron" . SPARSER::PROTEIN) ("p53 and MDA" . SPARSER::COLLECTION)
    ("p53-siRNA" . SPARSER::COLLECTION) ("Nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDKN1A (p21waf) and GADD45" . SPARSER::COLLECTION)
    ("p53 and U251" . SPARSER::COLLECTION) ("LDLR" . SPARSER::PROTEIN)
    ("FDPS" . SPARSER::PROTEIN) ("MVK" . SPARSER::PROTEIN)
    ("isoprenoid" . SPARSER::MOLECULE)
    ("type, severity and persistence" . SPARSER::COLLECTION)
    ("CHO and lipid" . SPARSER::COLLECTION)
    ("proteins and oncoproteins" . SPARSER::COLLECTION)
    ("isoprenoids" . SPARSER::MOLECULE) ("HMGCR" . SPARSER::PROTEIN)
    ("kinase, farnesyl diphosphate synthase and farnesyl"
     . SPARSER::COLLECTION)
    ("-hydroxy-3" . SPARSER::COLLECTION) ("coenzyme" . SPARSER::MOLECULE)
    ("pifithrin-alpha" . SPARSER::DRUG) ("SREBP2" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("Nutlin 3a" . SPARSER::DRUG)
    ("FDFT1" . SPARSER::PROTEIN)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("farnesyl diphosphate synthase" . SPARSER::PROTEIN)
    ("rapamycin and the oxidant H 2 O 2" . SPARSER::COLLECTION)
    ("FOXOs and sirtuins" . SPARSER::COLLECTION)
    ("H 2 O 2 and an inhibitor" . SPARSER::COLLECTION)
    ("cell cycle suppressors and promoters" . SPARSER::COLLECTION)
    ("RAC3, p21 and p16" . SPARSER::COLLECTION)
    ("rapamycin- or H 2 O 2" . SPARSER::COLLECTION)
    ("p21 and p16" . SPARSER::COLLECTION)
    ("FOXO3A and SIRT1" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("p53–p21" . SPARSER::COLLECTION)
    ("rapamycin or H 2 O 2" . SPARSER::COLLECTION)
    ("H 2 O 2 and rapamycin" . SPARSER::COLLECTION)
    ("H 2 O 2 or rapamycin" . SPARSER::COLLECTION)
    ("Hydrogen peroxide or rapamycin" . SPARSER::COLLECTION)
    ("FOXO1A, FOXO3A and SIRT1" . SPARSER::COLLECTION)
    ("p53/p21" . SPARSER::COLLECTION)
    ("hydrogen peroxide or rapamycin" . SPARSER::COLLECTION)
    ("Lamin B1" . SPARSER::PROTEIN) ("β -Gal" . SPARSER::PROTEIN)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("NF- κ B" . SPARSER::PROTEIN)
    ("RAC3" . SPARSER::PROTEIN)
    ("Receptor-associated coactivator 3" . SPARSER::PROTEIN)
    ("PPARs and ER" . SPARSER::COLLECTION)
    ("SREBP1c and LXR" . SPARSER::COLLECTION)
    ("this viral protein" . SPARSER::PROTEIN)
    ("LXR and LXR-regulated genes" . SPARSER::COLLECTION)
    ("SREBP1c and CH25H" . SPARSER::COLLECTION)
    ("MED1, LXRα and ESR1" . SPARSER::COLLECTION)
    ("DDX5, BRD8, KAT5 and PPARγ" . SPARSER::COLLECTION)
    ("bright" . SPARSER::PROTEIN) ("preadipocytes" . SPARSER::PROTEIN)
    ("multifunctional coactivators" . SPARSER::PROTEIN)
    ("DDX5 and NRIP1" . SPARSER::COLLECTION)
    ("NRs and their coregulators" . SPARSER::COLLECTION)
    ("LXR and SREBP1c" . SPARSER::COLLECTION) ("sera" . SPARSER::PROTEIN)
    ("DPP" . SPARSER::MOLECULE) ("fludarabine" . SPARSER::DRUG)
    ("GAA" . SPARSER::PROTEIN) ("AGG" . SPARSER::MOLECULE)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("JaK/STAT" . SPARSER::COLLECTION) ("JaK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PPARγ and its target gene FABP1 ( xref )" . SPARSER::COLLECTION)
    ("both ESR1 and its target genes PDK4, PTGDS and PEPCK ( xref , *p < 0.05 vs NT cells)"
     . SPARSER::COLLECTION)
    ("PDK4, PTGDS and PEPCK" . SPARSER::COLLECTION)
    ("PEPCK" . SPARSER::PROTEIN) ("PTGDS" . SPARSER::PROTEIN)
    ("ABCA1, SCD-1, SREBP1c, FAS and CH25OH" . SPARSER::COLLECTION)
    ("PPARγ and its transcriptional coregulators BRD8 and KAT5 ( xref )"
     . SPARSER::COLLECTION)
    ("its coactivator MED1 ( xref , p < 0.05) as well as ESR1"
     . SPARSER::COLLECTION)
    ("several NRs (i.e. LXRα, PPARγ and ESR1) and related coregulators (i.e. MED1, BRD8, KAT5, DDX5)"
     . SPARSER::COLLECTION)
    ("BRD8 and KAT5" . SPARSER::COLLECTION)
    ("NRs and transcriptional coregulators" . SPARSER::COLLECTION)
    ("viral protein p17" . SPARSER::PROTEIN)
    ("gene or protein" . SPARSER::COLLECTION)
    ("CXCR2 and syndecan-2" . SPARSER::COLLECTION)
    ("receptors and coregulators" . SPARSER::COLLECTION)
    ("LXR/SREBP1c" . SPARSER::COLLECTION)
    ("LXR and its coactivator MED1" . SPARSER::COLLECTION)
    ("NRs and their related coregulators" . SPARSER::COLLECTION)
    ("-1c" . SPARSER::COLLECTION) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("sterol" . SPARSER::PROTEIN) ("receptor (LXR)" . SPARSER::RECEPTOR)
    ("FXR" . SPARSER::PROTEIN) ("heparan" . SPARSER::MOLECULE)
    ("NRTIs" . SPARSER::DRUG)
    ("LXR target genes (SREBP1c and FAS) and lipid accumulation"
     . SPARSER::COLLECTION)
    ("SREBP1c and FAS" . SPARSER::COLLECTION)
    ("Jak/STAT" . SPARSER::COLLECTION)
    ("This viral protein" . SPARSER::PROTEIN) ("LXR" . SPARSER::PROTEIN)
    ("49 nuclear hormone receptors (NRs) and 35 transcriptional coregulators"
     . SPARSER::COLLECTION)
    ("CH25H" . SPARSER::PROTEIN)
    ("cholesterol 25-hydroxylase" . SPARSER::PROTEIN)
    ("FABP1" . SPARSER::PROTEIN) ("PDK4" . SPARSER::PROTEIN)
    ("SCD-1" . SPARSER::PROTEIN) ("PSMC5" . SPARSER::PROTEIN)
    ("BRD8" . SPARSER::PROTEIN) ("NCOA1" . SPARSER::PROTEIN)
    ("RARα" . SPARSER::PROTEIN) ("TR3" . SPARSER::PROTEIN)
    ("TR2" . SPARSER::PROTEIN) ("DDX5" . SPARSER::PROTEIN)
    ("SA1" . SPARSER::PROTEIN) ("Cholesterol Oxidase" . SPARSER::PROTEIN)
    ("hESR1" . SPARSER::PROTEIN) ("STAT-3" . SPARSER::PROTEIN)
    ("Farnesoid X receptor" . SPARSER::PROTEIN)
    ("syndecan-2" . SPARSER::PROTEIN) ("CXCR2" . SPARSER::PROTEIN)
    ("Pr55Gag" . SPARSER::PROTEIN) ("SREBP1c" . SPARSER::PROTEIN)
    ("EGFR (and most likely its downstream substrates, which include RAS) and the ER"
     . SPARSER::COLLECTION)
    ("tamoxifene" . SPARSER::MOLECULE)
    ("ER and aromatase" . SPARSER::COLLECTION)
    ("an unexpected additional potential therapeutic biomarker"
     . SPARSER::MOLECULE)
    ("KRAS and the functional activation components" . SPARSER::COLLECTION)
    ("druggable RTKs" . SPARSER::PROTEIN)
    ("KRAS and PAK1/2" . SPARSER::COLLECTION)
    ("KRAS-LCK-PAK1/PAK2" . SPARSER::COLLECTION) ("LCK" . SPARSER::PROTEIN)
    ("PAK1/PAK2" . SPARSER::COLLECTION) ("RAS/Raf/MEK" . SPARSER::COLLECTION)
    ("LCM-RPPA" . SPARSER::COLLECTION) ("pure ADs" . SPARSER::PROTEIN)
    ("adeno-squamous components" . SPARSER::COMPONENT)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY)
    ("activated KRAS effectors and several RTKs" . SPARSER::COLLECTION)
    ("Ron" . SPARSER::PROTEIN) ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Receptor Tyrosine Kinases (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("therapeutic biomarkers" . SPARSER::MOLECULE)
    ("a more intricate RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT-mTOR" . SPARSER::COLLECTION) ("AKT/mTOR" . SPARSER::COLLECTION)
    ("ADs" . SPARSER::PROTEIN) ("J4" . SPARSER::PROTEIN)
    ("growth factor receptor–bound protein 2" . SPARSER::PROTEIN)
    ("Smad-2" . SPARSER::PROTEIN) ("p90" . SPARSER::PROTEIN)
    ("Elk-1" . SPARSER::PROTEIN) ("b-Raf" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("particular ROCK2" . SPARSER::PROTEIN)
    ("a rather uncommon example" . SPARSER::EXAMPLE)
    ("antihypertensive" . SPARSER::DRUG)
    ("vascular smooth muscle" . SPARSER::PROTEIN)
    ("The last reference gene" . SPARSER::GENE)
    ("β-actin (ACTB)" . SPARSER::PROTEIN)
    ("Rho kinase (ROCK) and myosin light-chain kinase (MLCK)"
     . SPARSER::COLLECTION)
    ("Smooth muscle" . SPARSER::PROTEIN)
    ("ROCK2 and MLCK" . SPARSER::COLLECTION)
    ("ROCK1, ROCK2 or MLCK" . SPARSER::COLLECTION)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION)
    ("ACTB and PGK1" . SPARSER::COLLECTION)
    ("ROCK2 and 41.9 ± 4" . SPARSER::COLLECTION)
    ("the predominant Rho kinase isoform" . SPARSER::ISOFORM)
    ("Rho kinase (ROCK, isoforms ROCK1 and ROCK2) and myosin-light chain kinase (MLCK)"
     . SPARSER::COLLECTION)
    ("Rho kinase (ROCK1 and ROCK2) and MLCK" . SPARSER::COLLECTION)
    ("the key enzymes Rho kinase (ROCK) and myosin-light chain kinase (MLCK)"
     . SPARSER::COLLECTION)
    ("Rho kinase (ROCK)" . SPARSER::PROTEIN)
    ("adrenoceptor" . SPARSER::PROTEIN)
    ("the classical adrenergic" . SPARSER::PROTEIN)
    ("adrenergic" . SPARSER::PROTEIN) ("ROCK and MLCK" . SPARSER::COLLECTION)
    ("ROCK1, ROCK2 and MLCK" . SPARSER::COLLECTION)
    ("macroscopically healthy human detrusor smooth muscle" . SPARSER::PROTEIN)
    ("Rho kinase (ROCK) and myosin-light chain kinase (MLCK)"
     . SPARSER::COLLECTION)
    ("MLCK" . SPARSER::PROTEIN) ("non-selective" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("myosin light-chain kinase" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("PGK1" . SPARSER::PROTEIN) ("Rho kinase 2" . SPARSER::PROTEIN)
    ("phosphoglycerate kinase 1" . SPARSER::PROTEIN)
    ("myosin-light chain kinase" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN)
    ("NRAS, RAF1 or BRAF" . SPARSER::COLLECTION)
    ("NF1 (99.8 %) and SOS1 (99.9 %)" . SPARSER::COLLECTION)
    ("PA" . SPARSER::PROTEIN)
    ("HRAS (NM_005343) and KRAS (NM_004985)" . SPARSER::COLLECTION)
    ("NF1 (NM_000267.3), PTPN11 (NM_002834), SOS1 (NM_005633), CBL (NM_005188), BRAF (NM_004333), RAF1 (NM_002880), SHOC2 (NM_007373), MAP2K2 (NM_030662), MAP2K1 (NM_002755), SPRED1 (NM_152594) , NRAS (NM_002524), HRAS (NM_005343) and KRAS (NM_004985)"
     . SPARSER::COLLECTION)
    ("exon-intron" . SPARSER::PROTEIN-PAIR)
    ("13 RASopathy-associated genes" . SPARSER::GENE)
    ("mild mental retardation" . SPARSER::PROTEIN)
    ("KRAS [ xref , xref ] and RRAS [ xref ]" . SPARSER::COLLECTION)
    ("SOS1 [ xref , xref ] , CBL [ xref – xref ] , BRAF [ xref ] , RAF1 [ xref , xref ] , SHOC2 [ xref ] , MAP2K1 [ xref ] , RIT1 [ xref ] , NRAS [ xref ], KRAS [ xref , xref ] and RRAS [ xref ]"
     . SPARSER::COLLECTION)
    ("RRAS" . SPARSER::PROTEIN) ("OMIM" . SPARSER::PROTEIN)
    ("NRAS-" . SPARSER::PROTEIN) ("NRAS  " . SPARSER::PROTEIN)
    ("NF1, PTPN11, SOS1, CBL, BRAF, RAF1, SHOC2, MAP2K2, MAP2K1, SPRED1, NRAS, HRAS and KRAS"
     . SPARSER::COLLECTION)
    ("RAS-MAPK" . SPARSER::COLLECTION) ("P24" . SPARSER::PROTEIN)
    ("RIT1" . SPARSER::PROTEIN) ("SPRED1" . SPARSER::PROTEIN)
    ("SHOC2" . SPARSER::PROTEIN) ("SOS1" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("multi" . SPARSER::PROTEIN) ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK1 and STMN1" . SPARSER::COLLECTION)
    ("a functional FANCC" . SPARSER::PROTEIN)
    ("NEK2, CENPE and Polo-Like Kinase-1" . SPARSER::COLLECTION)
    ("S16- and S38-STMN1" . SPARSER::COLLECTION) ("PD220" . SPARSER::PROTEIN)
    ("cells PD220" . SPARSER::PROTEIN)
    ("anti-STMN1 or anti-phospho-specific" . SPARSER::COLLECTION)
    ("protein and group D2" . SPARSER::COLLECTION)
    ("FANCA and FANCD2" . SPARSER::COLLECTION) ("S16-" . SPARSER::PROTEIN)
    ("FancC  -/- and wild-type cells showed similar total STMN1 protein levels"
     . SPARSER::COLLECTION)
    ("anti-STMN1 or anti-phospho-STMN1" . SPARSER::COLLECTION)
    ("anti-FANCC antibodies or secondary antibodies" . SPARSER::COLLECTION)
    ("secondary antibodies" . SPARSER::ANTIBODY) ("FancC" . SPARSER::PROTEIN)
    ("a centrosomic protein" . SPARSER::PROTEIN)
    ("FANCC L554P and FANCC" . SPARSER::COLLECTION)
    ("STMN1 and mutant" . SPARSER::COLLECTION)
    ("FANCC and STMN1" . SPARSER::COLLECTION)
    ("GFP-FANCC" . SPARSER::COLLECTION) ("delG" . SPARSER::PROTEIN)
    ("-STMN1" . SPARSER::COLLECTION) ("sepharose" . SPARSER::MOLECULE)
    ("STMN1-FANCC" . SPARSER::COLLECTION) ("this mutated form" . SPARSER::FORM)
    ("FANCC-STMN1" . SPARSER::COLLECTION)
    ("STMN1 and STMN2" . SPARSER::COLLECTION)
    ("the ubiquitous STMN1" . SPARSER::PROTEIN)
    ("FANCC as well as full-length FANCC" . SPARSER::COLLECTION)
    ("STMN2 and FANCC" . SPARSER::COLLECTION)
    ("a complex and co-localizes" . SPARSER::COLLECTION)
    ("α/β" . SPARSER::PROTEIN)
    ("a pseudo-phosphorylated 4-Glu STMN1 mutant" . SPARSER::MUTANT)
    ("STMN1-tubulin" . SPARSER::COLLECTION)
    ("α/β-tubulin" . SPARSER::COLLECTION)
    ("the ubiquitous form" . SPARSER::FORM)
    ("SCG10 or STMN2" . SPARSER::COLLECTION)
    ("SCLIP or STMN3" . SPARSER::COLLECTION)
    ("RB3 or STMN4" . SPARSER::COLLECTION) ("SCLIP" . SPARSER::PROTEIN)
    ("small microtubule-associated proteins" . SPARSER::PROTEIN)
    ("STMN" . SPARSER::PROTEIN)
    ("the microtubule-associated protein Stathmin-2 (STMN2) and substrate"
     . SPARSER::COLLECTION)
    ("the mitotic cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("FA and FA-like" . SPARSER::COLLECTION)
    ("a two-protein substrate (FANCD2 and FANCI) and downstream effectors (FANCD1, FANCJ, FANCM, FANCN, FANCO, FANCP, FANCQ, FANCS)"
     . SPARSER::COLLECTION)
    ("FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL"
     . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("FANCM" . SPARSER::PROTEIN)
    ("acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("supernumerary centrosomes" . SPARSER::PROTEIN)
    ("FANCA- and FANCD2-mutant" . SPARSER::COLLECTION)
    ("centrosomes" . SPARSER::PROTEIN)
    ("a ubiquitous cytosolic protein" . SPARSER::PROTEIN)
    ("NEK2" . SPARSER::PROTEIN) ("group D" . SPARSER::PROTEIN)
    ("Centrin-2" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN) ("Gal-4" . SPARSER::PROTEIN)
    ("AH109 S" . SPARSER::DRUG) ("Aurora-B" . SPARSER::PROTEIN)
    ("Centrin 2" . SPARSER::PROTEIN) ("H10" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P16" . SPARSER::PROTEIN)
    ("Glutathione-S-transferase" . SPARSER::PROTEIN) ("S25" . SPARSER::PROTEIN)
    ("S16" . SPARSER::PROTEIN) ("STMN4" . SPARSER::PROTEIN)
    ("RB3" . SPARSER::PROTEIN) ("STMN3" . SPARSER::PROTEIN)
    ("SCG10-like protein" . SPARSER::PROTEIN) ("SCG10" . SPARSER::PROTEIN)
    ("STMN-1" . SPARSER::PROTEIN) ("STMN2" . SPARSER::PROTEIN)
    ("Stathmin-2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("group C" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("FGF2 and FGFR2" . SPARSER::COLLECTION)
    ("tobacco, smoking, and alcohol" . SPARSER::COLLECTION)
    ("podoplanin and ABCG2" . SPARSER::COLLECTION)
    ("podoplanin" . SPARSER::PROTEIN) ("Shi" . SPARSER::PROTEIN)
    ("only FGF-2 and FGFR-2" . SPARSER::PROTEIN)
    ("chemotactic cytokines and other growth factors" . SPARSER::COLLECTION)
    ("chemotactic cytokines" . SPARSER::PROTEIN)
    ("connective tissue matrix" . SPARSER::PROTEIN-FAMILY)
    ("Several promising FGFR tyrosine kinase inhibitors and FGFR-blocking antibodies"
     . SPARSER::COLLECTION)
    ("VEGF and hepatocyte growth factor" . SPARSER::COLLECTION)
    ("FGFs/FGFRs" . SPARSER::COLLECTION) ("FGFRs" . SPARSER::PROTEIN)
    ("FGF-2and FGFR-2" . SPARSER::COLLECTION)
    ("both OSMF (n = 3) and LKP (n = 4)" . SPARSER::COLLECTION)
    ("FGF-2, FGFR-2 and FGFR-2" . SPARSER::COLLECTION)
    ("FGFR-2 (rs = 0.321, p<0.001) and FGFR-3 (rs = 0.353, p<0.000)"
     . SPARSER::COLLECTION)
    ("FGF-2 and receptors" . SPARSER::COLLECTION)
    ("FGF-2 , FGFR-2 and FGFR-3" . SPARSER::COLLECTION)
    ("FGF-2 and its receptors (FGFR-2 and FGFR-3)" . SPARSER::COLLECTION)
    ("LKP and OSMF" . SPARSER::COLLECTION) ("HNC" . SPARSER::PROTEIN)
    ("FGFR-3 and FGFR-4" . SPARSER::COLLECTION) ("flg" . SPARSER::PROTEIN)
    ("genes and oncogenes" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("OSMF and LKP" . SPARSER::COLLECTION)
    ("FGF-2 and FGFR-2" . SPARSER::COLLECTION)
    ("FGF-2, FGFR-2 and FGFR-3" . SPARSER::COLLECTION)
    ("FGF-2 and its receptors FGFR-2 and FGFR-3" . SPARSER::COLLECTION)
    ("FGFR-2 and FGFR-3" . SPARSER::COLLECTION) ("OSMF" . SPARSER::PROTEIN)
    ("LKP" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("FGFR- 3" . SPARSER::PROTEIN) ("Green fluorescent" . SPARSER::PROTEIN)
    ("FGFR-4" . SPARSER::PROTEIN) ("FGFR-1" . SPARSER::PROTEIN)
    ("FGFR-3" . SPARSER::PROTEIN) ("FGFR-2" . SPARSER::PROTEIN)
    ("Fibroblast growth factor-2" . SPARSER::PROTEIN)
    ("HSPB5 and HSPB2" . SPARSER::COLLECTION)
    ("disease-associated alleles" . SPARSER::ALLELE)
    ("mitochondrial HspB2" . SPARSER::PROTEIN)
    ("HspB2 and/or HspB5" . SPARSER::COLLECTION)
    ("HspB2/HspB5" . SPARSER::COLLECTION)
    ("HspB3 and HspB2" . SPARSER::COLLECTION)
    ("HspB3 or HspB8" . SPARSER::COLLECTION)
    ("alcohol dehydrogenase and α-synuclein" . SPARSER::COLLECTION)
    ("DMPK" . SPARSER::PROTEIN) ("GAPDH and CS" . SPARSER::COLLECTION)
    ("soluble GAPDH" . SPARSER::PROTEIN)
    ("β-Tubulin and GAPDH" . SPARSER::COLLECTION)
    ("cardiac protein" . SPARSER::PROTEIN)
    ("respiratory complex I cytochrome C-oxidase" . SPARSER::COLLECTION)
    ("cytochrome C-oxidase" . SPARSER::COLLECTION)
    ("a soluble protein" . SPARSER::PROTEIN)
    ("3-phosphate dehydrogenase (GAPDH)" . SPARSER::PROTEIN)
    ("these 32 mitochondria-associated proteins" . SPARSER::PROTEIN)
    ("primarily myofibril proteins and the other primarily fermentation/respiration proteins"
     . SPARSER::COLLECTION)
    ("the other primarily fermentation/respiration proteins"
     . SPARSER::PROTEIN)
    ("primarily myofibril proteins" . SPARSER::PROTEIN)
    ("identified disease-associated human alleles" . SPARSER::ALLELE)
    ("HspB9 and HspB10" . SPARSER::COLLECTION) ("HspB9" . SPARSER::PROTEIN)
    ("HspB2, OGDH, and MCCC2" . SPARSER::COLLECTION)
    ("149 unique proteins" . SPARSER::PROTEIN)
    ("were run" . SPARSER::PROTEIN-FAMILY)
    ("HspB5 and HspB2" . SPARSER::COLLECTION)
    ("EIF4A2 and GARS" . SPARSER::COLLECTION)
    ("HspB2 and HspB1" . SPARSER::COLLECTION) ("GARS" . SPARSER::PROTEIN)
    ("HspB2 and HspB5" . SPARSER::COLLECTION)
    ("prey and human HSPB2" . SPARSER::COLLECTION)
    ("viable mitochondria" . SPARSER::PROTEIN)
    ("phosphocreatine" . SPARSER::MOLECULE)
    ("cardiac ejection fraction" . SPARSER::COMPONENT)
    ("cardiac specific troponin-I" . SPARSER::PROTEIN)
    ("Flox" . SPARSER::PROTEIN) ("cardiac HSPB2" . SPARSER::PROTEIN)
    ("cKO" . SPARSER::PROTEIN) ("HspB1, HspB3 and HspB5" . SPARSER::COLLECTION)
    ("the detergent insoluble fraction" . SPARSER::COMPONENT)
    ("the soluble fractions" . SPARSER::COMPONENT)
    ("HspB1, HspB3, HspB5, HspB6 and HspB8" . SPARSER::COLLECTION)
    ("HspB5 [ xref ] and HspB8 [ xref ]" . SPARSER::COLLECTION)
    ("HspB3 [ xref , xref ], HspB5 [ xref ] and HspB8 [ xref ]"
     . SPARSER::COLLECTION)
    ("NTg" . SPARSER::PROTEIN) ("MyHC" . SPARSER::PROTEIN)
    ("HSPB2 and HSPB5" . SPARSER::COLLECTION)
    ("HspB2 (also known as Myotonic Dystrophy Protein Kinase Binding Protein, MKBP [ xref ]) and HspB5 (also known as alpha-B crystallin, CryAB)"
     . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN) ("MKBP" . SPARSER::PROTEIN)
    ("inheritable Mendelian traits" . SPARSER::PROTEIN)
    ("the cardiac yeast two-hybrid HspB2 interactome targets resident mitochondrial client proteins"
     . SPARSER::PROTEIN)
    ("HspB5" . SPARSER::PROTEIN)
    ("the cardiac-restricted Heat Shock Protein B-2" . SPARSER::PROTEIN)
    ("amyloid beta" . SPARSER::PROTEIN) ("Cardiac muscle" . SPARSER::PROTEIN)
    ("tissue-type" . SPARSER::PROTEIN)
    ("alcohol dehydrogenase" . SPARSER::PROTEIN)
    ("Citrate synthase" . SPARSER::PROTEIN)
    ("3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("MCCC2" . SPARSER::PROTEIN) ("EIF4A2" . SPARSER::PROTEIN)
    ("Troponin-I" . SPARSER::PROTEIN) ("troponin-I" . SPARSER::PROTEIN)
    ("beta-Tubulin" . SPARSER::PROTEIN) ("citrate synthase" . SPARSER::PROTEIN)
    ("Trp-Leu" . SPARSER::MOLECULE) ("Cardiac Troponin-I" . SPARSER::PROTEIN)
    ("Troponin I" . SPARSER::PROTEIN) ("S-T" . SPARSER::PROTEIN)
    ("HspB3" . SPARSER::PROTEIN) ("histone3" . SPARSER::PROTEIN)
    ("HspB8" . SPARSER::PROTEIN) ("HspB6" . SPARSER::PROTEIN)
    ("HspB1" . SPARSER::PROTEIN) ("I/R" . SPARSER::PROTEIN)
    ("HSF1" . SPARSER::PROTEIN)
    ("heat shock transcription factor 1" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::DRUG) ("HSPB2" . SPARSER::PROTEIN)
    ("HSPB5" . SPARSER::PROTEIN) ("HspB2" . SPARSER::PROTEIN)
    ("B-2" . SPARSER::PROTEIN) ("a valuable biomarker" . SPARSER::MOLECULE)
    ("valuable therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("Cyclin E and CDK2" . SPARSER::COLLECTION)
    ("Cyclin D1, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("Rb-1" . SPARSER::PROTEIN) ("TBX5" . SPARSER::PROTEIN)
    ("substrates and inhibitors" . SPARSER::COLLECTION)
    ("preparing
crystalline ternary complexes"
     . SPARSER::BIO-COMPLEX)
    ("the conformation or chemical function of a catalytic
residue"
     . SPARSER::COLLECTION)
    ("H180R
HDAC8 and G304R HDAC8"
     . SPARSER::COLLECTION)
    ("substrate or product" . SPARSER::COLLECTION)
    ("only H180R HDAC8 and G304R
HDAC8—each"
     . SPARSER::COLLECTION)
    ("only H180R HDAC8" . SPARSER::PROTEIN)
    ("induced-fit" . SPARSER::PROTEIN-FAMILY)
    ("both G304R
HDAC8 and H180R HDAC8"
     . SPARSER::COLLECTION)
    ("inhibitors
and substrates"
     . SPARSER::COLLECTION)
    ("HDAC8, or P91L" . SPARSER::COLLECTION)
    ("P91L HDAC8 and D233G HDAC8" . SPARSER::COLLECTION)
    ("Molecule" . SPARSER::MOLECULE) ("-Lys" . SPARSER::COLLECTION)
    ("HDAC8 and hydroxamate" . SPARSER::COLLECTION)
    ("inhibitors and substrates" . SPARSER::COLLECTION)
    ("wild-type HDAC8 and D233G–Y306F HDAC8" . SPARSER::COLLECTION)
    ("typical hydroxamate inhibitors" . SPARSER::INHIBITOR)
    ("HDAC8–TSA" . SPARSER::COLLECTION)
    ("class I HDACs and HDAC-related
enzymes"
     . SPARSER::COLLECTION)
    ("polyamine" . SPARSER::MOLECULE) ("hydroxamate" . SPARSER::MOLECULE)
    ("substrate or inhibitor" . SPARSER::COLLECTION)
    ("guanidinium" . SPARSER::MOLECULE)
    ("substrates or inhibitors" . SPARSER::COLLECTION)
    ("the double mutants P91L–Y306F
HDAC8 and D233G–Y306F HDAC8"
     . SPARSER::COLLECTION)
    ("lysine and acetate" . SPARSER::COLLECTION)
    ("histone and
nonhistone"
     . SPARSER::COLLECTION)
    ("the acetylated lysines of SMC3" . SPARSER::PROTEIN)
    ("separase" . SPARSER::PROTEIN)
    ("ESCO1 and
ESCO2"
     . SPARSER::COLLECTION)
    ("ATPase–ATPase" . SPARSER::COLLECTION)
    ("SMC1A and SMC3" . SPARSER::COLLECTION) ("ring" . SPARSER::PROTEIN)
    ("the zinc-dependent deacetylase
HDAC8"
     . SPARSER::PROTEIN)
    ("the
accessory protein NIPBL"
     . SPARSER::PROTEIN)
    ("HDAC8, SMC3, and RAD21" . SPARSER::COLLECTION)
    ("-benzamide" . SPARSER::DRUG)
    ("the double mutants D233G–Y306F and P91L–Y306F" . SPARSER::COLLECTION)
    ("SMC1A, SMC3, and RAD21, or
proteins"
     . SPARSER::COLLECTION)
    ("RAD21, or
proteins"
     . SPARSER::COLLECTION)
    ("NIPBL and HDAC8" . SPARSER::COLLECTION) ("NIPBL" . SPARSER::PROTEIN)
    ("CdLS" . SPARSER::PROTEIN)
    ("amino
acid"
     . SPARSER::AMINO-ACID)
    ("5–2" . SPARSER::PROTEIN) ("OH-" . SPARSER::MOLECULE)
    ("His-Lys" . SPARSER::MOLECULE) ("cm –1" . SPARSER::PROTEIN)
    ("M –1 " . SPARSER::PROTEIN) ("1-L" . SPARSER::PROTEIN)
    ("histone deacetylase 8" . SPARSER::PROTEIN) ("Hos1" . SPARSER::PROTEIN)
    ("ESCO2" . SPARSER::PROTEIN) ("ESCO1" . SPARSER::PROTEIN)
    ("P91" . SPARSER::PROTEIN) ("RAD21" . SPARSER::PROTEIN)
    ("SMC3" . SPARSER::PROTEIN) ("SMC1A" . SPARSER::PROTEIN)
    ("proliferating myoblasts" . SPARSER::PROTEIN)
    ("c-Myb-RET" . SPARSER::COLLECTION)
    ("c-Myb and myogenin" . SPARSER::COLLECTION)
    ("MyoD1 and myogenin" . SPARSER::COLLECTION)
    ("selected muscle-specific genes ACTN2" . SPARSER::PROTEIN)
    ("MyoD, myogenin, Myf5 and MRF4" . SPARSER::COLLECTION)
    ("mim1" . SPARSER::PROTEIN) ("mim" . SPARSER::PROTEIN)
    ("CKM" . SPARSER::PROTEIN) ("c-myb and myogenin" . SPARSER::COLLECTION)
    ("c-Myb protein and myogenin" . SPARSER::COLLECTION)
    ("normal skeletal muscle" . SPARSER::PROTEIN)
    ("ARMS and ERMS" . SPARSER::COLLECTION) ("miRNas" . SPARSER::PROTEIN)
    ("Myogenin" . SPARSER::PROTEIN) ("MyoD and myogenin" . SPARSER::COLLECTION)
    ("desmin, actins, myosins, and creatine" . SPARSER::COLLECTION)
    ("creatine" . SPARSER::PROTEIN) ("myosins" . SPARSER::PROTEIN)
    ("actins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myeloid and erythroid" . SPARSER::COLLECTION)
    ("migratory C2C12 myoblasts" . SPARSER::PROTEIN) ("U6 " . SPARSER::PROTEIN)
    ("MyoD1" . SPARSER::PROTEIN) ("Myb-binding protein 1A" . SPARSER::PROTEIN)
    ("cyclinB1" . SPARSER::PROTEIN) ("cathepsin D" . SPARSER::PROTEIN)
    ("TNNC2" . SPARSER::PROTEIN) ("MYH8" . SPARSER::PROTEIN)
    ("ACTN2" . SPARSER::PROTEIN) ("Myf5" . SPARSER::PROTEIN)
    ("c-myb" . SPARSER::PROTEIN) ("miR-126" . SPARSER::PROTEIN)
    ("c-Myb protein" . SPARSER::PROTEIN)
    ("Bcl -x and Fas" . SPARSER::COLLECTION)
    ("DAF-16/FOXO" . SPARSER::COLLECTION) ("TCER-1" . SPARSER::COLLECTION)
    ("an automatized genome-wide siRNA" . SPARSER::PROTEIN)
    ("the pro-apoptotic Fas isoform" . SPARSER::ISOFORM)
    ("Bak and Bcl-x" . SPARSER::COLLECTION)
    ("Jurkat-shTCERG1" . SPARSER::PROTEIN-PAIR)
    ("the apoptotic inducers" . SPARSER::MOLECULE)
    ("the transcriptional elongation" . SPARSER::PROTEIN)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("FasL/Fas" . SPARSER::COLLECTION) ("DISC" . SPARSER::BIO-COMPLEX)
    ("the long pro-apoptotic isoform" . SPARSER::ISOFORM)
    ("the pro-apoptotic isoform" . SPARSER::ISOFORM)
    ("a soluble receptor" . SPARSER::RECEPTOR)
    ("anti-Fas/CDK9" . SPARSER::COLLECTION)
    ("APO-1/CD95" . SPARSER::COLLECTION)
    ("the agonistic monoclonal anti-Fas/CD95 antibody" . SPARSER::ANTIBODY)
    ("anti-Fas/CD95" . SPARSER::COLLECTION) ("/Bcl-x" . SPARSER::COLLECTION)
    ("homo-oligomers" . SPARSER::PROTEIN)
    ("staurosporine and oxaliplatin" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bcl-x S variant" . SPARSER::VARIANT)
    ("damage-inducer" . SPARSER::PROTEIN)
    ("wether other apoptotic inducers" . SPARSER::MOLECULE)
    ("doxorubicin and oxaliplatin" . SPARSER::COLLECTION)
    ("green-fluorescent JC-1 monomers" . SPARSER::MONOMER)
    ("spontaneously forming red-fluorescent JC-1" . SPARSER::MOLECULE)
    ("significantly less p20 and p17" . SPARSER::COLLECTION)
    ("p20 and p17" . SPARSER::COLLECTION)
    ("a p11 subunit and a p20 peptide" . SPARSER::COLLECTION)
    ("the mature p17 subunit" . SPARSER::FRAGMENT)
    ("the 17 kDa (p17) and 11 kDa (p11) subunits" . SPARSER::COLLECTION)
    ("a secondary antibody" . SPARSER::PROTEIN)
    ("PHA/IL-2" . SPARSER::COLLECTION)
    ("pGeneClip-shTCERG1-C1" . SPARSER::COLLECTION)
    ("Annexin-V specifically binds phosphatidylserine" . SPARSER::PROTEIN)
    ("shRNA or shRNA" . SPARSER::COLLECTION) ("tetracycline" . SPARSER::DRUG)
    ("the apoptotic genes Bcl-x and Fas/CD95" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bcl-x S isoform" . SPARSER::ISOFORM)
    ("coordinating transcriptional elongation" . SPARSER::PROTEIN)
    ("hyperphosphorylated RNAPII and transcriptional elongation"
     . SPARSER::COLLECTION)
    ("RNAPII" . SPARSER::PROTEIN)
    ("the elongation and splicing-related factor TCERG1" . SPARSER::COLLECTION)
    ("ceramide and protein phosphatase-1" . SPARSER::COLLECTION)
    ("a general kinase inhibitor and inducer" . SPARSER::COLLECTION)
    ("Staurosporine" . SPARSER::DRUG) ("Bax and/or Bak" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bax and Bak proteins" . SPARSER::PROTEIN)
    ("pro-apoptotic short (Bcl-x S ) isoforms" . SPARSER::ISOFORM)
    ("pro-apoptotic isoforms" . SPARSER::ISOFORM)
    ("a soluble isoform" . SPARSER::ISOFORM)
    ("multiexonic human genes" . SPARSER::GENE)
    ("both the Bcl-x and Fas/CD95 genes" . SPARSER::COLLECTION)
    ("Fas/CD95" . SPARSER::COLLECTION)
    ("the pro-apoptotic mitochondrial membrane protein Bak" . SPARSER::PROTEIN)
    ("caspase-3 and PARP-1" . SPARSER::COLLECTION)
    ("Bcl-x and Fas" . SPARSER::COLLECTION) ("Bcl -x" . SPARSER::PROTEIN)
    ("lymphoproliferative syndrome" . SPARSER::PROTEIN)
    ("DAF-16" . SPARSER::PROTEIN) ("SAP155" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("APO-1" . SPARSER::PROTEIN)
    ("p20" . SPARSER::PROTEIN) ("18h" . SPARSER::PROTEIN)
    ("1-C" . SPARSER::PROTEIN) ("T-Rex" . SPARSER::PROTEIN-FAMILY)
    ("SB1" . SPARSER::PROTEIN) ("TCERG1" . SPARSER::PROTEIN)
    ("target or biomarker" . SPARSER::COLLECTION)
    ("prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("weak reversible non-competitive inhibitors" . SPARSER::INHIBITOR)
    ("GW7647 and Pimozide" . SPARSER::COLLECTION) ("Pimozide" . SPARSER::DRUG)
    ("Usp7" . SPARSER::PROTEIN) ("Usp14 and UCHL5" . SPARSER::COLLECTION)
    ("Usp14" . SPARSER::PROTEIN) ("PCNA and FANCD2" . SPARSER::COLLECTION)
    ("Usp1 and Uaf-1" . SPARSER::COLLECTION)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("Usp22 and Usp26" . SPARSER::COLLECTION) ("Usp22" . SPARSER::PROTEIN)
    ("Usp10" . SPARSER::PROTEIN)
    ("variants and ligand-independent activation" . SPARSER::COLLECTION)
    ("a valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("PSA, TMPRSS2 and KLK2" . SPARSER::COLLECTION)
    ("Usp12/WDR20" . SPARSER::COLLECTION) ("Usp12/Uaf-1" . SPARSER::COLLECTION)
    ("AR, Usp12, Uaf-1 and WDR20 and β-galactosidase" . SPARSER::COLLECTION)
    ("WDR20 and β-galactosidase" . SPARSER::COLLECTION)
    ("Usp12 and AR" . SPARSER::COLLECTION) ("Usp1/Uaf-1" . SPARSER::COLLECTION)
    ("Usp12 , Uaf-1 and WDR20" . SPARSER::COLLECTION)
    ("Usp12, Uaf-1 or WDR20" . SPARSER::COLLECTION)
    ("AR and Usp12" . SPARSER::COLLECTION)
    ("Usp12 and Uaf-1" . SPARSER::COLLECTION)
    ("Usp12 or Uaf-1" . SPARSER::COLLECTION)
    ("WDR20, Uaf-1 and Usp12" . SPARSER::COLLECTION)
    ("Usp12, Uaf-1 and WDR20" . SPARSER::COLLECTION)
    ("Usp1-Uaf-1" . SPARSER::COLLECTION)
    ("Usp1-associated factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the only other reported targets" . SPARSER::TARGET-PROTEIN)
    ("H2A and H2B" . SPARSER::COLLECTION)
    ("PHLPP and PHLPPL" . SPARSER::COLLECTION) ("PHLPPL" . SPARSER::PROTEIN)
    ("PHLPP" . SPARSER::PROTEIN) ("Usp1" . SPARSER::PROTEIN)
    ("Usp46" . SPARSER::PROTEIN) ("AR-AKT" . SPARSER::COLLECTION)
    ("deubiquitinase (DUB)" . SPARSER::DEUBIQUITINASE)
    ("late stage PC" . SPARSER::PROTEIN)
    ("Uaf-1 or WDR20" . SPARSER::COLLECTION)
    ("Usp12/Uaf-1/WDR20" . SPARSER::COLLECTION)
    ("Uaf-1 and WDR20" . SPARSER::COLLECTION) ("Uaf-1" . SPARSER::PROTEIN)
    ("targets and biomarkers" . SPARSER::COLLECTION)
    ("WDR48" . SPARSER::PROTEIN) ("GW7647" . SPARSER::DRUG)
    ("UCHL5" . SPARSER::PROTEIN) ("Usp26" . SPARSER::PROTEIN)
    ("WDR20" . SPARSER::PROTEIN) ("Usp12" . SPARSER::PROTEIN)
    ("glycosaminoglycan" . SPARSER::MOLECULE) ("sulphate" . SPARSER::MOLECULE)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("supramolecular complexes" . SPARSER::BIO-COMPLEX)
    ("FLT3 and CXCR4" . SPARSER::COLLECTION)
    ("FLT3 as well as CXCR4" . SPARSER::COLLECTION) ("pre" . SPARSER::PROTEIN)
    ("CD97 and LPAR1" . SPARSER::COLLECTION) ("ATX" . SPARSER::PROTEIN)
    ("the PDGFR (α and β isoform) receptor and the KIT protein"
     . SPARSER::COLLECTION)
    ("FLK1 protein (VEGFR2), the PDGFR (α and β isoform) receptor and the KIT protein"
     . SPARSER::COLLECTION)
    ("a FLT3 inhibitor as well as a selective inhibitor" . SPARSER::COLLECTION)
    ("VEGF and PDGF receptor" . SPARSER::COLLECTION)
    ("FLT3, STAT5, and ERK" . SPARSER::COLLECTION)
    ("Midostaurin" . SPARSER::DRUG) ("PKC412 or SU5614" . SPARSER::COLLECTION)
    ("CD97 and CD58" . SPARSER::COLLECTION)
    ("CD305 and CD63" . SPARSER::COLLECTION)
    ("either CD97 or the ligand CD55 [ xref ]" . SPARSER::COLLECTION)
    ("malignant HSPCs" . SPARSER::PROTEIN) ("TM7" . SPARSER::PROTEIN)
    ("therapeutics and diagnostics" . SPARSER::COLLECTION)
    ("Leukemic and normal HSPCs" . SPARSER::PROTEIN)
    ("HSPC" . SPARSER::PROTEIN) ("Pre" . SPARSER::PROTEIN)
    ("both normal HSPCs" . SPARSER::PROTEIN)
    ("SDF-1/CXCR4" . SPARSER::COLLECTION)
    ("FLT3 and CD97" . SPARSER::COLLECTION) ("trypan" . SPARSER::DRUG)
    ("NPM1 (37% vs. 15%, p < 0.0001) and FLT3 genes (38% vs. 10%, p < 0.0001)"
     . SPARSER::COLLECTION)
    ("FLT3 and NPM1" . SPARSER::COLLECTION)
    ("proteins and components" . SPARSER::COLLECTION)
    ("EGF-TM7" . SPARSER::COLLECTION)
    ("cytokines and adhesion molecules" . SPARSER::COLLECTION)
    ("HSPCs" . SPARSER::PROTEIN) ("LPA" . SPARSER::LPA)
    ("PKC412 and SU5614" . SPARSER::COLLECTION) ("wildtype" . SPARSER::PROTEIN)
    ("ITD" . SPARSER::PROTEIN) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("RS4" . SPARSER::PROTEIN) ("LPAR1" . SPARSER::PROTEIN)
    ("LPA receptor 1" . SPARSER::PROTEIN) ("FLK1" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN) ("CD305" . SPARSER::PROTEIN)
    ("CD317" . SPARSER::PROTEIN) ("CD58" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("Lysophosphatidic acid" . SPARSER::LPA)
    ("annexin-V" . SPARSER::PROTEIN) ("Thy-1" . SPARSER::PROTEIN)
    ("CD55" . SPARSER::PROTEIN) ("Rho-A" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA) ("SU5614" . SPARSER::MOLECULE)
    ("PKC412" . SPARSER::DRUG) ("EOL-1" . SPARSER::PROTEIN)
    ("CD97" . SPARSER::PROTEIN) ("Myc and Cyclin E" . SPARSER::COLLECTION)
    ("Cyclin E, c-Myc, c-Jun, Mcl-1, and Notch-1" . SPARSER::COLLECTION)
    ("SOX10 and MIA" . SPARSER::COLLECTION)
    ("SK-Mel-Bcl2" . SPARSER::COLLECTION) ("Mel" . SPARSER::PROTEIN)
    ("anti-Fbxw7α or anti-SOX10" . SPARSER::COLLECTION)
    ("LiCl or AR-A014418" . SPARSER::COLLECTION)
    ("Myc-GSK3β" . SPARSER::COLLECTION)
    ("GSK3β and SOX10" . SPARSER::COLLECTION)
    ("HA-Fbxw7α" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("Myc-Fbxw7α" . SPARSER::COLLECTION) ("HA-SOX10" . SPARSER::COLLECTION)
    ("Flag-Fbxw7α" . SPARSER::COLLECTION) ("Myc-SOX10" . SPARSER::COLLECTION)
    ("SOX10 and Fbxw7α" . SPARSER::COLLECTION)
    ("Fbxw7α and SOX10" . SPARSER::COLLECTION)
    ("dsRed-SOX10" . SPARSER::COLLECTION) ("dsRed" . SPARSER::PROTEIN)
    ("anti-Myc or anti-HA" . SPARSER::COLLECTION)
    ("the only Fbxw7 isoform" . SPARSER::ISOFORM) ("Fbxw7α" . SPARSER::PROTEIN)
    ("Fbxw7α-SOX10" . SPARSER::COLLECTION)
    ("factor 2, NF-κB2 and Granulocyte colony stimulating factor"
     . SPARSER::COLLECTION)
    ("Sterol" . SPARSER::PROTEIN)
    ("phosphoserine or phosphothreonine" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("MCS4 and MCS7" . SPARSER::COLLECTION) ("TRAP" . SPARSER::PROTEIN)
    ("MCS" . SPARSER::PROTEIN) ("lineage-specific genes" . SPARSER::GENE)
    ("SOX10 and its downstream gene MIA" . SPARSER::COLLECTION)
    ("MIA" . SPARSER::PROTEIN) ("32P" . SPARSER::|32P|)
    ("α at" . SPARSER::PROTEIN)
    ("melanoma inhibitory activity" . SPARSER::PROTEIN)
    ("T-2" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("AR-A014418" . SPARSER::DRUG) ("G-CSFR" . SPARSER::PROTEIN)
    ("Granulocyte colony stimulating factor" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("Ubc9" . SPARSER::PROTEIN)
    ("MCS4" . SPARSER::PROTEIN) ("MED1" . SPARSER::PROTEIN)
    ("Mediator complex subunit 1" . SPARSER::PROTEIN)
    ("Sox10" . SPARSER::PROTEIN) ("HMG-box" . SPARSER::PROTEIN)
    ("Fbxw7" . SPARSER::PROTEIN) ("NSCL" . SPARSER::PROTEIN)
    ("STAT6/Bcl-xL" . SPARSER::COLLECTION)
    ("two mature miRNAs" . SPARSER::PROTEIN)
    ("miRNAs/miRs" . SPARSER::COLLECTION)
    ("Generic tumor-suppressive drugs" . SPARSER::DRUG)
    ("STAT6 and Bcl-xL" . SPARSER::COLLECTION)
    ("RNA or miR-361-5p" . SPARSER::COLLECTION) ("miRs" . SPARSER::PROTEIN)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("single-stranded RNAs" . SPARSER::RNA)
    ("signal transducer and activator of transcription 6" . SPARSER::PROTEIN)
    ("accurate HER2" . SPARSER::PROTEIN)
    ("at least 4 fragments" . SPARSER::FRAGMENT)
    ("a multimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("STIP-USP7-Mdm2-p53" . SPARSER::COLLECTION)
    ("the p53-Mdm2-USP7 ternary complex" . SPARSER::BIO-COMPLEX)
    ("p53-Mdm2-USP7" . SPARSER::COLLECTION)
    ("USP7 and its targets Mdm2 and/or p53" . SPARSER::COLLECTION)
    ("its targets Mdm2 and/or p53" . SPARSER::COLLECTION)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("USP7 and Mdm2 or p53" . SPARSER::COLLECTION)
    ("the latter two proteins" . SPARSER::PROTEIN)
    ("USP7 and Mdm2" . SPARSER::COLLECTION)
    ("USP7 and p53" . SPARSER::COLLECTION)
    ("two different ternary complexes" . SPARSER::BIO-COMPLEX)
    ("USP7 and either Mdm2 or p53" . SPARSER::COLLECTION)
    ("either anti-Mdm2 (Figure xref ) or anti-p53 (Figure xref ) antibodies"
     . SPARSER::COLLECTION)
    ("anti-Mdm2 or anti-p53" . SPARSER::COLLECTION)
    ("USP7-p53" . SPARSER::COLLECTION) ("USP7-Mdm2" . SPARSER::COLLECTION)
    ("USP7-Mdm2-p53" . SPARSER::COLLECTION) ("STIP-p53" . SPARSER::COLLECTION)
    ("STIP-Mdm2" . SPARSER::COLLECTION)
    ("STIP and Mdm2 or STIP and p53" . SPARSER::COLLECTION)
    ("Mdm2 or STIP and p53" . SPARSER::COLLECTION)
    ("anti-Mdm2 and anti-p53" . SPARSER::COLLECTION)
    ("Mdm2 and P53" . SPARSER::COLLECTION)
    ("p53 and STIP" . SPARSER::COLLECTION)
    ("Mdm2, p53 and USP7" . SPARSER::COLLECTION)
    ("p53, Mdm2, or USP7" . SPARSER::COLLECTION)
    ("GST-STIP" . SPARSER::COLLECTION) ("STIP-USP7" . SPARSER::COLLECTION)
    ("the anti-USP7" . SPARSER::ANTIBODY)
    ("STIP and p53" . SPARSER::COLLECTION) ("Flag-STIP" . SPARSER::COLLECTION)
    ("pCMV-Flag-STIP" . SPARSER::COLLECTION)
    ("USP7 and STIP" . SPARSER::COLLECTION)
    ("Texas Red and FITC" . SPARSER::COLLECTION)
    ("Texas red-conjugated secondary antibody" . SPARSER::PROTEIN)
    ("USP7 and the two proteins" . SPARSER::COLLECTION)
    ("two ternary complexes" . SPARSER::BIO-COMPLEX)
    ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("STIP and USP7" . SPARSER::COLLECTION) ("rod" . SPARSER::PROTEIN)
    ("a unique class" . CLASS) ("tryptophan-tryptophan" . SPARSER::COLLECTION)
    ("Mdm2 or p53" . SPARSER::COLLECTION) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("p53 or Mdm2" . SPARSER::COLLECTION)
    ("ternary protein" . SPARSER::PROTEIN)
    ("STIP-USP7-p53" . SPARSER::COLLECTION)
    ("STIP-USP7-Mdm2" . SPARSER::COLLECTION)
    ("STIP and a fraction" . SPARSER::COLLECTION)
    ("a novel macromolecular scaffold" . SPARSER::SCAFFOLD)
    ("STIP" . SPARSER::PROTEIN) ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("ubiquitins" . SPARSER::PROTEIN) ("TFIP11" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("G-patch" . SPARSER::PROTEIN-FAMILY)
    ("ip1" . SPARSER::PROTEIN) ("soluble IFs and GIG" . SPARSER::COLLECTION)
    ("IFs and GIG" . SPARSER::COLLECTION)
    ("GIG and Cul3" . SPARSER::COLLECTION)
    ("the previously reported GIG binding partners microtubule-associated protein 1b light chain"
     . SPARSER::PROTEIN)
    ("1b" . SPARSER::PROTEIN)
    ("HSP90AA1 (inducible cytosolic HSP90) and HSP90AB1 (constitutive cytosolic HSP90)"
     . SPARSER::COLLECTION)
    ("the only E3 ligase" . SPARSER::LIGASE)
    ("NEFL and PRPH" . SPARSER::COLLECTION)
    ("PRPH and GIG" . SPARSER::COLLECTION)
    ("GIG and VIM" . SPARSER::COLLECTION)
    ("GIG and NF-L, PRPH and VIM" . SPARSER::COLLECTION)
    ("NF-L, PRPH and VIM" . SPARSER::COLLECTION) ("UBC" . SPARSER::PROTEIN)
    ("Hsp70, HSPA9, and HSPD1" . SPARSER::COLLECTION)
    ("HSP90AA1 and HSP90AB1" . SPARSER::COLLECTION)
    ("GIG and intermediate filaments" . SPARSER::COLLECTION)
    ("Kelch" . SPARSER::PROTEIN)
    ("NEFL, NEFM, NEFH, PRPH and INA" . SPARSER::COLLECTION)
    ("Kelch-interactors" . SPARSER::PROTEIN-PAIR)
    ("additional ribosomal proteins" . SPARSER::PROTEIN)
    ("PRPH and α-internexin (INA)" . SPARSER::COLLECTION)
    ("heavy chain (NEFH)" . SPARSER::PROTEIN)
    ("medium chain (NEFM)" . SPARSER::PROTEIN)
    ("PRPH and α-internexin" . SPARSER::COLLECTION) ("PRPH" . SPARSER::PROTEIN)
    ("NEFH" . SPARSER::PROTEIN) ("NEFM" . SPARSER::PROTEIN)
    ("the ribosomal complex" . SPARSER::BIO-COMPLEX) ("TOF" . SPARSER::PROTEIN)
    ("target IFs and other substrates" . SPARSER::COLLECTION)
    ("neurofilament light chain (NEFL) and peripherin (PRPH)"
     . SPARSER::COLLECTION)
    ("light chain (NEFL)" . SPARSER::PROTEIN)
    ("GIG and IFs" . SPARSER::COLLECTION) ("peripherin" . SPARSER::PROTEIN)
    ("NEFL" . SPARSER::PROTEIN)
    ("several microtubule-associated proteins" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein (GFAP)" . SPARSER::PROTEIN)
    ("VIM" . SPARSER::PROTEIN) ("desmin" . SPARSER::PROTEIN)
    ("cullin-RING" . SPARSER::PROTEIN-PAIR)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("Cul3 and ring box protein 1 (Rbx1)" . SPARSER::COLLECTION)
    ("the E3 ligase MYCBP2 and the heat shock proteins HSP90AA1/AB1"
     . SPARSER::COLLECTION)
    ("GIG" . SPARSER::PROTEIN) ("IFs" . SPARSER::PROTEIN)
    ("gigaxonin (GIG)" . SPARSER::PROTEIN)
    ("a ubiquitously-expressed BTB/Kelch cytoplasmic protein"
     . SPARSER::PROTEIN)
    ("gigaxonin" . SPARSER::PROTEIN) ("GAN" . SPARSER::PROTEIN)
    ("MAP8" . SPARSER::PROTEIN) ("MAP1b" . SPARSER::PROTEIN)
    ("NF-L" . SPARSER::PROTEIN) ("MYC binding protein" . SPARSER::PROTEIN)
    ("HSPD1" . SPARSER::PROTEIN) ("HSPA9" . SPARSER::PROTEIN)
    ("HSP90AB1" . SPARSER::PROTEIN) ("α-internexin" . SPARSER::PROTEIN)
    ("medium chain" . SPARSER::PROTEIN) ("lamin B2" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("cullin 3" . SPARSER::PROTEIN) ("Bric-a-brac" . SPARSER::PROTEIN)
    ("HSP90AA1" . SPARSER::PROTEIN) ("MYCBP2" . SPARSER::PROTEIN)
    ("proteins or DNA" . SPARSER::COLLECTION) ("CpGs" . SPARSER::PROTEIN)
    ("premalignant GC" . SPARSER::PROTEIN)
    ("promoter and intron" . SPARSER::COLLECTION)
    ("SRC, LYN and MYC" . SPARSER::COLLECTION)
    ("PP2 and SU6656" . SPARSER::COLLECTION)
    ("chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("kinases, SRC and LYN" . SPARSER::COLLECTION)
    ("MYC and the three studied kinases" . SPARSER::COLLECTION)
    ("MYC and CKB" . SPARSER::COLLECTION) ("MYC and SRC" . SPARSER::COLLECTION)
    ("MYC and LYN" . SPARSER::COLLECTION)
    ("SRC (p < 0.001, by χ 2 test) and LYN (p < 0.004, by χ 2 test)"
     . SPARSER::COLLECTION)
    ("MYC or kinase" . SPARSER::COLLECTION)
    ("Kinases and MYC" . SPARSER::COLLECTION)
    ("SRC , LYN and CKB" . SPARSER::COLLECTION)
    ("a partially methylated promoter" . SPARSER::PROMOTER)
    ("SRC [0.062 (0.08) versus 0.375 (0.33); p < 0.001; Mann-Whitney test; xref ] and LYN [0.127 (0.11) versus 0.500 (0.39); p < 0.001; xref ]"
     . SPARSER::COLLECTION)
    ("SRC (p < 0.001, ρ = -0.834; p < 0.001, ρ = -0.718; respectively; xref ) and LYN (p < 0.001, ρ = -0.792; p < 0.001, ρ = -0.654; respectively; xref )"
     . SPARSER::COLLECTION)
    ("SRC and CKB" . SPARSER::COLLECTION) ("LYN and CKB" . SPARSER::COLLECTION)
    ("SRC [0.135 (0.31) versus 0.563 (0.23); p < 0.001] and LYN [0.238 (0.40) versus 0.7063 (0.26); p < 0.001]"
     . SPARSER::COLLECTION)
    ("BSP" . SPARSER::PROTEIN)
    ("significantly higher SRC and LYN protein" . SPARSER::PROTEIN)
    ("SRC (p < 0.001, ρ = -0.734; p < 0.001, ρ = -0.806, respectively) and LYN (p < 0.001, ρ = -0.643; p < 0.001, ρ = -0.703, respectively)"
     . SPARSER::COLLECTION)
    ("LYN (p < 0.001, ρ = 0.762) and CKB (p < 0.001, ρ = 0.819)"
     . SPARSER::COLLECTION)
    ("SRC (p < 0.001, ρ = 0.856, Spearman correlation test), LYN (p < 0.001, ρ = 0.762) and CKB (p < 0.001, ρ = 0.819)"
     . SPARSER::COLLECTION)
    ("SRC or LYN" . SPARSER::COLLECTION)
    ("several glucose transporters and glycolytic enzymes"
     . SPARSER::COLLECTION)
    ("a robust biomarker" . SPARSER::MOLECULE)
    ("RNA or protein" . SPARSER::COLLECTION)
    ("kinases and MYC" . SPARSER::COLLECTION)
    ("a cell cycle regulator and transcription factor [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("the fourth most frequent cancer type and the second highest cause"
     . SPARSER::COLLECTION)
    ("a possible biomarker" . SPARSER::MOLECULE)
    ("SRC and LYN" . SPARSER::COLLECTION)
    ("SRC, LYN and CKB" . SPARSER::COLLECTION) ("LYN" . SPARSER::PROTEIN)
    ("modulators and effectors" . SPARSER::COLLECTION)
    ("SU6656" . SPARSER::PROTEIN) ("Cell membrane" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("creatine kinase" . SPARSER::PROTEIN)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("BRAF V600E and KRAS" . SPARSER::COLLECTION)
    ("BRAF and EGFR" . SPARSER::COLLECTION)
    ("EGFR and vemurafenib" . SPARSER::COLLECTION)
    ("cetuximab and irinotecan" . SPARSER::COLLECTION)
    ("rare KRAS or NRAS" . SPARSER::COLLECTION)
    ("KRAS or NRAS" . SPARSER::COLLECTION)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("PIK3CA or AKT" . SPARSER::COLLECTION)
    ("Correlative Biomarkers" . SPARSER::MOLECULE)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("the concurrently enrolled cohort" . SPARSER::MOLECULE)
    ("enrolled cohort" . SPARSER::MOLECULE) ("ECGs" . SPARSER::DRUG)
    ("new cutaneous SCCs" . SPARSER::PROTEIN) ("SCCs" . SPARSER::PROTEIN)
    ("AEs" . SPARSER::PROTEIN)
    ("BRAF V600E mutation–positive metastatic CRC" . SPARSER::PROTEIN)
    ("the mutated form" . SPARSER::FORM)
    ("The unique conformation" . SPARSER::BIO-CONFORMATION)
    ("serrated" . SPARSER::PROTEIN) ("KRAS and NRAS" . SPARSER::COLLECTION)
    ("BRAF V600E–positive metastatic CRC" . SPARSER::PROTEIN)
    ("Vemurafenib" . SPARSER::DRUG) ("p14" . SPARSER::PROTEIN)
    ("hMLH1" . SPARSER::PROTEIN) ("MINT2" . SPARSER::PROTEIN)
    ("MINT1" . SPARSER::PROTEIN) ("SIRT1 and lncRNA" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("pre-adipocytes" . SPARSER::PROTEIN-PAIR)
    ("CBFA1 and osteocalcin" . SPARSER::COLLECTION)
    ("osteocalcin" . SPARSER::PROTEIN) ("siRNA-SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 and HIF1α-AS1" . SPARSER::COLLECTION)
    ("pWPXL-SIRT1" . SPARSER::COLLECTION) ("pirfenidone" . SPARSER::DRUG)
    ("receptor-Smad3" . SPARSER::COLLECTION) ("HOX" . SPARSER::PROTEIN)
    ("leukemia 1" . SPARSER::PROTEIN) ("CBFA1" . SPARSER::PROTEIN)
    ("core-binding factor alpha" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("SRT1" . SPARSER::PROTEIN) ("Murine Leukemia Virus" . SPARSER::PROTEIN)
    ("CpG binding protein" . SPARSER::PROTEIN) ("HOXD10" . SPARSER::PROTEIN)
    ("the latter physiological mediators" . SPARSER::PROTEIN)
    ("The latter gene" . SPARSER::GENE) ("SKA2 or miRNA" . SPARSER::COLLECTION)
    ("their mature forms" . SPARSER::FORM) ("the latter gene" . SPARSER::GENE)
    ("Ska2" . SPARSER::PROTEIN) ("Ska" . SPARSER::PROTEIN)
    ("hypoxia and stress-related genes" . SPARSER::COLLECTION)
    ("extensive biochemical reagents and computational tools"
     . SPARSER::COLLECTION)
    ("extensive biochemical reagents" . SPARSER::MOLECULE)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("exogenous PlGF" . SPARSER::PROTEIN) ("pGL3-PAI-3" . SPARSER::COLLECTION)
    ("pGL3-PAI-1-3" . SPARSER::COLLECTION) ("pGL3-ET-1" . SPARSER::COLLECTION)
    ("PPAR-α antibody or control rabbit IgG" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("SKA2-luc" . SPARSER::PROTEIN-PAIR)
    ("the latter miRNAs" . SPARSER::PROTEIN)
    ("the synthetic PPAR-α agonist fenofibrate and the PPAR-α antagonist GW6471"
     . SPARSER::COLLECTION)
    ("shRNA and HIF-1α" . SPARSER::COLLECTION)
    ("SKA2 and miRNA" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAP kinase) and c-Jun ( xref C)"
     . SPARSER::COLLECTION)
    ("PI3K, MAP kinase and c-Jun" . SPARSER::COLLECTION)
    ("PPAR-α and HIF-1α" . SPARSER::COLLECTION) ("SCA" . SPARSER::PROTEIN)
    ("Berkeley" . SPARSER::PROTEIN)
    ("kinetochore-associated protein-2 (SKA2) gene" . SPARSER::GENE)
    ("HIF-1α and its downstream target genes" . SPARSER::COLLECTION)
    ("ET-1 and PAI-1 " . SPARSER::COLLECTION)
    ("Berkeley-SS" . SPARSER::PROTEIN-PAIR)
    ("hypoxia, transforming growth factor-β (TGF-β) and lipopolysaccharide (LPS) [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("The prothrombic state" . SPARSER::BIO-STATE)
    ("tissue factor [ xref ] and plasminogen activator inhibitor-1 (PAI-1)"
     . SPARSER::COLLECTION)
    ("haemolysis-associated PH" . SPARSER::PROTEIN)
    ("Endothelin-1 (ET-1) and nitric oxide (NO)" . SPARSER::COLLECTION)
    ("fenofibrate" . SPARSER::DRUG)
    ("HIF-1α and peroxisome" . SPARSER::COLLECTION)
    ("BK-SS" . SPARSER::COLLECTION) ("PlGF" . SPARSER::PROTEIN)
    ("SCD" . SPARSER::PROTEIN) ("Fenofibrate" . SPARSER::DRUG)
    ("ET-1 and PAI-1" . SPARSER::COLLECTION) ("Twist-1" . SPARSER::PROTEIN)
    ("PAI-3" . SPARSER::PROTEIN) ("GW6471" . SPARSER::DRUG)
    ("pre-miRNAs" . SPARSER::RNA) ("pre-miRNA" . SPARSER::RNA)
    ("α-globin" . SPARSER::PROTEIN) ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAI-1 " . SPARSER::PROTEIN) ("tissue factor" . SPARSER::PROTEIN)
    ("ET-1 " . SPARSER::PROTEIN) ("SKA2 " . SPARSER::PROTEIN)
    ("placenta growth factor" . SPARSER::PROTEIN)
    ("Endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SKA2" . SPARSER::PROTEIN) ("ET-1" . SPARSER::PROTEIN)
    ("CDC7-DBF4" . SPARSER::COLLECTION)
    ("kinase and MAP2K1" . SPARSER::COLLECTION)
    ("ERK1 and p44-MAPK" . SPARSER::COLLECTION) ("enzastaurin" . SPARSER::DRUG)
    ("Neri" . SPARSER::PROTEIN) ("MAPK3, DBF4B and CDC7" . SPARSER::COLLECTION)
    ("PKC-β2" . SPARSER::COLLECTION)
    ("PPAR-α and PPAR-γ" . SPARSER::COLLECTION)
    ("subtypes, PPAR-α, PPAR-γ and PPAR-δ" . SPARSER::COLLECTION)
    ("family, and PPARs" . SPARSER::COLLECTION) ("PPARs" . SPARSER::PROTEIN)
    ("Glucose and lipid" . SPARSER::COLLECTION)
    ("IκB and NF-κB" . SPARSER::COLLECTION)
    ("-IκB-NF-κB" . SPARSER::COLLECTION)
    ("high ambient glucose" . SPARSER::PROTEIN)
    ("NF-κB and the IκB-bound complex" . SPARSER::COLLECTION)
    ("glucose and sustained PKC-β 2" . SPARSER::COLLECTION)
    ("IκBα and IκBβ" . SPARSER::COLLECTION)
    ("an atypical Ras-like protein" . SPARSER::PROTEIN)
    ("IκBα/IκBβ" . SPARSER::COLLECTION)
    ("immediate-early genes and genes" . SPARSER::COLLECTION)
    ("genes and genes" . SPARSER::COLLECTION)
    ("Ad5-PKC-β 2" . SPARSER::COLLECTION) ("-NF-κB" . SPARSER::COLLECTION)
    ("p65/RELA" . SPARSER::COLLECTION) ("RELA" . SPARSER::PROTEIN)
    ("A PPAR-δ-specific mouse monoclonal antibody" . SPARSER::DRUG)
    ("theoretical PI" . SPARSER::PROTEIN) ("normal glucose" . SPARSER::PROTEIN)
    ("group and PO" . SPARSER::COLLECTION) ("HG" . SPARSER::MOLECULE)
    ("p-PKC-β 2" . SPARSER::COLLECTION)
    ("only one molecule or signaling pathway" . SPARSER::COLLECTION)
    ("molecule or signaling pathway" . SPARSER::COLLECTION)
    ("-phosphoinositide 3-kinase" . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("diacylglycerol-protein" . SPARSER::COLLECTION)
    ("polyol" . SPARSER::MOLECULE) ("high-glucose" . SPARSER::PROTEIN)
    ("PKC-β2-NF-κB" . SPARSER::COLLECTION)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("PKC-β 2" . SPARSER::COLLECTION) ("raf-1" . SPARSER::PROTEIN)
    ("phospholipase A2" . SPARSER::PROTEIN) ("p44-MAPK" . SPARSER::PROTEIN)
    ("LY317615" . SPARSER::DRUG) ("PPAR-α" . SPARSER::PROTEIN)
    ("IκBβ" . SPARSER::PROTEIN) ("DBF4" . SPARSER::PROTEIN)
    ("CDC7" . SPARSER::PROTEIN)
    ("cell division cycle 7-related protein kinase" . SPARSER::PROTEIN)
    ("MAPK3" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 3" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("g protein" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN) ("PKC-δ" . SPARSER::PROTEIN)
    ("Ras-like protein" . SPARSER::PROTEIN)
    ("VEGF and HIF" . SPARSER::COLLECTION)
    ("fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) ( xref )"
     . SPARSER::COLLECTION)
    ("VEGF, fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) ( xref )"
     . SPARSER::COLLECTION)
    ("c-Jun and HIF-1α" . SPARSER::COLLECTION)
    ("retinas and HUVECs" . SPARSER::COLLECTION)
    ("successful anti-angiogenic" . SPARSER::DRUG)
    ("CCN1/CYR61" . SPARSER::COLLECTION) ("IPL" . SPARSER::PROTEIN)
    ("the hyperoxia and hyperoxia-scrambled siRNA" . SPARSER::COLLECTION)
    ("hyperoxia" . SPARSER::PROTEIN)
    ("the hyperoxia group (32.5±1.8) and the hyperoxia-scrambled siRNA group (31.4±2.6)"
     . SPARSER::COLLECTION)
    ("hyperoxia-CCN1" . SPARSER::COLLECTION) ("retinas" . SPARSER::DRUG)
    ("the retinal vasculature" . SPARSER::PROTEIN)
    ("the hypoxia (protein, 0.53±0.02, 0.36±0.01 and 0.37±0.01, respectively) and hypoxia-scrambled siRNA (protein, 0.49±0.07, 0.42±0.03 and 0.42±0.03, respectively)"
     . SPARSER::COLLECTION)
    ("p-PI3K" . SPARSER::COLLECTION)
    ("the hypoxia and hypoxia-scrambled siRNA" . SPARSER::COLLECTION)
    ("hypoxia-CCN1" . SPARSER::COLLECTION)
    ("CCN1/Cyr61-PI3K/AKT" . SPARSER::COLLECTION)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("proteins, growth factors and cytokines" . SPARSER::COLLECTION)
    ("CCN1/Cyr61" . SPARSER::COLLECTION)
    ("pathological states" . SPARSER::BIO-STATE)
    ("The matricellular protein" . SPARSER::PROTEIN)
    ("clock" . SPARSER::PROTEIN) ("CCN1, PI3K and AKT" . SPARSER::COLLECTION)
    ("CCN1/Cyr61-phosphoinositide 3-kinase" . SPARSER::COLLECTION)
    ("CCN" . SPARSER::PROTEIN-FAMILY) ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("Forkhead box O3" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("P11" . SPARSER::PROTEIN) ("P17" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN) ("CCN1" . SPARSER::PROTEIN)
    ("family member 1" . SPARSER::PROTEIN) ("Cyr61" . SPARSER::PROTEIN)
    ("WT p53 (MCF-7 and A549) or mutant p53 (MDA-MB-231, PC-3M, and HCT116)"
     . SPARSER::COLLECTION)
    ("PI3-K–Akt" . SPARSER::COLLECTION)
    ("receptor–Ras–Raf–MAPK" . SPARSER::COLLECTION)
    ("mTORC2 and genotoxic drugs" . SPARSER::COLLECTION)
    ("mTORC2–CIP2A–PP2A" . SPARSER::COLLECTION)
    ("CIP2A and PP2Ac" . SPARSER::COLLECTION)
    ("Argonautes" . SPARSER::PROTEIN-FAMILY)
    ("genotoxic drugs" . SPARSER::DRUG)
    ("proapoptotic miRNAs" . SPARSER::PROTEIN)
    ("prosurvival miRNAs" . SPARSER::PROTEIN)
    ("CIP2A/c-Myc" . SPARSER::COLLECTION)
    ("c-Myc–associated PP2A" . SPARSER::PROTEIN)
    ("CIP2A–PP2A–c-Myc" . SPARSER::COLLECTION)
    ("CIP2A and PP2A" . SPARSER::COLLECTION)
    ("both PP2Ac (the catalytic subunit of PP2A; xref and Fig. S4 D) and CIP2A ( xref )"
     . SPARSER::COLLECTION)
    ("PP242 or Rictor depletion ( xref )" . SPARSER::COLLECTION)
    ("rapamycin or Raptor" . SPARSER::COLLECTION)
    ("PP242- or Rictor knockdown–induced apoptosis ( xref ; and Fig. S3 B)"
     . SPARSER::COLLECTION)
    ("PP242-" . SPARSER::DRUG) ("mTORC2 and miR-9-3p" . SPARSER::COLLECTION)
    ("E2F3, MDM2, or PDK1" . SPARSER::COLLECTION)
    ("E2F1, E2F3, MDM2, and PDK1" . SPARSER::COLLECTION)
    ("a widely used genotoxic drug" . SPARSER::DRUG)
    ("rapamycin-" . SPARSER::DRUG)
    ("rapamycin (mTORC1 inhibitor) or PP242 (mTORC1/2 kinase inhibitor)"
     . SPARSER::COLLECTION)
    ("a proapoptotic miRNA" . SPARSER::PROTEIN)
    ("directly targets E2F1" . SPARSER::PROTEIN)
    ("PI3-K–PDK1" . SPARSER::COLLECTION)
    ("IRS-1–PI3-K–PDK1" . SPARSER::COLLECTION)
    ("mTORC2 specifically senses growth factors" . SPARSER::GROWTH-FACTOR)
    ("mTOR, mSIN1, mLST8, and rapamycin-insensitive companion of mTOR"
     . SPARSER::COLLECTION)
    ("c-Myc– and miR-9-3p" . SPARSER::COLLECTION) ("c-Myc–" . SPARSER::PROTEIN)
    ("c-Myc and miR-9-3p" . SPARSER::COLLECTION) ("CD21" . SPARSER::PROTEIN)
    ("CD23" . SPARSER::PROTEIN) ("CD 23" . SPARSER::PROTEIN)
    ("CD19 antigen" . SPARSER::PROTEIN) ("Pri-miRNA" . SPARSER::RNA)
    ("pSG5" . SPARSER::PROTEIN) ("CS 6" . SPARSER::PROTEIN)
    ("BR 3" . SPARSER::PROTEIN) ("pp242" . SPARSER::DRUG)
    ("Ago2" . SPARSER::PROTEIN) ("PP2Ac" . SPARSER::PROTEIN)
    ("1 B" . SPARSER::PROTEIN) ("1 A" . SPARSER::PROTEIN)
    ("PI3-K" . SPARSER::PROTEIN) ("GβL" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN)
    ("regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("rapamycin-insensitive companion of mTOR" . SPARSER::PROTEIN)
    ("CIP2A" . SPARSER::PROTEIN)
    ("adjuvant pro-metastatic gene" . SPARSER::GENE)
    ("pro-angiogenic mediators" . SPARSER::PROTEIN)
    ("thyroid and CRC" . SPARSER::COLLECTION)
    ("HGF/c-MET" . SPARSER::COLLECTION) ("HGF and c-MET" . SPARSER::COLLECTION)
    ("independent prognostic biomarker" . SPARSER::MOLECULE)
    ("CRC and nodal" . SPARSER::COLLECTION)
    ("thrombospondin 1" . SPARSER::PROTEIN) ("C-MET" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("Bcl-2 (anti-apoptotic factor) and Bax" . SPARSER::COLLECTION)
    ("numerous pro-apoptotic genes" . SPARSER::GENE)
    ("pro-apoptotic protein" . SPARSER::PROTEIN)
    ("ABCA1 and ABCB1" . SPARSER::COLLECTION)
    ("drug resistance-associated ABCG2" . SPARSER::PROTEIN)
    ("ABCG2 and the stemness genes CD133, Oct-4 and EpCAM"
     . SPARSER::COLLECTION)
    ("NaK-ATPase" . SPARSER::COLLECTION)
    ("CD133, Oct-4 and EpCAM" . SPARSER::COLLECTION)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("anti-apoptotic gene Bcl-2 and pro-apoptotic Bax" . SPARSER::COLLECTION)
    ("pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("the chemotherapeutic drugs carboplatin" . SPARSER::DRUG)
    ("Dysadherin" . SPARSER::PROTEIN)
    ("the chemotherapeutic drugs" . SPARSER::DRUG)
    ("CD133, CD44, EpCAM and Oct-4" . SPARSER::COLLECTION)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("a valuable potential target" . SPARSER::TARGET-PROTEIN)
    ("DNA-targeting drugs and apoptotic cell death" . SPARSER::COLLECTION)
    ("dysadherin and stemness" . SPARSER::COLLECTION)
    ("dysadherin" . SPARSER::PROTEIN) ("ABCA1" . SPARSER::PROTEIN)
    ("CS6" . SPARSER::PROTEIN) ("BCL -2" . SPARSER::PROTEIN)
    ("OCT-4" . SPARSER::PROTEIN) ("bis-benzimide" . SPARSER::MOLECULE)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("TAGLN" . SPARSER::PROTEIN)
    ("co-transfected" . SPARSER::PROTEIN)
    ("ROCK1-co-transfected" . SPARSER::PROTEIN-PAIR)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("ROCKs" . SPARSER::PROTEIN-FAMILY) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("a novel human cancer-associated miRNA" . SPARSER::PROTEIN)
    ("tumor suppressor gene and oncogene" . SPARSER::COLLECTION)
    ("transcription factor 3" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("ROCK-1" . SPARSER::PROTEIN) ("s 15" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN)
    ("AR, HOXB13, and FOXA1" . SPARSER::COLLECTION)
    ("publicly available gene" . SPARSER::GENE)
    ("FOXA1 or HOXB13" . SPARSER::COLLECTION)
    ("HOXB13 or FOXA1" . SPARSER::COLLECTION)
    ("AR, HOXB13 and FOXA1" . SPARSER::COLLECTION)
    ("FOXA1, HOXB13 and AR" . SPARSER::COLLECTION)
    ("HOXB13 and FOXA1" . SPARSER::COLLECTION)
    ("AR and FOXA1" . SPARSER::COLLECTION)
    ("the AR and the forkhead transcription factor FOXA1 ( xref )"
     . SPARSER::COLLECTION)
    ("AR and co-factor" . SPARSER::COLLECTION)
    ("the AR’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXA1 and HOXB13" . SPARSER::COLLECTION)
    ("The genome-wide map" . SPARSER::PROTEIN) ("HOXB1" . SPARSER::PROTEIN)
    ("HNF-3" . SPARSER::PROTEIN) ("De-" . SPARSER::MOLECULE)
    ("HOXB13" . SPARSER::PROTEIN) ("TERT or hTR" . SPARSER::COLLECTION)
    ("multimeric form" . SPARSER::FORM)
    ("heterozygous TERT" . SPARSER::PROTEIN)
    ("a larger fraction" . SPARSER::COMPONENT)
    ("hTR and H/ACA" . SPARSER::COLLECTION)
    ("dimers and aggregates" . SPARSER::COLLECTION)
    ("a template-complementary oligonucleotide" . SPARSER::MOLECULE)
    ("Monomeric TERT" . SPARSER::PROTEIN) ("TERTs" . SPARSER::PROTEIN)
    ("co-expressed ACP- and MCP-tagged WT TERT" . SPARSER::COLLECTION)
    ("Cy5-labeled O-purified MCP-tagged WT TERT, TERT-∆PAL, and TERT-20N complexes"
     . SPARSER::COLLECTION)
    ("OB" . SPARSER::PROTEIN) ("oligosaccharide" . SPARSER::MOLECULE)
    ("reconstituted holoenzyme or minimal RNPs" . SPARSER::COLLECTION)
    ("minimal RNPs" . SPARSER::PROTEIN)
    ("the longest product DNAs" . SPARSER::DNA) ("TERT-" . SPARSER::PROTEIN)
    ("PAL" . SPARSER::PROTEIN)
    ("18% proline, 14% arginine, and 12% glycine" . SPARSER::COLLECTION)
    ("only TERT monomer RNPs" . SPARSER::PROTEIN)
    ("approximately 100 amino acids" . SPARSER::AMINO-ACID)
    ("monomer or dimer" . SPARSER::COLLECTION)
    ("holoenzyme and ∼10 nM K d" . SPARSER::COLLECTION)
    ("minimal RNP" . SPARSER::PROTEIN)
    ("at least some TERT monomer RNPs" . SPARSER::PROTEIN)
    ("monomeric TERT" . SPARSER::PROTEIN)
    ("Inactive RNP and hTR-free TERT" . SPARSER::COLLECTION)
    ("an associated shelterin complex" . SPARSER::BIO-COMPLEX)
    ("GGGTTA-3" . SPARSER::COLLECTION) ("dATP" . SPARSER::DATP)
    ("synthase and CoA-biotin" . SPARSER::COLLECTION)
    ("biotin-TERT" . SPARSER::COLLECTION) ("Streptavidin" . SPARSER::PROTEIN)
    ("TERT and biotin" . SPARSER::COLLECTION) ("biotin" . SPARSER::PROTEIN)
    ("TERT monomer or TERT dimer" . SPARSER::COLLECTION)
    ("TERT monomer and TERT dimer" . SPARSER::COLLECTION)
    ("labeling ACP-TERT" . SPARSER::COLLECTION)
    ("synthase and CoA-Cy5" . SPARSER::COLLECTION)
    ("biotin–streptavidin" . SPARSER::PROTEIN-PAIR)
    ("TERT or RNA" . SPARSER::COLLECTION) ("hTR or hTR" . SPARSER::COLLECTION)
    ("synthase and CoA-Cy3" . SPARSER::COLLECTION)
    ("MCP-TERT" . SPARSER::COLLECTION) ("ACP-TERT" . SPARSER::COLLECTION)
    ("ACP- and MCP-tagged TERTs" . SPARSER::COLLECTION)
    ("ACP-" . SPARSER::PROTEIN) ("dTTP" . SPARSER::MOLECULE)
    ("dGTP" . SPARSER::DGTP)
    ("catalytically active minimal RNP" . SPARSER::PROTEIN)
    ("a triple FLAG peptide" . SPARSER::PEPTIDE)
    ("ACP or MCP" . SPARSER::COLLECTION) ("ACP/MCP" . SPARSER::COLLECTION)
    ("bacterial proteins" . SPARSER::PROTEIN)
    ("ACP and MCP" . SPARSER::COLLECTION) ("MCP" . SPARSER::PROTEIN)
    ("human telomerase holoenzyme and minimal recombinant RNPs"
     . SPARSER::COLLECTION)
    ("minimal recombinant RNPs" . SPARSER::PROTEIN)
    ("minimal recombinant RNP" . SPARSER::PROTEIN)
    ("acyl carrier protein (ACP)" . SPARSER::PROTEIN)
    ("Coenzyme" . SPARSER::MOLECULE) ("ACP" . SPARSER::PROTEIN)
    ("individual macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("dimeric TERT RNPs" . SPARSER::PROTEIN) ("RNPs" . SPARSER::PROTEIN)
    ("one TERT and one hTR" . SPARSER::COLLECTION)
    ("RRL-reconstituted minimal RNP" . SPARSER::PROTEIN)
    ("monomeric subunits" . SPARSER::PROTEIN)
    ("the minimal Tetrahymena telomerase RNP" . SPARSER::PROTEIN)
    ("in vitro transcribed full-length hTR ( xref ) or a half-sized RNA"
     . SPARSER::COLLECTION)
    ("a half-sized RNA" . SPARSER::RNA)
    ("dyskerin, NHP2, NOP10, GAR1, and TCAB1" . SPARSER::COLLECTION)
    ("TERT and the 451-nucleotide mature hTR" . SPARSER::COLLECTION)
    ("the 451-nucleotide mature hTR" . SPARSER::RNA)
    ("dyskerin, NHP2, NOP10, and GAR1" . SPARSER::COLLECTION)
    ("Cajal" . SPARSER::PROTEIN) ("dyskerin" . SPARSER::PROTEIN)
    ("ACA" . SPARSER::PROTEIN) ("TEN-domain-truncated TERT" . SPARSER::PROTEIN)
    ("TERT and hTR" . SPARSER::COLLECTION) ("telomerases" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("ribonucleoprotein (RNP)" . SPARSER::PROTEIN) ("hTR" . SPARSER::RNA)
    ("RNP" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("telosome" . SPARSER::BIO-COMPLEX) ("replisome" . SPARSER::BIO-COMPLEX)
    ("‘complexes’" . SPARSER::BIO-COMPLEX)
    ("just one component protein" . SPARSER::PROTEIN)
    ("cellular holoenzyme and minimal recombinant enzyme"
     . SPARSER::COLLECTION)
    ("minimal recombinant enzyme" . SPARSER::ENZYME)
    ("cellular holoenzyme" . SPARSER::PROTEIN)
    ("heterogeneous DNA-bound TERT monomer and dimer" . SPARSER::COLLECTION)
    ("monomer and dimer" . SPARSER::COLLECTION)
    ("Tel2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("A-14" . SPARSER::PROTEIN)
    ("U3" . SPARSER::PROTEIN) ("acyl carrier protein" . SPARSER::PROTEIN)
    ("TPP1" . SPARSER::PROTEIN) ("TCAB1" . SPARSER::PROTEIN)
    ("GAR1" . SPARSER::PROTEIN) ("NOP10" . SPARSER::PROTEIN)
    ("NHP2" . SPARSER::PROTEIN)
    ("proto-oncogene and matrix metallopeptidase 14" . SPARSER::COLLECTION)
    ("FAs and Wnt" . SPARSER::COLLECTION)
    ("the most aggressive form" . SPARSER::FORM)
    ("exogenous oleate" . SPARSER::MOLECULE)
    ("saturated FAs stabilized cytosolic β-catenin" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE)
    ("anti-β-catenin" . SPARSER::COLLECTION)
    ("oleate and Wnt3a" . SPARSER::COLLECTION)
    ("β-catenin and wild-type FAF1 or mutant FAF1" . SPARSER::COLLECTION)
    ("FAF1 or mutant" . SPARSER::COLLECTION) ("UAS" . SPARSER::PROTEIN)
    ("Oleate" . SPARSER::MOLECULE) ("siRNA or siRNAs" . SPARSER::COLLECTION)
    ("FAs and FAF1" . SPARSER::COLLECTION)
    ("two homologous proteins" . SPARSER::PROTEIN) ("Ubxd8" . SPARSER::PROTEIN)
    ("FAs and β-catenin" . SPARSER::COLLECTION)
    ("FAF1/β-catenin" . SPARSER::COLLECTION)
    ("Fas-associated factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NH2" . SPARSER::MOLECULE)
    ("matrix metallopeptidase 14" . SPARSER::PROTEIN)
    ("β-Trcp" . SPARSER::PROTEIN) ("SCD1" . SPARSER::PROTEIN)
    ("stearoyl-CoA" . SPARSER::MOLECULE) ("β-Catenin" . SPARSER::PROTEIN)
    ("Insig-1" . SPARSER::PROTEIN) ("acylase" . SPARSER::PROTEIN)
    ("the acetylated substrate or NAD +" . SPARSER::COLLECTION)
    ("no particular hot" . SPARSER::PROTEIN)
    ("further highlighting SIRT6" . SPARSER::PROTEIN)
    ("The SIRT6 mutants D63Y and A89S" . SPARSER::COLLECTION)
    ("PDK1, GLUT1, LDHa and LDHb" . SPARSER::COLLECTION)
    ("LDHa" . SPARSER::PROTEIN) ("MYC-" . SPARSER::PROTEIN)
    ("Glucose" . SPARSER::PROTEIN)
    ("the ribosomal genes RPL3" . SPARSER::PROTEIN)
    ("HIF1α or MYC" . SPARSER::COLLECTION)
    ("the only two mutants" . SPARSER::MUTANT)
    ("50 μM H3K9Ac peptide and 0.5 mM NAD + in the presence"
     . SPARSER::COLLECTION)
    ("bacterial Sir2Tm" . SPARSER::PROTEIN)
    ("nearly negligible deacetylase activity" . SPARSER::PROTEIN)
    ("substrates and products" . SPARSER::COLLECTION)
    ("50 μM H3K9Ac peptide and 0.5 mM NAD +" . SPARSER::COLLECTION)
    ("Proline" . SPARSER::AMINO-ACID) ("nicotinamide" . SPARSER::PROTEIN)
    ("the backbone amide nitrogen and carbonyl oxygen" . SPARSER::COLLECTION)
    ("asparagine (D25N) and a glutamic acid" . SPARSER::COLLECTION)
    ("HIF1a and MYC" . SPARSER::COLLECTION)
    ("a key tumor suppressor and critical node" . SPARSER::COLLECTION)
    ("HIF1α and MYC" . SPARSER::COLLECTION) ("RPS15A" . SPARSER::PROTEIN)
    ("RPL23" . SPARSER::PROTEIN) ("M −1" . SPARSER::PROTEIN)
    ("Sir2Tm" . SPARSER::PROTEIN) ("Deacetylase activity" . SPARSER::PROTEIN)
    ("Glutamic acid" . SPARSER::AMINO-ACID) ("K33" . SPARSER::PROTEIN)
    ("Aspartic acid" . SPARSER::AMINO-ACID) ("HIF1a" . SPARSER::PROTEIN)
    ("K56" . SPARSER::PROTEIN) ("intra-protein" . SPARSER::COLLECTION)
    ("the pS210 and pS184 residues" . SPARSER::COLLECTION)
    ("pS210 and pS184" . SPARSER::COLLECTION) ("TSG" . SPARSER::PROTEIN)
    ("CPEB1-Pin1" . SPARSER::COLLECTION) ("Pin1-PKC" . SPARSER::COLLECTION)
    ("Asp, Arg and Lys" . SPARSER::COLLECTION)
    ("Glu, Gln and Asn" . SPARSER::COLLECTION)
    ("Neither NF1 nor NF2" . SPARSER::COLLECTION) ("Prolyl" . SPARSER::PROTEIN)
    ("cis/trans isomerase" . SPARSER::COLLECTION) ("Mos" . SPARSER::PROTEIN)
    ("the repression complex and the recruitment" . SPARSER::COLLECTION)
    ("Pin1 and CPEB1" . SPARSER::COLLECTION) ("Nedd4L" . SPARSER::PROTEIN)
    ("β1–β2" . SPARSER::COLLECTION) ("β2- and β3-strand" . SPARSER::COLLECTION)
    ("β2-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1D-" . SPARSER::PROTEIN)
    ("an optimal substrate" . SPARSER::SUBSTRATE)
    ("complex  " . SPARSER::BIO-COMPLEX) ("PPIase" . SPARSER::PROTEIN)
    ("β1- and β2" . SPARSER::COLLECTION) ("β1-" . SPARSER::PROTEIN)
    ("apo" . SPARSER::PROTEIN) ("Peptide" . SPARSER::PEPTIDE)
    ("Fmoc" . SPARSER::MOLECULE) ("CPEB1" . SPARSER::PROTEIN)
    ("Pin1-CPEB1" . SPARSER::PROTEIN-PAIR)
    ("the NF1 or the NF2" . SPARSER::COLLECTION)
    ("NF1 or NF2" . SPARSER::COLLECTION) ("NF1 and NF2" . SPARSER::COLLECTION)
    ("NF1 (88–183) and NF2 (196–293)" . SPARSER::COLLECTION)
    ("Ser-Pro" . SPARSER::COLLECTION) ("CPE" . SPARSER::PROTEIN)
    ("MII" . SPARSER::PROTEIN) ("tryptophan" . SPARSER::AMINO-ACID)
    ("peptidyl-prolyl" . SPARSER::COLLECTION) ("CPEB" . SPARSER::PROTEIN)
    ("L-Arg" . SPARSER::PROTEIN) ("Q9BZB8" . SPARSER::PROTEIN)
    ("Isoform 1" . SPARSER::PROTEIN) ("Q13526" . SPARSER::PROTEIN)
    ("trans isomerase" . SPARSER::PROTEIN) ("Nedd4" . SPARSER::PROTEIN)
    ("β1" . SPARSER::PROTEIN) ("H- 15" . SPARSER::PROTEIN)
    ("Cdc2" . SPARSER::PROTEIN) ("pS210" . SPARSER::DRUG)
    ("β−TrCP" . SPARSER::PROTEIN) ("CSF" . SPARSER::PROTEIN)
    ("the major excitatory neurotransmitter" . SPARSER::MOLECULE)
    ("neuroprotective anti-oxidant genes" . SPARSER::GENE)
    ("Neither GS nor FOXO3a (neuronal or glia immunoreactivity)"
     . SPARSER::COLLECTION)
    ("PMD" . SPARSER::PROTEIN) ("GFAP" . SPARSER::PROTEIN)
    ("FOXO3a and GS" . SPARSER::COLLECTION)
    ("this population-representative cohort" . SPARSER::MOLECULE)
    ("yrs" . SPARSER::PROTEIN) ("-Akt-FOXO" . SPARSER::COLLECTION)
    ("Forkhead" . SPARSER::PROTEIN)
    ("astrocyte-associated EAAT2" . SPARSER::PROTEIN)
    ("neurotransmitters" . SPARSER::MOLECULE) ("Astrocytes" . SPARSER::PROTEIN)
    ("Glial" . SPARSER::PROTEIN) ("GS" . SPARSER::PROTEIN)
    ("MRC" . SPARSER::PROTEIN) ("β 1 " . SPARSER::PROTEIN)
    ("FOXO3A" . SPARSER::PROTEIN) ("AT8" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glutamine synthetase" . SPARSER::PROTEIN) ("EAAT2" . SPARSER::PROTEIN)
    ("glutamine synthetase" . SPARSER::PROTEIN)
    ("A key serine residue" . SPARSER::MOLECULE)
    ("multimeric RAD51" . SPARSER::PROTEIN)
    ("the associated high-penetrance c" . SPARSER::PROTEIN)
    ("Dec" . SPARSER::PROTEIN) ("Variant" . SPARSER::VARIANT)
    ("Variants" . SPARSER::VARIANT)
    ("the much rarer pathogenic variant" . SPARSER::VARIANT)
    ("OR 2" . SPARSER::MOLECULE) ("Therapeutics" . SPARSER::THERAPEUTICS)
    ("IRIF" . SPARSER::PROTEIN)
    ("small-molecule inhibitors of USP4, USP15, and/or USP11"
     . SPARSER::COLLECTION)
    ("USP4, USP11 and USP15" . SPARSER::COLLECTION)
    ("possible DDR" . SPARSER::PROTEIN)
    ("USP4, USP15 and USP11" . SPARSER::COLLECTION)
    ("USP-DUB" . SPARSER::COLLECTION)
    ("immunoprecipitation-western blot" . SPARSER::PROTEIN)
    ("GFP-USP15" . SPARSER::COLLECTION)
    ("which forms part" . SPARSER::COMPONENT)
    ("USP15 and USP11" . SPARSER::COLLECTION)
    ("relevant E3 ubiquitin ligases" . SPARSER::LIGASE)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("zinc-binding" . SPARSER::PROTEIN)
    ("CtIP, MRE11, and RAD50" . SPARSER::COLLECTION)
    ("palm" . SPARSER::PROTEIN) ("GFP-FLAG-MRE11" . SPARSER::COLLECTION)
    ("GFP-CtIP" . SPARSER::COLLECTION) ("GFP-FLAG" . SPARSER::COLLECTION)
    ("GFP-FLAG-fused" . SPARSER::COLLECTION)
    ("RAD50 and MRE11" . SPARSER::COLLECTION)
    ("USP4 or SART3" . SPARSER::COLLECTION) ("bromo" . SPARSER::MOLECULE)
    ("γH2AX and S4S8p" . SPARSER::COLLECTION)
    ("sub-nuclear foci (IRIF)" . SPARSER::PROTEIN)
    ("protein A (RPA)" . SPARSER::PROTEIN) ("nucleoprotein" . SPARSER::PROTEIN)
    ("FLAG-epitope-tagged USP4" . SPARSER::PROTEIN)
    ("GFP or GFP-USP4" . SPARSER::COLLECTION)
    ("catalytic cysteine" . SPARSER::AMINO-ACID)
    ("USP4 and targets USP4" . SPARSER::COLLECTION)
    ("its spliceosomal substrate PRP3" . SPARSER::PROTEIN)
    ("U4/U6" . SPARSER::COLLECTION) ("complemented" . SPARSER::PROTEIN)
    ("exogenous GFP-fused USP4" . SPARSER::PROTEIN)
    ("GFP-fused" . SPARSER::COLLECTION) ("USP4-2" . SPARSER::COLLECTION)
    ("GFP-USP4" . SPARSER::COLLECTION)
    ("the radiomimetic chemical phleomycin" . SPARSER::MOLECULE)
    ("CtIP and DNA ligase IV" . SPARSER::COLLECTION)
    ("phleomycin" . SPARSER::MOLECULE) ("complementary DDR" . SPARSER::PROTEIN)
    ("USP4, USP11, and USP15" . SPARSER::COLLECTION)
    ("previously established DDR" . SPARSER::PROTEIN)
    ("USP4, USP15, and USP11" . SPARSER::COLLECTION)
    ("deubiquitylases" . SPARSER::DEUBIQUITYLASE)
    ("Substrates" . SPARSER::SUBSTRATE)
    ("53BP1 and the BRCA1-A complex" . SPARSER::COLLECTION)
    ("RNF8 and RNF168" . SPARSER::COLLECTION) ("DNA-end" . SPARSER::DNA)
    ("Amino acids" . SPARSER::AMINO-ACID) ("LT1" . SPARSER::PROTEIN)
    ("CD-" . SPARSER::PROTEIN) ("intercalating agent" . SPARSER::DRUG)
    ("Cyclin-A" . SPARSER::PROTEIN) ("S4S" . SPARSER::PROTEIN-FAMILY)
    ("RPA2" . SPARSER::PROTEIN) ("PRP3" . SPARSER::PROTEIN)
    ("SART3" . SPARSER::PROTEIN) ("U4" . SPARSER::PROTEIN)
    ("XRCC4" . SPARSER::PROTEIN) ("DNA ligase IV" . SPARSER::PROTEIN)
    ("USP15" . SPARSER::PROTEIN) ("E2s" . SPARSER::MOLECULE)
    ("E1s" . SPARSER::MOLECULE) ("RNF168" . SPARSER::PROTEIN)
    ("histone 2" . SPARSER::PROTEIN) ("N-MYC and DNMT" . SPARSER::COLLECTION)
    ("miRNAs-MYC" . SPARSER::COLLECTION)
    ("MYC and specific miRNAs [ xref ]" . SPARSER::COLLECTION)
    ("gene and microRNA" . SPARSER::COLLECTION)
    ("MYC or N-MYC" . SPARSER::COLLECTION)
    ("N-MYC and MYC" . SPARSER::COLLECTION)
    ("MYC and N-MYC" . SPARSER::COLLECTION) ("Hsa" . SPARSER::PROTEIN)
    ("DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("HDAC3 and EZH2" . SPARSER::COLLECTION)
    ("DNMTs and N-MYC" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3A, DNMT3B and NMYC" . SPARSER::COLLECTION)
    ("NMYC" . SPARSER::PROTEIN)
    ("DNMT1 , DNMT3A , DNMT3B and MYCN" . SPARSER::COLLECTION)
    ("MYCN and DNMT" . SPARSER::COLLECTION) ("GEP" . SPARSER::PROTEIN)
    ("miR-29a" . SPARSER::PROTEIN)
    ("hsa-miR-29a, hsa-miR-29b, hsa-miR-513a-5p, and hsa-miR-628-3p"
     . SPARSER::COLLECTION)
    ("hsa-miR-29a" . SPARSER::COLLECTION)
    ("nuclear factor-kB pathways-associated miRNAs" . SPARSER::PROTEIN)
    ("HC" . SPARSER::PROTEIN) ("DNMT" . SPARSER::PROTEIN)
    ("the currently available FISH" . SPARSER::PROTEIN)
    ("IG" . SPARSER::MOLECULE) ("IGH" . SPARSER::PROTEIN)
    ("microRNA and gene" . SPARSER::COLLECTION)
    ("hsa-miR-29" . SPARSER::COLLECTION) ("DNA-methyl" . SPARSER::DNA)
    ("-MYC" . SPARSER::COLLECTION) ("DNMT3" . SPARSER::PROTEIN)
    ("N-MYC" . SPARSER::PROTEIN)
    ("DNA (cytosine-5)-methyltransferase 1" . SPARSER::PROTEIN)
    ("hsa-Let-7" . SPARSER::RNA) ("group B" . SPARSER::PROTEIN)
    ("CD10" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("fibrotic foci" . SPARSER::PROTEIN) ("kinase (FAK)" . SPARSER::KINASE)
    ("siRNA or NC" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("the fibroblastic foci" . SPARSER::PROTEIN)
    ("deubiquitylase" . SPARSER::DEUBIQUITYLASE)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("Fibroblastic foci" . SPARSER::PROTEIN)
    ("USP13 and PTEN" . SPARSER::COLLECTION)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("fibroblastic foci" . SPARSER::PROTEIN) ("Siah2" . SPARSER::PROTEIN)
    ("USP3" . SPARSER::PROTEIN) ("hyaluronan synthase2" . SPARSER::PROTEIN)
    ("USP13" . SPARSER::PROTEIN) ("LFS and LFLS" . SPARSER::COLLECTION)
    ("an arginine (R) or proline (P)" . SPARSER::COLLECTION)
    ("CPC" . SPARSER::PROTEIN) ("LFS or LFLS" . SPARSER::COLLECTION)
    ("MYCN" . SPARSER::PROTEIN) ("the hypomorphic allele" . SPARSER::ALLELE)
    ("the most immature, and malignant form" . SPARSER::FORM)
    ("NB" . SPARSER::PROTEIN) ("LFS" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("AR/ER/PgR" . SPARSER::COLLECTION)
    ("PIK3CA kinase domain mutant (PIK3CAkin) and PIK3CA helical domain mutant (PIK3CAhel)"
     . SPARSER::COLLECTION)
    ("PIK3CA helical domain mutant" . SPARSER::MUTANT)
    ("IGF and PI3K-AKT" . SPARSER::COLLECTION)
    ("receptors (AR)" . SPARSER::RECEPTOR)
    ("estrogen (ER)" . SPARSER::MOLECULE)
    ("epidermal growth factor receptor (EGFR) and HER2" . SPARSER::COLLECTION)
    ("Phosphoinositide 3-kinase–protein kinase B" . SPARSER::COLLECTION)
    ("larger cohorts" . SPARSER::MOLECULE) ("Kappa" . SPARSER::PROTEIN-FAMILY)
    ("ER/PgR/AR" . SPARSER::COLLECTION) ("ER/PgR" . SPARSER::COLLECTION)
    ("ER, PgR, Ki67, HER2 and androgen receptor" . SPARSER::COLLECTION)
    ("Amino acid" . SPARSER::AMINO-ACID) ("PIK3" . SPARSER::PROTEIN)
    ("ACLY, ACC1 or ETV4" . SPARSER::COLLECTION)
    ("ACC1 [ xref – xref ] or ETV4 [ xref – xref ]" . SPARSER::COLLECTION)
    ("methyltransferase and demethylase" . SPARSER::COLLECTION)
    ("ACC1, ACLY or α-KG" . SPARSER::COLLECTION)
    ("lipogenic inhibitors" . SPARSER::INHIBITOR)
    ("ACLY and ACC1" . SPARSER::COLLECTION) ("tri" . SPARSER::PROTEIN)
    ("water or DMSO" . SPARSER::COLLECTION) ("TET" . SPARSER::PROTEIN)
    ("a hypoxic trigger" . SPARSER::PROTEIN) ("diM" . SPARSER::PROTEIN-FAMILY)
    ("malate, and citrate" . SPARSER::COLLECTION)
    ("pyruvate and lactate" . SPARSER::COLLECTION)
    ("lipogenic enzymes" . SPARSER::ENZYME)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("ACC1 (shACC1) and ACLY (shACLY)" . SPARSER::COLLECTION)
    ("ETV4 (shETV4), ACC1 (shACC1) and ACLY (shACLY)" . SPARSER::COLLECTION)
    ("CTSS, COL13A1, DUSP6 and SERPINE1" . SPARSER::COLLECTION)
    ("CTSS" . SPARSER::PROTEIN)
    ("PLEC ( xref ) and DUSP6 ( xref )" . SPARSER::COLLECTION)
    ("at least two potential direct ETV4 target genes" . SPARSER::GENE)
    ("PLEC" . SPARSER::PROTEIN)
    ("NQO1, CYP1B1 and SERPINE1" . SPARSER::COLLECTION)
    ("BIK, TNFRSF9, TNFAIP3, GLIPR1, DDIT and TRIB3" . SPARSER::COLLECTION)
    ("DDIT" . SPARSER::PROTEIN) ("BIK" . SPARSER::PROTEIN)
    ("ETV4, ACC1 or ACLY" . SPARSER::COLLECTION)
    ("ACC1, ACLY or ETV4" . SPARSER::COLLECTION)
    ("ACC1/ACLY" . SPARSER::COLLECTION)
    ("neither ETV1 nor ETV5" . SPARSER::COLLECTION)
    ("ETV1 and ETV5" . SPARSER::COLLECTION)
    ("ACLY, ACC1 and ETV4" . SPARSER::COLLECTION)
    ("available NADPH" . SPARSER::PROTEIN)
    ("NADPH and ATP" . SPARSER::COLLECTION)
    ("acetyl-CoA and oxaloacetate" . SPARSER::COLLECTION)
    ("ACACB" . SPARSER::PROTEIN) ("metformin" . SPARSER::DRUG)
    ("malonyl" . SPARSER::PROTEIN) ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("had at least two distinct shRNA" . SPARSER::PROTEIN)
    ("Genome-wide pooled shRNA" . SPARSER::PROTEIN)
    ("ACLY-ACC1-ETV4" . SPARSER::COLLECTION)
    ("genome-wide pooled shRNA" . SPARSER::PROTEIN)
    ("NAD+, NOS and α-ketoglutarate" . SPARSER::COLLECTION)
    ("NOS" . SPARSER::PROTEIN) ("Metabolites" . SPARSER::MOLECULE)
    ("dehydrogenase and fumarate hydratase" . SPARSER::COLLECTION)
    ("histone and DNA" . SPARSER::COLLECTION)
    ("ATP citrate lyase (ACLY)" . SPARSER::PROTEIN)
    ("co-factors and modulators" . SPARSER::COLLECTION)
    ("MondoA:Mlx" . SPARSER::BIO-COMPLEX) ("TXNIP" . SPARSER::PROTEIN)
    ("Mlx" . SPARSER::PROTEIN) ("MondoA" . SPARSER::PROTEIN)
    ("HIFs" . SPARSER::PROTEIN-FAMILY)
    ("valuable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("LA or hypoxia" . SPARSER::COLLECTION)
    ("glucose or amino acids" . SPARSER::COLLECTION)
    ("tumor cells survive hypoxia" . SPARSER::PROTEIN)
    ("survive hypoxia" . SPARSER::PROTEIN)
    ("many lipogenic inhibitors" . SPARSER::INHIBITOR)
    ("ACC1 and ACLY" . SPARSER::COLLECTION)
    ("ACC1 or ACLY" . SPARSER::COLLECTION)
    ("ACLY or ACC1" . SPARSER::COLLECTION)
    ("ACACA or ACC1" . SPARSER::COLLECTION) ("ACLY" . SPARSER::PROTEIN)
    ("genome-wide shRNA" . SPARSER::PROTEIN) ("Fe(II)" . SPARSER::MOLECULE)
    ("COL13A1" . SPARSER::PROTEIN) ("TRIB3" . SPARSER::PROTEIN)
    ("GLIPR1" . SPARSER::PROTEIN) ("TNFAIP3" . SPARSER::PROTEIN)
    ("TNFRSF9" . SPARSER::PROTEIN) ("SERPINE1" . SPARSER::PROTEIN)
    ("ETV5" . SPARSER::PROTEIN) ("ETV1" . SPARSER::PROTEIN)
    ("PEA3" . SPARSER::PROTEIN) ("NADP+" . SPARSER::MOLECULE)
    ("PANC–1" . SPARSER::PROTEIN) ("HIF–2α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("EPAS1" . SPARSER::PROTEIN) ("fumarate hydratase" . SPARSER::PROTEIN)
    ("HIF–1α" . SPARSER::PROTEIN) ("ETV4" . SPARSER::PROTEIN)
    ("ATP citrate lyase" . SPARSER::PROTEIN) ("ACC1" . SPARSER::PROTEIN)
    ("non-cardiotoxic selective COX-2 inhibitors and/or agents"
     . SPARSER::COLLECTION)
    ("pAKT, MAPK, MEK and pErk" . SPARSER::COLLECTION)
    ("pErk" . SPARSER::PROTEIN) ("MAPK and AKT" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases, integrins, and ion channels"
     . SPARSER::COLLECTION)
    ("that PGE 2 and its metabolite play essential roles in initiating and regulating lung tumorigenesis"
     . SPARSER::COLLECTION)
    ("arachidonate-associated bioactive lipids" . SPARSER::LIPID)
    ("COX and lipoxygenase" . SPARSER::COLLECTION)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COX-2 and PGE 2" . SPARSER::COLLECTION) ("synthase" . SPARSER::PROTEIN)
    ("COX-2 or PGE 2" . SPARSER::COLLECTION)
    ("COX-2 and its metabolite" . SPARSER::COLLECTION)
    ("enzymes and PGE 2" . SPARSER::COLLECTION)
    ("PGF 2α and PGD 2" . SPARSER::COLLECTION)
    ("MAPK/Erk" . SPARSER::COLLECTION)
    ("MEK and P-Erk1/2" . SPARSER::COLLECTION) ("P-Erk1/2" . SPARSER::PROTEIN)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("RAS/MAPK/Erk" . SPARSER::COLLECTION)
    ("this enzyme and its arachidonate metabolite 13,14-dihydro-15-keto-PGE 2"
     . SPARSER::COLLECTION)
    ("a urinary metabolite" . SPARSER::MOLECULE) ("PGEM" . SPARSER::MOLECULE)
    ("KRAS-" . SPARSER::PROTEIN)
    ("transforming growth factor-β1 and epidermal growth factor"
     . SPARSER::COLLECTION)
    ("transforming growth factor-β1" . SPARSER::COLLECTION)
    ("PGs" . SPARSER::PROTEIN)
    ("a membrane-associated GTPase signaling protein" . SPARSER::PROTEIN)
    ("less MEK and p-Erk1/2 protein" . SPARSER::COLLECTION)
    ("p-Erk1/2" . SPARSER::COLLECTION) ("K-ras/COX-2" . SPARSER::COLLECTION)
    ("COX2" . SPARSER::PROTEIN) ("PGD 2" . SPARSER::PROTEIN)
    ("PGF 2α" . SPARSER::MOLECULE) ("P-Erk" . SPARSER::PROTEIN)
    ("15-PGDH" . SPARSER::PROTEIN) ("thromboxane B 2" . SPARSER::MOLECULE)
    ("K-ras" . SPARSER::PROTEIN)
    ("a comprehensive predictive biomarker" . SPARSER::MOLECULE)
    ("PD-1 or CTLA4" . SPARSER::COLLECTION)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("EMT and macrophage" . SPARSER::COLLECTION)
    ("trastuzumab and chemotherapy" . SPARSER::COLLECTION)
    ("PTEN or PDCD4" . SPARSER::COLLECTION)
    ("EMT and targets PTEN and PDCD4" . SPARSER::COLLECTION)
    ("doxorubicin ( p = 0.012) and trastuzumab ( p = 0.001)"
     . SPARSER::COLLECTION)
    ("paclitaxel, doxorubicin, or trastuzumab" . SPARSER::COLLECTION)
    ("preoperative trastuzumab and chemotherapy" . SPARSER::COLLECTION)
    ("preoperative trastuzumab" . SPARSER::DRUG)
    ("chemotherapeutic drugs or trastuzumab" . SPARSER::COLLECTION)
    ("drugs or trastuzumab" . SPARSER::COLLECTION)
    ("PTEN and PDCD4" . SPARSER::COLLECTION)
    ("14 functionally relevant miRNAs" . SPARSER::PROTEIN)
    ("EMT and anti-tumor" . SPARSER::COLLECTION)
    ("STAT3/NF-κB" . SPARSER::COLLECTION)
    ("mesenchymal traits" . SPARSER::PROTEIN)
    ("specific predictive clinical biomarkers" . SPARSER::MOLECULE)
    ("HER and non-HER" . SPARSER::COLLECTION)
    ("receptor-antibody" . SPARSER::COLLECTION) ("/AKT" . SPARSER::COLLECTION)
    ("immunomodulatory drugs" . SPARSER::DRUG)
    ("PTEN (rs = −0.502; p = 0.005) and PDCD4 (rs = −0.426; p = 0.019)"
     . SPARSER::COLLECTION)
    ("IRS 4" . SPARSER::PROTEIN) ("miR-221–3p" . SPARSER::MOLECULE)
    ("CTLA4" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("MiR-21" . SPARSER::PROTEIN) ("PDCD4" . SPARSER::PROTEIN)
    ("pentapeptide" . SPARSER::MOLECULE) ("MEK–ERK" . SPARSER::COLLECTION)
    ("Pi3K/AKT" . SPARSER::COLLECTION)
    ("Oct-4 and Nanog" . SPARSER::COLLECTION) ("Formalin" . SPARSER::MOLECULE)
    ("the histological subtypes" . SPARSER::PROTEIN)
    ("the well-investigated epithelial, neural, and placental cadherins"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ca 2+ -dependent transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("metastatic GCTs" . SPARSER::PROTEIN)
    ("the different histological subtypes" . SPARSER::PROTEIN)
    ("antibody or siRNA" . SPARSER::COLLECTION) ("GCTs" . SPARSER::PROTEIN)
    ("H2O2" . SPARSER::DRUG) ("Si-RNA" . SPARSER::RNA)
    ("ADH-1" . SPARSER::PROTEIN) ("Pi3K" . SPARSER::PROTEIN)
    ("N-Cadherin" . SPARSER::PROTEIN) ("Oct-4" . SPARSER::PROTEIN)
    ("CDH2" . SPARSER::PROTEIN)
    ("HDAC1, HDAC2 and HDAC3" . SPARSER::COLLECTION)
    ("an active HDAC3 complex" . SPARSER::BIO-COMPLEX)
    ("TSA (which inhibits Class I HDACs [ xref ]) and valproic acid (which inhibits Class I/II HDACs [ xref ])"
     . SPARSER::COLLECTION)
    ("polymerized microtubules" . SPARSER::PROTEIN)
    ("tubulin–HDAC3" . SPARSER::COLLECTION) ("spin" . SPARSER::PROTEIN)
    ("the active complex" . SPARSER::BIO-COMPLEX)
    ("a purified active HDAC3–SMRT complex" . SPARSER::BIO-COMPLEX)
    ("HDAC3–SMRT" . SPARSER::COLLECTION)
    ("KD and eGFP–HDAC3-expressing" . SPARSER::COLLECTION)
    ("KD and eGFP–HDAC3-overexpressing" . SPARSER::COLLECTION)
    ("MEGF10–GFP" . SPARSER::COLLECTION) ("GFP–HDAC3" . SPARSER::COLLECTION)
    ("HDAC3–GFP" . SPARSER::COLLECTION) ("eGFP–HDAC3" . SPARSER::COLLECTION)
    ("HDAC3 or HDAC6" . SPARSER::COLLECTION) ("sirna" . SPARSER::PROTEIN)
    ("eGFP–EB1" . SPARSER::COLLECTION) ("EB1" . SPARSER::PROTEIN)
    ("HDAC6 and SIRT2" . SPARSER::COLLECTION) ("HDACS" . SPARSER::PROTEIN)
    ("HDAC3, and MS-275" . SPARSER::COLLECTION)
    ("HDAC2 and HDAC3" . SPARSER::COLLECTION) ("benzamide" . SPARSER::DRUG)
    ("TNF and IL-6" . SPARSER::COLLECTION)
    ("transducing-β-like protein 1 (TBL1) and TBL1-related proteins"
     . SPARSER::COLLECTION)
    ("transcription (STAT) proteins STAT1 [ xref ] and STAT3 [ xref ]"
     . SPARSER::COLLECTION)
    ("ataxin–1NCoR–SMRT" . SPARSER::COLLECTION) ("emerin" . SPARSER::PROTEIN)
    ("HDAC3–protein" . SPARSER::COLLECTION) ("Ins" . SPARSER::PROTEIN)
    ("the nuclear receptor co-repressor (NCoR) or the homologous SMRT (silencing mediator of retinoic and thyroid receptors) complex"
     . SPARSER::COLLECTION)
    ("the homologous SMRT (silencing mediator of retinoic and thyroid receptors) complex"
     . SPARSER::BIO-COMPLEX)
    ("NCoR/SMRT" . SPARSER::COLLECTION) ("NCoR" . SPARSER::PROTEIN)
    ("SIRT1, SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("SIRT1–SIRT7" . SPARSER::COLLECTION)
    ("HDAC4, HDAC5, HDAC7 and HDAC9" . SPARSER::COLLECTION)
    ("HDAC6 and HDAC10" . SPARSER::COLLECTION)
    ("HDAC1–HDAC3" . SPARSER::COLLECTION) ("‘histone’" . SPARSER::PROTEIN)
    ("receptors (SMRT)" . SPARSER::RECEPTOR)
    ("retinoic and thyroid" . SPARSER::COLLECTION) ("DAD" . SPARSER::PROTEIN)
    ("retinoic" . SPARSER::PROTEIN) ("MEGF10" . SPARSER::PROTEIN)
    ("1–2 " . SPARSER::PROTEIN)
    ("Microtubule-associated protein" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("MS-275" . SPARSER::DRUG) ("MGCD0103" . SPARSER::DRUG)
    ("TBL1" . SPARSER::PROTEIN) ("NCoR1" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("ataxin–1" . SPARSER::PROTEIN) ("P  4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nuclear receptor co-repressor" . SPARSER::PROTEIN)
    ("SIRT5" . SPARSER::PROTEIN) ("SIRT4" . SPARSER::PROTEIN)
    ("HDAC10" . SPARSER::PROTEIN) ("HDAC9" . SPARSER::PROTEIN)
    ("HDAC5" . SPARSER::PROTEIN) ("HDAC8" . SPARSER::PROTEIN)
    ("HDAC3 " . SPARSER::PROTEIN) ("Histone deacetylase 3" . SPARSER::PROTEIN)
    ("the mitotic form" . SPARSER::FORM)
    ("different pathological states" . SPARSER::BIO-STATE)
    ("Hsp72 or Nek6" . SPARSER::COLLECTION)
    ("Astral microtubules" . SPARSER::PROTEIN)
    ("reduced astral microtubules" . SPARSER::PROTEIN)
    ("Nek6" . SPARSER::PROTEIN) ("TACC3" . SPARSER::PROTEIN)
    ("Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a eukaryotic protein" . SPARSER::PROTEIN) ("PIMT" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("post-translational state" . SPARSER::BIO-STATE)
    ("a eukaryotic glutamyl methyltransferase" . SPARSER::PROTEIN)
    ("isoprenylcysteine carboxyl methyltransferase (ICMT) and leucine carboxyl methyltransferase (LCMT1)"
     . SPARSER::COLLECTION)
    ("ICMT" . SPARSER::PROTEIN) ("isoaspartate" . SPARSER::MOLECULE)
    ("mouse neutrophils and mammalian targets" . SPARSER::COLLECTION)
    ("protein methylase II being erythrocyte membrane proteins and the pituitary hormone ACTH"
     . SPARSER::COLLECTION)
    ("protein methylase II being erythrocyte membrane proteins"
     . SPARSER::PROTEIN)
    ("ACTH" . SPARSER::PROTEIN)
    ("CheR-regulated bacterial chemotaxis" . SPARSER::PROTEIN)
    ("lysyl" . SPARSER::MOLECULE) ("amine" . SPARSER::MOLECULE)
    ("methyltransferase or protein" . SPARSER::COLLECTION)
    ("methanol" . SPARSER::MOLECULE) ("AdoMet" . SPARSER::MOLECULE)
    ("acidic residue methyltransferase 1" . SPARSER::PROTEIN)
    ("C6orf211" . SPARSER::PROTEIN)
    ("O-methyltransferase activity" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("isoprenylcysteine carboxyl methyltransferase" . SPARSER::PROTEIN)
    ("PCMT1" . SPARSER::PROTEIN) ("O-methyltransferase 1" . SPARSER::PROTEIN)
    ("O-methyltransferase" . SPARSER::PROTEIN) ("BK" . SPARSER::PROTEIN)
    ("PP4c" . SPARSER::PROTEIN) ("Stathmin" . SPARSER::PROTEIN)
    ("stathmin" . SPARSER::PROTEIN) ("LT" . SPARSER::PROTEIN)
    ("MCC" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("keratin-5" . SPARSER::PROTEIN) ("HIF-1/NF-kB" . SPARSER::COLLECTION)
    ("HIF-1-" . SPARSER::PROTEIN) ("HIF-1 and NF-kB" . SPARSER::COLLECTION)
    ("IKKβ and NF-kB" . SPARSER::COLLECTION)
    ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("gene and demonstration" . SPARSER::COLLECTION)
    ("ERβ and IKKβ" . SPARSER::COLLECTION)
    ("IKKβ and NF-κB" . SPARSER::COLLECTION)
    ("HIF-1α/IKKβ" . SPARSER::COLLECTION)
    ("response element (HRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("IKKα and IKKγ" . SPARSER::COLLECTION)
    ("IKKβ and p" . SPARSER::COLLECTION) ("-IκBα" . SPARSER::COLLECTION)
    ("IKKβ/IκBα" . SPARSER::COLLECTION)
    ("an aggressive variant" . SPARSER::VARIANT)
    ("ERβ and HIF-1α and p65" . SPARSER::COLLECTION)
    ("ERβ and p65" . SPARSER::COLLECTION)
    ("HIF-1α and p65" . SPARSER::COLLECTION)
    ("ERβ and HIF-1" . SPARSER::COLLECTION)
    ("RelA (p65) and p50" . SPARSER::COLLECTION)
    ("the heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("ERβ and NF-κB" . SPARSER::COLLECTION) ("IKKβ/p65" . SPARSER::COLLECTION)
    ("ERβ or hypoxia" . SPARSER::COLLECTION)
    ("p65 and ERβ" . SPARSER::COLLECTION) ("ERβ2" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("PHD2" . SPARSER::PROTEIN) ("prolyl hydroxylase 2" . SPARSER::PROTEIN)
    ("EMT, and MMP" . SPARSER::COLLECTION)
    ("EMT, and survivin" . SPARSER::COLLECTION)
    ("the principal ECM-degrading enzymes" . SPARSER::ENZYME)
    ("IWR-1 increased E-cadherin" . SPARSER::PROTEIN)
    ("survivin and Snail" . SPARSER::COLLECTION)
    ("β-catenin and survivin" . SPARSER::COLLECTION)
    ("10 ng/ml TNF-α and/or 10 μM IWR-1" . SPARSER::COLLECTION)
    ("β-catenin, survivin, and Snail" . SPARSER::COLLECTION)
    ("pcDNA-Survivin" . SPARSER::COLLECTION) ("pcDNA" . SPARSER::PROTEIN)
    ("si-Survivin" . SPARSER::PROTEIN-PAIR)
    ("pcDNA-survivin" . SPARSER::PROTEIN-PAIR) ("Myr" . SPARSER::MOLECULE)
    ("human CRCs and PI3K/Akt inhibitors" . SPARSER::COLLECTION)
    ("Vimentin and Snail" . SPARSER::COLLECTION)
    ("N-cadherin and Snail" . SPARSER::COLLECTION)
    ("the mesenchymal markers N-cadherin, Vimentin and Snail"
     . SPARSER::COLLECTION)
    ("N-cadherin, Vimentin and Snail" . SPARSER::COLLECTION)
    ("The epithelial marker E-cadherin and the mesenchymal markers N-cadherin, Snail, and Vimentin"
     . SPARSER::COLLECTION)
    ("the mesenchymal markers N-cadherin, Snail, and Vimentin"
     . SPARSER::COLLECTION)
    ("N-cadherin, Snail, and Vimentin" . SPARSER::COLLECTION)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("APC, Axin, and glycogen synthase" . SPARSER::COLLECTION)
    ("Wnt/ β-catenin" . SPARSER::COLLECTION)
    ("EMT and survivin" . SPARSER::COLLECTION) ("p34" . SPARSER::PROTEIN)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("Wnt/ β" . SPARSER::PROTEIN) ("IWR-1" . SPARSER::PROTEIN)
    ("proteins, MCP1 and IL1β" . SPARSER::COLLECTION)
    ("a ubiquitous actin binding protein" . SPARSER::PROTEIN)
    ("IL-1β and MCP1" . SPARSER::COLLECTION)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("cofilin-shRNA" . SPARSER::COLLECTION) ("LV" . SPARSER::MOLECULE)
    ("cofilin1 shRNA (Lv-cofilin1-shRNA) and non-silencing shRNA (Lv-control-shRNA)"
     . SPARSER::COLLECTION)
    ("Rhodamine" . SPARSER::PROTEIN) ("p-cofilin1" . SPARSER::COLLECTION)
    ("group and SHR-C" . SPARSER::COLLECTION)
    ("NF-κB and cofilin1" . SPARSER::COLLECTION)
    ("MCP1 and IL1β" . SPARSER::COLLECTION) ("SBP" . SPARSER::PROTEIN)
    ("proanthocyanidin" . SPARSER::DRUG)
    ("anthocyanins and flavonols" . SPARSER::COLLECTION)
    ("NF-κB, and AP-1" . SPARSER::COLLECTION)
    ("TNF-α, IL-6, IL-8, IL-1β, and MCP-1" . SPARSER::COLLECTION)
    ("MEK/MAPK" . SPARSER::COLLECTION) ("flavonols" . SPARSER::MOLECULE)
    ("anthocyanins" . SPARSER::MOLECULE) ("RelA/p65" . SPARSER::COLLECTION)
    ("monocyte chemotactic protein 1(MCP1) and Interleukin-1β (IL1β)"
     . SPARSER::COLLECTION)
    ("Inactive" . SPARSER::INACTIVE)
    ("A ubiquitously inflammatory transcription factor" . SPARSER::PROTEIN)
    ("MCP-1 and IL-1β" . SPARSER::COLLECTION) ("Rel/p65" . SPARSER::COLLECTION)
    ("MCP1 and IL-1β" . SPARSER::COLLECTION)
    ("interleukin-1β (IL1β) and NF-κB" . SPARSER::COLLECTION)
    ("Haematoxylin" . SPARSER::MOLECULE)
    ("Twenty-four-hour urinary protein" . SPARSER::PROTEIN)
    ("creatinine and urea" . SPARSER::COLLECTION)
    ("creatinine" . SPARSER::PROTEIN) ("proanthocyanidins" . SPARSER::DRUG)
    ("Cofilin-1" . SPARSER::PROTEIN) ("band 3" . SPARSER::PROTEIN)
    ("–3 " . SPARSER::PROTEIN) ("L −1" . SPARSER::PROTEIN)
    ("Cofilin1" . SPARSER::PROTEIN) ("Interleukin-1β" . SPARSER::PROTEIN)
    ("HK2" . SPARSER::PROTEIN) ("HK-2" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein 1" . SPARSER::PROTEIN)
    ("cofilin1" . SPARSER::PROTEIN) ("cofilin-1" . SPARSER::PROTEIN)
    ("pPR" . SPARSER::PROTEIN-FAMILY) ("trastuzumab (BASAL)" . SPARSER::DRUG)
    ("c  " . SPARSER::PROTEIN) ("the MTS cohort" . SPARSER::MOLECULE)
    ("healthy age-matched CTR" . SPARSER::PROTEIN)
    ("the therapeutic mAbs" . SPARSER::DRUG)
    ("rituximab and cetuximab" . SPARSER::COLLECTION)
    ("CD20 and EGFR" . SPARSER::COLLECTION)
    ("the predominant effector" . SPARSER::EFFECTOR)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("the FcγRIIIA 158F and/or the FcγRIIA 131R variants"
     . SPARSER::COLLECTION)
    ("Tetra" . SPARSER::MOLECULE) ("NEO" . SPARSER::PROTEIN)
    ("trastuzumab " . SPARSER::DRUG) ("FcγRIIIA " . SPARSER::PROTEIN)
    ("H/R" . SPARSER::PROTEIN) ("CD32" . SPARSER::PROTEIN)
    ("FcγRII" . SPARSER::PROTEIN) ("CD64" . SPARSER::PROTEIN)
    ("FcγRs" . SPARSER::PROTEIN-FAMILY) ("FcγR" . SPARSER::PROTEIN-FAMILY)
    ("FcγRIIA" . SPARSER::PROTEIN) ("FcγRIIIA" . SPARSER::PROTEIN)
    ("calponin" . SPARSER::PROTEIN) ("smoothelin" . SPARSER::PROTEIN)
    ("The myristoylation‐deficient mutant and the phosphorylation‐deficient mutant"
     . SPARSER::COLLECTION)
    ("available PIP 2" . SPARSER::PIP2) ("PI3K or PLC" . SPARSER::COLLECTION)
    ("phospholipase C (PLC) or phosphoinositide 3‐kinase (PI3K)"
     . SPARSER::COLLECTION)
    ("detected weak expression MARCKS" . SPARSER::PROTEIN)
    ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("significantly change basal membrane‐associated PIP 2" . SPARSER::PIP2)
    ("fluorescent protein" . SPARSER::PROTEIN) ("PH" . SPARSER::PROTEIN)
    ("MARCKS, G2A, or S4G" . SPARSER::COLLECTION)
    ("G2A and S4G" . SPARSER::COLLECTION)
    ("WT bovine MARCKS" . SPARSER::PROTEIN)
    ("bovine MARCKS" . SPARSER::PROTEIN) ("CRIB" . SPARSER::DRUG)
    ("MARCKS and cortactin" . SPARSER::COLLECTION)
    ("GTPases, Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("basic amino acids" . SPARSER::AMINO-ACID)
    ("substrate (MARCKS)" . SPARSER::SUBSTRATE) ("MARCKS" . SPARSER::PROTEIN)
    ("myristoylated" . SPARSER::PROTEIN) ("G2A" . SPARSER::PROTEIN)
    ("SM 22" . SPARSER::PROTEIN) ("PDGF receptor" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("αSMA" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIP 2" . SPARSER::PIP2) ("TPO/MPL" . SPARSER::COLLECTION)
    ("CBL and KIT" . SPARSER::COLLECTION)
    ("ASXL1 and ASXL2" . SPARSER::COLLECTION)
    ("Nras(G12) or KIT" . SPARSER::COLLECTION) ("Nras" . SPARSER::PROTEIN)
    ("a homozygous form" . SPARSER::FORM)
    ("mutants (Q367P, Y371S) and a deletion mutant (ΔE8/9)"
     . SPARSER::COLLECTION)
    ("KIT and MPL" . SPARSER::COLLECTION) ("Src and Syk" . SPARSER::COLLECTION)
    ("normal HSCs" . SPARSER::PROTEIN)
    ("ubiquitin ligase (CBL)" . SPARSER::PROTEIN)
    ("KIT and TP53" . SPARSER::COLLECTION) ("AKT/ERK" . SPARSER::COLLECTION)
    ("RAS-associated pathway genes" . SPARSER::GENE)
    ("AML-ETO-induced leukemia" . SPARSER::PROTEIN)
    ("Src and RTKs" . SPARSER::COLLECTION)
    ("INCB018424 and TG101209" . SPARSER::COLLECTION)
    ("JAK/Src" . SPARSER::COLLECTION) ("shUBASH-2" . SPARSER::COLLECTION)
    ("RUNX1 and C/EBPα" . SPARSER::COLLECTION)
    ("UBASH3A/Sts-2" . SPARSER::COLLECTION)
    ("the CBL-interacting proteins, UBASH3B/Sts-1 ," . SPARSER::PROTEIN)
    ("STAT, AKT, ERK and Src" . SPARSER::COLLECTION)
    ("STAT/AKT/ERK" . SPARSER::COLLECTION)
    ("STAT/AKT/ERK/Src" . SPARSER::COLLECTION) ("TPO" . SPARSER::PROTEIN)
    ("shR-CBL" . SPARSER::COLLECTION)
    ("Both mutant CBL and AML1-ETO proteins" . SPARSER::COLLECTION)
    ("MPO-" . SPARSER::PROTEIN) ("CD33-" . SPARSER::PROTEIN)
    ("CD19-" . SPARSER::PROTEIN) ("MPO" . SPARSER::PROTEIN)
    ("GFP (i.e. CBL) and Thy1" . SPARSER::COLLECTION)
    ("UBASH3B/Sts-1-CBL" . SPARSER::COLLECTION)
    ("SCF, GM-CSF, and IL-3" . SPARSER::COLLECTION)
    ("NSGS" . SPARSER::PROTEIN-FAMILY) ("HSCs" . SPARSER::PROTEIN)
    ("TULA-2" . SPARSER::COLLECTION)
    ("EGFR, FLT3, KIT, MPL and Src" . SPARSER::COLLECTION)
    ("CBFB-MYH11" . SPARSER::COLLECTION)
    ("a heterodimeric transcription factor complex" . SPARSER::BIO-COMPLEX)
    ("RUNX1 and CBFB" . SPARSER::COLLECTION) ("CBFB" . SPARSER::PROTEIN)
    ("/t" . SPARSER::COLLECTION) ("CBF" . SPARSER::PROTEIN)
    ("UBASH3B/Sts-1" . SPARSER::COLLECTION)
    ("STAT5/AKT/ERK/Src" . SPARSER::COLLECTION)
    ("AML1-ETO-induced leukemia" . SPARSER::PROTEIN)
    ("AML1-ETO" . SPARSER::COLLECTION) ("ETO" . SPARSER::PROTEIN)
    ("ASXL2" . SPARSER::PROTEIN) ("ASXL1" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN) ("SOX4" . SPARSER::PROTEIN)
    ("UBASH3A" . SPARSER::PROTEIN) ("AF9" . SPARSER::PROTEIN)
    ("CD79a" . SPARSER::PROTEIN) ("CD13" . SPARSER::PROTEIN)
    ("CD33" . SPARSER::PROTEIN) ("hIL-3" . SPARSER::PROTEIN)
    ("IL2" . SPARSER::PROTEIN) ("TG101209" . SPARSER::DRUG)
    ("Thy1" . SPARSER::PROTEIN) ("IL2RG" . SPARSER::PROTEIN)
    ("MYH11" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("UBASH3B" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("One excellent example" . SPARSER::EXAMPLE)
    ("mutated alleles" . SPARSER::ALLELE) ("adequate DNA" . SPARSER::DNA)
    ("contralateral lobes" . SPARSER::PROTEIN) ("lobes" . SPARSER::PROTEIN)
    ("RET/PTC" . SPARSER::COLLECTION)
    ("the same or different histologic variants" . SPARSER::VARIANT)
    ("histologic variants" . SPARSER::VARIANT)
    ("follicular variant" . SPARSER::VARIANT)
    ("a BRAF -positive classic variant" . SPARSER::VARIANT)
    ("the follicular variants" . SPARSER::VARIANT)
    ("follicular variants" . SPARSER::VARIANT)
    ("The follicular variant" . SPARSER::VARIANT)
    ("the same histologic variant" . SPARSER::VARIANT)
    ("The one BRAF -positive encapsulated follicular variant"
     . SPARSER::VARIANT)
    ("the encapsulated follicular variant" . SPARSER::VARIANT)
    ("multifocal PTC" . SPARSER::PROTEIN) ("ray" . SPARSER::PROTEIN)
    ("salivary DNA" . SPARSER::DNA) ("microbial DNAs" . SPARSER::DNA)
    ("BRAF/MEK" . SPARSER::COLLECTION) ("BRAFV" . SPARSER::PROTEIN)
    ("a special column matrix" . SPARSER::PROTEIN-FAMILY)
    ("DNA and mutant" . SPARSER::COLLECTION)
    ("PIK3CA and EGFR" . SPARSER::COLLECTION) ("PNA-LNA" . SPARSER::COLLECTION)
    ("shorter LNA" . SPARSER::PROTEIN) ("Oligonucleotides" . SPARSER::MOLECULE)
    ("unambiguous melting" . SPARSER::DRUG) ("fluorescein" . SPARSER::MOLECULE)
    ("PNA and DNA" . SPARSER::COLLECTION) ("DNA and DNA" . SPARSER::COLLECTION)
    ("thermostable restriction enzymes" . SPARSER::ENZYME)
    ("only DNA containing target allele" . SPARSER::ALLELE)
    ("PNA-locked nucleic acid (LNA) PCR clamp" . SPARSER::PROTEIN-FAMILY)
    ("PNA-" . SPARSER::PROTEIN) ("PNA" . SPARSER::PROTEIN)
    ("KRAS, p53 and EGFR" . SPARSER::COLLECTION)
    ("macrophages and the digested DNA" . SPARSER::COLLECTION)
    ("our unique TMA" . SPARSER::MOLECULE)
    ("correlative biomarker" . SPARSER::MOLECULE)
    ("correlative biomarkers" . SPARSER::MOLECULE) ("Cao" . SPARSER::MOLECULE)
    ("multiple commercially available MET antibodies" . SPARSER::ANTIBODY)
    ("using TMAs and a method of quantitated immunohistochemistry (AQUA)"
     . SPARSER::COLLECTION)
    ("the correlative biomarker" . SPARSER::MOLECULE)
    ("two-sided rank" . SPARSER::PROTEIN) ("MAD" . SPARSER::PROTEIN)
    ("a larger RCC TMA" . SPARSER::MOLECULE) ("AQUA" . SPARSER::MOLECULE)
    ("a useful predictive biomarker" . SPARSER::MOLECULE)
    ("the actual therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("VEGFR2 and MET" . SPARSER::COLLECTION) ("AMG" . SPARSER::PROTEIN)
    ("inhibitors and antibodies" . SPARSER::COLLECTION)
    ("sunitinib, and sorafenib" . SPARSER::COLLECTION)
    ("Aims" . SPARSER::PROTEIN) ("Hepatocyte Growth Factor" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor Receptor" . SPARSER::PROTEIN)
    ("the predominant methylation state" . SPARSER::BIO-STATE)
    ("cellular HSPA1" . SPARSER::PROTEIN) ("KMT" . SPARSER::PROTEIN)
    ("the previously uncharacterized MTF16 enzymes" . SPARSER::ENZYME)
    ("HSPA" . SPARSER::PROTEIN-FAMILY) ("MTF" . SPARSER::PROTEIN)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("MTase" . SPARSER::PROTEIN)
    ("SET" . SPARSER::PROTEIN) ("four possible states" . SPARSER::BIO-STATE)
    ("demethylases and protein" . SPARSER::COLLECTION)
    ("targets and diagnostic/prognostic" . SPARSER::COLLECTION)
    ("the otherwise globular histone proteins" . SPARSER::PROTEIN)
    ("sugars and lipids" . SPARSER::COLLECTION) ("sugars" . SPARSER::MOLECULE)
    ("macromolecules" . SPARSER::MOLECULE)
    ("signaling-associated proteins" . SPARSER::PROTEIN)
    ("the stress-inducible Hsp70 protein HSPA1" . SPARSER::PROTEIN)
    ("Cho" . SPARSER::PROTEIN) ("S - adenosylmethionine" . SPARSER::DRUG)
    ("SMYD3" . SPARSER::PROTEIN) ("MAP3K2" . SPARSER::PROTEIN)
    ("CA 125" . SPARSER::DRUG) ("Asp-N" . SPARSER::PROTEIN)
    ("METTL21A" . SPARSER::PROTEIN) ("SET domain" . SPARSER::PROTEIN)
    ("DOT1L" . SPARSER::PROTEIN) ("HSPA1" . SPARSER::PROTEIN)
    ("shRNA and HER2" . SPARSER::COLLECTION)
    ("AKT and FOXO1" . SPARSER::COLLECTION)
    ("metastatic foci" . SPARSER::PROTEIN)
    ("suppressor and promoter" . SPARSER::COLLECTION)
    ("AKT (pAKT) and its substrate GSK-3 β (pGSK-3 β )" . SPARSER::COLLECTION)
    ("LY294002 or AKT" . SPARSER::COLLECTION)
    ("HER2 and FOXO1" . SPARSER::COLLECTION)
    ("orthotopic GC" . SPARSER::PROTEIN)
    ("shRNA or HER2" . SPARSER::COLLECTION)
    ("shRNA or FOXO1" . SPARSER::COLLECTION)
    ("class O (FOXO)" . SPARSER::PROTEIN) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("advanced metastatic GC" . SPARSER::PROTEIN)
    ("FOXO1/HER2" . SPARSER::COLLECTION)
    ("FOXO1 and HER2" . SPARSER::COLLECTION) ("32 P" . SPARSER::|32P|)
    ("FOXO1A" . SPARSER::PROTEIN) ("β -galactosidase" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN) ("class O" . SPARSER::PROTEIN)
    ("PEITC" . SPARSER::DRUG) ("multimeric complexes" . SPARSER::BIO-COMPLEX)
    ("Sp1, pur-α and hnRNP-K" . SPARSER::COLLECTION)
    ("bicalutamide" . SPARSER::DRUG) ("KLF" . SPARSER::PROTEIN)
    ("the associated antagonistic transcription factors Sp1 and pur-α"
     . SPARSER::COLLECTION)
    ("the hAR promoter and 5" . SPARSER::COLLECTION)
    ("pur-α-rich LNCaP" . SPARSER::PROTEIN)
    ("Sp1 or pur-α" . SPARSER::COLLECTION)
    ("UTR ARS and Sp1-3 sites" . SPARSER::COLLECTION)
    ("Sp1 and pur-α" . SPARSER::COLLECTION)
    ("both the ARS and Sp1-3 regions of the 5" . SPARSER::COLLECTION)
    ("Ig" . SPARSER::MOLECULE)
    ("The only commercially available enzyme" . SPARSER::ENZYME)
    ("The ubiquitous protein hnRNP-K" . SPARSER::PROTEIN)
    ("RNA and DNA" . SPARSER::COLLECTION)
    ("The commercial anti-pur-α antibody" . SPARSER::ANTIBODY)
    ("dimers and multimers" . SPARSER::COLLECTION)
    ("guanine-rich single stranded DNA or the equivalent sequences"
     . SPARSER::COLLECTION)
    ("natural Sp1" . SPARSER::PROTEIN) ("somatostatin" . SPARSER::PROTEIN)
    ("CRE" . SPARSER::PROTEIN) ("labelled oligonucleotide" . SPARSER::MOLECULE)
    ("guanine and cyctosine" . SPARSER::COLLECTION)
    ("DU145 and LNCaP" . SPARSER::COLLECTION)
    ("LNCaP and non-responsive" . SPARSER::COLLECTION)
    ("Sp1-1" . SPARSER::COLLECTION)
    ("only chimpanzee sharing both GC" . SPARSER::PROTEIN)
    ("even less homology" . SPARSER::PROTEIN)
    ("publically available DNA" . SPARSER::DNA) ("GGN" . SPARSER::PROTEIN)
    ("ARS" . SPARSER::SUPPRESSOR)
    ("stimulatory Sp1 and inhibitory pur-α" . SPARSER::COLLECTION)
    ("stimulatory Sp1" . SPARSER::PROTEIN)
    ("the immediate promoter" . SPARSER::PROMOTER)
    ("essential transcription cofactors" . SPARSER::PROTEIN)
    ("Suppressor (ARS)" . SPARSER::SUPPRESSOR)
    ("a composite NF-κB" . SPARSER::PROTEIN)
    ("the upregulatory GC" . SPARSER::PROTEIN)
    ("Suppressor" . SPARSER::SUPPRESSOR) ("tetramers" . SPARSER::TETRAMER)
    ("the TATA-binding protein and TBP-associated factor 4 (TAF4)"
     . SPARSER::COLLECTION)
    ("TBP-associated factor 4" . SPARSER::PROTEIN)
    ("isoflavone" . SPARSER::MOLECULE)
    ("FOXA1 and GATA2" . SPARSER::COLLECTION) ("PCa (CRPC)" . SPARSER::PROTEIN)
    ("the positive transcription factor Sp1 and the repressor protein pur-α"
     . SPARSER::COLLECTION)
    ("pur" . SPARSER::PROTEIN) ("recurrent PCa (CRPC)" . SPARSER::PROTEIN)
    ("phenethyl isothiocyanate" . SPARSER::DRUG) ("CREB-1" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE) ("Sp1-3" . SPARSER::PROTEIN)
    ("Protein-A" . SPARSER::PROTEIN) ("Protein-G" . SPARSER::PROTEIN)
    ("hnRNP-K" . SPARSER::PROTEIN) ("B-myb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAF4" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("GATA2" . SPARSER::PROTEIN) ("Caspase 3 or Nexin" . SPARSER::COLLECTION)
    ("Nexin" . SPARSER::PROTEIN)
    ("HOPX [ xref ] and CDO1 [ xref ]" . SPARSER::COLLECTION)
    ("HOPX" . SPARSER::PROTEIN) ("Reprimo" . SPARSER::PROTEIN)
    ("systemic iPS" . SPARSER::PROTEIN)
    ("the p53 aberration group and the p53 non-aberration group"
     . SPARSER::COLLECTION)
    ("S-1 postoperative adjuvant" . SPARSER::DRUG)
    ("the chemotherapeutic agent CDDP" . SPARSER::DRUG)
    ("CDDP" . SPARSER::DRUG) ("the intestinal type" . TYPE)
    ("SHM" . SPARSER::DRUG) ("RFS" . SPARSER::PROTEIN)
    ("PGP9.5, NMDAR2B, or CCNA1" . SPARSER::COLLECTION)
    ("PGP9.5, NMDAR2B, and CCNA1" . SPARSER::COLLECTION)
    ("PGP9.5, NAMDR2B and CCNA1" . SPARSER::COLLECTION)
    ("PGP9.5, NMDAR2N, and CCNA1" . SPARSER::COLLECTION)
    ("NMDAR" . SPARSER::PROTEIN)
    ("PGP9 . 5 , NMDAR2B and CCNA1" . SPARSER::COLLECTION)
    ("CCNA1 (p<0.0001) and PGP9 . 5 (p = 0.03)" . SPARSER::COLLECTION)
    ("NMDAR2B (p = 0.10) and DAPK (p = 0.05)" . SPARSER::COLLECTION)
    ("PGP9 . 5 , NMDAR2B , CCNA1 , and DAPK" . SPARSER::COLLECTION)
    ("DAPK" . SPARSER::PROTEIN)
    ("highly relevant methylated genes" . SPARSER::GENE)
    ("TSGs" . SPARSER::PROTEIN) ("PUM" . SPARSER::PROTEIN)
    ("intestinal type" . TYPE)
    ("PGP9 . 5 , NMDAR2B , and CCNA1" . SPARSER::COLLECTION)
    ("genes identified candidate tumor suppressor genes" . SPARSER::GENE)
    ("CDO1" . SPARSER::PROTEIN) ("IgG 2a" . SPARSER::PROTEIN)
    ("PGP9.5" . SPARSER::PROTEIN) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("S-1" . SPARSER::PROTEIN) ("NMDAR2B" . SPARSER::PROTEIN)
    ("PGP9 . 5" . SPARSER::PROTEIN) ("Nutlin-3 and RITA" . SPARSER::COLLECTION)
    ("RITA" . SPARSER::PROTEIN) ("ATM/Chk2" . SPARSER::COLLECTION)
    ("a pro-apoptotic activator" . SPARSER::ACTIVATOR)
    ("p53, E2F and Cdc25" . SPARSER::COLLECTION)
    ("AMPK and mTOR" . SPARSER::COLLECTION)
    ("AMPK and Ulk1" . SPARSER::COLLECTION) ("Atg1" . SPARSER::PROTEIN)
    ("protein (TSC)" . SPARSER::PROTEIN)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("p70S6K and 4EBP1" . SPARSER::COLLECTION)
    ("Cdk4 or Cdk6" . SPARSER::COLLECTION)
    ("structural ions" . SPARSER::MOLECULE)
    ("camptothecin and etoposide" . SPARSER::COLLECTION)
    ("γ-H2AX and Chk2" . SPARSER::COLLECTION)
    ("Rad3-related protein (ATR)" . SPARSER::PROTEIN)
    ("phosphatases and BRCA1" . SPARSER::COLLECTION)
    ("Chk2 and Chk1" . SPARSER::COLLECTION) ("chloroquine" . SPARSER::PROTEIN)
    ("a ubiquitin- and LC3-binding protein" . SPARSER::COLLECTION)
    ("AMPK-mTOR" . SPARSER::COLLECTION)
    ("Cyclin D1/Cdk4" . SPARSER::COLLECTION)
    ("Cyclin D1 and its catalytic partner Cdk4" . SPARSER::COLLECTION)
    ("Cdk/cyclin" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("iodide (PI)" . SPARSER::PROTEIN)
    ("ester (CFSE)" . SPARSER::MOLECULE) ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("AMPK/mTOR" . SPARSER::COLLECTION) ("oxidant" . SPARSER::PROTEIN)
    ("protein kinase kinase (CAMKK)" . SPARSER::PROTEIN)
    ("a catalytic α subunit and regulatory β and γ subunits"
     . SPARSER::COLLECTION)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("mitochondria and glucose" . SPARSER::COLLECTION)
    ("BRCA1 (BReast CAncer gene 1) and p53" . SPARSER::COLLECTION)
    ("E2F-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a pro-apoptotic inducer" . SPARSER::PROTEIN)
    ("nitroxoline" . SPARSER::DRUG) ("Nitroxoline" . SPARSER::DRUG)
    ("chk2" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("p-Rb" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("Ulk1" . SPARSER::PROTEIN) ("Ulk 1" . SPARSER::PROTEIN)
    ("UNC-51" . SPARSER::PROTEIN) ("Cdk6" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("hormone-sensitive" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("MetAP2" . SPARSER::PROTEIN) ("protein kinase kinase" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F-1" . SPARSER::PROTEIN)
    ("promyelocytic leukemia protein" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("further support silibinin's" . SPARSER::DRUG)
    ("further support silibinin" . SPARSER::DRUG)
    ("XPG and XPF protein" . SPARSER::COLLECTION)
    ("ERCC1-XPF" . SPARSER::COLLECTION) ("functional TFIIH" . SPARSER::PROTEIN)
    ("ERCC1/XPF" . SPARSER::COLLECTION) ("XPC and TFIIH" . SPARSER::COLLECTION)
    ("helicase and ATPase" . SPARSER::COLLECTION) ("sunscreen" . SPARSER::DRUG)
    ("DDB1, DDB2 and p53" . SPARSER::COLLECTION)
    ("XPG and XPF" . SPARSER::COLLECTION)
    ("effectors, GADD45α and p21" . SPARSER::COLLECTION)
    ("p53 and its downstream effectors (GADD45α and p21)"
     . SPARSER::COLLECTION)
    ("silibinin (100 μM) and/or pifithrin-α (7 μM)" . SPARSER::COLLECTION)
    ("Silibinin" . SPARSER::DRUG) ("p53 and NER" . SPARSER::COLLECTION)
    ("damage-containing DNA" . SPARSER::DNA)
    ("XPF-ERCC1" . SPARSER::COLLECTION) ("endonucleases" . SPARSER::PROTEIN)
    ("XPA and RPA" . SPARSER::COLLECTION)
    ("helicase (XPB and XPD) and kinase (cdk7)" . SPARSER::COLLECTION)
    ("xeroderma pigmentosum (XP) and Cockayne" . SPARSER::COLLECTION)
    ("CS" . SPARSER::PROTEIN) ("GGR" . SPARSER::PROTEIN)
    ("cyclobutane pyrimidine dimers (CPDs) and 6–4 photoproducts (6–4 PPs)"
     . SPARSER::COLLECTION)
    ("these findings further support silibinin's" . SPARSER::DRUG)
    ("these findings further support silibinin" . SPARSER::DRUG)
    ("NER and p53" . SPARSER::COLLECTION) ("XPA-" . SPARSER::PROTEIN)
    ("XPA and GADD45α" . SPARSER::COLLECTION)
    ("p53 and GADD45α" . SPARSER::COLLECTION) ("XPG" . SPARSER::PROTEIN)
    ("CPDs" . SPARSER::PROTEIN) ("cyclobutane" . SPARSER::MOLECULE)
    ("silibinin" . SPARSER::DRUG) ("XPF protein" . SPARSER::PROTEIN)
    ("Cdk7" . SPARSER::PROTEIN) ("ERCC1" . SPARSER::PROTEIN)
    ("cdk7" . SPARSER::PROTEIN)
    ("PARP, calpaina and AIF" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("MSH3, MSH6, and PMS2" . SPARSER::COLLECTION)
    ("MLH1 and MSH2" . SPARSER::COLLECTION)
    ("MLH1, MSH2, MSH3, MSH6, and PMS2" . SPARSER::COLLECTION)
    ("MSH2, MSH6, and PMS2" . SPARSER::COLLECTION) ("Von" . SPARSER::PROTEIN)
    ("methylated MGMT promoter" . SPARSER::PROMOTER)
    ("a methylated MGMT gene promoter" . SPARSER::PROMOTER)
    ("verapamil" . SPARSER::DRUG) ("MSH2 and MSH6" . SPARSER::COLLECTION)
    ("MLH1, MSH2, MSH3, MSH6 and PMS2" . SPARSER::COLLECTION)
    ("O6-BG" . SPARSER::COLLECTION) ("BG" . SPARSER::PROTEIN)
    ("Aza" . SPARSER::DRUG) ("MGMT and MMR" . SPARSER::COLLECTION)
    ("MLH1, MSH2, MLH3, MLH6 and PMS2" . SPARSER::COLLECTION)
    ("MLH" . SPARSER::PROTEIN) ("normal guanine" . SPARSER::PROTEIN)
    ("carboxamide" . SPARSER::MOLECULE) ("MTIC" . SPARSER::DRUG)
    ("Temozolomide (TMZ)" . SPARSER::DRUG)
    ("a second-generation imidazotetrazine lipophilic prodrug" . SPARSER::DRUG)
    ("prodrug" . SPARSER::DRUG)
    ("P-glycoprotein and CD133" . SPARSER::COLLECTION)
    ("the MGMT promoter and O(6)-benzylguanine" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN) ("CD 133" . SPARSER::PROTEIN)
    ("MSH3" . SPARSER::PROTEIN) ("triton X-100" . SPARSER::MOLECULE)
    ("P-gp" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("MLH3" . SPARSER::PROTEIN) ("O6" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN)
    ("53BP1, DNA-PK or HDAC" . SPARSER::COLLECTION)
    ("53BP1, RIF1, RAP80 and pDNA-PK" . SPARSER::COLLECTION)
    ("MRE11, CtIP and RAD51" . SPARSER::COLLECTION)
    ("FANCA- or FANCD2-siRNA-depleted" . SPARSER::COLLECTION)
    ("FA-C and FA-D2" . SPARSER::COLLECTION)
    ("the Fancd2-single mutant" . SPARSER::MUTANT)
    ("at least two proteins" . SPARSER::PROTEIN)
    ("CtIP and TIP60" . SPARSER::COLLECTION)
    ("chromatin and H4K16" . SPARSER::COLLECTION) ("FANCC-" . SPARSER::PROTEIN)
    ("FANCA-" . SPARSER::PROTEIN) ("TIP60 and FANCD2" . SPARSER::COLLECTION)
    ("broken DNA" . SPARSER::DNA)
    ("chromatin-associated subnuclear foci" . SPARSER::PROTEIN)
    ("targets, and deacetylases (HDAC)" . SPARSER::COLLECTION)
    ("targets, and deacetylases" . SPARSER::COLLECTION)
    ("FANCA or FANCD2" . SPARSER::COLLECTION)
    ("S3A and S3B" . SPARSER::COLLECTION)
    ("S3A, S3B and S3C" . SPARSER::COLLECTION) ("pDNA" . SPARSER::PROTEIN)
    ("HR and c-NHEJ" . SPARSER::COLLECTION)
    ("the RAP80/BRCA1 complex instead of the CtIP/BRCA1 complex"
     . SPARSER::COLLECTION)
    ("CtIP/BRCA1" . SPARSER::COLLECTION) ("RAP80/BRCA1" . SPARSER::COLLECTION)
    ("still monoubiquitinable FANCD2" . SPARSER::PROTEIN)
    ("a wt (PD-20corr) or a non-monoubiquitinable (PD20KR)"
     . SPARSER::COLLECTION)
    ("KR" . SPARSER::PROTEIN-FAMILY) ("BRCA1/CtIP" . SPARSER::COLLECTION)
    ("BRCA1/RAP80" . SPARSER::COLLECTION) ("HR, or CtIP" . SPARSER::COLLECTION)
    ("BACH1/FANCJ" . SPARSER::COLLECTION)
    ("MMC, RAP80 and 53BP1" . SPARSER::COLLECTION)
    ("53BP1 and RAP80" . SPARSER::COLLECTION)
    ("53BP1 or RAP80" . SPARSER::COLLECTION)
    ("53BP1, RAP80 and RIF1" . SPARSER::COLLECTION)
    ("S1B and S1C" . SPARSER::COLLECTION)
    ("RIF1 and pDNA-PKcs subnuclear foci" . SPARSER::COLLECTION)
    ("pDNA-PKcs subnuclear foci" . SPARSER::PROTEIN)
    ("pDNA-PKcs" . SPARSER::COLLECTION)
    ("PKcs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("γH2AX and MDC1" . SPARSER::COLLECTION)
    ("MRE11, FANCD2 and RAD51" . SPARSER::COLLECTION)
    ("the classical ICL-inducing agent MMC" . SPARSER::PROTEIN)
    ("γH2AX, MRE11, MDC1, FANCD2 and RAD51" . SPARSER::COLLECTION)
    ("anti-HR and pro-NHEJ" . SPARSER::COLLECTION)
    ("FANCS/BRCA1" . SPARSER::COLLECTION) ("FANCQ/XPF" . SPARSER::COLLECTION)
    ("FANCO/RAD51C" . SPARSER::COLLECTION)
    ("FANCN/PALB2" . SPARSER::COLLECTION) ("FANCJ/BRIP1" . SPARSER::COLLECTION)
    ("FANCD1/BRCA2" . SPARSER::COLLECTION) ("FANCS" . SPARSER::PROTEIN-FAMILY)
    ("FANCQ" . SPARSER::PROTEIN) ("FANCP" . SPARSER::PROTEIN)
    ("FANCO" . SPARSER::PROTEIN) ("FANCN" . SPARSER::PROTEIN)
    ("FANCJ" . SPARSER::PROTEIN) ("Ub-FANCI" . SPARSER::COLLECTION)
    ("Ub-FANCD2" . SPARSER::COLLECTION)
    ("mitomycin C (MMC) and cisplatin" . SPARSER::COLLECTION)
    ("exogenous anti-cancer chemotherapeutic drugs" . SPARSER::DRUG)
    ("endogenous cellular metabolites" . SPARSER::PROTEIN)
    ("MMC" . SPARSER::PROTEIN) ("malondialdehyde" . SPARSER::MOLECULE)
    ("stalled replication fork-associated DNA" . SPARSER::DNA)
    ("53BP1, RIF1 and RAP80" . SPARSER::COLLECTION)
    ("subnuclear foci" . SPARSER::PROTEIN) ("FA-D2" . SPARSER::PROTEIN)
    ("FA-C" . SPARSER::PROTEIN) ("KU80" . SPARSER::PROTEIN)
    ("S3B" . SPARSER::PROTEIN) ("Histone H4" . SPARSER::PROTEIN)
    ("BACH1" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("Mitomycin C" . SPARSER::DRUG)
    ("Fanconi anemia complementation group C" . SPARSER::PROTEIN)
    ("RAD51C" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("RIF1" . SPARSER::PROTEIN)
    ("cross-complementing (XRCC)" . SPARSER::PROTEIN)
    ("XRCC1, and XRCC3" . SPARSER::COLLECTION)
    ("XRCC1 and XRCC3" . SPARSER::COLLECTION)
    ("XRCC1 or XRCC3" . SPARSER::COLLECTION)
    ("XRCC1 (rs25487) and XRCC3 (rs861539)" . SPARSER::COLLECTION)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("XRCC3" . SPARSER::PROTEIN)
    ("x-ray repair" . SPARSER::PROTEIN) ("ROS and ER" . SPARSER::COLLECTION)
    ("curcumin and quercetin" . SPARSER::COLLECTION)
    ("porphyrins" . SPARSER::MOLECULE)
    ("NAC, GSH, and DTT" . SPARSER::COLLECTION)
    ("cysteines" . SPARSER::AMINO-ACID) ("reductant" . SPARSER::MOLECULE)
    ("protein or Keap1" . SPARSER::COLLECTION) ("arsenite" . SPARSER::DRUG)
    ("BiP and PDI" . SPARSER::COLLECTION) ("BiP" . SPARSER::PROTEIN)
    ("calnexin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the exogenous H 2 O 2" . SPARSER::DRUG)
    ("a likely chemico-biological trigger" . SPARSER::PROTEIN)
    ("LMB" . SPARSER::MOLECULE) ("Nrf2 or Bach1" . SPARSER::COLLECTION)
    ("anti-Nrf2 and anti-Bach1" . SPARSER::COLLECTION)
    ("Abs" . SPARSER::PROTEIN) ("Nrf2 and Bach1" . SPARSER::COLLECTION)
    ("GSH and DTT" . SPARSER::COLLECTION) ("Trolox" . SPARSER::MOLECULE)
    ("vit" . SPARSER::PROTEIN)
    ("rotenone (a mitochondrial ROS inhibitor) and apocynin (a NADPH oxidase inhibitor)"
     . SPARSER::COLLECTION)
    ("apocynin" . SPARSER::MOLECULE)
    ("steroidal dexamethasone" . SPARSER::PROTEIN)
    ("diphenyleneiodonium" . SPARSER::DRUG)
    ("MAPKK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Polymyxin" . SPARSER::MOLECULE)
    ("polymyxin" . SPARSER::MOLECULE) ("endotoxin" . SPARSER::MOLECULE)
    ("Gold" . SPARSER::MOLECULE)
    ("Nrf2, NF-κB, and AP-1" . SPARSER::COLLECTION)
    ("prooxidant" . SPARSER::MOLECULE)
    ("iron, and carbon monoxide (CO)" . SPARSER::COLLECTION)
    ("iron, and carbon monoxide" . SPARSER::COLLECTION)
    ("protein and Bach1" . SPARSER::COLLECTION)
    ("N-acetylcysteine and glutathione" . SPARSER::COLLECTION)
    ("thiol" . SPARSER::MOLECULE) ("nanoparticles" . SPARSER::MOLECULE)
    ("S-S" . SPARSER::PROTEIN) ("cullin-3" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("CM-H" . SPARSER::MOLECULE) ("Leptomycin B" . SPARSER::MOLECULE)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tert -butylhydroquinone" . SPARSER::DRUG)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("BTB and CNC homolog 1" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("HO-2" . SPARSER::PROTEIN) ("NQO2" . SPARSER::PROTEIN)
    ("NAD(P) H" . SPARSER::MOLECULE)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("Bach1" . SPARSER::PROTEIN) ("VEGF-A and TGF-β 1" . SPARSER::COLLECTION)
    ("Smad 2 and Smad 3" . SPARSER::COLLECTION) ("SARA" . SPARSER::PROTEIN)
    ("TNF-α, IFN-γ, and IL-2" . SPARSER::COLLECTION)
    ("IL-1β, TNF-α, IL-6, and GM-CSF" . SPARSER::COLLECTION)
    ("TGF-β1, Smad 2, and VEGF-A" . SPARSER::COLLECTION)
    ("TGF-β 1 and VEGF-A" . SPARSER::COLLECTION)
    ("polymorphic variants" . SPARSER::VARIANT)
    ("polymorphic alleles" . SPARSER::ALLELE)
    ("receptor and JNK" . SPARSER::COLLECTION)
    ("ING" . SPARSER::PROTEIN-FAMILY) ("VEGFRs" . SPARSER::PROTEIN)
    ("TGFβ and TGFβ" . SPARSER::COLLECTION)
    ("SMADs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the progressive and fibrotic form" . SPARSER::FORM)
    ("a reliable biomarker" . SPARSER::MOLECULE)
    ("TGF-β 1 , and Smad 2" . SPARSER::COLLECTION) ("LFT" . SPARSER::PROTEIN)
    ("BAL" . SPARSER::PROTEIN) ("TGF-β/Smad" . SPARSER::COLLECTION)
    ("Smad anchor for receptor activation" . SPARSER::PROTEIN)
    ("Vascular Endothelial Growth Factor A" . SPARSER::PROTEIN)
    ("Mothers Against Decapentaplegic Homolog 7" . SPARSER::PROTEIN)
    ("Mothers Against Decapentaplegic Homolog 3" . SPARSER::PROTEIN)
    ("Mothers Against Decapentaplegic Homolog 2" . SPARSER::PROTEIN)
    ("Smad 7" . SPARSER::PROTEIN) ("Smad 3" . SPARSER::PROTEIN)
    ("TGF-β 2" . SPARSER::PROTEIN) ("TGF-β 3" . SPARSER::PROTEIN)
    ("Smad 2" . SPARSER::PROTEIN) ("TGF-β 1" . SPARSER::PROTEIN)
    ("ipilimumab and nivolumab" . SPARSER::COLLECTION)
    ("dacarbazine" . SPARSER::DRUG) ("nivolumab" . SPARSER::DRUG)
    ("ipilimumab" . SPARSER::DRUG) ("CDKN2A and PTEN" . SPARSER::COLLECTION)
    ("ceritinib" . SPARSER::DRUG)
    ("severe combined immunodeficiency (SCID)" . SPARSER::PROTEIN)
    ("ALK  ATI , negative controls ( ALK  ATI-KD and empty vector), and positive controls (oncogenic ALK variants ALK  F1174L , EML4–ALK , and wild type)"
     . SPARSER::COLLECTION)
    ("the HA–ALK ATI and vice versa" . SPARSER::COLLECTION)
    ("HA–ALK" . SPARSER::COLLECTION) ("ATI-KD" . SPARSER::COLLECTION)
    ("methionine" . SPARSER::AMINO-ACID) ("each mutated form" . SPARSER::FORM)
    ("EML4–ALK" . SPARSER::COLLECTION) ("ATGs" . SPARSER::DRUG)
    ("RNA-" . SPARSER::RNA) ("DNA-" . SPARSER::DNA)
    ("only ALK  ATI" . SPARSER::PROTEIN) ("-RACE" . SPARSER::COLLECTION)
    ("RACE" . SPARSER::PROTEIN) ("a northern blot" . SPARSER::PROTEIN)
    ("ATI" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("SHP-2" . SPARSER::PROTEIN)
    ("PRAS40" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("p44/42" . SPARSER::PROTEIN) ("ALK 1" . SPARSER::PROTEIN)
    ("Tyrosine Kinase" . SPARSER::PROTEIN) ("nV5" . SPARSER::PROTEIN)
    ("12- O -tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("RPL27" . SPARSER::PROTEIN) ("RPS13" . SPARSER::PROTEIN)
    ("MACS 1" . SPARSER::PROTEIN) ("chr2" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ASA" . SPARSER::PROTEIN) ("growth restrictive RPS7 gene" . SPARSER::GENE)
    ("many viral oncoproteins" . SPARSER::PROTEIN)
    ("genes and warrants" . SPARSER::COLLECTION)
    ("merely added another viral oncoprotein" . SPARSER::PROTEIN)
    ("HBV-associated HCC" . SPARSER::PROTEIN)
    ("another ribosomal gene RPS7" . SPARSER::PROTEIN)
    ("RPS27a" . SPARSER::PROTEIN) ("the viral protein" . SPARSER::PROTEIN)
    ("p300 and CBP" . SPARSER::COLLECTION) ("paralogue" . SPARSER::PROTEIN)
    ("SIRT7 and DUB" . SPARSER::COLLECTION)
    ("SIRT7 and this DUB" . SPARSER::COLLECTION)
    ("ubiquitinases" . SPARSER::UBIQUITINASE)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("viral oncoprotein HBx" . SPARSER::PROTEIN)
    ("HBx and RPS7" . SPARSER::COLLECTION)
    ("a viral oncoprotein" . SPARSER::PROTEIN)
    ("shRNA and SIRT7" . SPARSER::COLLECTION)
    ("histone-acetyltransferases" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION) ("Viral HBx" . SPARSER::PROTEIN)
    ("ribosomal gene RPS7" . SPARSER::PROTEIN)
    ("SIRT7 and HBx" . SPARSER::COLLECTION) ("cellular DUB" . SPARSER::PROTEIN)
    ("DUB" . SPARSER::PROTEIN) ("DUBs" . SPARSER::PROTEIN)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("intense SIRT7" . SPARSER::PROTEIN) ("Complementing" . SPARSER::PROTEIN)
    ("IHH" . SPARSER::PROTEIN) ("viral HBx" . SPARSER::PROTEIN)
    ("HBx and SIRT7" . SPARSER::COLLECTION)
    ("a viral oncoprotein HBx" . SPARSER::PROTEIN)
    ("acetylase" . SPARSER::PROTEIN)
    ("adenoviral E1A oncoprotein and SV 40 large T antigen"
     . SPARSER::COLLECTION)
    ("adenoviral E1A oncoprotein" . SPARSER::PROTEIN)
    ("a highly selective NAD + -dependent H3K18ac deacetylase activity and selectively targets genes"
     . SPARSER::COLLECTION)
    ("selectively targets genes" . SPARSER::GENE)
    ("RPS7-Mdm2" . SPARSER::COLLECTION) ("p53-Mdm2" . SPARSER::COLLECTION)
    ("Ribosomal proteins" . SPARSER::PROTEIN) ("RPs" . SPARSER::PROTEIN)
    ("growth restrictive ribosomal protein RPS7" . SPARSER::PROTEIN)
    ("HBx-SIRT7" . SPARSER::COLLECTION)
    ("SIRT7 and RPS7" . SPARSER::COLLECTION)
    ("SIRT7 and H3K18ac" . SPARSER::COLLECTION)
    ("lithium chloride" . SPARSER::DRUG) ("RPS27" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("USP37" . SPARSER::PROTEIN)
    ("ribosomal protein S7" . SPARSER::PROTEIN)
    ("Ribosomal protein S7" . SPARSER::PROTEIN) ("RPS7" . SPARSER::PROTEIN)
    ("K18" . SPARSER::PROTEIN) ("pro and anti-oncogenic" . SPARSER::COLLECTION)
    ("complete media (CM)" . SPARSER::PROTEIN)
    ("NC and miR-212 inhibitor (Figure xref )" . SPARSER::COLLECTION)
    ("NC or anti-miR-212" . SPARSER::COLLECTION) ("EBM" . SPARSER::PROTEIN)
    ("both complete media" . SPARSER::PROTEIN) ("SFM" . SPARSER::PROTEIN)
    ("SIRT1, LC3B-I/II and GAPDH" . SPARSER::COLLECTION)
    ("LC3B-I/II" . SPARSER::PROTEIN-PAIR) ("media (SFM)" . SPARSER::PROTEIN)
    ("the NC and miR-212 inhibitor" . SPARSER::COLLECTION)
    ("tumor suppressor gene, SMAD2, FOXA1 and SGK3" . SPARSER::COLLECTION)
    ("mature miRNAs" . SPARSER::PROTEIN)
    ("differentially expressed miRNAs" . SPARSER::PROTEIN)
    ("highly stable noncoding small ∼22nt gene-regulatory RNAs" . SPARSER::RNA)
    ("these essential components" . SPARSER::COMPONENT)
    ("Atg5, Atg7, and Atg8" . SPARSER::COLLECTION) ("Atg7" . SPARSER::PROTEIN)
    ("an essential negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("Androgen Receptor (AR) and cell cycle proteins" . SPARSER::COLLECTION)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("clinically robust biomarkers" . SPARSER::MOLECULE)
    ("SIRT-1" . SPARSER::PROTEIN) ("SGK3" . SPARSER::PROTEIN)
    ("Lin28B" . SPARSER::PROTEIN) ("Androgen Receptor" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("sirtuin 1" . SPARSER::PROTEIN)
    ("E2, p53 and miR-23a" . SPARSER::COLLECTION)
    ("p53 and caspase-3/7" . SPARSER::COLLECTION)
    ("p53 target genes and cell death in HCC cells [ xref ]"
     . SPARSER::COLLECTION)
    ("even one allele" . SPARSER::ALLELE) ("p53 and ERα" . SPARSER::COLLECTION)
    ("E2 and p53" . SPARSER::COLLECTION)
    ("a functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("these tumor suppressive miRNAs and oncomirs" . SPARSER::COLLECTION)
    ("miRNAs and oncomirs" . SPARSER::COLLECTION)
    ("the tumor suppressive miRNAs" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("FITC and PI" . SPARSER::COLLECTION)
    ("E2 and miR-23a" . SPARSER::COLLECTION)
    ("E2 ( p < 0.0001) and miR-23a mimic ( p < 0.01)" . SPARSER::COLLECTION)
    ("Neither E2 nor miR-23a" . SPARSER::COLLECTION)
    ("miR-23a and XIAP" . SPARSER::COLLECTION)
    ("siRNA-ERα" . SPARSER::COLLECTION) ("ERα and p53" . SPARSER::COLLECTION)
    ("DOX" . SPARSER::PROTEIN) ("doxorubicin (DOX)" . SPARSER::PROTEIN)
    ("the 84 apoptotic miRNAs" . SPARSER::PROTEIN)
    ("p53 and miR-23a" . SPARSER::COLLECTION)
    ("miR-23a and p53" . SPARSER::COLLECTION)
    ("10 downregulated apoptotic miRNAs" . SPARSER::PROTEIN)
    ("doxorubicin hydrochloride" . SPARSER::DRUG)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("32kD" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("Caspase-7" . SPARSER::PROTEIN)
    ("ICI 182,780" . SPARSER::DRUG) ("miR-23a" . SPARSER::MOLECULE)
    ("compensatory RTK" . SPARSER::PROTEIN) ("onartuzumab" . SPARSER::DRUG)
    ("the experimental arm" . SPARSER::PROTEIN)
    ("Erlotinib and Tivantinib" . SPARSER::COLLECTION)
    ("EGFR or MET" . SPARSER::COLLECTION) ("Tivantinib" . SPARSER::DRUG)
    ("proteins, EGFR and MET" . SPARSER::COLLECTION)
    ("expressed at least one RTK" . SPARSER::PROTEIN)
    ("MET and IGF-1R" . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION)
    ("EGFR and MET" . SPARSER::COLLECTION)
    ("MET and HER3" . SPARSER::COLLECTION)
    ("collaborative enzyme" . SPARSER::ENZYME)
    ("Gefitinib, erlotinib, and afatinib" . SPARSER::COLLECTION)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("significantly higher RR" . SPARSER::MOLECULE)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("erlotinib and afatinib" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("monoclonal antibodies and small molecule inhibitors"
     . SPARSER::COLLECTION)
    ("EGFR/MET" . SPARSER::COLLECTION)
    ("key receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGF1R" . SPARSER::PROTEIN) ("NFKB" . SPARSER::PROTEIN)
    ("SRC-NFKB" . SPARSER::PROTEIN-PAIR) ("Ras-ERK1/2" . SPARSER::COLLECTION)
    ("Chk1 and SRC" . SPARSER::COLLECTION)
    ("the dual SRC/ABL-inhibitor dasatinib" . SPARSER::DRUG)
    ("a clinically available drug" . SPARSER::DRUG)
    ("CDK4/6-cyclinD1" . SPARSER::COLLECTION)
    ("Wee1 and Chk1" . SPARSER::COLLECTION)
    ("Chk1 or Wee1" . SPARSER::COLLECTION)
    ("two chemotherapeutic drugs" . SPARSER::DRUG)
    ("the clinically available dual Src/Abl kinase inhibitor dasatinib"
     . SPARSER::DRUG)
    ("Src/Abl" . SPARSER::COLLECTION) ("FGR" . SPARSER::PROTEIN)
    ("SRC/MAPK" . SPARSER::COLLECTION) ("CDK4/6-cyclin" . SPARSER::COLLECTION)
    ("Cdt1 and cyclin" . SPARSER::COLLECTION) ("RM" . SPARSER::MOLECULE)
    ("bendamustine and bortezomib" . SPARSER::COLLECTION)
    ("bendamustine" . SPARSER::DRUG) ("BCRP" . SPARSER::PROTEIN)
    ("the last years Chk1 inhibitors" . SPARSER::INHIBITOR)
    ("gemcitabine, hydroxyurea, and cytarabine" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE) ("antimetabolites" . SPARSER::DRUG)
    ("p16INK4" . SPARSER::PROTEIN) ("Dasatinib" . SPARSER::DRUG)
    ("S-G2" . SPARSER::PROTEIN) ("Cis-platin" . SPARSER::DRUG)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("REC-1" . SPARSER::PROTEIN) ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MRP-1" . SPARSER::PROTEIN) ("MDR-1" . SPARSER::PROTEIN)
    ("PF-00477736" . SPARSER::DRUG) ("NF-κB/VEGF-C" . SPARSER::COLLECTION)
    ("RASSF2, RASSF4, RASSF5, and RASSF6" . SPARSER::COLLECTION)
    ("oncogenes or other factors" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("VEGF-C or VEGF-D" . SPARSER::COLLECTION)
    ("RASSF8-RNAi–transduced EC109" . SPARSER::PROTEIN)
    ("-AKT" . SPARSER::COLLECTION) ("EC109" . SPARSER::PROTEIN)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("EC109-RASSF8" . SPARSER::PROTEIN-PAIR)
    ("RASSF8 or RASSF8-RNAi" . SPARSER::COLLECTION)
    ("BALB/c-nu" . SPARSER::COLLECTION) ("hyaluronan" . SPARSER::PROTEIN)
    ("ANT" . SPARSER::PROTEIN)
    ("a powerful metastatic suppressor and a potential biomarker"
     . SPARSER::COLLECTION)
    ("Sav/RASSF/Hpo" . SPARSER::COLLECTION) ("RA" . SPARSER::PROTEIN)
    ("Hpo" . SPARSER::PROTEIN) ("family (RASSF)" . SPARSER::PROTEIN-FAMILY)
    ("VEGF-C/VEGFR-3" . SPARSER::COLLECTION)
    ("extracellular signal–regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lymphangiogenic regulators" . SPARSER::REGULATOR)
    ("VEGF-C and VEGF-D" . SPARSER::COLLECTION) ("LaminB1" . SPARSER::PROTEIN)
    ("Anti–" . SPARSER::ANTIBODY) ("anti–VEGF" . SPARSER::DRUG)
    ("LYVE-1" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("RASSF6" . SPARSER::PROTEIN) ("RASSF5" . SPARSER::PROTEIN)
    ("RASSF4" . SPARSER::PROTEIN) ("RASSF2" . SPARSER::PROTEIN)
    ("platelet-derived growth factor-BB" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("P65" . SPARSER::PROTEIN) ("c-nu" . SPARSER::PROTEIN)
    ("RASSF7" . SPARSER::PROTEIN) ("VEGFR-3" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGF-D" . SPARSER::PROTEIN) ("VEGF-C" . SPARSER::PROTEIN)
    ("RASSF8" . SPARSER::PROTEIN) ("family 8" . SPARSER::PROTEIN)
    ("osmotic stress resistance genes" . SPARSER::GENE)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("taurine and sorbitol" . SPARSER::COLLECTION)
    ("CSAD and AKR1B1" . SPARSER::COLLECTION) ("CSAD" . SPARSER::PROTEIN)
    ("sorbitol" . SPARSER::PROTEIN) ("taurine" . SPARSER::MOLECULE)
    ("Fnip1" . SPARSER::PROTEIN) ("paraquat" . SPARSER::MOLECULE)
    ("insoluble glycogen polymers" . SPARSER::MOLECULE)
    ("soluble glucose molecules" . SPARSER::MOLECULE)
    ("compatible osmolytes" . SPARSER::MOLECULE)
    ("Pax8-Cre" . SPARSER::COLLECTION)
    ("hyperosmotic stress glycogen" . SPARSER::PROTEIN)
    ("gpdh-1 or gpdh-2" . SPARSER::COLLECTION) ("atg" . SPARSER::DRUG)
    ("aak-2(ok524) triple mutant" . SPARSER::MUTANT)
    ("aak-1 and aak-2" . SPARSER::COLLECTION) ("pygl-1" . SPARSER::COLLECTION)
    ("gsy-1" . SPARSER::COLLECTION) ("wt, and NaCl" . SPARSER::COLLECTION)
    ("Glycogen" . SPARSER::PROTEIN)
    ("L4 ( xref ) flcn-1(ok975) mutant" . SPARSER::MUTANT)
    ("osm" . SPARSER::PROTEIN) ("wt and flcn-1" . SPARSER::COLLECTION)
    ("FLCN/AMPK" . SPARSER::COLLECTION)
    ("FNIP1 and FNIP2" . SPARSER::COLLECTION)
    ("several osmotic stress resistance mutants" . SPARSER::MUTANT)
    ("compatible organic osmolytes" . SPARSER::MOLECULE)
    ("Water" . SPARSER::MOLECULE) ("organic osmolytes" . SPARSER::MOLECULE)
    ("osmolytes" . SPARSER::MOLECULE) ("phosphorylase" . SPARSER::PROTEIN)
    ("the organic osmolyte glycerol" . SPARSER::PROTEIN)
    ("gpdh-1 and gpdh-2" . SPARSER::COLLECTION)
    ("osmolyte" . SPARSER::MOLECULE) ("flcn" . SPARSER::PROTEIN)
    ("-AMP-activated protein kinase (AMPK) and its negative regulator Folliculin (FLCN)"
     . SPARSER::COLLECTION)
    ("Folliculin (FLCN)" . SPARSER::PROTEIN)
    ("-AMP-activated" . SPARSER::COLLECTION) ("Folliculin" . SPARSER::PROTEIN)
    ("K 2" . SPARSER::PROTEIN) ("cdc-42" . SPARSER::PROTEIN)
    ("NFAT5" . SPARSER::PROTEIN) ("AKR1B1" . SPARSER::PROTEIN)
    ("5-Aminoimidazole-4-Carboxamide" . SPARSER::MOLECULE)
    ("Pax8" . SPARSER::PROTEIN) ("PMK-1" . SPARSER::PROTEIN)
    ("pmk-1" . SPARSER::PROTEIN) ("aak-1" . SPARSER::PROTEIN)
    ("aak-2" . SPARSER::PROTEIN) ("UDP-glucose" . SPARSER::MOLECULE)
    ("FNIP2" . SPARSER::PROTEIN) ("FNIP1" . SPARSER::PROTEIN)
    ("gpdh-1" . SPARSER::PROTEIN)
    ("glycerol-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("C . elegans)" . SPARSER::PROTEIN)
    ("the other seven polymorphic variants" . SPARSER::VARIANT)
    ("five polymorphic variants" . SPARSER::VARIANT)
    ("gene and gene" . SPARSER::COLLECTION) ("Fan" . SPARSER::PROTEIN)
    ("another seven polymorphic variants" . SPARSER::VARIANT)
    ("eight polymorphic variants of COX-2 and the HCC development risk"
     . SPARSER::COLLECTION)
    ("eight polymorphic variants" . SPARSER::VARIANT)
    ("COX-2 and HCC" . SPARSER::COLLECTION)
    ("angiogenic growth factors and tumour promoters" . SPARSER::COLLECTION)
    ("angiogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("new HCC" . SPARSER::PROTEIN) ("alcohol" . SPARSER::DRUG)
    ("the eight polymorphic variants" . SPARSER::VARIANT)
    ("microsomal epoxide hydrolase" . SPARSER::PROTEIN)
    ("Cyclo-oxygenase-2" . SPARSER::PROTEIN)
    ("cyclo-oxygenase-2" . SPARSER::PROTEIN)
    ("ATP7A and ATP7B" . SPARSER::COLLECTION) ("wt" . SPARSER::PROTEIN)
    ("CTR1 and SCO2" . SPARSER::COLLECTION) ("wt-p53" . SPARSER::COLLECTION)
    ("a copper-dependent enzyme" . SPARSER::ENZYME)
    ("wt p53 or the Y220C p53 mutant (Gori et al. xref )"
     . SPARSER::COLLECTION)
    ("fructose-2" . SPARSER::COLLECTION) ("TIGAR" . SPARSER::PROTEIN)
    ("MeS" . SPARSER::MOLECULE)
    ("SCO2 and Copper transporter" . SPARSER::COLLECTION)
    ("wt p53 and its Y220C mutant" . SPARSER::COLLECTION)
    ("FFAs" . SPARSER::PROTEIN) ("Oxidase" . SPARSER::PROTEIN)
    ("chelating agent" . SPARSER::MOLECULE)
    ("NAD-dependent deacetylase sirtuin-1" . SPARSER::PROTEIN)
    ("palmitic acids" . SPARSER::MOLECULE) ("I-19" . SPARSER::PROTEIN)
    ("ATP7B" . SPARSER::PROTEIN) ("ATP7A" . SPARSER::PROTEIN)
    ("phospho-protein" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("CTR1" . SPARSER::PROTEIN) ("SCO2" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN)
    ("HDAC2 and other HDACs" . SPARSER::COLLECTION)
    ("CD40, CD86 and c-Jun" . SPARSER::COLLECTION)
    ("arginase" . SPARSER::PROTEIN)
    ("c-Jun, NF-κB and Bcl-6" . SPARSER::COLLECTION)
    ("the most relevant anti-inflammatory HDACs" . SPARSER::PROTEIN)
    ("COPD/emphysema" . SPARSER::COLLECTION) ("LNAs" . SPARSER::PROTEIN)
    ("many immune-related genes" . SPARSER::GENE)
    ("cigarette smoke and smoke-derived nCB that is phagocytosed by diverse lung APCs"
     . SPARSER::COLLECTION)
    ("Il6 and Cd40" . SPARSER::COLLECTION) ("Cd40" . SPARSER::PROTEIN)
    ("IL-6 and IL-17A" . SPARSER::COLLECTION)
    ("severe emphysema" . SPARSER::PROTEIN)
    ("LPS and anti-CD40" . SPARSER::COLLECTION) ("-Cre" . SPARSER::COLLECTION)
    ("Cd11c" . SPARSER::PROTEIN) ("HDAC4 and emphysema" . SPARSER::COLLECTION)
    ("HDAC4 or Hdac4" . SPARSER::COLLECTION)
    ("mRNA and HDAC4" . SPARSER::COLLECTION) ("LNA" . SPARSER::PROTEIN)
    ("Acvr2b" . SPARSER::PROTEIN) ("Hdac4" . SPARSER::PROTEIN)
    ("the critical miR-22-dependent genes" . SPARSER::GENE)
    ("MAP kinases, MEK1, p38α, Erk1/2 and Jnk" . SPARSER::COLLECTION)
    ("RPPA" . SPARSER::PROTEIN) ("NF-κB2" . SPARSER::PROTEIN)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("cytokine and co-stimulatory" . SPARSER::COLLECTION)
    ("IL-6 and co-stimulatory" . SPARSER::COLLECTION)
    ("Il1b, Il6, Il23a and Cd86" . SPARSER::COLLECTION)
    ("LPS-" . SPARSER::PROTEIN) ("Cd86" . SPARSER::PROTEIN)
    ("Il23a" . SPARSER::PROTEIN) ("Il6" . SPARSER::PROTEIN)
    ("Il1b" . SPARSER::PROTEIN)
    ("miR-22–sufficient control APCs" . SPARSER::PROTEIN)
    ("LPS or agonistic CD40 antibody" . SPARSER::COLLECTION)
    ("agonistic CD40 antibody" . SPARSER::ANTIBODY)
    ("CD86 and CD40" . SPARSER::COLLECTION)
    ("MMP13 and MMP14" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN) ("ciglitazone" . SPARSER::DRUG)
    ("NF-κB and related genes" . SPARSER::COLLECTION)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("AP-1 or NF-κB" . SPARSER::COLLECTION)
    ("Jnk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CSK" . SPARSER::PROTEIN)
    ("CD11c-Cre" . SPARSER::COLLECTION)
    ("significantly less IL-1β" . SPARSER::PROTEIN)
    ("MMP9 and MMP2" . SPARSER::COLLECTION)
    ("an insoluble substance" . SPARSER::SUBSTANCE)
    ("substance" . SPARSER::SUBSTANCE) ("Cigarette" . SPARSER::DRUG)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("experimental emphysema" . SPARSER::PROTEIN)
    ("DCs and expression of pulmonary emphysema resulting"
     . SPARSER::COLLECTION)
    ("pulmonary emphysema" . SPARSER::PROTEIN) ("DCs" . SPARSER::MOLECULE)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX) ("RISC" . SPARSER::PROTEIN)
    ("argonaute" . SPARSER::PROTEIN-FAMILY)
    ("IL-6 and osteopontin" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN)
    ("Interferon-γ (IFN-γ) and interleukin 17A (IL-17A)" . SPARSER::COLLECTION)
    ("neutrophils and macrophages" . SPARSER::COLLECTION)
    ("Interferon-γ" . SPARSER::PROTEIN) ("elastases" . SPARSER::PROTEIN)
    ("Elastin" . SPARSER::PROTEIN) ("Emphysema" . SPARSER::PROTEIN)
    ("Pulmonary emphysema" . SPARSER::PROTEIN) ("COPD" . SPARSER::PROTEIN)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("mDCs" . SPARSER::PROTEIN) ("MiR" . SPARSER::PROTEIN)
    ("beta-mercaptoethanol" . SPARSER::MOLECULE) ("18H" . SPARSER::PROTEIN)
    ("IL17A" . SPARSER::PROTEIN) ("tert -Butyl" . SPARSER::MOLECULE)
    ("c-2" . SPARSER::PROTEIN) ("IL-5" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("P100" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("Il23" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP14" . SPARSER::PROTEIN) ("CCL8" . SPARSER::PROTEIN)
    ("pri-miRNA" . SPARSER::RNA) ("MIP-1β" . SPARSER::PROTEIN)
    ("MIP-1" . SPARSER::PROTEIN) ("histone deacetylase 4" . SPARSER::PROTEIN)
    ("peroxisome proliferator activated receptor gamma" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("CD1a" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN) ("interleukin 17A" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("RNAs and further biological material" . SPARSER::COLLECTION)
    ("c-Met and vascular endothelial growth factor receptor 2"
     . SPARSER::COLLECTION)
    ("Erk/MAP kinase" . SPARSER::COLLECTION)
    ("p44/42-MAP kinase" . SPARSER::PROTEIN-PAIR)
    ("VEGF and VCAM-1" . SPARSER::COLLECTION)
    ("hepatocyte growth factor/scatter factor receptor" . SPARSER::COLLECTION)
    ("hematoxylin/eosin (HE)" . SPARSER::MOLECULE)
    ("140kDa" . SPARSER::PROTEIN)
    ("crizotinib and foretinib" . SPARSER::COLLECTION)
    ("p44/p42" . SPARSER::COLLECTION)
    ("2.5 μM crizotinib and 1.25 μM foretinib" . SPARSER::COLLECTION)
    ("the mesenchymal intermediate filament vimentin" . SPARSER::PROTEIN)
    ("CD326/EpCAM" . SPARSER::COLLECTION)
    ("VCAM-1 and VEGF" . SPARSER::COLLECTION)
    ("ICAM-1, PDGF-BB and TNF-α" . SPARSER::COLLECTION)
    ("HGF and the related receptor c-Met" . SPARSER::COLLECTION)
    ("the SMARCA4 gene and the related SMARCB1 gene" . SPARSER::COLLECTION)
    ("SCCOHT" . TYPE) ("the hypercalcemic type (SCCOHT)" . TYPE)
    ("KRAS, BRAF, ERBB2, PTEN, CTNNB1, and PIK3CA" . SPARSER::COLLECTION)
    ("foretinib" . SPARSER::DRUG) ("BIN" . SPARSER::PROTEIN)
    ("chemokine and growth factor" . SPARSER::COLLECTION)
    ("SCCOHT-1" . SPARSER::COLLECTION) ("DNA 2" . SPARSER::PROTEIN)
    ("PF-02341066" . SPARSER::DRUG) ("GSK1363089" . SPARSER::DRUG)
    ("D11" . SPARSER::PROTEIN) ("CC1" . SPARSER::PROTEIN)
    ("C-11" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("CXCL8" . SPARSER::PROTEIN)
    ("scatter factor receptor" . SPARSER::PROTEIN)
    ("HGF receptor" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("C-Met" . SPARSER::PROTEIN) ("CD326" . SPARSER::PROTEIN)
    ("epithelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("beta-1" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN) ("PDGF-BB" . SPARSER::PROTEIN)
    ("SMARCB1" . SPARSER::PROTEIN) ("BRG1 protein" . SPARSER::PROTEIN)
    ("SMARCA4" . SPARSER::PROTEIN) ("G2 accumulation" . SPARSER::PROTEIN)
    ("only histone proteins" . SPARSER::PROTEIN)
    ("wild-type p21 and R156A mutant p21" . SPARSER::COLLECTION)
    ("p21 or R156A-mutant" . SPARSER::COLLECTION)
    ("HA-PRMT6" . SPARSER::COLLECTION) ("p21 and PRMT6" . SPARSER::COLLECTION)
    ("lysine and arginine" . SPARSER::COLLECTION)
    ("CRL4 CDT2 (CUL4A or CUL4B-DDB1-CDT2) and APC/C CDC20"
     . SPARSER::COLLECTION)
    ("CUL4B-DDB1-CDT2" . SPARSER::COLLECTION)
    ("SKP1-CUL1-SKP2" . SPARSER::COLLECTION)
    ("ASK1 and JNK" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("- 3" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("p21 proteins" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("Tip 60" . SPARSER::PROTEIN) ("DDB1" . SPARSER::PROTEIN)
    ("CUL4B" . SPARSER::PROTEIN) ("CUL4A" . SPARSER::PROTEIN)
    ("CDT2" . SPARSER::PROTEIN) ("CRL4" . SPARSER::PROTEIN)
    ("CUL1" . SPARSER::PROTEIN) ("SKP1" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN)
    ("Proliferating Cell Nuclear Antigen" . SPARSER::PROTEIN)
    ("PRMT6" . SPARSER::PROTEIN)
    ("protein arginine methyltransferase 6" . SPARSER::PROTEIN)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least 10–30% mutant DNA" . SPARSER::DNA) ("HCCs" . SPARSER::PROTEIN)
    ("AFP, HBsAg, TP53, Ki-67, and EGFR" . SPARSER::COLLECTION)
    ("TP53 as well as Ki-67" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib, and afatinib" . SPARSER::COLLECTION)
    ("a 170 kDa transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Raf-1, B-Raf, VEGFR2, PDGFR, and c-Kit" . SPARSER::COLLECTION)
    ("AFP, HBsAg, TP53, and Ki-67" . SPARSER::COLLECTION)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("Epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("Tumor protein p53" . SPARSER::PROTEIN)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("TGF- α" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN)
    ("ESR1 [ xref , xref ] or different genes or gene regulators"
     . SPARSER::COLLECTION)
    ("systemic lupus erythematosus (SLE)" . SPARSER::PROTEIN)
    ("ESRs" . SPARSER::PROTEIN) ("excessive estrogen" . SPARSER::MOLECULE)
    ("D-L" . SPARSER::PROTEIN) ("M-H" . SPARSER::PROTEIN)
    ("Ex2" . SPARSER::PROTEIN) ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("the no bony metastasis group" . SPARSER::MOLECULE)
    ("the bony metastasis group" . SPARSER::MOLECULE)
    ("group, and HSP27" . SPARSER::COLLECTION)
    ("the pro-inflammatory mediators IL-6 and IL-8" . SPARSER::COLLECTION)
    ("HSP110, HSP90, HSP70, HSP60, HSP27, and ubiquitin" . SPARSER::COLLECTION)
    ("HSP27, TNF-α, and IL-6" . SPARSER::COLLECTION)
    ("HSP27, TNF-α and IL-6" . SPARSER::COLLECTION)
    ("HSP27 and TNF-α, IL-6, and CD3" . SPARSER::COLLECTION)
    ("the NI BPH group and inflammatory BPH group" . SPARSER::COLLECTION)
    ("HSP27 and TNF-α" . SPARSER::COLLECTION)
    ("TNF-α, IL-6 and CD3" . SPARSER::COLLECTION)
    ("HSP27 and inflammatory cytokines TNF-α" . SPARSER::COLLECTION)
    ("HSP27, TNF-α, IL-6 and CD3" . SPARSER::COLLECTION)
    ("PSA, and CRP" . SPARSER::COLLECTION)
    ("PSA and CRP" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("TNF-α, IL-6, and CD3" . SPARSER::COLLECTION)
    ("TNF-α, IL-6, CD3 and HSP27" . SPARSER::COLLECTION)
    ("HSP 27, TNF-α, IL-6, and CD3" . SPARSER::COLLECTION)
    ("HSPB1" . SPARSER::PROTEIN) ("HSP110" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("HSP60" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("the previously reported c" . SPARSER::PROTEIN)
    ("the previously reported family" . SPARSER::PROTEIN-FAMILY)
    ("highly penetrant susceptibility genes" . SPARSER::GENE)
    ("POT1 , TERT, ACD and TERF2IP" . SPARSER::COLLECTION)
    ("ACD and TERF2IP" . SPARSER::COLLECTION) ("shelterin" . SPARSER::PROTEIN)
    ("p16 and p14ARF" . SPARSER::COLLECTION)
    ("POT1 and TERT" . SPARSER::COLLECTION) ("UK" . SPARSER::PROTEIN)
    ("CDK4 , BAP1 , and genes" . SPARSER::COLLECTION)
    ("ACD" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("protection of telomeres 1" . SPARSER::PROTEIN)
    ("BRCA1 associated protein 1" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("POT1" . SPARSER::PROTEIN) ("TERF2IP" . SPARSER::PROTEIN)
    ("BAP1" . SPARSER::PROTEIN) ("FAT and kinase" . SPARSER::COLLECTION)
    ("p70S6K, S6RP, and 4EBP1" . SPARSER::COLLECTION)
    ("caspase 3/caspase 7" . SPARSER::COLLECTION)
    ("abnormal foci" . SPARSER::PROTEIN) ("malignant foci" . SPARSER::PROTEIN)
    ("RP" . SPARSER::PROTEIN)
    ("mTOR(L2220F) and mTOR(D2512H)" . SPARSER::COLLECTION)
    ("a bona fide oncoprotein" . SPARSER::PROTEIN)
    ("AKT1 and AKT3" . SPARSER::COLLECTION)
    ("a serine–threonine kinase and a component" . SPARSER::COLLECTION)
    ("kinase, and FATC" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("FATC" . SPARSER::PROTEIN-FAMILY) ("lobe" . SPARSER::PROTEIN)
    ("FAT" . SPARSER::PROTEIN) ("TRRAP" . SPARSER::PROTEIN)
    ("p70 S6 kinase, S6 ribosomal protein, and eukaryotic translation initiation factor 4E–binding protein 1 in these cells"
     . SPARSER::COLLECTION)
    ("serine–threonine" . SPARSER::COLLECTION) ("PI3K–AKT" . SPARSER::PROTEIN)
    ("Glo 3" . SPARSER::PROTEIN) ("caspase 7" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E binding protein 1"
     . SPARSER::PROTEIN)
    ("FK506" . SPARSER::DRUG)
    ("regulatory associated protein of mTOR" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("MMP and VEGF" . SPARSER::COLLECTION)
    ("MMP9 and VEGFA" . SPARSER::COLLECTION) ("VEGFA" . SPARSER::PROTEIN)
    ("the local vasculature" . SPARSER::PROTEIN)
    ("TCF3 and LEF1" . SPARSER::COLLECTION)
    ("ESR1/β-catenin" . SPARSER::COLLECTION)
    ("implanted endometrial fragments" . SPARSER::FRAGMENT)
    ("β-catenin and ESR1" . SPARSER::COLLECTION)
    ("no visible endometrial fragments" . SPARSER::FRAGMENT)
    ("No visible endometrial fragments" . SPARSER::FRAGMENT)
    ("MMP9 (∼3.5-fold) and VEGF (∼4.2-fold)" . SPARSER::COLLECTION)
    ("VEGF and MMP9" . SPARSER::COLLECTION)
    ("MMP9 and VEGF" . SPARSER::COLLECTION)
    ("ESR1 and LEF1/TCF3" . SPARSER::COLLECTION)
    ("LEF1/TCF3" . SPARSER::COLLECTION)
    ("ESR1, TCF3, and LEF1" . SPARSER::COLLECTION)
    ("ESR1/TCF3/LEF1" . SPARSER::COLLECTION)
    ("β-catenin/TCF3/LEF1" . SPARSER::COLLECTION)
    ("TCF3/LEF1" . SPARSER::COLLECTION)
    ("ESR1 and β-catenin" . SPARSER::COLLECTION)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("E 2 and β-catenin" . SPARSER::COLLECTION)
    ("estrogen and β-catenin" . SPARSER::COLLECTION)
    ("the multifunctional serine/threonine kinase glycogen synthase kinase"
     . SPARSER::KINASE)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY) ("estrogens" . SPARSER::MOLECULE)
    ("ESR1, β-catenin, and lymphoid" . SPARSER::COLLECTION)
    ("ESR" . SPARSER::PROTEIN)
    ("estrogen and beta-catenin" . SPARSER::COLLECTION)
    ("–3 " . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("Beta-catenin" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("E 2" . SPARSER::MOLECULE) ("17β-estradiol" . SPARSER::PROTEIN)
    ("PI3K/PTEN/Akt" . SPARSER::COLLECTION)
    ("Ras/Raf/EK/ERK" . SPARSER::COLLECTION) ("Flt–3" . SPARSER::COLLECTION)
    ("EK" . SPARSER::PROTEIN) ("PD98059 and LY294002" . SPARSER::COLLECTION)
    ("PI3K/SGK" . SPARSER::COLLECTION) ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK1/2" . SPARSER::COLLECTION)
    ("MAPK and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("Pten and Tsc1" . SPARSER::COLLECTION)
    ("PI3K, JNK and ERK" . SPARSER::COLLECTION)
    ("p-P70 S6K-protein" . SPARSER::COLLECTION)
    ("mTOR and its downstream effector p70S6K" . SPARSER::COLLECTION)
    ("the mammalian target of rapamycin (mTOR) and its effector p70 S6 kinase (p70 S6K )"
     . SPARSER::COLLECTION)
    ("eIF4 and p70 S6K" . SPARSER::COLLECTION)
    ("mTOR and p70S6K" . SPARSER::COLLECTION)
    ("mTOR and RPS6" . SPARSER::COLLECTION)
    ("CDK1 and MAP4K4" . SPARSER::COLLECTION)
    ("S2, mTOR and RPS6" . SPARSER::COLLECTION)
    ("Eif4G1 and Eif2S2" . SPARSER::COLLECTION)
    ("RPL8, RPL22 and RPS23" . SPARSER::COLLECTION)
    ("Eif2S2" . SPARSER::PROTEIN) ("Eif4G1" . SPARSER::PROTEIN)
    ("eIF4 and p70S6K" . SPARSER::COLLECTION) ("eIF4" . SPARSER::PROTEIN)
    ("Delta" . SPARSER::PROTEIN) ("SAM" . SPARSER::MOLECULE)
    ("ERK (PD98059) and JNK (JNK Inhibitor II)" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("EMF-ELF" . SPARSER::COLLECTION)
    ("mTOR, Akt and MAPKs" . SPARSER::COLLECTION) ("BrdU" . SPARSER::DRUG)
    ("EMF" . SPARSER::PROTEIN) ("ELF-EMF" . SPARSER::COLLECTION)
    ("ELF" . SPARSER::PROTEIN) ("PEA15" . SPARSER::PROTEIN)
    ("P70 S6K" . SPARSER::PROTEIN) ("RPS23" . SPARSER::PROTEIN)
    ("RPL22" . SPARSER::PROTEIN) ("RPL8" . SPARSER::PROTEIN)
    ("RPS6" . SPARSER::PROTEIN) ("MAP4K4" . SPARSER::PROTEIN)
    ("RPS18" . SPARSER::PROTEIN) ("arginines" . SPARSER::AMINO-ACID)
    ("SUMO" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the AR's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyglutamine" . SPARSER::MOLECULE) ("X-linked" . SPARSER::PROTEIN)
    ("FGFR4 and poorer" . SPARSER::COLLECTION) ("qter" . SPARSER::DRUG)
    ("gene, rs1966265 and rs351855" . SPARSER::COLLECTION)
    ("gene, rs2234909 and rs3135848" . SPARSER::COLLECTION)
    ("ER or PR" . SPARSER::COLLECTION)
    ("estrogen receptor (ER) or progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("the TC and CC genotype" . SPARSER::COLLECTION)
    ("AG and GG" . SPARSER::COLLECTION) ("AG" . SPARSER::PROTEIN)
    ("gene and rs1966265 and rs351855" . SPARSER::COLLECTION)
    ("the human fibroblast growth factor ( FGF ) and receptor family"
     . SPARSER::COLLECTION)
    ("fibroblast growth factor ( FGF )" . SPARSER::PROTEIN-FAMILY)
    ("an intronic variant" . SPARSER::VARIANT)
    ("FGFR3 and rs1966265 and rs351855" . SPARSER::COLLECTION)
    ("FGFR3 and FGFR4" . SPARSER::COLLECTION) ("MMP1" . SPARSER::PROTEIN)
    ("Fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("FGFR4" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("vimentin, ANX1 and HSP27" . SPARSER::COLLECTION)
    ("expression strong HSP27" . SPARSER::PROTEIN)
    ("ANX1 and its family member ANX2" . SPARSER::COLLECTION)
    ("H 2 O 2 and GSSG" . SPARSER::COLLECTION) ("GSSG" . SPARSER::DRUG)
    ("membranous vimentin" . SPARSER::PROTEIN)
    ("MnSOD, Prdx, ICDH, α-enolase and UDP-glucose dehydrogenase"
     . SPARSER::COLLECTION)
    ("PD HCC and MD HCC" . SPARSER::COLLECTION)
    ("HSP 27 and ANX1" . SPARSER::COLLECTION)
    ("HSP27 and ANX1" . SPARSER::COLLECTION)
    ("ANX1 and vimentin" . SPARSER::COLLECTION)
    ("actin, PCNA and Na-K +" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("ICDH" . SPARSER::PROTEIN)
    ("ANX1 and ANX2" . SPARSER::COLLECTION)
    ("stress-associated proteins" . SPARSER::PROTEIN)
    ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dehydrogenase (ICDH)" . SPARSER::PROTEIN)
    ("Prdx" . SPARSER::PROTEIN-FAMILY)
    ("some independent differentiation-associated biomarkers"
     . SPARSER::MOLECULE)
    ("at least 15 different plasma proteins" . SPARSER::PROTEIN)
    ("varieties" . SPARSER::VARIETY)
    ("biomarkers and therapeutic strategies" . SPARSER::COLLECTION)
    ("ANX1 or HSP27" . SPARSER::COLLECTION) ("highly invasive types" . TYPE)
    ("ANX1 and HSP27" . SPARSER::COLLECTION)
    ("dehydrogenase, α-enolase and UDP-glucose dehydrogenase"
     . SPARSER::COLLECTION)
    ("enolase" . SPARSER::PROTEIN) ("isocitrate" . SPARSER::PROTEIN)
    ("NADP" . SPARSER::MOLECULE) ("peroxiredoxin" . SPARSER::PROTEIN)
    ("MnSOD" . SPARSER::PROTEIN)
    ("disulfide isomerase (PDI)" . SPARSER::PROTEIN)
    ("ANX–2" . SPARSER::COLLECTION) ("ANX" . SPARSER::PROTEIN)
    ("reliable biomarkers" . SPARSER::MOLECULE) ("HSP 27" . SPARSER::PROTEIN)
    ("ANX2" . SPARSER::PROTEIN) ("pH 3" . SPARSER::MOLECULE)
    ("CS4" . SPARSER::PROTEIN) ("murine leukemia virus" . SPARSER::PROTEIN)
    ("ANXA1" . SPARSER::PROTEIN) ("Triton X–100" . SPARSER::MOLECULE)
    ("ANX4" . SPARSER::PROTEIN) ("Annexin1" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRβ1" . SPARSER::PROTEIN)
    ("UDP-glucose dehydrogenase" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN) ("heat shock protein–27" . SPARSER::PROTEIN)
    ("HSC–70" . SPARSER::PROTEIN) ("HSP75" . SPARSER::PROTEIN)
    ("GRP78" . SPARSER::PROTEIN) ("ANX1" . SPARSER::PROTEIN)
    ("Annexin 1" . SPARSER::PROTEIN)
    ("bevacizumab and VEGFR" . SPARSER::COLLECTION) ("Avastin" . SPARSER::DRUG)
    ("a possible downstream molecule" . SPARSER::MOLECULE)
    ("Ranibizumab" . SPARSER::DRUG) ("p-Akt" . SPARSER::COLLECTION)
    ("FMK" . SPARSER::PROTEIN) ("soluble substances" . SPARSER::SUBSTANCE)
    ("VWF and CD34" . SPARSER::COLLECTION) ("VWF" . SPARSER::PROTEIN)
    ("matrigel" . SPARSER::PROTEIN) ("whose gene" . SPARSER::GENE)
    ("Annexin V and PI" . SPARSER::COLLECTION)
    ("Annexin V and propidium" . SPARSER::COLLECTION)
    ("GFP and CD31" . SPARSER::COLLECTION) ("sham" . SPARSER::DRUG)
    ("luciferase and green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("luciferase and green fluorescent protein" . SPARSER::COLLECTION)
    ("a well-recognized cysteine protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prostaglandin E 2 [ xref ] and a profile" . SPARSER::COLLECTION)
    ("urinary plasminogen activator" . SPARSER::PROTEIN)
    ("ephrin-A1" . SPARSER::PROTEIN) ("PIA" . SPARSER::PROTEIN)
    ("D35" . SPARSER::PROTEIN) ("von Willebrand factor" . SPARSER::PROTEIN)
    ("CASP3" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("Syndecan-1" . SPARSER::PROTEIN) ("ephrin-A" . SPARSER::PROTEIN-FAMILY)
    ("anti-angiogenic" . SPARSER::DRUG)
    ("tubulin stabilizers like epothilones as well as signaling inhibitors that preclude"
     . SPARSER::COLLECTION)
    ("epothilones" . SPARSER::MOLECULE) ("stabilizers" . SPARSER::MOLECULE)
    ("Chk1 and Wee1" . SPARSER::COLLECTION)
    ("Chk1 [ xref ] and ATR [ xref ]" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("Nutlin and related compounds" . SPARSER::COLLECTION)
    ("hyperactive Mdm2" . SPARSER::PROTEIN)
    ("p53-wildtype" . SPARSER::PROTEIN-PAIR) ("ethynyl" . SPARSER::MOLECULE)
    ("cleaved PARP as well as γH2AX" . SPARSER::COLLECTION)
    ("p53 or p21" . SPARSER::COLLECTION)
    ("p53 as well as p21" . SPARSER::COLLECTION)
    ("gemcitabine and Wee1i" . SPARSER::COLLECTION)
    ("Gemcitabine or the combination" . SPARSER::COLLECTION)
    ("gemcitabine and/or the Wee1 inhibitor MK-1775 (termed Wee1i from here on)"
     . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG)
    ("DNA damage-induced kinases" . SPARSER::KINASE)
    ("deoxyribonucleotide" . SPARSER::MOLECULE) ("Nutlin" . SPARSER::DRUG)
    ("the Wee1 inhibitor MK-1775 and/or the nucleoside analogue gemcitabine"
     . SPARSER::COLLECTION)
    ("RNAse A" . SPARSER::PROTEIN) ("beta-Actin" . SPARSER::PROTEIN)
    ("polo-like" . SPARSER::PROTEIN) ("MK2" . SPARSER::PROTEIN)
    ("Histone3" . SPARSER::PROTEIN) ("Z-VAD-FMK" . SPARSER::DRUG)
    ("Histone2" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Histone 2" . SPARSER::PROTEIN) ("MK-1775" . SPARSER::DRUG)
    ("Nutlin-3a" . SPARSER::DRUG) ("Wee1" . SPARSER::PROTEIN)
    ("MDM2 inhibitors and Bcl-2 inhibitors" . SPARSER::COLLECTION)
    ("TKI- and Bcl-2" . SPARSER::COLLECTION) ("TKI-" . SPARSER::PROTEIN)
    ("Bcl" . SPARSER::PROTEIN)
    ("Bcl-xL and Mcl-1 protein" . SPARSER::COLLECTION)
    ("Nutlin3a and its combination" . SPARSER::COLLECTION)
    ("Bcl-2 or Bcr-Abl" . SPARSER::COLLECTION)
    ("nutlin3a and ABT-737 or nutlin3a and nilotinib" . SPARSER::COLLECTION)
    ("ABT-737 or nutlin3a and nilotinib" . SPARSER::COLLECTION)
    ("p-CrkL" . SPARSER::COLLECTION) ("CrkL" . SPARSER::PROTEIN)
    ("Noxa or Bim" . SPARSER::COLLECTION)
    ("nutlin3a and ABT-737" . SPARSER::COLLECTION)
    ("Noxa and Bim" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bcl-2 protein Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nutlin3a and nilotinib" . SPARSER::COLLECTION)
    ("ABT-737, or nutlin3a" . SPARSER::COLLECTION) ("CFSE" . SPARSER::DRUG)
    ("ABT-737 or nilotinib" . SPARSER::COLLECTION) ("8b" . SPARSER::PROTEIN)
    ("significantly lower p53 RNA ( P = 0.015) and higher MDM2 RNA ( P = 0.009)"
     . SPARSER::COLLECTION)
    ("the Bcl-2 inhibitor ABT-737 and the TKI nilotinib" . SPARSER::COLLECTION)
    ("a key tumor suppressor gene" . SPARSER::PROTEIN)
    ("inhibitor-" . SPARSER::INHIBITOR) ("Nilotinib" . SPARSER::DRUG)
    ("ABT-737 and nilotinib" . SPARSER::COLLECTION)
    ("the MDM2 inhibitor nutlin3a and its combination" . SPARSER::COLLECTION)
    ("the dual Bcl-2 and Bcl-xL inhibitor ABT-737" . SPARSER::DRUG)
    ("Given p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("Given p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcr-Abl, Bcl-2, and p53" . SPARSER::COLLECTION)
    ("ABL1" . SPARSER::PROTEIN) ("carboxy-fluorescein" . SPARSER::DRUG)
    ("CXCL-12" . SPARSER::PROTEIN) ("Bcl-6" . SPARSER::PROTEIN)
    ("P72" . SPARSER::PROTEIN) ("MI-219" . SPARSER::DRUG)
    ("Nutlin3a" . SPARSER::DRUG) ("nutlin3a" . SPARSER::DRUG)
    ("STAT3 and NF-κB" . SPARSER::COLLECTION) ("RTA" . SPARSER::PROTEIN)
    ("OPB" . SPARSER::MOLECULE) ("STAT3-Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2 and STAT3" . SPARSER::COLLECTION)
    ("a potential tripartite interacting complex" . SPARSER::BIO-COMPLEX)
    ("Rac1 (N17) as well as mutants" . SPARSER::COLLECTION)
    ("STAT3 [ xref ] and active Rac1" . SPARSER::COLLECTION)
    ("Bcl-2, Rac1 and STAT3" . SPARSER::COLLECTION)
    ("Bcl-2 and the small GTPase Rac1" . SPARSER::COLLECTION)
    ("active Rac1 and intracellular O 2  •−" . SPARSER::COLLECTION)
    ("active (CA)" . SPARSER::ACTIVE) ("DPI" . SPARSER::PROTEIN)
    ("active Rac1 and intracellular superoxide" . SPARSER::COLLECTION)
    ("STAT1 or STAT5" . SPARSER::COLLECTION) ("vis" . SPARSER::DRUG)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("STAT5 and STAT6" . SPARSER::COLLECTION)
    ("STAT1 and STAT4" . SPARSER::COLLECTION)
    ("Rac1, Bcl-2 and STAT3" . SPARSER::COLLECTION)
    ("cellular redox" . SPARSER::PROTEIN) ("Bcl-2-Rac1" . SPARSER::COLLECTION)
    ("mitochondrial STAT3" . SPARSER::PROTEIN) ("Electron" . SPARSER::MOLECULE)
    ("ETC" . SPARSER::PROTEIN)
    ("Jak2 (Janus kinase 2) and TYK2 (tyrosine kinase 2)"
     . SPARSER::COLLECTION)
    ("what makes STAT3" . SPARSER::PROTEIN)
    ("the viral oncogene" . SPARSER::ONCOGENE) ("v-src" . SPARSER::COLLECTION)
    ("src" . SPARSER::PROTEIN)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("Rac1-Bcl-2" . SPARSER::COLLECTION)
    ("Rac1 and Bcl-2" . SPARSER::COLLECTION)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("STAT3 and Bcl-2" . SPARSER::COLLECTION)
    ("Rac1 and NADPH oxidase" . SPARSER::COLLECTION)
    ("Bcl-2 and Rac1" . SPARSER::COLLECTION) ("Mg2+" . SPARSER::MOLECULE)
    ("Ca2+" . SPARSER::CALCIUM-ION) ("CDKN2A" . SPARSER::PROTEIN)
    ("SOD1" . SPARSER::PROTEIN) ("superoxide dismutase 1" . SPARSER::PROTEIN)
    ("GRIM19" . SPARSER::PROTEIN) ("STA-21" . SPARSER::DRUG)
    ("EHT1864" . SPARSER::DRUG) ("STAT4" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("LMW-PTP" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("tyrosine kinase 2" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("ABT199" . SPARSER::DRUG) ("pro-oxidant" . SPARSER::MOLECULE)
    ("genes or gene" . SPARSER::COLLECTION) ("antiestrogen" . SPARSER::DRUG)
    ("ESR1-associated genes" . SPARSER::GENE)
    ("mRNA and trastuzumab" . SPARSER::COLLECTION)
    ("HER2 and ER" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("continuous HER2" . SPARSER::PROTEIN) ("central HER2" . SPARSER::PROTEIN)
    ("Central Cancer Treatment Group (NCCTG) and National Surgical Adjuvant Breast and Bowel Project (NSABP) National Cancer Institute-supported Cancer Cooperative Groups"
     . SPARSER::COLLECTION)
    ("Group (NCCTG)" . SPARSER::MOLECULE)
    ("protein, RNA, or DNA" . SPARSER::COLLECTION)
    ("trastuzumab, pertuzumab, and lapatinib" . SPARSER::COLLECTION)
    ("central FISH" . SPARSER::PROTEIN)
    ("doxorubicin and cyclophosphamide" . SPARSER::COLLECTION)
    ("paclitaxel and trastuzumab" . SPARSER::COLLECTION)
    ("protein or gene" . SPARSER::COLLECTION) ("RPLP0" . SPARSER::PROTEIN)
    ("p17" . SPARSER::PROTEIN)
    ("the large consecutive cohort" . SPARSER::MOLECULE)
    ("the consecutive cohort" . SPARSER::MOLECULE)
    ("consecutive primary CRCs" . SPARSER::PROTEIN)
    ("consecutive primary CRC" . SPARSER::PROTEIN)
    ("KRAS , p53 , and BRAF" . SPARSER::COLLECTION)
    ("c- MYC" . SPARSER::PROTEIN) ("S2S" . SPARSER::MOLECULE)
    ("D5S346" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("State" . SPARSER::BIO-STATE) ("mutated allele" . SPARSER::ALLELE)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("/centromeres" . SPARSER::COLLECTION)
    ("a monoallelic c" . SPARSER::PROTEIN)
    ("ER (Figure xref ) and PR (Figure xref )" . SPARSER::COLLECTION)
    ("Foci" . SPARSER::PROTEIN) ("sentinel" . SPARSER::DRUG)
    ("PALB2, CHEK2, ATM, NBN, TP53, CDH1, PTEN, STK11 and NF1"
     . SPARSER::COLLECTION)
    ("NBN" . SPARSER::PROTEIN) ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("TN" . SPARSER::PROTEIN) ("the mutated BRCA1 allele" . SPARSER::ALLELE)
    ("A 20" . SPARSER::PROTEIN) ("BRCA-1" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN)
    ("destructive liquid nitrogen" . SPARSER::MOLECULE)
    ("PCP and EMT" . SPARSER::COLLECTION) ("Ki67-" . SPARSER::PROTEIN)
    ("both YAP1 and its downstream targets" . SPARSER::COLLECTION)
    ("YAP1 and its downstream targets" . SPARSER::COLLECTION)
    ("troponin" . SPARSER::PROTEIN) ("Tie2-Cre" . SPARSER::COLLECTION)
    ("a conditional YAP1 allele" . SPARSER::ALLELE)
    ("Tnnt2–Cre" . SPARSER::COLLECTION) ("CHD" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("CTGF and AXL" . SPARSER::COLLECTION)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("Yap1" . SPARSER::PROTEIN)
    ("Tie2" . SPARSER::PROTEIN) ("Tnnt2" . SPARSER::PROTEIN)
    ("Yes-associated protein 1" . SPARSER::PROTEIN)
    ("the smaller cohort" . SPARSER::MOLECULE)
    ("levamisole" . SPARSER::MOLECULE) ("PART" . SPARSER::COMPONENT)
    ("a new light" . SPARSER::PROTEIN) ("purely predictive type" . TYPE)
    ("Nodal" . SPARSER::PROTEIN) ("fluorouracil " . SPARSER::DRUG)
    ("HSF" . SPARSER::PROTEIN)
    ("Colorectal Cancer Study Group (ABCSG)" . SPARSER::MOLECULE)
    ("Group (ABCSG)" . SPARSER::MOLECULE) ("Still no drug" . SPARSER::DRUG)
    ("oxaliplatin, irinotecan, capecitabine, cetuximab, and bevacizumab"
     . SPARSER::COLLECTION)
    ("Adjuvant" . SPARSER::DRUG) ("N1 and N2" . SPARSER::COLLECTION)
    ("Colon cancer" . SPARSER::PROTEIN) ("N2 " . SPARSER::PROTEIN)
    ("N1 " . SPARSER::PROTEIN) ("5FU" . SPARSER::DRUG)
    ("TC" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC)"
     . SPARSER::COLLECTION)
    ("repetitive nucleotide" . SPARSER::NUCLEOTIDE)
    ("ZNF676" . SPARSER::PROTEIN) ("the subsequent DDR" . SPARSER::PROTEIN)
    ("the secondary electrons" . SPARSER::MOLECULE)
    ("substantial SSB" . SPARSER::PROTEIN) ("electrons" . SPARSER::MOLECULE)
    ("a transparent media" . SPARSER::PROTEIN) ("slab" . SPARSER::PROTEIN)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("histone deacetylase and demethylase" . SPARSER::COLLECTION)
    ("ATPases" . SPARSER::PROTEIN) ("macroH2A" . SPARSER::PROTEIN)
    ("PcG" . SPARSER::PROTEIN-FAMILY) ("Tankyrase" . SPARSER::PROTEIN)
    ("PARP1 and Ku" . SPARSER::COLLECTION) ("SUV39h1" . SPARSER::PROTEIN)
    ("IDPs" . SPARSER::PROTEIN)
    ("MDC1, and co-inhibition" . SPARSER::COLLECTION)
    ("strong ATM/DNA–PK" . SPARSER::COLLECTION)
    ("TRF2 and 53BP1" . SPARSER::COLLECTION)
    ("monitoring subcellular DDR" . SPARSER::PROTEIN)
    ("SSBs and DSBs" . SPARSER::COLLECTION) ("SSBs" . SPARSER::PROTEIN)
    ("GFP-TRF2" . SPARSER::COLLECTION)
    ("PARP1, PARP2 and PARP3" . SPARSER::COLLECTION)
    ("DEA" . SPARSER::MOLECULE) ("PARG" . SPARSER::PROTEIN)
    ("Chk1 (pChk1) and Chk2 (pChk2)" . SPARSER::COLLECTION)
    ("AK" . SPARSER::PROTEIN) ("pan-nuclear γH2AX" . SPARSER::PROTEIN)
    ("ATM and DNA–PK inhibitors (Ai and Di, respectively) and PARP inhibitor (NU1025 or olaparib)"
     . SPARSER::COLLECTION)
    ("kinase/PARP" . SPARSER::COLLECTION) ("ATM/DNA–PK" . SPARSER::COLLECTION)
    ("GFP-NTH1" . SPARSER::COLLECTION)
    ("radiation causes pan-nuclear γH2AX" . SPARSER::PROTEIN)
    ("ATM and DNA–PK" . SPARSER::COLLECTION)
    ("kinases and PARP" . SPARSER::COLLECTION) ("CtIP" . SPARSER::PROTEIN)
    ("group A (XPA)" . SPARSER::PROTEIN) ("XPA" . SPARSER::PROTEIN)
    ("CPD" . SPARSER::PROTEIN) ("proteins and protein" . SPARSER::COLLECTION)
    ("TRF2-YFP" . SPARSER::COLLECTION) ("EGFP-53BP1" . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN) ("DDRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mira" . SPARSER::PROTEIN) ("modifiers" . SPARSER::MOLECULE)
    ("SSB" . SPARSER::PROTEIN) ("PARPs" . SPARSER::MOLECULE)
    ("NIR" . SPARSER::PROTEIN) ("PtK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53-binding protein 1 (53BP1 or TP53BP1) and telomeric repeat binding factor 2 (TRF2)"
     . SPARSER::COLLECTION)
    ("53BP1 or TP53BP1" . SPARSER::COLLECTION)
    ("types and amounts" . SPARSER::COLLECTION)
    ("exogenous DNA" . SPARSER::DNA) ("53BP1 and TRF2" . SPARSER::COLLECTION)
    ("SNF2" . SPARSER::PROTEIN) ("ALC1" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("SUV39h" . SPARSER::PROTEIN)
    ("PARP3" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("DNA–PK" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN) ("NU7026" . SPARSER::DRUG)
    ("PARP1" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("DNA–PKcs" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("B-H" . SPARSER::PROTEIN) ("Ph3" . SPARSER::MOLECULE)
    ("L-Glutamine" . SPARSER::MOLECULE) ("NTH1" . SPARSER::PROTEIN)
    ("PtK2" . SPARSER::PROTEIN)
    ("telomeric repeat binding factor 2" . SPARSER::PROTEIN)
    ("TP53BP1" . SPARSER::PROTEIN) ("p53-binding protein 1" . SPARSER::PROTEIN)
    ("TRF2" . SPARSER::PROTEIN) ("luminal and HER2" . SPARSER::COLLECTION)
    ("the so-called triple-positive disease patient group" . SPARSER::MOLECULE)
    ("the pathology-based subtypes" . SPARSER::PROTEIN)
    ("receptors and HER-2" . SPARSER::COLLECTION)
    ("ER, PR, and HER-2" . SPARSER::COLLECTION)
    ("luminal-type (7) and HER2-type (6)" . SPARSER::COLLECTION)
    ("HER2-type and 15 basal-type" . SPARSER::COLLECTION)
    ("/FAC" . SPARSER::COLLECTION) ("methotrexate" . SPARSER::DRUG)
    ("CMF" . SPARSER::PROTEIN) ("epirubicin" . SPARSER::DRUG)
    ("FAC" . SPARSER::PROTEIN) ("cyclophosphamide" . SPARSER::DRUG)
    ("AC" . SPARSER::PROTEIN) ("NCCN" . SPARSER::MOLECULE)
    ("p  " . SPARSER::PROTEIN) ("Her2+" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN) ("type B" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN)
    ("GATA3, miR-125a-5p, FOXP3 and IL-6R" . SPARSER::COLLECTION)
    ("MCF-10A, Lin28 and let-7a" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("Ets-1 and Ets-2" . SPARSER::COLLECTION) ("valproate" . SPARSER::DRUG)
    ("the canonical transcription factor" . SPARSER::PROTEIN)
    ("Valproate" . SPARSER::DRUG)
    ("oxidized low-density lipoprotein-stimulated monocyte-derived macrophages"
     . SPARSER::PROTEIN)
    ("miR-125a-5p and IL-6R" . SPARSER::COLLECTION)
    ("GATA3 and miR-125a-5p" . SPARSER::COLLECTION)
    ("miR-125a-5p and its target genes" . SPARSER::COLLECTION)
    ("GATA3, miR-125a-5p, IL-6R, STAT3 and FOXP3" . SPARSER::COLLECTION)
    ("ago-NC and anti-NC" . SPARSER::COLLECTION)
    ("miR-125a-5p directly targets IL-6R and STAT3" . SPARSER::COLLECTION)
    ("protein and miR-125a-5p" . SPARSER::COLLECTION)
    ("anti-CD3/CD28" . SPARSER::COLLECTION)
    ("Jurkat-HA-FOXP3" . SPARSER::COLLECTION)
    ("PIP-Myc-GATA3" . SPARSER::COLLECTION) ("PIP" . SPARSER::PROTEIN)
    ("Jurkat" . SPARSER::PROTEIN) ("IL-6 and TGF-β" . SPARSER::COLLECTION)
    ("STAT3/FOXP3" . SPARSER::COLLECTION)
    ("IL-6R and STAT3" . SPARSER::COLLECTION)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-2" . SPARSER::PROTEIN) ("HNF4" . SPARSER::PROTEIN)
    ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ets-2" . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("MiR-125a-5p" . SPARSER::MOLECULE)
    ("R-2" . SPARSER::PROTEIN) ("mir-125a-5p" . SPARSER::MOLECULE)
    ("interleukin 6 receptor" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN) ("protein and scaffold" . SPARSER::COLLECTION)
    ("vesicular endothelial growth factor (VEGF)" . SPARSER::PROTEIN)
    ("pathological type and size of tumors" . SPARSER::COLLECTION)
    ("pathological type" . TYPE) ("Cyclooxygenase" . SPARSER::PROTEIN)
    ("COX-2 and Ki-67" . SPARSER::COLLECTION)
    ("cyclooxygenase-2 (COX-2) and Ki-67" . SPARSER::COLLECTION)
    ("immediate early" . SPARSER::PROTEIN) ("COX-1" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("the HER2 IHC positive group" . SPARSER::MOLECULE)
    ("the HER2 IHC negative group" . SPARSER::MOLECULE)
    ("Trastuzumab" . SPARSER::DRUG) ("SRM" . SPARSER::PROTEIN)
    ("T-DM1" . SPARSER::PROTEIN) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("FISH and Immunohistochemistry" . SPARSER::COLLECTION)
    ("lepidic component" . SPARSER::COMPONENT)
    ("the main histologic subtypes" . SPARSER::PROTEIN)
    ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("two different histological components" . SPARSER::COMPONENT)
    ("mut-EGFR" . SPARSER::COLLECTION) ("mut" . SPARSER::PROTEIN)
    ("EGFR tyrosine inhibitors and kinase inhibitors (TKIs)"
     . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN)
    ("mutated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK)"
     . SPARSER::COLLECTION)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ADCs" . SPARSER::PROTEIN)
    ("the most frequently diagnosed histological type" . TYPE)
    ("ADC" . SPARSER::PROTEIN) ("just one histologic type" . TYPE)
    ("at least two different histologic types" . TYPE)
    ("all histologic components" . SPARSER::COMPONENT)
    ("available tumor components" . SPARSER::COMPONENT)
    ("two different histologic types" . TYPE)
    ("surfactant protein C" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER, PR, HER-2, and ki67" . SPARSER::COLLECTION)
    ("ER− and PR−" . SPARSER::COLLECTION) ("HER2+" . SPARSER::PROTEIN)
    ("Oct-1/Runx2" . SPARSER::COLLECTION) ("C-T-T-T" . SPARSER::COLLECTION)
    ("ER−HER2+" . SPARSER::COLLECTION)
    ("P = 3.4 × 10 −2 and 1.4 × 10 −2" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("ER, PR, HER2, and Ki-67" . SPARSER::COLLECTION)
    ("Oct-1" . SPARSER::PROTEIN) ("T-T" . SPARSER::PROTEIN)
    ("C-T" . SPARSER::PROTEIN) ("T-C-C" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("mercaptoethanol" . SPARSER::MOLECULE)
    ("Atm" . SPARSER::PROTEIN) ("FA-histone" . SPARSER::COLLECTION)
    ("MCM" . SPARSER::PROTEIN)
    ("separately loaded/removed H2A-H2B" . SPARSER::COLLECTION)
    ("H2A-H2B" . SPARSER::COLLECTION) ("histone-histone" . SPARSER::COLLECTION)
    ("properly mature chromatin-incorporated histones" . SPARSER::PROTEIN)
    ("mature nucleosomal forms and the presence of FA-Lys adducts"
     . SPARSER::COLLECTION)
    ("mature nucleosomal forms" . SPARSER::FORM) ("PCAF" . SPARSER::PROTEIN)
    ("histone/chromatin" . SPARSER::COLLECTION)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("heterochromatic protein-1" . SPARSER::PROTEIN)
    ("dNTP" . SPARSER::MOLECULE)
    ("bleomycin and camptothecin" . SPARSER::COLLECTION)
    ("Ser824-KAP1 and Thr68-CHK2" . SPARSER::COLLECTION)
    ("ATM and KAT5" . SPARSER::COLLECTION)
    ("ATM and its target proteins" . SPARSER::COLLECTION)
    ("FA or other reactive carbonyls" . SPARSER::COLLECTION)
    ("Trypan" . SPARSER::DRUG) ("the most extensive ATM" . SPARSER::PROTEIN)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FA- and H 2 O 2" . SPARSER::COLLECTION) ("FA-" . SPARSER::PROTEIN)
    ("monomeric ATM" . SPARSER::PROTEIN)
    ("ATM-chromatin" . SPARSER::COLLECTION)
    ("phospho-ATM, phospho-CHK2 or phospho-KAP1" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION) ("p-CHK2" . SPARSER::COLLECTION)
    ("ATRi" . SPARSER::MOLECULE) ("aphidicolin" . SPARSER::PROTEIN)
    ("phospho-ATM or phospho-CHK2" . SPARSER::COLLECTION)
    ("preferentially targeted soluble CHK2 kinase" . SPARSER::KINASE)
    ("CPT or bleomycin" . SPARSER::COLLECTION)
    ("CPT and bleomycin" . SPARSER::COLLECTION)
    ("dramatically stronger inducer" . SPARSER::MOLECULE)
    ("ATR kinase (monitored by phosphorylation of its target Ser317 in CHK1 kinase) and more potent inducers"
     . SPARSER::COLLECTION)
    ("the radiomimetic bleomycin" . SPARSER::DRUG)
    ("camptothecin (CPT)" . SPARSER::DRUG)
    ("a classic replication stressor hydroxyurea (HU)" . SPARSER::DRUG)
    ("camptothecin" . SPARSER::DRUG) ("poison" . SPARSER::MOLECULE)
    ("HU" . SPARSER::DRUG) ("ATM, CHK2 and KAP1" . SPARSER::COLLECTION)
    ("two other DNA damage-responsive kinases, ATR and DNAPK"
     . SPARSER::COLLECTION)
    ("kinases, ATR and DNAPK" . SPARSER::COLLECTION)
    ("DNAPK" . SPARSER::PROTEIN) ("FA, ATM and CHK2" . SPARSER::COLLECTION)
    ("FA-chromatin" . SPARSER::COLLECTION)
    ("toxic aldehydes" . SPARSER::MOLECULE) ("Aldh2" . SPARSER::PROTEIN)
    ("aldehyde" . SPARSER::MOLECULE) ("Formaldehyde" . SPARSER::MOLECULE)
    ("Aldehydes" . SPARSER::MOLECULE) ("aldehydes" . SPARSER::MOLECULE)
    ("lamin" . SPARSER::PROTEIN) ("heterochromatin" . SPARSER::PROTEIN)
    ("TQ" . SPARSER::DRUG) ("SQ" . SPARSER::MOLECULE)
    ("KAT5-ATM" . SPARSER::COLLECTION) ("KAT5 and ATM" . SPARSER::COLLECTION)
    ("formaldehyde (FA)" . SPARSER::MOLECULE)
    ("the main DNA damage-responsive kinase ATM" . SPARSER::PROTEIN)
    ("DPC" . SPARSER::MOLECULE) ("DNA and protein" . SPARSER::COLLECTION)
    ("N -acetylcysteine" . SPARSER::DRUG) ("H2B" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::PROTEIN) ("c-ABL" . SPARSER::PROTEIN)
    ("γ–H2AX" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("pS4" . SPARSER::PROTEIN)
    ("pS15" . SPARSER::PROTEIN) ("K-10" . SPARSER::PROTEIN)
    ("NU9056" . SPARSER::DRUG) ("KU60019" . SPARSER::DRUG)
    ("HP1α" . SPARSER::PROTEIN) ("TIP60" . SPARSER::PROTEIN)
    ("NH 2" . SPARSER::MOLECULE) ("autosomal recessive" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tip60" . SPARSER::PROTEIN) ("KAT5" . SPARSER::PROTEIN)
    ("MRE11" . SPARSER::PROTEIN) ("KAP1" . SPARSER::PROTEIN)
    ("Chk1 and p53" . SPARSER::COLLECTION) ("ATR/ATM" . SPARSER::COLLECTION)
    ("acetyltransferase and lysine" . SPARSER::COLLECTION)
    ("methyltransferases" . SPARSER::PROTEIN) ("labile" . SPARSER::PROTEIN)
    ("DNMTs" . SPARSER::PROTEIN) ("CDH1, p16 and MGMT" . SPARSER::COLLECTION)
    ("MGMT siRNA or control siRNA" . SPARSER::COLLECTION)
    ("siRNA or MGMT" . SPARSER::COLLECTION)
    ("pcDNA-MGMT" . SPARSER::COLLECTION)
    ("ERp29 and MGMT" . SPARSER::COLLECTION)
    ("siRNA, or ERp29" . SPARSER::COLLECTION)
    ("DNMT3A or 3B" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("dC" . SPARSER::MOLECULE) ("CDH1 and MGMT" . SPARSER::COLLECTION)
    ("O  6 -methylguanine-DNA methyltransferase (MGMT)" . SPARSER::PROTEIN)
    ("the DNA-damage" . SPARSER::DNA) ("XBP1/p58 IPK" . SPARSER::COLLECTION)
    ("adherens/tight junctions proteins ( e.g ., E-cadherin and ZO-1) and polarity proteins ( e.g ., Par3 and Scribble)"
     . SPARSER::COLLECTION)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("Par3 and Scribble" . SPARSER::COLLECTION) ("Par3" . SPARSER::PROTEIN)
    ("Scribble" . SPARSER::PROTEIN)
    ("PDI, ERp72 and ERp57" . SPARSER::COLLECTION)
    ("oxido" . SPARSER::MOLECULE)
    ("oxido-reductases, isomerases and chaperones" . SPARSER::COLLECTION)
    ("isomerases" . SPARSER::ISOMERASE) ("PDI" . SPARSER::PROTEIN)
    ("Endoplasmic reticulum protein 29" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("E-Cadherin" . SPARSER::PROTEIN)
    ("DNA repair protein" . SPARSER::PROTEIN) ("DNMT-1" . SPARSER::PROTEIN)
    ("DNMT3B" . SPARSER::PROTEIN) ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("O  6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("p58 IPK" . SPARSER::PROTEIN) ("XBP1" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("connexin43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gap junction protein" . SPARSER::PROTEIN) ("ERp57" . SPARSER::PROTEIN)
    ("ERp72" . SPARSER::PROTEIN) ("oxido-reductases" . SPARSER::PROTEIN)
    ("disulfide isomerase" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("O 6 -methylguanine DNA-methyltransferase" . SPARSER::PROTEIN)
    ("ERp29" . SPARSER::PROTEIN) ("DCC" . SPARSER::PROTEIN)
    ("that fedratinib’s" . SPARSER::DRUG) ("Enzyme" . SPARSER::ENZYME)
    ("a unique conformation" . SPARSER::BIO-CONFORMATION)
    ("receptor and kinase" . SPARSER::COLLECTION)
    ("kinase conformational state" . SPARSER::BIO-STATE)
    ("subdomains" . SPARSER::PROTEIN)
    ("SRC, ABL and FAK" . SPARSER::COLLECTION) ("p-MEK" . SPARSER::COLLECTION)
    ("p-STAT5" . SPARSER::COLLECTION) ("p-Jak2" . SPARSER::COLLECTION)
    ("EGFR and dasatinib" . SPARSER::COLLECTION)
    ("SRC/ABL" . SPARSER::COLLECTION) ("PDGFR" . SPARSER::PROTEIN)
    ("active or inactive" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EPO or MPL" . SPARSER::COLLECTION) ("EPO" . SPARSER::PROTEIN)
    ("luciferase and JAK2-V617F variants" . SPARSER::COLLECTION)
    ("the ATP and the substrate site" . SPARSER::COLLECTION)
    ("both ATP and substrate-binding sites" . SPARSER::COLLECTION)
    ("ATP and substrate" . SPARSER::COLLECTION)
    ("protein and ligand" . SPARSER::COLLECTION)
    ("JAK2 and its resistant variants" . SPARSER::COLLECTION)
    ("TEL-JAK3" . SPARSER::COLLECTION) ("TEL-JAK1" . SPARSER::COLLECTION)
    ("JAK1-" . SPARSER::PROTEIN) ("STAT5 or BCL2" . SPARSER::COLLECTION)
    ("JAK1 or JAK3" . SPARSER::COLLECTION)
    ("JAK1 and JAK3" . SPARSER::COLLECTION) ("JAK1-JAK2" . SPARSER::COLLECTION)
    ("ATP and peptide" . SPARSER::COLLECTION) ("Fedratinib" . SPARSER::DRUG)
    ("kinase conformation and activation" . SPARSER::COLLECTION)
    ("Phe" . SPARSER::AMINO-ACID)
    ("AZD1480 and lestaurtinib" . SPARSER::COLLECTION)
    ("IL-3, and greater" . SPARSER::COLLECTION)
    ("lestaurtinib and fedratinib" . SPARSER::COLLECTION)
    ("AZD" . SPARSER::DRUG)
    ("a unique conformational state" . SPARSER::BIO-STATE)
    ("ABL and SRC" . SPARSER::COLLECTION)
    ("cysteine or phenylalanine" . SPARSER::COLLECTION)
    ("Gln" . SPARSER::AMINO-ACID) ("van" . SPARSER::PROTEIN)
    ("DFG" . SPARSER::PROTEIN) ("the ATP-site" . SPARSER::ATP)
    ("ATP-site" . SPARSER::ATP) ("state, and receptor" . SPARSER::COLLECTION)
    ("JH" . SPARSER::PROTEIN) ("the conformational state" . SPARSER::BIO-STATE)
    ("exogenous cytokines" . SPARSER::PROTEIN)
    ("four structural hot" . SPARSER::PROTEIN)
    ("SRC (PDB:2SRC) and ABL kinases (PDB: 1OPJ, 1OPL, 2G2H and 2G2I)"
     . SPARSER::COLLECTION)
    ("OPL" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("two clinically relevant JAK2 inhibitors" . SPARSER::INHIBITOR)
    ("ruxolitinib and fedratinib" . SPARSER::COLLECTION)
    ("HDAC, BCL2 and interferon–alpha" . SPARSER::COLLECTION)
    ("ABL" . SPARSER::PROTEIN)
    ("a catalytically incompetent kinase" . SPARSER::KINASE)
    ("lestaurtinib" . SPARSER::DRUG) ("ruxolitinib" . SPARSER::DRUG)
    ("fedratinib" . SPARSER::DRUG) ("TIP3" . SPARSER::PROTEIN)
    ("SAR302503" . SPARSER::DRUG) ("For 3" . SPARSER::PROTEIN)
    ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SHP1" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN) ("P58" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Jak2" . SPARSER::PROTEIN) ("interferon–alpha" . SPARSER::PROTEIN)
    ("AZD1480" . SPARSER::DRUG) ("INCB018424" . SPARSER::DRUG)
    ("EGFRvIII− and EGFRvIII+" . SPARSER::COLLECTION)
    ("the EGFRvIII+ DKMG subline" . SPARSER::PROTEIN)
    ("ERK1 and AKT" . SPARSER::COLLECTION)
    ("the DKMG EGFRvIII+ subline" . SPARSER::PROTEIN)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION)
    ("IR and anti-EGFR" . SPARSER::COLLECTION)
    ("EGFRvIII− or EGFRvIII+" . SPARSER::COLLECTION)
    ("the EGFRvIII− DKMG subline" . SPARSER::PROTEIN)
    ("EGFR, EGFRvIII, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("residual γH2AX/53BP1 foci" . SPARSER::PROTEIN)
    ("γH2AX/53BP1" . SPARSER::COLLECTION)
    ("EGFRvIII and ERK2" . SPARSER::COLLECTION)
    ("EGFR, EGFRvIII, AKT and ERK1" . SPARSER::COLLECTION)
    ("BS153 EGFRvIII− and + sublines" . SPARSER::COLLECTION)
    ("the EGFRvIII− subline and vice versa" . SPARSER::COLLECTION)
    ("antibody and EGFRvIII−" . SPARSER::COLLECTION)
    ("EGFRvIII− and + sublines" . SPARSER::COLLECTION)
    ("EGFRvIII- and + sublines" . SPARSER::COLLECTION)
    ("EGFRvIII-" . SPARSER::PROTEIN)
    ("EGFRvIII, DKMG and BS153" . SPARSER::COLLECTION)
    ("egfr" . SPARSER::PROTEIN)
    ("the EGFRvIII− and + sublines" . SPARSER::COLLECTION)
    ("EGFRvIII−" . SPARSER::PROTEIN)
    ("using Western blot and flow cytometry" . SPARSER::PROTEIN)
    ("BS" . SPARSER::PROTEIN) ("EGFRvIII" . SPARSER::PROTEIN)
    ("Histone H2AX" . SPARSER::PROTEIN) ("p 4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CAS-1" . SPARSER::PROTEIN) ("c-Jun/AP-1" . SPARSER::COLLECTION)
    ("anisomycin" . SPARSER::DRUG) ("Mcl-1 and Bcl-x" . SPARSER::COLLECTION)
    ("ACNU and TMZ" . SPARSER::COLLECTION) ("hydroxyurea (HU)" . SPARSER::DRUG)
    ("hydroxyurea" . SPARSER::DRUG) ("ribonucleotide" . SPARSER::MOLECULE)
    ("lovastatin" . SPARSER::DRUG) ("nitric" . SPARSER::PROTEIN)
    ("AP-1/c-Jun" . SPARSER::COLLECTION)
    ("strong induction ofbim EL" . SPARSER::PROTEIN)
    ("the cytoskeleton-associated motor complex" . SPARSER::BIO-COMPLEX)
    ("EL and BIM" . SPARSER::COLLECTION) ("UV" . SPARSER::PROTEIN)
    ("BIM-shRNA" . SPARSER::COLLECTION)
    ("TMZ- and ACNU-induced death in glioma cells" . SPARSER::COLLECTION)
    ("bak and bim" . SPARSER::COLLECTION) ("bak" . SPARSER::PROTEIN)
    ("TMZ-" . SPARSER::DRUG) ("JNK and p38K" . SPARSER::COLLECTION)
    ("fasL" . SPARSER::PROTEIN) ("c-fos and xpf" . SPARSER::COLLECTION)
    ("xpf" . SPARSER::PROTEIN) ("NER-endonuclease" . SPARSER::COLLECTION)
    ("UV-light" . SPARSER::COLLECTION) ("XPF" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN)
    ("c-Jun or another component" . SPARSER::COLLECTION)
    ("ERK1/2 and p38K" . SPARSER::COLLECTION)
    ("JNK, p38K and ERK1/2" . SPARSER::COLLECTION)
    ("TMZ and ACNU-induced cell death in glioma cells" . SPARSER::COLLECTION)
    ("the predominant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-MeG" . SPARSER::DRUG) ("XPC and DDB2" . SPARSER::COLLECTION)
    ("NER" . SPARSER::PROTEIN) ("p21, XPC and DDB2" . SPARSER::COLLECTION)
    ("XPC" . SPARSER::PROTEIN)
    ("TMZ and ACNU-induced cytotoxicity" . SPARSER::COLLECTION)
    ("TMZ and ACNU-induced cell death and DNA repair in glioma cells"
     . SPARSER::COLLECTION)
    ("caspase-8 and -9" . SPARSER::COLLECTION)
    ("100 μM TMZ or 50 μM ACNU" . SPARSER::COLLECTION) ("CNU" . SPARSER::DRUG)
    ("JNK and its target c-Jun" . SPARSER::COLLECTION)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("carmustine" . SPARSER::DRUG)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TMZ and CNUs" . SPARSER::COLLECTION) ("MAPK/p38" . SPARSER::COLLECTION)
    ("CNUs" . SPARSER::DRUG) ("genotoxins" . SPARSER::MOLECULE)
    ("DNA repair genes [ xref , xref – xref ] and pro-apoptotic genes [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("JNK (c-Jun N-terminal kinase), p38K (p38 kinase) and ERK1/2 (extracellular signal-regulated kinases 1/2)"
     . SPARSER::COLLECTION)
    ("mitogene-activated protein kinase" . SPARSER::COLLECTION)
    ("a dimeric transcription factor" . SPARSER::PROTEIN)
    ("Fos, Jun or ATF" . SPARSER::COLLECTION)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("xpc and ddb2" . SPARSER::COLLECTION) ("ddb2" . SPARSER::PROTEIN)
    ("ddb" . SPARSER::DRUG) ("xpc" . SPARSER::PROTEIN)
    ("the chloroethylating agents ACNU [ xref ] and BCNU [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("chloroethylating agents ACNU" . SPARSER::DRUG)
    ("topotecan and irinotecan" . SPARSER::COLLECTION) ("BCNU" . SPARSER::DRUG)
    ("topotecan" . SPARSER::DRUG) ("receptor (FAS)" . SPARSER::RECEPTOR)
    ("p53 and AP-1" . SPARSER::COLLECTION) ("N1-O 6" . SPARSER::COLLECTION)
    ("nimustine (ACNU) and lomustine (CCNU)" . SPARSER::COLLECTION)
    ("lomustine" . SPARSER::DRUG) ("-methylguanine" . SPARSER::MOLECULE)
    ("MeG" . SPARSER::DRUG) ("the pro-apoptotic gene BIM" . SPARSER::PROTEIN)
    ("TMZ and ACNU" . SPARSER::COLLECTION)
    ("JNK and c-Jun" . SPARSER::COLLECTION)
    ("TMZ or ACNU" . SPARSER::COLLECTION)
    ("Jun kinase (JNK) and c-Jun" . SPARSER::COLLECTION)
    ("the anticancer drugs temozolomide (TMZ) and nimustine (ACNU)"
     . SPARSER::COLLECTION)
    ("temozolomide (TMZ)" . SPARSER::DRUG) ("ACNU" . SPARSER::DRUG)
    ("nimustine" . SPARSER::DRUG) ("anti-ERK" . SPARSER::PROTEIN)
    ("FTY720" . SPARSER::DRUG) ("Smac/DIABLO" . SPARSER::PROTEIN)
    ("dynein light chain" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DDB2" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("FRA1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("O  6" . SPARSER::PROTEIN) ("U87MG" . SPARSER::PROTEIN)
    ("a valid novel therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("RAB27B-" . SPARSER::PROTEIN)
    ("caveolin-1, and DRAM" . SPARSER::COLLECTION) ("DRAM" . SPARSER::PROTEIN)
    ("RAR" . SPARSER::PROTEIN) ("RAB27B or p53" . SPARSER::COLLECTION)
    ("platelets" . SPARSER::PROTEIN)
    ("the most aggressive and lethal forms" . SPARSER::FORM)
    ("PDAC" . SPARSER::MOLECULE) ("RAB27B and p53" . SPARSER::COLLECTION)
    ("TSAP6" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("ER-α" . SPARSER::PROTEIN) ("Rab family" . SPARSER::PROTEIN)
    ("RAB27B" . SPARSER::PROTEIN)
    ("the RNAP II elongation complex" . SPARSER::BIO-COMPLEX)
    ("Sp1, c-Myc, AP-2, AP-4, and NF-1" . SPARSER::COLLECTION)
    ("NF-1" . SPARSER::PROTEIN) ("PAF" . SPARSER::PROTEIN-FAMILY)
    ("SPT5 CTR and RNAP II CTR" . SPARSER::PROTEIN)
    ("CTR and RNAP" . SPARSER::COLLECTION)
    ("CDK9 and cyclin-T" . SPARSER::COLLECTION)
    ("CCNT1 or CCNT2" . SPARSER::COLLECTION) ("NGN" . SPARSER::PROTEIN)
    ("carboxy" . SPARSER::MOLECULE)
    ("the eukaryotic SPT4-SPT5 complex" . SPARSER::BIO-COMPLEX)
    ("SPT4-SPT5" . SPARSER::COLLECTION) ("pol" . SPARSER::PROTEIN)
    ("senescence-associated β-galactosidase" . SPARSER::PROTEIN)
    ("SUPT5H -specfic shRNA" . SPARSER::PROTEIN)
    ("Meanwhile hTERT mRNA" . SPARSER::PROTEIN)
    ("SUPT5H and hTERT" . SPARSER::COLLECTION)
    ("analysis showed distinct DNA" . SPARSER::DNA)
    ("SPT5-antibody" . SPARSER::COLLECTION)
    ("chromatin and normal IgG" . SPARSER::COLLECTION)
    ("normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein and DNA" . SPARSER::COLLECTION)
    ("proteins and streptavidin-agarose" . SPARSER::COLLECTION)
    ("-biotinylated double-stranded oligonucleotide DNA" . SPARSER::DNA)
    ("oligonucleotide" . SPARSER::MOLECULE)
    ("a novel tumor biomarker or a cancer therapeutic target"
     . SPARSER::COLLECTION)
    ("WT1 and p53" . SPARSER::COLLECTION)
    ("mRNA and telomerase activity" . SPARSER::COLLECTION)
    ("telomerase RNA component, and telomerase accessory proteins"
     . SPARSER::PROTEIN)
    ("telomerase RNA component, and telomerase" . SPARSER::COLLECTION)
    ("holoenzyme" . SPARSER::PROTEIN)
    ("protein and activator" . SPARSER::COLLECTION)
    ("hTERT" . SPARSER::PROTEIN) ("NaHCO3" . SPARSER::DRUG)
    ("AP-4" . SPARSER::PROTEIN) ("AP-2" . SPARSER::PROTEIN)
    ("CCNT2" . SPARSER::PROTEIN) ("CCNT1" . SPARSER::PROTEIN)
    ("SPT4" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("H-2" . SPARSER::PROTEIN) ("streptavidin-agarose" . SPARSER::DRUG)
    ("WT1" . SPARSER::PROTEIN) ("telomerase RNA component" . SPARSER::RNA)
    ("SUPT5H" . SPARSER::PROTEIN) ("SPT5" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("a novel diagnostic biomarker" . SPARSER::MOLECULE)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("c-myc and cyclin" . SPARSER::COLLECTION)
    ("both an oncogene and metastasis suppressor" . SPARSER::COLLECTION)
    ("EMT and stem-like" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("NDRG1, β-catenin and CD44" . SPARSER::COLLECTION)
    ("IRS" . SPARSER::PROTEIN)
    ("which increases nuclear β-catenin and its down-stream target CD44 [ xref ]"
     . SPARSER::COLLECTION)
    ("NDRG1, which increases nuclear β-catenin and its down-stream target CD44 [ xref ]"
     . SPARSER::COLLECTION)
    ("which increases nuclear β-catenin" . SPARSER::PROTEIN)
    ("NDRG1 and β-catenin" . SPARSER::COLLECTION)
    ("NDRG1/sh" . SPARSER::COLLECTION)
    ("the successful β-catenin" . SPARSER::PROTEIN)
    ("NDRG1 and sh" . SPARSER::COLLECTION) ("FOP" . SPARSER::PROTEIN)
    ("-ATPase" . SPARSER::COLLECTION) ("-K +" . SPARSER::MOLECULE)
    ("NDRG1 and NDRG1" . SPARSER::COLLECTION)
    ("exogenous protein" . SPARSER::PROTEIN)
    ("approximately 45 kDa" . SPARSER::PROTEIN)
    ("approximately 43 and 45 kDa" . SPARSER::PROTEIN)
    ("p-GSK3β" . SPARSER::COLLECTION) ("p-β-catenin" . SPARSER::COLLECTION)
    ("gold" . SPARSER::MOLECULE) ("OCT4 and NANOG" . SPARSER::COLLECTION)
    ("NANOG, SOX2, OCT4 , and ALDH1" . SPARSER::COLLECTION)
    ("NANOG" . SPARSER::PROTEIN) ("CD44 and CD133" . SPARSER::COLLECTION)
    ("β-catenin and CD44" . SPARSER::COLLECTION)
    ("EMT and β-catenin" . SPARSER::COLLECTION)
    ("NDRG1 and nuclear β-catenin" . SPARSER::COLLECTION)
    ("NDRG1 and CD44" . SPARSER::COLLECTION)
    ("this latter molecule" . SPARSER::MOLECULE) ("B-27" . SPARSER::PROTEIN)
    ("Wnt3a" . SPARSER::PROTEIN) ("Prrx1" . SPARSER::PROTEIN)
    ("ALDH1" . SPARSER::PROTEIN) ("NDRG1" . SPARSER::PROTEIN)
    ("N-myc downstream-regulated gene" . SPARSER::PROTEIN)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("MEFs and HRAS" . SPARSER::COLLECTION)
    ("pro- and anti-tumorigenic" . SPARSER::COLLECTION)
    ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("KRAS G12D and KRAS G13D" . SPARSER::COLLECTION)
    ("CRC-" . SPARSER::PROTEIN)
    ("HRAS G12V and KRAS G12V" . SPARSER::COLLECTION)
    ("wild-type KRAS and other human RAS family isoforms"
     . SPARSER::COLLECTION)
    ("KRAS G13D and KRAS G12D" . SPARSER::COLLECTION)
    ("KRAS or KRAS" . SPARSER::COLLECTION)
    ("KRAS G12D and KRAS G12V [ xref ]" . SPARSER::COLLECTION)
    ("KRAS G13D , KRAS G12D and KRAS G12V [ xref ]" . SPARSER::COLLECTION)
    ("ATG5 or BECN1" . SPARSER::COLLECTION) ("AV" . SPARSER::MOLECULE)
    ("KRAS , ATG5 or BECN1" . SPARSER::COLLECTION)
    ("FLAG-KRAS G13D and FLAG-KRAS G12V (Figure xref )" . SPARSER::COLLECTION)
    ("KRAS " . SPARSER::PROTEIN) ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("the classical effectors" . SPARSER::EFFECTOR)
    ("the respective KRAS variant" . SPARSER::VARIANT)
    ("KRAS G12D or KRAS G12V" . SPARSER::COLLECTION)
    ("KRAS G13D , KRAS G12D or KRAS G12V" . SPARSER::COLLECTION)
    ("GFP-Atg8p" . SPARSER::PROTEIN-PAIR) ("siRNA-" . SPARSER::PROTEIN)
    ("Atg5-Atg12" . SPARSER::COLLECTION) ("Atg5" . SPARSER::PROTEIN)
    ("Atg" . SPARSER::DRUG) ("vacuolar hydrolases" . SPARSER::PROTEIN)
    ("GFP-Atg8" . SPARSER::COLLECTION) ("hydrolases" . SPARSER::PROTEIN)
    ("KRAS G12D and KRAS G12V" . SPARSER::COLLECTION)
    ("KRAS G13D , KRAS G12D and KRAS G12V" . SPARSER::COLLECTION)
    ("PMSF" . SPARSER::MOLECULE) ("long-lived proteins" . SPARSER::PROTEIN)
    ("-KRAS" . SPARSER::COLLECTION) ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATG" . SPARSER::DRUG) ("HRAS" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("URA3" . SPARSER::PROTEIN)
    ("TRP1" . SPARSER::PROTEIN) ("MAP2K2" . SPARSER::PROTEIN)
    ("MAP2K1" . SPARSER::PROTEIN) ("APG5L" . SPARSER::PROTEIN)
    ("KRAS2" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS family" . SPARSER::PROTEIN) ("ATG5" . SPARSER::PROTEIN)
    ("Beclin 1" . SPARSER::PROTEIN) ("Atg12" . SPARSER::PROTEIN)
    ("ATG8" . SPARSER::PROTEIN) ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLAG-KRAS" . SPARSER::PROTEIN) ("Bafilomycin A1" . SPARSER::DRUG)
    ("Ras2" . SPARSER::PROTEIN) ("S. cerevisiae" . SPARSER::PROTEIN)
    ("FLCN-mTOR" . SPARSER::COLLECTION) ("nitrogen (BUN)" . SPARSER::MOLECULE)
    ("our previously developed knockout mouse Flcn  flox/flox"
     . SPARSER::COLLECTION)
    ("the most common histologic variant" . SPARSER::VARIANT)
    ("AQP1, PAX2, and CK7" . SPARSER::COLLECTION)
    ("kidney-specific homozygous knockout mice Flcn  flox/flox"
     . SPARSER::COLLECTION)
    ("a universal cancer suppressor" . SPARSER::SUPPRESSOR)
    ("universal renal tumor suppressor" . SPARSER::SUPPRESSOR)
    ("TSC/TSC2" . SPARSER::COLLECTION) ("FH" . SPARSER::PROTEIN)
    ("type 1 (HPRC)" . SPARSER::PROTEIN) ("HPRC" . SPARSER::PROTEIN)
    ("VHL" . SPARSER::PROTEIN) ("folliculin" . SPARSER::PROTEIN)
    ("mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)"
     . SPARSER::COLLECTION)
    ("Ksp-Cre" . SPARSER::COLLECTION) ("flox/flox" . SPARSER::COLLECTION)
    ("flox" . SPARSER::PROTEIN) ("Flcn" . SPARSER::PROTEIN)
    ("FLCN" . SPARSER::PROTEIN) ("Ribosomal Protein" . SPARSER::PROTEIN)
    ("Foxn1" . SPARSER::PROTEIN) ("IFN-alpha" . SPARSER::PROTEIN)
    ("interferon alpha" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("PAX2" . SPARSER::PROTEIN) ("kidney-specific cadherin" . SPARSER::PROTEIN)
    ("von Hippel-Lindau" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("excellent ALK antibodies" . SPARSER::ANTIBODY)
    ("FAM150A, ALK and LTK" . SPARSER::COLLECTION)
    ("FAM150B-ALK" . SPARSER::COLLECTION)
    ("a very strong activator" . SPARSER::ACTIVATOR)
    ("different RTKs and their ligands" . SPARSER::COLLECTION)
    ("heparin, or heparin" . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("proteins and heparin" . SPARSER::COLLECTION) ("NB1" . SPARSER::PROTEIN)
    ("ALK-DelGR" . SPARSER::PROTEIN-PAIR)
    ("FAM150 and ALK" . SPARSER::COLLECTION)
    ("heparin and FAM150" . SPARSER::COLLECTION)
    ("available agonist/antagonist ALK antibodies" . SPARSER::ANTIBODY)
    ("glycines" . SPARSER::AMINO-ACID)
    ("FAM150A and FAM150B and ALK" . SPARSER::COLLECTION)
    ("FAM150B and ALK" . SPARSER::COLLECTION)
    ("FAM150A and ALK" . SPARSER::COLLECTION)
    ("LTK and ALK" . SPARSER::COLLECTION)
    ("a future potential therapeutic arm " . SPARSER::PROTEIN)
    ("arm " . SPARSER::PROTEIN) ("ligands " . SPARSER::LIGAND)
    ("ALKs" . SPARSER::PROTEIN) ("Drosophila and HEN-1" . SPARSER::COLLECTION)
    ("bb" . SPARSER::MOLECULE) ("ALK-LTK" . SPARSER::COLLECTION)
    ("heparin and the FAM150 ligands" . SPARSER::COLLECTION)
    ("very basic proteins" . SPARSER::PROTEIN)
    ("MDK and PTN" . SPARSER::COLLECTION)
    ("FAM150A or FAM150B " . SPARSER::COLLECTION) ("CLB" . SPARSER::PROTEIN)
    ("FAM150A-ALK" . SPARSER::COLLECTION) ("FAM150-ALK" . SPARSER::COLLECTION)
    ("Drosophila " . SPARSER::PROTEIN) ("FAM150" . SPARSER::PROTEIN)
    ("ALK-FAM150" . SPARSER::PROTEIN-PAIR)
    ("both HA-tagged FAM150A and HA-tagged FAM150B" . SPARSER::COLLECTION)
    ("ALK and FAM150A" . SPARSER::COLLECTION)
    ("FAM150A and FAM150B " . SPARSER::COLLECTION)
    ("FAM150B " . SPARSER::PROTEIN) ("SPR" . SPARSER::PROTEIN)
    ("Gal" . SPARSER::PROTEIN) ("FAM150A" . SPARSER::PROTEIN)
    ("human midkine (MDK) and pleiotrophin (PTN)" . SPARSER::COLLECTION)
    ("midkine (MDK)" . SPARSER::PROTEIN)
    ("previously proposed vertebrate ligands" . SPARSER::LIGAND)
    ("PTN" . SPARSER::PROTEIN) ("pleiotrophin " . SPARSER::PROTEIN)
    ("MDK" . SPARSER::PROTEIN) ("midkine" . SPARSER::PROTEIN)
    ("FAM150A or FAM150B" . SPARSER::COLLECTION) ("FAM150B" . SPARSER::PROTEIN)
    ("FAM150A " . SPARSER::PROTEIN)
    ("purified FAM150A protein as well as FAM150A-HA and FAM150B-HA"
     . SPARSER::COLLECTION)
    ("FAM150A-HA and FAM150B-HA" . SPARSER::COLLECTION)
    ("FAM150B-HA" . SPARSER::PROTEIN-PAIR)
    ("FAM150A-HA" . SPARSER::PROTEIN-PAIR) ("heparin" . SPARSER::PROTEIN)
    ("employed antibodies" . SPARSER::ANTIBODY)
    ("downstream pERK5 ( xref ) and pERK1/2 ( xref )" . SPARSER::COLLECTION)
    ("pERK5 " . SPARSER::PROTEIN) ("pERK" . SPARSER::PROTEIN)
    ("exogenous ALK" . SPARSER::PROTEIN) ("Sf21" . SPARSER::PROTEIN)
    ("crizotinib " . SPARSER::DRUG) ("ALK and LTK" . SPARSER::COLLECTION)
    ("ALK and the related LTK" . SPARSER::COLLECTION)
    ("their membrane proximal ECD" . SPARSER::PROTEIN)
    ("the elusive ligands" . SPARSER::LIGAND) ("ALK " . SPARSER::PROTEIN)
    ("receptor " . SPARSER::RECEPTOR) ("ECDs" . SPARSER::PROTEIN)
    ("LTK" . SPARSER::PROTEIN) ("LDLa" . SPARSER::PROTEIN)
    ("a classical receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ligand " . SPARSER::MOLECULE)
    ("the human ALK protein alongside either FAM150A or FAM150B"
     . SPARSER::COLLECTION)
    ("FAM150A or FAM150B" . SPARSER::COLLECTION)
    ("what signal molecules" . SPARSER::MOLECULE)
    ("FAM150A and FAM150B" . SPARSER::COLLECTION) ("FAM" . SPARSER::PROTEIN)
    ("ALK 4" . SPARSER::PROTEIN) ("protein-G" . SPARSER::PROTEIN)
    ("ALK 5 µ" . SPARSER::PROTEIN) ("ALK 5" . SPARSER::PROTEIN)
    ("serum albumin " . SPARSER::PROTEIN) ("Tween20" . SPARSER::MOLECULE)
    ("sodium bicarbonate" . SPARSER::DRUG)
    ("Monoclonal antibody" . SPARSER::DRUG)
    ("Triton X-100" . SPARSER::MOLECULE) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("HEN-1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("pERK1/2 " . SPARSER::PROTEIN) ("A-5 protein" . SPARSER::PROTEIN)
    ("HEN-1 " . SPARSER::PROTEIN)
    ("Anaplastic Lymphoma Kinase" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN)
    ("a promising prognostic biomarker" . SPARSER::MOLECULE)
    ("AREG mRNA and the secretion AREG protein" . SPARSER::COLLECTION)
    ("oncoproteins, E6 and E7" . SPARSER::COLLECTION)
    ("p53 and pRb" . SPARSER::COLLECTION)
    ("TGF -α, AREG , and EGFR" . SPARSER::COLLECTION)
    ("a potential prognostic biomarker" . SPARSER::MOLECULE)
    ("many cell proliferation-associated genes" . SPARSER::GENE)
    ("especially HPV type 16 and type 18" . SPARSER::COLLECTION)
    ("especially HPV type" . TYPE)
    ("HPV16-E6 or HPV16-E6/E7" . SPARSER::COLLECTION)
    ("β-TrCP and LATS1/2" . SPARSER::COLLECTION)
    ("HT3-CTRL and HT3-E6" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("AG1478 and verteporfin" . SPARSER::COLLECTION)
    ("Verteporfin" . SPARSER::DRUG)
    ("verteporfin and AG1478" . SPARSER::COLLECTION)
    ("AG1478 or verteporfin" . SPARSER::COLLECTION) ("MXIV" . SPARSER::PROTEIN)
    ("verteporfin" . SPARSER::DRUG) ("LATS1/2" . SPARSER::PROTEIN)
    ("TGF-α and AREG" . SPARSER::COLLECTION)
    ("S10 and S13" . SPARSER::COLLECTION)
    ("EGFR/MEK/ERK" . SPARSER::COLLECTION) ("EGFR/PI3K" . SPARSER::COLLECTION)
    ("ME180-MXIV" . SPARSER::PROTEIN-PAIR)
    ("amphiregulin ( AREG )" . SPARSER::PROTEIN)
    ("LATS1/2-MOB1" . SPARSER::PROTEIN-PAIR)
    ("LATS1 and MOB1" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("TGF-α/EGFR" . SPARSER::COLLECTION)
    ("TGF-α and EGFR" . SPARSER::COLLECTION)
    ("Amphiregulin (AREG)" . SPARSER::PROTEIN)
    ("Amphiregulin" . SPARSER::PROTEIN) ("ME180-" . SPARSER::PROTEIN)
    ("ME180" . SPARSER::PROTEIN) ("ME180-CTRL" . SPARSER::PROTEIN-PAIR)
    ("CTRL" . SPARSER::PROTEIN)
    ("the ME180-YAP group (952.5 ± 124.3) and the ME180-YAP S127A group (963.1 ± 232.6)"
     . SPARSER::COLLECTION)
    ("almost all genes" . SPARSER::GENE)
    ("ERBB4, Runx1, and Runx2" . SPARSER::COLLECTION) ("ME" . SPARSER::PROTEIN)
    ("Yes-associated protein" . SPARSER::PROTEIN)
    ("the growth-promoting transcriptional co-activator Yes-associated protein"
     . SPARSER::PROTEIN)
    ("Sav" . SPARSER::PROTEIN) ("ERBB" . SPARSER::PROTEIN)
    ("a major etiological molecule" . SPARSER::MOLECULE)
    ("TGF-α, AREG, and EGFR" . SPARSER::COLLECTION)
    ("TGF-α and amphiregulin" . SPARSER::COLLECTION)
    ("AREG" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("KE6" . SPARSER::PROTEIN) ("keratin-14" . SPARSER::PROTEIN)
    ("β-TrcP" . SPARSER::PROTEIN) ("s 5a" . SPARSER::PROTEIN)
    ("Transforming growth factor alpha" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("small t antigen" . SPARSER::PROTEIN) ("TGF -α" . SPARSER::PROTEIN)
    ("SOCS6" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("S13" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("S9B" . SPARSER::PROTEIN)
    ("End1" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("ERBB4" . SPARSER::PROTEIN) ("WWTR1" . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("MOB1" . SPARSER::PROTEIN)
    ("large tumor suppressor kinase 1" . SPARSER::PROTEIN)
    ("Salvador homolog 1" . SPARSER::PROTEIN)
    ("Drosophila )" . SPARSER::PROTEIN) ("TGF-α" . SPARSER::PROTEIN)
    ("the predominant component" . SPARSER::COMPONENT)
    ("KRAS or EGFR" . SPARSER::COLLECTION)
    ("dual altered driver genes" . SPARSER::GENE)
    ("the same histologic subtypes" . SPARSER::PROTEIN)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("proteins and EGFR" . SPARSER::COLLECTION) ("mucin" . SPARSER::PROTEIN)
    ("Components" . SPARSER::COMPONENT) ("had available DNA" . SPARSER::DNA)
    ("ALK-EML4" . SPARSER::COLLECTION) ("LCM" . SPARSER::PROTEIN-FAMILY)
    ("ALK and EGFR" . SPARSER::COLLECTION) ("ALK/EGFR" . SPARSER::COLLECTION)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acceptor" . SPARSER::MOLECULE)
    ("these heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("various heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("mTORC2 and cAMP" . SPARSER::COLLECTION)
    ("chemotactic gradient cues" . SPARSER::PROTEIN-FAMILY)
    ("Chemotaxis" . SPARSER::PROTEIN) ("P2Y2 and A2a" . SPARSER::COLLECTION)
    ("P2Y2 or A2a" . SPARSER::COLLECTION)
    ("mTOR and MAPK" . SPARSER::COLLECTION)
    ("mTORC1 and MAPK" . SPARSER::COLLECTION)
    ("fMLP and UTP" . SPARSER::COLLECTION)
    ("p38 and mTOR" . SPARSER::COLLECTION)
    ("p38 and mTORC1" . SPARSER::COLLECTION) ("Suramin" . SPARSER::DRUG)
    ("p38, mTORC1, and mTORC2" . SPARSER::COLLECTION)
    ("suramin" . SPARSER::DRUG) ("P2Y2, and UTP" . SPARSER::COLLECTION)
    ("UTP" . SPARSER::MOLECULE) ("receptors and mTOR" . SPARSER::COLLECTION)
    ("mTOR and mitochondria" . SPARSER::COLLECTION)
    ("purinergic receptors" . SPARSER::PROTEIN)
    ("carbenoxolone" . SPARSER::DRUG)
    ("Rapamycin and PP242" . SPARSER::COLLECTION)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION) ("Rhod" . SPARSER::PROTEIN)
    ("leukotriene" . SPARSER::MOLECULE)
    ("the nonhydrolyzable ATP analogue ATPγS" . SPARSER::PROTEIN)
    ("hydrazone (CCCP)" . SPARSER::MOLECULE) ("hydrazone" . SPARSER::MOLECULE)
    ("fMLP" . SPARSER::PROTEIN) ("external cues" . SPARSER::PROTEIN-FAMILY)
    ("tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTORC2 and AC9" . SPARSER::COLLECTION)
    ("cAMP/protein" . SPARSER::COLLECTION)
    ("P2Y2 and A3" . SPARSER::COLLECTION) ("FPR" . SPARSER::PROTEIN)
    ("ATP and other nucleotides ( xref ; xref )" . SPARSER::COLLECTION)
    ("adenosine (A1, A2a, A2b, and A3), P2X receptors recognizing ATP (P2X1-7), and P2Y receptors recognizing ATP"
     . SPARSER::COLLECTION)
    ("external chemotactic cues" . SPARSER::PROTEIN-FAMILY)
    ("LEGI" . SPARSER::PROTEIN)
    ("polymorphonuclear neutrophils" . SPARSER::PROTEIN)
    ("Efficient chemotaxis" . SPARSER::PROTEIN)
    ("rapamycin or PP242" . SPARSER::COLLECTION)
    ("chemotactic cues" . SPARSER::PROTEIN-FAMILY)
    ("Neutrophils" . SPARSER::PROTEIN) ("mTOR and P2Y2" . SPARSER::COLLECTION)
    ("cAMP/PKA" . SPARSER::COLLECTION) ("Neutrophil" . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("Fluo4" . SPARSER::DRUG)
    ("min −1" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("CD39" . SPARSER::PROTEIN) ("panx1" . SPARSER::PROTEIN)
    ("pannexin 1" . SPARSER::PROTEIN) ("cAMP-dependent" . SPARSER::PROTEIN)
    ("CGS21680" . SPARSER::MOLECULE) ("S3 B" . SPARSER::PROTEIN)
    ("JC-1" . SPARSER::MOLECULE) ("LTB4" . SPARSER::PROTEIN)
    ("ATPγS" . SPARSER::PROTEIN) ("AC9" . SPARSER::PROTEIN)
    ("formyl peptide receptor" . SPARSER::PROTEIN) ("P2X1" . SPARSER::PROTEIN)
    ("adenosine monophosphate" . SPARSER::MOLECULE) ("PP242" . SPARSER::DRUG)
    ("Adenosine triphosphate" . SPARSER::MOLECULE) ("P2Y2" . SPARSER::PROTEIN)
    ("mRNA and ncRNA" . SPARSER::COLLECTION)
    ("comprehensive mapping" . SPARSER::PROTEIN)
    ("mRNAs and microRNAs" . SPARSER::COLLECTION)
    ("some mRNAs and one mRNA" . SPARSER::COLLECTION)
    ("XIST" . SPARSER::PROTEIN) ("bisulphite" . SPARSER::MOLECULE)
    ("formins" . SPARSER::PROTEIN) ("Formin" . SPARSER::PROTEIN)
    ("formin" . SPARSER::PROTEIN) ("Formins" . SPARSER::PROTEIN)
    ("Stat" . SPARSER::PROTEIN) ("CD74 and FMNL2" . SPARSER::COLLECTION)
    ("miRNAs and lncRNAs" . SPARSER::COLLECTION)
    ("BC‐related genes and oestrogen responsive genes" . SPARSER::COLLECTION)
    ("mRNA and lncRNAs" . SPARSER::COLLECTION)
    ("Around 723 differentially" . SPARSER::PROTEIN)
    ("mRNA and lncRNA" . SPARSER::COLLECTION)
    ("lncRNA and protein‐coding" . SPARSER::COLLECTION)
    ("180K Agilent human lncRNA+mRNA Array v2.0" . SPARSER::PROTEIN)
    ("ER−, PR− and HER2−" . SPARSER::COLLECTION) ("HER2−" . SPARSER::PROTEIN)
    ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("lncRNAs and mRNAs" . SPARSER::COLLECTION)
    ("miRNA–mRNA" . SPARSER::COLLECTION) ("miRNA–miRNA" . SPARSER::COLLECTION)
    ("Xist" . SPARSER::PROTEIN) ("Mature miRNAs" . SPARSER::PROTEIN)
    ("ncRNA" . SPARSER::RNA) ("CTNNB1" . SPARSER::PROTEIN)
    ("S11" . SPARSER::PROTEIN) ("NFAT1" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("FMNL2" . SPARSER::PROTEIN) ("etc ." . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN) ("HBP1" . SPARSER::PROTEIN)
    ("pCR2" . SPARSER::PROTEIN) ("functional RNA" . SPARSER::RNA)
    ("CD74" . SPARSER::PROTEIN)
    ("carboplatin or other chemotherapeutic doublet agents"
     . SPARSER::COLLECTION)
    ("ECOG-PS" . SPARSER::COLLECTION) ("PS" . SPARSER::PROTEIN)
    ("mutated patients received erlotinib" . SPARSER::DRUG)
    ("Vinorelbine" . SPARSER::DRUG)
    ("The latter received pemetrexed" . SPARSER::DRUG)
    ("HSP90–Src" . SPARSER::COLLECTION)
    ("multiple oncogenic HSP90 client proteins" . SPARSER::PROTEIN)
    ("EMT and 5-FU" . SPARSER::COLLECTION)
    ("PI3K, Akt, and NF-κB" . SPARSER::COLLECTION)
    ("driving EMT" . SPARSER::PROTEIN)
    ("extracellular HSP90 and Src" . SPARSER::COLLECTION)
    ("several HSP90 client proteins" . SPARSER::PROTEIN)
    ("Src, EGFR, IGF-1R, and Akt" . SPARSER::COLLECTION)
    ("FAK, Erk1/2 and mTOR" . SPARSER::COLLECTION)
    ("HSP90/Src" . SPARSER::COLLECTION)
    ("5-FU and dasatinib" . SPARSER::COLLECTION)
    ("Src and Akt" . SPARSER::COLLECTION)
    ("HSP90 and Src" . SPARSER::COLLECTION)
    ("Akt (LY294002) or EGFR (erlotinib)" . SPARSER::COLLECTION)
    ("AAG" . SPARSER::PROTEIN) ("TYMS, Src and pSrc" . SPARSER::COLLECTION)
    ("pSrc" . SPARSER::PROTEIN) ("HSP90 client proteins" . SPARSER::PROTEIN)
    ("EGFR, IGF-1R, and Src" . SPARSER::COLLECTION)
    ("EGFR, IGF-1R, Src, Akt, and mTOR" . SPARSER::COLLECTION)
    ("Erk, mTOR, and p70S6K" . SPARSER::COLLECTION)
    ("EGFR, IGF-1R, Src, and Akt" . SPARSER::COLLECTION)
    ("several kinases and their effectors" . SPARSER::COLLECTION)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("EGFR, IGF-1R, Src, FAK, Akt, Erk1/2, mTOR, MEK1/2, and p70S6K"
     . SPARSER::COLLECTION)
    ("β-catenin and TGF-β1" . SPARSER::COLLECTION) ("diphenyl" . SPARSER::DRUG)
    ("clinically available inhibitors" . SPARSER::INHIBITOR)
    ("Src or HSP90" . SPARSER::COLLECTION)
    ("several client oncoproteins" . SPARSER::PROTEIN)
    ("Src, ErbB2, Akt, and Raf" . SPARSER::COLLECTION)
    ("cetuximab, cisplatin and oxaliplatin" . SPARSER::COLLECTION)
    ("antimetabolite" . SPARSER::DRUG) ("HSP90-Src" . SPARSER::COLLECTION)
    ("HSP90 or Src" . SPARSER::COLLECTION)
    ("HSP90 or constitutive active Src" . SPARSER::COLLECTION)
    ("client proteins" . SPARSER::PROTEIN) ("subline" . SPARSER::PROTEIN)
    ("TYMS" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("actinomycin D or 8AA" . SPARSER::COLLECTION)
    ("DNA damage-independent cancer therapeutics" . SPARSER::THERAPEUTICS)
    ("Chemotherapeutic drugs" . SPARSER::DRUG)
    ("mRNA-MDM2" . SPARSER::COLLECTION)
    ("p53-dependent transcriptional elongation" . SPARSER::PROTEIN)
    ("more active transcriptional elongation" . SPARSER::PROTEIN)
    ("enzymes and RNA" . SPARSER::COLLECTION)
    ("pig-3 and 14–3-3 σ" . SPARSER::COLLECTION) ("pig-3" . SPARSER::PROTEIN)
    ("low dose actinomycin D or 8AA" . SPARSER::COLLECTION)
    ("Inhibitors of general transcription and RNA synthesis"
     . SPARSER::COLLECTION)
    ("the p21 ( p = 0.029) gene and a trend" . SPARSER::COLLECTION)
    ("p53 and H3K36" . SPARSER::COLLECTION)
    ("chromatin and pre-mRNA" . SPARSER::COLLECTION)
    ("active transcriptional elongation" . SPARSER::PROTEIN)
    ("Lysine" . SPARSER::AMINO-ACID)
    ("p21 (+7011) and puma (+6014) genes" . SPARSER::COLLECTION)
    ("productive transcriptional elongation" . SPARSER::PROTEIN)
    ("TEFb" . SPARSER::PROTEIN)
    ("ubiquitin-proteosome" . SPARSER::PROTEIN-PAIR)
    ("the p21 target gene's" . SPARSER::GENE)
    ("p21 ( p = 0.005) and puma ( p = 0.023) genes" . SPARSER::COLLECTION)
    ("the previously investigated p21 gene" . SPARSER::GENE)
    ("wild-type p53 and high MDM2" . SPARSER::COLLECTION)
    ("dysfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("etoposide or actinomycin D" . SPARSER::COLLECTION)
    ("nucleoside" . SPARSER::MOLECULE)
    ("ribosomal proteins" . SPARSER::PROTEIN) ("rRNA" . SPARSER::PROTEIN)
    ("high MDM2 as well as mutant p53 [ xref ]" . SPARSER::COLLECTION)
    ("Inducers" . SPARSER::MOLECULE)
    ("had compromised transcriptional elongation" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("TFIIE" . SPARSER::PROTEIN-FAMILY)
    ("genes and forms" . SPARSER::COLLECTION)
    ("standard chemotherapeutic DNA" . SPARSER::DNA)
    ("homozygous G/G mdm2 SNP309" . SPARSER::PROTEIN)
    ("alterative MDM2" . SPARSER::PROTEIN) ("MDM2-p53" . SPARSER::COLLECTION)
    ("adenosine" . SPARSER::PROTEIN)
    ("etoposide and actinomycin D" . SPARSER::COLLECTION)
    ("total and initiated RNA polymerase II" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN) ("p21 and puma" . SPARSER::COLLECTION)
    ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-Histone" . SPARSER::PROTEIN) ("Cdk9" . SPARSER::PROTEIN)
    ("N-20" . SPARSER::PROTEIN) ("C-16" . SPARSER::PROTEIN)
    ("gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RPL26" . SPARSER::PROTEIN)
    ("serine 2" . SPARSER::PROTEIN) ("CDK9" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("Actinomycin D" . SPARSER::MOLECULE)
    ("ML-1" . SPARSER::PROTEIN) ("MST1 and LATS1" . SPARSER::COLLECTION)
    ("the predominant transducers" . SPARSER::PROTEIN)
    ("transducers" . SPARSER::PROTEIN) ("CTGF and EMT" . SPARSER::COLLECTION)
    ("a typical target gene" . SPARSER::GENE)
    ("TAZ and 4SA" . SPARSER::COLLECTION)
    ("TAZ, 4SA, or 4SA-S51A" . SPARSER::COLLECTION)
    ("Merlin and TAZ" . SPARSER::COLLECTION)
    ("Merlin and 4SA" . SPARSER::COLLECTION)
    ("×GTIIC-luciferase" . SPARSER::COLLECTION)
    ("MST and LATS" . SPARSER::COLLECTION) ("LATS" . SPARSER::PROTEIN)
    ("MST" . SPARSER::PROTEIN) ("LATS1 or MST1" . SPARSER::COLLECTION)
    ("LATS1 and MST1/2" . SPARSER::COLLECTION)
    ("Sh-TAZ-1" . SPARSER::COLLECTION) ("HA-TAZ" . SPARSER::COLLECTION)
    ("TAZ (BxPC-3/AsPC-1-pBABE-TAZ) and PANC-1" . SPARSER::COLLECTION)
    ("-Sh-TAZ-2" . SPARSER::COLLECTION) ("Merlin/NF2" . SPARSER::COLLECTION)
    ("Ezrin" . SPARSER::PROTEIN)
    ("cytoskeleton-associated proteins" . SPARSER::PROTEIN)
    ("connective tissue growth factor (CTGF) and survivin"
     . SPARSER::COLLECTION)
    ("CTGF" . SPARSER::PROTEIN) ("TEAD" . SPARSER::PROTEIN)
    ("TAZ and its paralog Yes-associated protein (YAP) [ xref ]"
     . SPARSER::COLLECTION)
    ("its paralog Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("LATS1 and LATS2" . SPARSER::COLLECTION)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("Merlin" . SPARSER::PROTEIN) ("TAZ" . SPARSER::PROTEIN)
    ("PANC-1" . SPARSER::PROTEIN) ("band 4.1 protein" . SPARSER::PROTEIN)
    ("band 4.1" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("LATS1" . SPARSER::PROTEIN)
    ("MST1" . SPARSER::PROTEIN) ("a larger cohort" . SPARSER::MOLECULE)
    ("TP53/MDM2" . SPARSER::COLLECTION) ("azacitidine" . SPARSER::DRUG)
    ("larger validation cohorts" . SPARSER::MOLECULE)
    ("del(5q) MDS and non-del(5q) MDS" . SPARSER::PROTEIN)
    ("MDS and non-del" . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN) ("MDM2/TP53" . SPARSER::COLLECTION)
    ("cytogenetic risk group" . SPARSER::MOLECULE)
    ("TP53 R72P and MDM2 SNP309" . SPARSER::COLLECTION)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("TP53 and MDM2" . SPARSER::COLLECTION) ("lenalidomide" . SPARSER::DRUG)
    ("free ribosomal proteins" . SPARSER::PROTEIN)
    ("TP53 R72P and MDM2 SNP309 SNPs" . SPARSER::COLLECTION)
    ("MDS" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("− 2" . SPARSER::PROTEIN) ("RPS14" . SPARSER::PROTEIN)
    ("SNP309" . SPARSER::PROTEIN) ("homolog of murine" . SPARSER::PROTEIN)
    ("a fully-active p53-MDM2 complex" . SPARSER::BIO-COMPLEX)
    ("p53-MDM2" . SPARSER::COLLECTION) ("Slug and MDM2" . SPARSER::COLLECTION)
    ("MDM2 and Ki-67" . SPARSER::COLLECTION)
    ("vimentin and Slug" . SPARSER::COLLECTION)
    ("BPH-1 or CAFTD" . SPARSER::COLLECTION)
    ("several phosphorylation-insensitive monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("Twist1 or Twist2, ZEB1, and ZEB2" . SPARSER::COLLECTION)
    ("Twist2, ZEB1, and ZEB2" . SPARSER::COLLECTION)
    ("BPH-1 or CAFTD03" . SPARSER::COLLECTION)
    ("SV40-transformed cells BPH-1 and CAFTD" . SPARSER::COLLECTION)
    ("p53, p21 or GDF-15" . SPARSER::COLLECTION)
    ("p53 and its downstream targets" . SPARSER::COLLECTION)
    ("p21 Cip1/Waf1" . SPARSER::COLLECTION)
    ("BPH-1 and CAFTD" . SPARSER::COLLECTION)
    ("MDM2 or MDMX" . SPARSER::COLLECTION)
    ("BPH-1 and CAFTD03" . SPARSER::COLLECTION)
    ("EMT and MET-like" . SPARSER::COLLECTION)
    ("MDMX and vimentin" . SPARSER::COLLECTION)
    ("EMT- and MET-like" . SPARSER::COLLECTION) ("EMT-" . SPARSER::PROTEIN)
    ("EMT or MET" . SPARSER::COLLECTION) ("SV" . SPARSER::MOLECULE)
    ("Slug and vimentin" . SPARSER::COLLECTION)
    ("EMT/MET" . SPARSER::COLLECTION)
    ("E-cadherin and MDM2" . SPARSER::COLLECTION)
    ("MDM2 and E-cadherin" . SPARSER::COLLECTION)
    ("Cell lines E2 and E4" . SPARSER::COLLECTION)
    ("MDM2 and MDMX" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("tumor microenvironment-associated molecules" . SPARSER::MOLECULE)
    ("/Slug" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("TGF" . SPARSER::DRUG) ("EMT and MET" . SPARSER::COLLECTION)
    ("EMT, cell migration, metastasis, and therapy resistance"
     . SPARSER::COLLECTION)
    ("Membrane-bound" . SPARSER::PROTEIN) ("pGL2" . SPARSER::PROTEIN)
    ("basic helix-loop-helix family" . SPARSER::PROTEIN)
    ("Twist2" . SPARSER::PROTEIN) ("GDF-15" . SPARSER::PROTEIN)
    ("MG-132" . SPARSER::DRUG) ("BPH-1" . SPARSER::PROTEIN)
    ("miR-200c" . SPARSER::MOLECULE) ("ZEB2" . SPARSER::PROTEIN)
    ("celecoxib" . SPARSER::DRUG) ("Celecoxib" . SPARSER::DRUG)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("Cdc42, and Rac1" . SPARSER::COLLECTION)
    ("Ras, Rac1, and RhoA" . SPARSER::COLLECTION) ("RhoB" . SPARSER::PROTEIN)
    ("prostaglandin and other eicosanoids [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("IL1β, IL6, or TNFα" . SPARSER::COLLECTION)
    ("eicosanoids" . SPARSER::MOLECULE)
    ("Rac1, RhoA, and Cdc42" . SPARSER::COLLECTION)
    ("RhoGDI (RhoGDI-1) and D4-GDI (RhoGDI-2)" . SPARSER::COLLECTION)
    ("RhoGDI-1" . SPARSER::COLLECTION)
    ("the homologous D4-GDI" . SPARSER::PROTEIN) ("Fritz" . SPARSER::PROTEIN)
    ("both RhoGDI [ xref , xref ] and D4-GDI [ xref ]" . SPARSER::COLLECTION)
    ("weak and diffuse RhoGDI" . SPARSER::PROTEIN)
    ("benign tumors RhoGDI" . SPARSER::PROTEIN)
    ("prostaglandin" . SPARSER::PROTEIN)
    ("RhoGDI and COX-2" . SPARSER::COLLECTION)
    ("Cdc42 or RhoA" . SPARSER::COLLECTION)
    ("Cdc42 and RhoA" . SPARSER::COLLECTION)
    ("RhoGDI and D4-GDI" . SPARSER::COLLECTION)
    ("Rho GTPase and COX-2" . SPARSER::COLLECTION)
    ("-1or RhoGDI-α" . SPARSER::COLLECTION) ("RhoGDI-3" . SPARSER::COLLECTION)
    ("GEF or GAP" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RhoGEFs" . SPARSER::PROTEIN)
    ("Rac1, Cdc42, and RhoA" . SPARSER::COLLECTION)
    ("GTPases and COX-2" . SPARSER::COLLECTION) ("RhoGDI" . SPARSER::PROTEIN)
    ("Prostaglandin E 2" . SPARSER::MOLECULE)
    ("β–mercaptoethanol" . SPARSER::MOLECULE)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("G-protein coupled" . SPARSER::PROTEIN) ("IL1β" . SPARSER::PROTEIN)
    ("D4-GDI" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("MAPK, ERK1/2 or JNK" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("p38, ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("JNK, p38 and ERK1/2" . SPARSER::COLLECTION)
    ("retinal intracellular adhesion molecule (ICAM)-1" . SPARSER::PROTEIN)
    ("STZ" . SPARSER::DRUG) ("ICAM" . SPARSER::PROTEIN-FAMILY)
    ("Superoxide" . SPARSER::MOLECULE)
    ("NOX1, NOX2, NOX4 and NOX5" . SPARSER::COLLECTION)
    ("MAPK, ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("IL-8, MCP-1 and IL-6 " . SPARSER::COLLECTION)
    ("IL-8, MCP-1 and IL-6" . SPARSER::COLLECTION)
    ("MCP-1 and IL-6" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("NOX1, NOX2 and NOX4 " . SPARSER::COLLECTION)
    ("NOX1, NOX2 and NOX4" . SPARSER::COLLECTION)
    ("active NADPH oxidase complex" . SPARSER::BIO-COMPLEX)
    ("NOX 1, NOX2 and NOX4" . SPARSER::COLLECTION)
    ("P-1 and P-2" . SPARSER::COLLECTION) ("P-1 or P-2" . SPARSER::COLLECTION)
    ("IL-8 and monocyte chemotactic protein-1(MCP-1)" . SPARSER::COLLECTION)
    ("IL-6, IL-8 and monocyte chemotactic protein-1(MCP-1)"
     . SPARSER::COLLECTION)
    ("monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("oxidants" . SPARSER::MOLECULE)
    ("MAPK and nuclear factor-κB (NF-κB)" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("rennin-angiotensin" . SPARSER::COLLECTION)
    ("angiotensin" . SPARSER::PROTEIN) ("rennin" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("various NOX homologues and cytoplasmic components" . SPARSER::COLLECTION)
    ("an indispensable part" . SPARSER::COMPONENT)
    ("NOX5 and DUOX1/2" . SPARSER::COLLECTION)
    ("An essential subunit" . SPARSER::FRAGMENT)
    ("NOX1 and NOX2" . SPARSER::COLLECTION)
    ("DUOX1 and DUOX2" . SPARSER::COLLECTION)
    ("p40 phox , p47 phox and p67" . SPARSER::COLLECTION)
    ("subunits, p22 phox and gp91 phox" . SPARSER::COLLECTION)
    ("The active NOX complex" . SPARSER::BIO-COMPLEX)
    ("an essential enzyme" . SPARSER::ENZYME)
    ("oxidase (NOX)" . SPARSER::PROTEIN) ("COX" . SPARSER::PROTEIN)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("IL" . SPARSER::PROTEIN)
    ("AMD" . SPARSER::PROTEIN) ("substances" . SPARSER::SUBSTANCE)
    ("MAPK and NF-κB" . SPARSER::COLLECTION)
    ("inflammatory cytokine" . SPARSER::PROTEIN)
    ("hRPE" . SPARSER::PROTEIN-FAMILY) ("RPE" . SPARSER::PROTEIN)
    ("an indispensable component" . SPARSER::COMPONENT)
    ("NOX" . SPARSER::PROTEIN) ("p-ERK1" . SPARSER::PROTEIN)
    ("1-2 " . SPARSER::PROTEIN) ("NOX 4" . SPARSER::PROTEIN)
    ("BAY11-7082" . SPARSER::DRUG) ("IL-6 " . SPARSER::PROTEIN)
    ("NOX4 " . SPARSER::PROTEIN) ("NOX3" . SPARSER::PROTEIN)
    ("gp91phox" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("NOX 1" . SPARSER::PROTEIN) ("P-1 " . SPARSER::PROTEIN)
    ("P-2" . SPARSER::PROTEIN) ("P-1" . SPARSER::PROTEIN)
    ("NOX5" . SPARSER::PROTEIN) ("DUOX2" . SPARSER::PROTEIN)
    ("DUOX1" . SPARSER::PROTEIN) ("p67" . SPARSER::PROTEIN)
    ("p47 phox" . SPARSER::PROTEIN) ("p40 phox" . SPARSER::PROTEIN)
    ("NOX2" . SPARSER::PROTEIN) ("gp91 phox" . SPARSER::PROTEIN)
    ("p22 phox" . SPARSER::PROTEIN) ("Cytochrome b" . SPARSER::PROTEIN)
    ("cytochrome b" . SPARSER::PROTEIN)
    ("Nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("NOX1" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("p22phox" . SPARSER::PROTEIN)
    ("a strong candidate target molecule" . SPARSER::MOLECULE)
    ("FL BARD1 and/or other isoforms" . SPARSER::COLLECTION)
    ("excessive collagen" . SPARSER::PROTEIN)
    ("other hitherto not identified target proteins" . SPARSER::PROTEIN)
    ("BARD1-BRCA1" . SPARSER::COLLECTION)
    ("BARD1 and BRCA1" . SPARSER::COLLECTION)
    ("the centrosomal protein gamma-tubulin" . SPARSER::PROTEIN)
    ("BRCA1-BARD1" . SPARSER::COLLECTION)
    ("FL BARD1 and its isoforms" . SPARSER::COLLECTION)
    ("up-regulating FL BARD1 and its isoforms" . SPARSER::COLLECTION)
    ("Exon and intron" . SPARSER::COLLECTION) ("Exon" . SPARSER::PROTEIN)
    ("CCL18, matrix metalloproteinase-7, and interleukin-8"
     . SPARSER::COLLECTION)
    ("a novel biomarker and possible treatment target" . SPARSER::COLLECTION)
    ("possible treatment target" . SPARSER::TARGET-PROTEIN)
    ("the tumor suppressor BARD1 and its pro-proliferative isoform BARD1β"
     . SPARSER::COLLECTION)
    ("namely N19 recognizing FL BARD1 and possibly small isoforms (Fig.  xref )"
     . SPARSER::COLLECTION)
    ("mainly FL BARD1" . SPARSER::PROTEIN)
    ("namely N19 recognizing FL BARD1" . SPARSER::PROTEIN)
    ("FL BARD1 and the spliced isoform BARD1β" . SPARSER::COLLECTION)
    ("smaller isoforms" . SPARSER::ISOFORM)
    ("previously identified BARD1 isoforms" . SPARSER::ISOFORM)
    ("the entire BARD1" . SPARSER::PROTEIN)
    ("FL BARD1 and/or BARD1 isoforms" . SPARSER::COLLECTION)
    ("p53 and Bax" . SPARSER::COLLECTION)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("FL BARD1 or other isoforms" . SPARSER::COLLECTION)
    ("BARD1, BARD1β, and BARD1ε" . SPARSER::COLLECTION)
    ("Only FL BARD1" . SPARSER::PROTEIN) ("annexin" . SPARSER::PROTEIN)
    ("BARD1 or BARD1β" . SPARSER::COLLECTION)
    ("fibronectin and E-cadherin" . SPARSER::COLLECTION)
    ("fibronectin and BARD1" . SPARSER::COLLECTION)
    ("Fibronectin" . SPARSER::PROTEIN)
    ("actin and fibronectin" . SPARSER::COLLECTION)
    ("hypoxia and TGF-β" . SPARSER::COLLECTION)
    ("TGF-β and BARD1" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NuLi-1" . SPARSER::COLLECTION)
    ("CCD" . SPARSER::PROTEIN) ("Bleomycin" . SPARSER::DRUG)
    ("xylazine" . SPARSER::DRUG) ("ketamine" . SPARSER::DRUG)
    ("bleomycin" . SPARSER::DRUG) ("haematoxylin" . SPARSER::MOLECULE)
    ("DAB" . SPARSER::MOLECULE) ("goat" . SPARSER::PROTEIN)
    ("BARD1-p25" . SPARSER::COLLECTION) ("BARD1-C20" . SPARSER::COLLECTION)
    ("BARD1 and α-smooth-muscle-actin" . SPARSER::COLLECTION)
    ("emphysema" . SPARSER::PROTEIN) ("Paris" . SPARSER::PROTEIN)
    ("BARD1 and isoform" . SPARSER::COLLECTION)
    ("BARD1 and its isoforms" . SPARSER::COLLECTION)
    ("full length (FL) BARD1 and/or its isoforms" . SPARSER::COLLECTION)
    ("endoglin" . SPARSER::PROTEIN)
    ("the breast cancer predisposition gene product BRCA1 and a tumor suppressor"
     . SPARSER::COLLECTION)
    ("Protein and mRNA" . SPARSER::COLLECTION)
    ("BARD1 and BARD1β" . SPARSER::COLLECTION)
    ("BARD1 and/or its isoforms" . SPARSER::COLLECTION)
    ("Differentially" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-7" . SPARSER::PROTEIN)
    ("CCL18" . SPARSER::PROTEIN) ("NADPH oxidase 4" . SPARSER::PROTEIN)
    ("P25" . SPARSER::PROTEIN) ("p25" . SPARSER::PROTEIN)
    ("C20" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN) ("PTEN and AIF" . SPARSER::COLLECTION)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("our colorectal carcinoma cohort" . SPARSER::MOLECULE)
    ("protein and EMT" . SPARSER::COLLECTION)
    ("PTEN-PI3K/Akt" . SPARSER::COLLECTION)
    ("AIF and WNT/β-catenin signaling target genes" . SPARSER::COLLECTION)
    ("peroxidase" . SPARSER::PROTEIN) ("whose cysteine" . SPARSER::AMINO-ACID)
    ("Akt/GSk-3β" . SPARSER::COLLECTION) ("AIF or NAC" . SPARSER::COLLECTION)
    ("p53 and Stat3" . SPARSER::COLLECTION)
    ("an internal mitochondrial protein" . SPARSER::PROTEIN)
    ("a translational variant" . SPARSER::VARIANT)
    ("Akt and GSK-3β" . SPARSER::COLLECTION)
    ("TCF4, LEF1, and MMP7" . SPARSER::COLLECTION)
    ("Snail, and Slug" . SPARSER::COLLECTION)
    ("AIF and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("the mesenchymal markers fibronectin and vimentin" . SPARSER::COLLECTION)
    ("E-cadherin and plakoglobin" . SPARSER::COLLECTION)
    ("fibronectin and vimentin" . SPARSER::COLLECTION)
    ("plakoglobin" . SPARSER::PROTEIN) ("AIF or PTEN" . SPARSER::COLLECTION)
    ("AIF and/or PTEN" . SPARSER::COLLECTION)
    ("AIF and WNT/β-catenin signaling target genes (Fig xref F and G, xref and xref )"
     . SPARSER::COLLECTION)
    ("DKK1, LEF1, MMP7, TCF4, AXIN2, and ID2" . SPARSER::COLLECTION)
    ("LEF/TCF-responsive promoter Topflash luciferase (containing two sets of three copies of the LEF/TCF-binding sites) and its mutant"
     . SPARSER::COLLECTION)
    ("LEF/TCF" . SPARSER::COLLECTION)
    ("lymphoid enhancer-binding factor-1/T-cell factor-1"
     . SPARSER::COLLECTION)
    ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("PTEN/Akt/GSK-3β" . SPARSER::COLLECTION)
    ("PTEN–AIF" . SPARSER::COLLECTION)
    ("AIF, AIFsh2 and AIFsh3" . SPARSER::COLLECTION)
    ("N-acetyl-l-cysteine (NAC)" . SPARSER::MOLECULE)
    ("AIF, Akt, and GSK3-3β" . SPARSER::COLLECTION)
    ("the oxidative PTEN" . SPARSER::PROTEIN)
    ("the mitochondrial complex I subunits NADH–ubiquinone oxidoreductase 75 kDa subunit (Ndufs1) and Ndufs3"
     . SPARSER::COLLECTION)
    ("Ndufs1" . SPARSER::PROTEIN) ("DCP" . SPARSER::DRUG)
    ("DTT" . SPARSER::MOLECULE) ("dithiothreitol" . SPARSER::PROTEIN)
    ("the oxidized band around 70 kDa" . SPARSER::PROTEIN)
    ("exogenous H 2 O 2" . SPARSER::DRUG)
    ("a band around 70 kDa" . SPARSER::PROTEIN)
    ("Mitochondria" . SPARSER::PROTEIN)
    ("mitochondrial PTEN" . SPARSER::PROTEIN) ("mito" . SPARSER::DRUG)
    ("an intramitochondrial protein" . SPARSER::PROTEIN)
    ("mitochondria-resided AIF and mitochondrial complex I subunit NADH–ubiquinone oxidoreductase 30 kDa subunit (Ndufs3)"
     . SPARSER::COLLECTION)
    ("Ndufs3" . SPARSER::PROTEIN)
    ("trypsin and/or Triton X-100" . SPARSER::COLLECTION)
    ("iodixanol" . SPARSER::DRUG)
    ("AIF and cytochrome c" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE)
    ("mitochondria or intermitochondria" . SPARSER::COLLECTION)
    ("FAD1- or FAD2-deleted AIF mutant" . SPARSER::COLLECTION)
    ("FAD2-deleted AIF mutant" . SPARSER::MUTANT)
    ("FAD1 and FAD2" . SPARSER::COLLECTION)
    ("FAD1-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAD1 and/or FAD2 domains-deleted AIF mutants" . SPARSER::COLLECTION)
    ("FAD2 domains-deleted AIF mutants" . SPARSER::MUTANT)
    ("FAD" . SPARSER::MOLECULE) ("AIF and AIFsh2" . SPARSER::COLLECTION)
    ("intro recombinant GST-tagged full-length AIF (AIF-FL) and its three fragments"
     . SPARSER::COLLECTION)
    ("AIF and PTEN" . SPARSER::COLLECTION) ("HA-PTEN" . SPARSER::COLLECTION)
    ("AIF-Flag" . SPARSER::COLLECTION) ("-PTEN" . SPARSER::COLLECTION)
    ("Flag-PTEN" . SPARSER::COLLECTION) ("AIF–PTEN" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XIAP and OPA1" . SPARSER::COLLECTION)
    ("the potential AIF-interacting proteins" . SPARSER::PROTEIN)
    ("mitogens" . SPARSER::MITOGEN)
    ("Both endogenous hydrogen peroxide (H 2 O 2 ) and exogenous hydrogen peroxide (H 2 O 2 )"
     . SPARSER::COLLECTION)
    ("exogenous hydrogen peroxide" . SPARSER::DRUG)
    ("disulphide" . SPARSER::MOLECULE)
    ("phosphatidylinositol" . SPARSER::MOLECULE) ("flavin" . SPARSER::MOLECULE)
    ("a bacterial oxygenase-coupled nicotinamide adenine dinucleotide (NADH)-dependent ferredoxin reductase"
     . SPARSER::PROTEIN)
    ("NADH" . SPARSER::MOLECULE) ("oxidoreductase" . SPARSER::PROTEIN)
    ("AIF" . SPARSER::PROTEIN) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K4" . SPARSER::PROTEIN) ("HCO 3" . SPARSER::MOLECULE)
    ("GSk-3β" . SPARSER::PROTEIN) ("C–E" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("ID2" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("LEF1" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN) ("T-cell factor-1" . SPARSER::PROTEIN)
    ("lymphoid enhancer-binding factor-1" . SPARSER::PROTEIN)
    ("WNT/β" . SPARSER::PROTEIN) ("N-acetyl-l-cysteine" . SPARSER::MOLECULE)
    ("Oxidoreductase activity" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN)
    ("NADH–ubiquinone oxidoreductase" . SPARSER::PROTEIN)
    ("Bcl-X" . SPARSER::PROTEIN) ("FAD1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHCHD4" . SPARSER::PROTEIN) ("OPA1" . SPARSER::PROTEIN)
    ("E3 ubiquitin–protein ligase CHIP" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide phosphate oxidase" . SPARSER::PROTEIN)
    ("thioredoxin-interacting protein" . SPARSER::PROTEIN)
    ("Prdx1" . SPARSER::PROTEIN) ("peroxiredoxin 1" . SPARSER::PROTEIN)
    ("PI3K–Akt" . SPARSER::PROTEIN) ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("glutathione reductase" . SPARSER::PROTEIN)
    ("ferredoxin reductase" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("Apoptosis-inducing" . SPARSER::PROTEIN)
    ("TAC3, KISS1R and kisspeptin" . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN) ("FSH" . SPARSER::DRUG)
    ("FSHB" . SPARSER::PROTEIN)
    ("a key hypothalamic activator" . SPARSER::ACTIVATOR)
    ("kisspeptin" . SPARSER::PROTEIN)
    ("CHD7 , FGFR1 and SOX10" . SPARSER::COLLECTION)
    ("GNRH" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA1 , CHEK2 and MSH6" . SPARSER::COLLECTION)
    ("robust cancer predisposition genes" . SPARSER::GENE)
    ("MSH5 and DMC1" . SPARSER::COLLECTION)
    ("MCM8 and MCM9" . SPARSER::COLLECTION) ("meiotic" . SPARSER::DRUG)
    ("Fbh1" . SPARSER::PROTEIN) ("RAP80 and Abraxas" . SPARSER::COLLECTION)
    ("FAM175A (Abraxas) and UIMC1 (RAP80)" . SPARSER::COLLECTION)
    ("BRE (BRCC45), FAM175A (Abraxas) and UIMC1 (RAP80)" . SPARSER::COLLECTION)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the associated variant" . SPARSER::VARIANT)
    ("HELB and SLC04A1" . SPARSER::COLLECTION)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ANM-associated SNPs in/near five genes" . SPARSER::GENE)
    ("KISS1R, TAC3, CHD7 , SOX10 and FGFR1" . SPARSER::COLLECTION)
    ("all ANM-associated SNPs in/near genes" . SPARSER::GENE)
    ("MR" . SPARSER::PROTEIN) ("urate" . SPARSER::MOLECULE)
    ("ovarian function genes" . SPARSER::GENE) ("POLG" . SPARSER::PROTEIN)
    ("delC" . SPARSER::PROTEIN) ("CHEK2 and BRSK1" . SPARSER::COLLECTION)
    ("mismatch" . SPARSER::PROTEIN) ("BRE" . SPARSER::PROTEIN)
    ("a known breast cancer susceptibility variant and all"
     . SPARSER::COLLECTION)
    ("GRAIL" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("aspartate" . SPARSER::PROTEIN) ("fine-mapping" . SPARSER::PROTEIN)
    ("HELB and SLCO4A1" . SPARSER::COLLECTION) ("estrone" . SPARSER::DRUG)
    ("HELB (rs75770066, MAF= 3.6%, beta = 0.85 year/allele, P=1.2×10 −31 ) and SLCO4A1 (rs140267842, MAF= 0.8%, beta=0.79, P=1.6×10 −8 )"
     . SPARSER::COLLECTION)
    ("The combined analysis identified missense alleles" . SPARSER::ALLELE)
    ("HELB" . SPARSER::PROTEIN) ("GCTA" . SPARSER::PROTEIN)
    ("POI" . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("GPR54" . SPARSER::PROTEIN) ("STARD3" . SPARSER::PROTEIN)
    ("DNA meiotic recombinase 1" . SPARSER::PROTEIN)
    ("DMC1" . SPARSER::PROTEIN) ("MCM9" . SPARSER::PROTEIN)
    ("FBXO18" . SPARSER::PROTEIN) ("RAP80" . SPARSER::PROTEIN)
    ("BRCC45" . SPARSER::PROTEIN) ("brca1" . SPARSER::PROTEIN)
    ("OR 1" . SPARSER::PROTEIN) ("FGFR1" . SPARSER::PROTEIN)
    ("SOX10" . SPARSER::PROTEIN) ("CHD7" . SPARSER::PROTEIN)
    ("TAC3" . SPARSER::PROTEIN) ("KISS1R" . SPARSER::PROTEIN)
    ("TDRD3" . SPARSER::PROTEIN) ("EIF2B4" . SPARSER::PROTEIN)
    ("MCM8" . SPARSER::PROTEIN) ("Autosomal recessive" . SPARSER::PROTEIN)
    ("BRSK1" . SPARSER::PROTEIN) ("PARP2" . SPARSER::PROTEIN)
    ("APEX1" . SPARSER::PROTEIN) ("MSH5" . SPARSER::PROTEIN)
    ("UIMC1" . SPARSER::PROTEIN) ("FAM175A" . SPARSER::PROTEIN)
    ("POLR2H" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("member 4A1" . SPARSER::PROTEIN)
    ("solute carrier organic anion transporter family" . SPARSER::PROTEIN)
    ("SLCO4A1" . SPARSER::PROTEIN) ("SE 1" . SPARSER::PROTEIN)
    ("BTK and JAKs" . SPARSER::COLLECTION)
    ("Ruxolitinib (psoriasis, myelofibrosis and rheumatoid arthritis) and Tofacitinib (psoriasis and rheumatoid arthritis)"
     . SPARSER::COLLECTION)
    ("Pacritinib" . SPARSER::DRUG) ("Lestaurtinib" . SPARSER::DRUG)
    ("CYT" . SPARSER::MOLECULE) ("Tofacitinib" . SPARSER::DRUG)
    ("Ruxolitinib" . SPARSER::DRUG) ("Rac1 and PIP5K1C" . SPARSER::COLLECTION)
    ("STAT, MAPK, and PI3K-AKT" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("a human T-cell lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("TEL-JAK2" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("c-" . SPARSER::PROTEIN) ("CXCR4-CXCL12" . SPARSER::COLLECTION)
    ("JAK2 and RhoA" . SPARSER::COLLECTION)
    ("both ICAM-1 (Figure xref ) and VCAM-1 (Figure xref )"
     . SPARSER::COLLECTION)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("LFA-1 and VLA-4" . SPARSER::COLLECTION)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("both AG490 and P1-" . SPARSER::COLLECTION) ("Penetratin" . SPARSER::DRUG)
    ("Tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JAKs" . SPARSER::PROTEIN)
    ("At least 67 intracellular signaling proteins" . SPARSER::PROTEIN)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("homeostatic chemokines" . SPARSER::PROTEIN)
    ("ZAP-70 and Syk" . SPARSER::COLLECTION)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the tumor suppressor gene p53 and other pro-apoptotic proteins"
     . SPARSER::COLLECTION)
    ("other pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("BAD" . SPARSER::PROTEIN)
    ("lymphocyte function-associated antigen-1 (LFA-1) and very late antigen-4 (VLA-4) integrins"
     . SPARSER::COLLECTION)
    ("very late antigen-4 (VLA-4) integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lymphocyte function-associated antigen-1" . SPARSER::PROTEIN)
    ("kinases (PTK)" . SPARSER::PROTEIN)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Chemokines" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("TG101348" . SPARSER::DRUG) ("PIP5K1C" . SPARSER::PROTEIN)
    ("PLD1" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("ZAP-70" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("TCL1" . SPARSER::PROTEIN) ("GTP-binding protein" . SPARSER::PROTEIN)
    ("VLA-4" . SPARSER::PROTEIN) ("antigen-4" . SPARSER::PROTEIN)
    ("LFA-1" . SPARSER::PROTEIN) ("antigen-1" . SPARSER::PROTEIN)
    ("Rep" . SPARSER::PROTEIN) ("TSC1/TSC2" . SPARSER::COLLECTION)
    ("highly druggable kinases and many inhibitors" . SPARSER::COLLECTION)
    ("TSC1-TSC2-RHEB-mTOR" . SPARSER::COLLECTION)
    ("Complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("prominent cortical actin" . SPARSER::PROTEIN)
    ("cytoskeletal actin" . SPARSER::PROTEIN) ("TSC1/2" . SPARSER::PROTEIN)
    ("rapamycin and NSC23766" . SPARSER::COLLECTION)
    ("TSC1/2-Rheb" . SPARSER::COLLECTION)
    ("functional Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RHEB and mTOR" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tsc1 or Tsc2" . SPARSER::COLLECTION) ("Tsc1" . SPARSER::PROTEIN)
    ("the canonical mTor" . SPARSER::PROTEIN) ("p70S6K" . SPARSER::PROTEIN)
    ("mTor" . SPARSER::PROTEIN)
    ("possible indirect effectors" . SPARSER::EFFECTOR)
    ("p125FAK, MKK3/6 and c-Src" . SPARSER::COLLECTION)
    ("RAC/PAK2" . SPARSER::COLLECTION)
    ("Ras-related C3 botulinum toxin substrate 1/p21 activated kinase 2"
     . SPARSER::COLLECTION)
    ("AICAR" . SPARSER::PROTEIN) ("Chk1/Chk2" . SPARSER::COLLECTION)
    ("mTOR substrate peptides as well as substrates for p70S6 kinase"
     . SPARSER::COLLECTION)
    ("especially transplantation medicine" . SPARSER::DRUG)
    ("mTOR, Raptor, LST8, PRAS and DEPTOR" . SPARSER::COLLECTION)
    ("LST8, mSIN1, DEPTOR and Protor" . SPARSER::COLLECTION)
    ("Protor" . SPARSER::PROTEIN-FAMILY) ("DEPTOR" . SPARSER::PROTEIN)
    ("PRAS" . SPARSER::PROTEIN-FAMILY) ("Raptor" . SPARSER::PROTEIN)
    ("FK" . SPARSER::MOLECULE) ("macrolide" . SPARSER::MOLECULE)
    ("Rapamycin and its analogues" . SPARSER::COLLECTION)
    ("sirolimus and everolimus" . SPARSER::COLLECTION)
    ("everolimus" . SPARSER::DRUG) ("sirolimus" . SPARSER::DRUG)
    ("p70S6 kinase and the eukaryotic initiation factor 4E (eIF4E)"
     . SPARSER::COLLECTION)
    ("4E-BP1 and 4E-BP2" . SPARSER::COLLECTION)
    ("TSC1-TSC2" . SPARSER::COLLECTION)
    ("a functional heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("hamartin (TSC1) and tuberin (TSC2)" . SPARSER::COLLECTION)
    ("TSC1-TSC2-RHEB" . SPARSER::COLLECTION)
    ("mTOR and p21RAC" . SPARSER::COLLECTION) ("RAC" . SPARSER::PROTEIN)
    ("RHEB" . SPARSER::PROTEIN) ("Tsc2" . SPARSER::PROTEIN)
    ("Drugs" . SPARSER::DRUG) ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("TSC1 or TSC2" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("Myc -tagged" . SPARSER::PROTEIN) ("Rheb1" . SPARSER::PROTEIN)
    ("Pak2" . SPARSER::PROTEIN) ("neuronal migration" . SPARSER::PROTEIN)
    ("p125FAK" . SPARSER::PROTEIN)
    ("p21 activated kinase 2" . SPARSER::PROTEIN)
    ("Ras-related C3 botulinum toxin substrate 1" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("mSIN1" . SPARSER::PROTEIN) ("LST8" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN) ("FKBP-12" . SPARSER::PROTEIN)
    ("4E-BP2" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN) ("PAK2" . SPARSER::PROTEIN)
    ("mask" . SPARSER::PROTEIN) ("EZH2 and LSD1" . SPARSER::COLLECTION)
    ("androgen, and HOTAIR" . SPARSER::COLLECTION)
    ("NOV and OPRK1" . SPARSER::COLLECTION) ("NOV" . SPARSER::PROTEIN)
    ("TMPRSS2 , FKBP5 , PSA , and KLK2" . SPARSER::COLLECTION)
    ("PSA , TMPRSS2 , FKBP5 , OPRK1 , and MET" . SPARSER::COLLECTION)
    ("sharp" . SPARSER::PROTEIN) ("MDM2-AR" . SPARSER::COLLECTION)
    ("AR and FLAG" . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::COLLECTION) ("FLAG-AR" . SPARSER::COLLECTION)
    ("CHX" . SPARSER::PROTEIN)
    ("down significantly more HOTAIR lncRNA" . SPARSER::RNA)
    ("EMD" . SPARSER::PROTEIN) ("streptavidin" . SPARSER::PROTEIN)
    ("HOTAIR and AR" . SPARSER::COLLECTION)
    ("aggressive PCa" . SPARSER::PROTEIN) ("recurrent PCa" . SPARSER::PROTEIN)
    ("ethanol-" . SPARSER::PROTEIN) ("ethanol" . SPARSER::PROTEIN)
    ("HOTAIR and several known AR-repressed genes" . SPARSER::COLLECTION)
    ("PSA and KLK2" . SPARSER::COLLECTION)
    ("these three AREs as well as a primer set" . SPARSER::COLLECTION)
    ("phytoestrogen" . SPARSER::DRUG) ("genistein" . SPARSER::PROTEIN)
    ("the tumor-suppressive SWI/SNF chromatin-modifying complex"
     . SPARSER::BIO-COMPLEX)
    ("benign, localized, and metastatic PCa" . SPARSER::PROTEIN)
    ("dys" . SPARSER::PROTEIN) ("LSD1/REST" . SPARSER::COLLECTION)
    ("REST" . SPARSER::PROTEIN)
    ("the polycomb repressive complexes" . SPARSER::BIO-COMPLEX)
    ("LncRNAs" . SPARSER::RNA) ("lncRNA-" . SPARSER::RNA)
    ("Not1" . SPARSER::PROTEIN) ("OPRK1" . SPARSER::PROTEIN)
    ("KLK2" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("SChLAP1" . SPARSER::PROTEIN) ("FAL1" . SPARSER::PROTEIN)
    ("chromatin regulators and transcription factors ( xref )"
     . SPARSER::COLLECTION)
    ("ATM and DNA-PKcs" . SPARSER::COLLECTION)
    ("DNA and recruitment of 8-oxoguanine-DNA glycosylase"
     . SPARSER::COLLECTION)
    ("ER- and androgen receptor" . SPARSER::COLLECTION)
    ("TOP1 and TOP2" . SPARSER::COLLECTION)
    ("so-called topological promoter" . SPARSER::PROMOTER)
    ("a distal promoter" . SPARSER::PROMOTER)
    ("polymerase (RNAP)" . SPARSER::PROTEIN) ("RNAP" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("BRG1 and PolII" . SPARSER::COLLECTION) ("SWI/SNF" . SPARSER::COLLECTION)
    ("SNF" . SPARSER::PROTEIN-FAMILY) ("SWI" . SPARSER::PROTEIN)
    ("TdT" . SPARSER::PROTEIN) ("UNG, DNA-PK, and Ku70" . SPARSER::COLLECTION)
    ("GRO-seq" . SPARSER::PROTEIN-PAIR) ("GRO" . SPARSER::PROTEIN)
    ("BRD4 and p300" . SPARSER::COLLECTION) ("ER or A3B" . SPARSER::COLLECTION)
    ("H 2 O 2 and estrogen" . SPARSER::COLLECTION)
    ("DNA-PK and ATM" . SPARSER::COLLECTION) ("ER-" . SPARSER::PROTEIN)
    ("anti-estrogens 4-hydroxytamoxifen (OHT) or fulvestrant (FUL)"
     . SPARSER::COLLECTION)
    ("4-hydroxytamoxifen (OHT)" . SPARSER::DRUG) ("UGI" . SPARSER::INHIBITOR)
    ("inhibitor (UGI)" . SPARSER::INHIBITOR)
    ("DNA glycosylase (UNG)" . SPARSER::PROTEIN) ("UNG" . SPARSER::PROTEIN)
    ("Cytidine" . SPARSER::MOLECULE) ("TFF1 and PDZK1" . SPARSER::COLLECTION)
    ("Fulvestrant" . SPARSER::DRUG) ("aka" . SPARSER::PROTEIN)
    ("fulvestrant" . SPARSER::DRUG) ("ER and A3B" . SPARSER::COLLECTION)
    ("TFF1, GREB1, FOS, and CTSD" . SPARSER::COLLECTION)
    ("CTSD" . SPARSER::PROTEIN) ("FOS" . SPARSER::PROTEIN)
    ("TFF1 and GREB1" . SPARSER::COLLECTION)
    ("other APOBECs and poor outcome in ER+ or ER− breast cancer"
     . SPARSER::COLLECTION)
    ("APOBECs" . SPARSER::BIO-COMPLEX) ("HR " . SPARSER::PROTEIN)
    ("p " . SPARSER::PROTEIN) ("ER−" . SPARSER::PROTEIN)
    ("A3A and A3B" . SPARSER::COLLECTION) ("RNA or DNA" . SPARSER::COLLECTION)
    ("uridine" . SPARSER::PROTEIN) ("APOBEC" . SPARSER::BIO-COMPLEX)
    ("FOXA1 and GATA3" . SPARSER::COLLECTION) ("Estrogens" . SPARSER::MOLECULE)
    ("sulforhodamine B" . SPARSER::MOLECULE)
    ("cytidine-deaminase" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("8-oxoguanine-DNA glycosylase" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("TOP2" . SPARSER::PROTEIN)
    ("TOP1" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("KU55933" . SPARSER::DRUG) ("NU7441" . SPARSER::MOLECULE)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("SCN2A1" . SPARSER::PROTEIN)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BRD4" . SPARSER::PROTEIN)
    ("SCN2A" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN) ("anti-estrogens" . SPARSER::DRUG)
    ("γH2AX" . SPARSER::PROTEIN) ("A–4" . SPARSER::PROTEIN)
    ("PBS2" . SPARSER::PROTEIN) ("DNA glycosylase" . SPARSER::PROTEIN)
    ("PDZK1" . SPARSER::PROTEIN) ("ICI182,780" . SPARSER::DRUG)
    ("anti-estrogen" . SPARSER::DRUG) ("AIB1" . SPARSER::PROTEIN)
    ("GREB1" . SPARSER::PROTEIN) ("A–S2" . SPARSER::PROTEIN)
    ("A3A" . SPARSER::PROTEIN) ("APOBEC1" . SPARSER::PROTEIN)
    ("apolipoprotein B" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("APOBEC3B" . SPARSER::PROTEIN) ("Estrogen receptor" . SPARSER::PROTEIN)
    ("capecitabine" . SPARSER::DRUG) ("p-PAK4" . SPARSER::COLLECTION)
    ("siRNA-PAK4" . SPARSER::COLLECTION) ("-PAK4" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN)
    ("high PAK4 group ( n  = 43) and low PAK4 group ( n  = 50)"
     . SPARSER::COLLECTION)
    ("the two-tailed paired t" . SPARSER::PROTEIN)
    ("Rac and Cdc42" . SPARSER::COLLECTION) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("Ras, Rho, Rac and Cdc42" . SPARSER::COLLECTION)
    ("proteins [ xref , xref ] and microRNAs [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("kinase (PAK)" . SPARSER::KINASE) ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("protein or microRNA" . SPARSER::COLLECTION) ("AC-3" . SPARSER::PROTEIN)
    ("RAC-alpha serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("Phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("m 2" . SPARSER::MOLECULE) ("-2 " . SPARSER::PROTEIN)
    ("DGCR6L" . SPARSER::PROTEIN)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("G-proteins" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("N-Myc and c-Myc" . SPARSER::COLLECTION)
    ("USP4–HDAC2–NF-κB" . SPARSER::COLLECTION)
    ("USP4–HDAC2–p53" . SPARSER::COLLECTION)
    ("HDAC1 or p300" . SPARSER::COLLECTION)
    ("USP4 or HDAC2" . SPARSER::COLLECTION)
    ("etoposide and TNFα" . SPARSER::COLLECTION)
    ("ARF-BP1 and HDAC2" . SPARSER::COLLECTION)
    ("HAUSP/MDM2/p53" . SPARSER::COLLECTION) ("HAUSP" . SPARSER::PROTEIN)
    ("both ARF-BP1 and its substrate HDAC2" . SPARSER::COLLECTION)
    ("specifically target HDAC2" . SPARSER::PROTEIN)
    ("TRAF2, TRAF6 and TAK1" . SPARSER::COLLECTION)
    ("interleukin-1-" . SPARSER::PROTEIN) ("receptor-" . SPARSER::RECEPTOR)
    ("USP" . SPARSER::PROTEIN) ("intact HDAC2" . SPARSER::PROTEIN)
    ("p21 and IκBα" . SPARSER::COLLECTION) ("USP4–HDAC2" . SPARSER::COLLECTION)
    ("TAK1 or TRAF2" . SPARSER::COLLECTION)
    ("TAK1, TRAF2 and TRAF6" . SPARSER::COLLECTION)
    ("HA-Ub" . SPARSER::COLLECTION) ("Flag-HDAC2" . SPARSER::COLLECTION)
    ("Ub" . SPARSER::PROTEIN) ("USP4 and HDAC2" . SPARSER::COLLECTION)
    ("Flag-" . SPARSER::PROTEIN-FAMILY) ("Myc-USP4" . SPARSER::COLLECTION)
    ("188–302 amino acids of USP4" . SPARSER::PROTEIN)
    ("GST-USP4" . SPARSER::COLLECTION) ("HDAC2 and USP4" . SPARSER::COLLECTION)
    ("the anti-HDAC2" . SPARSER::ANTIBODY)
    ("exogenous Myc-tagged USP4" . SPARSER::PROTEIN)
    ("HDAC2 and USPs" . SPARSER::COLLECTION) ("USPs" . SPARSER::PROTEIN)
    ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("the E2 ubiquitin conjugase Ubc8 and the E3 ubiquitin ligase RLIM"
     . SPARSER::COLLECTION)
    ("Ubc8" . SPARSER::PROTEIN) ("HECT" . SPARSER::PROTEIN)
    ("MULE" . SPARSER::PROTEIN) ("RLIM" . SPARSER::PROTEIN)
    ("Ubc" . SPARSER::PROTEIN) ("conjugase" . SPARSER::PROTEIN)
    ("VPA" . SPARSER::PROTEIN) ("Rel" . SPARSER::PROTEIN)
    ("STAT3 and nuclear factor (NF)-κB" . SPARSER::COLLECTION)
    ("p53, E2F1, STAT1, STAT3 and nuclear factor (NF)-κB"
     . SPARSER::COLLECTION)
    ("p21, MDM2, Bax, Puma and Noxa" . SPARSER::COLLECTION)
    ("acetyl-transferases and HDACs" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("phylogenetic analysis and sequence homology" . SPARSER::PROTEIN)
    ("peptidase" . SPARSER::PROTEIN) ("Nonidet P-40" . SPARSER::DRUG)
    ("D -1" . SPARSER::PROTEIN) ("H-3" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("TβRI" . SPARSER::PROTEIN)
    ("adenosine A2A receptor" . SPARSER::PROTEIN)
    ("ARF-binding protein 1" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("USP11" . SPARSER::PROTEIN) ("ARF-BP-1" . SPARSER::PROTEIN)
    ("valproic acid" . SPARSER::MOLECULE)
    ("acetyl-transferases" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("USP4" . SPARSER::PROTEIN)
    ("glutathione, thioredoxin, and mercaptan" . SPARSER::COLLECTION)
    ("oxidase" . SPARSER::PROTEIN)
    ("Nrf2 and its downstream genes" . SPARSER::COLLECTION)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a basic redox-sensitive bZIP transcription factor" . SPARSER::PROTEIN)
    ("DNA and cause mucous injuries [ xref , xref ]" . SPARSER::COLLECTION)
    ("radical" . SPARSER::MOLECULE) ("Nfr2" . SPARSER::PROTEIN)
    ("lamin B1" . SPARSER::PROTEIN) ("Nrf2 a" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN)
    ("MMP2 [ xref ] and MMP9 [ xref ]" . SPARSER::COLLECTION)
    ("MMP7 and CD44" . SPARSER::COLLECTION)
    ("ECM or adhesion proteins [ xref , xref ]" . SPARSER::COLLECTION)
    ("MMP7 and β-catenin, and TNM" . SPARSER::COLLECTION)
    ("β-catenin, and TNM" . SPARSER::COLLECTION)
    ("log-rank " . SPARSER::PROTEIN) ("rank " . SPARSER::PROTEIN)
    ("CD44, MMP7, and β-catenin" . SPARSER::COLLECTION)
    ("KAI/CD82" . SPARSER::COLLECTION) ("TCF/LEF" . SPARSER::COLLECTION)
    ("LEF" . SPARSER::PROTEIN)
    ("type IV collagen, fibronectin, and laminin" . SPARSER::COLLECTION)
    ("elastin" . SPARSER::PROTEIN) ("matrilysin" . SPARSER::PROTEIN)
    ("an extensively expressed class I transmembrane glycoprotein"
     . SPARSER::PROTEIN)
    ("MMP7 and β-catenin" . SPARSER::COLLECTION)
    ("CD44 and MMP7" . SPARSER::COLLECTION)
    ("CD44, MMP7 and β-catenin" . SPARSER::COLLECTION)
    ("KAI1/CD82" . SPARSER::COLLECTION) ("type IV collagen" . SPARSER::PROTEIN)
    ("hyaluronic acid" . SPARSER::MOLECULE) ("MMP7" . SPARSER::PROTEIN)
    ("KAI1" . SPARSER::PROTEIN)
    ("the intratumoral vasculature" . SPARSER::PROTEIN)
    ("MMP-9/VEGF" . SPARSER::COLLECTION)
    ("EGFR/IL-8/neutrophil" . SPARSER::COLLECTION)
    ("a distinct intravasation-sustaining intratumoral vasculature"
     . SPARSER::PROTEIN)
    ("employing purified forms" . SPARSER::FORM)
    ("VEGF or neutrophil" . SPARSER::COLLECTION)
    ("soluble VEGF" . SPARSER::PROTEIN)
    ("their major attractant" . SPARSER::PROTEIN)
    ("soluble VEGF protein" . SPARSER::PROTEIN)
    ("a critical angiogenesis inducer and important regulator"
     . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the host angiogenic vasculature" . SPARSER::PROTEIN)
    ("VEGF and IL-8" . SPARSER::COLLECTION)
    ("a permeable intravasation-sustaining vasculature" . SPARSER::PROTEIN)
    ("primary tumor-attracted inflammatory neutrophils" . SPARSER::PROTEIN)
    ("the bioavailable VEGF" . SPARSER::PROTEIN)
    ("VEGF and neutrophil" . SPARSER::COLLECTION)
    ("MMP-9 or VEGF" . SPARSER::COLLECTION)
    ("bioavailable VEGF" . SPARSER::PROTEIN)
    ("a host-specific MMP-9 mAb" . SPARSER::DRUG)
    ("soluble (bioavailable) human VEGF" . SPARSER::PROTEIN)
    ("VEGF and IL8" . SPARSER::COLLECTION)
    ("inflammatory neutrophils" . SPARSER::PROTEIN)
    ("permeable dextran" . SPARSER::DEXTRAN)
    ("TRITC-dextran" . SPARSER::MOLECULE) ("dextran" . SPARSER::DEXTRAN)
    ("TRITC" . SPARSER::MOLECULE)
    ("Intratumoral Angiogenic Vasculature" . SPARSER::PROTEIN)
    ("intravasation-sustaining angiogenic vasculature" . SPARSER::PROTEIN)
    ("just total EGFR" . SPARSER::PROTEIN)
    ("intratumoral vasculature" . SPARSER::PROTEIN)
    ("total and activated (phosphorylated) EGFR" . SPARSER::PROTEIN)
    ("red fluorescent lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an intratumoral angiogenic vasculature" . SPARSER::PROTEIN)
    ("microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("30-μm–sized intratumoral vasculature" . SPARSER::PROTEIN)
    ("angiogenic vasculature" . SPARSER::PROTEIN)
    ("hi/diss" . SPARSER::PROTEIN)
    ("their angiogenic vasculature" . SPARSER::PROTEIN)
    ("the distal CAM" . SPARSER::PROTEIN) ("Alu" . SPARSER::PROTEIN)
    ("Intravasation-Sustaining Angiogenic Vasculature" . SPARSER::PROTEIN)
    ("Vasculature" . SPARSER::PROTEIN)
    ("tumor-induced angiogenic vasculature" . SPARSER::PROTEIN)
    ("PC-hi/diss or HEp-hi/diss" . SPARSER::COLLECTION)
    ("PC-hi/diss" . SPARSER::PROTEIN-PAIR)
    ("their respective lo/diss variants" . SPARSER::VARIANT)
    ("approximately five-fold more EGFR protein" . SPARSER::PROTEIN)
    ("lo/diss" . SPARSER::PROTEIN) ("PC-lo/diss" . SPARSER::PROTEIN-PAIR)
    ("catalytically release angiogenesis-inducing VEGF" . SPARSER::PROTEIN)
    ("a unique form" . SPARSER::FORM)
    ("fluorescent dextrans" . SPARSER::DEXTRAN)
    ("fluorescent lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dextrans" . SPARSER::DEXTRAN)
    ("robust angiogenic vasculature" . SPARSER::PROTEIN)
    ("CAM" . SPARSER::PROTEIN)
    ("the entire intratumoral vasculature" . SPARSER::PROTEIN)
    ("the major attractant" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("attractant" . SPARSER::PROTEIN)
    ("the EGFR and small molecule tyrosine kinase inhibitors"
     . SPARSER::COLLECTION)
    ("the highly permeable angiogenic vasculature" . SPARSER::PROTEIN)
    ("a VEGF-dependent angiogenic vasculature" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9, and neutrophil" . SPARSER::COLLECTION)
    ("interleukin" . SPARSER::PROTEIN)
    ("a distinct intratumoral vasculature" . SPARSER::PROTEIN)
    ("matrix-bound" . SPARSER::PROTEIN) ("D-10" . SPARSER::PROTEIN)
    ("HT-1080" . SPARSER::PROTEIN) ("anti-VEGF" . SPARSER::DRUG)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN)
    ("DYRK2, NLRP4 and DTX4" . SPARSER::COLLECTION)
    ("DYRK2-EDVP" . SPARSER::PROTEIN-PAIR)
    ("IRF3 and type I" . SPARSER::COLLECTION)
    ("-2 or -3" . SPARSER::COLLECTION)
    ("the MG132-treated control group" . SPARSER::MOLECULE)
    ("IRF3, IFNB1 and RANTES" . SPARSER::COLLECTION) ("INF" . SPARSER::PROTEIN)
    ("NLRP4-DTX4" . SPARSER::COLLECTION)
    ("NLRP4 and TBK1" . SPARSER::COLLECTION)
    ("DTX4 and DYRK2" . SPARSER::COLLECTION)
    ("the IFN-β promoter or the expression of downstream genes"
     . SPARSER::COLLECTION)
    ("IFNB1, RNATES and ISG15" . SPARSER::COLLECTION)
    ("phosphomimetic TBK1 S527D and S527E mutants" . SPARSER::MUTANT)
    ("phosphatase (CIP)" . SPARSER::PHOSPHATASE) ("CIP" . SPARSER::PROTEIN)
    ("mutant (MT)" . SPARSER::MUTANT) ("ubiquitin-K63" . SPARSER::COLLECTION)
    ("SeV-" . SPARSER::PROTEIN) ("TBK1 and IKKε" . SPARSER::COLLECTION)
    ("DYRK2 and TBK1" . SPARSER::COLLECTION)
    ("RIG-I, VISA, MITA, IKKε and IRF3" . SPARSER::COLLECTION)
    ("MITA" . SPARSER::PROTEIN) ("IKKε-" . SPARSER::PROTEIN)
    ("VISA-" . SPARSER::PROTEIN) ("RIG-I-" . SPARSER::PROTEIN)
    ("DYRK2 and signaling components" . SPARSER::COLLECTION)
    ("VSV and HSV-1" . SPARSER::COLLECTION) ("THP-1" . SPARSER::PROTEIN)
    ("promoter and ISRE" . SPARSER::COLLECTION)
    ("SeV and HSV-1" . SPARSER::COLLECTION)
    ("IFNB1 and RANTES" . SPARSER::COLLECTION)
    ("the IFN-β promoter and the ISRE" . SPARSER::COLLECTION)
    ("SeV" . SPARSER::PROTEIN) ("eIF2Bε" . SPARSER::PROTEIN)
    ("katanin" . SPARSER::PROTEIN) ("DH" . SPARSER::PROTEIN)
    ("DYRK" . SPARSER::PROTEIN)
    ("dual-specificity tyrosine-phosphorylation-regulated kinases"
     . SPARSER::KINASE)
    ("DYRKs" . SPARSER::PROTEIN) ("SHP2, SHIP1 or PPM1B" . SPARSER::COLLECTION)
    ("A20, OPTN, NEMO, TRIM11 and RNF11" . SPARSER::COLLECTION)
    ("SIKE" . SPARSER::PROTEIN) ("Nrdp1 and MIBs" . SPARSER::COLLECTION)
    ("MIB1 and MIB2" . SPARSER::COLLECTION) ("MIBs" . SPARSER::DRUG)
    ("DAI, IFI16, DDX41, LSm14A and cGAS" . SPARSER::COLLECTION)
    ("cGAS" . SPARSER::PROTEIN) ("DAI" . SPARSER::PROTEIN)
    ("cytokines and type I" . SPARSER::COLLECTION)
    ("RIG-I and MDA5" . SPARSER::COLLECTION)
    ("MAVS, IPS-1, or Cardif" . SPARSER::COLLECTION)
    ("Cardif" . SPARSER::PROTEIN)
    ("RIG-I, MDA5, and LGP2" . SPARSER::COLLECTION)
    ("helicase/ATPase" . SPARSER::COLLECTION) ("helicase" . SPARSER::PROTEIN)
    ("IRF3/IRF7" . SPARSER::COLLECTION) ("TBK1/IKKε" . SPARSER::COLLECTION)
    ("TLR3 and TLR4" . SPARSER::COLLECTION)
    ("NF-κB and MAP kinases" . SPARSER::COLLECTION)
    ("antiviral genes" . SPARSER::GENE)
    ("NOD-like receptors (NLRs) and DNA receptors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("microbial components" . SPARSER::COMPONENT) ("NLRs" . SPARSER::PROTEIN)
    ("tyrosine-" . SPARSER::AMINO-ACID)
    ("NF-κB and IRF3" . SPARSER::COLLECTION) ("Q9Y2E6" . SPARSER::PROTEIN)
    ("Q96MN2" . SPARSER::PROTEIN) ("Q9UHD2" . SPARSER::PROTEIN)
    ("Q92630" . SPARSER::PROTEIN) ("IFN beta" . SPARSER::PROTEIN)
    ("IFN Beta" . SPARSER::PROTEIN) ("ISG15" . SPARSER::PROTEIN)
    ("IFNB1" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("Negative Regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("CRMP4" . SPARSER::PROTEIN) ("IFN-b" . SPARSER::PROTEIN)
    ("RNF11" . SPARSER::PROTEIN) ("TRIM11" . SPARSER::PROTEIN)
    ("A20" . SPARSER::PROTEIN) ("TAX1BP1" . SPARSER::PROTEIN)
    ("PPM1B" . SPARSER::PROTEIN) ("MIB2" . SPARSER::PROTEIN)
    ("MIB1" . SPARSER::PROTEIN) ("Nrdp1" . SPARSER::PROTEIN)
    ("LSm14A" . SPARSER::PROTEIN) ("DDX41" . SPARSER::PROTEIN)
    ("IFI16" . SPARSER::PROTEIN) ("LGP2" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN) ("IRF7" . SPARSER::PROTEIN)
    ("IKKε" . SPARSER::PROTEIN) ("DTX4" . SPARSER::PROTEIN)
    ("NLRP4" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("TANK-binding kinase 1" . SPARSER::PROTEIN) ("DYRK2" . SPARSER::PROTEIN)
    ("regulated kinase 2" . SPARSER::PROTEIN)
    ("ABCB1 and c-Myc" . SPARSER::COLLECTION)
    ("EMT and ABCB1" . SPARSER::COLLECTION)
    ("E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("mesenchymal marker N-cadherin" . SPARSER::PROTEIN)
    ("the mesenchymal marker N-cadherin" . SPARSER::PROTEIN)
    ("an evolutionarily conserved basic transcription factor"
     . SPARSER::PROTEIN)
    ("ABCB1, ABCC1 and ABCG2" . SPARSER::COLLECTION)
    ("Multidrug" . SPARSER::PROTEIN) ("SALL" . SPARSER::PROTEIN)
    ("SALL4 and c-Myc" . SPARSER::COLLECTION)
    ("antineoplastic drugs" . SPARSER::DRUG)
    ("N-cadherin and ABCB1" . SPARSER::COLLECTION)
    ("mesenchymal cell marker N-cadherin" . SPARSER::PROTEIN)
    ("ABCA3" . SPARSER::PROTEIN) ("HEC1" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("ABCG2" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("SALL4" . SPARSER::PROTEIN) ("Quad" . SPARSER::DRUG)
    ("Duo" . SPARSER::PROTEIN)
    ("ESR1 and oestrogen-dependent traits" . SPARSER::COLLECTION)
    ("oxytocin and the oxytocin receptor" . SPARSER::COLLECTION)
    ("ESR1 and OXTR" . SPARSER::COLLECTION)
    ("one causative variant" . SPARSER::VARIANT)
    ("17,787 autosomal genes" . SPARSER::GENE)
    ("only three key genes" . SPARSER::GENE) ("relevant genes" . SPARSER::GENE)
    ("ESR2 and CYP19A1" . SPARSER::COLLECTION)
    ("OXT and CD38" . SPARSER::COLLECTION)
    ("OAC, and SNPs" . SPARSER::COLLECTION) ("gene ( OXTR )" . SPARSER::GENE)
    ("smooth muscle" . SPARSER::PROTEIN) ("Oxytocin" . SPARSER::PROTEIN)
    ("OAC and BO" . SPARSER::COLLECTION) ("protein ( OXT )" . SPARSER::PROTEIN)
    ("oxytocin receptor ( OXTR )" . SPARSER::PROTEIN)
    ("hydrolase" . SPARSER::PROTEIN) ("OXT" . SPARSER::PROTEIN)
    ("OXTR" . SPARSER::PROTEIN) ("oxytocin" . SPARSER::PROTEIN)
    ("OAC" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("oxytocin receptor" . SPARSER::PROTEIN) ("CYP19A1" . SPARSER::PROTEIN)
    ("a universal reference gene" . SPARSER::GENE)
    ("HPRT1 and PSMB6" . SPARSER::COLLECTION)
    ("carbamazepine- and phenytoin-refractory epileptic patients"
     . SPARSER::COLLECTION)
    ("carbamazepine-" . SPARSER::DRUG)
    ("paracetamol, and piroxicam" . SPARSER::COLLECTION)
    ("piroxicam" . SPARSER::DRUG) ("paracetamol" . SPARSER::MOLECULE)
    ("indomethacin" . SPARSER::DRUG) ("NSAIDs" . SPARSER::DRUG)
    ("carbamazepine and phenytoin" . SPARSER::COLLECTION)
    ("phenytoin and carbamazepine" . SPARSER::COLLECTION)
    ("carbamazepine" . SPARSER::DRUG) ("phenytoin" . SPARSER::DRUG)
    ("xenobiotics" . SPARSER::MOLECULE) ("electrophiles" . SPARSER::MOLECULE)
    ("HIF1α (Hypoxia Inducible Factor 1, alpha subunit) and VEGF (Vascular Endothelial Growth Factor)"
     . SPARSER::COLLECTION)
    ("ARNO and ARF6" . SPARSER::COLLECTION) ("ARF6-" . SPARSER::PROTEIN)
    ("a GTPase-activating protein and a downstream effector"
     . SPARSER::COLLECTION)
    ("RALA and RALB" . SPARSER::COLLECTION)
    ("secretagogue" . SPARSER::MOLECULE) ("exocyst" . SPARSER::BIO-COMPLEX)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RALB" . SPARSER::PROTEIN)
    ("RALA" . SPARSER::PROTEIN) ("SPG21 and HPRT1" . SPARSER::COLLECTION)
    ("least variably expressed genes" . SPARSER::GENE)
    ("HPRT1 and SPG21" . SPARSER::COLLECTION)
    ("13 previously reported reference genes" . SPARSER::GENE)
    ("B2M/GAPDH" . SPARSER::COLLECTION)
    ("PSMB6 , HPRT1 , B2M , and GAPDH" . SPARSER::COLLECTION)
    ("a universal reference gene or geneset" . SPARSER::COLLECTION)
    ("gene or geneset" . SPARSER::COLLECTION)
    ("universal inflammation-impervious reference genes" . SPARSER::GENE)
    ("the least reliable reference genes" . SPARSER::GENE)
    ("inflammation-stable reference genes" . SPARSER::GENE)
    ("a few reported studies wherein reference genes" . SPARSER::GENE)
    ("PSMB6 and HPRT1" . SPARSER::COLLECTION)
    ("GAPDH and B2M" . SPARSER::COLLECTION)
    ("SDHA , PSMB6 , and HPRT1" . SPARSER::COLLECTION)
    ("B2M and GAPDH" . SPARSER::COLLECTION)
    ("ICAM1 , VCAM1 and MCP1" . SPARSER::COLLECTION)
    ("VCAM1 and MCP1" . SPARSER::COLLECTION)
    ("glyceraldehyde-3-phosphate dehydrogenase ( GAPDH )" . SPARSER::PROTEIN)
    ("α-tubulin ( TUBA1B ) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein"
     . SPARSER::COLLECTION)
    ("succinate dehydrogenase complex subunit A ( SDHA ), α-tubulin ( TUBA1B ) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein"
     . SPARSER::COLLECTION)
    ("polypeptide ( YWHAZ )" . SPARSER::PROTEIN)
    ("β-actin ( ACTB )" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("monooxygenase" . SPARSER::PROTEIN)
    ("RLIP76 and MRP1" . SPARSER::COLLECTION)
    ("inflammation-impervious reference genes" . SPARSER::GENE)
    ("universal reference genes" . SPARSER::GENE)
    ("genes and genesets" . SPARSER::COLLECTION)
    ("ACTB and GAPDH" . SPARSER::COLLECTION)
    ("GAPDH and YWHAZ" . SPARSER::COLLECTION)
    ("HPRT1 and SDHA" . SPARSER::COLLECTION) ("SDHA" . SPARSER::PROTEIN)
    ("YWHAZ" . SPARSER::PROTEIN) ("ACTB" . SPARSER::PROTEIN)
    ("intra-" . SPARSER::PROTEIN)
    ("ischemia and hypoxia" . SPARSER::COLLECTION)
    ("epilepsy" . SPARSER::PROTEIN)
    ("the pro-inflammatory tumor necrosis factor α (TNF-α) cytokine"
     . SPARSER::PROTEIN)
    ("transporters" . SPARSER::PROTEIN)
    ("tumor necrosis factor alpha (TNF-α) pro-inflammatory molecule"
     . SPARSER::MOLECULE)
    ("Genes and pathways" . SPARSER::COLLECTION) ("BBB" . SPARSER::PROTEIN)
    ("tumor-associated ischemia" . SPARSER::PROTEIN)
    ("Vascular Endothelial" . SPARSER::PROTEIN)
    ("alpha subunit" . SPARSER::PROTEIN)
    ("Hypoxia Inducible Factor 1" . SPARSER::PROTEIN)
    ("ADP-ribosylation factor 6" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("SPG21" . SPARSER::PROTEIN)
    ("tryptophan 5-monooxygenase" . SPARSER::PROTEIN)
    ("succinate dehydrogenase complex subunit A" . SPARSER::PROTEIN)
    ("phosphomannomutase 1" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("β2-microglobulin" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("VCAM1" . SPARSER::PROTEIN)
    ("cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("ICAM1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("multidrug resistance protein 1" . SPARSER::PROTEIN)
    ("TUBA1B" . SPARSER::PROTEIN) ("PSMB6" . SPARSER::PROTEIN)
    ("PMM1" . SPARSER::PROTEIN) ("HPRT1" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN) ("ABCC1" . SPARSER::PROTEIN)
    ("MRP1" . SPARSER::PROTEIN) ("ATP-dependent" . SPARSER::PROTEIN)
    ("RALBP1" . SPARSER::PROTEIN) ("Bak and MCL-1" . SPARSER::COLLECTION)
    ("mitotic inhibitors" . SPARSER::INHIBITOR)
    ("PUMA and BIM" . SPARSER::COLLECTION)
    ("carboplatin and Paclitaxel" . SPARSER::COLLECTION)
    ("anthracycline" . SPARSER::MOLECULE)
    ("The pro-apoptotic protein Bak" . SPARSER::PROTEIN)
    ("c-PARP" . SPARSER::COLLECTION) ("c" . SPARSER::PROTEIN)
    ("Bak and Taxol" . SPARSER::COLLECTION)
    ("Bak and hormone/HER2" . SPARSER::COLLECTION)
    ("Bak and molecular subtypes" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER, PR and HER2" . SPARSER::COLLECTION) ("taxane" . SPARSER::DRUG)
    ("a sensitive biomarker and favorable prognostic factor"
     . SPARSER::COLLECTION)
    ("Luminal and HER2" . SPARSER::COLLECTION) ("MCL-1" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG) ("Prism" . SPARSER::PROTEIN)
    ("XXX" . SPARSER::PROTEIN) ("mitotic Gravin −/− MEFs" . SPARSER::PROTEIN)
    ("Gravin preferentially anchors two mitotic kinases" . SPARSER::KINASE)
    ("xxx" . SPARSER::PROTEIN) ("gravin" . SPARSER::PROTEIN)
    ("the astral microtubules" . SPARSER::PROTEIN)
    ("a new macromolecular signaling scaffold" . SPARSER::SCAFFOLD)
    ("murine seminiferous tubule sections lacking Gravin" . SPARSER::PROTEIN)
    ("as yet unknown mitotic substrates" . SPARSER::SUBSTRATE)
    ("a unique kinase complex" . SPARSER::BIO-COMPLEX)
    ("preferentially anchor Plk1" . SPARSER::PROTEIN)
    ("p766-Gravin (green) and DNA (blue)" . SPARSER::COLLECTION)
    ("tilt" . SPARSER::DRUG)
    ("The Gravin macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("Gravin-Plk1" . SPARSER::COLLECTION)
    ("histone 2B-Green Fluorescent Protein" . SPARSER::COLLECTION)
    ("GST-Gravin" . SPARSER::COLLECTION) ("p210-Plk1" . SPARSER::COLLECTION)
    ("Gravin-associated PKA" . SPARSER::PROTEIN)
    ("PKI" . SPARSER::PROTEIN-FAMILY) ("cpm" . SPARSER::PROTEIN)
    ("Kemptide" . SPARSER::MOLECULE) ("Centrobin" . SPARSER::PROTEIN)
    ("Pericentrin" . SPARSER::PROTEIN)
    ("Gravin and both kinases" . SPARSER::COLLECTION)
    ("p766-Gravin/Plk1" . SPARSER::COLLECTION) ("Cenexin" . SPARSER::PROTEIN)
    ("Gravin null MEFs" . SPARSER::PROTEIN) ("p766-Gravin" . SPARSER::PROTEIN)
    ("p766-Gravin-Plk1" . SPARSER::PROTEIN-PAIR)
    ("protein–protein" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("p-Gravin" . SPARSER::COLLECTION) ("PCM" . SPARSER::PROTEIN)
    ("an upstream mitotic kinase" . SPARSER::KINASE)
    ("two essential cell cycle regulator kinases" . SPARSER::PROTEIN)
    ("Gravin/AKAP12/SSeCKS" . SPARSER::COLLECTION)
    ("SSeCKS" . SPARSER::PROTEIN) ("anchor" . SPARSER::ANCHOR)
    ("astral microtubules" . SPARSER::PROTEIN)
    ("the mitotic kinases" . SPARSER::KINASE)
    ("a macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("Gravin/AKAP12" . SPARSER::COLLECTION) ("Gravin" . SPARSER::PROTEIN)
    ("glucose oxidase" . SPARSER::PROTEIN) ("anti-Par" . SPARSER::DRUG)
    ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("histone 2B" . SPARSER::PROTEIN) ("p210" . SPARSER::PROTEIN)
    ("p-210" . SPARSER::PROTEIN) ("VX-680" . SPARSER::DRUG)
    ("Kinase activity" . SPARSER::PROTEIN) ("PAR6" . SPARSER::PROTEIN)
    ("p-H3" . SPARSER::PROTEIN) ("Histone 3" . SPARSER::PROTEIN)
    ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("A-kinase anchoring protein" . SPARSER::PROTEIN)
    ("Oct3" . SPARSER::PROTEIN) ("AKAP12" . SPARSER::PROTEIN)
    ("HDAC and Rb" . SPARSER::COLLECTION)
    ("the late HPV 31 promoter" . SPARSER::PROMOTER)
    ("viral chromatin" . SPARSER::PROTEIN) ("viral DNAs" . SPARSER::DNA)
    ("bringing E1 proteins" . SPARSER::PROTEIN)
    ("NBS1 and RAD51" . SPARSER::COLLECTION)
    ("ATM and CHK2" . SPARSER::COLLECTION)
    ("the viral replication protein" . SPARSER::PROTEIN)
    ("Rad51 and NBS1" . SPARSER::COLLECTION)
    ("ATM or CHK2" . SPARSER::COLLECTION) ("ATM and ATR" . SPARSER::COLLECTION)
    ("HPV genomic DNA and histone deacetylation activity"
     . SPARSER::COLLECTION)
    ("histones or specifically targets histones" . SPARSER::COLLECTION)
    ("specifically targets histones" . SPARSER::PROTEIN)
    ("viral replication proteins E1 and E2" . SPARSER::COLLECTION)
    ("E1 and E2" . SPARSER::COLLECTION) ("northern blot" . SPARSER::PROTEIN)
    ("p53 and the SIRT2 target" . SPARSER::COLLECTION)
    ("EX-527 or DMSO" . SPARSER::COLLECTION)
    ("Southern blot" . SPARSER::PROTEIN) ("puromycin" . SPARSER::DRUG)
    ("SIRT1 or GFP" . SPARSER::COLLECTION)
    ("p53, HDAC, and Rb" . SPARSER::COLLECTION)
    ("HDAC or Rb" . SPARSER::COLLECTION)
    ("the E7(L67R) HDAC binding mutant or the E7(LHCYE) Rb binding mutant( xref )"
     . SPARSER::COLLECTION)
    ("selected using G418 and lysates" . SPARSER::COLLECTION)
    ("HPV31 E6 (L37S) and E7 (L67R and LHCYE)" . SPARSER::COLLECTION)
    ("previously described mutants" . SPARSER::MUTANT)
    ("E6 or E7" . SPARSER::COLLECTION) ("a viral protein" . SPARSER::PROTEIN)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY) ("Neo" . SPARSER::PROTEIN)
    ("pSV" . SPARSER::PROTEIN) ("deacetylases and p300" . SPARSER::COLLECTION)
    ("–SIRT7" . SPARSER::COLLECTION) ("cofactor" . SPARSER::MOLECULE)
    ("polymerases" . SPARSER::PROTEIN)
    ("both viral chromatin" . SPARSER::PROTEIN)
    ("NBS1 and Rad51" . SPARSER::COLLECTION)
    ("E6 and E7" . SPARSER::COLLECTION) ("oncoproteins" . SPARSER::PROTEIN)
    ("1K" . SPARSER::PROTEIN) ("Gag-Pol" . SPARSER::PROTEIN)
    ("CIN1" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("1-1" . SPARSER::PROTEIN) ("K10" . SPARSER::PROTEIN)
    ("L37" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NAD+" . SPARSER::MOLECULE)
    ("SIRT7" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("EX-527" . SPARSER::DRUG) ("Ras-Raf-MEK-ERK1/2" . SPARSER::COLLECTION)
    ("the Flt3 inhibitor ponatinib and the B-Raf V600E inhibitor vemurafenib"
     . SPARSER::COLLECTION)
    ("the Bcr-Abl/c-Kit inhibitor imatinib, the EGFR inhibitors erlotinib and gefitinib, the Flt3 inhibitor ponatinib and the B-Raf V600E inhibitor vemurafenib"
     . SPARSER::COLLECTION)
    ("Classical examples" . SPARSER::EXAMPLE)
    ("Bcr-Abl/c-Kit" . SPARSER::COLLECTION)
    ("GLIS3, PTPN2, BACH2 and Cathepsin H" . SPARSER::COLLECTION)
    ("tocilizumab" . SPARSER::DRUG) ("respective cytokines" . SPARSER::PROTEIN)
    ("phospho-Bad (Ser136) and phospho-Bim (Ser69)" . SPARSER::COLLECTION)
    ("EGFR, HER2 and PI3K" . SPARSER::COLLECTION)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("prednisolone" . SPARSER::DRUG) ("Mcl-1 or Bcl-2" . SPARSER::COLLECTION)
    ("the rapid available pre-made Bim" . SPARSER::PROTEIN)
    ("simultaneously targets various critical nodal" . SPARSER::PROTEIN)
    ("the Hsp90 inhibitor XL888 [ xref ] or ganetespib [ xref ]"
     . SPARSER::COLLECTION)
    ("ganetespib" . SPARSER::DRUG) ("Trametinib" . SPARSER::DRUG)
    ("trametinib" . SPARSER::DRUG) ("MEK and Mcl-1" . SPARSER::COLLECTION)
    ("BI" . SPARSER::PROTEIN) ("vemurafenib" . SPARSER::DRUG)
    ("Mcl-1, Bcl-2 and XIAP" . SPARSER::COLLECTION) ("TP" . SPARSER::PROTEIN)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("AXL and vascular endothelial" . SPARSER::COLLECTION)
    ("Bim and p27" . SPARSER::COLLECTION) ("VEGFR" . SPARSER::PROTEIN)
    ("RON" . SPARSER::PROTEIN) ("Foretinib" . SPARSER::DRUG)
    ("the dual ALK/c-Met inhibitor crizotinib" . SPARSER::DRUG)
    ("ALK/c-Met" . SPARSER::COLLECTION) ("c-Met-" . SPARSER::PROTEIN)
    ("The dual anaplastic lymphoma kinase (ALK) and c-Met receptor tyrosine kinase inhibitor CM-118"
     . SPARSER::COLLECTION)
    ("The dual anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("c-Met-EGFR" . SPARSER::COLLECTION)
    ("EphA2 and AXL" . SPARSER::COLLECTION) ("-EGFR" . SPARSER::COLLECTION)
    ("EphA2" . SPARSER::PROTEIN) ("HGFR" . SPARSER::PROTEIN)
    ("AXL" . SPARSER::PROTEIN) ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("paxillin and NGAL" . SPARSER::COLLECTION)
    ("paxillin [ xref ] or neutrophil gelatinase-associated lipocalin (NGAL) [ xref ]"
     . SPARSER::COLLECTION)
    ("neutrophil gelatinase-associated lipocalin (NGAL)" . SPARSER::PROTEIN)
    ("NGAL" . SPARSER::PROTEIN) ("paxillin" . SPARSER::PROTEIN)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("IGF1 and IL-6" . SPARSER::COLLECTION) ("Flavopiridol" . SPARSER::DRUG)
    ("Bim-" . SPARSER::PROTEIN) ("flavopiridol" . SPARSER::DRUG)
    ("obatoclax or ABT-737" . SPARSER::COLLECTION)
    ("obatoclax" . SPARSER::DRUG) ("GSK3 and Bim" . SPARSER::COLLECTION)
    ("The PI3K/mTOR dual inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("B cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("mTORC1/TORC2" . SPARSER::COLLECTION)
    ("Bid, Bad and Bim" . SPARSER::COLLECTION)
    ("The dual TORC1/2 inhibitor AZD8055" . SPARSER::DRUG)
    ("K-Ras or B-Raf" . SPARSER::COLLECTION)
    ("dual TORC1/TORC2 inhibitors" . SPARSER::INHIBITOR)
    ("TORC1/TORC2" . SPARSER::COLLECTION)
    ("rituximab [ xref ] and IFNα [ xref ]" . SPARSER::COLLECTION)
    ("vinorelbine [ xref ] and taxoids [ xref , xref ]" . SPARSER::COLLECTION)
    ("The mTOR inhibitors rapamycin (Sirolimus) and RAD001 (Everolimus)"
     . SPARSER::COLLECTION)
    ("mitoxantrone" . SPARSER::DRUG) ("Everolimus" . SPARSER::MOLECULE)
    ("Sirolimus" . SPARSER::DRUG) ("Ras-MEK-ERK1/2" . SPARSER::COLLECTION)
    ("Bcl-xL, Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("Bax, Bak, Bad and Bim" . SPARSER::COLLECTION)
    ("Bcl-2/Bax" . SPARSER::COLLECTION)
    ("Mcl-1:Bim and Mcl-1:Noxa" . SPARSER::COLLECTION)
    ("Mcl-1:Noxa" . SPARSER::BIO-COMPLEX) ("Mcl-1:Bim" . SPARSER::BIO-COMPLEX)
    ("indole" . SPARSER::DRUG) ("MLL" . SPARSER::PROTEIN)
    ("other chemotherapeutic drugs" . SPARSER::DRUG)
    ("melphalan, dexamethasone and bortezomib" . SPARSER::COLLECTION)
    ("Bak/Bax" . SPARSER::COLLECTION) ("GX" . SPARSER::PROTEIN)
    ("Obatoclax" . SPARSER::DRUG) ("idelalisib" . SPARSER::DRUG)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("AKT and mTOR" . SPARSER::COLLECTION) ("Bcl-2:Bim" . SPARSER::BIO-COMPLEX)
    ("ABT-263 and ABT-199" . SPARSER::COLLECTION)
    ("acute lymphocytic leukemia" . SPARSER::PROTEIN)
    ("rituximab" . SPARSER::DRUG) ("Navitoclax" . SPARSER::DRUG)
    ("ABT-737 and carboplatin" . SPARSER::COLLECTION)
    ("Mcl-1/Bcl-2/Bcl-xL" . SPARSER::COLLECTION)
    ("BEZ235 and ABT-737" . SPARSER::COLLECTION)
    ("The dual PI3K/mTOR inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("The BH3 mimetic ABT-737" . SPARSER::DRUG) ("bis" . SPARSER::PROTEIN)
    ("Ras-MEK-ERK" . SPARSER::COLLECTION)
    ("increased anti-viral and anti-tumor immune responses"
     . SPARSER::COLLECTION)
    ("Frataxin" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("GLP-1 and exendin-4" . SPARSER::COLLECTION)
    ("glucose and dexamethasone" . SPARSER::COLLECTION)
    ("Txnip" . SPARSER::PROTEIN) ("Trx" . SPARSER::PROTEIN)
    ("Osteocalcin" . SPARSER::PROTEIN)
    ("JNK or neutralizing ROS" . SPARSER::COLLECTION)
    ("autocrine TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the adenomatous polyposis coli (APC) gene" . SPARSER::GENE)
    ("The homeotic transcription factor Six1" . SPARSER::PROTEIN)
    ("BHD" . SPARSER::PROTEIN) ("rapidly increase Bim EL" . SPARSER::PROTEIN)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("dynein light chain 1 and Bim" . SPARSER::COLLECTION)
    ("ElonginB-Cullin2-CIS" . SPARSER::COLLECTION) ("CIS" . SPARSER::PROTEIN)
    ("ElonginB" . SPARSER::PROTEIN) ("Imatinib" . SPARSER::DRUG)
    ("MAPK-ERK" . SPARSER::COLLECTION) ("Pyruvate" . SPARSER::PROTEIN)
    ("Bim and PTEN" . SPARSER::COLLECTION) ("Proteasomal" . SPARSER::PROTEIN)
    ("Src, PI3K or Akt" . SPARSER::COLLECTION)
    ("lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("PLZF/ZBTB16" . SPARSER::COLLECTION) ("PLZF" . SPARSER::PROTEIN)
    ("glucocorticoid-induced leucine zipper (GILZ)" . SPARSER::PROTEIN)
    ("GILZ" . SPARSER::PROTEIN) ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("FoxO3, c-Jun and Runx1" . SPARSER::COLLECTION)
    ("Bcl-2 and other anti-apoptotic proteins" . SPARSER::COLLECTION)
    ("T acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("pediatric acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("Glucocorticoids" . SPARSER::PROTEIN)
    ("Glucocorticoid" . SPARSER::PROTEIN)
    ("CD28-CD80/CD86" . SPARSER::COLLECTION)
    ("CD80/CD86" . SPARSER::COLLECTION)
    ("IL-6 and IGF-1" . SPARSER::COLLECTION)
    ("Phosphoinositide" . SPARSER::PROTEIN) ("Chloroquine" . SPARSER::PROTEIN)
    ("c-Myc and PI3K/Akt in high-risk T-ALL [ xref ]" . SPARSER::COLLECTION)
    ("c-Myc or PI3K/Akt pathway inhibitors" . SPARSER::COLLECTION)
    ("T cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Trichostatin" . SPARSER::MOLECULE)
    ("the methyl-CpG-binding protein MeCP2 and the SIN3a/histone deacetylase 1/2 (HDAC1/2) co-repressor complex [ xref ]"
     . SPARSER::COLLECTION)
    ("NPM/ALK" . SPARSER::COLLECTION)
    ("Baculoviral inhibitor" . SPARSER::INHIBITOR)
    ("BIRC5/Survivin" . SPARSER::COLLECTION) ("Survivin" . SPARSER::PROTEIN)
    ("imatinib- and nilotinib-induced apoptosis" . SPARSER::COLLECTION)
    ("imatinib-" . SPARSER::DRUG) ("nilotinib" . SPARSER::DRUG)
    ("Bim and Bad" . SPARSER::COLLECTION) ("Bmf or Puma" . SPARSER::COLLECTION)
    ("Bcl-Abl" . SPARSER::COLLECTION) ("Gleevec" . SPARSER::DRUG)
    ("Abl" . SPARSER::PROTEIN) ("Lapatinib" . SPARSER::DRUG)
    ("EGFR/ERK" . SPARSER::COLLECTION) ("CD147 (EMMPRIN)" . SPARSER::PROTEIN)
    ("EMMPRIN" . SPARSER::PROTEIN)
    ("the mitochondria and cause anoikis" . SPARSER::COLLECTION)
    ("EL , LC8 and Beclin-1" . SPARSER::COLLECTION)
    ("Cip or p27" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("HER2/neu" . SPARSER::COLLECTION) ("neu" . SPARSER::PROTEIN)
    ("mesothelin" . SPARSER::PROTEIN) ("Anoikis" . SPARSER::PROTEIN)
    ("Bik and Bim" . SPARSER::COLLECTION) ("Bortezomib" . SPARSER::DRUG)
    ("c-Raf" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("BMK" . SPARSER::PROTEIN) ("vAbl" . SPARSER::PROTEIN)
    ("/p53" . SPARSER::COLLECTION) ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("MSCs" . SPARSER::PROTEIN) ("acinar luminal" . SPARSER::DRUG)
    ("ErbB2 and v-Src" . SPARSER::COLLECTION) ("Oncogenes" . SPARSER::ONCOGENE)
    ("acinus" . SPARSER::PROTEIN) ("TRAF1 and TRAF2" . SPARSER::COLLECTION)
    ("The signal adaptor TNFR-associated factor 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NP" . SPARSER::PROTEIN) ("Bim and caspase 3" . SPARSER::COLLECTION)
    ("Bim/Mcl-1" . SPARSER::COLLECTION)
    ("the Kelch-like ECH-associated protein-1" . SPARSER::PROTEIN)
    ("LPS and the transcriptional inhibitor D(+)-galactosamine"
     . SPARSER::COLLECTION)
    ("Bid and Bim" . SPARSER::COLLECTION)
    ("-galactosamine" . SPARSER::MOLECULE)
    ("galactosamine" . SPARSER::MOLECULE) ("JNK and Bim" . SPARSER::COLLECTION)
    ("acetaminophen" . SPARSER::DRUG) ("Paracetamol" . SPARSER::MOLECULE)
    ("Acetaminophen" . SPARSER::DRUG)
    ("the BH3 mimetic ABT-737" . SPARSER::DRUG)
    ("Bim/Bid" . SPARSER::COLLECTION) ("Bim and Bid" . SPARSER::COLLECTION)
    ("A Bim-BH3 mimetic (TAT-BH3) peptide" . SPARSER::PEPTIDE)
    ("LPS or thioglycollate" . SPARSER::COLLECTION)
    ("thioglycollate" . SPARSER::MOLECULE) ("JNK-c-Jun" . SPARSER::COLLECTION)
    ("ERB" . SPARSER::PROTEIN)
    ("Pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("the basic leucine zipper transcription factor 2" . SPARSER::PROTEIN)
    ("Bcl2l11" . SPARSER::PROTEIN) ("Clec4e" . SPARSER::PROTEIN)
    ("RAGE" . SPARSER::PROTEIN) ("Bim and Nur77" . SPARSER::COLLECTION)
    ("Bim or Puma" . SPARSER::COLLECTION)
    ("Bid, Noxa or Bak" . SPARSER::COLLECTION)
    ("Puma and Bax" . SPARSER::COLLECTION) ("cytokine-" . SPARSER::PROTEIN)
    ("mitochondrial complex I" . SPARSER::PROTEIN) ("SNpc" . SPARSER::PROTEIN)
    ("H 2 O 2 or β-amyloid" . SPARSER::COLLECTION)
    ("the available Bcl-2" . SPARSER::PROTEIN) ("gyrus" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN) ("thrombopoietin" . SPARSER::PROTEIN)
    ("fluorouracil" . SPARSER::DRUG) ("/c-kit" . SPARSER::COLLECTION)
    ("IgE" . SPARSER::PROTEIN) ("SHP2 and ERK" . SPARSER::COLLECTION)
    ("RI" . SPARSER::MOLECULE) ("IL-3 and GM-CSF" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl2A1" . SPARSER::COLLECTION) ("Bcl2A1" . SPARSER::PROTEIN)
    ("etoposide and paclitaxel" . SPARSER::COLLECTION)
    ("FasL" . SPARSER::PROTEIN)
    ("Both immature and mature neutrophils" . SPARSER::PROTEIN)
    ("autoantibody" . SPARSER::PROTEIN) ("CD40 or TLRs" . SPARSER::COLLECTION)
    ("the bacterial lipopeptide Pam 3 Cys" . SPARSER::AMINO-ACID)
    ("TLR2, and CpG" . SPARSER::COLLECTION) ("Pam" . SPARSER::PROTEIN)
    ("lipopeptide" . SPARSER::PROTEIN) ("Macrophages" . SPARSER::PROTEIN)
    ("CD22 and Siglec-G" . SPARSER::COLLECTION)
    ("Lyn and Bim" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("lectins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCR- and lipopolysaccharide" . SPARSER::COLLECTION)
    ("BCR-" . SPARSER::PROTEIN) ("TRAIL or TGFβ" . SPARSER::COLLECTION)
    ("soluble anti-μ antibody" . SPARSER::ANTIBODY)
    ("The microbial virulence factor protein A" . SPARSER::PROTEIN)
    ("IL-4 and BAFF" . SPARSER::COLLECTION)
    ("the tumor necrosis factor family (BAFF) and A proliferation-inducing ligand (APRIL)"
     . SPARSER::COLLECTION)
    ("family (BAFF)" . SPARSER::PROTEIN-FAMILY) ("APRIL" . SPARSER::PROTEIN)
    ("BAFF" . SPARSER::PROTEIN) ("receptor (BCR)" . SPARSER::RECEPTOR)
    ("Agonistic antibodies" . SPARSER::ANTIBODY) ("Urelumab" . SPARSER::DRUG)
    ("TNFR" . SPARSER::PROTEIN) ("PD-1/PD-L1" . SPARSER::COLLECTION)
    ("anti-CD3-" . SPARSER::ANTIBODY) ("PD-L1/PD-1" . SPARSER::COLLECTION)
    ("UbA" . SPARSER::PROTEIN) ("TRA" . SPARSER::PROTEIN)
    ("Bcl-2 and the inositol triphosphate receptor (IP3R)"
     . SPARSER::COLLECTION)
    ("Bim and Bmf" . SPARSER::COLLECTION) ("Bim and Fas" . SPARSER::COLLECTION)
    ("Fas" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("myeloid and B-lymphoid" . SPARSER::COLLECTION)
    ("studied Bax −/− Bim −/− and Bak −/− Bim −/− mice" . SPARSER::COLLECTION)
    ("superantigen" . SPARSER::MOLECULE)
    ("FoxO3a and AP-1" . SPARSER::COLLECTION)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION)
    ("Cdk4 and its downstream effector B-Myb" . SPARSER::COLLECTION)
    ("a dominant-negative form" . SPARSER::FORM)
    ("PAR1, Bim, ERK or p38" . SPARSER::COLLECTION)
    ("ERK1/2 and p38" . SPARSER::COLLECTION) ("prothrombin" . SPARSER::PROTEIN)
    ("FXa" . SPARSER::PROTEIN)
    ("Cyclin D1, Cdk4 and Bim" . SPARSER::COLLECTION)
    ("thrombin and peptide" . SPARSER::COLLECTION)
    ("Raf-MEK-ERK1/2" . SPARSER::COLLECTION)
    ("Src/Ras/ERK" . SPARSER::COLLECTION)
    ("bim and foxO3a" . SPARSER::COLLECTION)
    ("Erythropoietin" . SPARSER::PROTEIN) ("mast cell" . SPARSER::PROTEIN)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("Raf/MAPK" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk4 and consequent de-repression" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN)
    ("various chemotherapeutic drugs" . SPARSER::DRUG)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-x" . SPARSER::COLLECTION)
    ("the Tax viral oncoprotein" . SPARSER::PROTEIN)
    ("ERK/RSK" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("Cyclin B1 and Bim" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("Cdk1/Cyclin B1" . SPARSER::COLLECTION)
    ("kinase and PP2A" . SPARSER::COLLECTION)
    ("PKA and Bim" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cAMP" . SPARSER::PROTEIN)
    ("CPT" . SPARSER::PROTEIN) ("PKA" . SPARSER::PROTEIN)
    ("homology (BCH)" . SPARSER::PROTEIN)
    ("BNIP2 and Cdc42GAP" . SPARSER::COLLECTION)
    ("PDK1/Akt" . SPARSER::COLLECTION) ("BCH" . SPARSER::PROTEIN)
    ("a physical complex" . SPARSER::BIO-COMPLEX)
    ("isomerase" . SPARSER::ISOMERASE) ("prolyl" . SPARSER::PROTEIN)
    ("HEK" . SPARSER::PROTEIN)
    ("transient focal cerebral ischemia" . SPARSER::PROTEIN)
    ("SP-1-, FoxO3a-, and E2F1-dependent" . SPARSER::COLLECTION)
    ("FoxO3a-" . SPARSER::PROTEIN) ("SP-1-" . SPARSER::PROTEIN)
    ("MEK/ERK1/2" . SPARSER::COLLECTION)
    ("Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("MEK or a BH3 mimetic drug" . SPARSER::COLLECTION)
    ("a BH3 mimetic drug" . SPARSER::DRUG) ("uPA" . SPARSER::PROTEIN)
    ("RSK1 and RSK2" . SPARSER::COLLECTION) ("β-TrCP1" . SPARSER::PROTEIN)
    ("β-TrCP or RSK1/2" . SPARSER::COLLECTION)
    ("ribosomal S6 kinase (RSK)" . SPARSER::PROTEIN-FAMILY)
    ("RSK" . SPARSER::PROTEIN)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("PI3K/mTORC" . SPARSER::COLLECTION) ("mTORC" . SPARSER::PROTEIN)
    ("MAPK1/ERK2" . SPARSER::COLLECTION)
    ("both the pro-apoptotic Bim and the anti-apoptotic Mcl-1"
     . SPARSER::COLLECTION)
    ("both the pro-apoptotic Bim" . SPARSER::PROTEIN)
    ("Mcl-1 and Bcl-xL" . SPARSER::COLLECTION)
    ("only Bim EL" . SPARSER::PROTEIN) ("Akt/mTOR" . SPARSER::COLLECTION)
    ("JNK or p38" . SPARSER::COLLECTION) ("Kinases" . SPARSER::KINASE)
    ("c-Myc, Mcl-1, Notch1 and c-Jun" . SPARSER::COLLECTION)
    ("MicroRNAs" . SPARSER::RNA) ("Bim, PTEN and FoxO3" . SPARSER::COLLECTION)
    ("PTEN and Bim" . SPARSER::COLLECTION) ("LAT" . SPARSER::PROTEIN)
    ("Linker" . SPARSER::LINKER) ("miR-301a" . SPARSER::COLLECTION)
    ("AraC" . SPARSER::DRUG) ("T-bet and Twist1" . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN)
    ("pediatric acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Dicer" . SPARSER::PROTEIN) ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("statins" . SPARSER::DRUG) ("SODD" . SPARSER::PROTEIN)
    ("Bag" . SPARSER::PROTEIN-FAMILY)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("RBPs" . SPARSER::PROTEIN) ("Mst1" . SPARSER::PROTEIN)
    ("-deoxycytidine" . SPARSER::COLLECTION)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("bim and foxO3" . SPARSER::COLLECTION) ("Promoters" . SPARSER::PROMOTER)
    ("Brahma" . SPARSER::PROTEIN) ("Brm" . SPARSER::PROTEIN)
    ("hnRNP" . SPARSER::PROTEIN) ("SRp55/SFRS6" . SPARSER::COLLECTION)
    ("Hara" . SPARSER::PROTEIN) ("arginine/serine (RS)" . SPARSER::COLLECTION)
    ("arginine/serine" . SPARSER::COLLECTION) ("Gli" . SPARSER::PROTEIN)
    ("Pnn" . SPARSER::PROTEIN) ("Pinin" . SPARSER::PROTEIN)
    ("c-Myc and SRSF1" . SPARSER::COLLECTION) ("SF2/ASF" . SPARSER::COLLECTION)
    ("a pre-mature Bim protein" . SPARSER::PROTEIN)
    ("the endemic form" . SPARSER::FORM)
    ("EBNA3A and EBNA3C" . SPARSER::COLLECTION) ("TRAIL-" . SPARSER::PROTEIN)
    ("primary paedriatric B-precursor acute lymphoblastic leukemia"
     . SPARSER::PROTEIN)
    ("c-Myc and Birc5" . SPARSER::COLLECTION) ("Birc5" . SPARSER::PROTEIN)
    ("ponatinib" . SPARSER::DRUG) ("p21 and Bim" . SPARSER::COLLECTION)
    ("panobinostat" . SPARSER::DRUG)
    ("I-BET 151 or CPI203" . SPARSER::COLLECTION)
    ("Bcl-2 and Cyclin D1" . SPARSER::COLLECTION) ("CPI" . SPARSER::PROTEIN)
    ("c-Myc and Bcl-2" . SPARSER::COLLECTION)
    ("the bromodomain and extra-terminal (BET) protein family [ xref ]"
     . SPARSER::COLLECTION)
    ("BET" . SPARSER::PROTEIN) ("bromodomain" . SPARSER::PROTEIN)
    ("mithramycin" . SPARSER::DRUG) ("Lrf/Pokemon" . SPARSER::COLLECTION)
    ("The erythroid myeloid ontogenic factor Pokemon" . SPARSER::PROTEIN)
    ("Lrf/Zbtb7a" . SPARSER::COLLECTION) ("POK" . SPARSER::PROTEIN)
    ("Pokemon/Lrf" . SPARSER::COLLECTION) ("Lrf" . SPARSER::PROTEIN)
    ("kinases and ERK1/2" . SPARSER::COLLECTION)
    ("Particularly interesting cysteine-histidine-rich protein-1"
     . SPARSER::PROTEIN)
    ("B lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("The two PRC2 subunits SUZ12 and the histone methyltransferase EZH2"
     . SPARSER::COLLECTION)
    ("Polycomb" . SPARSER::PROTEIN) ("cerebral ischemia" . SPARSER::PROTEIN)
    ("YY1 and RelA" . SPARSER::COLLECTION)
    ("YY1 or RelA" . SPARSER::COLLECTION)
    ("the Yin Yang 1 (YY1)-RelA (p65) complex" . SPARSER::BIO-COMPLEX)
    ("-RelA" . SPARSER::COLLECTION) ("Yin" . SPARSER::PROTEIN)
    ("YY-1-RelA" . SPARSER::COLLECTION) ("Dinaciclib" . SPARSER::DRUG)
    ("Purvalanol" . SPARSER::MOLECULE)
    ("Bim and the anti-apoptotic proteins Bcl-2, Bcl-xL and Mcl-1 [ xref ]"
     . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Mcl-1/Bim" . SPARSER::COLLECTION) ("Mutant" . SPARSER::MUTANT)
    ("Bim or STAT-1" . SPARSER::COLLECTION)
    ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("thapsigargin and tunicamycin" . SPARSER::COLLECTION)
    ("GADD153 and Bim" . SPARSER::COLLECTION) ("striatum" . SPARSER::PROTEIN)
    ("huntingtin" . SPARSER::PROTEIN) ("-C/EBPα" . SPARSER::COLLECTION)
    ("CHOP/GADD153" . SPARSER::COLLECTION)
    ("Puma and Noxa" . SPARSER::COLLECTION)
    ("CHOP-C/EBPα" . SPARSER::COLLECTION) ("CHOP" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein (XIAP)" . SPARSER::PROTEIN)
    ("microtubules, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Bax and Bax" . SPARSER::COLLECTION)
    ("caspase 9 and caspase 3" . SPARSER::COLLECTION)
    ("XIAP" . SPARSER::PROTEIN) ("EZH2 and Bim" . SPARSER::COLLECTION)
    ("polycomb" . SPARSER::PROTEIN) ("E2F1 and Bim" . SPARSER::COLLECTION)
    ("suberoylanilide hydroxamic acid (SAHA)" . SPARSER::DRUG)
    ("SAHA" . SPARSER::DRUG) ("HDACi" . SPARSER::MOLECULE)
    ("Inhibitors" . SPARSER::INHIBITOR) ("Hrk/DP5" . SPARSER::COLLECTION)
    ("MKP2/DUSP4" . SPARSER::COLLECTION)
    ("Runx1 and FoxO3a" . SPARSER::COLLECTION) ("Runx3" . SPARSER::PROTEIN)
    ("SNAI" . SPARSER::PROTEIN-FAMILY) ("Snail" . SPARSER::PROTEIN)
    ("Runx2 and c-Jun" . SPARSER::COLLECTION)
    ("JNK/c-Jun" . SPARSER::COLLECTION) ("TGFβ and TNFα" . SPARSER::COLLECTION)
    ("CA1" . SPARSER::PROTEIN) ("CBP/p300" . SPARSER::COLLECTION)
    ("CBP and p300" . SPARSER::COLLECTION)
    ("NF-Y and FoxO3a" . SPARSER::COLLECTION) ("ICB" . SPARSER::PROTEIN)
    ("CCAAT" . SPARSER::PROTEIN) ("CBP" . SPARSER::PROTEIN)
    ("The heterotrimeric transcription factor NF-Y" . SPARSER::PROTEIN)
    ("growth factor and cytokine" . SPARSER::COLLECTION)
    ("p27 Kip1 , p21 Cip1 and Bim" . SPARSER::COLLECTION)
    ("activated phosphorylated Akt and its phosphatases (e.g., PHLPP2)"
     . SPARSER::COLLECTION)
    ("PML" . SPARSER::PROTEIN) ("Casein" . SPARSER::PROTEIN)
    ("FoxO3a/Bim" . SPARSER::COLLECTION) ("kinase (SGK)" . SPARSER::KINASE)
    ("SGK" . SPARSER::PROTEIN)
    ("IκB kinase (IKK) and Akt (PKB)" . SPARSER::COLLECTION)
    ("kinase (IKK)" . SPARSER::KINASE) ("PKB" . SPARSER::PROTEIN)
    ("AP-1" . SPARSER::PROTEIN) ("MEK/ERK" . SPARSER::COLLECTION)
    ("BDNF" . SPARSER::PROTEIN) ("Bim and Noxa" . SPARSER::COLLECTION)
    ("Cytokines" . SPARSER::PROTEIN) ("forkhead" . SPARSER::PROTEIN)
    ("FKHR-L1/FoxO3a" . SPARSER::COLLECTION)
    ("c-Jun, FoxO or c-Myb" . SPARSER::COLLECTION)
    ("FoxO and Myb" . SPARSER::COLLECTION) ("Myb" . SPARSER::PROTEIN)
    ("the proximal bim promoter" . SPARSER::PROMOTER)
    ("FoxO, c-Myb or c-Jun" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("FoxO, c-Myb and c-Jun" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("ERK/MAPK" . SPARSER::COLLECTION)
    ("inactive heterodimers" . SPARSER::HETERODIMER)
    ("Hsc70 and Hsp27" . SPARSER::COLLECTION) ("-301a" . SPARSER::COLLECTION)
    ("Pokemon" . SPARSER::PROTEIN) ("c-Jun and RelA" . SPARSER::COLLECTION)
    ("Runx1-3" . SPARSER::COLLECTION)
    ("Paclitaxel and Vinblastine" . SPARSER::COLLECTION)
    ("Vinblastine" . SPARSER::DRUG) ("Paclitaxel" . SPARSER::DRUG)
    ("Tripartite motif containing 17 (Trim17) and β-transducin"
     . SPARSER::COLLECTION)
    ("the E3 ligases Mcl-1 ubiquitin ligase E3 (Mule), F-Box and WD repeat domain containing 7 (Fbw7), Tripartite motif containing 17 (Trim17) and β-transducin"
     . SPARSER::COLLECTION)
    ("Fbw7" . SPARSER::PROTEIN) ("transducin" . SPARSER::PROTEIN)
    ("Trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the apoptogenic proteins cytochrome C" . SPARSER::PROTEIN)
    ("Smac" . SPARSER::PROTEIN) ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("Mcl-1 and Bim" . SPARSER::COLLECTION)
    ("The p53- and BRCA1-regulated stress protein GADD45a"
     . SPARSER::COLLECTION)
    ("microtubule-associated components" . SPARSER::COMPONENT)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bim-Beclin-1-DYNLL1" . SPARSER::COLLECTION)
    ("MAPK8/JNK" . SPARSER::COLLECTION)
    ("paclitaxel and vinorelbine" . SPARSER::COLLECTION)
    ("vinorelbine" . SPARSER::DRUG) ("oligomeric Bak" . SPARSER::PROTEIN)
    ("Bax [ xref ] and Bim" . SPARSER::COLLECTION)
    ("Bid, Bim and Puma" . SPARSER::COLLECTION) ("caspases" . SPARSER::PROTEIN)
    ("larger oligomers" . SPARSER::PROTEIN) ("Activator" . SPARSER::ACTIVATOR)
    ("inactive Bax monomers" . SPARSER::MONOMER)
    ("the monomeric inactive conformation" . SPARSER::BIO-CONFORMATION)
    ("Bcl-2/Bcl-xL" . SPARSER::COLLECTION) ("Bax/Bak" . SPARSER::COLLECTION)
    ("BCR" . SPARSER::PROTEIN) ("Bcl-xL and Bax" . SPARSER::COLLECTION)
    ("Bcl-xL and Bim" . SPARSER::COLLECTION)
    ("Bak and Bax" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL or Bcl-w" . SPARSER::COLLECTION)
    ("the more distant viral homologues adenovirus E1B19K and Epstein-Barr virus BHRF-1"
     . SPARSER::COLLECTION)
    ("the more distant viral homologues adenovirus E1B19K" . SPARSER::PROTEIN)
    ("the baculoviral caspase inhibitor P35" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL and Bcl-w" . SPARSER::COLLECTION)
    ("CHO" . SPARSER::PROTEIN)
    ("growth factor or cytokine" . SPARSER::COLLECTION)
    ("anoikis" . SPARSER::PROTEIN) ("Bim/Bik" . SPARSER::COLLECTION)
    ("Bim and Bik" . SPARSER::COLLECTION) ("sIgM" . SPARSER::PROTEIN)
    ("Bim and Puma" . SPARSER::COLLECTION)
    ("Puma- and Bim-double-deficient" . SPARSER::COLLECTION)
    ("Puma-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Puma and Bim" . SPARSER::COLLECTION) ("/Puma" . SPARSER::COLLECTION)
    ("Puma or Bim" . SPARSER::COLLECTION)
    ("superantigens (Mtv-9 and Staphylococcus enterotoxin B) and male antigen HY"
     . SPARSER::COLLECTION)
    ("HY" . SPARSER::MOLECULE) ("enterotoxin" . SPARSER::PROTEIN)
    ("superantigens" . SPARSER::MOLECULE)
    ("ionomycin and cytokine" . SPARSER::COLLECTION)
    ("paclitaxel" . SPARSER::DRUG) ("IgM and IgG" . SPARSER::COLLECTION)
    ("IgM" . SPARSER::PROTEIN)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lymphoid" . SPARSER::PROTEIN) ("bim" . SPARSER::PROTEIN)
    ("the pro-apoptotic BH3-containing Bim" . SPARSER::PROTEIN)
    ("the BH3-mimetic drug ABT-737" . SPARSER::DRUG)
    ("vorinostat" . SPARSER::DRUG)
    ("the pre-mature TGA stop codon" . SPARSER::PROTEIN)
    ("TGA" . SPARSER::PROTEIN) ("BimA" . SPARSER::PROTEIN)
    ("the classical isoforms" . SPARSER::ISOFORM)
    ("Bcl-2 or Mcl-1" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bax protein" . SPARSER::PROTEIN)
    ("EL and Bim" . SPARSER::COLLECTION) ("dynein" . SPARSER::PROTEIN)
    ("channel-forming Bcl-2 family proteins" . SPARSER::PROTEIN)
    ("amino acids (LRRIGDEFN)" . SPARSER::AMINO-ACID)
    ("pre-B acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Da" . SPARSER::MOLECULE) ("EL" . SPARSER::PROTEIN)
    ("at least 18 different isoforms" . SPARSER::ISOFORM)
    ("Bcl2L11" . SPARSER::PROTEIN) ("Isoforms" . SPARSER::ISOFORM)
    ("only one Bim allele" . SPARSER::ALLELE)
    ("the multi-domain pro-apoptotic proteins Bak, Bax and Bok"
     . SPARSER::COLLECTION)
    ("The BH3-only pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bak, Bax and Bok" . SPARSER::COLLECTION)
    ("these pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("glucocorticoid" . SPARSER::PROTEIN)
    ("Bad, Bik, Bmf, Bid, Hrk, Noxa and Puma" . SPARSER::COLLECTION)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Noxa" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hrk" . SPARSER::PROTEIN)
    ("Bid" . SPARSER::PROTEIN) ("Bmf" . SPARSER::PROTEIN)
    ("Bik" . SPARSER::PROTEIN)
    ("a death agonist and survival antagonist [ xref ]" . SPARSER::COLLECTION)
    ("Bax and Bak" . SPARSER::COLLECTION)
    ("the anti-apoptotic Bcl-2 proteins Mcl-1, Bcl-2, Bcl-xL, Bcl-w, Bfl-1 and Epstein-Barr virus (EBV) BHRF-1"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic Bcl-2 proteins Bad, Bak, Bok and Bax"
     . SPARSER::COLLECTION)
    ("Bad, Bak, Bok and Bax" . SPARSER::COLLECTION)
    ("BHRF-1" . SPARSER::COLLECTION) ("Bok" . SPARSER::PROTEIN)
    ("Bak" . SPARSER::PROTEIN) ("Bad" . SPARSER::PROTEIN)
    ("the gene Bcl-2 related ovarian death agonist (BOD)" . SPARSER::AGONIST)
    ("agonist (BOD)" . SPARSER::AGONIST) ("BOD" . SPARSER::PROTEIN)
    ("BIM" . SPARSER::PROTEIN)
    ("Bim and its regulatory proteins" . SPARSER::COLLECTION)
    ("an essential pro-apoptotic protein" . SPARSER::PROTEIN)
    ("many pharmaceutical agents target" . SPARSER::TARGET-PROTEIN)
    ("Bim" . SPARSER::PROTEIN) ("Cathepsin H" . SPARSER::PROTEIN)
    ("IL-6R" . SPARSER::PROTEIN) ("XL888" . SPARSER::DRUG)
    ("Hsp90 inhibitor XL888" . SPARSER::DRUG)
    ("AXL receptor tyrosine kinase" . SPARSER::PROTEIN)
    ("Gas6" . SPARSER::PROTEIN) ("MST1R" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("CDCP1" . SPARSER::PROTEIN) ("CUB domain" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("AZD6244" . SPARSER::DRUG)
    ("DUSP6" . SPARSER::PROTEIN) ("Ets-1" . SPARSER::PROTEIN)
    ("neutrophil gelatinase-associated lipocalin" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN) ("MK-2206" . SPARSER::MOLECULE)
    ("TORC2" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("RAD001" . SPARSER::DRUG) ("AT-101" . SPARSER::DRUG)
    ("GS-1101" . SPARSER::DRUG) ("ABT-199" . SPARSER::DRUG)
    ("B-ALL" . SPARSER::PROTEIN) ("AZD8055" . SPARSER::DRUG)
    ("TORC1" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("FBW7" . SPARSER::PROTEIN)
    ("BEZ235" . SPARSER::DRUG) ("exendin-4" . SPARSER::PROTEIN)
    ("Thioredoxin-interacting protein" . SPARSER::PROTEIN)
    ("thioredoxin-1" . SPARSER::PROTEIN) ("anti-oxidants" . SPARSER::DRUG)
    ("Complex I" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("FoxC1" . SPARSER::PROTEIN) ("forkhead box C1" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("IGF-R" . SPARSER::PROTEIN)
    ("Six1" . SPARSER::PROTEIN) ("Smad7" . SPARSER::PROTEIN)
    ("dynein light chain 1" . SPARSER::PROTEIN) ("RACK1" . SPARSER::PROTEIN)
    ("Receptor for activated C kinase" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN) ("CPT-11" . SPARSER::DRUG)
    ("Drg1" . SPARSER::PROTEIN) ("PKM2" . SPARSER::PROTEIN)
    ("Hsc70-interacting protein" . SPARSER::PROTEIN)
    ("G1P3" . SPARSER::PROTEIN) ("GSTM1" . SPARSER::PROTEIN)
    ("Glutathione S-Transferase mu 1" . SPARSER::PROTEIN)
    ("KLF13" . SPARSER::PROTEIN) ("ZBTB16" . SPARSER::PROTEIN)
    ("CRM1" . SPARSER::PROTEIN) ("Exportin 1" . SPARSER::PROTEIN)
    ("glucocorticoid-induced leucine zipper" . SPARSER::PROTEIN)
    ("CD86" . SPARSER::PROTEIN) ("CD80" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("PDPK1" . SPARSER::PROTEIN)
    ("PF02341066" . SPARSER::DRUG) ("HDAC1" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN) ("SIN3a" . SPARSER::PROTEIN)
    ("MeCP2" . SPARSER::PROTEIN) ("CpG-binding protein" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("LBH589" . SPARSER::DRUG)
    ("STI-571" . SPARSER::DRUG) ("PTK6" . SPARSER::PROTEIN)
    ("Protein tyrosine kinase 6" . SPARSER::PROTEIN)
    ("CD147" . SPARSER::PROTEIN)
    ("extracellular matrix metalloproteinase inducer" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("Cox2" . SPARSER::PROTEIN)
    ("v-Abl" . SPARSER::PROTEIN) ("p19 Arf" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN) ("4-1BB" . SPARSER::PROTEIN)
    ("Keap-1" . SPARSER::PROTEIN) ("SGK1" . SPARSER::PROTEIN)
    ("Wnt/β" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("Pdx-1" . SPARSER::PROTEIN) ("IRS2" . SPARSER::PROTEIN)
    ("Insulin receptor substrate 2" . SPARSER::PROTEIN)
    ("Pdx1" . SPARSER::PROTEIN) ("cathepsin H" . SPARSER::PROTEIN)
    ("MKK7" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 7" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN) ("BACH2" . SPARSER::PROTEIN)
    ("transcription factor 2" . SPARSER::PROTEIN) ("Idd13" . SPARSER::PROTEIN)
    ("l11" . SPARSER::PROTEIN) ("SAP130" . SPARSER::PROTEIN)
    ("spliceosome-associated protein" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("Cdk5" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 5" . SPARSER::PROTEIN)
    ("CD41" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("PGE 2" . SPARSER::DRUG) ("m157" . SPARSER::PROTEIN-FAMILY)
    ("Ly6C" . SPARSER::PROTEIN) ("CD27" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("Ly49H" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("MyD88" . SPARSER::PROTEIN) ("sialic acid" . SPARSER::MOLECULE)
    ("CD22" . SPARSER::PROTEIN) ("Sialic acid" . SPARSER::MOLECULE)
    ("TLR9" . SPARSER::PROTEIN) ("TLR3" . SPARSER::PROTEIN)
    ("anti-IgM" . SPARSER::PROTEIN)
    ("A proliferation-inducing ligand" . SPARSER::PROTEIN)
    ("activating factor" . SPARSER::PROTEIN) ("CD137" . SPARSER::PROTEIN)
    ("TRAF1" . SPARSER::PROTEIN) ("TRAF-1" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("4-1BBL" . SPARSER::PROTEIN)
    ("CD137L" . SPARSER::PROTEIN) ("IL-7 receptor" . SPARSER::PROTEIN)
    ("Nur77" . SPARSER::PROTEIN) ("Retinoic acid" . SPARSER::MOLECULE)
    ("KLRG1" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PD-L1" . SPARSER::PROTEIN) ("B7-H1" . SPARSER::PROTEIN)
    ("IP3R" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("CD3ε" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("Amyloid-β" . SPARSER::MOLECULE) ("c-Fos" . SPARSER::PROTEIN)
    ("β-Amyloid" . SPARSER::MOLECULE) ("β-amyloid" . SPARSER::MOLECULE)
    ("G-protein" . SPARSER::PROTEIN) ("SHP2" . SPARSER::PROTEIN)
    ("FGF4" . SPARSER::PROTEIN)
    ("fibroblast growth factor-4" . SPARSER::PROTEIN)
    ("GLP-1" . SPARSER::PROTEIN) ("Glucagon-like peptide" . SPARSER::PROTEIN)
    ("foxO3a" . SPARSER::PROTEIN) ("IL-15" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN) ("cdc20" . SPARSER::PROTEIN)
    ("PRKAR1A" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDK1" . SPARSER::PROTEIN) ("Cdc42GAP" . SPARSER::PROTEIN)
    ("BNIP2" . SPARSER::PROTEIN) ("BMCC1" . SPARSER::PROTEIN)
    ("S1P1" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("SphK1" . SPARSER::PROTEIN) ("Sphingosine kinase 1" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("Sodium arsenite" . SPARSER::DRUG) ("JIP3" . SPARSER::PROTEIN)
    ("Pin1" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("RSK2" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("ERK2" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase 1" . SPARSER::PROTEIN)
    ("Interleukin-3" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("miR-193b" . SPARSER::MOLECULE) ("miR-29" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("SHIP1" . SPARSER::PROTEIN) ("phosphatase 1" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("Twist1" . SPARSER::PROTEIN) ("miR-92a" . SPARSER::MOLECULE)
    ("miR-181a" . SPARSER::MOLECULE) ("pro-B" . SPARSER::DRUG)
    ("FoxO4" . SPARSER::PROTEIN) ("HMG-CoA" . SPARSER::DRUG)
    ("Hsp40" . SPARSER::PROTEIN) ("STE20" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("Lys9" . SPARSER::PROTEIN)
    ("a chain" . SPARSER::PROTEIN) ("Histone deacetylase" . SPARSER::PROTEIN)
    ("foxO3" . SPARSER::PROTEIN) ("Sam68" . SPARSER::PROTEIN)
    ("sucrose nonfermenting" . SPARSER::PROTEIN)
    ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("subfamily a" . SPARSER::PROTEIN) ("matrix associated" . SPARSER::PROTEIN)
    ("SWI/SNF related" . SPARSER::PROTEIN)
    ("Heterogeneous nuclear ribonucleoprotein" . SPARSER::PROTEIN)
    ("PTBP1" . SPARSER::PROTEIN)
    ("Polypyrimidine tract binding protein 1" . SPARSER::PROTEIN)
    ("Zn 2+" . SPARSER::MOLECULE) ("PLX4720" . SPARSER::DRUG)
    ("SFRS6" . SPARSER::PROTEIN) ("SRp55" . SPARSER::PROTEIN)
    ("GLIS3" . SPARSER::PROTEIN) ("zinc finger protein" . SPARSER::PROTEIN)
    ("SRSF1" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("EBNA3C" . SPARSER::PROTEIN) ("EBNA3A" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("Tax protein" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("I-BET151" . SPARSER::MOLECULE) ("I-BET 151" . SPARSER::MOLECULE)
    ("Brd4" . SPARSER::PROTEIN) ("Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SP-1" . SPARSER::PROTEIN) ("GATA-1" . SPARSER::PROTEIN)
    ("Zbtb7a" . SPARSER::PROTEIN)
    ("Tripartite motif containing 33" . SPARSER::PROTEIN)
    ("Spi-1" . SPARSER::PROTEIN) ("YY-1" . SPARSER::PROTEIN)
    ("erythroid-derived 2, like 2" . SPARSER::PROTEIN)
    ("mTORC1" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("PTPN2" . SPARSER::PROTEIN) ("β-cell" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("STAT-1" . SPARSER::PROTEIN) ("ATF4" . SPARSER::PROTEIN)
    ("Activating transcription factor 4" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("GADD153" . SPARSER::PROTEIN)
    ("C/EBP homologous protein" . SPARSER::PROTEIN)
    ("C/EBPα" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("Angiotensin II" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::MOLECULE)
    ("ASK1" . SPARSER::PROTEIN) ("regulated kinase 1" . SPARSER::PROTEIN)
    ("DP5" . SPARSER::PROTEIN) ("DUSP4" . SPARSER::PROTEIN)
    ("MKP2" . SPARSER::PROTEIN) ("SNAI2" . SPARSER::PROTEIN)
    ("CKIε" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27 Kip1" . SPARSER::PROTEIN) ("PHLPP2" . SPARSER::PROTEIN)
    ("Promyelocytic leukemia" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("SIRT1" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("Activator protein-1" . SPARSER::PROTEIN) ("STI571" . SPARSER::DRUG)
    ("FoxO3" . SPARSER::PROTEIN) ("FKHR-L1" . SPARSER::PROTEIN)
    ("Egr-1" . SPARSER::PROTEIN) ("early growth response 1" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("Hsp27" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("301a" . SPARSER::PROTEIN)
    ("PINCH-1" . SPARSER::PROTEIN) ("SPi-1" . SPARSER::PROTEIN)
    ("HoxB8" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("Runx1" . SPARSER::PROTEIN) ("NF-Y" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN) ("WP1130" . SPARSER::DRUG)
    ("Mcl-1 protein" . SPARSER::PROTEIN) ("USP9X" . SPARSER::PROTEIN)
    ("mTORC2" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("β-TrCP" . SPARSER::PROTEIN)
    ("Tripartite motif containing 17" . SPARSER::PROTEIN)
    ("F-Box and WD repeat domain containing 7" . SPARSER::PROTEIN)
    ("Mcl-1 ubiquitin ligase E3" . SPARSER::PROTEIN)
    ("granzyme B" . SPARSER::PROTEIN) ("HtrA2" . SPARSER::PROTEIN)
    ("Second mitochondria-derived activator of caspase" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("EF-1α" . SPARSER::PROTEIN)
    ("GADD45a" . SPARSER::PROTEIN) ("MAPK8" . SPARSER::PROTEIN)
    ("DYNLL1" . SPARSER::PROTEIN) ("LC8" . SPARSER::PROTEIN)
    ("ABT-737-" . SPARSER::DRUG) ("VDAC2" . SPARSER::PROTEIN)
    ("E1B19K" . SPARSER::PROTEIN) ("P35" . SPARSER::PROTEIN)
    ("in Chinese hamster" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("IL-7" . SPARSER::PROTEIN) ("CD127" . SPARSER::PROTEIN)
    ("IL-7R" . SPARSER::PROTEIN) ("interleukin-7 receptor" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("ABT-737" . SPARSER::DRUG)
    ("BH4" . SPARSER::PROTEIN-FAMILY) ("isoform 11" . SPARSER::PROTEIN)
    ("isoform 6" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("2-4" . SPARSER::PROTEIN) ("Bcl2L" . SPARSER::PROTEIN)
    ("BH2" . SPARSER::MOLECULE) ("BH1" . SPARSER::PROTEIN)
    ("Bfl-1" . SPARSER::PROTEIN) ("Bcl-w" . SPARSER::PROTEIN)
    ("Bcl-2L" . SPARSER::PROTEIN) ("Bcl-2-like" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("cl-2" . SPARSER::PROTEIN)
    ("AO" . SPARSER::PROTEIN) ("LA" . SPARSER::PROTEIN)
    ("PKCα and PKCβ" . SPARSER::COLLECTION)
    ("classical and novel PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rottlerin" . SPARSER::DRUG) ("aPKC" . SPARSER::PROTEIN)
    ("TRPs" . SPARSER::PROTEIN) ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a particularly aggressive form" . SPARSER::FORM)
    ("trpc6" . SPARSER::PROTEIN) ("Several causative genes" . SPARSER::GENE)
    ("podocin" . SPARSER::PROTEIN) ("nephrin" . SPARSER::PROTEIN)
    ("proteins " . SPARSER::PROTEIN) ("proteinuria" . SPARSER::PROTEIN)
    ("PLC" . SPARSER::PROTEIN) ("phospholipase" . SPARSER::PROTEIN)
    ("cation" . SPARSER::MOLECULE) ("DAG" . SPARSER::DAG)
    ("diacylglycerol" . SPARSER::PROTEIN) ("TRP" . SPARSER::AMINO-ACID)
    ("glycerol" . SPARSER::PROTEIN)
    ("Transient receptor potential canonical‐6 (TRPC6) ion channels"
     . SPARSER::PROTEIN-FAMILY)
    ("nPKCδ" . SPARSER::PROTEIN) ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fluo 4" . SPARSER::DRUG) ("PKCγ" . SPARSER::PROTEIN)
    ("PKCζ" . SPARSER::PROTEIN) ("PKCδ" . SPARSER::PROTEIN)
    ("Gö6983" . SPARSER::DRUG) ("GF109203X" . SPARSER::DRUG)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("angiotensin II" . SPARSER::PROTEIN) ("P112" . SPARSER::PROTEIN)
    ("cation channel" . SPARSER::PROTEIN)
    ("Transient receptor potential cation channel" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("activator 1" . SPARSER::PROTEIN)
    ("TRPC6" . SPARSER::PROTEIN)
    ("genetic variants and different types" . SPARSER::COLLECTION)
    ("chronic leukemia" . SPARSER::PROTEIN) ("Arg/Pro " . SPARSER::COLLECTION)
    ("PB" . SPARSER::PROTEIN) ("acute leukemia (AL)" . SPARSER::PROTEIN)
    ("Leukemia" . SPARSER::PROTEIN) ("acute leukemia" . SPARSER::PROTEIN)
    ("Arg/Arg " . SPARSER::COLLECTION) ("Pro/Pro " . SPARSER::COLLECTION)
    ("Arg/Pro" . SPARSER::COLLECTION) ("Pro/Pro" . SPARSER::COLLECTION)
    ("Arg " . SPARSER::AMINO-ACID) ("Pro " . SPARSER::AMINO-ACID)
    ("Tumor Suppressor Protein" . SPARSER::PROTEIN)
    ("tumor protein p53" . SPARSER::PROTEIN) ("iodine" . SPARSER::MOLECULE)
    ("only 21 PTC" . SPARSER::PROTEIN) ("Gao" . SPARSER::PROTEIN)
    ("GATA" . SPARSER::PROTEIN) ("aggressive PTC" . SPARSER::PROTEIN)
    ("allele and GG" . SPARSER::COLLECTION)
    ("2 different primary miRNAs" . SPARSER::PROTEIN)
    ("The 3 mature miRNAs" . SPARSER::PROTEIN)
    ("allele and CC" . SPARSER::COLLECTION) ("TP-53" . SPARSER::PROTEIN)
    ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("p53 and MGMT" . SPARSER::COLLECTION)
    ("the aggressive subtypes" . SPARSER::PROTEIN)
    ("methylated promoters" . SPARSER::PROMOTER) ("GH" . SPARSER::PROTEIN)
    ("Lau" . SPARSER::MOLECULE)
    ("a methylated promoter showed high-level MGMT" . SPARSER::PROTEIN)
    ("a methylated MGMT promoter" . SPARSER::PROMOTER)
    ("MSP" . SPARSER::PROTEIN) ("p53, and Ki-67" . SPARSER::COLLECTION)
    ("bromocriptine" . SPARSER::MOLECULE) ("cabergoline" . SPARSER::DRUG)
    ("methylated MGMT promoters" . SPARSER::PROMOTER) ("TMZ" . SPARSER::DRUG)
    ("Temozolomide" . SPARSER::DRUG) ("dopamine" . SPARSER::DRUG)
    ("absent MGMT" . SPARSER::PROTEIN)
    ("Methylated MGMT promoter" . SPARSER::PROMOTER)
    ("MGMT, Ki-67, and p53" . SPARSER::COLLECTION)
    ("methylguanine" . SPARSER::MOLECULE) ("Sp1" . SPARSER::PROTEIN)
    ("SS3" . SPARSER::PROTEIN) ("growth hormone" . SPARSER::PROTEIN)
    ("sp1" . SPARSER::PROTEIN) ("alkylating agent" . SPARSER::MOLECULE)
    ("O 6" . SPARSER::PROTEIN)
    ("a potential drug target" . SPARSER::TARGET-PROTEIN)
    ("Dax-1 ( xref ) and Prox1 ( xref )" . SPARSER::COLLECTION)
    ("Dax-1" . SPARSER::PROTEIN) ("CtBP" . SPARSER::PROTEIN)
    ("SMRT" . SPARSER::PROTEIN) ("-GAAGTCCA-3" . SPARSER::COLLECTION)
    ("-TGAAGGTGA-3" . SPARSER::COLLECTION) ("retinoid" . SPARSER::PROTEIN)
    ("CCND1 and CCNE1" . SPARSER::COLLECTION)
    ("CCNB1, CCNB2 and MYC" . SPARSER::COLLECTION)
    ("β-catenin and LRH-1" . SPARSER::COLLECTION)
    ("LRH-1 and β-catenin" . SPARSER::COLLECTION)
    ("transporter" . SPARSER::PROTEIN) ("PCTP" . SPARSER::PROTEIN)
    ("phosphatidylcholine" . SPARSER::MOLECULE) ("MSI" . SPARSER::PROTEIN)
    ("Only 146 genes" . SPARSER::GENE)
    ("a transcriptionally repressive state" . SPARSER::BIO-STATE)
    ("SHP and NRIP1" . SPARSER::COLLECTION)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("HA-LRH-1" . SPARSER::COLLECTION) ("LRH-1 and p53" . SPARSER::COLLECTION)
    ("TFF1 and NRIP1" . SPARSER::COLLECTION) ("si-p53" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("CCNB1, CCNB2 and CCNE2" . SPARSER::COLLECTION)
    ("Genes and Genomes" . SPARSER::COLLECTION) ("v" . SPARSER::PROTEIN)
    ("The larger 541aa variant" . SPARSER::VARIANT)
    ("polypeptides" . SPARSER::PEPTIDE)
    ("immunomodulatory glucocorticoids" . SPARSER::PROTEIN)
    ("Cyp11A1 and Cyp11B1" . SPARSER::COLLECTION)
    ("Cyp11A1" . SPARSER::PROTEIN) ("steroidogenic" . SPARSER::PROTEIN)
    ("Cyp" . SPARSER::PROTEIN)
    ("the cyclin E1 and D1 gene promoters ( xref )" . SPARSER::COLLECTION)
    ("ERα, and LRH-1" . SPARSER::COLLECTION) ("aromatase" . SPARSER::PROTEIN)
    ("Nanog" . SPARSER::PROTEIN) ("octamer" . SPARSER::PROTEIN)
    ("SHP" . SPARSER::PROTEIN) ("pyrimidine and R" . SPARSER::COLLECTION)
    ("-YCAAGGYCR-3" . SPARSER::COLLECTION)
    ("NR5A, or Ftz-F1" . SPARSER::COLLECTION) ("NRs" . SPARSER::PROTEIN)
    ("C-terminal binding protein" . SPARSER::PROTEIN)
    ("Prox1" . SPARSER::PROTEIN)
    ("transcriptionally active form" . SPARSER::PROTEIN)
    ("SLC10A3" . SPARSER::PROTEIN) ("H3K4Me3" . SPARSER::PROTEIN)
    ("NRIP1" . SPARSER::PROTEIN) ("TFF1" . SPARSER::PROTEIN)
    ("H3K27Ac" . SPARSER::MOLECULE) ("ddH 2" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("Tissue Type" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE) ("CYP19" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("steroid hormone" . SPARSER::MOLECULE) ("Oct4" . SPARSER::PROTEIN)
    ("transcription factor 4" . SPARSER::PROTEIN) ("NR0B2" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("Ftz-F1" . SPARSER::PROTEIN)
    ("NR5A2" . SPARSER::PROTEIN) ("LRH-1" . SPARSER::PROTEIN)
    ("Derivatives" . SPARSER::DERIVATIVE)
    ("soluble growth factors" . SPARSER::GROWTH-FACTOR)
    ("Ras, MAP kinases, and PI3K" . SPARSER::COLLECTION)
    ("Erk, p38, and JNK" . SPARSER::COLLECTION) ("ZF" . SPARSER::PROTEIN)
    ("both TRAF6 (E3 Ubiquitin Protein Ligase) and NEMO" . SPARSER::COLLECTION)
    ("NEMO" . SPARSER::PROTEIN) ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("MCPIP1–p53" . SPARSER::COLLECTION) ("MCPIP1-p53" . SPARSER::COLLECTION)
    ("MCPIP1 or p53" . SPARSER::COLLECTION)
    ("MCPIP1 and p53" . SPARSER::COLLECTION)
    ("MAP kinases, NF-κB, and MCPIP1" . SPARSER::COLLECTION)
    ("HFF" . SPARSER::PROTEIN)
    ("vehicle-treated matrices" . SPARSER::PROTEIN-FAMILY)
    ("SC-514 or TPCK" . SPARSER::COLLECTION) ("amide" . SPARSER::MOLECULE)
    ("ketone" . SPARSER::MOLECULE) ("TPCK" . SPARSER::MOLECULE)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("Erk, p38, or JNK" . SPARSER::COLLECTION) ("p-p65" . SPARSER::COLLECTION)
    ("HFFs" . SPARSER::PROTEIN) ("MCP-1 and MCPIP1" . SPARSER::COLLECTION)
    ("MEK, p38, or JNK" . SPARSER::COLLECTION)
    ("stress-released matrices" . SPARSER::PROTEIN-FAMILY)
    ("the LY294002-treated released matrix" . SPARSER::PROTEIN-FAMILY)
    ("MCPIP1/actin" . SPARSER::COLLECTION)
    ("the stress-released matrix" . SPARSER::PROTEIN-FAMILY)
    ("the respective target kinase" . SPARSER::KINASE)
    ("commercially-available small molecules U0126" . SPARSER::DRUG)
    ("MAP kinases or Akt" . SPARSER::COLLECTION)
    ("Erk and p38" . SPARSER::COLLECTION) ("/Akt" . SPARSER::COLLECTION)
    ("MAP kinases and Akt" . SPARSER::COLLECTION)
    ("GFP-HFF" . SPARSER::PROTEIN-PAIR) ("MAT" . SPARSER::PROTEIN)
    ("MCPIP1-Flag" . SPARSER::COLLECTION)
    ("the nested stress-released matrix" . SPARSER::PROTEIN-FAMILY)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("kinases, NF-κB, and p53" . SPARSER::COLLECTION)
    ("MAP" . SPARSER::PROTEIN) ("FPCM" . SPARSER::PROTEIN-FAMILY)
    ("viral DNA" . SPARSER::DNA) ("JNK and NF-κB" . SPARSER::COLLECTION)
    ("LPS" . SPARSER::PROTEIN)
    ("A relevant signaling molecule" . SPARSER::MOLECULE)
    ("a stress-released matrix" . SPARSER::PROTEIN-FAMILY)
    ("the stress-released 3D collagen matrix" . SPARSER::PROTEIN-FAMILY)
    ("mitogen-activated protein kinases, phosphoinositide 3-kinase, and NF-κB"
     . SPARSER::COLLECTION)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN)
    ("Ubiquitin Specific Peptidase 10" . SPARSER::PROTEIN)
    ("USP10" . SPARSER::PROTEIN) ("IKK-2" . SPARSER::PROTEIN)
    ("IκB-α" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("SC-514" . SPARSER::PROTEIN) ("L-phenylalanine" . SPARSER::MOLECULE)
    ("N- p" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("ZC3H12A" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCPIP1" . SPARSER::PROTEIN)
    ("a dominant-negative DVL mutant" . SPARSER::MUTANT)
    ("INPP5e and PI3K" . SPARSER::COLLECTION)
    ("INPP5e or PI3K" . SPARSER::COLLECTION) ("INPP5e" . SPARSER::PROTEIN)
    ("proper BB" . SPARSER::MOLECULE) ("PLK" . SPARSER::PROTEIN)
    ("improper protein" . SPARSER::PROTEIN)
    ("PTEN or its mutant derivatives" . SPARSER::COLLECTION)
    ("derivatives" . SPARSER::DERIVATIVE) ("pic" . SPARSER::BIO-COMPLEX)
    ("the catalytically inactive PTEN C124S nor the protein phosphatase dead Y138L mutants ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("an 18-amino-acid peptide" . SPARSER::PEPTIDE)
    ("employing purified PTEN" . SPARSER::PROTEIN)
    ("WT PTEN and previously characterized mutants" . SPARSER::COLLECTION)
    ("previously characterized mutants" . SPARSER::MUTANT)
    ("WT PTEN and the DACS mutant" . SPARSER::COLLECTION)
    ("GST-PTEN" . SPARSER::COLLECTION) ("PLK1/AURKA" . SPARSER::COLLECTION)
    ("HEF-1/Aurora kinase A/HDAC6" . SPARSER::COLLECTION)
    ("the ciliary BB" . SPARSER::MOLECULE) ("pericentrin" . SPARSER::PROTEIN)
    ("PTEN–DVL2" . SPARSER::COLLECTION) ("more severe BB" . SPARSER::MOLECULE)
    ("Dsh-GFP" . SPARSER::COLLECTION) ("GFP-Dsh" . SPARSER::COLLECTION)
    ("PTEN–DVL" . SPARSER::COLLECTION)
    ("a dominant-negative DVL" . SPARSER::PROTEIN)
    ("PTEN–Dsh" . SPARSER::COLLECTION) ("Centrin-RFP" . SPARSER::COLLECTION)
    ("dDIX-Dsh-GFP" . SPARSER::COLLECTION)
    ("PTEN and Dsh" . SPARSER::COLLECTION) ("dDIX-Dsh" . SPARSER::COLLECTION)
    ("Dsh" . SPARSER::PROTEIN) ("PTEN and DVL2" . SPARSER::COLLECTION)
    ("DVL2–PTEN" . SPARSER::COLLECTION) ("DVL2 and DVL3" . SPARSER::COLLECTION)
    ("preys" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ependymal MCCs" . SPARSER::PROTEIN)
    ("day 14 of pregnancy and embryonic tracheas" . SPARSER::COLLECTION)
    ("dams" . SPARSER::PROTEIN) ("FoxJ1" . SPARSER::PROTEIN)
    ("a Pten conditional knockout allele" . SPARSER::ALLELE)
    ("Cre-recombinase" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("Pten" . SPARSER::PROTEIN)
    ("gamma-tubulin or RFP-tagged Centrin" . SPARSER::COLLECTION)
    ("CLAMP-green fluorescent protein" . SPARSER::COLLECTION)
    ("CLAMP" . SPARSER::PROTEIN-FAMILY)
    ("the BB marker Centrin-red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("Centrin" . SPARSER::PROTEIN) ("BBs and alignment" . SPARSER::COLLECTION)
    ("BBs" . SPARSER::MOLECULE) ("BB" . SPARSER::MOLECULE)
    ("epidermal MCCs" . SPARSER::PROTEIN)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dorsal elongation" . SPARSER::PROTEIN) ("elongation" . SPARSER::PROTEIN)
    ("deafness" . SPARSER::PROTEIN) ("Joubert" . SPARSER::PROTEIN-FAMILY)
    ("MCCs" . SPARSER::PROTEIN)
    ("a central component in WNT signalling and planar cell polarity (PCP)"
     . SPARSER::COLLECTION)
    ("PCP" . SPARSER::PROTEIN) ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DVL" . SPARSER::PROTEIN) ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN) ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("N -terminally" . SPARSER::PROTEIN)
    ("phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("DVL 2" . SPARSER::PROTEIN) ("BI2536" . SPARSER::DRUG)
    ("MLN8237" . SPARSER::DRUG) ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SP6" . SPARSER::PROTEIN) ("messenger RNAs" . SPARSER::RNA)
    ("INPP5" . SPARSER::PROTEIN) ("aurora kinase A" . SPARSER::PROTEIN)
    ("PLK-1" . SPARSER::PROTEIN) ("IC261" . SPARSER::DRUG)
    ("Aurora kinase A" . SPARSER::PROTEIN) ("HEF-1" . SPARSER::PROTEIN)
    ("Polo-like kinase" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("DVL2" . SPARSER::PROTEIN) ("CSNK1E" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN) ("PIK3R2" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("P10" . SPARSER::PROTEIN)
    ("P3–5" . SPARSER::PROTEIN) ("FOXJ1" . SPARSER::PROTEIN)
    ("gamma-tubulin" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN) ("PIP 3" . SPARSER::PIP3)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("Nat" . SPARSER::PROTEIN) ("IF" . SPARSER::PROTEIN)
    ("centromeric Sgo2" . SPARSER::PROTEIN)
    ("the phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("Haspin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bub-KD" . SPARSER::PROTEIN-PAIR)
    ("H2A-pT120-Sgo1" . SPARSER::PROTEIN-PAIR) ("WAPL" . SPARSER::PROTEIN)
    ("Cdh1" . SPARSER::PROTEIN) ("Cdh" . SPARSER::PROTEIN)
    ("Sli15/INCENP" . SPARSER::COLLECTION) ("INCENP" . SPARSER::PROTEIN)
    ("Saccharomyces" . SPARSER::PROTEIN) ("Bub1-Bub3" . SPARSER::COLLECTION)
    ("Bub1-" . SPARSER::PROTEIN) ("Δ259–276" . SPARSER::PROTEIN)
    ("-KD" . SPARSER::COLLECTION) ("GFP-Bub1" . SPARSER::COLLECTION)
    ("proportionally more Bub1-KD" . SPARSER::COLLECTION)
    ("Bub3–Bub1" . SPARSER::COLLECTION) ("Sgo1 and Sgo2" . SPARSER::COLLECTION)
    ("protein or Bub1" . SPARSER::COLLECTION)
    ("the more severe KD mutant" . SPARSER::MUTANT)
    ("mRFP-Histone H2B" . SPARSER::COLLECTION)
    ("the only Bub1 substrate" . SPARSER::SUBSTRATE)
    ("nocodazole or taxol" . SPARSER::COLLECTION) ("taxol" . SPARSER::DRUG)
    ("triple MYC and green fluorescence protein (GFP)-tagged Bub1"
     . SPARSER::COLLECTION)
    ("triple MYC" . SPARSER::PROTEIN) ("lacI" . SPARSER::PROTEIN)
    ("MYC and Lac repressor ( LacI )-fused Bub1 WT and Bub1 KD"
     . SPARSER::COLLECTION)
    ("MYC and Lac" . SPARSER::COLLECTION) ("-fused" . SPARSER::COLLECTION)
    ("LacI" . SPARSER::PROTEIN) ("MYC" . SPARSER::PROTEIN)
    ("thymidine-" . SPARSER::PROTEIN) ("Δ229–256" . SPARSER::PROTEIN)
    ("Bub1 or phosphatase" . SPARSER::COLLECTION)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("mitotic kinases" . SPARSER::KINASE) ("Plk1/Mps1" . SPARSER::COLLECTION)
    ("refs" . SPARSER::PROTEIN) ("ATM/ATR" . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("ATM" . SPARSER::PROTEIN)
    ("CDK1 or mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("−1 and +5" . SPARSER::COLLECTION)
    ("contained neither lysine nor arginine" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID)
    ("Lys-C, Glu-C and elastase" . SPARSER::COLLECTION)
    ("elastase" . SPARSER::PROTEIN) ("exp" . SPARSER::PROTEIN)
    ("Bub1-KD" . SPARSER::COLLECTION)
    ("the heavy isotopic variants" . SPARSER::VARIANT)
    ("arginine and lysine" . SPARSER::COLLECTION)
    ("Alanine" . SPARSER::AMINO-ACID)
    ("a phosphospecific antibody" . SPARSER::PROTEIN)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEI-S332/shugoshin" . SPARSER::COLLECTION)
    ("APC/Cdc20" . SPARSER::COLLECTION)
    ("BubR1, Mad1 and Mad2" . SPARSER::COLLECTION)
    ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mad" . SPARSER::PROTEIN)
    ("cyclosome" . SPARSER::PROTEIN) ("PP2A and PP1" . SPARSER::COLLECTION)
    ("the macromolecular KMN complex" . SPARSER::BIO-COMPLEX)
    ("Bub1–Bub3" . SPARSER::COLLECTION) ("Lys-Ile" . SPARSER::COLLECTION)
    ("MELT" . SPARSER::DRUG) ("Bub1-Bub3-BubR1" . SPARSER::COLLECTION)
    ("centromeres" . SPARSER::PROTEIN) ("Sgo" . SPARSER::PROTEIN)
    ("shugoshin" . SPARSER::PROTEIN) ("MS 3" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("SgoL1" . SPARSER::PROTEIN)
    ("CENP-A" . SPARSER::PROTEIN) ("hMis12" . SPARSER::PROTEIN)
    ("3–2" . SPARSER::PROTEIN) ("3–1" . SPARSER::PROTEIN)
    ("UTR-4" . SPARSER::PROTEIN) ("UTR-3" . SPARSER::PROTEIN)
    ("UTR-2" . SPARSER::PROTEIN) ("UTR-1" . SPARSER::PROTEIN)
    ("U20" . SPARSER::PROTEIN) ("14–3–3" . SPARSER::PROTEIN)
    ("pH3" . SPARSER::MOLECULE) ("Sli15" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("Ipl1" . SPARSER::PROTEIN)
    ("KNL-1" . SPARSER::PROTEIN) ("PtK 2" . SPARSER::PROTEIN)
    ("Sgo2" . SPARSER::PROTEIN) ("GL2" . SPARSER::DRUG)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mis12" . SPARSER::HUMAN-PROTEIN-FAMILY) ("−2" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("Glu-C" . SPARSER::PROTEIN)
    ("Lys-C" . SPARSER::PROTEIN) ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("MEI-S332" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("mitotic centromere-associated kinesin" . SPARSER::PROTEIN)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KNL1" . SPARSER::PROTEIN)
    ("Mps1" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("Sgo1" . SPARSER::PROTEIN)
    ("HER2-" . SPARSER::PROTEIN)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("trastuzumab- and/or lapatinib-" . SPARSER::COLLECTION)
    ("lapatinib-" . SPARSER::DRUG) ("trastuzumab-" . SPARSER::DRUG)
    ("GRB2, PIK3CB, and RAF1" . SPARSER::COLLECTION)
    ("HER2-HER3" . SPARSER::COLLECTION) ("maps" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN) ("heat-map" . SPARSER::PROTEIN)
    ("receptor (HR)" . SPARSER::RECEPTOR) ("PgR" . SPARSER::PROTEIN)
    ("HER-1, HER-3, and HER-4" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR) ("the anti-HER2" . SPARSER::ANTIBODY)
    ("epidermal growth factor receptor-2" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("trastuzumab" . SPARSER::DRUG)
    ("RAF1" . SPARSER::PROTEIN) ("PIK3CB" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("ARID1" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("HER-1" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("AR and KDM4" . SPARSER::COLLECTION)
    ("AR, KDM4B, KDM4A, c-myc and p27 kip1" . SPARSER::COLLECTION)
    ("AR, KDM4A, KDM4B and c-myc" . SPARSER::COLLECTION)
    ("Skp" . SPARSER::PROTEIN) ("AR-c-myc" . SPARSER::COLLECTION)
    ("AR-KDM4A" . SPARSER::COLLECTION) ("KDM4" . SPARSER::PROTEIN)
    ("c-myc/p27 kip1" . SPARSER::COLLECTION)
    ("KDM4B/KDM4A" . SPARSER::COLLECTION) ("AR-KDM4" . SPARSER::PROTEIN-PAIR)
    ("KDM4B, KDM4A, AR, and c-myc" . SPARSER::COLLECTION)
    ("KDM4A and ki67" . SPARSER::COLLECTION)
    ("p27 kip1 and H3K4" . SPARSER::COLLECTION)
    ("AR and KDM4A" . SPARSER::COLLECTION)
    ("p16, PTEN and p53" . SPARSER::COLLECTION)
    ("/p16/PTEN/p53" . SPARSER::COLLECTION)
    ("KDM4C and KDM4D" . SPARSER::COLLECTION)
    ("promoter and H3K9" . SPARSER::COLLECTION)
    ("KDM4B, c-myc, and ki67" . SPARSER::COLLECTION)
    ("AR or KDM4B" . SPARSER::COLLECTION)
    ("AR and KDM4B" . SPARSER::COLLECTION)
    ("KDM1A, JMJD1C, and SMAD4" . SPARSER::COLLECTION)
    ("methylase" . SPARSER::PROTEIN)
    ("AR and other epigenetic regulators" . SPARSER::COLLECTION)
    ("AR-KDM4B" . SPARSER::COLLECTION) ("demethylases" . SPARSER::PROTEIN)
    ("Enzymes" . SPARSER::ENZYME)
    ("estrogen and progestogens" . SPARSER::COLLECTION)
    ("progestogens" . SPARSER::MOLECULE) ("870 new EC" . SPARSER::PROTEIN)
    ("AR, KDM4B, KDM4A, and c-myc" . SPARSER::COLLECTION)
    ("KDM4B and KDM4A" . SPARSER::COLLECTION)
    ("KDM4B and AR" . SPARSER::COLLECTION)
    ("KDM4A and AR" . SPARSER::COLLECTION) ("demethylase" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Protein A" . SPARSER::PROTEIN) ("NBP1" . SPARSER::PROTEIN)
    ("C-myc" . SPARSER::PROTEIN) ("KDM5A" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN) ("KDM4D" . SPARSER::PROTEIN)
    ("KDM4C" . SPARSER::PROTEIN) ("ki67" . SPARSER::PROTEIN)
    ("JMJD1C" . SPARSER::PROTEIN) ("KDM1A" . SPARSER::PROTEIN)
    ("K26" . SPARSER::PROTEIN) ("H1.4" . SPARSER::PROTEIN)
    ("JMJD2A" . SPARSER::PROTEIN) ("p27 kip1" . SPARSER::PROTEIN)
    ("KDM4A" . SPARSER::PROTEIN) ("KDM4B" . SPARSER::PROTEIN)
    ("repressive E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("targets or drugs" . SPARSER::COLLECTION)
    ("functionally relevant miRNAs" . SPARSER::PROTEIN)
    ("E2F1 and E2F7" . SPARSER::COLLECTION)
    ("sequentially deleted DLEU2 promoters" . SPARSER::PROMOTER)
    ("hg" . SPARSER::MOLECULE) ("Bcl-2 or Cyclin E1" . SPARSER::COLLECTION)
    ("Bcl-2 and cyclin E1" . SPARSER::COLLECTION)
    ("multidrug" . SPARSER::PROTEIN)
    ("Bcl-2 [ xref , xref ] and Cyclin E1 [ xref ]" . SPARSER::COLLECTION)
    ("Bcl-2 and Cyclin E1" . SPARSER::COLLECTION)
    ("Down-regulated mature miRNAs" . SPARSER::PROTEIN)
    ("tamoxifen-" . SPARSER::MOLECULE) ("Chromatin" . SPARSER::PROTEIN)
    ("ER and receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("Tamoxifen" . SPARSER::MOLECULE) ("E2F7" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("Dual-luciferase" . SPARSER::PROTEIN)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("6B" . SPARSER::PROTEIN)
    ("miR-15b" . SPARSER::MOLECULE) ("1-4" . SPARSER::PROTEIN)
    ("1-8" . SPARSER::PROTEIN) ("14-3-3 zeta" . SPARSER::PROTEIN)
    ("miR-221" . SPARSER::PROTEIN) ("DLEU2" . SPARSER::PROTEIN)
    ("miR-16" . SPARSER::PROTEIN) ("that MDM2's" . SPARSER::PROTEIN)
    ("DNAs and RNAs" . SPARSER::COLLECTION)
    ("Protein-RNA binding" . SPARSER::COLLECTION)
    ("mdm2 and p21" . SPARSER::COLLECTION)
    ("p53, cdk4 and fgf-2" . SPARSER::COLLECTION) ("mdmx" . SPARSER::PROTEIN)
    ("a hitherto unknown p53 gene target" . SPARSER::TARGET-PROTEIN)
    ("cdk4 and fgf-2" . SPARSER::COLLECTION) ("Map" . SPARSER::PROTEIN)
    ("MDM2 and p21" . SPARSER::COLLECTION)
    ("CDKN1A and MDM2" . SPARSER::COLLECTION) ("oligomer" . SPARSER::MOLECULE)
    ("tetramer" . SPARSER::TETRAMER)
    ("oligomerisation" . SPARSER::PROTEIN-FAMILY)
    ("HA-MDM2" . SPARSER::COLLECTION) ("BIP" . SPARSER::PROTEIN)
    ("eIF2α" . SPARSER::PROTEIN) ("eIF" . SPARSER::PROTEIN)
    ("PERK" . SPARSER::PROTEIN) ("thapsigargin (THAP)" . SPARSER::MOLECULE)
    ("tunicamycin and thapsigargin" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE) ("tunicamycin" . SPARSER::MOLECULE)
    ("p53 and masks p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and masks" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("p21  CDKN1A ( p21Cip1/Waf1 ) and mdm2" . SPARSER::COLLECTION)
    ("p21Cip1/Waf1" . SPARSER::COLLECTION) ("DNA-damage" . SPARSER::DNA)
    ("CDKN1A and MDM2 protein" . SPARSER::COLLECTION)
    ("CDKN1A and mdm2" . SPARSER::COLLECTION) ("L11" . SPARSER::PROTEIN)
    ("RNA binding" . SPARSER::PROTEIN) ("fgf-2" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("Cox-2" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN) ("s 2" . SPARSER::MOLECULE)
    ("COP-1" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("IRE-1" . SPARSER::PROTEIN) ("ATF6" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDM2 protein" . SPARSER::PROTEIN) ("mdm2" . SPARSER::PROTEIN)
    ("Allele" . SPARSER::ALLELE)
    ("transmitted likely pathogenic variants p" . SPARSER::PROTEIN)
    ("bilateral RB" . SPARSER::PROTEIN) ("unilateral RB" . SPARSER::PROTEIN)
    ("MDM2 (OMIM) and MDM4 (OMIM)" . SPARSER::COLLECTION)
    ("any pathogenic variant" . SPARSER::VARIANT)
    ("A recurrent substitution p" . SPARSER::PROTEIN)
    ("mature mRNA" . SPARSER::PROTEIN) ("RBF" . SPARSER::PROTEIN)
    ("transcription factor (ATF)" . SPARSER::PROTEIN)
    ("ATF" . SPARSER::PROTEIN) ("SP1" . SPARSER::PROTEIN)
    ("Isoleucine" . SPARSER::AMINO-ACID) ("isoleucine" . SPARSER::AMINO-ACID)
    ("asparagine" . SPARSER::AMINO-ACID) ("Ile" . SPARSER::AMINO-ACID)
    ("a nonfunctional truncated protein" . SPARSER::PROTEIN)
    ("aberrant mRNAs" . SPARSER::PROTEIN)
    ("premature termination codons" . SPARSER::PROTEIN)
    ("Leu" . SPARSER::AMINO-ACID) ("Asn" . SPARSER::AMINO-ACID)
    ("The premature stop codon" . SPARSER::PROTEIN) ("CGA" . SPARSER::PROTEIN)
    ("bilateral and unilateral RB" . SPARSER::PROTEIN)
    ("unilateral and bilateral RB" . SPARSER::PROTEIN)
    ("32 bilateral RB" . SPARSER::PROTEIN) ("heritable RB" . SPARSER::PROTEIN)
    ("hereditary RB" . SPARSER::PROTEIN) ("phosphoprotein" . SPARSER::PROTEIN)
    ("CDS" . SPARSER::PROTEIN) ("The causative RB gene" . SPARSER::GENE)
    ("MIM" . SPARSER::PROTEIN) ("the mutational variants" . SPARSER::VARIANT)
    ("ten intronic variants" . SPARSER::VARIANT)
    ("strabismus" . SPARSER::PROTEIN) ("retina" . SPARSER::DRUG)
    ("MDM4" . SPARSER::PROTEIN) ("RBF1" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("autosomal dominant" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("p105RB" . SPARSER::PROTEIN)
    ("NF-kappaB and NFAT" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("calcineurin" . SPARSER::PROTEIN) ("OPTN" . SPARSER::PROTEIN)
    ("glucocorticoids" . SPARSER::PROTEIN)
    ("both mutant and wild-type MYOC alleles" . SPARSER::COLLECTION)
    ("NFkappaB" . SPARSER::PROTEIN)
    ("MYOCs Y437H and Q368X" . SPARSER::COLLECTION)
    ("the mild glaucoma-causing mutation MYOC A427T" . SPARSER::PROTEIN)
    ("propeller" . SPARSER::PROTEIN-FAMILY)
    ("a cryptic peroxisomal targeting signal type 1" . SPARSER::PROTEIN)
    ("an extracellular chaperone" . SPARSER::PROTEIN)
    ("the dystrophin-associated protein complex" . SPARSER::BIO-COMPLEX)
    ("dystrophin" . SPARSER::PROTEIN) ("biologic" . SPARSER::DRUG)
    ("the western blot" . SPARSER::PROTEIN)
    ("The mild glaucoma-causing mutant A427T" . SPARSER::PROTEIN)
    ("Doxycycline" . SPARSER::DRUG) ("transgenes" . SPARSER::PROTEIN)
    ("MYOC transgenes" . SPARSER::PROTEIN)
    ("the mutant MYOC A427T or wild-type MYOC transgenes"
     . SPARSER::COLLECTION)
    ("the severe MYOC mutation Y437H" . SPARSER::PROTEIN)
    ("a mild variant" . SPARSER::VARIANT)
    ("MYOC and MYOCs" . SPARSER::COLLECTION)
    ("IL1B, IL6, TGFB2 and FOXO1" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("Flotilin-1" . SPARSER::COLLECTION)
    ("five-bladed beta-propellers" . SPARSER::PROTEIN-FAMILY)
    ("propellers" . SPARSER::PROTEIN-FAMILY)
    ("olfactomedin" . SPARSER::PROTEIN) ("polypeptide" . SPARSER::PROTEIN)
    ("myocilin" . SPARSER::PROTEIN) ("IL1/NF-kappaB" . SPARSER::COLLECTION)
    ("E-selectin (SELE)" . SPARSER::PROTEIN)
    ("Q368X or A427T" . SPARSER::COLLECTION) ("A427T" . SPARSER::PROTEIN)
    ("the intracellularly retained mutant MYOC A427T or wild-type MYOC"
     . SPARSER::COLLECTION)
    ("MYOC A427T" . SPARSER::PROTEIN)
    ("the severe MYOC mutant Y437H" . SPARSER::PROTEIN)
    ("IL6 and TGFB2" . SPARSER::COLLECTION)
    ("IL1B and ACTA2" . SPARSER::COLLECTION)
    ("ACTA2 and FOXO1" . SPARSER::COLLECTION) ("Q368X" . SPARSER::PROTEIN)
    ("IL1A and IL1B" . SPARSER::COLLECTION) ("MYOCs" . SPARSER::PROTEIN)
    ("MYOCs Q368X" . SPARSER::PROTEIN) ("IL1B and IL6" . SPARSER::COLLECTION)
    ("TGFB2 and ACTA2" . SPARSER::COLLECTION)
    ("The immortalized human trabecular meshwork line TM-1" . SPARSER::PROTEIN)
    ("MYOC" . SPARSER::PROTEIN) ("IL-1/NF-κB" . SPARSER::COLLECTION)
    ("SELE" . SPARSER::PROTEIN) ("NFATC1" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("PTS1" . SPARSER::PROTEIN)
    ("IL1RA" . SPARSER::PROTEIN) ("IL-1alpha" . SPARSER::PROTEIN)
    ("CD62E" . SPARSER::PROTEIN) ("AQP1" . SPARSER::PROTEIN)
    ("signal peptide" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Interleukin-1" . SPARSER::PROTEIN) ("E-selectin" . SPARSER::PROTEIN)
    ("ELAM-1" . SPARSER::PROTEIN) ("adhesion molecule" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("TGFB2" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("IL1A" . SPARSER::PROTEIN) ("TM-1" . SPARSER::PROTEIN)
    ("open angle" . SPARSER::PROTEIN)
    ("CD133 and β‐catenin" . SPARSER::COLLECTION)
    ("gemcitabine and the apoptotic cell number" . SPARSER::COLLECTION)
    ("Gemcitabine" . SPARSER::DRUG)
    ("Severe intratumoural hypoxia" . SPARSER::PROTEIN)
    ("antagonists" . SPARSER::MOLECULE)
    ("CD133 (Fig.  xref H–J) and β‐catenin (Fig.  xref B–D)"
     . SPARSER::COLLECTION)
    ("PARP and caspase‐3 and down‐regulated" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("CCK" . SPARSER::PROTEIN)
    ("up‐regulated pancreatic cancer mesenchymal marker vimentin and N‐cadherin"
     . SPARSER::COLLECTION)
    ("vimentin and N‐cadherin" . SPARSER::COLLECTION)
    ("NC and DKK3" . SPARSER::COLLECTION) ("Lef" . SPARSER::PROTEIN)
    ("Tcf" . SPARSER::PROTEIN) ("DKK" . SPARSER::PROTEIN)
    ("Aspc" . SPARSER::PROTEIN) ("DKK3 and DKK3" . SPARSER::COLLECTION)
    ("a potential tumour suppressor" . SPARSER::SUPPRESSOR)
    ("anti" . SPARSER::PROTEIN) ("EMT and drug" . SPARSER::COLLECTION)
    ("TCF" . SPARSER::PROTEIN) ("gemcitabine" . SPARSER::DRUG)
    ("the human Dickkopf family and an antagonist" . SPARSER::COLLECTION)
    ("Dickkopf" . SPARSER::PROTEIN) ("E–G" . SPARSER::PROTEIN)
    ("B–D" . SPARSER::PROTEIN) ("D–H" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN) ("Histone 1" . SPARSER::PROTEIN)
    ("sodium chloride" . SPARSER::DRUG) ("CoCl 2" . SPARSER::MOLECULE)
    ("N 2" . SPARSER::PROTEIN) ("cyclinD1" . SPARSER::PROTEIN)
    ("Dickkopf family" . SPARSER::PROTEIN-FAMILY) ("DKK3" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("TGF- β/SMAD3" . SPARSER::COLLECTION)
    ("TGFB1/MMP13" . SPARSER::COLLECTION) ("BMP" . SPARSER::PROTEIN)
    ("interleukin-1 (IL-1) and metalloproteinase-1" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("collagen, proteoglycan, osteonectin and perlecan" . SPARSER::COLLECTION)
    ("perlecan" . SPARSER::PROTEIN) ("osteonectin" . SPARSER::PROTEIN)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("COL2A1 and AGC1" . SPARSER::COLLECTION) ("TGFB" . SPARSER::PROTEIN)
    ("TGFB1 and MMP13" . SPARSER::COLLECTION)
    ("TGFB1 , BMP2 , SMAD3 , and MMP13" . SPARSER::COLLECTION)
    ("TGFB1 , BMP2 , and MMP13" . SPARSER::COLLECTION)
    ("TGFB1 , SMAD3 and MMP13" . SPARSER::COLLECTION)
    ("AGC1 and COL2A1" . SPARSER::COLLECTION)
    ("type II collagen (COL2A1) and aggrecan (AGC1)" . SPARSER::COLLECTION)
    ("cartilage-specific ECM components" . SPARSER::COMPONENT)
    ("gene ( ASPN)" . SPARSER::GENE) ("chondrocytes" . SPARSER::PROTEIN)
    ("aggrecan" . SPARSER::PROTEIN) ("ASPN" . SPARSER::PROTEIN)
    ("asporin" . SPARSER::PROTEIN) ("TGF-β/SMAD3" . SPARSER::COLLECTION)
    ("SMAD3 and MMP13" . SPARSER::COLLECTION)
    ("both TGFB1 ( rho  = −0.50, p  = 0.02) and MMP13 ( rho  = −0.48, p  = 0.02)"
     . SPARSER::COLLECTION)
    ("SMAD3 ( rho  = 0.50, p  = 0.003) and MMP13 ( rho  = 0.46, p  = 0.007)"
     . SPARSER::COLLECTION)
    ("rho  " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFB1 , SMAD3 , and MMP13" . SPARSER::COLLECTION)
    ("TGFB1 , BMP2, SMAD3 and MMP13" . SPARSER::COLLECTION)
    ("TGFB1 and BMP2" . SPARSER::COLLECTION)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Smad1" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("ALK1" . SPARSER::PROTEIN) ("interleukin-1" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 13" . SPARSER::PROTEIN)
    ("mothers against decapentaplegic homolog 3" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("GDF5" . SPARSER::PROTEIN)
    ("Growth differentiation factor 5" . SPARSER::PROTEIN)
    ("AGC1" . SPARSER::PROTEIN) ("COL2A1" . SPARSER::PROTEIN)
    ("transforming growth factor beta 1" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("TGFB1" . SPARSER::PROTEIN)
    ("SseK3 and the host protein" . SPARSER::COLLECTION)
    ("related bacterial effectors" . SPARSER::EFFECTOR)
    ("AvrA" . SPARSER::PROTEIN) ("protein (SKIP)" . SPARSER::PROTEIN)
    ("SIFs" . SPARSER::PROTEIN-FAMILY) ("SKIP" . SPARSER::PROTEIN)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab5 and Vps34" . SPARSER::COLLECTION) ("Vps34" . SPARSER::PROTEIN)
    ("Vps" . SPARSER::PROTEIN) ("SopB" . SPARSER::PROTEIN)
    ("SIF" . SPARSER::PROTEIN-FAMILY)
    ("a monoclonal anti-ubiquitin antibody" . SPARSER::ANTIBODY)
    ("TRIM32 and SseK3" . SPARSER::COLLECTION) ("Rab1b" . SPARSER::PROTEIN)
    ("DrrA" . SPARSER::PROTEIN) ("glycosyltransferases" . SPARSER::PROTEIN)
    ("myc-TRIM32" . SPARSER::COLLECTION)
    ("GST and GST-SseK3 proteins" . SPARSER::COLLECTION)
    ("UDP-GlcNAc" . SPARSER::MOLECULE) ("GST-SseK3" . SPARSER::COLLECTION)
    ("GST-NleB1" . SPARSER::COLLECTION) ("glucosamine" . SPARSER::MOLECULE)
    ("FADD and TRADD" . SPARSER::COLLECTION) ("NleB1" . SPARSER::PROTEIN)
    ("EGFP-NleB1" . SPARSER::PROTEIN-PAIR) ("EGFP-SseK3" . SPARSER::COLLECTION)
    ("SseK3 and TRIM32" . SPARSER::COLLECTION)
    ("GFP-Ssek3" . SPARSER::COLLECTION) ("Ssek3" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("nanotrap" . SPARSER::PROTEIN)
    ("GFP-nanotrap" . SPARSER::COLLECTION) ("Myc-TRIM32" . SPARSER::COLLECTION)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("18 unique peptides" . SPARSER::PEPTIDE) ("trypsin" . SPARSER::PROTEIN)
    ("EGFP" . SPARSER::PROTEIN) ("GFP-SseK3" . SPARSER::COLLECTION)
    ("TNFR1-associated death domain protein (TRADD) and FAS-associated death domain protein (FADD) [ xref ]"
     . SPARSER::COLLECTION)
    ("FAS-associated death domain protein (FADD)" . SPARSER::PROTEIN)
    ("FADD" . SPARSER::PROTEIN) ("TRADD" . SPARSER::PROTEIN)
    ("effectors, NleB, NleE and NleC" . SPARSER::COLLECTION)
    ("pro-inflammatory genes" . SPARSER::GENE)
    ("the sseK1/2/3 triple mutant" . SPARSER::MUTANT) ("ST" . SPARSER::PROTEIN)
    ("SL" . SPARSER::PROTEIN) ("homologous effectors" . SPARSER::EFFECTOR)
    ("SPI1 and SPI2" . SPARSER::COLLECTION) ("SS" . SPARSER::PROTEIN)
    ("SseK3" . SPARSER::PROTEIN) ("sseK3" . SPARSER::PROTEIN)
    ("SseK3-TRIM32" . SPARSER::COLLECTION) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("Nod1" . SPARSER::PROTEIN) ("SspH2" . SPARSER::PROTEIN)
    ("SGT1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MEKK4" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("poly-ubiquitin" . SPARSER::PROTEIN) ("D-X" . SPARSER::PROTEIN)
    ("Rab1" . SPARSER::PROTEIN) ("SPI 2" . SPARSER::PROTEIN)
    ("SPI 1" . SPARSER::PROTEIN) ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("T-1" . SPARSER::PROTEIN) ("K 3" . SPARSER::PROTEIN)
    ("AD1" . SPARSER::PROTEIN) ("IκB" . SPARSER::PROTEIN)
    ("CD107a" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN) ("p230" . SPARSER::PROTEIN)
    ("FAS-associated death domain protein" . SPARSER::PROTEIN)
    ("TNFR1-associated death domain protein" . SPARSER::PROTEIN)
    ("Cullin1" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("SPI2" . SPARSER::PROTEIN)
    ("SPI1" . SPARSER::PROTEIN) ("TRIM32" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins or microRNAs" . SPARSER::COLLECTION)
    ("p53, hypoxia and lncRNA" . SPARSER::COLLECTION)
    ("p53 and DBH" . SPARSER::COLLECTION)
    ("DBH-AS1 gene and use chromatin immunoprecipitation assays to further confirm"
     . SPARSER::COLLECTION)
    ("p53 and DBH-AS1" . SPARSER::COLLECTION)
    ("p53 and HBx-related lncRNA DBH-AS1" . SPARSER::COLLECTION)
    ("p53 and other tumour suppressor genes" . SPARSER::COLLECTION)
    ("lincRNA" . SPARSER::RNA) ("HBx and DBH-AS1" . SPARSER::COLLECTION)
    ("p-ERK, p-p38 and p-JNK" . SPARSER::COLLECTION)
    ("Sh" . SPARSER::PROTEIN-FAMILY)
    ("CDK6, CCND1 and CCNE1" . SPARSER::COLLECTION)
    ("cyclins (CCNs) and cyclin-dependent kinases (CDKs)"
     . SPARSER::COLLECTION)
    ("CDKIs" . SPARSER::DRUG) ("CCNs" . SPARSER::PROTEIN)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("SiRNAs" . SPARSER::PROTEIN)
    ("cells stably re-expressing HBx" . SPARSER::PROTEIN)
    ("stably re-expressing HBx" . SPARSER::PROTEIN)
    ("p-p38 and p-JNK MAPK (Figure xref )" . SPARSER::COLLECTION)
    ("p-ERK, p-p38 and p-JNK MAPK (Figure xref )" . SPARSER::COLLECTION)
    ("phospho-p38 (p-p38) and phosphor-JNK (p-JNK) MAPK" . SPARSER::COLLECTION)
    ("phospho-ERK (p-ERK), phospho-p38 (p-p38) and phosphor-JNK (p-JNK) MAPK"
     . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION)
    ("c-Jun N-terminal kinase (JNK) and p38" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38"
     . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE)
    ("caspase 3/caspase 3" . SPARSER::COLLECTION)
    ("caspase 3 and its active form" . SPARSER::COLLECTION)
    ("EdU" . SPARSER::DRUG) ("Lv" . SPARSER::MOLECULE)
    ("LncRNA" . SPARSER::RNA) ("cirrhosis" . SPARSER::PROTEIN)
    ("AFP" . SPARSER::PROTEIN) ("a potential oncogene" . SPARSER::ONCOGENE)
    ("ERK/p38/JNK" . SPARSER::COLLECTION) ("Quercetin" . SPARSER::MOLECULE)
    ("quercetin" . SPARSER::MOLECULE) ("UFC" . SPARSER::PROTEIN)
    ("ATB" . SPARSER::PROTEIN) ("250 000 new HCC" . SPARSER::PROTEIN)
    ("p16, p21 and p27" . SPARSER::COLLECTION) ("HBsAg" . SPARSER::DRUG)
    ("DBH" . SPARSER::PROTEIN) ("HCC" . SPARSER::PROTEIN)
    ("HBx" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("Caspase3" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("PVT1" . SPARSER::PROTEIN) ("MEG3" . SPARSER::PROTEIN)
    ("p-p38" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Annexin-V" . SPARSER::PROTEIN) ("p18" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("hepatitis B surface antigen" . SPARSER::DRUG)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("HIF-1α and EWS-FLI-1 proteins" . SPARSER::COLLECTION)
    ("RAS, p-ERK, HIF-1α and EWS-FLI-1 proteins" . SPARSER::COLLECTION)
    ("SCF/c-kit" . SPARSER::COLLECTION) ("pVHL" . SPARSER::PROTEIN)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("HIF-1α and its targets" . SPARSER::COLLECTION)
    ("GLUT1 and VEGF" . SPARSER::COLLECTION)
    ("RAS and MEK1" . SPARSER::COLLECTION)
    ("RAS and the downstream kinase" . SPARSER::COLLECTION)
    ("SK" . SPARSER::PROTEIN)
    ("RAS and its downstream target" . SPARSER::COLLECTION)
    ("HIF-1α and EWS-FLI-1 (26% and 27%, p = 0.01 and p = 0.0052, respectively)"
     . SPARSER::COLLECTION)
    ("RAS and p-ERK" . SPARSER::COLLECTION)
    ("HIF-1α and EWS-FLI-1 proteins (Figure xref )" . SPARSER::COLLECTION)
    ("RAS, p-ERK, HIF-1α and EWS-FLI-1" . SPARSER::COLLECTION)
    ("Tubulin" . SPARSER::PROTEIN)
    ("8 hrs and 16 hrs (Figure xref )" . SPARSER::COLLECTION)
    ("Hypoxia" . SPARSER::PROTEIN)
    ("HIF-1α, VEGF and GLUT-1" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN)
    ("Salirasib and U0126" . SPARSER::COLLECTION)
    ("RAS and U0126" . SPARSER::COLLECTION) ("27 available DNA" . SPARSER::DNA)
    ("protein and p-ERK" . SPARSER::COLLECTION)
    ("RAS and its downstream target p-ERK" . SPARSER::COLLECTION)
    ("RAS and HIF-1α" . SPARSER::COLLECTION)
    ("significantly reduced HIF-1α and EWS-FLI-1 proteins"
     . SPARSER::COLLECTION)
    ("MEK1 or a dominant negative RAS mutant" . SPARSER::COLLECTION)
    ("RAS/MAPK" . SPARSER::COLLECTION) ("-Akt-mTOR" . SPARSER::COLLECTION)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("ETS" . SPARSER::PROTEIN)
    ("both HIF-1α and EWS-FLI-1 proteins" . SPARSER::COLLECTION)
    ("Salirasib" . SPARSER::DRUG)
    ("a negative regulator of HIF-1α and EWS-FLI-1" . SPARSER::COLLECTION)
    ("EWS-FLI-1" . SPARSER::COLLECTION) ("EWS" . SPARSER::PROTEIN)
    ("let-7 and RAS protein levels and its downstream target p-ERK"
     . SPARSER::COLLECTION)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("ES-1" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("α-TUBULIN" . SPARSER::PROTEIN) ("phospho-ERK" . SPARSER::PROTEIN)
    ("let7" . SPARSER::RNA) ("actinomycin-D" . SPARSER::MOLECULE)
    ("HMGA2" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("HIF-1β" . SPARSER::PROTEIN)
    ("von Hippel-Lindau protein" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN) ("ES1" . SPARSER::DRUG)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("GLUT-1" . SPARSER::PROTEIN) ("Akt-mTOR" . SPARSER::PROTEIN)
    ("FLI-1" . SPARSER::PROTEIN) ("sugar" . SPARSER::MOLECULE)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HPL" . SPARSER::PROTEIN)
    ("GST-CBLC" . SPARSER::COLLECTION)
    ("exogenous wild type CBLC" . SPARSER::PROTEIN)
    ("CBL and CBLC" . SPARSER::COLLECTION)
    ("CBLC and ARF1" . SPARSER::COLLECTION) ("ARF1/COPI" . SPARSER::COLLECTION)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CBLC and SRC" . SPARSER::COLLECTION)
    ("a membrane-associated tyrosine kinase" . SPARSER::PROTEIN)
    ("the viral homolog of SRC" . SPARSER::PROTEIN)
    ("SRC and ARF1" . SPARSER::COLLECTION)
    ("both cis Golgi-localized giantin and trans-Golgi network-localized TGN46"
     . SPARSER::COLLECTION)
    ("trans-Golgi network-localized TGN46" . SPARSER::PROTEIN)
    ("giantin" . SPARSER::PROTEIN)
    ("CBL, CBLB, and CBLC" . SPARSER::COLLECTION)
    ("Giantin" . SPARSER::PROTEIN) ("CBL or CBLB" . SPARSER::COLLECTION)
    ("MannII-GFP" . SPARSER::COLLECTION)
    ("the respective siRNAs" . SPARSER::PROTEIN)
    ("Mannosidase" . SPARSER::PROTEIN)
    ("multivalent adaptor proteins as well as E3 ubiquitin ligases"
     . SPARSER::COLLECTION)
    ("multivalent adaptor proteins" . SPARSER::PROTEIN)
    ("GTPases and SRC" . SPARSER::COLLECTION)
    ("cell-intrinsic cues" . SPARSER::PROTEIN-FAMILY)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("CBLC, and CBLC" . SPARSER::COLLECTION)
    ("light and electron" . SPARSER::COLLECTION)
    ("CBL and CBLB" . SPARSER::COLLECTION) ("CBL" . SPARSER::PROTEIN)
    ("CBLC" . SPARSER::PROTEIN) ("SKI-1" . SPARSER::PROTEIN)
    ("CUL5" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("CIN85" . SPARSER::PROTEIN) ("Cullin-5" . SPARSER::PROTEIN)
    ("v-Src" . SPARSER::PROTEIN) ("TGN46" . SPARSER::PROTEIN)
    ("ARPC1B" . SPARSER::PROTEIN) ("DAB2" . SPARSER::PROTEIN)
    ("S . cerevisiae" . SPARSER::PROTEIN) ("SRC kinase" . SPARSER::PROTEIN)
    ("depressed Ca 2+" . SPARSER::CALCIUM-ION) ("mGluR" . SPARSER::PROTEIN)
    ("two genetically-distinct forms" . SPARSER::FORM)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("EGTA" . SPARSER::MOLECULE)
    ("ATP-induced global Ca 2+" . SPARSER::CALCIUM-ION)
    ("purinergic GPCR receptors" . SPARSER::RECEPTOR)
    ("Ctr-2" . SPARSER::COLLECTION) ("Ctr" . SPARSER::PROTEIN)
    ("two distinct and independent genes—hamartin ( TSC1 ) or tuberin ( TSC2 )"
     . SPARSER::COLLECTION)
    ("ionomycin" . SPARSER::DRUG)
    ("hamartin ( TSC1 ) or tuberin ( TSC2 )" . SPARSER::COLLECTION)
    ("seizures" . SPARSER::PROTEIN) ("tuberin" . SPARSER::PROTEIN)
    ("hamartin" . SPARSER::PROTEIN) ("FMRP" . SPARSER::PROTEIN)
    ("syndromic forms" . SPARSER::FORM)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neurotransmitter" . SPARSER::MOLECULE)
    ("as yet no objective biomarkers" . SPARSER::MOLECULE)
    ("TSC1 and TSC2" . SPARSER::COLLECTION) ("inositol" . SPARSER::PROTEIN)
    ("ASD" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE) ("glutamate receptor" . SPARSER::PROTEIN)
    ("IP 3 R3" . SPARSER::PROTEIN) ("IP 3 R2" . SPARSER::PROTEIN)
    ("IP 3 R1" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("MgSO 4" . SPARSER::DRUG)
    ("Mg 2+" . SPARSER::MOLECULE)
    ("Inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("D-2" . SPARSER::PROTEIN) ("FMR1" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("IP 3 R" . SPARSER::PROTEIN)
    ("IP 3" . SPARSER::IP3) ("G protein-coupled" . SPARSER::PROTEIN)
    ("IP 3 Rs" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("TSC1" . SPARSER::PROTEIN) ("APC1 or APC2" . SPARSER::COLLECTION)
    ("APC1 and APC2" . SPARSER::COLLECTION)
    ("APC2, APC2∆R2 or APC2∆B" . SPARSER::COLLECTION)
    ("our two residue phosphomimetic mutant" . SPARSER::MUTANT)
    ("the phosphomimetic mutant" . SPARSER::MUTANT)
    ("phosphorylatable" . SPARSER::PROTEIN) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("Sw480" . SPARSER::PROTEIN) ("hAxin1" . SPARSER::PROTEIN)
    ("Axin-puncta" . SPARSER::COLLECTION) ("AXIN" . SPARSER::PROTEIN)
    ("APC2∆SAMPS" . SPARSER::PROTEIN) ("APC-" . SPARSER::PROTEIN)
    ("Transfected Flag-tagged fly APC2 and Flag-tagged human APC1"
     . SPARSER::COLLECTION)
    ("GFP-tagged fly Axin or human Axin1" . SPARSER::COLLECTION)
    ("simply use human antibodies" . SPARSER::ANTIBODY)
    ("GFP or RFP-tagged APC or Axin" . SPARSER::COLLECTION)
    ("no potential CK1" . SPARSER::PROTEIN) ("GST/GSK3" . SPARSER::COLLECTION)
    ("Axin-APC" . SPARSER::COLLECTION) ("APC-Axin" . SPARSER::COLLECTION)
    ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FRAP or perhaps" . SPARSER::COLLECTION)
    ("gentle detergents" . SPARSER::MOLECULE)
    ("detergents" . SPARSER::MOLECULE) ("APC and β-cat" . SPARSER::COLLECTION)
    ("arm" . SPARSER::PROTEIN)
    ("either alanines (APC2AA) or aspartic acid (APC2DD; hoping for a phosphomimic effect)"
     . SPARSER::COLLECTION)
    ("alanines" . SPARSER::AMINO-ACID)
    ("Axin and beta-catenin" . SPARSER::COLLECTION)
    ("Axin/APC2" . SPARSER::COLLECTION) ("Axin/APC" . SPARSER::COLLECTION)
    ("letter" . SPARSER::MOLECULE)
    ("our two-residue phosphomimetic mutant" . SPARSER::MUTANT)
    ("epsilon" . SPARSER::PROTEIN)
    ("a parallel phosphomimetic mutant" . SPARSER::MUTANT)
    ("serine/threonines" . SPARSER::COLLECTION)
    ("FRAP, and co-IP" . SPARSER::COLLECTION)
    ("the more modest size complexes" . SPARSER::BIO-COMPLEX)
    ("polymers" . SPARSER::MOLECULE) ("monomer" . SPARSER::MONOMER)
    ("a large multimeric complex" . SPARSER::BIO-COMPLEX)
    ("APC:GSK3:CK1" . SPARSER::BIO-COMPLEX)
    ("protein 1:1:1:1" . SPARSER::COLLECTION)
    ("APC and phospho-βcat" . SPARSER::COLLECTION)
    ("an indestructible form" . SPARSER::FORM)
    ("cadherin-catenin" . SPARSER::COLLECTION) ("Wingless" . SPARSER::PROTEIN)
    ("maternally APC2 APC1 mutant and 50%" . SPARSER::COLLECTION)
    ("maternally APC2 APC1 mutant" . SPARSER::MUTANT)
    ("embryos maternally and zygotically APC2 APC1 double mutant"
     . SPARSER::MUTANT)
    ("APC or APC2DD" . SPARSER::COLLECTION)
    ("a phosphomimetic APC2" . SPARSER::PROTEIN)
    ("either fly APC2 or human APC1" . SPARSER::COLLECTION)
    ("Axin:APC2Arm" . SPARSER::PROTEIN-PAIR)
    ("Axin:Arm" . SPARSER::BIO-COMPLEX) ("APC2ΔSAMPs" . SPARSER::PROTEIN)
    ("Axin:APC2ΔSAMPs" . SPARSER::BIO-COMPLEX)
    ("APC2∆SAMPs:Axin" . SPARSER::BIO-COMPLEX) ("LiCl" . SPARSER::DRUG)
    ("APC2∆SAMPs" . SPARSER::PROTEIN)
    ("threonines and serines" . SPARSER::COLLECTION)
    ("APCs" . SPARSER::PROTEIN) ("Axin:APC2∆SAMPs" . SPARSER::BIO-COMPLEX)
    ("Armrpt:Axin" . SPARSER::BIO-COMPLEX) ("both APC2's" . SPARSER::PROTEIN)
    ("Both APC2's" . SPARSER::PROTEIN)
    ("the destruction complex's" . SPARSER::BIO-COMPLEX)
    ("GFP/RFP" . SPARSER::COLLECTION)
    ("exogenous hAxin1-RFP" . SPARSER::COLLECTION)
    ("Flag-APC2" . SPARSER::COLLECTION) ("hAxin1-RFP" . SPARSER::COLLECTION)
    ("GFP-APC2" . SPARSER::COLLECTION) ("Axin or Axin" . SPARSER::COLLECTION)
    ("the multimeric destruction complex" . SPARSER::BIO-COMPLEX)
    ("monomers" . SPARSER::MONOMER)
    ("both recovery (mobile) fraction and t 1/2" . SPARSER::COLLECTION)
    ("Axin-RFP" . SPARSER::COLLECTION) ("APC2-GFP" . SPARSER::COLLECTION)
    ("smaller puncta" . SPARSER::PROTEIN) ("functional APC" . SPARSER::PROTEIN)
    ("the largest APC + Axin puncta" . SPARSER::PROTEIN)
    ("our SIM data—once again APC + Axin puncta" . SPARSER::PROTEIN)
    ("Axin and APC:Axin" . SPARSER::COLLECTION)
    ("oligomers" . SPARSER::PROTEIN) ("Axin and APC" . SPARSER::COLLECTION)
    ("Axin–APC" . SPARSER::COLLECTION)
    ("macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("aa" . SPARSER::MOLECULE) ("fly APC2's" . SPARSER::PROTEIN)
    ("IPs" . SPARSER::PROTEIN) ("APC2 and Axin" . SPARSER::COLLECTION)
    ("APC2:Axin" . SPARSER::BIO-COMPLEX)
    ("Axin and APC2" . SPARSER::COLLECTION)
    ("a shorter APC2 mutant" . SPARSER::MUTANT)
    ("Axin:APC" . SPARSER::BIO-COMPLEX) ("hAxin" . SPARSER::PROTEIN)
    ("GFP- or RFP-tagged APC2 or Axin" . SPARSER::COLLECTION)
    ("APC2 or Axin" . SPARSER::COLLECTION)
    ("Axin or APC2" . SPARSER::COLLECTION) ("GFP-" . SPARSER::PROTEIN)
    ("APC and the destruction complex" . SPARSER::COLLECTION)
    ("APC and other destruction complex proteins" . SPARSER::COLLECTION)
    ("tankyrase" . SPARSER::PROTEIN) ("MCR" . SPARSER::PROTEIN)
    ("an essential part" . SPARSER::COMPONENT)
    ("APC/Axin" . SPARSER::COLLECTION) ("exploring APC's" . SPARSER::PROTEIN)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dvl-Axin" . SPARSER::COLLECTION) ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytoskeletal regulators" . SPARSER::REGULATOR) ("Arm" . SPARSER::PROTEIN)
    ("DIX" . SPARSER::PROTEIN-FAMILY) ("βTrCP and βcat" . SPARSER::COLLECTION)
    ("SCF" . SPARSER::PROTEIN) ("APC or Axin" . SPARSER::COLLECTION)
    ("CK1 and GSK3" . SPARSER::COLLECTION)
    ("the scaffold Axin ( xref ) and the kinases GSK3 and CK1"
     . SPARSER::COLLECTION)
    ("APC ( xref ), the scaffold Axin ( xref ) and the kinases GSK3 and CK1"
     . SPARSER::COLLECTION)
    ("APC and Axin" . SPARSER::COLLECTION) ("APC:Axin" . SPARSER::BIO-COMPLEX)
    ("the active destruction complex" . SPARSER::BIO-COMPLEX)
    ("FRAP" . SPARSER::PROTEIN)
    ("the scaffold Axin and the kinases GSK3 and CK1" . SPARSER::COLLECTION)
    ("GSK3 and CK1" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("Axin 1" . SPARSER::PROTEIN)
    ("g10" . SPARSER::PROTEIN) ("L15" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("N-term" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("Axin1" . SPARSER::PROTEIN) ("AXIN2" . SPARSER::PROTEIN)
    ("AXIN1" . SPARSER::PROTEIN) ("APC2" . SPARSER::PROTEIN)
    ("APC1" . SPARSER::PROTEIN) ("SW480" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("Wnt receptor" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("βcatenin" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN) ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("possible MT1-MMP" . SPARSER::PROTEIN)
    ("testicular protein kinase" . SPARSER::KINASE) ("LacZ" . SPARSER::PROTEIN)
    ("SPRY4 and MT1-MMP" . SPARSER::COLLECTION)
    ("MT1-MMP and SPRY" . SPARSER::COLLECTION)
    ("SPRY1, SPRY2 and SPRY4" . SPARSER::COLLECTION)
    ("Sprouty" . SPARSER::PROTEIN-FAMILY) ("shMT1-MMP" . SPARSER::COLLECTION)
    ("SPRY1, SPRY2, and SPRY4" . SPARSER::COLLECTION)
    ("MT1-MMP and SPRY4" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("SPRY1 and SPRY2" . SPARSER::COLLECTION) ("NCC" . SPARSER::PROTEIN)
    ("SPROUTY" . SPARSER::PROTEIN-FAMILY) ("SPRY" . SPARSER::PROTEIN)
    ("Vascular Growth Factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("/Akt/GSK3β" . SPARSER::COLLECTION)
    ("enzyme and activator" . SPARSER::COLLECTION)
    ("MMPs and growth factors" . SPARSER::COLLECTION)
    ("a zinc dependent type-1 transmembrane metalloproteinase"
     . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("an aggressive form" . SPARSER::FORM) ("MMP2/RAC1" . SPARSER::COLLECTION)
    ("shMT1" . SPARSER::PROTEIN) ("SPRY2" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::GROWTH-FACTOR) ("SPRY1" . SPARSER::PROTEIN)
    ("SPRY3" . SPARSER::PROTEIN) ("PI3Kδ" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::GROWTH-FACTOR) ("RAC1" . SPARSER::PROTEIN)
    ("SPRY4" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("Matrix Metalloproteinase" . SPARSER::PROTEIN)
    ("an aggressive breast cancer variant" . SPARSER::VARIANT)
    ("TP73 , MLH1 , RASSF1A and BRCA1" . SPARSER::COLLECTION)
    ("functional biomarker" . SPARSER::MOLECULE)
    ("mutagens" . SPARSER::MOLECULE) ("RAF and PI3K" . SPARSER::COLLECTION)
    ("proteins, RAF and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("RASSF" . SPARSER::PROTEIN-FAMILY)
    ("protein or RNA" . SPARSER::COLLECTION)
    ("TP73 and RASSF1A" . SPARSER::COLLECTION) ("MAI" . SPARSER::PROTEIN)
    ("BRCA1 and MLH1" . SPARSER::COLLECTION)
    ("BRCA1 , MLH1 and RASSF1A" . SPARSER::COLLECTION)
    ("TP73 ( p  = 0.017) and RASSF1A ( p  = 0.005)" . SPARSER::COLLECTION)
    ("the pleomorphic ILCs" . SPARSER::PROTEIN)
    ("classic ILCs" . SPARSER::PROTEIN)
    ("the classic and pleomorphic ILCs" . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN)
    ("RASSF1A , TP73 , MLH1 and BRCA1" . SPARSER::COLLECTION)
    ("the classic ILC" . SPARSER::PROTEIN)
    ("20 classic ILC" . SPARSER::PROTEIN)
    ("pleomorphic ILC biomarkers" . SPARSER::MOLECULE)
    ("dinucleotide" . SPARSER::MOLECULE)
    ("pre-operative MRI" . SPARSER::PROTEIN) ("MRI" . SPARSER::PROTEIN)
    ("the apocrine differentiation marker gross cystic disease fluid protein 15 (GCDFP15) and the androgen receptor (AR) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("E-cadherin and p53" . SPARSER::COLLECTION)
    ("pleomorphic ILCs" . SPARSER::PROTEIN)
    ("gene and genes" . SPARSER::COLLECTION) ("‘luminal’" . SPARSER::DRUG)
    ("cytokeratin (CK)" . SPARSER::PROTEIN-FAMILY)
    ("CK8 and CK18" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("classic and pleomorphic ILCs" . SPARSER::PROTEIN)
    ("ILCs" . SPARSER::PROTEIN) ("a more aggressive form" . SPARSER::FORM)
    ("classical ILC" . SPARSER::PROTEIN) ("Pleomorphic ILC" . SPARSER::PROTEIN)
    ("classic ILC and pleomorphic ILC" . SPARSER::COLLECTION)
    ("loss of heterozygosity or promoter" . SPARSER::COLLECTION)
    ("the second most prevalent histological breast cancer type" . TYPE)
    ("possible biomarkers" . SPARSER::MOLECULE)
    ("TP73 , RASSF1A , MLH1 and BRCA1" . SPARSER::COLLECTION)
    ("pleomorphic ILC and IDC" . SPARSER::COLLECTION)
    ("MLH1 and BRCA1" . SPARSER::COLLECTION) ("classic ILC" . SPARSER::PROTEIN)
    ("TP73 and MLH1" . SPARSER::COLLECTION) ("MLH1" . SPARSER::PROTEIN)
    ("16 pleomorphic ILC" . SPARSER::PROTEIN)
    ("20 classical ILC" . SPARSER::PROTEIN)
    ("classic ILC and IDC" . SPARSER::COLLECTION)
    ("ILC and IDC" . SPARSER::COLLECTION)
    ("pleomorphic ILC" . SPARSER::PROTEIN) ("ILC" . SPARSER::PROTEIN)
    ("RASSF 1" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("GCDFP15" . SPARSER::PROTEIN)
    ("gross cystic disease fluid protein 15" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("p120-catenin" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN) ("CK8" . SPARSER::PROTEIN)
    ("TP73" . SPARSER::PROTEIN) ("BRAF and AHR" . SPARSER::COLLECTION)
    ("possible novel therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("AHR and CYP1B" . SPARSER::COLLECTION) ("chalcone" . SPARSER::MOLECULE)
    ("potential anticancer drugs" . SPARSER::DRUG)
    ("CYP1A1/CYP1B1" . SPARSER::COLLECTION)
    ("AHR and CYP1B1" . SPARSER::COLLECTION)
    ("BRAF, RAF265 and SB590885" . SPARSER::COLLECTION)
    ("a functional cytosolic AHR multicomponent complex"
     . SPARSER::BIO-COMPLEX)
    ("AHR-associated ancillary proteins" . SPARSER::PROTEIN)
    ("AHR/ARNT" . SPARSER::COLLECTION) ("ERK1 or MEK1" . SPARSER::COLLECTION)
    ("typical AHR activators (e.g. TCDD, benzo[a]pyrene) trigger MAP kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pyrene" . SPARSER::PROTEIN)
    ("its nuclear dimerization partner ARNT and its repressor AHRR"
     . SPARSER::COLLECTION)
    ("exogenous ligands" . SPARSER::LIGAND)
    ("RAF265 or SB590885" . SPARSER::COLLECTION)
    ("both the exogenous BRAF V600E and/or the endogenous BRAF"
     . SPARSER::COLLECTION)
    ("both the exogenous BRAF V600E" . SPARSER::PROTEIN)
    ("heterozygous state" . SPARSER::BIO-STATE)
    ("CYP1A1 and CYP1B1" . SPARSER::COLLECTION)
    ("included normal thyroid" . SPARSER::PROTEIN) ("ATC" . SPARSER::DRUG)
    ("PDTC" . SPARSER::DRUG) ("FTC" . SPARSER::DRUG)
    ("absent AHR" . SPARSER::PROTEIN)
    ("a strong and homogeneous cytoplasmic AHR" . SPARSER::PROTEIN)
    ("a weak cytoplasmic and nuclear AHR" . SPARSER::PROTEIN)
    ("vs" . SPARSER::PROTEIN) ("AHR , AHRR and ARNT" . SPARSER::COLLECTION)
    ("AHR, AHRR and ARNT" . SPARSER::COLLECTION)
    ("BRAF V600E and AHR" . SPARSER::COLLECTION)
    ("AHR and MAPK" . SPARSER::COLLECTION)
    ("This active complex" . SPARSER::BIO-COMPLEX) ("XRE" . SPARSER::PROTEIN)
    ("xenobiotic" . SPARSER::MOLECULE) ("ARNT" . SPARSER::PROTEIN)
    ("the HSP90-interacting protein p23 and the AHR-interacting protein AIP [ xref ]"
     . SPARSER::COLLECTION)
    ("AIP" . SPARSER::PROTEIN) ("-dioxin (TCDD)" . SPARSER::MOLECULE)
    ("-dioxin" . SPARSER::MOLECULE) ("TCDD" . SPARSER::PROTEIN)
    ("PAH" . SPARSER::PROTEIN) ("ligand-" . SPARSER::LIGAND)
    ("Active" . SPARSER::ACTIVE) ("raf/mil" . SPARSER::COLLECTION)
    ("v-raf" . SPARSER::PROTEIN-PAIR) ("mil" . SPARSER::PROTEIN)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Thyroid" . SPARSER::PROTEIN)
    ("a potential novel therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("PTC" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor (AHR)" . SPARSER::PROTEIN)
    ("dioxin" . SPARSER::MOLECULE) ("AHR" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("tissue type" . SPARSER::PROTEIN) ("AF 3" . SPARSER::PROTEIN)
    ("H-RAS" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("CYP1" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("N-RAS" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("ERK1" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p -ERK" . SPARSER::PROTEIN) ("RAF265" . SPARSER::DRUG)
    ("SB590885" . SPARSER::DRUG) ("K1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NADPH-quinone-oxidoreductase" . SPARSER::PROTEIN)
    ("UGT1A6" . SPARSER::PROTEIN) ("UDP-" . SPARSER::PROTEIN)
    ("CYP1B1" . SPARSER::PROTEIN) ("CYP1A1" . SPARSER::PROTEIN)
    ("Aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("PAR1 and other GPCRs" . SPARSER::COLLECTION) ("TAB2-" . SPARSER::PROTEIN)
    ("myocardial ischemia" . SPARSER::PROTEIN) ("ischemia" . SPARSER::PROTEIN)
    ("Itch" . SPARSER::PROTEIN) ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK or ERK1/2" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("JNK, ERK1/2, and p38" . SPARSER::COLLECTION)
    ("an intermediary ubiquitin-binding protein" . SPARSER::PROTEIN)
    ("K63-ubiquitin" . SPARSER::COLLECTION)
    ("PAR1 and P2Y 1" . SPARSER::COLLECTION)
    ("inflammatory GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the purinergic GPCR P2Y 1" . SPARSER::PROTEIN)
    ("TAB2 or NEDD4-2" . SPARSER::COLLECTION)
    ("Evans blue–conjugated albumin" . SPARSER::PROTEIN)
    ("albumin" . SPARSER::PROTEIN) ("SB203580 or DMSO" . SPARSER::COLLECTION)
    ("monolayers" . SPARSER::PROTEIN)
    ("ubiquitin and TAB1–TAB2" . SPARSER::COLLECTION)
    ("ADP and receptor" . SPARSER::COLLECTION)
    ("the purinergic P2Y 1 receptor" . SPARSER::RECEPTOR)
    ("Ubiquitin" . SPARSER::PROTEIN) ("JNK and MEK1/2" . SPARSER::COLLECTION)
    ("p38, JNK, and ERK1/2" . SPARSER::COLLECTION)
    ("MKK3 or MKK6" . SPARSER::COLLECTION) ("MEFs" . SPARSER::PROTEIN)
    ("PAR1 endocytic puncta" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("NZF" . SPARSER::PROTEIN) ("hyperosmotic NaCl" . SPARSER::PROTEIN)
    ("MKK3/MKK6" . SPARSER::COLLECTION) ("p38 and MSK1" . SPARSER::COLLECTION)
    ("thrombin or peptide" . SPARSER::COLLECTION)
    ("nonspecific (ns) siRNA" . SPARSER::PROTEIN)
    ("AIP4, NEDD4-1, NEDD4-2, WWP1, and WWP2" . SPARSER::COLLECTION)
    ("ligases" . SPARSER::PROTEIN)
    ("the cytokine tumor necrosis factor-α (TNF) triggered a comparable increase in p38 phosphorylation in both PAR1 WT and 0K HeLa cells ( xref )"
     . SPARSER::COLLECTION)
    ("tumor necrosis factor-α (TNF)" . SPARSER::PROTEIN)
    ("mitogen-" . SPARSER::MITOGEN) ("mitogen" . SPARSER::MITOGEN)
    ("Agonist" . SPARSER::AGONIST) ("hot" . SPARSER::PROTEIN)
    ("phosphoinositide" . SPARSER::PROTEIN) ("lysines" . SPARSER::AMINO-ACID)
    ("the G protein–coupled purinergic P2Y 1 receptor" . SPARSER::RECEPTOR)
    ("ubiquitin- and TAB1–TAB2–dependent" . SPARSER::COLLECTION)
    ("ubiquitin-" . SPARSER::PROTEIN)
    ("ubiquitin and TAB1–TAB2–dependent" . SPARSER::COLLECTION)
    ("YPX" . SPARSER::PROTEIN) ("ALIX" . SPARSER::PROTEIN)
    ("MAP2Ks—MKK3" . SPARSER::COLLECTION) ("Thrombin" . SPARSER::PROTEIN)
    ("The P2Y 1 purinergic GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MKK3 and MKK6" . SPARSER::COLLECTION)
    ("G protein–coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("thrombin" . SPARSER::PROTEIN) ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("M1" . SPARSER::MOLECULE)
    ("N -ethylmaleimide" . SPARSER::MOLECULE) ("P2Y1" . SPARSER::PROTEIN)
    ("NEDD4.2" . SPARSER::PROTEIN) ("Phos-Tag" . SPARSER::DRUG)
    ("p42/44" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("NEDD4L" . SPARSER::PROTEIN) ("ATF2" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY) ("anti-PAR" . SPARSER::DRUG)
    ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-12" . SPARSER::PROTEIN) ("MAP3K" . SPARSER::PROTEIN)
    ("TAK1" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("K3" . SPARSER::PROTEIN) ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phos-tag" . SPARSER::DRUG) ("U0126" . SPARSER::DRUG)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1–4" . SPARSER::PROTEIN)
    ("early endosome antigen 1" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN) ("Npl4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SB202190" . SPARSER::DRUG) ("WWP2" . SPARSER::PROTEIN)
    ("WWP1" . SPARSER::PROTEIN) ("NEDD4-1" . SPARSER::PROTEIN)
    ("AIP4" . SPARSER::PROTEIN) ("NEDD4" . SPARSER::PROTEIN)
    ("neural precursor cell expressed developmentally down-regulated protein 4"
     . SPARSER::PROTEIN)
    ("1 D" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase 1" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN)
    ("stress-activated protein kinase 1" . SPARSER::PROTEIN)
    ("purinergic receptor" . SPARSER::PROTEIN)
    ("MAP2Ks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP3Ks" . SPARSER::PROTEIN-FAMILY)
    ("G protein–coupled" . SPARSER::PROTEIN) ("P2Y 1" . SPARSER::PROTEIN)
    ("MKK6" . SPARSER::PROTEIN) ("MKK3" . SPARSER::PROTEIN)
    ("protein-2" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("G protein–coupled receptor" . SPARSER::PROTEIN)
    ("PAR1" . SPARSER::PROTEIN) ("receptor 1" . SPARSER::PROTEIN)
    ("TAB2" . SPARSER::PROTEIN) ("NEDD4-2" . SPARSER::PROTEIN)
    ("K63" . SPARSER::PROTEIN)
    ("its promoter or interacting with transcription factors that regulate miR-125a expression"
     . SPARSER::COLLECTION)
    ("EMT and MMPs" . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin, MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("TIMPs" . SPARSER::PROTEIN)
    ("cyclin B1 [ xref , xref ] and cdc2 [ xref ]" . SPARSER::COLLECTION)
    ("p21 [ xref ] and p53 [ xref ]" . SPARSER::COLLECTION)
    ("JAK2-STAT3" . SPARSER::COLLECTION)
    ("MMP-2, MMP-9, and N-cadherin" . SPARSER::COLLECTION)
    ("proteins and c-myc" . SPARSER::COLLECTION)
    ("miR-125a and STAT3" . SPARSER::COLLECTION)
    ("effectors, cyclin B1, cdc2, c-myc, MMP-2, MMP-9, and EMT"
     . SPARSER::COLLECTION)
    ("E6/E7-siRNA" . SPARSER::COLLECTION) ("E6/E7" . SPARSER::COLLECTION)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("-2, MMP-9 and EMT" . SPARSER::COLLECTION)
    ("cyclin B1 and cdc2" . SPARSER::COLLECTION)
    ("Considerable genes" . SPARSER::GENE)
    ("directly binding STAT3" . SPARSER::PROTEIN) ("MiRNAs" . SPARSER::PROTEIN)
    ("MicroRNA" . SPARSER::RNA) ("MMP-2" . SPARSER::PROTEIN)
    ("cdc2" . SPARSER::PROTEIN) ("MiR-125a" . SPARSER::PROTEIN)
    ("elegans" . SPARSER::PROTEIN) ("IFT25-IFT27" . SPARSER::COLLECTION)
    ("Ubxn10" . SPARSER::PROTEIN) ("ciliary GFP-UBXN10" . SPARSER::COLLECTION)
    ("UBXN10 as well as UBXN7 and FAF2" . SPARSER::COLLECTION)
    ("a 1-2 MDa complex and a ~150 kDa complex (also occupied by UBXN10)"
     . SPARSER::COLLECTION)
    ("CLUAP1 and the 150 kDa form" . SPARSER::COLLECTION)
    ("a heterodimeric form" . SPARSER::FORM)
    ("the 1-2 MDa size fractions and an increase in smaller molecular weight fractions ( xref )"
     . SPARSER::COLLECTION)
    ("IFT81, IFT25 and IFT27" . SPARSER::COLLECTION)
    ("fractions" . SPARSER::COMPONENT)
    ("IFT25 and IFT27" . SPARSER::COLLECTION)
    ("IFT81 and IFT57" . SPARSER::COLLECTION) ("KDa" . SPARSER::PROTEIN)
    ("MDa" . SPARSER::DRUG) ("either DMSO or NMS-873" . SPARSER::COLLECTION)
    ("GFP-IFT43" . SPARSER::COLLECTION)
    ("EYFP-IFT88-UBXN10-mCHERRY" . SPARSER::COLLECTION)
    ("EYFP-IFT88" . SPARSER::COLLECTION)
    ("DMSO, the ATP-competitive inhibitor DBeQ, or the allosteric inhibitors NMS-862 and NMS-873 ( xref ) and the percentage"
     . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP) ("VCP or UBXN10" . SPARSER::COLLECTION)
    ("UBXN10-VCP" . SPARSER::COLLECTION)
    ("Met-Glu-Val-Pro-Arg" . SPARSER::COLLECTION)
    ("FAF1-VCP" . SPARSER::COLLECTION)
    ("VCP or UFD1L-NPLOC4 within cilia" . SPARSER::COLLECTION)
    ("UBXN10-mCHERRY" . SPARSER::COLLECTION) ("IFT" . SPARSER::PROTEIN)
    ("mCHERRY" . SPARSER::PROTEIN) ("the ciliary tip" . SPARSER::PROTEIN)
    ("discrete puncta" . SPARSER::PROTEIN)
    ("IFT-B subunit" . SPARSER::PROTEIN-PAIR)
    ("GFP-UBXN10" . SPARSER::COLLECTION) ("tip" . SPARSER::PROTEIN)
    ("LLC-PK1" . SPARSER::PROTEIN) ("GST-VCP" . SPARSER::COLLECTION)
    ("Weaker" . SPARSER::PROTEIN) ("VCP or GST" . SPARSER::COLLECTION)
    ("GST-pulldowns" . SPARSER::PROTEIN-PAIR) ("HA" . SPARSER::PROTEIN)
    ("extract-derived IFT-B subunits" . SPARSER::FRAGMENT)
    ("HA-UBXN10" . SPARSER::COLLECTION)
    ("IFT88, IFT74 and TTC26" . SPARSER::COLLECTION)
    ("IFT81 and WDR45L" . SPARSER::COLLECTION)
    ("proteins (UNC13 A, B and WDR45L) and UFD1L-NPLOC4" . SPARSER::COLLECTION)
    ("PP4-SMEK" . SPARSER::COLLECTION) ("SMEK" . SPARSER::PROTEIN)
    ("TBC1D15 and TBC1D17" . SPARSER::COLLECTION)
    ("AMFR, DERLIN2, AUP1, BAG6 and UBAC2" . SPARSER::COLLECTION)
    ("AMFR" . SPARSER::PROTEIN)
    ("Several UBXD-associated proteins" . SPARSER::PROTEIN)
    ("GSK3β and CDC42BPB" . SPARSER::COLLECTION) ("UBXN2B" . SPARSER::PROTEIN)
    ("VCP-UBXN2B" . SPARSER::PROTEIN-PAIR)
    ("proteins, and CRL" . SPARSER::COLLECTION)
    ("UBXN2A and UBXN6" . SPARSER::COLLECTION)
    ("ASPSCR1, and NSFL1C" . SPARSER::COLLECTION)
    ("UFD1L and/or NPLOC4" . SPARSER::COLLECTION)
    ("BAG" . SPARSER::PROTEIN-FAMILY)
    ("UBXN2A and UBXN2B" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bona fide interactors" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN) ("agarose" . SPARSER::MOLECULE)
    ("available antibodies" . SPARSER::ANTIBODY)
    ("a physical map" . SPARSER::PROTEIN)
    ("proteins, UFD1L, NPLOC4, or VCP" . SPARSER::COLLECTION)
    ("Mapping" . SPARSER::PROTEIN)
    ("candidate ciliary proteins" . SPARSER::PROTEIN)
    ("the unstudied adaptor UBXN10 and the intraflagellar transport B (IFT-B) complex"
     . SPARSER::COLLECTION)
    ("UBXN10" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ligase" . SPARSER::LIGASE)
    ("UFD1L-NPLOC4" . SPARSER::COLLECTION) ("polyubiquitin" . SPARSER::PROTEIN)
    ("UBA" . SPARSER::PROTEIN) ("DDR" . SPARSER::PROTEIN)
    ("VCP-UBXN10" . SPARSER::COLLECTION)
    ("VCP and UBXN10" . SPARSER::COLLECTION)
    ("the intraflagellar transport B (IFT-B) complex" . SPARSER::BIO-COMPLEX)
    ("p97 or CDC48" . SPARSER::COLLECTION) ("VCP" . SPARSER::PROTEIN)
    ("pT7" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("B12" . SPARSER::PROTEIN) ("B-1" . SPARSER::PROTEIN)
    ("P40" . SPARSER::PROTEIN) ("C-HA" . SPARSER::PROTEIN)
    ("mL −1" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("IFT27" . SPARSER::PROTEIN) ("IFT25" . SPARSER::PROTEIN)
    ("1-2" . SPARSER::PROTEIN) ("IFT57" . SPARSER::PROTEIN)
    ("BBS5" . SPARSER::PROTEIN) ("IFT43" . SPARSER::PROTEIN)
    ("IFT46" . SPARSER::PROTEIN) ("CLUAP1" . SPARSER::PROTEIN)
    ("MYC-tagged" . SPARSER::PROTEIN) ("IFT81" . SPARSER::PROTEIN)
    ("TTC26" . SPARSER::PROTEIN) ("IFT74" . SPARSER::PROTEIN)
    ("IFT88" . SPARSER::PROTEIN) ("WDR45L" . SPARSER::PROTEIN)
    ("UNC13" . SPARSER::PROTEIN) ("PP4" . SPARSER::PROTEIN)
    ("TBC1D17" . SPARSER::PROTEIN) ("TBC1D15" . SPARSER::PROTEIN)
    ("DERLIN2" . SPARSER::PROTEIN) ("UBXD8" . SPARSER::PROTEIN)
    ("CDC42BPB" . SPARSER::PROTEIN) ("NSFL1C" . SPARSER::PROTEIN)
    ("FAF1" . SPARSER::PROTEIN) ("KCTD13" . SPARSER::PROTEIN)
    ("KCTD10" . SPARSER::PROTEIN) ("TNFAIP1" . SPARSER::PROTEIN)
    ("CUL3" . SPARSER::PROTEIN) ("UBXN1" . SPARSER::PROTEIN)
    ("UBXN2A" . SPARSER::PROTEIN) ("α-HA" . SPARSER::MOLECULE)
    ("ASPSCR1" . SPARSER::PROTEIN) ("NPLOC4" . SPARSER::PROTEIN)
    ("UFD1L" . SPARSER::PROTEIN) ("p97" . SPARSER::PROTEIN)
    ("potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("mTOR/p70S6K1/HIF-1a/VEGF" . SPARSER::COLLECTION)
    ("GSK-3β-" . SPARSER::PROTEIN) ("mTOR/p70S6k1" . SPARSER::COLLECTION)
    ("β-catenin and mTOR" . SPARSER::COLLECTION)
    ("GSK-3β and phospho-GSK3β" . SPARSER::COLLECTION)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION)
    ("p-p70S6K1" . SPARSER::COLLECTION) ("p-mTOR" . SPARSER::PROTEIN-PAIR)
    ("HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("MTOR/p70S6K1" . SPARSER::COLLECTION)
    ("exogenous GSK-3β" . SPARSER::PROTEIN) ("U251" . SPARSER::PROTEIN)
    ("U251-GSK-3β" . SPARSER::PROTEIN-PAIR)
    ("U251-GFP" . SPARSER::PROTEIN-PAIR) ("U87-GSK-3β" . SPARSER::COLLECTION)
    ("U87-GFP" . SPARSER::COLLECTION) ("HIF-1 and VEGF" . SPARSER::COLLECTION)
    ("Types" . TYPE) ("GSK-3β and GSK-3β" . SPARSER::COLLECTION)
    ("AKT and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("GSK-3a and GSK-3β" . SPARSER::COLLECTION)
    ("a multifunctional Ser/Thr kinase" . SPARSER::KINASE)
    ("Ser/Thr" . SPARSER::COLLECTION) ("mTOR/p70S6K1" . SPARSER::COLLECTION)
    ("mTOR and p70S6K1" . SPARSER::COLLECTION)
    ("β-catenin, HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("p-GSK-3β" . SPARSER::COLLECTION) ("β-Tubulin" . SPARSER::PROTEIN)
    ("l-glutamine" . SPARSER::MOLECULE) ("HIF-1a" . SPARSER::PROTEIN)
    ("p70S6k1" . SPARSER::PROTEIN) ("beta-catenin" . SPARSER::PROTEIN)
    ("HIF-1" . SPARSER::PROTEIN) ("GSK-3a" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN) ("p70S6K1" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN)
    ("PKCε and cytoplasmic deacetylases" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ApoE4" . SPARSER::PROTEIN)
    ("ApoE" . SPARSER::PROTEIN) ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("these migration-associated genes and the regulatory mechanisms influenced by nuclear HDAC6"
     . SPARSER::COLLECTION)
    ("these migration-associated genes" . SPARSER::GENE)
    ("p21- and p53-targeting genes [ xref , xref ]" . SPARSER::COLLECTION)
    ("p21-" . SPARSER::PROTEIN)
    ("p300, LCoR, NF-κB, and Runx2" . SPARSER::COLLECTION)
    ("LCoR" . SPARSER::PROTEIN)
    ("HDAC6 and ΔN-HDAC6-His" . SPARSER::COLLECTION)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("NF-κB-MMP2" . SPARSER::PROTEIN-PAIR) ("HDAC6-Flag" . SPARSER::COLLECTION)
    ("p50 and p52" . SPARSER::COLLECTION) ("p50/RelA" . SPARSER::COLLECTION)
    ("RelA" . SPARSER::PROTEIN) ("-K  +" . SPARSER::MOLECULE)
    ("α-tubulin, cortactin, heat shock protein 90, β-catenin, and peroxiredoxins"
     . SPARSER::COLLECTION)
    ("peroxiredoxins" . SPARSER::PROTEIN) ("SE" . SPARSER::PROTEIN)
    ("tetrapeptide" . SPARSER::MOLECULE) ("Glu" . SPARSER::AMINO-ACID)
    ("NES" . SPARSER::PROTEIN) ("a unique isoform" . SPARSER::ISOFORM)
    ("their primary homology" . SPARSER::PROTEIN) ("anti-β" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("H 2 O 2" . SPARSER::DRUG)
    ("PKCε" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 1" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("apolipoprotein E4" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("HDAC11" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("HDAC3" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("K  +" . SPARSER::MOLECULE)
    ("heat shock protein 90" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("Histone deacetylase 6" . SPARSER::PROTEIN)
    ("the enzyme HO-1 and the anti-oxidant pathway Nrf2" . SPARSER::COLLECTION)
    ("the CD36 scavenger receptor, the enzyme HO-1 and the anti-oxidant pathway Nrf2"
     . SPARSER::COLLECTION)
    ("iron and carbon monoxide" . SPARSER::COLLECTION)
    ("iron" . SPARSER::MOLECULE) ("- 1" . SPARSER::PROTEIN)
    ("antioxidant and detoxification enzymes" . SPARSER::COLLECTION)
    ("curcumin and sulforaphane" . SPARSER::COLLECTION)
    ("electrophile" . SPARSER::MOLECULE)
    ("two respective PPAR-γ and Nrf2 agonists" . SPARSER::AGONIST)
    ("monocytes, HO-1 and CD163" . SPARSER::COLLECTION)
    ("the pro-inflammatory monocytes" . SPARSER::PROTEIN)
    ("hemoglobin and heme" . SPARSER::COLLECTION)
    ("the soluble form" . SPARSER::FORM)
    ("CD36, Nrf2 and PPARγ" . SPARSER::COLLECTION)
    ("CD36, CD163, HO-1 and IL-10" . SPARSER::COLLECTION)
    ("heme" . SPARSER::PROTEIN) ("CD36 and IL-10" . SPARSER::COLLECTION)
    ("IL-10, IP-10 and RANTES" . SPARSER::COLLECTION)
    ("-GPI" . SPARSER::COLLECTION)
    ("monocytes, and fibrin" . SPARSER::COLLECTION)
    ("fibrin" . SPARSER::PROTEIN)
    ("the monocyte/macrophage receptor CD36 and the detoxifying enzyme HO-1"
     . SPARSER::COLLECTION)
    ("CD163 and IL-10" . SPARSER::COLLECTION)
    ("PPARγ, Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("CD36, Nrf2, PPARγ and HO-1" . SPARSER::COLLECTION)
    ("IL-10 and CD163" . SPARSER::COLLECTION) ("Rosiglitazone" . SPARSER::DRUG)
    ("two respective PPAR-γ and Nrf2 inducers" . SPARSER::MOLECULE)
    ("PPAR-γ and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2/HO-1/CD36" . SPARSER::COLLECTION)
    ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD36 and PPAR-γ" . SPARSER::COLLECTION)
    ("CD36, PPAR-γ, Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("CD14 and CD16" . SPARSER::COLLECTION) ("haptoglobin" . SPARSER::PROTEIN)
    ("HO-1 and carbon monoxide" . SPARSER::COLLECTION)
    ("oxygenase" . SPARSER::PROTEIN) ("haem" . SPARSER::MOLECULE)
    ("elevated pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF, IFNγ and MCP-1" . SPARSER::COLLECTION)
    ("PPARγ and Nrf2" . SPARSER::COLLECTION)
    ("haemoglobin" . SPARSER::MOLECULE)
    ("the peroxisome proliferator-activated receptor gamma (PPARγ) and the nuclear factor erythroid-derived 2-like"
     . SPARSER::COLLECTION)
    ("chondroitin" . SPARSER::MOLECULE) ("CD36 and TLR2" . SPARSER::COLLECTION)
    ("ERK, p38, MAPK, JNK and NF-kB" . SPARSER::COLLECTION)
    ("GPI" . SPARSER::PROTEIN) ("JNK" . SPARSER::PROTEIN)
    ("oxLDL" . SPARSER::MOLECULE) ("PRRs" . SPARSER::PROTEIN)
    ("a severe form" . SPARSER::FORM) ("CD36 and HO-1" . SPARSER::COLLECTION)
    ("the transcription factor Nrf2 and the enzyme HO-1" . SPARSER::COLLECTION)
    ("two respective PPARγ or Nrf2 activators" . SPARSER::ACTIVATOR)
    ("rosiglitazone or sulforaphane" . SPARSER::COLLECTION)
    ("PPARγ or Nrf2" . SPARSER::COLLECTION) ("rosiglitazone" . SPARSER::DRUG)
    ("CD36, PPARγ, Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("Polychromatic flow cytometry" . SPARSER::PROTEIN)
    ("CD36 and Haem-Oxygenase-1" . SPARSER::COLLECTION)
    ("Oxygenase" . SPARSER::PROTEIN) ("Haem" . SPARSER::MOLECULE)
    ("inflammatory macrophages" . SPARSER::PROTEIN)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("the most severe forms" . SPARSER::FORM) ("PAM" . SPARSER::PROTEIN)
    ("sCD163" . SPARSER::PROTEIN) ("PPAR-γ" . SPARSER::PROTEIN)
    ("CD16" . SPARSER::PROTEIN) ("CD163" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("NF-E2" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("CD36" . SPARSER::PROTEIN)
    ("FANCD2, FANCF and FANCL" . SPARSER::COLLECTION)
    ("FANCA, FANCG, FANCF, or FANCC" . SPARSER::COLLECTION)
    ("FANCC and FANCF" . SPARSER::COLLECTION)
    ("chromatin or site" . SPARSER::COLLECTION)
    ("FANCL-siRNA" . SPARSER::COLLECTION)
    ("proteins, FANCC, FANCE, FANCG and FANCA" . SPARSER::COLLECTION)
    ("FANCA-FANCG-FAAP20" . SPARSER::COLLECTION)
    ("FANCC-FANCE-FANCF" . SPARSER::COLLECTION)
    ("FANCB-FANCL-FAAP100" . SPARSER::COLLECTION) ("FANCG" . SPARSER::PROTEIN)
    ("FANCA" . SPARSER::PROTEIN) ("FANCE" . SPARSER::PROTEIN)
    ("FANCC" . SPARSER::PROTEIN) ("FANCB" . SPARSER::PROTEIN)
    ("eight upstream FA protein and some FA-associated proteins form"
     . SPARSER::COLLECTION)
    ("some FA-associated proteins form" . SPARSER::FORM)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("ID" . SPARSER::PROTEIN)
    ("crosslinker" . SPARSER::PROTEIN)
    ("caspase-3, caspase-9, and PARP" . SPARSER::COLLECTION)
    ("caspase-dependent apoptpsis-associated proteins" . SPARSER::PROTEIN)
    ("FANCD2, and FANCF and FANCL" . SPARSER::COLLECTION)
    ("FANCF and FANCL" . SPARSER::COLLECTION) ("FANCF " . SPARSER::PROTEIN)
    ("FANCF, or FANCL, or FANCD2" . SPARSER::COLLECTION)
    ("FANCL, or FANCD2" . SPARSER::COLLECTION)
    ("FANCD2 and FANCF, or FANCL" . SPARSER::COLLECTION)
    ("FANCF, or FANCL" . SPARSER::COLLECTION)
    ("FANCD2 and FANCF" . SPARSER::COLLECTION)
    ("FANCF or FANCL" . SPARSER::COLLECTION)
    ("FANCD2-siRNA-2" . SPARSER::COLLECTION)
    ("FANCF and FANCL" . SPARSER::COLLECTION)
    ("FANCL-siRNA-1" . SPARSER::COLLECTION) ("-siRNA-2" . SPARSER::COLLECTION)
    ("FANCF-siRNA-1" . SPARSER::COLLECTION)
    ("FANCL-siRNA-3" . SPARSER::COLLECTION)
    ("FANCF-siRNA-3" . SPARSER::COLLECTION)
    ("FANCF, FANCL, and FANCD2" . SPARSER::COLLECTION)
    ("siRNA-3" . SPARSER::COLLECTION) ("siRNA-2" . SPARSER::COLLECTION)
    ("siRNA-1" . SPARSER::COLLECTION)
    ("FANCF, FANCL and FANCD2" . SPARSER::COLLECTION)
    ("melphalan" . SPARSER::DRUG) ("foci" . SPARSER::PROTEIN)
    ("HR or TLC" . SPARSER::COLLECTION) ("TLC" . SPARSER::PROTEIN)
    ("the downstream FA proteins (FANC-D1, N, J, O, P) and additional DNA repair proteins"
     . SPARSER::COLLECTION)
    ("FANC" . SPARSER::PROTEIN-FAMILY)
    ("FANCD2 and its paralog FANCI [ xref ]" . SPARSER::COLLECTION)
    ("FANCI" . SPARSER::PROTEIN) ("ICL" . SPARSER::PROTEIN)
    ("ICLs" . SPARSER::PROTEIN) ("FANCF and/or FANCL" . SPARSER::COLLECTION)
    ("FANCF, FANCL, or FANCD2" . SPARSER::COLLECTION)
    ("FA/BRCA" . SPARSER::COLLECTION) ("FANCL" . SPARSER::PROTEIN)
    ("FANCF" . SPARSER::PROTEIN) ("/BRCA" . SPARSER::COLLECTION)
    ("DDP" . SPARSER::PROTEIN) ("FA" . SPARSER::PROTEIN)
    ("Cisplatin" . SPARSER::DRUG) ("A-G" . SPARSER::PROTEIN)
    ("FAAP20" . SPARSER::PROTEIN) ("C-E" . SPARSER::PROTEIN)
    ("B-L" . SPARSER::PROTEIN) ("FAAP100" . SPARSER::PROTEIN)
    ("Na3VO4" . SPARSER::MOLECULE) ("caspase-9" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("FANC-A" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("a PD causative gene" . SPARSER::GENE)
    ("DJ-1 and PINK1" . SPARSER::COLLECTION)
    ("parkin and p53" . SPARSER::COLLECTION) ("parkin" . SPARSER::PROTEIN)
    ("p53, p38, phospho-p38, and Bax" . SPARSER::COLLECTION)
    ("rotenone and 6-hydroxydopamine" . SPARSER::COLLECTION)
    ("chemicals" . SPARSER::MOLECULE)
    ("the phosphomimetic p53 T304/377D mutant" . SPARSER::MUTANT)
    ("phosphomimetic T304/377D or G2019S mutants" . SPARSER::COLLECTION)
    ("phosphomimetic T304/377D" . SPARSER::PROTEIN)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("p21 and MDM2" . SPARSER::COLLECTION)
    ("CHK1 and CHK2" . SPARSER::COLLECTION) ("Lys" . SPARSER::AMINO-ACID)
    ("a phosphomimetic protein" . SPARSER::PROTEIN)
    ("The Western blot" . SPARSER::PROTEIN)
    ("exogenous FLAG-p21" . SPARSER::COLLECTION)
    ("FLAG-p21" . SPARSER::COLLECTION)
    ("T304/377D and T304/377A" . SPARSER::COLLECTION)
    ("T304/377D " . SPARSER::PROTEIN)
    ("LRRK2 G2019S or the phosphomimetic p53 T304/377D" . SPARSER::COLLECTION)
    ("the phosphomimetic p53 T304/377D" . SPARSER::PROTEIN)
    ("T304/377D" . SPARSER::PROTEIN) ("waf" . SPARSER::PROTEIN)
    ("CHK1, and CHK2" . SPARSER::COLLECTION)
    ("CDK7-cycH-p36" . SPARSER::COLLECTION) ("cycH" . SPARSER::PROTEIN)
    ("TFIIH" . SPARSER::PROTEIN) ("pS" . SPARSER::PROTEIN)
    ("Inhibitor" . SPARSER::INHIBITOR) ("LRRK2-IN-1" . SPARSER::COLLECTION)
    ("IN-1" . SPARSER::PROTEIN) ("p53 or LRRK2" . SPARSER::COLLECTION)
    ("Moesin" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("threonines" . SPARSER::AMINO-ACID)
    ("a commercial phospho-specific antibody" . SPARSER::ANTIBODY)
    ("TXR" . SPARSER::PROTEIN) ("p-TXR" . SPARSER::COLLECTION)
    ("TSR" . SPARSER::PROTEIN) ("TKR" . SPARSER::PROTEIN)
    ("ΔN" . SPARSER::PROTEIN) ("GST-ΔN" . SPARSER::COLLECTION)
    ("DA" . SPARSER::MOLECULE) ("GST" . SPARSER::PROTEIN)
    ("PD causative genes" . SPARSER::GENE)
    ("Parkin, DJ-1, and α-synuclein" . SPARSER::COLLECTION)
    ("MPTP, rotenone, and 6-hydroxydopamine" . SPARSER::COLLECTION)
    ("MPTP" . SPARSER::PROTEIN)
    ("a translational regulator" . SPARSER::REGULATOR)
    ("several ribosomal proteins" . SPARSER::PROTEIN)
    ("Bcl-2 [ xref ] and Snapin [ xref ]" . SPARSER::COLLECTION)
    ("the mitogen-activated protein kinase kinase family [ xref ], eukaryotic initiation factor 4E-binding protein (4E-BP; [ xref ]), Akt1 [ xref ], ribosomal protein s15 [ xref ], endophilin A [ xref ], Rab5 [ xref ], Bcl-2 [ xref ] and Snapin [ xref ]"
     . SPARSER::COLLECTION)
    ("ArfGAP1" . SPARSER::PROTEIN) ("tau" . SPARSER::PROTEIN)
    ("potential LRRK2 kinase substrates" . SPARSER::SUBSTRATE)
    ("kinase and GTPase" . SPARSER::COLLECTION)
    ("the Parkinson’s disease (PD)-causative genes" . SPARSER::GENE)
    ("DJ - 1 and PINK1" . SPARSER::COLLECTION) ("SNCA" . SPARSER::PROTEIN)
    ("p53 T304/377D mutants and the mid-brain lysates" . SPARSER::COLLECTION)
    ("the phosphomimetic p53 T304/377D mutants" . SPARSER::MUTANT)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("LRRK2 and p53" . SPARSER::COLLECTION)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("iPS" . SPARSER::PROTEIN)
    ("phospho-Threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("FGF8" . SPARSER::PROTEIN) ("CHIR99021" . SPARSER::MOLECULE)
    ("NA 3 VO 4" . SPARSER::MOLECULE) ("hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("C-D" . SPARSER::PROTEIN) ("CCK 8" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("p36" . SPARSER::PROTEIN) ("CDK7" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("DJ-1" . SPARSER::PROTEIN)
    ("6-hydroxydopamine" . SPARSER::DRUG) ("endophilin A" . SPARSER::PROTEIN)
    ("s15" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("4E-BP" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PINK1" . SPARSER::PROTEIN) ("DJ - 1" . SPARSER::PROTEIN)
    ("PARK2" . SPARSER::PROTEIN) ("α-synuclein" . SPARSER::PROTEIN)
    ("LRRK2" . SPARSER::PROTEIN) ("Leucine-rich repeat" . SPARSER::PROTEIN)
    ("CCNA2, CCNB1 and CCNB2" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("AURKA , AURKB , PLK1 , PLK4 , CHEK2 , CDC25A and CDC25C"
     . SPARSER::COLLECTION)
    ("AURKB" . SPARSER::PROTEIN) ("p21 and E2F4" . SPARSER::COLLECTION)
    ("FOXM1 ( xref ) and MAD2L1 ( xref , xref )" . SPARSER::COLLECTION)
    ("BUB1B ( xref , xref ), CENPA ( xref ), CENPE ( xref ), CENPF ( xref ), FOXM1 ( xref ) and MAD2L1 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("CENPF" . SPARSER::PROTEIN) ("CENPE" . SPARSER::PROTEIN)
    ("CENPA" . SPARSER::PROTEIN)
    ("CKS2 ( xref ) or HMMR ( RHAMM ) ( xref )" . SPARSER::COLLECTION)
    ("CDC25A ( xref ), CKS1B ( xref ), CKS2 ( xref ) or HMMR ( RHAMM ) ( xref )"
     . SPARSER::COLLECTION)
    ("HMMR ( RHAMM )" . SPARSER::PROTEIN) ("RHAMM" . SPARSER::PROTEIN)
    ("HMMR" . SPARSER::PROTEIN)
    ("PRC1 ( xref ) or PTTG1 ( xref )" . SPARSER::COLLECTION)
    ("AURKA" . SPARSER::PROTEIN) ("Examples" . SPARSER::EXAMPLE)
    ("more currently unknown DREAM target genes" . SPARSER::GENE)
    ("indeed strong candidate targets" . SPARSER::TARGET-PROTEIN)
    ("GAS2L3 only two components" . SPARSER::COMPONENT)
    ("Bub1 , Ccna2 and Ccnb1" . SPARSER::COLLECTION)
    ("p130 and E2F4" . SPARSER::COLLECTION)
    ("the largest fraction" . SPARSER::COMPONENT)
    ("p53-p21" . SPARSER::COLLECTION) ("E2F4 and p130" . SPARSER::COLLECTION)
    ("LIN9, E2F4 and p130" . SPARSER::COLLECTION)
    ("BUB1 , CCNA2 , CHEK2 , MELK , RAD18 and RAD54L" . SPARSER::COLLECTION)
    ("CCNB1 and POLD1" . SPARSER::COLLECTION)
    ("POLD1 ( xref ) and RAD54L ( xref )" . SPARSER::COLLECTION)
    ("CCNA2 ( xref , xref , xref , xref ), CCNB1 ( xref – xref , xref ), POLD1 ( xref ) and RAD54L ( xref )"
     . SPARSER::COLLECTION)
    ("orthologs" . SPARSER::PROTEIN) ("complement" . SPARSER::PROTEIN)
    ("the MDM2 inhibitor nutlin-3a or the pyrimidine analogue 5-FU"
     . SPARSER::COLLECTION)
    ("DMSO" . SPARSER::MOLECULE) ("solvent" . SPARSER::MOLECULE)
    ("TTCGAT" . SPARSER::PROTEIN)
    ("many potential target genes" . SPARSER::GENE)
    ("E2F4, LIN9, LIN54 and p130" . SPARSER::COLLECTION)
    ("−1" . SPARSER::PROTEIN) ("210 potential target genes" . SPARSER::GENE)
    ("a global map" . SPARSER::PROTEIN)
    ("Rad18 (TTCGAG) and Rad54l (TTCGAT) ( xref )" . SPARSER::COLLECTION)
    ("Bub1 (TTCGAA), Chek2 (TTTGTA), Melk (TTTGAT), Pold1 (TTTGAG), Rad18 (TTCGAG) and Rad54l (TTCGAT) ( xref )"
     . SPARSER::COLLECTION)
    ("Ccnb1 (TTTAAA)" . SPARSER::PROTEIN) ("Ccnb2 (TTTGAA)" . SPARSER::PROTEIN)
    ("Rad54l (TTCGAT)" . SPARSER::PROTEIN) ("Rad54l" . SPARSER::PROTEIN)
    ("Pold1" . SPARSER::PROTEIN) ("Chek2" . SPARSER::PROTEIN)
    ("Mybl2" . SPARSER::PROTEIN) ("Ccnb2" . SPARSER::PROTEIN)
    ("Ccnb1" . SPARSER::PROTEIN) ("Ccna2" . SPARSER::PROTEIN)
    ("possibly all genes" . SPARSER::GENE)
    ("B-MYB (MMB) and FOXM1 proteins ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("the previously repressed genes" . SPARSER::GENE)
    ("DREAM and MMB" . SPARSER::COLLECTION)
    ("late cell cycle genes" . SPARSER::GENE)
    ("p53-p21-DREAM" . SPARSER::COLLECTION) ("MMB" . SPARSER::PROTEIN)
    ("p130 and p107" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BUB1 , CCNA2 , CCNB1 , CHEK2 , MELK , POLD1 , RAD18 and RAD54L"
     . SPARSER::COLLECTION)
    ("MELK" . SPARSER::PROTEIN)
    ("CCNB2 , KIF23 and PLK4" . SPARSER::COLLECTION)
    ("DREAM" . SPARSER::PROTEIN) ("cyclin F" . SPARSER::PROTEIN)
    ("CDC25C" . SPARSER::PROTEIN) ("PLK1" . SPARSER::PROTEIN)
    ("MAD2L1" . SPARSER::PROTEIN) ("BUB1B" . SPARSER::PROTEIN)
    ("CKS2" . SPARSER::PROTEIN) ("CKS1B" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("PTTG1" . SPARSER::PROTEIN)
    ("PRC1" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("CDC25B" . SPARSER::PROTEIN) ("CDC20" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("GAS2" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("nutlin-3a" . SPARSER::DRUG) ("−3" . SPARSER::PROTEIN)
    ("LIN54" . SPARSER::PROTEIN) ("LIN9" . SPARSER::PROTEIN)
    ("Rad54" . SPARSER::PROTEIN) ("Rad18" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN) ("B-Myb" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("E 2F4" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("RAD54L" . SPARSER::PROTEIN) ("RAD18" . SPARSER::PROTEIN)
    ("POLD1" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("CCNA2" . SPARSER::PROTEIN) ("BUB1" . SPARSER::PROTEIN)
    ("MYBL2" . SPARSER::PROTEIN) ("B-MYB" . SPARSER::PROTEIN)
    ("PLK4" . SPARSER::PROTEIN) ("KIF23" . SPARSER::PROTEIN)
    ("CCNB2" . SPARSER::PROTEIN) ("HOXA-AS2-EZH2" . SPARSER::COLLECTION)
    ("CyclinE/CDK2" . SPARSER::COLLECTION)
    ("CyclinD/CDK6" . SPARSER::COLLECTION)
    ("CyclinD/CDK4" . SPARSER::COLLECTION)
    ("CyclinE" . SPARSER::PROTEIN-FAMILY) ("CyclinD" . SPARSER::PROTEIN)
    ("a key catalytic subunit" . SPARSER::PROTEIN)
    ("relevant molecular components" . SPARSER::COMPONENT)
    ("cis" . SPARSER::PROTEIN) ("SFPQ/PTBP2" . SPARSER::COLLECTION)
    ("SFPQ" . SPARSER::PROTEIN) ("proteins or RNAs" . SPARSER::COLLECTION)
    ("GC-associated lncRNAs" . SPARSER::RNA)
    ("sh-HOXA-AS2" . SPARSER::COLLECTION) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("methyltransferase-1" . SPARSER::COLLECTION)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("PLK3 and DDIT3" . SPARSER::COLLECTION)
    ("potential downstream target genes" . SPARSER::GENE)
    ("P21/PLK3/DDIT3" . SPARSER::COLLECTION) ("fas" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN) ("CyclinD1/CDK2/CDK6" . SPARSER::COLLECTION)
    ("si-NC" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("-HOXA-AS2" . SPARSER::COLLECTION) ("si-HOXA-AS2" . SPARSER::COLLECTION)
    ("relative high HOXA-AS2 group ( n = 28, HOXA-AS2 expression ratio≥median ratio) and relative low HOXA-AS2 group ( n = 27, HOXA-AS2 expression ratio≤median ratio)"
     . SPARSER::COLLECTION)
    ("relative low HOXA-AS2 group" . SPARSER::MOLECULE)
    ("relative high HOXA-AS2 group" . SPARSER::MOLECULE)
    ("a potential biomarker" . SPARSER::MOLECULE) ("water" . SPARSER::MOLECULE)
    ("HOTAIR" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("ncRNAs" . SPARSER::RNA)
    ("a candidate prognostic biomarker" . SPARSER::MOLECULE)
    ("P21, PLK3, and DDIT3" . SPARSER::COLLECTION)
    ("P21, PLK3 and DDIT3" . SPARSER::COLLECTION)
    ("HOXA-AS2" . SPARSER::COLLECTION) ("HOXA" . SPARSER::PROTEIN)
    ("lncRNAs" . SPARSER::RNA) ("MAS 5" . SPARSER::PROTEIN)
    ("Plk3" . SPARSER::PROTEIN) ("PTBP2" . SPARSER::PROTEIN)
    ("MALAT1" . SPARSER::PROTEIN) ("GAS5" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("SUZ12" . SPARSER::PROTEIN)
    ("tumor suppressor P53" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::MOLECULE) ("si-RNA" . SPARSER::RNA)
    ("CyclinD1" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("NB4" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("zeste homolog 2" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("DDIT3" . SPARSER::PROTEIN)
    ("PLK3" . SPARSER::PROTEIN) ("AS2" . SPARSER::PROTEIN)
    ("sunitinib" . SPARSER::DRUG) ("pazopanib" . SPARSER::DRUG)
    ("linifanib" . SPARSER::DRUG) ("EIF2AK2 and EIF2A" . SPARSER::COLLECTION)
    ("NPM-ALK" . SPARSER::COLLECTION) ("NPM" . SPARSER::PROTEIN)
    ("JAK1, JAK2 and SRC" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("AKT-MTOR" . SPARSER::COLLECTION) ("p-MET" . SPARSER::COLLECTION)
    ("specifically target MET" . SPARSER::PROTEIN)
    ("MET, AKT, MTOR and STAT3" . SPARSER::COLLECTION) ("HCQ" . SPARSER::DRUG)
    ("crizotinib or a combination" . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("p-EIF2A" . SPARSER::COLLECTION) ("p-EIF2AK2" . SPARSER::COLLECTION)
    ("EIF2A and EIF2AK2" . SPARSER::COLLECTION)
    ("total or phosphorylated STAT3" . SPARSER::PROTEIN)
    ("p-MTOR" . SPARSER::COLLECTION)
    ("LC3-II ( xref ) as well as the punctate" . SPARSER::COLLECTION)
    ("STAT3, AKT and MTOR" . SPARSER::COLLECTION)
    ("MTOR and STAT3" . SPARSER::COLLECTION) ("electron" . SPARSER::MOLECULE)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG)
    ("the MTOR-targeted agent temsirolimus [ xref ] and the proteasome inhibitor bortezomib [ xref ]"
     . SPARSER::COLLECTION)
    ("bortezomib" . SPARSER::DRUG) ("temsirolimus" . SPARSER::DRUG)
    ("hydroxychloroquine" . SPARSER::DRUG)
    ("sorafenib and cetuximab" . SPARSER::COLLECTION)
    ("sorafenib" . SPARSER::DRUG)
    ("nonessential intracellular components" . SPARSER::COMPONENT)
    ("PI3K-AKT-MTOR" . SPARSER::COLLECTION)
    ("RAS-ERK-MAPK" . SPARSER::COLLECTION) ("MTOR" . SPARSER::PROTEIN)
    ("Tyr" . SPARSER::AMINO-ACID)
    ("a transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HGF/SF" . SPARSER::COLLECTION)
    ("hepatocyte growth factor/scatter factor" . SPARSER::COLLECTION)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("Food" . SPARSER::MOLECULE) ("IGFR" . SPARSER::PROTEIN)
    ("the pharmacological inhibitors or shRNAs" . SPARSER::COLLECTION)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("BECN1" . SPARSER::PROTEIN) ("LC-3" . SPARSER::PROTEIN)
    ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("PIK3C3" . SPARSER::PROTEIN) ("EIF2AK2" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN) ("p-ERK" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("LC3-II" . SPARSER::PROTEIN)
    ("PI3K-AKT" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("EIF2A" . SPARSER::PROTEIN) ("B-Raf and N-Ras" . SPARSER::COLLECTION)
    ("the original cohort" . SPARSER::MOLECULE)
    ("multi-institutional cohort" . SPARSER::MOLECULE)
    ("EGFRs" . SPARSER::PROTEIN)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("rare codons" . SPARSER::PROTEIN) ("log-rank" . SPARSER::PROTEIN)
    ("K-Ras rare codons" . SPARSER::PROTEIN) ("codons" . SPARSER::PROTEIN)
    ("PR or CR" . SPARSER::COLLECTION) ("codon" . SPARSER::PROTEIN)
    ("144 (54.6%) male and 119 (43.4%) female" . SPARSER::COLLECTION)
    ("bevacizumab and FOLFIRI or bevacizumab and FOLFOXIRI [ xref ]"
     . SPARSER::COLLECTION)
    ("bevacizumab and FOLFIRI or bevacizumab and FOLFOXIRI"
     . SPARSER::COLLECTION)
    ("bevacizumab and FOLFOXIRI" . SPARSER::COLLECTION)
    ("bevacizumab and FOLFOXIRI [ xref ]" . SPARSER::COLLECTION)
    ("K-Ras and B-Raf" . SPARSER::COLLECTION) ("valine" . SPARSER::AMINO-ACID)
    ("glycine" . SPARSER::AMINO-ACID)
    ("B-Raf and PIK3CA" . SPARSER::COLLECTION)
    ("K-Ras and N-Ras" . SPARSER::COLLECTION)
    ("metastatic CRC" . SPARSER::PROTEIN)
    ("an established predictive biomarker" . SPARSER::MOLECULE)
    ("CRCs" . SPARSER::PROTEIN) ("a homogenous cohort" . SPARSER::MOLECULE)
    ("bevacizumab" . SPARSER::DRUG)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("mCRC" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("\\or" . SPARSER::PROTEIN) ("B-Raf" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("c-Src and p38" . SPARSER::COLLECTION)
    ("gonadotropin" . SPARSER::PROTEIN)
    ("E-cadherin or N-cadherin" . SPARSER::COLLECTION)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("αvβ5 and αvβ6" . SPARSER::COLLECTION)
    ("Integrin β3 forms only two α-β heterodimers" . SPARSER::HETERODIMER)
    ("αvβ3 and αIIbβ3" . SPARSER::COLLECTION)
    ("liposomal doxorubicin" . SPARSER::PROTEIN) ("STM" . SPARSER::PROTEIN)
    ("ACE" . SPARSER::PROTEIN) ("Sotatercept" . SPARSER::DRUG)
    ("estradiol" . SPARSER::PROTEIN) ("Inhbb" . SPARSER::PROTEIN)
    ("Integrin" . SPARSER::PROTEIN) ("SMAD2 or SMAD3" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("SMAD2/SMAD3" . SPARSER::COLLECTION)
    ("activin/TGF-β" . SPARSER::COLLECTION)
    ("vitronectin-, fibronectin-, Matrigel- or collagen" . SPARSER::COLLECTION)
    ("Matrigel-" . SPARSER::PROTEIN) ("fibronectin-" . SPARSER::PROTEIN)
    ("vitronectin-" . SPARSER::PROTEIN) ("collagen" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN) ("Activin" . SPARSER::PROTEIN)
    ("pro- and anti-proliferative" . SPARSER::COLLECTION)
    ("sizeable cohorts" . SPARSER::MOLECULE)
    ("activins and their receptors" . SPARSER::COLLECTION)
    ("endocrine" . SPARSER::PROTEIN) ("activins" . SPARSER::PROTEIN)
    ("homodimers" . SPARSER::HOMODIMER) ("disulfide" . SPARSER::MOLECULE)
    ("Activins" . SPARSER::PROTEIN)
    ("unopposed estrogen and favorable prognosis" . SPARSER::COLLECTION)
    ("estrogen and favorable prognosis" . SPARSER::COLLECTION)
    ("two clinicopathological types" . TYPE) ("dimer" . SPARSER::DIMER)
    ("activin/inhibin" . SPARSER::COLLECTION) ("inhibin" . SPARSER::PROTEIN)
    ("activin" . SPARSER::PROTEIN) ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("CA-3" . SPARSER::PROTEIN) ("T-3" . SPARSER::PROTEIN)
    ("AG-3" . SPARSER::PROTEIN) ("AT-3" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("B-5" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN) ("ITGB3" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β1" . SPARSER::PROTEIN) ("αvβ6" . SPARSER::PROTEIN)
    ("αvβ5" . SPARSER::PROTEIN) ("αIIbβ3" . SPARSER::PROTEIN)
    ("ACVR2B" . SPARSER::PROTEIN) ("ACVR2A" . SPARSER::PROTEIN)
    ("receptor type" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("SB431542" . SPARSER::DRUG)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("SMAD2" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B subunit" . SPARSER::PROTEIN) ("RQ" . SPARSER::MOLECULE)
    ("a frank leukemia" . SPARSER::PROTEIN) ("CR" . SPARSER::PROTEIN)
    ("Gemtuzumab" . SPARSER::DRUG) ("Cytarabine" . SPARSER::MOLECULE)
    ("Sorafenib" . SPARSER::DRUG) ("the mutated allele" . SPARSER::ALLELE)
    ("Hydroxyurea" . SPARSER::DRUG) ("intra" . SPARSER::PROTEIN)
    ("Intra-run" . SPARSER::COLLECTION) ("Intra" . SPARSER::PROTEIN)
    ("intra-run" . SPARSER::PROTEIN-PAIR) ("OCI" . SPARSER::PROTEIN)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("CIR" . SPARSER::PROTEIN)
    ("RR" . SPARSER::MOLECULE) ("Nucleophosmin" . SPARSER::PROTEIN)
    ("bad" . SPARSER::PROTEIN) ("FMS" . SPARSER::PROTEIN)
    ("AC220" . SPARSER::DRUG) ("AML3" . SPARSER::PROTEIN)
    ("CR1" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("PAX3 and PAX7" . SPARSER::COLLECTION) ("PAX7/FKHR" . SPARSER::COLLECTION)
    ("PAX3/FKHR" . SPARSER::COLLECTION)
    ("MSC or myogenic" . SPARSER::COLLECTION) ("adipocytes" . SPARSER::PROTEIN)
    ("PAX7, MYF5, MyoD and MRF4" . SPARSER::COLLECTION)
    ("HGF-MET" . SPARSER::COLLECTION)
    ("Tumor-associated neutrophils" . SPARSER::PROTEIN)
    ("myogenin, myostatin and MEF2A" . SPARSER::COLLECTION)
    ("myogenin and MyoD" . SPARSER::COLLECTION)
    ("receptor and HGF" . SPARSER::COLLECTION)
    ("HGF and MET" . SPARSER::COLLECTION) ("myotube" . SPARSER::PROTEIN)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Our group [ xref ] and others [ xref ]" . SPARSER::COLLECTION)
    ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("MYF5 and PAX7" . SPARSER::COLLECTION)
    ("osteoblastic RUNX2 and adipogenic PPARG2" . SPARSER::COLLECTION)
    ("adipogenic PPARG2" . SPARSER::PROTEIN)
    ("osteoblastic RUNX2" . SPARSER::PROTEIN)
    ("PAX3, PAX7, MYF5, MyoD and MRF4" . SPARSER::COLLECTION)
    ("blasticidin" . SPARSER::MOLECULE)
    ("MEF2A, myogenin and myostatin" . SPARSER::COLLECTION)
    ("myogenin and myostatin" . SPARSER::COLLECTION)
    ("myostatin" . SPARSER::PROTEIN) ("myogenin" . SPARSER::PROTEIN)
    ("SMS-CTR" . SPARSER::COLLECTION) ("CTR" . SPARSER::PROTEIN)
    ("SMS" . SPARSER::PROTEIN) ("MyoD" . SPARSER::PROTEIN)
    ("only one ligand" . SPARSER::MOLECULE) ("SF" . SPARSER::PROTEIN)
    ("family (RTK)" . SPARSER::PROTEIN-FAMILY)
    ("PAX7-FKHR" . SPARSER::COLLECTION) ("PAX3-FKHR" . SPARSER::COLLECTION)
    ("FKHR" . SPARSER::PROTEIN) ("skeletal myoblasts" . SPARSER::PROTEIN)
    ("myoblasts" . SPARSER::PROTEIN) ("HGF and SDF-1" . SPARSER::COLLECTION)
    ("chemotaxis" . SPARSER::PROTEIN) ("VEGF" . SPARSER::PROTEIN)
    ("NOD" . SPARSER::PROTEIN) ("TPR-MET" . SPARSER::COLLECTION)
    ("TPR" . SPARSER::PROTEIN) ("ARMS" . SPARSER::PROTEIN)
    ("MSC" . SPARSER::PROTEIN) ("MYH2" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("miR-125a" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("PPARG2" . SPARSER::PROTEIN) ("RUNX2" . SPARSER::PROTEIN)
    ("MRF4" . SPARSER::PROTEIN) ("MYF5" . SPARSER::PROTEIN)
    ("Ly6G" . SPARSER::PROTEIN) ("miR-133a" . SPARSER::PROTEIN)
    ("miR-1" . SPARSER::PROTEIN) ("MYH2A" . SPARSER::PROTEIN)
    ("myosin heavy chain 2" . SPARSER::PROTEIN) ("MEF2A" . SPARSER::PROTEIN)
    ("myocyte enhancer factor 2A" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN) ("PAX7" . SPARSER::PROTEIN)
    ("PAX3" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("mTOR/AKT" . SPARSER::COLLECTION)
    ("a possible therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a strong biomarker" . SPARSER::MOLECULE) ("HDQ-PI" . SPARSER::COLLECTION)
    ("EML4-ALK" . SPARSER::COLLECTION) ("histologic type" . TYPE)
    ("an orally bioavailable tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("the most aggressive subtypes" . SPARSER::PROTEIN)
    ("PI3-kinase/AKT" . SPARSER::COLLECTION)
    ("EML4 [ xref ] and MYH9" . SPARSER::COLLECTION)
    ("KIF5B [ xref ], NPM1 [ xref ], RET, ROS [ xref ], VCL [ xref ], TFG [ xref ], EML4 [ xref ] and MYH9"
     . SPARSER::COLLECTION)
    ("TFG" . SPARSER::PROTEIN) ("VCL" . SPARSER::PROTEIN)
    ("nucleophosmin" . SPARSER::PROTEIN)
    ("aggressive subtypes" . SPARSER::PROTEIN)
    ("ALK tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("Ki67" . SPARSER::PROTEIN) ("CD30" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MT-3" . SPARSER::PROTEIN)
    ("CEP2" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYH9" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("p23" . SPARSER::PROTEIN) ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("the principal regulator" . SPARSER::REGULATOR)
    ("monoclonal anti-receptor antibodies" . SPARSER::ANTIBODY)
    ("cardiac glycosides" . SPARSER::MOLECULE) ("GSK" . SPARSER::PROTEIN)
    ("tyrosine phosphorylated HDAC6" . SPARSER::PROTEIN)
    ("TSA and tubastatin" . SPARSER::COLLECTION) ("amiloride" . SPARSER::DRUG)
    ("Calpain (ALLN, calpeptin) and Calcineurin (cyclosporine A)"
     . SPARSER::COLLECTION)
    ("CaMK (KN-62), Calpain (ALLN, calpeptin) and Calcineurin (cyclosporine A)"
     . SPARSER::COLLECTION)
    ("Bim1 or inhibitors" . SPARSER::COLLECTION)
    ("EGF-HDAC6-tubulin" . SPARSER::COLLECTION)
    ("calpeptin" . SPARSER::MOLECULE) ("chelator" . SPARSER::MOLECULE)
    ("calcium or pH" . SPARSER::COLLECTION)
    ("HDAC6 and tubulin" . SPARSER::COLLECTION)
    ("EEA1 and LAMP2" . SPARSER::COLLECTION) ("cortactin" . SPARSER::PROTEIN)
    ("in vitro polymerized microtubules" . SPARSER::PROTEIN)
    ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("ouabain and gramicidin" . SPARSER::COLLECTION)
    ("both Low Na + and High Na + (Fig.  xref )" . SPARSER::COLLECTION)
    ("TSA" . SPARSER::PROTEIN) ("trichostatin" . SPARSER::MOLECULE)
    ("Alexa Fluor 488-conjugated EGF" . SPARSER::PROTEIN)
    ("a calcineurin inhibitor (cyclosporin A; Additional file xref : Figure S3) or the PKC inhibitor (Bim1; data not shown)"
     . SPARSER::COLLECTION)
    ("EGF, ouabain or gramicidin" . SPARSER::COLLECTION)
    ("Calpeptin" . SPARSER::MOLECULE) ("KN" . SPARSER::PROTEIN)
    ("CaMK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGFR-Akt" . SPARSER::COLLECTION)
    ("EGFR-MAPK" . SPARSER::COLLECTION)
    ("PD98059 or Akt" . SPARSER::COLLECTION)
    ("EGFR, Erk1/2 and Akt" . SPARSER::COLLECTION)
    ("anti-phospho-EGFR (Y1173) antibody and phospho-specific antibodies"
     . SPARSER::COLLECTION)
    ("Erk1/2 and Akt" . SPARSER::COLLECTION) ("CoroNa" . SPARSER::MOLECULE)
    ("Calpain" . SPARSER::PROTEIN) ("Kinase" . SPARSER::KINASE)
    ("Calcineurin" . SPARSER::PROTEIN) ("BAPTA" . SPARSER::MOLECULE)
    ("ouabain- or gramicidin" . SPARSER::COLLECTION)
    ("ouabain-" . SPARSER::DRUG)
    ("ouabain or gramicidin" . SPARSER::COLLECTION) ("KCl" . SPARSER::MOLECULE)
    ("NaCl" . SPARSER::PROTEIN) ("valinomycin" . SPARSER::MOLECULE)
    ("ionophore" . SPARSER::MOLECULE) ("Monensin" . SPARSER::DRUG)
    ("monovalent cations" . SPARSER::MOLECULE) ("cations" . SPARSER::MOLECULE)
    ("Gramicidin" . SPARSER::DRUG) ("monensin" . SPARSER::DRUG)
    ("gramicidin" . SPARSER::DRUG)
    ("a noticeable band around 54 kDa" . SPARSER::PROTEIN)
    ("histones, p53 and tubulin" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN)
    ("the cardiac glycoside ouabain" . SPARSER::DRUG)
    ("glycoside" . SPARSER::MOLECULE) ("ouabain" . SPARSER::DRUG)
    ("the best characterized pump-associated signaling molecule"
     . SPARSER::MOLECULE)
    ("caveolin-1, and EGFR" . SPARSER::COLLECTION)
    ("an auxiliary third subunit" . SPARSER::FRAGMENT)
    ("two essential subunits" . SPARSER::PROTEIN) ("ions" . SPARSER::MOLECULE)
    ("microtubules" . SPARSER::PROTEIN) ("polymer" . SPARSER::MOLECULE)
    ("Class" . CLASS) ("IIb" . SPARSER::DRUG)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("chaperones" . SPARSER::PROTEIN) ("acetyl" . SPARSER::MOLECULE)
    ("HATs" . SPARSER::PROTEIN) ("EGF-EGFR" . SPARSER::COLLECTION)
    ("clathrin" . SPARSER::PROTEIN) ("HDAC" . SPARSER::PROTEIN)
    ("ionophores" . SPARSER::MOLECULE)
    ("EGFR, Na,K-ATPase and tubulin" . SPARSER::COLLECTION)
    ("ATPase" . SPARSER::PROTEIN) ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("SP5" . SPARSER::PROTEIN) ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("PKCα" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor kinase 2" . SPARSER::PROTEIN)
    ("Na + /H +" . SPARSER::PROTEIN) ("phospholipase C" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("perinuclear region" . SPARSER::PROTEIN)
    ("LAMP2" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("HDAC7" . SPARSER::PROTEIN)
    ("Bim1" . SPARSER::PROTEIN) ("cyclosporin A" . SPARSER::MOLECULE)
    ("calcineurin inhibitor" . SPARSER::PROTEIN) ("PP2" . SPARSER::DRUG)
    ("green fluorescent" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("CaM kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1C" . SPARSER::PROTEIN)
    ("Na +" . SPARSER::MOLECULE) ("a polypeptide" . SPARSER::PROTEIN)
    ("ATPase activity" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("α-tubulin" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("histone deacetylase" . SPARSER::PROTEIN)
    ("NR" . SPARSER::PROTEIN) ("HD" . SPARSER::PROTEIN)
    ("FDA" . SPARSER::PROTEIN)
    ("Talazoparib (BMN) and Olaparib (AZD)" . SPARSER::COLLECTION)
    ("Olaparib" . SPARSER::DRUG) ("Talazoparib" . SPARSER::DRUG)
    ("Arp2/3 and WAVE2" . SPARSER::COLLECTION)
    ("the primary viral receptor, CD4, and co-receptor, CXCR4 or CCR5"
     . SPARSER::COLLECTION)
    ("receptor, CD4, and co-receptor, CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("p-TEFb" . SPARSER::PROTEIN-PAIR)
    ("pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("PMA- and TNFα-stimulated MDM" . SPARSER::COLLECTION)
    ("PMA-" . SPARSER::PROTEIN) ("TNFα and PMA" . SPARSER::COLLECTION)
    ("LTR" . SPARSER::PROTEIN) ("TNFα or PMA" . SPARSER::COLLECTION)
    ("LTR-luciferase" . SPARSER::PROTEIN-PAIR) ("ABA" . SPARSER::PROTEIN)
    ("TNFα, or PMA" . SPARSER::COLLECTION)
    ("phalloidin and G-actin" . SPARSER::COLLECTION)
    ("Actin" . SPARSER::PROTEIN) ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("respective receptors" . SPARSER::PROTEIN)
    ("the primary viral receptor" . SPARSER::RECEPTOR)
    ("co-receptor, CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("primary MDM" . SPARSER::PROTEIN)
    ("Wang" . SPARSER::PROTEIN) ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AZT" . SPARSER::DRUG) ("EB" . SPARSER::PROTEIN-FAMILY)
    ("HIV-1 ADA (Ebenbichler et al., xref ) and HIV-1 JRFL (Naif et al., xref )"
     . SPARSER::COLLECTION)
    ("primary human monocyte-derived macrophages (MDM)" . SPARSER::PROTEIN)
    ("Rom" . SPARSER::PROTEIN)
    ("an enzyme and a scaffold protein" . SPARSER::COLLECTION)
    ("inflammation-associated genes" . SPARSER::GENE)
    ("transcription-regulating supramolecular complexes"
     . SPARSER::BIO-COMPLEX)
    ("chromatin and histone" . SPARSER::COLLECTION) ("NAD" . SPARSER::MOLECULE)
    ("macrophages and microglia" . SPARSER::COLLECTION)
    ("microglia" . SPARSER::PROTEIN) ("neurotoxins" . SPARSER::PROTEIN)
    ("glial" . SPARSER::PROTEIN) ("TNFα-" . SPARSER::PROTEIN)
    ("PMA or TNFα" . SPARSER::COLLECTION) ("PMA" . SPARSER::PROTEIN)
    ("human primary monocyte-derived macrophages (MDM)" . SPARSER::PROTEIN)
    ("MDM" . SPARSER::PROTEIN) ("WAVE2" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("envelope protein" . SPARSER::PROTEIN) ("DNAse I" . SPARSER::PROTEIN)
    ("serine 3" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Chemokine receptor" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("gag protein" . SPARSER::PROTEIN)
    ("Filamentous actin" . SPARSER::BIO-COMPLEX)
    ("dual-luciferase" . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("target cell" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("AZD2281" . SPARSER::DRUG) ("H-1" . SPARSER::PROTEIN)
    ("PJ34" . SPARSER::DRUG) ("elongation factor" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("Rho GTPase" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("enteric" . SPARSER::PROTEIN) ("calpastatin" . SPARSER::PROTEIN)
    ("VirA" . SPARSER::PROTEIN) ("calpain" . SPARSER::PROTEIN)
    ("the bacterial virulence effector IpgD" . SPARSER::PROTEIN-FAMILY)
    ("serines" . SPARSER::AMINO-ACID) ("IpgD" . SPARSER::PROTEIN-FAMILY)
    ("the cellular NADPH" . SPARSER::PROTEIN)
    ("HDM2 and proteasomal" . SPARSER::COLLECTION) ("STD" . SPARSER::PROTEIN)
    ("cytidine" . SPARSER::MOLECULE)
    ("cytidine deaminase (AID)" . SPARSER::PROTEIN)
    ("Macrophage Migration Inhibitory Factor (MIF)" . SPARSER::PROTEIN)
    ("NFkB" . SPARSER::PROTEIN) ("ink4a/ARF" . SPARSER::COLLECTION)
    ("functional ARF" . SPARSER::PROTEIN)
    ("HDM2 and ARF-BP1" . SPARSER::COLLECTION)
    ("Mule/ARF-BP1" . SPARSER::COLLECTION) ("Mule" . SPARSER::PROTEIN)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("siRNA or chemical inhibitor Nutlin3" . SPARSER::COLLECTION)
    ("chemical" . SPARSER::MOLECULE) ("VacA" . SPARSER::PROTEIN-FAMILY)
    ("CagA–p53" . SPARSER::COLLECTION)
    ("The bacteria specifically target p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a bacterial protein CagA" . SPARSER::PROTEIN)
    ("cytotoxin" . SPARSER::PROTEIN) ("CagA" . SPARSER::PROTEIN)
    ("PAI" . SPARSER::PROTEIN) ("vacA" . SPARSER::PROTEIN-FAMILY)
    ("Complex" . SPARSER::BIO-COMPLEX)
    ("viral proteins E1B-55K and E4orf6" . SPARSER::COLLECTION)
    ("E1B-55K and E4orf6" . SPARSER::COLLECTION)
    ("Rbx1, and Elongins" . SPARSER::COLLECTION)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("Elongins" . SPARSER::PROTEIN)
    ("proteasomes" . SPARSER::PROTEIN) ("proteasomal" . SPARSER::PROTEIN)
    ("adenoviral protein E1B-55K and human papillomavirus (HPV) protein E6"
     . SPARSER::COLLECTION)
    ("adenoviral protein E1B-55K" . SPARSER::PROTEIN)
    ("E1B-55K and E6" . SPARSER::COLLECTION)
    ("viral protein" . SPARSER::PROTEIN) ("tp53" . SPARSER::PROTEIN)
    ("p53 and mTOR" . SPARSER::COLLECTION)
    ("proteins and miRNAs" . SPARSER::COLLECTION)
    ("nutrient" . SPARSER::MOLECULE) ("the protein’s" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("calpain inhibitor" . SPARSER::PROTEIN)
    ("cytidine deaminase" . SPARSER::PROTEIN)
    ("Macrophage Migration Inhibitory Factor" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN)
    ("apoptosis-stimulating protein of p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ASPP2" . SPARSER::PROTEIN) ("ink4a" . SPARSER::PROTEIN)
    ("p19ARF" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("ARF-BP1" . SPARSER::PROTEIN) ("Nutlin3" . SPARSER::DRUG)
    ("HDM2" . SPARSER::PROTEIN) ("T4SS" . SPARSER::PROTEIN-FAMILY)
    ("vacuolating cytotoxin A" . SPARSER::PROTEIN) ("Rbx1" . SPARSER::PROTEIN)
    ("Cullin2" . SPARSER::PROTEIN) ("Cullin5" . SPARSER::PROTEIN)
    ("E4orf6" . SPARSER::PROTEIN) ("E6AP" . SPARSER::PROTEIN)
    ("Ad5" . SPARSER::PROTEIN) ("E1B-55K" . SPARSER::PROTEIN)
    ("T-Ag" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("T antigen" . SPARSER::MOLECULE) ("larger cohort" . SPARSER::MOLECULE)
    ("EpCAM" . SPARSER::PROTEIN) ("PTEN and ERG" . SPARSER::COLLECTION)
    ("PTEN (PTEN=0 or PTEN=1, yellow or red dots) and CTCs"
     . SPARSER::COLLECTION)
    ("Representative FISH" . SPARSER::PROTEIN)
    ("PTEN or ERG" . SPARSER::COLLECTION) ("ERG" . SPARSER::PROTEIN)
    ("Heterogeneous PTEN protein" . SPARSER::PROTEIN)
    ("Representative examples" . SPARSER::EXAMPLE)
    ("two PTEN and two CEP10" . SPARSER::COLLECTION)
    ("PTEN and the centromeric marker CEP10" . SPARSER::COLLECTION)
    ("retained CTCs showed evaluable FISH" . SPARSER::PROTEIN)
    ("docetaxel" . SPARSER::DRUG) ("PTEN and CEP10" . SPARSER::COLLECTION)
    ("enzalutamide and abiraterone acetate" . SPARSER::COLLECTION)
    ("tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("PTEN/PI3K/AKT" . SPARSER::COLLECTION)
    ("FISH and immunohistochemistry" . SPARSER::COLLECTION)
    ("G17" . SPARSER::PROTEIN) ("RP11" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("CK-19" . SPARSER::PROTEIN) ("CK 1" . SPARSER::PROTEIN)
    ("abiraterone acetate" . SPARSER::DRUG)
    ("tensin homolog" . SPARSER::PROTEIN) ("HR 2" . SPARSER::PROTEIN)
    ("MMP9, and PCNA" . SPARSER::COLLECTION)
    ("MMP9, PCNA and p21" . SPARSER::COLLECTION)
    ("GCN5 and E2F1, Co-IP and X-ChIP" . SPARSER::COLLECTION)
    ("E2F1, Co-IP and X-ChIP" . SPARSER::COLLECTION)
    ("GCN5 and E2F1" . SPARSER::COLLECTION)
    ("STAT3 and AKT" . SPARSER::COLLECTION)
    ("U87 and U251" . SPARSER::COLLECTION)
    ("Both Western blot" . SPARSER::PROTEIN)
    ("Weak cytoplasmic GCN5" . SPARSER::PROTEIN)
    ("PCNA, and MMP9" . SPARSER::COLLECTION)
    ("histone lysine acetyltransferases (KATs) and histone deacetylases (HDACs)"
     . SPARSER::COLLECTION)
    ("HDACs" . SPARSER::PROTEIN) ("KATs" . SPARSER::PROTEIN)
    ("Histone" . SPARSER::PROTEIN)
    ("a potential molecular target" . SPARSER::TARGET-PROTEIN)
    ("PCNA and MMP9" . SPARSER::COLLECTION) ("p-AKT" . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION) ("PCNA and matrix" . SPARSER::COLLECTION)
    ("metallopeptidase" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("GRASP or CNK3/IPCEF1" . SPARSER::COLLECTION)
    ("R-Ras/RLIP76" . SPARSER::COLLECTION)
    ("ARF6 and Rac1" . SPARSER::COLLECTION)
    ("establishing focal complexes and focal adhesions" . SPARSER::COLLECTION)
    ("Rac1 and Rho" . SPARSER::COLLECTION)
    ("complexes and focal adhesions" . SPARSER::COLLECTION)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("R-Ras and β1-integrin" . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN)
    ("cytohesin-2/ARNO dually controls integrin and R-Ras"
     . SPARSER::COLLECTION)
    ("EHD1/ARNO" . SPARSER::COLLECTION) ("vitronectin" . SPARSER::PROTEIN)
    ("dominant-negative ARF6 puncta" . SPARSER::PROTEIN)
    ("R-Ras/integrin" . SPARSER::COLLECTION)
    ("dominant-negative R-Ras" . SPARSER::PROTEIN)
    ("dominant-negative ARF1" . SPARSER::PROTEIN)
    ("ARF1, and ARF6" . SPARSER::COLLECTION)
    ("R-Ras/EHD1" . SPARSER::COLLECTION)
    ("EHD1, and R-Ras" . SPARSER::COLLECTION)
    ("E156K-ARNO, α5-integrin and EHD1" . SPARSER::COLLECTION)
    ("EHD1 and α5-integrin" . SPARSER::COLLECTION)
    ("cytohesin-3/GRP1" . SPARSER::COLLECTION)
    ("α5β1-integrin" . SPARSER::COLLECTION) ("Punctate" . SPARSER::PROTEIN)
    ("R-Ras and α5-integrin" . SPARSER::COLLECTION)
    ("R-Ras and active" . SPARSER::COLLECTION)
    ("R-Ras or E156K-ARNO" . SPARSER::COLLECTION)
    ("integrin and R-Ras" . SPARSER::COLLECTION)
    ("stimulated β1-integrin recycling, cell spreading, and migration ( xref , xref )"
     . SPARSER::COLLECTION)
    ("integrin and/or R-Ras" . SPARSER::COLLECTION)
    ("R-Ras, and R-Ras" . SPARSER::COLLECTION) ("siRNA–" . SPARSER::PROTEIN)
    ("EHD1 or R-Ras" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("EHD1/R-Ras" . SPARSER::COLLECTION)
    ("masks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S5, C and D" . SPARSER::COLLECTION)
    ("universal control small interfering RNA" . SPARSER::RNA)
    ("R-Ras and EHD1" . SPARSER::COLLECTION)
    ("EHD1/Rab8a" . SPARSER::COLLECTION)
    ("Rab8a or Rab11a" . SPARSER::COLLECTION)
    ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab8a and EHD1" . SPARSER::COLLECTION)
    ("EHD1 and R-Ras" . SPARSER::COLLECTION)
    ("Rab8a and Rab11a" . SPARSER::COLLECTION) ("Rab8a" . SPARSER::PROTEIN)
    ("EHD1 and 43N R-Ras" . SPARSER::COLLECTION) ("puncta" . SPARSER::PROTEIN)
    ("dominant-negative (43N) R-Ras" . SPARSER::PROTEIN)
    ("EHD1 and GEF" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("digitonin" . SPARSER::MOLECULE)
    ("cytohesin-2/ARNO-EHD1" . SPARSER::COLLECTION) ("saponin" . SPARSER::DRUG)
    ("mCherry-ARNO" . SPARSER::COLLECTION) ("punctate" . SPARSER::PROTEIN)
    ("peripheral ARFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARF6 and ARF1" . SPARSER::COLLECTION)
    ("traffic using Rab11" . SPARSER::PROTEIN)
    ("ARF6 ( xref ) and Eps-15 homology domain–containing protein 1 (EHD1; xref )"
     . SPARSER::COLLECTION)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A unique R-Ras effector" . SPARSER::EFFECTOR)
    ("GRASP and CNK3/IPCEF1" . SPARSER::COLLECTION) ("CNK" . SPARSER::PROTEIN)
    ("GRASP" . SPARSER::PROTEIN) ("a robust activator" . SPARSER::ACTIVATOR)
    ("cortical actin" . SPARSER::PROTEIN)
    ("class I ARFs (ARF1, ARF2, ARF3) and class II ARFs (ARF4, ARF5)"
     . SPARSER::COLLECTION)
    ("ARFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins and directly activating enzymes" . SPARSER::COLLECTION)
    ("Accessory proteins" . SPARSER::PROTEIN) ("GEFs" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an immobile barrier" . SPARSER::PROTEIN)
    ("R-Ras and integrin" . SPARSER::COLLECTION)
    ("R-Ras/ARNO" . SPARSER::COLLECTION)
    ("Eps15-homology" . SPARSER::COLLECTION) ("homology" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("ARF" . SPARSER::PROTEIN) ("GEF" . SPARSER::GEF)
    ("R-Ras and integrins" . SPARSER::COLLECTION)
    ("Cytohesin-2/ARNO" . SPARSER::COLLECTION)
    ("cytohesin-2/ARNO" . SPARSER::COLLECTION) ("ARNO" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("l -glutamine" . SPARSER::MOLECULE) ("Myc-tagged" . SPARSER::PROTEIN)
    ("anti–β" . SPARSER::PROTEIN) ("BRAG2" . SPARSER::PROTEIN)
    ("SecinH3" . SPARSER::DRUG) ("N-R" . SPARSER::PROTEIN)
    ("GRP1" . SPARSER::PROTEIN) ("cytohesin-3" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("Rab11a" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN) ("RIN2" . SPARSER::PROTEIN)
    ("Rab5" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab25" . SPARSER::PROTEIN) ("Rab4" . SPARSER::PROTEIN)
    ("Rab8" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("Rab21" . SPARSER::PROTEIN) ("β1-Integrin" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("RLIP76" . SPARSER::PROTEIN)
    ("N-Ras" . SPARSER::PROTEIN) ("Ras family" . SPARSER::PROTEIN)
    ("Rac-GEF" . SPARSER::PROTEIN) ("IPCEF1" . SPARSER::PROTEIN)
    ("β1-integrin" . SPARSER::PROTEIN) ("ARF-GEFs" . SPARSER::PROTEIN)
    ("ARF6" . SPARSER::PROTEIN) ("ARF5" . SPARSER::PROTEIN)
    ("ARF4" . SPARSER::PROTEIN) ("ARF3" . SPARSER::PROTEIN)
    ("ARF2" . SPARSER::PROTEIN) ("ARF1" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("GTPase-activating" . SPARSER::PROTEIN) ("domain 1" . SPARSER::PROTEIN)
    ("Eps15" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("EHD1" . SPARSER::PROTEIN) ("Cytohesin-2" . SPARSER::PROTEIN)
    ("cytohesin-2" . SPARSER::PROTEIN) ("R-Ras" . SPARSER::PROTEIN)
    ("common targetable miRNA" . SPARSER::PROTEIN)
    ("mTOR, Akt and TGF-β" . SPARSER::COLLECTION)
    ("miRNAs and the BRCA2-C" . SPARSER::COLLECTION)
    ("BRCA2-N comparison ‘only’ 96 miRNAs" . SPARSER::PROTEIN)
    ("Drosha" . SPARSER::PROTEIN) ("Tanic" . SPARSER::DRUG)
    ("met" . SPARSER::AMINO-ACID)
    ("ACVR1B, BTG2, CDK6, DVL3, and FAS" . SPARSER::COLLECTION)
    ("FGFs or E2F" . SPARSER::COLLECTION) ("FGFs" . SPARSER::PROTEIN)
    ("ACTA11, ACVR1B, CDLDN19, and FGF11" . SPARSER::COLLECTION)
    ("CASP2, and FAS" . SPARSER::COLLECTION)
    ("FGF11, and ITGA2B" . SPARSER::COLLECTION)
    ("CDH5, DACVR1B, DVL3, ERBB3, LRP6, and RPS20" . SPARSER::COLLECTION)
    ("BTG2, CDK6, E2F2, PPP2R2A, and RBL2" . SPARSER::COLLECTION)
    ("ACTA" . SPARSER::PROTEIN)
    ("BTG2, BTRC, CDK6, and E2F1" . SPARSER::COLLECTION)
    ("BCL2, FAS, TNF, and PTEN" . SPARSER::COLLECTION)
    ("ACTA2, ACVR1B, FGF1, PRKACB, and PTEN" . SPARSER::COLLECTION)
    ("FGF9 and PIK3R1" . SPARSER::COLLECTION)
    ("DNM3, FGF1, FGF9, and RAB7A" . SPARSER::COLLECTION)
    ("FOXO3 and PTPN1" . SPARSER::COLLECTION) ("PRKACB" . SPARSER::PROTEIN)
    ("FAS" . SPARSER::PROTEIN) ("BTRC" . SPARSER::PROTEIN)
    ("hsa" . SPARSER::PROTEIN) ("ECM-" . SPARSER::PROTEIN)
    ("gene and pathway" . SPARSER::COLLECTION)
    ("Target" . SPARSER::TARGET-PROTEIN)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("parts" . SPARSER::COMPONENT)
    ("all the microarray specifically differentially miRNAs"
     . SPARSER::PROTEIN)
    ("the BRCA1 and BRCA2 axis-specific miRNAs" . SPARSER::PROTEIN)
    ("miR" . SPARSER::PROTEIN)
    ("PR, ER, CK5/6, CK14, EGFR, or Ki-67" . SPARSER::COLLECTION)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("FC" . SPARSER::PROTEIN)
    ("cohort, and HER2" . SPARSER::COLLECTION) ("ductal type" . TYPE)
    ("ER, PR, and HER2" . SPARSER::COLLECTION) ("classes" . CLASS)
    ("aims" . SPARSER::PROTEIN)
    ("new diagnostic biomarkers" . SPARSER::MOLECULE)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("estrogen receptor (ER) [ xref , xref ] and progesterone receptor (PR) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("BRCA1-" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("miR-125a-5p" . SPARSER::MOLECULE) ("b-5" . SPARSER::PROTEIN)
    ("hsa-let-7" . SPARSER::RNA) ("v19" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("miR-10b" . SPARSER::MOLECULE) ("miR-29b" . SPARSER::MOLECULE)
    ("RBL2" . SPARSER::PROTEIN) ("PPP2R2A" . SPARSER::PROTEIN)
    ("RPS20" . SPARSER::PROTEIN) ("LRP6" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("CDH5" . SPARSER::PROTEIN)
    ("ITGA2B" . SPARSER::PROTEIN) ("CASP2" . SPARSER::PROTEIN)
    ("FGF11" . SPARSER::PROTEIN) ("PTPN1" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("RAB7A" . SPARSER::PROTEIN)
    ("DNM3" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("FGF9" . SPARSER::PROTEIN) ("FGF1" . SPARSER::PROTEIN)
    ("ACVR1B" . SPARSER::PROTEIN) ("ACTA2" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("DVL3" . SPARSER::PROTEIN)
    ("BTG2" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("Stathmin1" . SPARSER::PROTEIN) ("miR-150-5p" . SPARSER::MOLECULE)
    ("miR-125b" . SPARSER::MOLECULE) ("Let-7" . SPARSER::RNA)
    ("let-7" . SPARSER::RNA) ("miR-21" . SPARSER::PROTEIN)
    ("CK14" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("BRCA 2" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("barrier" . SPARSER::PROTEIN)
    ("the two distinct mitochondrial toxins" . SPARSER::MOLECULE)
    ("toxins" . SPARSER::MOLECULE) ("cyclosporine" . SPARSER::DRUG)
    ("cyclophilin" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("staurosporin" . SPARSER::MOLECULE) ("homologue" . SPARSER::PROTEIN)
    ("a rather poor inducer" . SPARSER::PROTEIN)
    ("BAX/BAK" . SPARSER::COLLECTION)
    ("the pro-apoptotic multidomain proteins" . SPARSER::PROTEIN)
    ("digitoxin" . SPARSER::DRUG) ("mCherry-Parkin" . SPARSER::COLLECTION)
    ("mCherry" . SPARSER::PROTEIN) ("a strong inducer" . SPARSER::PROTEIN)
    ("RFP-LC3B" . SPARSER::COLLECTION) ("MTG" . SPARSER::PROTEIN)
    ("DAPI" . SPARSER::DRUG) ("phenylindole" . SPARSER::MOLECULE)
    ("MEF" . SPARSER::PROTEIN) ("STS or CCCP" . SPARSER::COLLECTION)
    ("BAX-GFP" . SPARSER::COLLECTION) ("the granular TFAM" . SPARSER::PROTEIN)
    ("-GFP" . SPARSER::COLLECTION) ("TFAM" . SPARSER::PROTEIN)
    ("the pro-apoptotic agent staurosporine" . SPARSER::MOLECULE)
    ("SMAC-GFP" . SPARSER::COLLECTION)
    ("SMAC and cytochrome c" . SPARSER::COLLECTION) ("SMAC" . SPARSER::PROTEIN)
    ("the protonophore CCCP or the pro-apoptotic pan-tyrosine kinase inhibitor staurosporine (STS) (Figure xref )"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic pan-tyrosine kinase inhibitor staurosporine (STS)"
     . SPARSER::MOLECULE)
    ("staurosporine (STS)" . SPARSER::MOLECULE) ("STS" . SPARSER::PROTEIN)
    ("staurosporine" . SPARSER::DRUG)
    ("a cationic lipophilic fluorochrome" . SPARSER::MOLECULE)
    ("fluorochrome" . SPARSER::MOLECULE) ("detergent" . SPARSER::MOLECULE)
    ("FITC" . SPARSER::MOLECULE) ("phalloidin" . SPARSER::MOLECULE)
    ("hydrazine (CCCP)" . SPARSER::DRUG) ("CCCP" . SPARSER::MOLECULE)
    ("hydrazine" . SPARSER::DRUG)
    ("this amphipathic cationic peptide" . SPARSER::PEPTIDE)
    ("antimicrobial peptides" . SPARSER::PEPTIDE)
    ("antibiotic" . SPARSER::DRUG) ("peptides" . SPARSER::PEPTIDE)
    ("MOMP" . SPARSER::PROTEIN) ("Parkin" . SPARSER::PROTEIN)
    ("the two pro-apoptotic multidomain proteins" . SPARSER::PROTEIN)
    ("BAX and BAK" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("BAX" . SPARSER::PROTEIN)
    ("an amphipathic cationic peptide" . SPARSER::PEPTIDE)
    ("D-glucose" . SPARSER::MOLECULE) ("LC3" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("DIOC 6" . SPARSER::DRUG)
    ("necrostatin-1" . SPARSER::MOLECULE) ("TOMM20" . SPARSER::PROTEIN)
    ("LC3B" . SPARSER::PROTEIN) ("DiOC 6" . SPARSER::DRUG)
    ("transcription factor A, mitochondrial" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("BCL-2" . SPARSER::PROTEIN)
    ("etoposide or doxorubicin" . SPARSER::COLLECTION)
    ("a possible p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and ΔNp73α" . SPARSER::COLLECTION) ("p63/p73" . SPARSER::COLLECTION)
    ("TA" . SPARSER::PROTEIN)
    ("different promoters and alternative splicing" . SPARSER::COLLECTION)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("Apaf-1, PUMA, p21, Bax and Mdm2" . SPARSER::COLLECTION)
    ("Bax" . SPARSER::PROTEIN) ("PUMA" . SPARSER::PROTEIN)
    ("p53 and components" . SPARSER::COLLECTION)
    ("either a p53-reactivating drug (PRIMA-1) or an siRNA approach"
     . SPARSER::COLLECTION)
    ("proapoptotic IGFBP-3" . SPARSER::PROTEIN)
    ("sphingolipids" . SPARSER::MOLECULE)
    ("the topoisomerase II inhibitors doxorubicin and etoposide"
     . SPARSER::COLLECTION)
    ("cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("olaparib and veliparib" . SPARSER::COLLECTION)
    ("veliparib" . SPARSER::DRUG) ("olaparib" . SPARSER::DRUG)
    ("carboplatin" . SPARSER::DRUG) ("platinum" . SPARSER::MOLECULE)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("sphingomyelinases" . SPARSER::PROTEIN) ("Ceramide" . SPARSER::MOLECULE)
    ("exogenous IGFBP-3" . SPARSER::PROTEIN) ("ceramide" . SPARSER::MOLECULE)
    ("pro-apoptotic lipids" . SPARSER::LIPID)
    ("sphingolipid" . SPARSER::MOLECULE)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("p63 and its truncated oncogenic form ΔNp63α [ xref ]"
     . SPARSER::COLLECTION)
    ("both doxorubicin- and etoposide-induced p21 and IGFBP-3 mRNA (Figure xref )"
     . SPARSER::COLLECTION)
    ("p21 and IGFBP-3" . SPARSER::COLLECTION)
    ("p21 or IGFBP-3" . SPARSER::COLLECTION)
    ("doxorubicin-" . SPARSER::PROTEIN)
    ("doxorubicin or etoposide" . SPARSER::COLLECTION)
    ("Doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN) ("Doxorubicin" . SPARSER::PROTEIN)
    ("Etoposide" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("1 μM doxorubicin or 20 μM etoposide" . SPARSER::COLLECTION)
    ("hypoxia and oncogene" . SPARSER::COLLECTION) ("IGF" . SPARSER::PROTEIN)
    ("six homologous proteins" . SPARSER::PROTEIN)
    ("IGF-1 and IGF-2" . SPARSER::COLLECTION) ("Cytotoxic" . SPARSER::PROTEIN)
    ("which lacks estrogen and progesterone receptors" . SPARSER::RECEPTOR)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION) ("progesterone" . SPARSER::PROTEIN)
    ("aggressive forms" . SPARSER::FORM)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN) ("MCF-10A" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE) ("housekeeping gene" . SPARSER::PROTEIN)
    ("F12" . SPARSER::PROTEIN) ("epidermal growth factor" . SPARSER::PROTEIN)
    ("p73" . SPARSER::PROTEIN) ("Apaf-1" . SPARSER::PROTEIN)
    ("sphingosine kinase 1" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG) ("ΔNp63α" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("caspase3" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("IGF-2" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("Insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("PRIMA-1" . SPARSER::PROTEIN)
    ("IGFBP-3" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("Serine" . SPARSER::AMINO-ACID)
    ("AR pSer(213) and acceleration of AR protein degradation"
     . SPARSER::COLLECTION)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("ASF/SF2" . SPARSER::COLLECTION) ("U2AF65" . SPARSER::PROTEIN)
    ("ASF" . SPARSER::PROTEIN)
    ("kinases or phosphatases" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("AR and Akt" . SPARSER::COLLECTION)
    ("homodimer or heterodimer" . SPARSER::COLLECTION)
    ("TMC-" . SPARSER::PROTEIN) ("AR or ubiquitin" . SPARSER::COLLECTION)
    ("ubiquitin" . SPARSER::PROTEIN) ("fractioned" . SPARSER::BIO-FRACTION)
    ("the major AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TMC or cAkt" . SPARSER::COLLECTION) ("TMC or PP-1" . SPARSER::COLLECTION)
    ("epoxomicin and MG132" . SPARSER::COLLECTION)
    ("epoxomicin" . SPARSER::DRUG) ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("TMC" . SPARSER::PROTEIN) ("tautomycetin" . SPARSER::DRUG)
    ("dAkt" . SPARSER::PROTEIN) ("cAkt" . SPARSER::PROTEIN)
    ("Akt, PP-1 and Mdm2" . SPARSER::COLLECTION)
    ("undetectable pAkt" . SPARSER::PROTEIN-FAMILY) ("pMdm" . SPARSER::DRUG)
    ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("LNCaP and LNCaP95" . SPARSER::COLLECTION) ("MAB" . SPARSER::DRUG)
    ("AR and PTEN" . SPARSER::COLLECTION) ("pSer" . SPARSER::PROTEIN)
    ("PTEN" . SPARSER::PROTEIN) ("ATT" . SPARSER::PROTEIN)
    ("PP-1 and Akt" . SPARSER::COLLECTION) ("NP40" . SPARSER::MOLECULE)
    ("SF2" . SPARSER::PROTEIN) ("U2AF" . SPARSER::BIO-COMPLEX)
    ("ligase activity" . SPARSER::PROTEIN) ("MG132" . SPARSER::PROTEIN)
    ("Protein phosphatase" . SPARSER::PROTEIN) ("PP-1" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG)
    ("EGFR, FASN, and PATs" . SPARSER::COLLECTION)
    ("EGFR, HER2, and HER4" . SPARSER::COLLECTION)
    ("plasma membrane-associated FASN" . SPARSER::PROTEIN)
    ("Palmitate" . SPARSER::PROTEIN)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("PARP and caspase 3" . SPARSER::COLLECTION)
    ("plasma membranous EGFR" . SPARSER::PROTEIN)
    ("lysosomal" . SPARSER::PROTEIN) ("FASN or PATs" . SPARSER::COLLECTION)
    ("HER2 and HER4" . SPARSER::COLLECTION) ("dimers" . SPARSER::DIMER)
    ("inactive" . SPARSER::INACTIVE) ("thioester" . SPARSER::MOLECULE)
    ("Cysteine" . SPARSER::AMINO-ACID) ("ERK and Akt" . SPARSER::COLLECTION)
    ("SH" . SPARSER::PROTEIN-FAMILY) ("PATs" . SPARSER::PROTEIN)
    ("acyltransferase (PAT)" . SPARSER::PROTEIN)
    ("acyltransferase" . SPARSER::PROTEIN)
    ("EGFR and FASN" . SPARSER::COLLECTION)
    ("membranous proteins" . SPARSER::PROTEIN) ("cerulenin" . SPARSER::DRUG)
    ("AEE788 or C225" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION) ("ΔECD-EGFR" . SPARSER::COLLECTION)
    ("external ligands" . SPARSER::LIGAND)
    ("the dimerized form" . SPARSER::FORM)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ligand" . SPARSER::LIGAND)
    ("both EGFR's" . SPARSER::PROTEIN)
    ("its extracellular ligands and small molecule tyrosine kinase inhibitors (TKIs) that block the tyrosine kinase domain"
     . SPARSER::COLLECTION)
    ("EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("amino acids and anchors" . SPARSER::COLLECTION)
    ("anchors" . SPARSER::ANCHOR) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("ECD" . SPARSER::PROTEIN) ("HER3 and HER4" . SPARSER::COLLECTION)
    ("HER2/Neu" . SPARSER::COLLECTION)
    ("FASN or palmitoyl" . SPARSER::COLLECTION)
    ("acyltransferases" . SPARSER::PROTEIN) ("TX100" . SPARSER::DRUG)
    ("BS3" . SPARSER::PROTEIN) ("pRK5" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("pErk1/2" . SPARSER::PROTEIN)
    ("Anti-EGFR" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("Glycine)" . SPARSER::PROTEIN) ("PAT2" . SPARSER::PROTEIN)
    ("AEE788" . SPARSER::DRUG) ("DU145" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CB" . SPARSER::PROTEIN) ("glutaminase" . SPARSER::PROTEIN)
    ("OGDH, MDH1, and GLUD1" . SPARSER::COLLECTION)
    ("the canonical AR target genes, cell growth and migration"
     . SPARSER::GENE)
    ("using exogenous radiolabeled lipids" . SPARSER::PROTEIN)
    ("Neutral lipids" . SPARSER::LIPID)
    ("proteins, and β-oxidation" . SPARSER::COLLECTION)
    ("lipid and phospholipid" . SPARSER::COLLECTION)
    ("AR-V7 (Figure xref and xref ) further indicating full-length AR's"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR-V7 (Figure xref and xref ) further indicating full-length AR"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("classical target genes" . SPARSER::GENE)
    ("PSA and FKBP5" . SPARSER::COLLECTION)
    ("biochemical components" . SPARSER::COMPONENT)
    ("glucose and glutamine" . SPARSER::COLLECTION)
    ("palmitate and oleate" . SPARSER::COLLECTION)
    ("palmitate or oleate" . SPARSER::COLLECTION)
    ("oleate" . SPARSER::MOLECULE) ("Lipids" . SPARSER::LIPID)
    ("p" . SPARSER::PROTEIN) ("AMPK and p-AMPK" . SPARSER::COLLECTION)
    ("AR or AR-V7" . SPARSER::COLLECTION) ("p-AMPK" . SPARSER::COLLECTION)
    ("AMPK [ xref ] and AR" . SPARSER::COLLECTION)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("FASN (fatty acid synthase) and ELOV7 (i.e. a long chain fatty acid elongase)"
     . SPARSER::COLLECTION)
    ("ACACA" . SPARSER::PROTEIN)
    ("fatty acid synthase (FASN)" . SPARSER::PROTEIN)
    ("FASN" . SPARSER::PROTEIN) ("ammonia" . SPARSER::MOLECULE)
    ("citrate and fumarate" . SPARSER::COLLECTION)
    ("citrate and malate" . SPARSER::COLLECTION)
    ("-glutamine" . SPARSER::COLLECTION)
    ("malate and fumarate" . SPARSER::COLLECTION)
    ("dehydrogenase (OGDH)" . SPARSER::PROTEIN) ("OGDH" . SPARSER::PROTEIN)
    ("Hormone" . SPARSER::MOLECULE) ("CoA" . SPARSER::MOLECULE)
    ("malate, and oxaloacetate" . SPARSER::COLLECTION)
    ("malate" . SPARSER::MOLECULE) ("-glucose" . SPARSER::COLLECTION)
    ("m+2, m+3, m+4, and m+6" . SPARSER::COLLECTION) ("FBP" . SPARSER::PROTEIN)
    ("Citrate" . SPARSER::PROTEIN)
    ("glutamine (Figure xref ) and AKG (Figure xref )" . SPARSER::COLLECTION)
    ("α-ketoglutarate (AKG) and oxaloacetate (OAA)" . SPARSER::COLLECTION)
    ("AR-V7 and AR" . SPARSER::COLLECTION) ("OAA" . SPARSER::MOLECULE)
    ("glucose/fructose" . SPARSER::COLLECTION)
    ("phosphoglycerate" . SPARSER::MOLECULE) ("PG" . SPARSER::PROTEIN)
    ("fructose" . SPARSER::PROTEIN) ("map" . SPARSER::PROTEIN)
    ("approximately 100 metabolites" . SPARSER::MOLECULE)
    ("pyruvate and glutamine" . SPARSER::COLLECTION)
    ("FCCP and rotenone" . SPARSER::COLLECTION) ("rotenone" . SPARSER::PROTEIN)
    ("FCCP" . SPARSER::MOLECULE) ("Seahorse" . SPARSER::PROTEIN)
    ("typical AR target genes" . SPARSER::GENE)
    ("FKBP5 and PSA" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("AR and AR-V7" . SPARSER::COLLECTION)
    ("nitrogen and carbon" . SPARSER::COLLECTION)
    ("lipids and nucleotides" . SPARSER::COLLECTION)
    ("Glutamine" . SPARSER::AMINO-ACID) ("glutamine" . SPARSER::AMINO-ACID)
    ("abiraterone" . SPARSER::DRUG) ("enzalutamide" . SPARSER::DRUG)
    ("16 unique amino acids" . SPARSER::AMINO-ACID)
    ("cryptic" . SPARSER::PROTEIN) ("States" . SPARSER::BIO-STATE)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("citrate" . SPARSER::PROTEIN) ("PCa" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("ELOVL7" . SPARSER::PROTEIN)
    ("alpha)" . SPARSER::PROTEIN) ("β-tubulin" . SPARSER::PROTEIN)
    ("oleic acid" . SPARSER::MOLECULE) ("Palmitic acid" . SPARSER::MOLECULE)
    ("amino acid synthesis" . SPARSER::PROTEIN-FAMILY)
    ("long chain" . SPARSER::PROTEIN) ("lipid droplet" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("GLUD1" . SPARSER::PROTEIN)
    ("MDH1" . SPARSER::PROTEIN) ("malate dehydrogenase 1" . SPARSER::PROTEIN)
    ("m+2" . SPARSER::MOLECULE) ("m+6" . SPARSER::PROTEIN)
    ("fructose-1,6-bisphosphate" . SPARSER::PROTEIN)
    ("glucose-6-phosphate" . SPARSER::MOLECULE) ("FKBP5" . SPARSER::PROTEIN)
    ("CYP17A1" . SPARSER::PROTEIN) ("MDV3100" . SPARSER::DRUG)
    ("anti-androgen" . SPARSER::DRUG) ("AR-V7" . SPARSER::PROTEIN)
    ("function-blocking monoclonal antibodies" . SPARSER::ANTIBODY)
    ("CD151, and IIF5 or P1B5" . SPARSER::COLLECTION)
    ("Tsr" . SPARSER::PROTEIN) ("CD151–integrin" . SPARSER::COLLECTION)
    ("c-Met and ErbB2" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("FAK and Graf" . SPARSER::COLLECTION)
    ("shed new light" . SPARSER::PROTEIN)
    ("CD151-associated α3 and α6 integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α3 and α6" . SPARSER::COLLECTION)
    ("the same protein complexes or TEM" . SPARSER::COLLECTION)
    ("CD151 and CD9" . SPARSER::COLLECTION)
    ("its associated integrin molecules" . SPARSER::MOLECULE)
    ("CD81 and its associated EWI-2 protein complexes" . SPARSER::COLLECTION)
    ("its associated EWI-2 protein complexes" . SPARSER::BIO-COMPLEX)
    ("laminins" . SPARSER::PROTEIN-FAMILY)
    ("pro-malignant genes" . SPARSER::GENE)
    ("micro-RNAs or epigenetic regulation [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("CD151 or α3" . SPARSER::COLLECTION) ("α3" . SPARSER::PROTEIN)
    ("potential biomarkers" . SPARSER::MOLECULE)
    ("CD151 or its associated α3β1 integrin" . SPARSER::COLLECTION)
    ("FAK- and Graf" . SPARSER::COLLECTION) ("FAK-" . SPARSER::PROTEIN)
    ("DOCK180 or ELMO1" . SPARSER::COLLECTION)
    ("CD151-α3" . SPARSER::PROTEIN-PAIR) ("/Rac1/Cdc42" . SPARSER::COLLECTION)
    ("exchange factors or RhoGAPs" . SPARSER::COLLECTION)
    ("GDP/GTP" . SPARSER::PROTEIN-PAIR) ("RhoGAPs" . SPARSER::PROTEIN)
    ("GTP" . SPARSER::NUCLEOTIDE) ("GDP" . SPARSER::NUCLEOTIDE)
    ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION) ("Integrins" . SPARSER::PROTEIN)
    ("the aggressive traits" . SPARSER::PROTEIN)
    ("two clinically relevant EGFR inhibitors" . SPARSER::INHIBITOR)
    ("Iressa" . SPARSER::DRUG) ("Tykerb" . SPARSER::DRUG)
    ("α3β1 integrin and its physiological ligand" . SPARSER::COLLECTION)
    ("CD151-integrin" . SPARSER::COLLECTION) ("Protein" . SPARSER::PROTEIN)
    ("CD151-associated α3 integrin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD151 and its associated LB integrins form protein complexes"
     . SPARSER::COLLECTION)
    ("its associated LB integrins form protein complexes"
     . SPARSER::BIO-COMPLEX)
    ("CD9, CD81 and CD82" . SPARSER::COLLECTION)
    ("-palmitate" . SPARSER::COLLECTION)
    ("integrins and tetraspanin" . SPARSER::COLLECTION)
    ("palmitate and form" . SPARSER::COLLECTION)
    ("palmitate" . SPARSER::PROTEIN)
    ("its associated protein complexes" . SPARSER::BIO-COMPLEX)
    ("CD151-associated α3β1 integrin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD151 or its associated LB integrins" . SPARSER::COLLECTION)
    ("CD9 and CD81" . SPARSER::COLLECTION)
    ("CD151 and LB integrins" . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG)
    ("a commercial glioma TMA" . SPARSER::MOLECULE) ("TMA" . SPARSER::MOLECULE)
    ("CD151 or α3β1" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("CD151 and its associated α3 integrin" . SPARSER::COLLECTION)
    ("its associated α3 integrin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD151 and its associated LB integrins" . SPARSER::COLLECTION)
    ("its associated LB integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tetraspanins form tight protein complexes" . SPARSER::BIO-COMPLEX)
    ("tetraspanins" . SPARSER::PROTEIN-FAMILY)
    ("CD151, CD9, CD81, and CD82" . SPARSER::COLLECTION)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("particularly LB integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α5β1 and αvβ3" . SPARSER::COLLECTION)
    ("α3β1, α6β1 and α6β4" . SPARSER::COLLECTION)
    ("laminin" . SPARSER::PROTEIN) ("α3β1" . SPARSER::PROTEIN)
    ("heterodimeric receptors" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::PROTEIN) ("This fatal type" . TYPE)
    ("the most aggressive types" . TYPE) ("IV" . SPARSER::PROTEIN)
    ("CD151-α3β1" . SPARSER::COLLECTION)
    ("EGFR, FAK or Graf" . SPARSER::COLLECTION) ("GTPase" . SPARSER::GTPASE)
    ("Graf" . SPARSER::PROTEIN) ("FAK and small GTPases" . SPARSER::COLLECTION)
    ("FAK" . SPARSER::PROTEIN)
    ("tight protein complexes" . SPARSER::BIO-COMPLEX)
    ("EGF/EGFR" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("CD151 and α3" . SPARSER::COLLECTION)
    ("CD151 and α3β1" . SPARSER::COLLECTION)
    ("Tetraspanin CD151 and its associated α3β1 integrin"
     . SPARSER::COLLECTION)
    ("its associated α3β1 integrin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("integrin" . SPARSER::PROTEIN) ("Tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("the most aggressive forms" . SPARSER::FORM) ("G10" . SPARSER::PROTEIN)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("palmitic acid" . SPARSER::MOLECULE)
    ("18 h" . SPARSER::PROTEIN) ("U6" . SPARSER::PROTEIN)
    ("U87" . SPARSER::PROTEIN) ("TS2" . SPARSER::PROTEIN)
    ("C11" . SPARSER::PROTEIN) ("1A" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN) ("EWI-2" . SPARSER::PROTEIN)
    ("micro-RNAs" . SPARSER::MICRO-RNA) ("ELMO1" . SPARSER::PROTEIN)
    ("DOCK180" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR) ("Rac1" . SPARSER::PROTEIN)
    ("TAE226" . SPARSER::DRUG) ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD82" . SPARSER::PROTEIN) ("CD81" . SPARSER::PROTEIN)
    ("CD9" . SPARSER::PROTEIN) ("αvβ3" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("ARHGAP26" . SPARSER::PROTEIN) ("CD151" . SPARSER::PROTEIN)
    ("cigarette smoke and the subsequent activation of the Elk1 and cAMP-response element-binding protein transcription factors"
     . SPARSER::COLLECTION)
    ("Elk1 and cAMP-response element-binding protein" . SPARSER::COLLECTION)
    ("Elk1" . SPARSER::PROTEIN) ("-Akt" . SPARSER::COLLECTION)
    ("DNase" . SPARSER::PROTEIN) ("gene and risk" . SPARSER::COLLECTION)
    ("thyroid" . SPARSER::PROTEIN) ("PAK1/LIMK1/cofilin" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::PROTEIN)
    ("GTPases, Rac and Cdc42" . SPARSER::COLLECTION)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPases" . SPARSER::GTPASE)
    ("some potential causal variants and genes" . SPARSER::COLLECTION)
    ("variants and genes" . SPARSER::COLLECTION) ("tobacco" . SPARSER::DRUG)
    ("cAMP-response element-binding protein" . SPARSER::PROTEIN)
    ("FRA-1" . SPARSER::PROTEIN) ("CRK-II" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P21-activated kinase 1" . SPARSER::PROTEIN)
    ("oxidative states" . SPARSER::BIO-STATE)
    ("intermediary metabolites" . SPARSER::PROTEIN)
    ("states" . SPARSER::BIO-STATE)
    ("enzymes and NADPH-oxidase" . SPARSER::COLLECTION)
    ("all available gene" . SPARSER::GENE)
    ("some relevant genes" . SPARSER::GENE)
    ("Nrf2 or genes" . SPARSER::COLLECTION)
    ("oxidative state" . SPARSER::BIO-STATE) ("metabolite" . SPARSER::MOLECULE)
    ("energetic substrates" . SPARSER::SUBSTRATE)
    ("oxaloacetate" . SPARSER::MOLECULE) ("pyruvate" . SPARSER::PROTEIN)
    ("phospholipids and enzymes" . SPARSER::COLLECTION)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("whole blood–derived RNA" . SPARSER::RNA)
    ("superoxide" . SPARSER::MOLECULE) ("92 unique genes" . SPARSER::GENE)
    ("the peroxisome proliferator-activated receptor (PPAR) and retinoic acid receptor-α families"
     . SPARSER::COLLECTION)
    ("the peroxisome proliferator-activated receptor (PPAR)"
     . SPARSER::RECEPTOR)
    ("PPAR" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("178 unique genes" . SPARSER::GENE)
    ("hydrate (NADPH)" . SPARSER::MOLECULE) ("thioredoxin" . SPARSER::PROTEIN)
    ("NADPH" . SPARSER::PROTEIN) ("hydrate" . SPARSER::MOLECULE)
    ("pentose" . SPARSER::MOLECULE)
    ("receptor and the retinoic acid receptor families" . SPARSER::COLLECTION)
    ("peroxisome" . SPARSER::PROTEIN)
    ("differentially expressed genes" . SPARSER::GENE)
    ("NADPH-oxidase" . SPARSER::PROTEIN) ("lactic acid" . SPARSER::MOLECULE)
    ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("NADPH oxidase" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("retinoic acid" . SPARSER::MOLECULE)
    ("oxidoreductase activity" . SPARSER::PROTEIN) ("p45" . SPARSER::PROTEIN)
    ("CALR gene and a higher triple-negative frequency" . SPARSER::COLLECTION)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("functionally mature neutrophils" . SPARSER::PROTEIN)
    ("mature neutrophils" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("neutrophils" . SPARSER::PROTEIN) ("neutrophil" . SPARSER::PROTEIN)
    ("type 1 and CALR" . SPARSER::COLLECTION) ("Rumi" . SPARSER::PROTEIN)
    ("their JAK2 V617F and CALR genotypes ( xref )" . SPARSER::COLLECTION)
    ("-mutant" . SPARSER::MUTANT) ("JAK2 , MPL and CALR" . SPARSER::COLLECTION)
    ("BCR-ABL1 -negative MPNs" . SPARSER::PROTEIN)
    ("TET2 , IDH1/2 , Ezh2 , DNMT3A and Asxl1" . SPARSER::COLLECTION)
    ("Asxl1" . SPARSER::PROTEIN) ("Ezh2" . SPARSER::PROTEIN)
    ("MPL , or CALR" . SPARSER::COLLECTION) ("Chen" . SPARSER::PROTEIN)
    ("group and PMF" . SPARSER::COLLECTION) ("Male" . SPARSER::MOLECULE)
    ("group and CALR" . SPARSER::COLLECTION) ("PLT" . SPARSER::PROTEIN)
    ("CALR or JAK2" . SPARSER::COLLECTION)
    ("MPL and CALR" . SPARSER::COLLECTION) ("the last exon" . SPARSER::PROTEIN)
    ("JAK2 and MPL" . SPARSER::COLLECTION) ("calreticulin" . SPARSER::PROTEIN)
    ("JAK2 or MPL" . SPARSER::COLLECTION) ("PV" . SPARSER::PROTEIN)
    ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CALR and JAK2" . SPARSER::COLLECTION) ("hemoglobin" . SPARSER::MOLECULE)
    ("MPL , and CALR" . SPARSER::COLLECTION) ("PMF" . SPARSER::PROTEIN)
    ("MPL" . SPARSER::PROTEIN) ("MPNs" . SPARSER::PROTEIN)
    ("CALR" . SPARSER::PROTEIN) ("JAK–STAT" . SPARSER::PROTEIN)
    ("JAK 2" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("type2" . SPARSER::PROTEIN) ("type1" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN)
    ("thrombopoietin receptor" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN) ("BCR-ABL" . SPARSER::PROTEIN)
    ("IKK-NF-kB" . SPARSER::COLLECTION) ("IKK" . SPARSER::PROTEIN)
    ("further bioactive molecules" . SPARSER::MOLECULE)
    ("growth factors and chemokines" . SPARSER::COLLECTION)
    ("CCL2 and CCL5" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor and other angiogenetic molecule"
     . SPARSER::COLLECTION)
    ("other angiogenetic molecule" . SPARSER::MOLECULE)
    ("TAM and RKIP" . SPARSER::COLLECTION) ("TAM" . SPARSER::PROTEIN)
    ("new vasculature" . SPARSER::PROTEIN) ("MECA" . SPARSER::PROTEIN-FAMILY)
    ("macrophages and CD31" . SPARSER::COLLECTION)
    ("CD31 and F4/80 antibodies" . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN) ("Luminal" . SPARSER::DRUG)
    ("Claudin" . SPARSER::PROTEIN) ("MCF7" . SPARSER::PROTEIN)
    ("inflammatory chemokines" . SPARSER::PROTEIN)
    ("RKIP/CCL5" . SPARSER::COLLECTION)
    ("macrophages in turn discharge angiogenetic growth factors and proteases"
     . SPARSER::COLLECTION)
    ("growth factors and proteases" . SPARSER::COLLECTION)
    ("RANTE/CCL5" . SPARSER::COLLECTION)
    ("several inflammatory chemokines, cytokines and growth factors"
     . SPARSER::COLLECTION)
    ("chemokines, cytokines and growth factors" . SPARSER::COLLECTION)
    ("vasculature" . SPARSER::PROTEIN) ("RKIP and CCL5" . SPARSER::COLLECTION)
    ("chemokine" . SPARSER::PROTEIN) ("RANTES/CCL5" . SPARSER::COLLECTION)
    ("RANTES" . SPARSER::PROTEIN) ("RKIP" . SPARSER::PROTEIN)
    ("CD-31" . SPARSER::PROTEIN) ("mL- 1" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("CXCL2" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("CCL5" . SPARSER::PROTEIN) ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("the important antiviral protein APOBEC3G" . SPARSER::PROTEIN)
    ("Vif or Vpr" . SPARSER::COLLECTION)
    ("IRF3 and NF-κB" . SPARSER::COLLECTION) ("Vpr/Vif" . SPARSER::COLLECTION)
    ("TRAIL" . SPARSER::PROTEIN) ("pDC" . SPARSER::PROTEIN)
    ("pDCs" . SPARSER::PROTEIN) ("interferon" . SPARSER::PROTEIN)
    ("Vpu-" . SPARSER::PROTEIN) ("STAT1 and IRF3" . SPARSER::COLLECTION)
    ("Vpu or the Nef protein" . SPARSER::COLLECTION) ("IRF" . SPARSER::PROTEIN)
    ("TRAF3 and uses proteins" . SPARSER::COLLECTION)
    ("TRIF" . SPARSER::PROTEIN) ("IRFs and NF-κB" . SPARSER::COLLECTION)
    ("IRFs" . SPARSER::PROTEIN) ("tubulin" . SPARSER::PROTEIN)
    ("an efficacious antiviral state" . SPARSER::BIO-STATE)
    ("an effective antiviral state" . SPARSER::BIO-STATE)
    ("RLR/IPS-1" . SPARSER::COLLECTION) ("Vif and Vpr" . SPARSER::COLLECTION)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Vif" . SPARSER::PROTEIN)
    ("Env" . SPARSER::PROTEIN) ("many viral proteins" . SPARSER::PROTEIN)
    ("Proteins" . SPARSER::PROTEIN)
    ("CARDIF, MAVS or VISA" . SPARSER::COLLECTION) ("VISA" . SPARSER::PROTEIN)
    ("MAVS" . SPARSER::PROTEIN) ("CARDIF" . SPARSER::PROTEIN)
    ("RLRs" . SPARSER::PROTEIN)
    ("Intracellular viral RNA ligands" . SPARSER::LIGAND)
    ("RNAse" . SPARSER::PROTEIN) ("at least one IFN" . SPARSER::DRUG)
    ("PAMP" . SPARSER::PROTEIN) ("VSV" . SPARSER::PROTEIN)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("directly antiviral proteins" . SPARSER::PROTEIN)
    ("modulators" . SPARSER::PROTEIN) ("Genes" . SPARSER::GENE)
    ("receptor (IFNAR)" . SPARSER::RECEPTOR) ("IFNAR" . SPARSER::PROTEIN)
    ("the Toll-like receptors (TLR) and RIG-I" . SPARSER::COLLECTION)
    ("receptors (TLR)" . SPARSER::RECEPTOR)
    ("viral components" . SPARSER::COMPONENT) ("RLR" . SPARSER::PROTEIN)
    ("helicases" . SPARSER::PROTEIN)
    ("the quintessential innate immune cytokines" . SPARSER::PROTEIN)
    ("IFNs" . SPARSER::DRUG) ("cytokines and effector" . SPARSER::COLLECTION)
    ("innate immune cytokines and other antiviral proteins"
     . SPARSER::COLLECTION)
    ("other antiviral proteins" . SPARSER::PROTEIN)
    ("innate immune cytokines" . SPARSER::PROTEIN)
    ("receptor (PRR)" . SPARSER::RECEPTOR) ("PRR" . SPARSER::PROTEIN)
    ("PAMPs" . SPARSER::PROTEIN) ("the innate immune viral RNA" . SPARSER::RNA)
    ("Vpu" . SPARSER::PROTEIN)
    ("important antiviral cytokines" . SPARSER::PROTEIN)
    ("IFN" . SPARSER::DRUG) ("Interferon" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("TLR7" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("CD4 molecule" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("IRF-3" . SPARSER::PROTEIN)
    ("NS1" . SPARSER::PROTEIN) ("NS3" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("anti-CD28" . SPARSER::PROTEIN)
    ("interleukin-2" . SPARSER::PROTEIN) ("p24" . SPARSER::PROTEIN)
    ("NL4" . SPARSER::PROTEIN) ("Interferon-α" . SPARSER::DRUG)
    ("RIG-I" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("IPS-1" . SPARSER::PROTEIN) ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antibody and TKI" . SPARSER::COLLECTION)
    ("Antibodies" . SPARSER::ANTIBODY)
    ("molecules and antibodies" . SPARSER::COLLECTION)
    ("HKI-272 and Rapamycin/HKI-272 combination" . SPARSER::COLLECTION)
    ("HKI-272 and rapamycin" . SPARSER::COLLECTION)
    ("Rapamycin and HKI-272" . SPARSER::COLLECTION)
    ("HER2, AKT and ERK" . SPARSER::COLLECTION)
    ("a PI3K and mTOR dual inhibitor" . SPARSER::INHIBITOR)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("shrinking H78Y mutant HER2" . SPARSER::PROTEIN)
    ("PLCγ, STAT5, AKT and Cyclin D1" . SPARSER::COLLECTION)
    ("rtTA" . SPARSER::PROTEIN) ("nick" . SPARSER::PROTEIN)
    ("dUTP" . SPARSER::MOLECULE)
    ("strong HER2 and phospho-HER2" . SPARSER::COLLECTION)
    ("HER2 and phospho-HER2" . SPARSER::COLLECTION)
    ("CC10-rtTA" . SPARSER::PROTEIN-PAIR) ("transgene" . SPARSER::PROTEIN)
    ("TetO" . SPARSER::PROTEIN) ("op" . SPARSER::MOLECULE)
    ("tet" . SPARSER::PROTEIN) ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("an irreversible dual inhibitor" . SPARSER::INHIBITOR)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("PLCγ and STAT5" . SPARSER::COLLECTION)
    ("HKI-272 and Rapamycin" . SPARSER::COLLECTION)
    ("doxycycline" . SPARSER::DRUG) ("salt" . SPARSER::MOLECULE)
    ("BRAF V600E and ALK R1275Q" . SPARSER::COLLECTION)
    ("PLCγ and MAPK" . SPARSER::COLLECTION)
    ("a 185-Kd transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK, PKC and AKT" . SPARSER::COLLECTION)
    ("a reasonable drug target" . SPARSER::TARGET-PROTEIN)
    ("HKI272 and mTOR" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("PLCγ1, STAT5 and AKT" . SPARSER::COLLECTION)
    ("relevant therapeutics" . SPARSER::THERAPEUTICS)
    ("NaVO3" . SPARSER::MOLECULE) ("IL-3" . SPARSER::PROTEIN)
    ("NVP-BEZ235" . SPARSER::DRUG) ("PI3K-Akt" . SPARSER::PROTEIN)
    ("CC10" . SPARSER::PROTEIN) ("β-globin" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("HKI272" . SPARSER::DRUG) ("HKI-272" . SPARSER::DRUG)
    ("STAT5" . SPARSER::PROTEIN) ("PLCγ1" . SPARSER::PROTEIN)
    ("metastatic GC" . SPARSER::PROTEIN) ("human GI PDC" . SPARSER::PROTEIN)
    ("monoclonal antibody-" . SPARSER::DRUG)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALK, ROS1, NTRK1, NTRK3 or RET" . SPARSER::COLLECTION)
    ("another bivalent Met" . SPARSER::AMINO-ACID)
    ("Previously reported anti-MET antibody" . SPARSER::ANTIBODY)
    ("EGFR and HER2" . SPARSER::COLLECTION) ("Erbitux" . SPARSER::DRUG)
    ("specifically targets MET, and cabozantinib" . SPARSER::COLLECTION)
    ("PHA-665752 and cabozantinib" . SPARSER::COLLECTION)
    ("MET, and cabozantinib" . SPARSER::COLLECTION)
    ("cabozantinib" . SPARSER::DRUG)
    ("MET as well as ALK [ xref – xref ]" . SPARSER::COLLECTION)
    ("PDCs" . SPARSER::PROTEIN) ("Crizotinib" . SPARSER::DRUG)
    ("GC and CRC" . SPARSER::COLLECTION)
    ("crizotinib (small molecule) and SAIT301 (monoclonal antibody)"
     . SPARSER::COLLECTION)
    ("his" . SPARSER::AMINO-ACID) ("DNAs" . SPARSER::DNA)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("Biomarker" . SPARSER::MOLECULE) ("SMC" . SPARSER::PROTEIN)
    ("PDC" . SPARSER::PROTEIN) ("formalin" . SPARSER::MOLECULE)
    ("ALK, ROS1, RET, NTRK1, and NTRK3" . SPARSER::COLLECTION)
    ("RET" . SPARSER::PROTEIN) ("ligase" . SPARSER::LIGASE)
    ("HGF" . SPARSER::PROTEIN)
    ("both MET tyrosine kinase inhibitors and a monoclonal antibody targeting MET"
     . SPARSER::COLLECTION)
    ("NEXT-1" . SPARSER::COLLECTION) ("NEXT" . SPARSER::PROTEIN)
    ("FISH" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pERK1/2" . SPARSER::PROTEIN)
    ("Tween 20" . SPARSER::MOLECULE) ("as 2" . SPARSER::PROTEIN)
    ("6-carboxyfluorescein" . SPARSER::DRUG) ("m1" . SPARSER::MOLECULE)
    ("GFPT1" . SPARSER::PROTEIN) ("POLR2A" . SPARSER::PROTEIN)
    ("OAZ1" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("XL184" . SPARSER::DRUG) ("PHA-665752" . SPARSER::DRUG)
    ("SAIT301" . SPARSER::DRUG) ("c-MET" . SPARSER::PROTEIN)
    ("NTRK3" . SPARSER::PROTEIN) ("NTRK1" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN)
    ("Casitas B-lineage lymphoma" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("leukemia" . SPARSER::PROTEIN)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("protein (EGFR)" . SPARSER::PROTEIN) ("peptide" . SPARSER::PEPTIDE)
    ("EGFR and EGFR" . SPARSER::COLLECTION)
    ("Afatinib or BIBW2992" . SPARSER::COLLECTION)
    ("ibrutinib and CO-1686" . SPARSER::COLLECTION)
    ("Afatinib" . SPARSER::DRUG) ("Cetuximab" . SPARSER::DRUG)
    ("H1975" . SPARSER::PROTEIN)
    ("Ibrutinib and the MEK inhibitor GSK1120212" . SPARSER::COLLECTION)
    ("Gefitinib and WZ4002" . SPARSER::COLLECTION) ("BID" . SPARSER::PROTEIN)
    ("PARP and Caspase-3" . SPARSER::COLLECTION)
    ("WZ4002 or CO-1686" . SPARSER::COLLECTION)
    ("WZ4002, CO1686 and AZD9291" . SPARSER::COLLECTION)
    ("AktS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ibrutinib-" . SPARSER::DRUG)
    ("AZD9291 and WZ4002" . SPARSER::COLLECTION)
    ("mutant and wt" . SPARSER::COLLECTION) ("ADP-Glo" . SPARSER::COLLECTION)
    ("Glo" . SPARSER::PROTEIN) ("ADP" . SPARSER::PROTEIN)
    ("WZ4002 and CO-1686" . SPARSER::COLLECTION)
    ("Ibrutinib and WZ4002" . SPARSER::COLLECTION) ("EC" . SPARSER::PROTEIN)
    ("acrylamide" . SPARSER::MOLECULE) ("PCI" . SPARSER::PROTEIN)
    ("BIBW2992, WZ4002, CO-1686, AZD9291 and Gefitinib" . SPARSER::COLLECTION)
    ("a potential drug" . SPARSER::DRUG)
    ("the EGFR secondary mutant" . SPARSER::MUTANT)
    ("BIBW2992, CO1686 and AZD9291" . SPARSER::COLLECTION)
    ("EGFR and BTK" . SPARSER::COLLECTION) ("cysteine" . SPARSER::AMINO-ACID)
    ("NCT" . SPARSER::PROTEIN)
    ("Gefitinib and Erlotinib" . SPARSER::COLLECTION)
    ("Neratinib and Dacomitinib" . SPARSER::COLLECTION)
    ("EGFR and mutant" . SPARSER::COLLECTION)
    ("WZ4002, CO-1686 and AZD9291" . SPARSER::COLLECTION)
    ("Ras/RAF/MEK/ERK" . SPARSER::COLLECTION) ("Dacomitinib" . SPARSER::DRUG)
    ("Neratinib" . SPARSER::DRUG) ("Apatinib" . SPARSER::DRUG)
    ("Erlotinib" . SPARSER::DRUG) ("Gefitinib" . SPARSER::DRUG)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MCL" . SPARSER::PROTEIN)
    ("PC-9 and H1975" . SPARSER::COLLECTION) ("PC-9" . SPARSER::PROTEIN)
    ("Ibrutinib" . SPARSER::DRUG) ("BTK" . SPARSER::PROTEIN)
    ("ibrutinib" . SPARSER::DRUG) ("or 2" . SPARSER::MOLECULE)
    ("p70 S6" . SPARSER::PROTEIN) ("M/L" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("alpha-" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("H11" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("L-glutamine" . SPARSER::MOLECULE) ("Caspase-3" . SPARSER::PROTEIN)
    ("CO1686" . SPARSER::DRUG) ("AZD9291" . SPARSER::DRUG)
    ("CO-1686" . SPARSER::DRUG) ("WZ4002" . SPARSER::DRUG)
    ("etc." . SPARSER::PROTEIN) ("PCI-32765" . SPARSER::DRUG)
    ("GSK1120212" . SPARSER::DRUG) ("ER–LKB1–AMPK" . SPARSER::COLLECTION)
    ("AMPKα, LKB1 and MO25" . SPARSER::COLLECTION)
    ("AMPKα–LKB1" . SPARSER::COLLECTION) ("only one part" . SPARSER::COMPONENT)
    ("homodimer" . SPARSER::HOMODIMER) ("heterodimer" . SPARSER::HETERODIMER)
    ("ERβ and ERα" . SPARSER::COLLECTION)
    ("heterodimers" . SPARSER::HETERODIMER)
    ("E2 and AMPK" . SPARSER::COLLECTION) ("ER–AMPK" . SPARSER::COLLECTION)
    ("AMP–ATP" . SPARSER::PROTEIN-PAIR) ("ER–LKB1" . SPARSER::COLLECTION)
    ("two accessory proteins, MO25 and STRAD" . SPARSER::COLLECTION)
    ("proteins, MO25 and STRAD" . SPARSER::COLLECTION)
    ("the respective ER" . SPARSER::PROTEIN)
    ("the last two domains" . SPARSER::PROTEIN) ("linker" . SPARSER::LINKER)
    ("scaffolds" . SPARSER::SCAFFOLD)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("the predominant isoform" . SPARSER::ISOFORM)
    ("isoform" . SPARSER::ISOFORM) ("lack functional ERs" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("scaffold" . SPARSER::SCAFFOLD)
    ("phosphatidylinositol 3-kinase (PI3K) and p130Cas (Crk-associated substrate)"
     . SPARSER::COLLECTION)
    ("hepatocytes" . SPARSER::PROTEIN)
    ("previously called GPR30" . SPARSER::PROTEIN) ("GPER" . SPARSER::PROTEIN)
    ("classical ERs" . SPARSER::PROTEIN)
    ("AMPK and its target ACC" . SPARSER::COLLECTION)
    ("agonists" . SPARSER::AGONIST) ("genesis" . SPARSER::PROTEIN)
    ("type " . TYPE) ("therapeutics" . SPARSER::THERAPEUTICS)
    ("a highly conserved heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("LKB1 and MO25" . SPARSER::COLLECTION)
    ("LKB1 as well as MO25 " . SPARSER::COLLECTION)
    ("LKB1–MO25–STRAD" . SPARSER::COLLECTION)
    ("ERβ and AMPKα" . SPARSER::COLLECTION) ("GFP-myc" . SPARSER::COLLECTION)
    ("anti-eGFP (ERα) or anti-flag (ERβ) antibodies" . SPARSER::COLLECTION)
    ("AID" . SPARSER::PROTEIN) ("KD" . SPARSER::PROTEIN)
    ("a western blot" . SPARSER::PROTEIN) ("myc" . SPARSER::PROTEIN)
    ("eGFP-tagged ERα or flag-tagged ERβ" . SPARSER::COLLECTION)
    ("ERα/ERβ" . SPARSER::COLLECTION) ("isoforms" . SPARSER::ISOFORM)
    ("flag" . SPARSER::PROTEIN-FAMILY) ("eGFP" . SPARSER::PROTEIN)
    ("SDS" . SPARSER::PROTEIN) ("ERα or ERβ" . SPARSER::COLLECTION)
    ("ERs and AMPK" . SPARSER::COLLECTION)
    ("blot or AMPK" . SPARSER::COLLECTION)
    ("antagonist (TPP)" . SPARSER::MOLECULE)
    ("an intact AMPK" . SPARSER::PROTEIN) ("TPP" . SPARSER::PROTEIN)
    ("a pure AMPK agonist" . SPARSER::AGONIST)
    ("E2 or PPT" . SPARSER::COLLECTION)
    ("a specific ERα (PPT) or ERβ (DPN) agonist" . SPARSER::COLLECTION)
    ("ERα (PPT)" . SPARSER::PROTEIN) ("DPN" . SPARSER::MOLECULE)
    ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pACC" . SPARSER::PROTEIN)
    ("total and phosphorylated AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("substrate" . SPARSER::SUBSTRATE) ("ACC" . SPARSER::PROTEIN)
    ("AMPK and AMPK" . SPARSER::COLLECTION) ("AMPK–LKB1" . SPARSER::COLLECTION)
    ("the two classical ERs" . SPARSER::PROTEIN)
    ("receptors (ER)" . SPARSER::RECEPTOR) ("glycogen" . SPARSER::PROTEIN)
    ("LKB1/AMPK" . SPARSER::COLLECTION) ("types " . TYPE)
    ("LKB1 and two accessory subunits" . SPARSER::COLLECTION)
    ("two accessory subunits" . SPARSER::PROTEIN) ("STRAD" . SPARSER::PROTEIN)
    ("the upstream liver kinase B 1 (LKB1) complex and calcium–calmodulin-dependent protein kinase kinase β (CaMKKβ)"
     . SPARSER::COLLECTION)
    ("CaMKK" . SPARSER::PROTEIN) ("intracellular AMP" . SPARSER::AMP)
    ("AMP" . SPARSER::AMP)
    ("a heterotrimeric enzyme complex" . SPARSER::BIO-COMPLEX)
    ("subunits" . SPARSER::FRAGMENT) ("subunit" . SPARSER::FRAGMENT)
    ("ERs" . SPARSER::PROTEIN) ("oestradiol" . SPARSER::MOLECULE)
    ("the classical oestrogen receptors (ERα and ERβ) and the catalytic subunit"
     . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE)
    ("the classical oestrogen receptors" . SPARSER::RECEPTOR)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("AMPK" . SPARSER::PROTEIN)
    ("LKB1–AMPK" . SPARSER::PROTEIN) ("scaffolding protein" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("AMPKα1" . SPARSER::PROTEIN)
    ("AMPKβ" . SPARSER::PROTEIN)
    ("Crk-associated substrate" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2 " . SPARSER::MOLECULE) ("GPR30" . SPARSER::PROTEIN)
    ("G protein-coupled estrogen receptor 1" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("S5B" . SPARSER::PROTEIN) ("S5" . SPARSER::MOLECULE)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("MO25 " . SPARSER::PROTEIN)
    ("S2" . SPARSER::MOLECULE) ("S1B" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("L -glutamine" . SPARSER::MOLECULE) ("G15" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("OSU-53" . SPARSER::DRUG)
    ("G-15" . SPARSER::PROTEIN) ("acetyl-CoA" . SPARSER::MOLECULE)
    ("myc-tagged" . SPARSER::PROTEIN) ("MO25" . SPARSER::PROTEIN)
    ("Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("calmodulin-dependent protein kinase" . SPARSER::PROTEIN)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMP-activated" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("IGFBP-5 and PIWIL1" . SPARSER::COLLECTION)
    ("PIWIL1 and MAEL" . SPARSER::COLLECTION) ("MAEL" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::PROTEIN) ("PIWIL2 and TGF-β" . SPARSER::COLLECTION)
    ("cell-cycle-related proteins" . SPARSER::PROTEIN)
    ("potentially useful diagnostic and prognostic biomarkers"
     . SPARSER::MOLECULE)
    ("Cyclins and CDKs" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN)
    ("PIWIL1, PIWIL3 or PIWIL4" . SPARSER::COLLECTION)
    ("Cyclins and Cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIWIL3 and PIWIL4" . SPARSER::COLLECTION)
    ("PIWIL1, PIWIL2, PIWIL3 and PIWIL4" . SPARSER::COLLECTION)
    ("piRNA" . SPARSER::RNA)
    ("both oncogenes and tumor suppressor genes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("oncogenes" . SPARSER::ONCOGENE)
    ("CDK2 and Cyclin A" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION) ("piRNAs" . SPARSER::RNA)
    ("PIWI" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IGFBP-5" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA binding protein" . SPARSER::PROTEIN) ("A–C" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("CDK1" . SPARSER::PROTEIN)
    ("reverse transcriptase " . SPARSER::PROTEIN) ("A-3" . SPARSER::PROTEIN)
    ("C-3" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("colon cancer" . SPARSER::PROTEIN) ("PIWIL4" . SPARSER::PROTEIN)
    ("PIWIL3" . SPARSER::PROTEIN) ("PIWIL1" . SPARSER::PROTEIN)
    ("PIWI-interacting RNAs" . SPARSER::RNA) ("Cyclin A" . SPARSER::PROTEIN)
    ("PIWIL2" . SPARSER::PROTEIN) ("Han" . SPARSER::PROTEIN)
    ("TERT-CLPTM1L" . SPARSER::COLLECTION) ("TERC" . SPARSER::PROTEIN)
    ("at least two plausible candidate genes" . SPARSER::GENE)
    ("TERT and CLTPM1L" . SPARSER::COLLECTION)
    ("KIT or platelet-derived growth factor receptor alpha"
     . SPARSER::COLLECTION)
    ("PDGFRalpha" . SPARSER::PROTEIN) ("KIT and PDGFRA" . SPARSER::COLLECTION)
    ("the receptor's" . SPARSER::RECEPTOR) ("KIT" . SPARSER::PROTEIN)
    ("the Kit gene or PDGFRA gene [ xref – xref ]" . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("TERT and CLPTM1L" . SPARSER::COLLECTION)
    ("TERT" . SPARSER::PROTEIN) ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bcl-xL" . SPARSER::PROTEIN)
    ("CRR9p" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("1L" . SPARSER::PROTEIN)
    ("Chr5" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("CLPTM1L" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR)
    ("repressive E2f4 complexes" . SPARSER::BIO-COMPLEX)
    ("E2f4" . SPARSER::PROTEIN) ("deacetylases" . SPARSER::PROTEIN)
    ("nucleosome" . SPARSER::PROTEIN)
    ("presumably condensed chromatin" . SPARSER::BIO-COMPLEX)
    ("Enhancers" . SPARSER::PROTEIN)
    ("previously described p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("GO" . SPARSER::PROTEIN) ("cofactors" . SPARSER::PROTEIN)
    ("IR and genotype" . SPARSER::COLLECTION)
    ("unstressed controls yielded 3552 and 1759 differentially"
     . SPARSER::PROTEIN)
    ("differentially" . SPARSER::PROTEIN)
    ("“proto-enhancers" . SPARSER::COLLECTION)
    ("accessible state" . SPARSER::BIO-STATE)
    ("RNA polymerase II (RNA polII) and the active histone"
     . SPARSER::COLLECTION)
    ("histone" . SPARSER::PROTEIN) ("protein-protein" . SPARSER::COLLECTION)
    ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("Cdkn1a and Mdm2" . SPARSER::COLLECTION) ("Cdkn1a" . SPARSER::PROTEIN)
    ("mapping" . SPARSER::PROTEIN) ("Trp" . SPARSER::AMINO-ACID)
    ("IR" . SPARSER::PROTEIN)
    ("microRNAs [ xref ] and long intergenic non-coding RNAs [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("long intergenic non-coding RNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("doxorubicin" . SPARSER::PROTEIN) ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-RRRCWWGYYY-3" . SPARSER::COLLECTION) ("pyrimidine" . SPARSER::DRUG)
    ("purine" . SPARSER::DRUG) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exonuclease" . SPARSER::PROTEIN)
    ("crucial p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("crucial p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypoxia" . SPARSER::PROTEIN) ("distal enhancers" . SPARSER::PROTEIN)
    ("active promoters" . SPARSER::PROMOTER) ("N c" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("protein A" . SPARSER::PROTEIN)
    ("6 B" . SPARSER::PROTEIN) ("NP-40" . SPARSER::DRUG)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("co-factors" . SPARSER::MOLECULE) ("K16" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("H3K4" . SPARSER::PROTEIN) ("RNA polymerase II" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("Taxol and pemetrexed" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG) ("Taxol" . SPARSER::DRUG)
    ("cisplatin" . SPARSER::DRUG) ("PI3K and MEK" . SPARSER::COLLECTION)
    ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY) ("II" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN) ("cohorts" . SPARSER::MOLECULE)
    ("loco" . SPARSER::PROTEIN) ("DR" . SPARSER::MOLECULE)
    ("Loco" . SPARSER::PROTEIN)
    ("neo-adjuvant treatment type ( P =0.04) and skip N ( P =0.002)"
     . SPARSER::COLLECTION)
    ("nodal" . SPARSER::PROTEIN)
    ("HER2 , PIK3CA and BRAF" . SPARSER::COLLECTION)
    ("Asp" . SPARSER::AMINO-ACID) ("Arg" . SPARSER::AMINO-ACID)
    ("Ala" . SPARSER::AMINO-ACID) ("Val" . SPARSER::AMINO-ACID)
    ("Cys" . SPARSER::AMINO-ACID) ("Gly" . SPARSER::AMINO-ACID)
    ("seven" . SPARSER::PROTEIN) ("CCI" . SPARSER::PROTEIN)
    ("neo" . SPARSER::PROTEIN) ("microscopic N types" . TYPE)
    ("max" . SPARSER::PROTEIN) ("IIIB" . SPARSER::DRUG)
    ("V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog ( KRAS ) oncogene"
     . SPARSER::ONCOGENE)
    ("ALK" . SPARSER::PROTEIN) ("histological subtypes" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("TNM" . SPARSER::MOLECULE)
    ("IA and IB" . SPARSER::COLLECTION) ("IB" . SPARSER::DRUG)
    ("IA" . SPARSER::MOLECULE) ("HR" . SPARSER::PROTEIN)
    ("the entire cohort" . SPARSER::MOLECULE) ("Cohort" . SPARSER::MOLECULE)
    ("TTR" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor ( EGFR ) and Kirsten rat sarcoma viral oncogene homolog ( KRAS ) ( mEGFR and mKRAS )"
     . SPARSER::COLLECTION)
    ("mEGFR and mKRAS" . SPARSER::COLLECTION) ("mEGFR" . SPARSER::PROTEIN)
    ("oncogene" . SPARSER::ONCOGENE) ("CXCL12" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN)
    ("C-X-C chemokine receptor type 4" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("Ki-ras" . SPARSER::PROTEIN)
    ("a cMet and Alk dual inhibitor" . SPARSER::INHIBITOR)
    ("a Bcr-Abl and Src dual inhibitor" . SPARSER::INHIBITOR)
    ("ICR62 and/or cetuximab" . SPARSER::COLLECTION)
    ("heregulin-EGFR-HER-3" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN)
    ("dual inhibitors of EGFR or EGFR/HER2" . SPARSER::COLLECTION)
    ("dual inhibitors" . SPARSER::INHIBITOR)
    ("EGFR/HER2" . SPARSER::COLLECTION)
    ("EGFR, HER-2 and HER-3" . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER-3" . SPARSER::COLLECTION)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, KRAS, NRAS, BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("the anti-EGFR mAb ICR62 and the EGFR TKI gefitinib"
     . SPARSER::COLLECTION)
    ("HER-2 and/or HER-3 ( xref ; xref ; xref )" . SPARSER::COLLECTION)
    ("ICR62 and cetuximab" . SPARSER::COLLECTION)
    ("MAPK and MET" . SPARSER::COLLECTION)
    ("HER-2, HER-3 and MET" . SPARSER::COLLECTION)
    ("EGFR, HER-2, HER-3, MET, Akt and MAPK" . SPARSER::COLLECTION)
    ("subsequent Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER-2, HER-3 or MET" . SPARSER::COLLECTION)
    ("EGFR and related proteins" . SPARSER::COLLECTION)
    ("neratinib, canertinib, sapitinib and afatinib" . SPARSER::COLLECTION)
    ("particular sapitinib and afatinib" . SPARSER::COLLECTION)
    ("sapitinib and afatinib" . SPARSER::COLLECTION)
    ("the Bcr-Abl inhibitor imatinib and dual Bcr-Abl and Src inhibitor dasatinib"
     . SPARSER::COLLECTION)
    ("the dual cMet and Alk inhibitor crizotinib" . SPARSER::DRUG)
    ("dual Bcr-Abl and Src inhibitor dasatinib" . SPARSER::DRUG)
    ("the reversible dual EGFR and HER-2 inhibitor lapatinib" . SPARSER::DRUG)
    ("the equipotent reversible pan-HER inhibitor sapitinib"
     . SPARSER::MOLECULE)
    ("afatinib, canertinib, and neratinib" . SPARSER::COLLECTION)
    ("Bcr-Abl and Src" . SPARSER::COLLECTION)
    ("cMet and Alk" . SPARSER::COLLECTION) ("crizotinib" . SPARSER::DRUG)
    ("cMet" . SPARSER::PROTEIN) ("dasatinib" . SPARSER::DRUG)
    ("imatinib" . SPARSER::DRUG) ("lapatinib" . SPARSER::DRUG)
    ("sapitinib" . SPARSER::MOLECULE) ("neratinib" . SPARSER::DRUG)
    ("canertinib" . SPARSER::DRUG) ("HER-2/HER-3" . SPARSER::COLLECTION)
    ("cetuximab or ICR62" . SPARSER::COLLECTION) ("STATs" . SPARSER::PROTEIN)
    ("MET and Src" . SPARSER::COLLECTION) ("JAK/STAT" . SPARSER::COLLECTION)
    ("kinases" . SPARSER::PROTEIN) ("JAK" . SPARSER::PROTEIN)
    ("HER-2, and HER-3" . SPARSER::COLLECTION)
    ("MAPK and Akt" . SPARSER::COLLECTION)
    ("EGFR and HER-2" . SPARSER::COLLECTION) ("RTKs" . SPARSER::PROTEIN)
    ("RTK" . SPARSER::PROTEIN)
    ("HER-3 and/or other alternative receptor tyrosine kinases"
     . SPARSER::COLLECTION)
    ("HER-2, HER-3 and/or other alternative receptor tyrosine kinases"
     . SPARSER::COLLECTION)
    ("other alternative receptor tyrosine kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER-2 or HER-3" . SPARSER::COLLECTION) ("pHER-3" . SPARSER::COLLECTION)
    ("EGFR and EGFR-AS1" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("alanine" . SPARSER::AMINO-ACID) ("proline" . SPARSER::AMINO-ACID)
    ("KRAS , NRAS, BRAF , PIK3CA , EGFR , ErbB2 , ErbB3, ErbB4 and TP53"
     . SPARSER::COLLECTION)
    ("ErbB2" . SPARSER::PROTEIN) ("NRAS" . SPARSER::PROTEIN)
    ("Ion" . SPARSER::MOLECULE) ("ErbB4" . SPARSER::PROTEIN)
    ("anti-EGFR mAb ICR62 or small molecule TKI gefitinib"
     . SPARSER::COLLECTION)
    ("Partial" . SPARSER::PROTEIN) ("DiF" . SPARSER::PROTEIN)
    ("Thr" . SPARSER::AMINO-ACID) ("Cbl" . SPARSER::PROTEIN)
    ("tyrosine" . SPARSER::AMINO-ACID)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("the DiFi parental and drug-resistant variants" . SPARSER::VARIANT)
    ("HER-2, HER-3 and HER-4" . SPARSER::COLLECTION)
    ("ICR62 and 113.74 " . SPARSER::COLLECTION)
    ("anti-EGFR mAb ICR62 or the reversible anti-EGFR TKI gefitinib"
     . SPARSER::COLLECTION)
    ("ICR62 and gefitinib" . SPARSER::COLLECTION)
    ("ICR62 or the EGFR TKI gefitinib" . SPARSER::COLLECTION)
    ("KRAS, BRAF and PI3K" . SPARSER::COLLECTION)
    ("ICR62 or cetuximab" . SPARSER::COLLECTION) ("BRAF" . SPARSER::PROTEIN)
    ("KRAS" . SPARSER::PROTEIN) ("mAbs or TKIs" . SPARSER::COLLECTION)
    ("TKIs" . SPARSER::PROTEIN) ("ligand or EGFR" . SPARSER::COLLECTION)
    ("Src and STAT" . SPARSER::COLLECTION) ("PLCϒ/PKC" . SPARSER::COLLECTION)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("RAS/RAF/MAPK" . SPARSER::COLLECTION)
    ("STAT" . SPARSER::PROTEIN) ("Src" . SPARSER::PROTEIN)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER-3 (erbB3) and HER-4 (erbB4)" . SPARSER::COLLECTION)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("erbB4" . SPARSER::PROTEIN) ("EGFR/erbB1" . SPARSER::COLLECTION)
    ("Neu" . SPARSER::PROTEIN) ("glycoprotein" . SPARSER::PROTEIN)
    ("afatinib" . SPARSER::DRUG) ("HER" . SPARSER::PROTEIN)
    ("mAbs" . SPARSER::DRUG) ("HER-2 and HER-3" . SPARSER::COLLECTION)
    ("gefitinib" . SPARSER::DRUG) ("TKI" . SPARSER::PROTEIN)
    ("mAb" . SPARSER::DRUG) ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("cetuximab" . SPARSER::DRUG)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p11" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN)
    ("F-box and WD repeat domain containing 7" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("TP53" . SPARSER::PROTEIN)
    ("ErbB3" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("growth factor receptor binding protein" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bis-Tris" . SPARSER::MOLECULE) ("ml −1" . SPARSER::PROTEIN)
    ("FL-1" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("PF04217903" . SPARSER::DRUG) ("ZD1839" . SPARSER::DRUG)
    ("BIBW2992" . SPARSER::DRUG) ("IgG2b" . SPARSER::BIO-COMPLEX)
    ("IgG2a" . SPARSER::PROTEIN) ("HER-4" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN) ("erbB1" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("HER-3" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("ICR62" . SPARSER::DRUG) ("anti-EGFR" . SPARSER::PROTEIN)
    ("PC-Lenti-AR" . SPARSER::COLLECTION) ("miRNA" . SPARSER::PROTEIN)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("dexamethasone" . SPARSER::PROTEIN) ("agonist" . SPARSER::AGONIST)
    ("GR" . SPARSER::PROTEIN) ("ARG" . SPARSER::PROTEIN)
    ("cyclin D1/2, CDK4/6, and CDKN1A" . SPARSER::COLLECTION)
    ("active cyclin D-CDK complexes and G 1 /S-phase transition"
     . SPARSER::COLLECTION)
    ("active cyclin D-CDK complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("DHT-treated HPr-1AR" . SPARSER::COLLECTION)
    ("p53 and CDKN1A" . SPARSER::COLLECTION)
    ("cyclin A2 and B1-3" . SPARSER::COLLECTION)
    ("fraction" . SPARSER::COMPONENT)
    ("androgen-treated HPr-1AR" . SPARSER::COLLECTION)
    ("cyclin D1/2" . SPARSER::PROTEIN)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("LNCaP (AR-positive) and PC-3 (AR-negative)" . SPARSER::COLLECTION)
    ("MDA" . SPARSER::DRUG) ("LNCaP" . SPARSER::PROTEIN)
    ("the CDK4 and CDK6 genes and transcriptional activation of the CDKN1A gene ( xref )"
     . SPARSER::COLLECTION)
    ("CDK4, and CDK6" . SPARSER::COLLECTION)
    ("cyclin D1/2-CDK4/6" . SPARSER::COLLECTION)
    ("mRNAs and CDK2 and CDKN1B" . SPARSER::COLLECTION)
    ("CDK2 and CDKN1B" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("cyclin D1 and D2 proteins" . SPARSER::COLLECTION)
    ("the mature RNA" . SPARSER::RNA)
    ("cyclin D1a and cyclin D1b" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("mature mRNAs" . SPARSER::PROTEIN)
    ("immature mRNA" . SPARSER::PROTEIN)
    ("cyclin D2, CDK4/6, and CDKN1A" . SPARSER::COLLECTION)
    ("cyclin D2, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("DRB" . SPARSER::PROTEIN)
    ("the cyclin D genes and CDK genes" . SPARSER::COLLECTION)
    ("ActD" . SPARSER::MOLECULE) ("PD0332991 and DHT" . SPARSER::COLLECTION)
    ("androgen and PD0332991" . SPARSER::COLLECTION)
    ("kinase" . SPARSER::KINASE) ("cyclin D and CDK" . SPARSER::COLLECTION)
    ("CDKN1A and CDKN1B" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("CDKs and CDK" . SPARSER::COLLECTION)
    ("cyclin D1 and D2 mRNAs" . SPARSER::COLLECTION)
    ("E2, A2, and B1-3" . SPARSER::COLLECTION)
    ("cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("cyclin and CDK" . SPARSER::COLLECTION) ("CDKs" . SPARSER::PROTEIN)
    ("DNA and flow" . SPARSER::COLLECTION) ("hydroxyflutamide" . SPARSER::DRUG)
    ("antagonist" . SPARSER::MOLECULE) ("mibolerone" . SPARSER::DRUG)
    ("phosphatidylserine, and PI" . SPARSER::COLLECTION)
    ("PI" . SPARSER::PROTEIN) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("Fluor" . SPARSER::MOLECULE) ("parental HPr-1" . SPARSER::PROTEIN)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("CDK4, CDK6, and CDKN1A" . SPARSER::COLLECTION)
    ("cyclin D2, CDK4, and CDK6" . SPARSER::COLLECTION)
    ("cyclin D-CDK" . SPARSER::COLLECTION)
    ("androgens and AR" . SPARSER::COLLECTION) ("ARGs" . SPARSER::PROTEIN)
    ("HPr-1" . SPARSER::PROTEIN) ("PC-3" . SPARSER::PROTEIN)
    ("RB-E2F" . SPARSER::COLLECTION) ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D and CDK4/6" . SPARSER::COLLECTION)
    ("cyclin D-CDK4/6" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("Complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin-dependent kinases (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDKN1B/p27" . SPARSER::COLLECTION) ("CDKN1A/p21" . SPARSER::COLLECTION)
    ("ligands" . SPARSER::LIGAND)
    ("epithelial AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prostatic" . SPARSER::PROTEIN) ("Androgen" . SPARSER::PROTEIN)
    ("cyclin D2 and CDK4/6" . SPARSER::COLLECTION)
    ("cyclin D and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HPr-1AR" . SPARSER::COLLECTION)
    ("HPr" . SPARSER::PROTEIN) ("androgen" . SPARSER::PROTEIN)
    ("androgen receptor (AR)" . SPARSER::PROTEIN) ("DHT" . SPARSER::PROTEIN)
    ("dihydrotestosterone" . SPARSER::DRUG) ("androgens" . SPARSER::DRUG)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("miR-34a" . SPARSER::MOLECULE)
    ("Cyclin D1" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("cyclin A2" . SPARSER::PROTEIN) ("Cyclin D3" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("PC-2" . SPARSER::PROTEIN) ("cyclin D1a" . SPARSER::PROTEIN)
    ("cyclin D1b" . SPARSER::PROTEIN) ("E1" . SPARSER::MOLECULE)
    ("Pre-mRNA" . SPARSER::RNA) ("pre-mRNA" . SPARSER::RNA)
    ("precursor mRNA" . SPARSER::RNA) ("kinase activity" . SPARSER::PROTEIN)
    ("PD0332991" . SPARSER::DRUG) ("T160" . SPARSER::PROTEIN)
    ("CDK 4" . SPARSER::PROTEIN) ("cyclin E2" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("B1-3" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E2" . SPARSER::MOLECULE)
    ("cyclin A1" . SPARSER::PROTEIN) ("CCNA1" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("CCNE2" . SPARSER::PROTEIN)
    ("RB protein" . SPARSER::PROTEIN) ("ADAM15" . SPARSER::PROTEIN)
    ("NUP88" . SPARSER::PROTEIN) ("PYGO2" . SPARSER::PROTEIN)
    ("RPL19" . SPARSER::PROTEIN) ("pre-mRNAs" . SPARSER::RNA)
    ("annexin V" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("POL proteins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("–3" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE) ("CDK6" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN) ("p-RB" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin D" . SPARSER::PROTEIN) ("G 2 /M" . SPARSER::PROTEIN)
    ("CDKN1A" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D" . SPARSER::PROTEIN) ("androgen receptor" . SPARSER::PROTEIN)
    ("the potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("siRNA and Lipofectamine" . SPARSER::COLLECTION)
    ("Nonspecific siRNA" . SPARSER::PROTEIN) ("antisense" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE) ("trypsinized" . SPARSER::PROTEIN)
    ("His" . SPARSER::AMINO-ACID) ("Group" . SPARSER::MOLECULE)
    ("solution" . SPARSER::MOLECULE) ("formaldehyde" . SPARSER::MOLECULE)
    ("FBS" . SPARSER::PROTEIN) ("Sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("reagent" . SPARSER::MOLECULE)
    ("HRP-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("HRP" . SPARSER::PROTEIN) ("Tris" . SPARSER::MOLECULE)
    ("antibodies" . SPARSER::ANTIBODY)
    ("5% bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("BSA" . SPARSER::PROTEIN) ("PBS" . SPARSER::PROTEIN)
    ("PVDF" . SPARSER::DRUG) ("polyacrylamide" . SPARSER::DRUG)
    ("sulfate" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("t" . SPARSER::PROTEIN)
    ("Eca109/pCMV-SOX2 and Eca109pCMV" . SPARSER::COLLECTION)
    ("Eca109/pCMV-SOX2" . SPARSER::PROTEIN-PAIR) ("pCMV" . SPARSER::PROTEIN)
    ("streptomycin" . SPARSER::DRUG) ("QC" . SPARSER::PROTEIN)
    ("media" . SPARSER::PROTEIN) ("RPMI" . SPARSER::PROTEIN)
    ("Bank" . SPARSER::PROTEIN) ("MET" . SPARSER::PROTEIN)
    ("their respective siRNAs" . SPARSER::PROTEIN)
    ("STAT3 or HIF-1α" . SPARSER::COLLECTION)
    ("STAT3 and HIF-1α" . SPARSER::COLLECTION)
    ("Eca-109/pCMV" . SPARSER::PROTEIN)
    ("the mesenchymal markers N-cadherin, fibronectin, vimentin and α-SMA"
     . SPARSER::COLLECTION)
    ("N-cadherin, fibronectin, vimentin and α-SMA" . SPARSER::COLLECTION)
    ("N-cadherin, vimentin, fibronectin and α-SMA" . SPARSER::COLLECTION)
    ("fibronectin" . SPARSER::PROTEIN) ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN) ("Eca-109/pCMV-SOX2" . SPARSER::COLLECTION)
    ("Matrigel" . SPARSER::PROTEIN) ("pCMV-SOX2" . SPARSER::PROTEIN-PAIR)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("Eca-1" . SPARSER::COLLECTION)
    ("STAT3/HIF-1α" . SPARSER::COLLECTION) ("Slug" . SPARSER::PROTEIN)
    ("EMT" . SPARSER::PROTEIN) ("SRY" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("serum albumin" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE) ("SOX-2" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("STAT3" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("carbohydrate" . SPARSER::MOLECULE) ("TX" . SPARSER::PROTEIN)
    ("Dr" . SPARSER::MOLECULE) ("dNTPs" . SPARSER::MOLECULE)
    ("using iPLEX reagents and protocols" . SPARSER::COLLECTION)
    ("San" . SPARSER::PROTEIN) ("reagents" . SPARSER::MOLECULE)
    ("delta" . SPARSER::PROTEIN) ("–1" . SPARSER::PROTEIN)
    ("mixture" . SPARSER::MOLECULE) ("-nuclease" . SPARSER::COLLECTION)
    ("nuclease" . SPARSER::PROTEIN) ("leukocytes" . SPARSER::PROTEIN)
    ("triglycerides, HDL-c and LDL-c" . SPARSER::COLLECTION)
    ("AC1-PC" . SPARSER::COLLECTION) ("PC" . SPARSER::PROTEIN)
    ("the southwestern part" . SPARSER::COMPONENT)
    ("phenotypic traits" . SPARSER::PROTEIN) ("HDLc" . SPARSER::MOLECULE)
    ("CETP and HDL-c" . SPARSER::COLLECTION)
    ("glucose and triglycerides" . SPARSER::COLLECTION)
    ("metabolic traits" . SPARSER::PROTEIN) ("molecules" . SPARSER::MOLECULE)
    ("its mature form" . SPARSER::FORM) ("Apo" . SPARSER::PROTEIN)
    ("apolipoprotein" . SPARSER::MOLECULE)
    ("male and female ESR1 knockout mice" . SPARSER::COLLECTION)
    ("male" . SPARSER::MOLECULE) ("families" . SPARSER::PROTEIN-FAMILY)
    ("HDL-c, LDL-c, and triglycerides" . SPARSER::COLLECTION)
    ("ESR1 and ESR2" . SPARSER::COLLECTION) ("microRNAs" . SPARSER::RNA)
    ("the exonic splicing enhancers sc35 and sf2" . SPARSER::COLLECTION)
    ("sc35 and sf2" . SPARSER::COLLECTION) ("sf2" . SPARSER::PROTEIN)
    ("sc35" . SPARSER::PROTEIN) ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("serine" . SPARSER::AMINO-ACID) ("arginine" . SPARSER::AMINO-ACID)
    ("enhancers" . SPARSER::PROTEIN) ("Pro" . SPARSER::AMINO-ACID)
    ("coactivators or co-repressors" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR) ("coactivators" . SPARSER::PROTEIN)
    ("exon" . SPARSER::PROTEIN) ("forms" . SPARSER::FORM)
    ("LEPR" . SPARSER::PROTEIN) ("variant" . SPARSER::VARIANT)
    ("Form" . SPARSER::FORM) ("LEP" . SPARSER::PROTEIN)
    ("leptin" . SPARSER::PROTEIN) ("estrogen" . SPARSER::MOLECULE)
    ("triol" . SPARSER::MOLECULE) ("ligand" . SPARSER::LIGAND)
    ("skeletal muscle" . SPARSER::PROTEIN) ("fat" . SPARSER::PROTEIN)
    ("effector" . SPARSER::EFFECTOR) ("Estrogen" . SPARSER::MOLECULE)
    ("lipoprotein" . SPARSER::PROTEIN)
    ("potential candidate genes" . SPARSER::GENE) ("freq" . SPARSER::PROTEIN)
    ("GC or GG" . SPARSER::COLLECTION) ("GC" . SPARSER::PROTEIN)
    ("allele (MAF)" . SPARSER::ALLELE) ("allele" . SPARSER::ALLELE)
    ("AIMs" . SPARSER::PROTEIN) ("LPL and CETP" . SPARSER::COLLECTION)
    ("TG and HDL-c" . SPARSER::COLLECTION)
    ("the lipoprotein lipase ( LPL ) and cholesteryl ester transfer protein ( CETP ) genes"
     . SPARSER::COLLECTION)
    ("low density lipoprotein (LDL) as well as VLDL [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("lipoprotein lipase ( LPL )" . SPARSER::PROTEIN)
    ("LDL" . SPARSER::PROTEIN) ("HDL" . SPARSER::PROTEIN)
    ("esters" . SPARSER::MOLECULE) ("cholesteryl" . SPARSER::PROTEIN)
    ("MetS or its components" . SPARSER::COLLECTION)
    ("ESR1 or ESR2" . SPARSER::COLLECTION) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("hormone" . SPARSER::MOLECULE) ("dL" . SPARSER::MOLECULE)
    ("high triglycerides (TG) and hyperglycemia [ xref ]"
     . SPARSER::COLLECTION)
    ("triglycerides (TG)" . SPARSER::MOLECULE)
    ("hyperglycemia" . SPARSER::PROTEIN) ("TG" . SPARSER::PROTEIN)
    ("triglycerides" . SPARSER::MOLECULE) ("ATP" . SPARSER::ATP)
    ("traits" . SPARSER::PROTEIN) ("CG or GG" . SPARSER::COLLECTION)
    ("AA" . SPARSER::MOLECULE)
    ("MetS and its components" . SPARSER::COLLECTION)
    ("variants" . SPARSER::VARIANT)
    ("ESR1 , LPL and CETP" . SPARSER::COLLECTION) ("CETP" . SPARSER::PROTEIN)
    ("LPL" . SPARSER::PROTEIN) ("MetS" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AC1" . SPARSER::PROTEIN)
    ("1B" . SPARSER::PROTEIN) ("B2B" . SPARSER::PROTEIN)
    ("1B1" . SPARSER::PROTEIN) ("small nucleolar RNA" . SPARSER::RNA)
    ("S10" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("LDL-c" . SPARSER::PROTEIN) ("low density lipoprotein" . SPARSER::PROTEIN)
    ("cholesteryl ester transfer protein" . SPARSER::PROTEIN)
    ("lipoprotein lipase" . SPARSER::PROTEIN) ("ESR2" . SPARSER::PROTEIN)
    ("HDL-c" . SPARSER::PROTEIN)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("type 2" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("RASSF1A , HIN-1 , MGMT , DAPK1 and GSTP1" . SPARSER::COLLECTION)
    ("HIN-1 and MGMT" . SPARSER::COLLECTION)
    ("PR and ER" . SPARSER::COLLECTION) ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER" . SPARSER::PROTEIN)
    ("RASSF1A [ xref , xref ] and HIN-1 [ xref ]" . SPARSER::COLLECTION)
    ("DAPK1 ( p  = 0.012 ) , HIN-1 ( p  = 0.005) and RASSF1A ( p  < 0.001)"
     . SPARSER::COLLECTION)
    ("MGMT , DAPK1 and GSTP1" . SPARSER::COLLECTION)
    ("RASSF1A and/or HIN-1" . SPARSER::COLLECTION)
    ("even both promoters" . SPARSER::PROMOTER) ("guanine" . SPARSER::PROTEIN)
    ("alleles" . SPARSER::ALLELE)
    ("Guanine–cytosine-rich sequences (resulting from methylated CpG dinucleotides) melt"
     . SPARSER::DRUG)
    ("thymine" . SPARSER::MOLECULE) ("adenine" . SPARSER::NUCLEOBASE)
    ("Guanine" . SPARSER::PROTEIN)
    ("finally high-resolution melting" . SPARSER::DRUG)
    ("the bisulfite-treated DNA" . SPARSER::DNA)
    ("thymines" . SPARSER::MOLECULE) ("cytosines" . SPARSER::NUCLEOBASE)
    ("DAPK1 and MGMT" . SPARSER::COLLECTION)
    ("HIN-1 , RASSF1A and MGMT" . SPARSER::COLLECTION)
    ("RASSF1A , DAPK1 and CCND2" . SPARSER::COLLECTION)
    ("HIN-1 ( p  = 0.005) and RASSF1A ( p  < 0.001)" . SPARSER::COLLECTION)
    ("CCND2 and DAPK1" . SPARSER::COLLECTION)
    ("HIN-1 and RASSF1A" . SPARSER::COLLECTION)
    ("RASSF1A , MGMT or DAPK1" . SPARSER::COLLECTION)
    ("promoters " . SPARSER::PROMOTER)
    ("HIN-1 , MGMT and GSTP1" . SPARSER::COLLECTION)
    ("RASSF1A , HIN-1 , MGMT , DAPK1 and CCND2" . SPARSER::COLLECTION)
    ("RASSF1A and HIN-1" . SPARSER::COLLECTION)
    ("RASSF1A , HIN-1 , MGMT , DAPK1 , and GSTP1" . SPARSER::COLLECTION)
    ("CCND2 and MGMT" . SPARSER::COLLECTION)
    ("CCND2 , GSTP1 and MGMT" . SPARSER::COLLECTION)
    ("DAPK1 , HIN-1 and RASSF1A" . SPARSER::COLLECTION)
    ("MGMT and/or DAPK1" . SPARSER::COLLECTION)
    ("MGMT and DAPK1" . SPARSER::COLLECTION)
    ("CCND2 , GSTP1 , HIN-1 and RASSF1A" . SPARSER::COLLECTION)
    ("derivative" . SPARSER::DERIVATIVE) ("melt" . SPARSER::DRUG)
    ("Melting" . SPARSER::DRUG) ("mixtures" . SPARSER::MOLECULE)
    ("bisulfite" . SPARSER::MOLECULE)
    ("O6-methylguanine-DNA methyltransferase ( MGMT ) and RASSF1A [ xref ]"
     . SPARSER::COLLECTION)
    ("HIN-1 , O6-methylguanine-DNA methyltransferase ( MGMT ) and RASSF1A [ xref ]"
     . SPARSER::COLLECTION)
    ("protein ( RIL )" . SPARSER::PROTEIN)
    ("RASSF1A and cadherin-13" . SPARSER::COLLECTION)
    ("RIL" . SPARSER::PROTEIN) ("-1" . SPARSER::PROTEIN)
    ("Yan" . SPARSER::PROTEIN) ("toxic catabolism" . SPARSER::PROTEIN)
    ("catabolism" . SPARSER::PROTEIN) ("Promoter" . SPARSER::PROMOTER)
    ("CpG" . SPARSER::PROTEIN) ("guanosine" . SPARSER::MOLECULE)
    ("phosphatidyl" . SPARSER::MOLECULE) ("cytosine" . SPARSER::NUCLEOBASE)
    ("biomarker" . SPARSER::MOLECULE)
    ("RASSF1A , HIN-1 and MGMT" . SPARSER::COLLECTION)
    ("LOQs" . SPARSER::PROTEIN)
    ("CCND2 , MGMT and RASSF1A" . SPARSER::COLLECTION)
    ("DAPK1 , GSTP1 and HIN-1" . SPARSER::COLLECTION)
    ("CCND2 , DAPK1 , GSTP1 , HIN-1 , MGMT and RASSF1A" . SPARSER::COLLECTION)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("melting" . SPARSER::DRUG)
    ("MGMT" . SPARSER::PROTEIN) ("biomarkers" . SPARSER::MOLECULE)
    ("CCND2  " . SPARSER::PROTEIN) ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("per 2 " . SPARSER::PROTEIN) ("MgCl 2" . SPARSER::MOLECULE)
    ("HER2" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("O6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("death-associated protein kinase 1" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("CDH13" . SPARSER::PROTEIN)
    ("cadherin-13" . SPARSER::PROTEIN)
    ("Ras association domain family member 1" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN) ("HIN-1" . SPARSER::PROTEIN)
    ("GSTP1" . SPARSER::PROTEIN) ("DAPK1" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN) ("adjuvant" . SPARSER::DRUG)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE) ("oxygen" . SPARSER::MOLECULE)
    ("smoke" . SPARSER::MOLECULE) ("cigarette" . SPARSER::DRUG)
    ("RR " . SPARSER::MOLECULE) ("glucosinolates" . SPARSER::MOLECULE)
    ("inducers" . SPARSER::MOLECULE)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("pro-inflammatory cytokines, chemokines, as well as other cell mediators"
     . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("enzyme" . SPARSER::ENZYME) ("Nrf2–antioxidant" . SPARSER::COLLECTION)
    ("GATA-3 and SOCS-3" . SPARSER::COLLECTION)
    ("T-bet and SOCS-5" . SPARSER::COLLECTION) ("ovalbumin" . SPARSER::PROTEIN)
    ("pro-" . SPARSER::AMINO-ACID) ("pro" . SPARSER::AMINO-ACID)
    ("redox" . SPARSER::PROTEIN) ("examples" . SPARSER::EXAMPLE)
    ("both aflatoxin and air pollutant metabolites [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("aflatoxin" . SPARSER::MOLECULE) ("cohort" . SPARSER::MOLECULE)
    ("run" . SPARSER::PROTEIN-FAMILY) ("transaminase" . SPARSER::PROTEIN)
    ("GCLM, GST1, and NQO1" . SPARSER::COLLECTION)
    ("GCLM (p = 0.03) and NQO1 (p = 0.047)" . SPARSER::COLLECTION)
    ("GCLM" . SPARSER::PROTEIN) ("Gene" . SPARSER::GENE)
    ("food" . SPARSER::MOLECULE) ("glucoraphanin" . SPARSER::DRUG)
    ("glucosinolate" . SPARSER::MOLECULE) ("allergen" . SPARSER::MOLECULE)
    ("a reasonable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("phase 2 cytoprotective enzymes" . SPARSER::ENZYME)
    ("an indirect antioxidant" . SPARSER::PROTEIN)
    ("antioxidants" . SPARSER::DRUG)
    ("macrophage migration inhibitory factor (MIF)" . SPARSER::PROTEIN)
    ("MAPK" . SPARSER::PROTEIN) ("MIF" . SPARSER::PROTEIN)
    ("light" . SPARSER::PROTEIN) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("cytoprotective enzymes" . SPARSER::ENZYME)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT) ("lipid" . SPARSER::LIPID)
    ("cytoprotective (antioxidant and anti-inflammatory) enzymes"
     . SPARSER::ENZYME)
    ("variety" . SPARSER::VARIETY) ("inducer" . SPARSER::PROTEIN)
    ("molecule" . SPARSER::MOLECULE) ("GSH" . SPARSER::DRUG)
    ("glutathione" . SPARSER::DRUG) ("enzymes" . SPARSER::ENZYME)
    ("erythroid" . SPARSER::PROTEIN) ("Antioxidant" . SPARSER::PROTEIN)
    ("phytochemicals" . SPARSER::DRUG) ("luminal" . SPARSER::DRUG)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("FEV" . SPARSER::PROTEIN) ("sulforaphane" . SPARSER::PROTEIN)
    ("a dietary antioxidant and antiinflammatory phytochemical"
     . SPARSER::COLLECTION)
    ("antiinflammatory phytochemical" . SPARSER::DRUG)
    ("a dietary antioxidant" . SPARSER::PROTEIN)
    ("phytochemical" . SPARSER::DRUG) ("antioxidant" . SPARSER::PROTEIN)
    ("Sulforaphane" . SPARSER::PROTEIN) ("BP" . SPARSER::PROTEIN)
    ("methacholine" . SPARSER::DRUG) ("SOCS-5" . SPARSER::PROTEIN)
    ("T-bet" . SPARSER::PROTEIN) ("SOCS-3" . SPARSER::PROTEIN)
    ("GATA-3" . SPARSER::PROTEIN) ("anti-oxidant" . SPARSER::DRUG)
    ("HO1" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("GST1" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("1 L" . SPARSER::PROTEIN)
    ("carbon monoxide" . SPARSER::MOLECULE) ("a 20 " . SPARSER::PROTEIN)
    ("vitamin C" . SPARSER::MOLECULE) ("β-catenin" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macrophage migration inhibitory factor" . SPARSER::PROTEIN)
    ("NfκB" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("Th2" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("TRAIP or its substrates" . SPARSER::COLLECTION)
    ("substrates" . SPARSER::SUBSTRATE) ("microRNA" . SPARSER::RNA)
    ("mRNAs" . SPARSER::PROTEIN) ("TRAIP and CYLD" . SPARSER::COLLECTION)
    ("cyclins and E2F" . SPARSER::COLLECTION)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("suppressor" . SPARSER::SUPPRESSOR) ("E2F1 and RB1" . SPARSER::COLLECTION)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("TM" . SPARSER::PROTEIN)
    ("tamoxifen" . SPARSER::MOLECULE)
    ("RB1, p107 and p130" . SPARSER::COLLECTION)
    ("E2F/pRB1" . SPARSER::COLLECTION) ("viral proteins" . SPARSER::PROTEIN)
    ("types" . TYPE) ("Sin3b" . SPARSER::PROTEIN) ("Sin3a" . SPARSER::PROTEIN)
    ("E2F4/p130" . SPARSER::COLLECTION) ("myogenic" . SPARSER::PROTEIN)
    ("complexes" . SPARSER::BIO-COMPLEX) ("PKC" . SPARSER::PROTEIN)
    ("activator and repressor" . SPARSER::COLLECTION)
    ("activator" . SPARSER::ACTIVATOR) ("Luciferase" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::RNA)
    ("internal and external cues" . SPARSER::PROTEIN-FAMILY)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("SD" . SPARSER::PROTEIN)
    ("A representative example" . SPARSER::EXAMPLE)
    ("example" . SPARSER::EXAMPLE) ("GFP or actin" . SPARSER::COLLECTION)
    ("TRAIP-FLAG" . SPARSER::COLLECTION) ("cycloheximide" . SPARSER::PROTEIN)
    ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("anti-GFP-antibody" . SPARSER::COLLECTION)
    ("antibody" . SPARSER::ANTIBODY) ("hygromycin" . SPARSER::MOLECULE)
    ("gene and protein" . SPARSER::COLLECTION) ("actin" . SPARSER::PROTEIN)
    ("blot" . SPARSER::PROTEIN)
    ("E2F1, CCNE1, and CCNB1" . SPARSER::COLLECTION)
    ("RPL13A, RPL3 and B2M" . SPARSER::COLLECTION)
    ("RPL13A, GAPDH, RPL3 and B2M" . SPARSER::COLLECTION)
    ("GAPDH" . SPARSER::PROTEIN) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE) ("nocodazole" . SPARSER::DRUG)
    ("thymidine" . SPARSER::PROTEIN) ("Mut" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("-TTTATCTC-3" . SPARSER::COLLECTION) ("-TTTGGCTC-3" . SPARSER::COLLECTION)
    ("the proximal 168 bp fragment" . SPARSER::FRAGMENT)
    ("part" . SPARSER::COMPONENT) ("luciferase" . SPARSER::PROTEIN)
    ("E2F1, E2F2, or E2F4" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("E2F1 and pRB1" . SPARSER::COLLECTION)
    ("TRAIP and cyclin E1" . SPARSER::COLLECTION)
    ("target" . SPARSER::TARGET-PROTEIN) ("targets" . SPARSER::TARGET-PROTEIN)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-Kinase (LY294002) or mTOR (rapamycin)" . SPARSER::COLLECTION)
    ("rapamycin" . SPARSER::DRUG) ("E2F1, E2F2 and E2F4" . SPARSER::COLLECTION)
    ("E2F1-E2F6" . SPARSER::COLLECTION) ("DP" . SPARSER::PROTEIN)
    ("the retinoblastoma protein (pRb) or the related pocket proteins p107 and p130 [ xref ]"
     . SPARSER::COLLECTION)
    ("p107 and p130" . SPARSER::COLLECTION) ("E2F1-E2F5" . SPARSER::COLLECTION)
    ("pRb" . SPARSER::PROTEIN)
    ("repressor (E2F3b-E2F5) and inhibitors (E2F6-E2F8)" . SPARSER::COLLECTION)
    ("E2F6-E2F8" . SPARSER::COLLECTION) ("E2F3b-E2F5" . SPARSER::COLLECTION)
    ("E2F1-E2F8" . SPARSER::COLLECTION) ("repressor" . SPARSER::REPRESSOR)
    ("activators" . SPARSER::ACTIVATOR) ("family" . SPARSER::PROTEIN-FAMILY)
    ("promoters" . SPARSER::PROMOTER) ("genes" . SPARSER::GENE)
    ("shRNA" . SPARSER::PROTEIN) ("PI3K or mTOR" . SPARSER::COLLECTION)
    ("ester" . SPARSER::MOLECULE) ("phorbol" . SPARSER::DRUG)
    ("calcium" . SPARSER::CALCIUM) ("keratinocytes" . SPARSER::PROTEIN)
    ("CYLD [ xref ] and Syk [ xref ]" . SPARSER::COLLECTION)
    ("CYLD and Syk" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR) ("Syk" . SPARSER::PROTEIN)
    ("CYLD" . SPARSER::PROTEIN) ("SAC" . SPARSER::PROTEIN)
    ("NOPO/TRAIP" . SPARSER::COLLECTION) ("NOPO" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT)
    ("a lysine instead of a glutamic acid" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN) ("lysine" . SPARSER::AMINO-ACID)
    ("Drosophila maternal effect-lethal mutants" . SPARSER::MUTANT)
    ("CG" . SPARSER::PROTEIN) ("mutants" . SPARSER::MUTANT)
    ("Drosophila" . SPARSER::PROTEIN) ("regulators" . SPARSER::REGULATOR)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("tumor necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("TRAFs" . SPARSER::PROTEIN) ("class" . CLASS)
    ("leucine" . SPARSER::AMINO-ACID) ("kDa" . SPARSER::PROTEIN)
    ("TRIP" . SPARSER::PROTEIN) ("Cycloheximide" . SPARSER::PROTEIN)
    ("TRAIP-GFP" . SPARSER::COLLECTION) ("state" . SPARSER::BIO-STATE)
    ("GFP" . SPARSER::PROTEIN) ("complex" . SPARSER::BIO-COMPLEX)
    ("fragment" . SPARSER::FRAGMENT) ("E2F2-" . SPARSER::PROTEIN)
    ("E2F1-" . SPARSER::PROTEIN) ("promoter" . SPARSER::PROMOTER)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("mTOR" . SPARSER::PROTEIN)
    ("TRAF-interacting protein (TRAIP)" . SPARSER::PROTEIN)
    ("TRAIP" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("K14" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("Sin3" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("CCNB1" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("RPL3" . SPARSER::PROTEIN)
    ("RPL13A" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("transcription factor" . SPARSER::PROTEIN) ("A-D" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("A-F" . SPARSER::PROTEIN)
    ("pRB1" . SPARSER::PROTEIN) ("CCNE1" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p130" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("E2F6" . SPARSER::PROTEIN) ("E2F5" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("E2F8" . SPARSER::PROTEIN)
    ("MAD2" . SPARSER::PROTEIN) ("DNA polymerase" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID)
    ("glutamic acid" . SPARSER::AMINO-ACID)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("amino acids" . SPARSER::AMINO-ACID) ("RNF206" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("TRAF-interacting protein" . SPARSER::PROTEIN)
    ("lipids, proteins, and DNA" . SPARSER::COLLECTION)
    ("proteins" . SPARSER::PROTEIN) ("lipids" . SPARSER::PROTEIN)
    ("cyclin E and cdk2" . SPARSER::COLLECTION)
    ("metabolites" . SPARSER::MOLECULE)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("caspase" . SPARSER::PROTEIN)
    ("MTT" . SPARSER::MOLECULE)
    ("traditional Chinese medicine" . SPARSER::DRUG)
    ("ginsenoside" . SPARSER::MOLECULE) ("curcumin" . SPARSER::DRUG)
    ("PCNA" . SPARSER::PROTEIN) ("fragments" . SPARSER::FRAGMENT)
    ("Hematoxylin" . SPARSER::MOLECULE) ("pifithrin" . SPARSER::DRUG)
    ("NAC" . SPARSER::PROTEIN) ("DCF" . SPARSER::PROTEIN)
    ("cyclin E and phospho-cdk2" . SPARSER::COLLECTION)
    ("phospho-p53, phospho-cdk2 and cyclin E" . SPARSER::COLLECTION)
    ("chromatin" . SPARSER::PROTEIN)
    ("caspase 3, caspase 9 and PARP" . SPARSER::COLLECTION)
    ("group" . SPARSER::MOLECULE) ("weaker" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN) ("medicine" . SPARSER::DRUG)
    ("glycosides" . SPARSER::MOLECULE) ("triterpene" . SPARSER::MOLECULE)
    ("type" . TYPE)
    ("oxaliplatin, resveratrol and irinotecan" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("resveratrol" . SPARSER::PROTEIN)
    ("oxaliplatin" . SPARSER::DRUG) ("drugs" . SPARSER::DRUG)
    ("component" . SPARSER::COMPONENT)
    ("thymidylate synthetase (TS)" . SPARSER::PROTEIN)
    ("DNA or RNA" . SPARSER::COLLECTION) ("TS" . SPARSER::PROTEIN)
    ("RNA" . SPARSER::RNA) ("DNA" . SPARSER::DNA)
    ("cytotoxic" . SPARSER::PROTEIN) ("fluorodeoxyuridine" . SPARSER::DRUG)
    ("the most widely used chemotherapeutic drug" . SPARSER::DRUG)
    ("uracil" . SPARSER::DRUG) ("analog" . SPARSER::ANALOG)
    ("ROS and p53" . SPARSER::COLLECTION) ("Ser" . SPARSER::AMINO-ACID)
    ("cytometry" . SPARSER::PROTEIN) ("ROS" . SPARSER::PROTEIN)
    ("caspase 9 and poly (ADP-ribose) polymerase (PARP)" . SPARSER::COLLECTION)
    ("caspase 3, caspase 9 and poly (ADP-ribose) polymerase (PARP)"
     . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("PARP" . SPARSER::PROTEIN)
    ("polymerase" . SPARSER::PROTEIN) ("AAD" . SPARSER::MOLECULE)
    ("components" . SPARSER::COMPONENT) ("CRC" . SPARSER::PROTEIN)
    ("drug" . SPARSER::DRUG) ("Fluorouracil" . SPARSER::DRUG)
    ("Anti-" . SPARSER::ANTIBODY) ("H2A" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("Triton X-100" . SPARSER::MOLECULE) ("Group V" . SPARSER::PROTEIN)
    ("Group III" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN) ("Caspase 9" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN) ("cdk2" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("L-15" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("N-acetylcysteine" . SPARSER::DRUG)
    ("RNase A" . SPARSER::PROTEIN) ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("caspase-3" . SPARSER::PROTEIN)
    ("thymidylate synthetase" . SPARSER::PROTEIN) ("CT-26" . SPARSER::PROTEIN)
    ("Histone H2A.X" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ADP-ribose" . SPARSER::MOLECULE)
    ("caspase 9" . SPARSER::PROTEIN) ("caspase 3" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("-2" . SPARSER::PROTEIN)
    ("monocytes or macrophages" . SPARSER::COLLECTION)
    ("an autocrine trigger" . SPARSER::PROTEIN) ("trigger" . SPARSER::PROTEIN)
    ("regulator" . SPARSER::REGULATOR) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("gene" . SPARSER::GENE) ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("p38 and ERK" . SPARSER::COLLECTION)
    ("TNF-α and IL-10" . SPARSER::COLLECTION)
    ("the principal receptor" . SPARSER::RECEPTOR)
    ("macrophage" . SPARSER::PROTEIN) ("the key cytokine" . SPARSER::PROTEIN)
    ("cytokine" . SPARSER::PROTEIN)
    ("TNF-α and MMP-1/-9" . SPARSER::COLLECTION)
    ("MMP-1 and -9" . SPARSER::COLLECTION)
    ("elaborate TNF-α" . SPARSER::PROTEIN) ("receptor" . SPARSER::RECEPTOR)
    ("siRNAs" . SPARSER::PROTEIN) ("TLR2 or TLR4" . SPARSER::COLLECTION)
    ("siRNA" . SPARSER::PROTEIN) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("receptors" . SPARSER::RECEPTOR)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("inhibitor" . SPARSER::INHIBITOR) ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("their specific pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("inhibitors" . SPARSER::INHIBITOR)
    ("MAPKs" . SPARSER::PROTEIN) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MeT" . SPARSER::AMINO-ACID) ("Met" . SPARSER::AMINO-ACID)
    ("mediators" . SPARSER::PROTEIN) ("pg" . SPARSER::MOLECULE)
    ("lactate dehydrogenase (LDH) and ADA" . SPARSER::COLLECTION)
    ("dehydrogenase (LDH)" . SPARSER::PROTEIN) ("ADA" . SPARSER::PROTEIN)
    ("LDH" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("lactate" . SPARSER::LACTATE) ("glucose" . SPARSER::PROTEIN)
    ("monocytes" . SPARSER::PROTEIN)
    ("cytokines, chemokines, ECM and proteases" . SPARSER::COLLECTION)
    ("proteases" . SPARSER::PROTEIN) ("chemokines" . SPARSER::PROTEIN)
    ("cytokines" . SPARSER::PROTEIN) ("active" . SPARSER::ACTIVE)
    ("ECM" . SPARSER::PROTEIN) ("TNF-α and MMP-9" . SPARSER::COLLECTION)
    ("form" . SPARSER::FORM) ("astrocytes" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("TNF-α and MMP" . SPARSER::COLLECTION)
    ("MMP" . SPARSER::PROTEIN) ("TLR2/ERK" . SPARSER::COLLECTION)
    ("TLR2 and TLR4" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION) ("protein" . SPARSER::PROTEIN)
    ("mRNA" . SPARSER::PROTEIN) ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLR2" . SPARSER::PROTEIN) ("MMP-1 and MMP-9" . SPARSER::COLLECTION)
    ("TNF-α, MMP-1 and MMP-9" . SPARSER::COLLECTION)
    ("TNF-α and MMP-1" . SPARSER::COLLECTION)
    ("TNF-α and MMPs" . SPARSER::COLLECTION) ("MTB" . SPARSER::PROTEIN)
    ("TBP" . SPARSER::PROTEIN) ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("TNF" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NF-κB" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN) ("CO 2" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE) ("PD98059" . SPARSER::MOLECULE)
    ("SP600125" . SPARSER::PROTEIN) ("SB203580" . SPARSER::DRUG)
    ("anti-" . SPARSER::ANTIBODY) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN) (NIL . SPARSER::GROWTH-FACTOR)
    ("MMP-9" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("H37" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)))